data_2m10_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m10 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.983 0 N-CA-C 108.487 -1.845 . . . . 72.23 108.487 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -89.86 143.44 26.79 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.273 -1.751 . . . . 62.34 106.273 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' A' ' 60' ' ' LEU . 19.1 mm -95.95 129.51 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 105.524 -2.028 . . . . 73.1 105.524 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CD2' HD22 ' A' ' 90' ' ' LEU . 2.2 p90 -137.07 152.41 50.03 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.81 -1.181 . . . . 73.35 107.81 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -106.53 146.34 30.74 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.044 -1.836 . . . . 74.4 106.044 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.1 m -142.26 152.66 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 105.958 -1.867 . . . . 73.31 105.958 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.85 132.04 56.04 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.381 -1.711 . . . . 74.15 106.381 172.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.03 139.13 49.9 Favored 'General case' 0 CA--C 1.457 -2.626 0 N-CA-C 106.833 -1.543 . . . . 70.24 106.833 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.49 131.36 38.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.927 -1.879 . . . . 73.01 105.927 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -67.28 -23.91 65.72 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.637 -0.875 . . . . 75.53 108.637 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 70.71 104.86 0.06 Allowed 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.171 0.988 . . . . 60.4 110.394 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 56.85 43.47 24.87 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-N 115.448 -0.796 . . . . 72.44 109.203 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 42.64 9.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.708 2.003 . . . . 73.23 116.031 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.1 m -126.88 129.78 48.89 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 106.437 -1.69 . . . . 75.22 106.437 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.3 167.34 12.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.836 -2.283 . . . . 74.41 104.836 168.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.56 68.62 0.27 Allowed Glycine 0 CA--C 1.47 -2.746 0 N-CA-C 104.507 -3.437 . . . . 72.22 104.507 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.4 mt -101.15 176.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.458 -2.793 . . . . 73.32 103.458 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.552 ' H ' HG22 ' A' ' 21' ' ' ILE . 70.9 m -138.28 165.07 27.65 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 106.402 -1.703 . . . . 73.13 106.402 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 m -152.33 177.15 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.085 -1.82 . . . . 64.4 106.085 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 10.0 t -160.95 166.21 28.71 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 104.0 -2.593 . . . . 62.32 104.0 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.97 -151.74 29.12 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.927 -1.669 . . . . 50.5 108.927 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 116.62 -70.64 0.28 Allowed Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.692 -1.363 . . . . 51.31 109.692 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 29' ' ' THR . 1.4 t -72.32 16.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.097 0.475 . . . . 64.22 111.252 -172.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 26' ' ' GLY . 35.7 t30 78.41 5.14 2.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.597 1.159 . . . . 73.41 108.743 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 27' ' ' VAL . 6.3 t -49.77 -171.36 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 C-N-CA 125.337 1.455 . . . . 75.42 112.037 169.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.4 p -38.56 -38.22 0.37 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.63 1.972 . . . . 73.41 115.164 -164.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.7 m -59.71 140.77 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.544 0.688 . . . . 74.1 110.215 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -41.62 -70.28 0.11 Allowed 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.029 1.332 . . . . 74.11 112.824 -170.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -87.97 15.74 6.87 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.632 -0.877 . . . . 62.4 108.632 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.43 -7.98 2.42 Favored Glycine 0 C--N 1.359 1.842 0 O-C-N 121.792 -0.567 . . . . 71.41 113.149 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.11 -178.64 49.44 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.656 -1.378 . . . . 64.31 109.656 -170.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mp -76.96 128.3 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 N-CA-C 101.922 -3.362 . . . . 52.24 101.922 170.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -107.08 147.56 29.85 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 104.089 -2.56 . . . . 72.25 104.089 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.47 102.22 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.724 -1.584 . . . . 74.52 106.724 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.442 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -72.82 -37.59 67.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.831 -1.531 . . . . 74.32 110.441 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.21 142.34 18.21 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 105.952 -1.87 . . . . 61.42 105.952 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -117.16 131.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 102.96 -2.978 . . . . 75.12 102.96 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.416 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -73.27 144.58 84.56 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 106.482 -1.673 . . . . 70.22 106.482 174.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 45' ' ' GLY . 65.4 Cg_endo -75.43 169.55 22.17 Favored 'Trans proline' 0 CA--C 1.462 -3.088 0 N-CA-C 105.07 -2.704 . . . . 62.52 105.07 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 66.51 -3.94 0.79 Allowed 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 124.04 0.837 . . . . 73.13 111.317 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -92.48 -179.2 40.97 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 108.122 -1.991 . . . . 71.42 108.122 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -51.74 63.09 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.118 -1.068 . . . . 75.24 108.118 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.97 65.18 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.277 -0.42 . . . . 73.43 110.882 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.61 -55.87 15.29 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.174 -0.328 . . . . 71.52 110.285 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.5 m -65.02 -31.24 72.37 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 122.056 -0.402 . . . . 64.14 111.256 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -81.3 -32.59 33.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.494 -1.669 . . . . 72.51 106.494 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.44 18.04 69.72 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 110.552 -1.019 . . . . 71.25 110.552 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -86.48 2.46 47.8 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.854 -1.165 . . . . 64.03 107.854 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -147.42 147.46 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 104.449 -2.426 . . . . 72.34 104.449 -168.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.97 167.11 30.87 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 104.186 -2.524 . . . . 74.32 104.186 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -66.3 145.41 55.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.121 -1.066 . . . . 74.25 108.121 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.7 -33.08 6.86 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 108.988 -1.645 . . . . 74.12 108.988 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.38 161.38 31.15 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 108.004 -1.11 . . . . 74.43 108.004 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.07 150.66 48.0 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 107.997 -1.112 . . . . 74.42 107.997 -172.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.01 139.24 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 105.705 -1.961 . . . . 74.24 105.705 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.452 ' CD1' HG21 ' A' ' 7' ' ' ILE . 16.3 mt -102.18 -59.49 1.69 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.992 -1.484 . . . . 74.44 106.992 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.55 150.4 50.74 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.199 -1.778 . . . . 71.33 106.199 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.44 120.33 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 105.015 -2.217 . . . . 75.11 105.015 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.4 t30 51.79 36.0 16.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.027 0.931 . . . . 75.44 109.979 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.34 -29.41 12.56 Favored Glycine 0 CA--C 1.474 -2.509 0 N-CA-C 108.134 -1.987 . . . . 44.14 108.134 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.69 115.32 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 108.383 -0.969 . . . . 72.45 108.383 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.9 m -55.4 115.54 2.35 Favored 'General case' 0 C--N 1.37 1.486 0 N-CA-C 107.193 -1.41 . . . . 44.13 107.193 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -101.33 -15.29 17.29 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 106.427 -1.694 . . . . 73.21 106.427 -165.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.09 128.77 37.37 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.498 -0.927 . . . . 75.22 108.498 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.98 57.78 Favored Glycine 0 CA--C 1.498 -0.977 0 N-CA-C 107.815 -2.114 . . . . 74.24 107.815 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.88 152.2 28.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.554 -2.017 . . . . 75.43 105.554 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.1 p -79.16 176.32 9.78 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.094 -0.706 . . . . 73.41 109.094 -172.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -70.34 -41.14 73.58 Favored 'General case' 0 C--O 1.21 -1.002 0 N-CA-C 108.726 -0.842 . . . . 75.43 108.726 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.67 -54.41 47.34 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.075 -1.015 . . . . 75.42 110.644 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -55.85 -34.96 65.91 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.441 -0.787 . . . . 75.1 111.294 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.72 -52.33 41.33 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.579 0.228 . . . . 73.02 111.282 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -74.95 -35.03 34.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 N-CA-C 108.276 -1.009 . . . . 74.5 108.276 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.41 -39.76 73.56 Favored 'General case' 0 N--CA 1.518 2.973 0 N-CA-C 105.775 -1.935 . . . . 72.03 105.775 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.2 m -69.3 -40.15 77.86 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.294 -1.503 . . . . 75.23 108.125 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.6 mt -64.71 -30.11 71.11 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.788 -0.449 . . . . 73.32 109.788 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -72.15 -57.67 4.06 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.529 -0.915 . . . . 74.52 108.529 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -69.14 48.11 0.07 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 122.918 0.487 . . . . 72.51 111.978 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.453 ' HG1' HG22 ' A' ' 86' ' ' VAL . 23.3 p -108.05 -175.58 2.82 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.21 -1.774 . . . . 74.2 106.21 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.06 -153.6 30.33 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 106.471 -2.652 . . . . 65.33 106.471 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.95 -54.86 20.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.75 -0.833 . . . . 73.13 108.75 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.9 t -95.07 142.74 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.335 -2.098 . . . . 75.44 105.335 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.453 HG22 ' HG1' ' A' ' 82' ' ' THR . 48.1 t -102.56 128.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 105.123 -2.177 . . . . 62.05 105.123 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -107.29 125.62 51.39 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 103.527 -2.768 . . . . 72.31 103.527 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.22 136.36 11.85 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.169 -1.048 . . . . 72.31 108.169 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -86.43 143.05 27.98 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 108.283 -1.006 . . . . 74.11 108.283 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -120.32 165.42 14.89 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 104.878 -2.267 . . . . 72.5 104.878 177.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.48 145.79 51.44 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 102.608 -3.108 . . . . 72.24 102.608 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -64.82 131.11 45.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.839 -1.171 . . . . 74.42 107.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.196 0 N-CA-C 106.892 -2.483 . . . . 72.35 106.892 -174.258 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . . . . . . 0 CA--C 1.497 -1.034 0 N-CA-C 108.511 -1.836 . . . . 71.24 108.511 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.66 135.07 40.44 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.817 -1.549 . . . . 62.33 106.817 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.461 HD12 HD13 ' A' ' 60' ' ' LEU . 22.4 mm -98.8 130.07 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 106.1 -1.815 . . . . 74.33 106.1 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.91 153.77 44.62 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.054 -1.091 . . . . 73.31 108.054 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -107.81 144.09 35.46 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 105.07 -2.196 . . . . 65.02 105.07 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.6 153.71 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 107.068 -1.456 . . . . 64.24 107.068 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB2' HG13 ' A' ' 85' ' ' VAL . 7.4 pt-20 -112.08 130.71 55.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.892 -1.892 . . . . 64.24 105.892 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.468 HD13 HD12 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -135.17 134.1 39.79 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.865 -1.532 . . . . 75.22 106.865 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 141.81 30.0 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 105.379 -2.082 . . . . 72.42 105.379 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HG2' HD22 ' A' ' 19' ' ' LEU . 42.3 mtpt -75.41 -31.83 60.53 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.178 -1.045 . . . . 73.4 108.178 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 68.4 110.59 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.122 -0.696 . . . . 75.05 109.122 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t70 58.3 32.15 21.72 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 107.992 -1.114 . . . . 73.33 107.992 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 43.13 19.04 0.01 OUTLIER 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.722 1.609 . . . . 62.31 113.324 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -90.56 119.36 30.75 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 106.215 -1.772 . . . . 65.53 106.215 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.586 ' CD1' ' H ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -111.6 -143.64 0.39 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 102.911 -2.996 . . . . 63.13 102.911 179.068 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.586 ' H ' ' CD1' ' A' ' 19' ' ' LEU . . . 103.36 66.25 0.73 Allowed Glycine 0 CA--C 1.474 -2.482 0 N-CA-C 106.855 -2.498 . . . . 74.24 106.855 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.6 mm -89.43 177.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 102.447 -3.168 . . . . 55.31 102.447 170.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.528 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.6 m -122.5 154.49 37.78 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.037 -2.579 . . . . 74.52 104.037 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.489 ' HA ' ' H ' ' A' ' 39' ' ' LYS . 30.9 m -149.25 176.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.424 -1.324 . . . . 71.34 107.424 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.15 -2.167 . . . . 71.52 105.15 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.53 -158.75 25.54 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 108.454 -1.858 . . . . 71.12 108.454 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.29 -95.06 0.3 Allowed Glycine 0 C--N 1.36 1.863 0 N-CA-C 109.08 -1.608 . . . . 63.44 109.08 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.31 17.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.433 1.093 . . . . 73.43 113.782 -165.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 85.79 6.04 0.43 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 124.437 1.095 . . . . 74.52 108.499 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.0 p -42.39 -169.44 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 127.044 2.138 . . . . 71.03 112.431 161.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -40.86 -33.1 0.27 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.126 1.37 . . . . 52.44 113.485 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 m -62.08 129.48 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 122.465 1.126 . . . . 73.43 110.318 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -51.17 -65.07 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.041 -1.436 . . . . 74.01 111.48 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -84.48 16.66 3.01 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.573 -0.704 . . . . 72.31 110.646 -171.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 47.36 65.51 2.3 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 111.372 -0.691 . . . . 62.03 111.372 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.83 -179.15 31.57 Favored Glycine 0 CA--C 1.457 -3.574 0 N-CA-C 103.98 -3.648 . . . . 73.31 103.98 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 131.72 35.44 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 N-CA-C 104.988 -2.227 . . . . 74.45 104.988 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.26 151.81 25.46 Favored 'General case' 0 CA--C 1.46 -2.503 0 N-CA-C 103.621 -2.733 . . . . 74.51 103.621 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.29 102.49 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 106.233 -1.766 . . . . 64.04 106.233 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.489 ' H ' ' HA ' ' A' ' 23' ' ' VAL . 46.9 tttp -71.82 -32.86 68.01 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.088 -0.96 . . . . 75.32 109.359 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.06 149.64 16.18 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 105.401 -2.074 . . . . 61.51 105.401 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.29 130.3 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 102.805 -3.035 . . . . 74.44 102.805 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.482 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 143.36 65.7 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 105.541 -2.022 . . . . 72.1 105.541 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 45' ' ' GLY . 97.8 Cg_endo -75.59 173.58 14.26 Favored 'Trans proline' 0 CA--C 1.464 -2.984 0 N-CA-C 106.428 -2.181 . . . . 75.24 106.428 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 71.22 -12.1 0.63 Allowed 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.364 1.04 . . . . 73.4 111.674 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -90.11 -179.71 44.15 Favored Glycine 0 CA--C 1.476 -2.388 0 N-CA-C 107.439 -2.264 . . . . 75.02 107.439 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.06 -52.79 45.74 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.675 -0.861 . . . . 70.13 108.675 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -49.27 66.8 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 116.217 -0.447 . . . . 73.42 110.281 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.16 -55.66 29.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.59 -0.522 . . . . 65.51 109.59 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -64.85 -32.66 74.46 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.557 -0.292 . . . . 74.01 111.595 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -81.61 -25.22 35.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.236 -1.764 . . . . 55.05 106.236 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 19.4 77.42 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 110.518 -1.033 . . . . 72.55 110.518 167.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -94.44 6.46 48.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.891 -1.151 . . . . 74.04 107.891 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.468 HD12 HD13 ' A' ' 12' ' ' LEU . 66.5 mt -144.02 138.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 103.804 -2.665 . . . . 74.01 103.804 -169.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -149.94 159.96 43.98 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 105.196 -2.15 . . . . 72.22 105.196 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -67.22 144.14 56.14 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.171 -1.048 . . . . 75.31 108.171 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.22 -32.66 7.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 108.081 -2.008 . . . . 73.01 108.081 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.65 155.16 30.67 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.128 -1.064 . . . . 70.14 108.128 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -116.27 141.54 48.02 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.783 -1.562 . . . . 73.12 106.783 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.55 126.07 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.138 -2.171 . . . . 73.14 105.138 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.461 HD13 HD12 ' A' ' 7' ' ' ILE . 75.2 mt -91.17 -59.12 2.24 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 107.668 -1.234 . . . . 72.2 107.668 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.89 149.81 49.12 Favored 'General case' 0 CA--C 1.472 -2.046 0 N-CA-C 106.51 -1.663 . . . . 73.3 106.51 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.4 110.88 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.629 -1.989 . . . . 65.24 105.629 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.82 44.82 25.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.173 1.389 . . . . 63.13 110.622 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.22 -31.85 8.25 Favored Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 108.186 -1.966 . . . . 65.34 108.186 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -81.56 116.79 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 107.56 -1.274 . . . . 65.22 107.56 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 t -55.32 126.64 25.83 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 108.281 -1.007 . . . . 61.13 108.281 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -97.23 -13.43 22.04 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.099 -1.815 . . . . 74.42 106.099 -171.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.1 127.62 32.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.787 -0.819 . . . . 63.25 108.787 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.54 66.21 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.817 -1.713 . . . . 74.4 108.817 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.65 148.06 39.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.067 -1.457 . . . . 64.21 107.067 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.5 p -82.82 -179.93 7.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.824 -1.176 . . . . 70.21 107.824 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.408 ' CE1' HG22 ' A' ' 23' ' ' VAL . 7.6 t60 -60.97 -51.39 69.47 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.213 -1.032 . . . . 71.44 108.213 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -52.95 -56.29 17.07 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 110.096 -0.335 . . . . 75.34 110.096 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.02 -47.63 77.45 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.509 -0.552 . . . . 74.33 109.509 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.404 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.42 -56.93 10.57 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.051 0.54 . . . . 75.34 111.242 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.24 -35.83 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 109.066 -0.716 . . . . 75.12 109.066 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.36 -32.54 74.24 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.338 -1.727 . . . . 74.4 106.338 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -74.22 -38.82 63.43 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.413 -1.429 . . . . 71.34 108.087 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.52 -48.67 74.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.61 -0.885 . . . . 75.44 108.61 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -55.88 13.58 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.582 -0.896 . . . . 74.24 108.582 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.24 60.95 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.97 0.891 . . . . 74.34 111.194 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 p -112.53 -176.11 2.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.54 -1.652 . . . . 72.22 106.54 171.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.59 -141.02 7.57 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 106.647 -2.581 . . . . 65.12 106.647 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 -55.13 12.89 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.785 -0.82 . . . . 74.53 108.785 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 11' ' ' GLU . 73.6 t -99.32 144.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.775 -1.194 . . . . 70.21 107.775 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.9 t -97.62 125.57 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 105.731 -1.952 . . . . 74.12 105.731 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -97.67 117.8 32.78 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.931 -2.248 . . . . 71.43 104.931 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.12 130.32 11.2 Favored 'General case' 0 CA--C 1.482 -1.637 0 C-N-CA 119.281 -0.968 . . . . 71.02 108.474 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.401 ' HB3' HD12 ' A' ' 60' ' ' LEU . 8.5 mp -83.06 143.51 30.54 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.354 -0.98 . . . . 74.31 108.354 177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.08 158.92 22.43 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.438 -1.69 . . . . 75.14 106.438 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -126.72 131.51 51.35 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 102.47 -3.159 . . . . 73.43 102.47 169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.496 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 30.1 mmmt -67.9 136.82 54.62 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 107.921 -1.14 . . . . 73.32 107.921 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.603 0 C-N-CA 119.9 -1.143 . . . . 72.5 110.725 -168.364 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . . . . . . 0 CA--C 1.493 -1.329 0 N-CA-C 109.73 -1.348 . . . . 75.51 109.73 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.09 146.96 23.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.472 -1.677 . . . . 73.13 106.472 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 mm -96.94 129.11 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 106.515 -1.661 . . . . 75.23 106.515 -173.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CD2' HD22 ' A' ' 90' ' ' LEU . 6.2 p90 -131.87 148.36 52.54 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 106.655 -1.609 . . . . 74.25 106.655 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.404 ' HG2' ' HG ' ' A' ' 89' ' ' LEU . 36.8 mt-10 -108.22 148.64 29.67 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 106.454 -1.684 . . . . 71.24 106.454 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.21 150.79 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.392 -1.707 . . . . 75.52 106.392 173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -120.48 138.92 53.56 Favored 'General case' 0 CA--C 1.465 -2.315 0 N-CA-C 104.533 -2.395 . . . . 72.33 104.533 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.08 144.83 28.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.423 -1.325 . . . . 73.34 107.423 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.34 123.65 29.28 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 105.883 -1.895 . . . . 73.31 105.883 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -71.33 -22.52 61.91 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.023 -0.732 . . . . 73.34 109.023 -173.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 t30 73.61 109.19 0.07 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.706 0.802 . . . . 73.24 109.767 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.33 53.02 12.54 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.364 1.065 . . . . 63.12 110.685 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 53.31 -8.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.811 1.782 . . . . 71.44 115.811 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.6 m -131.39 130.22 42.32 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.379 -1.341 . . . . 75.21 107.379 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.5 179.84 3.84 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 104.242 -2.503 . . . . 75.23 104.242 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.02 53.57 0.46 Allowed Glycine 0 CA--C 1.475 -2.456 0 N-CA-C 106.644 -2.582 . . . . 42.41 106.644 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.551 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.9 mt -87.85 176.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 104.573 -2.381 . . . . 71.1 104.573 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.551 ' H ' HG22 ' A' ' 21' ' ' ILE . 77.1 m -141.78 167.28 22.52 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 106.312 -1.736 . . . . 63.23 106.312 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.476 ' HB ' HG21 ' A' ' 36' ' ' ILE . 6.2 m -148.79 172.92 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.073 -1.454 . . . . 64.12 107.073 -167.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.8 t -154.37 160.8 41.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 103.902 -2.629 . . . . 72.05 103.902 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.19 -164.95 31.22 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 108.02 -2.032 . . . . 63.44 108.02 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 133.61 -88.69 0.26 Allowed Glycine 0 CA--C 1.479 -2.203 0 N-CA-C 108.418 -1.873 . . . . 61.03 108.418 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.63 16.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.028 0 C-N-CA 122.551 0.341 . . . . 71.2 111.446 -171.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 26' ' ' GLY . 7.1 t30 85.39 5.99 0.48 Allowed 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.483 1.113 . . . . 71.43 108.784 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -45.41 -171.05 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 126.279 1.832 . . . . 72.21 112.987 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 p -40.45 -40.71 1.26 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 127.272 2.229 . . . . 75.11 114.002 -164.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.46 135.82 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.64 0.733 . . . . 71.11 110.286 -173.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -39.69 -66.96 0.25 Allowed 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.017 1.327 . . . . 75.11 113.475 -171.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -77.72 -13.34 59.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.322 -0.951 . . . . 54.34 109.866 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.95 -14.62 64.77 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.361 -1.496 . . . . 65.13 109.361 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.78 -179.87 53.17 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.172 -1.571 . . . . 62.12 109.172 -173.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.476 HG21 ' HB ' ' A' ' 23' ' ' VAL . 19.3 mm -86.32 117.87 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 103.929 -2.619 . . . . 72.3 103.929 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.83 154.5 19.53 Favored 'General case' 0 CA--C 1.463 -2.399 0 N-CA-C 105.275 -2.12 . . . . 70.22 105.275 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.44 102.45 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 N-CA-C 106.206 -1.775 . . . . 74.01 106.206 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -71.16 -41.63 70.15 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 113.966 -1.47 . . . . 74.44 109.735 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.97 143.8 17.18 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 105.418 -2.067 . . . . 74.12 105.418 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.8 133.53 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.655 -2.72 . . . . 74.13 103.655 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.505 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.35 148.78 78.0 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 106.163 -1.791 . . . . 74.41 106.163 175.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 45' ' ' GLY . 68.1 Cg_endo -74.87 169.24 23.05 Favored 'Trans proline' 0 CA--C 1.458 -3.301 0 N-CA-C 105.438 -2.562 . . . . 61.33 105.438 -175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 65.04 -1.36 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.877 0.736 . . . . 75.33 111.942 166.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -86.75 171.59 43.34 Favored Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 106.702 -2.559 . . . . 72.04 106.702 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.95 67.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.405 -0.961 . . . . 75.44 108.405 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . . . -53.78 -50.82 65.25 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.283 -0.872 . . . . 73.02 110.717 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -63.24 -56.27 17.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 120.872 0.368 . . . . 54.44 110.112 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -34.88 71.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.207 0.603 . . . . 71.2 110.982 -172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.5 ' CG ' ' HE ' ' A' ' 52' ' ' ARG . 6.3 t70 -83.2 -34.52 25.9 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.698 -1.593 . . . . 74.12 106.698 -174.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.81 16.25 61.82 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 110.638 -0.985 . . . . 63.35 110.638 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HE ' ' CG ' ' A' ' 50' ' ' ASP . 67.3 mtt180 -91.89 6.09 47.51 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 118.361 1.08 . . . . 74.43 108.201 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 2.9 mp -147.71 148.41 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.227 -2.509 . . . . 72.44 104.227 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -158.6 171.8 19.45 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 104.541 -2.392 . . . . 74.1 104.541 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -67.05 146.46 54.29 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.556 -0.905 . . . . 74.02 108.556 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.77 -32.95 6.98 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 109.263 -1.535 . . . . 74.21 109.263 169.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.434 ' CG ' ' HZ3' ' A' ' 92' ' ' LYS . 67.0 m-20 -73.43 158.52 34.82 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.662 -1.236 . . . . 72.35 107.662 176.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.471 HH22 ' CD ' ' A' ' 91' ' ' GLU . 24.6 ttp85 -123.88 143.79 50.15 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.741 -1.207 . . . . 61.11 107.741 -165.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.0 t -95.21 139.36 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.929 -1.878 . . . . 74.42 105.929 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 89' ' ' LEU . 46.2 mt -102.01 -58.88 1.8 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.314 -1.365 . . . . 72.13 107.314 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.73 151.52 48.28 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.115 -1.809 . . . . 71.33 106.115 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.38 127.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.616 -2.365 . . . . 71.23 104.616 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.0 t30 59.04 31.28 21.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.91 0.862 . . . . 73.14 109.371 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.77 -8.14 73.96 Favored Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 109.156 -1.578 . . . . 43.43 109.156 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.77 118.52 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.572 0 N-CA-C 106.493 -1.669 . . . . 72.23 106.493 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 t -55.99 118.63 4.82 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.729 -1.211 . . . . 63.2 107.729 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.2 tm? -104.87 -13.47 15.81 Favored 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 106.552 -1.648 . . . . 70.34 106.552 -167.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.55 127.41 31.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.501 -0.749 . . . . 71.11 109.054 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.83 61.99 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.315 -1.914 . . . . 51.44 108.315 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -82.39 154.81 25.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.158 -1.793 . . . . 74.3 106.158 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.8 p -81.29 176.83 9.41 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.781 0.801 . . . . 75.43 110.393 -168.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -58.48 -50.79 72.46 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.815 1.246 . . . . 74.0 107.906 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -55.13 -54.48 42.68 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 122.063 -0.398 . . . . 75.12 110.759 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -53.93 -41.34 67.62 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.864 -0.421 . . . . 74.21 109.864 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.33 -54.27 27.94 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 122.798 0.439 . . . . 73.43 110.33 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.62 -38.5 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 109.302 -0.629 . . . . 74.14 109.302 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.6 -32.74 72.87 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 105.801 -1.926 . . . . 73.41 105.801 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -70.69 -46.46 63.1 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.175 -1.578 . . . . 65.13 108.05 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.36 -30.3 69.47 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 109.388 -0.597 . . . . 72.23 109.388 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -59.9 2.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.139 -1.43 . . . . 61.33 107.139 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -48.73 -20.59 0.49 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 126.163 1.785 . . . . 72.21 114.019 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -74.13 171.84 12.83 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.35 -0.844 . . . . 74.32 109.422 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.23 -148.69 5.4 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.1 -1.2 . . . . 74.24 110.1 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -70.82 -55.93 7.43 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.839 -0.8 . . . . 62.44 108.839 -170.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.06 142.58 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.727 0 N-CA-C 104.428 -2.434 . . . . 75.13 104.428 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.65 134.9 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 104.987 -2.227 . . . . 64.43 104.987 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -103.46 121.32 42.59 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.085 -2.561 . . . . 65.41 104.085 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 125.91 14.4 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 107.914 -1.143 . . . . 64.14 107.914 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.444 ' HB3' HD12 ' A' ' 60' ' ' LEU . 4.3 mp -81.9 144.39 31.0 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 107.999 -1.111 . . . . 64.3 107.999 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.459 HD22 ' CD2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -117.28 162.18 18.31 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.105 -2.183 . . . . 75.34 105.105 174.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.471 ' CD ' HH22 ' A' ' 58' ' ' ARG . 41.5 tt0 -129.01 144.58 51.23 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 102.254 -3.239 . . . . 75.0 102.254 163.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.434 ' HZ3' ' CG ' ' A' ' 57' ' ' ASP . 26.2 mmmt -57.88 140.78 51.2 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.721 0.772 . . . . 74.42 110.389 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.83 0 N-CA-C 104.132 -3.587 . . . . 53.53 104.132 174.51 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.033 0 N-CA-C 108.819 -1.712 . . . . 43.52 108.819 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.66 139.9 38.45 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 106.691 -1.596 . . . . 74.54 106.691 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -99.42 130.25 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 106.718 -1.586 . . . . 73.34 106.718 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -137.5 154.23 49.9 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 108.005 -1.109 . . . . 64.41 108.005 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.66 143.56 33.65 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.232 -1.766 . . . . 71.24 106.232 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.1 m -142.54 151.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.511 -1.663 . . . . 62.5 106.511 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.82 129.21 56.52 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 106.213 -1.773 . . . . 72.41 106.213 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.51 140.21 50.5 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 108.493 -0.928 . . . . 75.52 108.493 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.04 137.76 32.02 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 105.818 -1.919 . . . . 64.32 105.818 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.43 -25.76 59.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.613 -0.884 . . . . 75.34 108.613 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 67.87 111.28 0.04 OUTLIER 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.184 -0.673 . . . . 62.31 109.184 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.12 40.29 30.2 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.35 -0.982 . . . . 73.31 108.35 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 t30 43.22 12.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.223 2.209 . . . . 73.24 114.649 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -97.11 129.17 44.55 Favored 'General case' 0 CA--C 1.494 -1.195 0 O-C-N 120.517 -1.364 . . . . 64.53 107.328 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 tp -124.78 142.51 51.37 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 102.738 -3.06 . . . . 75.31 102.738 173.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.51 64.34 0.27 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 106.406 -2.678 . . . . 54.13 106.406 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.0 mm -87.89 177.35 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 104.929 -2.248 . . . . 74.41 104.929 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.549 ' H ' HG22 ' A' ' 21' ' ' ILE . 16.8 m -124.78 156.85 37.08 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 103.662 -2.718 . . . . 74.13 103.662 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.7 m -150.53 171.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 108.092 -1.077 . . . . 73.55 108.092 -166.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -161.99 164.75 28.17 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.498 -2.408 . . . . 72.53 104.498 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.62 -160.84 22.76 Favored Glycine 0 CA--C 1.486 -1.774 0 N-CA-C 107.052 -2.419 . . . . 73.12 107.052 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.72 -104.84 0.56 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 108.89 -1.684 . . . . 70.11 108.89 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.82 16.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 113.374 0.879 . . . . 74.32 113.374 -164.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 86.64 12.96 0.14 Allowed 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.804 1.242 . . . . 73.42 108.877 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 p -46.15 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 124.334 1.054 . . . . 74.43 110.859 155.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.7 m -29.46 -44.02 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.487 1.662 . . . . 71.44 115.487 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.472 ' HB ' ' CZ ' ' A' ' 37' ' ' TYR . 30.0 m -76.12 140.22 17.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.22 -0.925 . . . . 74.31 108.517 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -68.31 -47.58 67.21 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.148 -0.97 . . . . 74.04 111.138 -171.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.418 ' HE1' ' CD ' ' A' ' 68' ' ' GLU . 8.3 t-80 -73.23 0.66 11.2 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.189 -0.319 . . . . 73.45 110.248 -166.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.97 61.21 7.11 Favored Glycine 0 C--N 1.362 1.991 0 N-CA-C 109.495 -1.442 . . . . 72.04 109.495 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.4 28.19 Favored Glycine 0 CA--C 1.454 -3.759 0 N-CA-C 103.721 -3.752 . . . . 63.4 103.721 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -90.61 131.17 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.707 0 N-CA-C 104.25 -2.5 . . . . 75.2 104.25 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.472 ' CZ ' ' HB ' ' A' ' 31' ' ' VAL . 3.7 m-30 -108.55 151.67 25.79 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 102.899 -3.0 . . . . 75.21 102.899 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.52 102.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 107.103 -1.443 . . . . 71.02 107.103 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -71.6 -36.61 70.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.196 -1.366 . . . . 74.42 110.113 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.71 152.7 14.08 Favored 'General case' 0 CA--C 1.466 -2.278 0 N-CA-C 105.464 -2.05 . . . . 70.03 105.464 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.71 136.16 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 104.308 -2.479 . . . . 63.45 104.308 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -75.24 145.22 79.83 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 106.259 -1.756 . . . . 74.22 106.259 174.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.83 168.38 24.36 Favored 'Trans proline' 0 CA--C 1.462 -3.09 0 N-CA-C 105.786 -2.428 . . . . 73.43 105.786 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 63.41 1.54 1.0 Allowed 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 123.665 0.603 . . . . 71.34 111.732 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.6 -178.22 41.11 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 106.667 -2.573 . . . . 65.34 106.667 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.67 -52.99 31.43 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 108.151 -1.055 . . . . 65.55 108.151 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.07 65.86 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.066 -0.516 . . . . 65.44 110.879 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -62.39 -56.11 21.44 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.56 -0.533 . . . . 75.42 109.56 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.7 m -62.79 -30.49 71.5 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.683 0.278 . . . . 62.14 111.232 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -77.21 -35.8 55.3 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.773 -1.566 . . . . 62.32 106.773 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.38 12.59 72.69 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.109 -1.596 . . . . 74.05 109.109 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -90.19 -1.93 57.99 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.275 -1.38 . . . . 73.1 107.275 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -142.77 145.26 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 102.857 -3.016 . . . . 72.22 102.857 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -156.79 173.03 17.58 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.699 -2.704 . . . . 73.43 103.699 170.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -66.35 145.62 55.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-O 121.391 0.615 . . . . 74.02 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -33.03 6.86 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.764 -1.734 . . . . 71.41 108.764 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -67.55 157.01 35.36 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.981 -0.748 . . . . 75.01 108.981 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -117.0 142.84 46.43 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.3 -1.37 . . . . 74.34 107.3 -166.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -93.01 126.71 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 105.761 -1.94 . . . . 74.22 105.761 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.47 -58.64 2.14 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 107.417 -1.327 . . . . 60.24 107.417 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.36 147.62 47.45 Favored 'General case' 0 CA--C 1.471 -2.079 0 N-CA-C 106.379 -1.712 . . . . 72.01 106.379 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.43 119.12 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 104.897 -2.26 . . . . 72.43 104.897 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.3 t30 52.28 38.06 23.81 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.046 0.938 . . . . 75.33 110.618 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.7 -18.38 57.29 Favored Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 108.784 -1.726 . . . . 74.21 108.784 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.3 117.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.888 0 N-CA-C 106.78 -1.563 . . . . 73.11 106.78 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.0 t -56.02 122.73 12.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.243 -1.021 . . . . 65.12 108.243 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.42 -16.63 24.38 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.431 -2.063 . . . . 75.31 105.431 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.418 ' CD ' ' HE1' ' A' ' 33' ' ' HIS . 53.3 mt-10 -59.85 123.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.816 -0.809 . . . . 73.2 108.816 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.56 -14.94 62.74 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 108.968 -1.653 . . . . 62.2 108.968 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.01 147.33 46.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.569 -1.271 . . . . 61.2 107.569 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 59.6 p -81.65 178.69 8.19 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.147 -1.427 . . . . 73.14 107.147 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -62.26 -51.06 69.23 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.935 -0.765 . . . . 74.05 108.935 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.57 -56.07 24.62 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 121.707 -0.621 . . . . 74.21 110.12 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -60.9 -45.49 94.42 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 110.184 -0.302 . . . . 55.22 110.184 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.65 -51.29 63.62 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-O 120.918 0.389 . . . . 60.43 110.716 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.63 -36.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.827 -1.175 . . . . 75.33 107.827 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.6 -34.19 73.85 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.031 -1.84 . . . . 70.43 106.031 -176.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.9 m -73.14 -42.32 62.97 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 107.393 -1.336 . . . . 75.43 107.393 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.78 -39.58 94.66 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 110.109 -0.33 . . . . 65.02 110.109 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.467 ' C ' ' H ' ' A' ' 82' ' ' THR . 30.9 ttt180 -75.99 -54.64 6.56 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.662 -0.815 . . . . 71.25 109.139 -175.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -70.48 47.78 0.1 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.039 0.447 . . . . 72.11 111.591 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 80' ' ' ARG . 7.1 p -101.08 -176.07 3.05 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.702 -1.962 . . . . 72.31 105.702 172.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.65 -157.26 18.57 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 107.113 -2.395 . . . . 20.31 107.113 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.34 -54.02 39.57 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.088 -0.708 . . . . 65.11 109.088 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.27 141.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 105.928 -1.879 . . . . 72.33 105.928 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.2 130.68 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.491 0 N-CA-C 105.718 -1.956 . . . . 75.31 105.718 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -107.17 124.61 49.97 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 105.413 -2.069 . . . . 72.41 105.413 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -156.36 136.55 12.89 Favored 'General case' 0 CA--C 1.473 -2.004 0 C-N-CA 119.01 -1.076 . . . . 75.5 108.458 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.33 141.0 33.23 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.394 -1.336 . . . . 75.41 107.394 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.8 159.02 18.7 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 104.595 -2.372 . . . . 75.2 104.595 174.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -123.4 134.4 53.98 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 101.292 -3.596 . . . . 51.42 101.292 164.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.76 130.29 44.28 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.163 -1.421 . . . . 73.4 107.163 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.463 -3.208 0 N-CA-C 107.303 -2.319 . . . . 23.15 107.303 -169.806 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.204 0 N-CA-C 109.567 -1.413 . . . . 74.54 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -99.77 153.8 18.83 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.869 -1.901 . . . . 74.43 105.869 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.421 HG21 ' CD1' ' A' ' 60' ' ' LEU . 4.6 mm -99.63 137.51 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 106.59 -1.633 . . . . 75.32 106.59 -169.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.434 ' CD2' HD22 ' A' ' 90' ' ' LEU . 9.1 p90 -135.28 151.96 51.05 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.302 -1.37 . . . . 74.14 107.302 170.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.426 ' OE2' ' HE1' ' A' ' 87' ' ' HIS . 52.8 mt-10 -108.09 147.29 31.42 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.237 -1.764 . . . . 73.53 106.237 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.415 HG13 ' HB3' ' A' ' 52' ' ' ARG . 35.1 m -142.96 152.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 105.984 -1.858 . . . . 62.5 105.984 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -118.71 127.25 53.39 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.745 -1.946 . . . . 75.41 105.745 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 137.69 45.45 Favored 'General case' 0 CA--C 1.474 -1.961 0 N-CA-C 107.694 -1.224 . . . . 70.34 107.694 -169.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.29 142.3 28.63 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.693 -1.965 . . . . 70.01 105.693 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -69.88 -32.41 70.74 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.413 -0.958 . . . . 75.21 108.413 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 75.03 107.08 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.607 0.763 . . . . 64.13 109.299 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 50.84 45.38 27.43 Favored 'General case' 0 C--N 1.37 1.474 0 C-N-CA 124.576 1.151 . . . . 43.3 110.937 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 54.97 -9.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.549 1.94 . . . . 74.21 113.805 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -84.3 158.28 21.24 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 119.975 1.262 . . . . 71.11 108.341 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.96 -157.15 0.78 Allowed 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 102.952 -2.981 . . . . 61.01 102.952 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.36 40.79 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.657 0 N-CA-C 105.292 -3.123 . . . . 55.22 105.292 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mm -87.99 175.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 103.438 -2.801 . . . . 75.44 103.438 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.7 m -147.61 159.55 43.64 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.358 -2.09 . . . . 73.3 105.358 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 m -150.4 167.3 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 N-CA-C 107.766 -1.198 . . . . 73.13 107.766 -164.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -166.17 169.49 14.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.665 -2.346 . . . . 63.41 104.665 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -138.61 14.64 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.695 -2.162 . . . . 72.22 107.695 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 101.77 -88.17 0.68 Allowed Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 109.404 -1.478 . . . . 64.02 109.404 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 16.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 112.832 0.679 . . . . 71.23 112.832 -165.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 26' ' ' GLY . 17.7 t-20 82.55 6.92 0.9 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.677 0.791 . . . . 74.13 109.301 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 t -46.28 -170.23 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.427 1.491 . . . . 63.32 111.478 160.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -35.08 -40.33 0.12 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.071 1.748 . . . . 75.3 114.982 -166.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 37' ' ' TYR . 34.6 m -72.25 142.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.559 -0.904 . . . . 62.23 108.559 -174.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 34' ' ' GLY . 98.4 mtt180 -66.19 -59.11 4.07 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 121.725 -0.609 . . . . 74.34 112.556 -167.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.537 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 22.8 t-160 -75.84 15.16 0.55 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.588 -0.695 . . . . 70.35 110.874 -164.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 32' ' ' ARG . . . 46.35 57.19 6.6 Favored Glycine 0 C--N 1.358 1.788 0 N-CA-C 109.559 -1.416 . . . . 64.14 109.559 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.95 178.27 23.78 Favored Glycine 1 CA--C 1.442 -4.49 0 N-CA-C 103.252 -3.939 . . . . 72.1 103.252 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.63 132.09 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 106.214 -1.772 . . . . 71.2 106.214 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 31' ' ' VAL . 2.7 m-85 -109.82 148.52 31.34 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.584 -2.747 . . . . 72.12 103.584 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.12 103.2 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 N-CA-C 106.702 -1.592 . . . . 74.44 106.702 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -70.58 -38.64 74.09 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.547 -1.206 . . . . 74.32 109.745 -174.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.35 155.56 17.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 N-CA-C 105.368 -2.086 . . . . 51.4 105.368 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.5 143.2 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 102.763 -3.051 . . . . 62.05 102.763 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -76.16 142.6 72.26 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 105.903 -1.888 . . . . 74.14 105.903 171.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.14 173.89 13.73 Favored 'Trans proline' 0 CA--C 1.472 -2.585 0 N-CA-C 105.896 -2.386 . . . . 64.14 105.896 -176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 69.66 -2.73 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.024 0.828 . . . . 71.21 111.213 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.57 -176.25 38.6 Favored Glycine 0 CA--C 1.48 -2.139 0 N-CA-C 107.221 -2.352 . . . . 63.01 107.221 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -52.84 46.75 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.137 -1.061 . . . . 75.52 108.137 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.53 -49.65 64.42 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.224 -0.444 . . . . 74.02 110.589 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -64.54 -55.98 17.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.819 0.342 . . . . 54.05 110.124 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 m -64.04 -29.66 70.79 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 121.928 -0.482 . . . . 73.41 111.694 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -78.56 -34.15 47.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 105.773 -1.936 . . . . 74.35 105.773 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.49 63.97 Favored Glycine 0 CA--C 1.482 -2.02 0 N-CA-C 108.898 -1.681 . . . . 62.0 108.898 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HB3' HG13 ' A' ' 10' ' ' VAL . 13.4 mmt180 -89.89 -2.62 58.23 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 107.805 -1.183 . . . . 75.5 107.805 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.8 mt -146.64 143.9 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 N-CA-C 103.26 -2.867 . . . . 74.43 103.26 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.496 ' CE1' ' OD1' ' A' ' 57' ' ' ASP . 25.6 p80 -153.23 165.39 35.83 Favored 'General case' 0 CA--C 1.463 -2.375 0 N-CA-C 104.497 -2.409 . . . . 74.52 104.497 173.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HE3' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -67.93 145.08 54.9 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.612 -1.255 . . . . 73.43 107.612 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.74 -32.72 7.09 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.493 -1.443 . . . . 52.52 109.493 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 68.1 m-20 -66.4 158.0 30.47 Favored 'General case' 0 C--N 1.373 1.588 0 N-CA-C 108.292 -1.003 . . . . 73.5 108.292 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.473 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 52.5 mtm-85 -112.7 137.66 50.67 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.506 -1.294 . . . . 72.41 107.506 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.36 128.49 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 105.08 -2.193 . . . . 74.01 105.08 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.421 ' CD1' HG21 ' A' ' 7' ' ' ILE . 17.5 mt -99.28 -59.14 1.78 Allowed 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 107.467 -1.309 . . . . 73.42 107.467 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.06 146.53 51.77 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 106.433 -1.691 . . . . 64.54 106.433 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.78 125.42 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.213 -2.514 . . . . 74.12 104.213 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.64 29.84 17.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.114 0.959 . . . . 73.02 109.287 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.06 -12.06 68.85 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 109.26 -1.536 . . . . 72.51 109.26 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.04 118.54 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.557 -1.645 . . . . 74.11 106.557 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.5 m -56.7 118.38 4.82 Favored 'General case' 0 C--N 1.368 1.381 0 N-CA-C 108.435 -0.95 . . . . 64.43 108.435 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -104.52 -10.82 17.37 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.136 -1.802 . . . . 71.01 106.136 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.91 126.59 28.09 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.655 -0.868 . . . . 73.51 108.655 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -13.37 67.16 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 108.963 -1.655 . . . . 63.53 108.963 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.4 152.89 30.1 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.228 -1.767 . . . . 64.51 106.228 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -81.73 179.24 7.91 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.952 -0.758 . . . . 64.05 108.952 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -67.44 -46.15 73.93 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 108.202 -1.036 . . . . 74.35 108.202 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -52.19 -56.43 14.65 Favored 'General case' 0 C--N 1.362 1.136 0 O-C-N 121.733 -0.604 . . . . 65.44 110.07 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -53.96 -42.63 69.11 Favored 'General case' 0 C--N 1.369 1.452 0 N-CA-C 110.0 -0.37 . . . . 73.44 110.0 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.1 -53.9 36.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.096 0.558 . . . . 74.21 110.432 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.57 -40.57 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.657 -1.238 . . . . 73.43 107.657 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.05 -37.27 76.61 Favored 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 106.823 -1.547 . . . . 72.43 106.823 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.3 m -74.01 -48.06 32.79 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 120.355 -1.466 . . . . 73.45 107.627 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 124.024 0.929 . . . . 74.43 109.933 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -70.07 -55.47 9.41 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.998 -1.112 . . . . 72.53 107.998 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -70.84 55.26 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.875 0.845 . . . . 70.21 110.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.447 HG22 HG12 ' A' ' 86' ' ' VAL . 10.1 p -104.79 -175.53 2.82 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.226 -1.768 . . . . 75.55 106.226 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.12 -155.73 31.97 Favored Glycine 0 CA--C 1.485 -1.815 0 N-CA-C 107.189 -2.364 . . . . 50.0 107.189 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -63.24 -55.34 25.71 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.023 -1.103 . . . . 74.35 108.023 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.48 144.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.673 -1.973 . . . . 70.53 105.673 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 82' ' ' THR . 46.8 t -103.01 131.84 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.715 0 N-CA-C 105.568 -2.012 . . . . 74.11 105.568 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.426 ' HE1' ' OE2' ' A' ' 9' ' ' GLU . 50.1 t-80 -112.5 124.18 51.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.089 -2.189 . . . . 63.45 105.089 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.29 136.4 14.74 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 107.781 -1.192 . . . . 73.51 107.781 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -81.29 140.14 35.0 Favored 'General case' 0 CA--C 1.469 -2.138 0 N-CA-C 107.712 -1.218 . . . . 74.52 107.712 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.434 HD22 ' CD2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -110.92 156.91 20.51 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.412 -2.44 . . . . 72.41 104.412 172.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.473 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.3 tt0 -118.75 129.82 55.47 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 101.566 -3.494 . . . . 71.1 101.566 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -66.89 129.24 39.23 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.225 -1.768 . . . . 71.21 106.225 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.475 -2.438 0 N-CA-C 107.835 -2.106 . . . . 42.44 107.835 -168.119 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.33 0 N-CA-C 109.348 -1.501 . . . . 62.34 109.348 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.5 138.52 39.26 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.432 -1.322 . . . . 73.2 107.432 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.432 HG21 ' CD1' ' A' ' 60' ' ' LEU . 10.1 mm -97.53 133.28 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.321 -1.363 . . . . 74.11 107.321 -172.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.89 153.21 42.9 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.139 -1.06 . . . . 71.34 108.139 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -104.94 146.83 28.49 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 105.942 -1.873 . . . . 70.23 105.942 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 m -140.61 150.0 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.78 -1.563 . . . . 74.22 106.78 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -108.67 127.86 54.35 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 105.142 -2.17 . . . . 64.5 105.142 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mp -129.6 140.08 51.28 Favored 'General case' 0 CA--C 1.448 -2.967 0 N-CA-C 107.528 -1.286 . . . . 73.15 107.528 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.57 140.07 31.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 104.964 -2.236 . . . . 75.54 104.964 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.67 -31.97 67.37 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.539 -1.282 . . . . 71.34 107.539 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 74.83 102.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.251 -1.389 . . . . 74.35 107.251 -175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.16 45.83 11.22 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.243 -0.89 . . . . 75.41 109.22 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.7 t30 45.34 3.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.816 2.046 . . . . 61.42 115.634 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -102.6 121.94 43.4 Favored 'General case' 0 CA--C 1.485 -1.548 0 O-C-N 120.358 -1.464 . . . . 61.34 107.049 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.9 tp -127.19 151.37 48.78 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 104.202 -2.518 . . . . 75.5 104.202 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.18 0.07 OUTLIER Glycine 0 CA--C 1.467 -2.934 0 N-CA-C 105.184 -3.166 . . . . 65.11 105.184 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.7 mm -89.22 178.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.415 -2.439 . . . . 64.42 104.415 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.585 ' H ' HG22 ' A' ' 21' ' ' ILE . 40.0 t -122.06 154.59 37.11 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 103.345 -2.835 . . . . 72.03 103.345 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.426 ' HB ' HG21 ' A' ' 36' ' ' ILE . 2.4 m -147.63 169.69 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 107.406 -1.331 . . . . 74.35 107.406 -164.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 t -162.67 165.88 25.16 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.884 -2.265 . . . . 64.34 104.884 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -152.67 31.24 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 107.067 -2.413 . . . . 42.34 107.067 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 118.48 -78.77 0.3 Allowed Glycine 0 CA--C 1.477 -2.332 0 N-CA-C 108.979 -1.649 . . . . 73.32 108.979 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.71 16.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 C-N-CA 124.557 1.143 . . . . 72.22 112.057 -168.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 26' ' ' GLY . 12.5 t-20 81.32 5.14 1.38 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.213 1.405 . . . . 65.42 108.072 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.1 p -49.02 -170.86 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 126.071 1.748 . . . . 70.45 113.186 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 m -31.43 -42.41 0.05 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.63 2.372 . . . . 64.12 115.089 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -62.75 134.91 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.816 0.817 . . . . 74.32 109.967 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -52.44 -50.25 62.95 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 114.855 -1.066 . . . . 75.14 112.404 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -90.31 16.95 7.78 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.208 -0.933 . . . . 74.12 110.079 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.09 62.63 2.0 Favored Glycine 0 C--N 1.368 2.327 0 N-CA-C 111.206 -0.758 . . . . 72.33 111.206 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.1 179.73 24.73 Favored Glycine 0 CA--C 1.455 -3.681 0 N-CA-C 104.162 -3.575 . . . . 70.13 104.162 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.426 HG21 ' HB ' ' A' ' 23' ' ' VAL . 8.6 mm -88.87 125.54 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 105.479 -2.045 . . . . 73.14 105.479 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -109.32 152.86 24.71 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 103.84 -2.652 . . . . 64.52 103.84 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.81 104.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.464 -1.68 . . . . 75.2 106.464 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.37 -31.93 69.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.729 -0.841 . . . . 64.43 108.729 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.49 146.22 16.6 Favored 'General case' 0 CA--C 1.459 -2.525 0 N-CA-C 105.645 -1.983 . . . . 63.25 105.645 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.89 122.46 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.349 -3.204 . . . . 74.42 102.349 172.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.79 146.23 72.1 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 106.052 -1.833 . . . . 73.45 106.052 178.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.5 173.61 14.2 Favored 'Trans proline' 0 CA--C 1.47 -2.679 0 N-CA-C 107.109 -1.919 . . . . 72.41 107.109 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 63.65 53.98 1.94 Allowed 'General case' 0 N--CA 1.422 -1.829 0 O-C-N 124.664 1.228 . . . . 72.32 108.136 164.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.34 176.53 37.87 Favored Glycine 0 CA--C 1.466 -2.992 0 N-CA-C 106.659 -2.576 . . . . 75.25 106.659 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.43 -52.73 24.02 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.661 -0.866 . . . . 62.4 108.661 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -49.32 67.45 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.623 -0.262 . . . . 71.25 110.558 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -59.53 -57.5 12.67 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 122.104 -0.373 . . . . 73.12 110.129 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -63.58 -28.7 70.11 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.581 0.229 . . . . 62.15 110.948 -170.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.34 -40.37 58.38 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.146 -1.427 . . . . 64.44 107.146 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.56 9.61 78.39 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 109.794 -1.322 . . . . 62.44 109.794 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -100.22 7.07 44.73 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.594 -1.262 . . . . 74.11 107.594 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mp -134.5 140.75 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 102.987 -2.968 . . . . 72.51 102.987 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -140.83 158.71 43.56 Favored 'General case' 0 CA--C 1.465 -2.325 0 N-CA-C 104.666 -2.346 . . . . 75.54 104.666 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.21 140.48 57.43 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.487 -1.672 . . . . 72.24 106.487 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.5 -32.83 6.34 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 108.663 -1.775 . . . . 72.04 108.663 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -67.45 155.92 37.84 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.119 -1.808 . . . . 74.03 106.119 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.423 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 1.6 ppt_? -133.38 156.55 47.44 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.233 -0.987 . . . . 72.3 109.247 -169.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -93.02 138.73 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.474 -1.676 . . . . 60.51 106.474 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.432 ' CD1' HG21 ' A' ' 7' ' ' ILE . 7.0 mt -99.12 -59.29 1.75 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.216 -1.772 . . . . 64.33 106.216 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.56 152.28 50.3 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 106.474 -1.676 . . . . 64.12 106.474 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.91 121.14 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 104.522 -2.399 . . . . 72.44 104.522 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.96 36.48 22.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.937 0.895 . . . . 74.11 110.532 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.95 -19.95 52.24 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.694 -1.762 . . . . 75.35 108.694 169.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.4 116.09 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 107.565 -1.272 . . . . 72.13 107.565 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -55.52 117.91 4.0 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 107.664 -1.236 . . . . 71.15 107.664 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -102.12 -13.09 17.62 Favored 'General case' 0 C--O 1.202 -1.402 0 N-CA-C 106.608 -1.627 . . . . 64.43 106.608 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.84 128.72 37.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.523 -0.917 . . . . 64.52 108.523 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.41 -17.67 58.65 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 108.239 -1.945 . . . . 61.03 108.239 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 106.316 -1.735 . . . . 74.41 106.316 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -84.77 -179.37 7.09 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.384 0.611 . . . . 74.53 109.362 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -60.89 -52.44 65.05 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.073 -1.084 . . . . 70.44 108.073 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -60.27 -44.83 94.98 Favored 'General case' 0 C--N 1.372 1.564 0 O-C-N 121.859 -0.525 . . . . 74.15 110.37 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -55.44 -46.6 76.72 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 109.171 -0.677 . . . . 74.51 109.171 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HB3' HG13 ' A' ' 36' ' ' ILE . . . -51.43 -53.83 32.9 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.893 -0.594 . . . . 63.04 110.722 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.16 -43.64 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.044 -1.095 . . . . 75.34 108.044 -171.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 t -68.04 -30.34 69.54 Favored 'General case' 0 C--O 1.193 -1.912 0 C-N-CA 116.924 -1.91 . . . . 75.14 107.253 -170.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -67.96 -43.42 79.06 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.876 -1.765 . . . . 74.42 106.892 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.68 -29.0 69.04 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 109.526 -0.546 . . . . 63.1 109.526 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.24 -60.39 2.29 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 107.77 -1.196 . . . . 75.12 107.77 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -58.85 -3.37 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.775 1.23 . . . . 74.34 113.607 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 p -73.97 -176.33 2.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.678 -0.86 . . . . 73.23 108.678 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.77 -149.17 24.42 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 109.432 -1.467 . . . . 64.42 109.432 -167.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -65.95 -55.18 18.15 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.177 -1.416 . . . . 75.5 107.177 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -100.68 144.36 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 N-CA-C 105.441 -2.059 . . . . 74.32 105.441 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -108.49 133.41 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 106.128 -1.804 . . . . 75.42 106.128 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -107.08 121.87 45.35 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 104.902 -2.259 . . . . 75.23 104.902 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.5 134.42 13.01 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.074 -1.084 . . . . 75.31 108.074 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -84.63 141.33 30.72 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 108.232 -1.025 . . . . 74.11 108.232 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.3 163.24 17.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.054 -2.202 . . . . 73.24 105.054 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.423 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 36.2 tt0 -124.17 137.28 54.56 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 102.25 -3.241 . . . . 64.42 102.25 166.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -61.16 149.88 36.01 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.822 -0.807 . . . . 75.01 108.822 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.678 0 N-CA-C 105.654 -2.978 . . . . 72.33 105.654 175.708 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.958 0 N-CA-C 108.598 -1.801 . . . . 73.02 108.598 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -78.91 132.37 36.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.435 -1.321 . . . . 74.2 107.435 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' A' ' 60' ' ' LEU . 18.5 mm -100.38 135.58 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 106.196 -1.779 . . . . 73.2 106.196 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -145.88 161.61 39.62 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 107.669 -1.234 . . . . 74.33 107.669 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.49 151.76 29.57 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 105.548 -2.019 . . . . 74.55 105.548 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -145.04 153.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 106.715 -1.587 . . . . 75.14 106.715 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -111.96 131.22 55.53 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 105.116 -2.179 . . . . 75.03 105.116 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.441 HD23 HD12 ' A' ' 53' ' ' ILE . 4.6 mp -136.76 145.15 44.27 Favored 'General case' 0 CA--C 1.462 -2.409 0 N-CA-C 107.881 -1.155 . . . . 74.14 107.881 174.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.15 144.83 26.67 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.139 -1.43 . . . . 74.33 107.139 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -75.22 -27.52 59.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.773 -1.195 . . . . 64.54 107.773 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 t30 71.02 96.89 0.07 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.831 0.852 . . . . 73.44 109.226 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 62.13 40.51 11.8 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.139 -1.06 . . . . 73.35 108.139 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 50.29 -8.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.067 2.547 . . . . 73.32 114.952 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.7 m -93.06 115.69 28.34 Favored 'General case' 0 CA--C 1.47 -2.105 0 N-CA-C 106.745 -1.576 . . . . 70.42 106.745 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.524 ' H ' HD21 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -87.12 -150.75 0.16 Allowed 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.516 -2.401 . . . . 74.45 104.516 173.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.79 29.89 0.02 OUTLIER Glycine 0 CA--C 1.463 -3.203 0 N-CA-C 107.169 -2.372 . . . . 71.2 107.169 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.38 176.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 103.14 -2.911 . . . . 62.21 103.14 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -151.04 166.48 30.6 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 104.166 -2.531 . . . . 54.4 104.166 172.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.06 177.32 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 107.827 -1.175 . . . . 74.32 107.827 -166.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 170.78 20.74 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.525 -2.398 . . . . 75.13 104.525 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.53 -153.16 24.81 Favored Glycine 0 CA--C 1.484 -1.854 0 N-CA-C 109.091 -1.604 . . . . 70.22 109.091 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.45 -80.93 0.32 Allowed Glycine 0 CA--C 1.477 -2.299 0 N-CA-C 108.864 -1.695 . . . . 61.44 108.864 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.71 16.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 122.755 0.422 . . . . 71.32 111.643 -166.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.3 t30 85.64 6.43 0.43 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.241 -1.022 . . . . 75.23 108.241 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -45.89 -168.39 0.0 OUTLIER 'General case' 0 C--O 1.192 -1.933 0 C-N-CA 126.821 2.048 . . . . 75.2 112.051 162.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.6 m -33.06 -43.58 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.568 1.547 . . . . 74.11 114.441 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.1 m -71.3 130.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 107.524 -1.287 . . . . 74.31 107.524 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -55.93 11.51 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 121.138 -0.976 . . . . 74.43 108.854 -166.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -61.74 -20.72 63.84 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 111.81 0.3 . . . . 61.43 111.81 -164.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 55.64 2.63 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 107.817 -2.113 . . . . 64.4 107.817 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.01 -179.77 29.62 Favored Glycine 0 CA--C 1.456 -3.629 1 N-CA-C 101.923 -4.471 . . . . 71.15 101.923 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.13 136.66 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.593 0 N-CA-C 104.734 -2.321 . . . . 65.31 104.734 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -105.48 151.43 24.27 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 103.487 -2.783 . . . . 71.34 103.487 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.95 101.41 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.724 -1.954 . . . . 74.21 105.724 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.09 -37.02 66.89 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.116 -1.402 . . . . 75.31 110.978 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.43 140.54 24.03 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.283 -1.747 . . . . 74.23 106.283 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.57 132.97 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 103.368 -2.827 . . . . 74.53 103.368 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 154.03 84.95 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 106.647 -1.612 . . . . 75.41 106.647 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.18 172.34 16.24 Favored 'Trans proline' 0 CA--C 1.472 -2.6 0 N-CA-C 107.079 -1.931 . . . . 55.11 107.079 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 53.41 55.67 8.38 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 124.612 1.195 . . . . 74.24 109.541 164.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.34 176.37 35.31 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 104.011 -3.635 . . . . 73.41 104.011 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.35 55.77 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 117.291 0.546 . . . . 74.43 109.765 -168.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.39 -49.79 63.73 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 122.542 -0.099 . . . . 70.23 111.115 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -62.86 -55.8 22.98 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 122.094 -0.379 . . . . 71.02 110.483 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 m -65.78 -29.03 69.46 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 110.051 -0.351 . . . . 73.13 110.051 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.14 -38.13 52.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.318 -1.734 . . . . 65.02 106.318 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 15.22 76.39 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 109.889 -1.285 . . . . 74.32 109.889 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -101.56 7.65 42.19 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.043 -1.465 . . . . 74.35 107.043 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.441 HD12 HD23 ' A' ' 12' ' ' LEU . 64.0 mt -141.49 143.72 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 103.756 -2.683 . . . . 75.2 103.756 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -141.63 169.31 17.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.089 -2.56 . . . . 75.31 104.089 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -68.09 138.47 55.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.569 -2.011 . . . . 62.02 105.569 164.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.04 -28.07 12.92 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 108.991 -1.644 . . . . 73.1 108.991 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.57 139.51 53.33 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 118.057 0.929 . . . . 72.12 108.708 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.7 130.24 56.12 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 104.839 -2.282 . . . . 73.25 104.839 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.75 130.61 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.281 -2.118 . . . . 73.44 105.281 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.433 ' CD1' HG21 ' A' ' 7' ' ' ILE . 19.8 mt -97.79 -58.31 2.02 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 106.366 -1.716 . . . . 73.35 106.366 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.7 151.47 50.21 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.51 -1.663 . . . . 71.43 106.51 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.08 117.93 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 105.485 -2.043 . . . . 73.21 105.485 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 t30 49.42 40.39 18.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.246 1.018 . . . . 71.22 111.033 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.68 7.05 Favored Glycine 0 CA--C 1.472 -2.621 0 N-CA-C 108.157 -1.977 . . . . 73.3 108.157 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.15 117.04 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 N-CA-C 108.643 -0.873 . . . . 72.42 108.643 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -56.27 126.17 25.05 Favored 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.377 -0.971 . . . . 75.34 108.377 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.66 -12.09 17.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.237 -1.764 . . . . 75.35 106.237 -169.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.8 124.31 19.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.677 -0.861 . . . . 74.03 108.677 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.81 -16.53 61.07 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.764 -1.735 . . . . 62.15 108.764 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.31 154.01 31.25 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 106.814 -1.55 . . . . 44.54 106.814 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.7 p -85.57 179.38 7.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.56 -0.904 . . . . 75.35 108.56 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -68.83 -42.92 76.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.559 -0.904 . . . . 74.11 108.559 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -56.35 16.18 Favored 'General case' 0 C--N 1.367 1.352 0 O-C-N 121.915 -0.491 . . . . 73.11 110.085 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -54.79 -45.11 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 122.19 -0.319 . . . . 71.41 110.248 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.03 -54.48 29.51 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 116.085 -0.507 . . . . 75.23 110.488 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.64 -38.17 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 108.758 -0.83 . . . . 75.4 108.758 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.2 t -56.29 -40.03 73.63 Favored 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 105.935 -1.876 . . . . 64.52 105.935 -173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 m -74.42 -48.84 25.24 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.054 -1.43 . . . . 72.23 109.194 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.11 -31.43 72.62 Favored 'General case' 0 C--N 1.368 1.391 0 N-CA-C 110.259 -0.274 . . . . 73.42 110.259 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -79.51 -53.71 6.61 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 108.246 -1.02 . . . . 74.05 108.246 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -68.79 53.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.295 1.045 . . . . 71.32 110.973 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 p -110.77 -175.74 2.79 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.384 -1.71 . . . . 74.1 106.384 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.1 -156.11 32.5 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.497 -2.641 . . . . 34.2 106.497 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -62.24 -54.69 37.23 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.784 -1.191 . . . . 73.5 107.784 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.46 142.36 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 106.461 -1.681 . . . . 75.41 106.461 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.9 t -103.71 132.17 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 N-CA-C 105.052 -2.203 . . . . 71.25 105.052 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -110.24 127.75 55.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.831 -2.285 . . . . 73.51 104.831 173.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 139.17 16.02 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.727 -1.212 . . . . 73.24 107.727 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.4 140.53 33.41 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 107.271 -1.381 . . . . 75.41 107.271 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.83 160.82 38.24 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.994 -1.457 . . . . 73.21 107.474 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -123.57 120.77 33.82 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.387 -2.079 . . . . 75.41 105.387 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.419 0.0 OUTLIER 34.79 -79.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 127.146 2.178 . . . . 75.33 116.195 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.461 -3.285 0 N-CA-C 106.043 -2.823 . . . . 33.22 106.043 -173.267 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.244 0 N-CA-C 108.946 -1.661 . . . . 74.42 108.946 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -75.9 137.24 40.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.557 -1.275 . . . . 72.41 107.557 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.8 mt -101.11 128.82 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 N-CA-C 107.653 -1.24 . . . . 72.45 107.653 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -139.76 156.23 46.88 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.212 -1.403 . . . . 64.41 107.212 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.1 145.93 31.86 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.483 -2.043 . . . . 62.21 105.483 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -140.39 151.69 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.038 -1.467 . . . . 72.43 107.038 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.58 128.54 54.91 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 105.35 -2.093 . . . . 64.13 105.35 168.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mp -132.27 143.93 50.25 Favored 'General case' 0 CA--C 1.454 -2.731 0 N-CA-C 107.438 -1.319 . . . . 72.0 107.438 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.66 142.18 28.4 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 105.521 -2.029 . . . . 72.31 105.521 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -71.72 -30.55 65.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.071 -1.085 . . . . 75.22 108.071 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 72.43 104.38 0.07 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.76 -0.83 . . . . 74.01 108.76 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 18' ' ' SER . 23.4 t70 62.27 46.47 6.05 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.817 0.847 . . . . 74.52 110.192 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 53.39 -9.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 127.12 2.168 . . . . 63.43 114.791 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 16' ' ' ASP . 14.7 m -109.61 149.69 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.203 -1.036 . . . . 63.24 108.203 -167.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.43 167.4 30.15 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 105.629 -1.989 . . . . 73.12 105.629 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.05 95.54 0.1 Allowed Glycine 0 CA--C 1.46 -3.356 0 N-CA-C 104.225 -3.55 . . . . 74.43 104.225 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.66 153.07 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.091 -2.929 . . . . 74.15 103.091 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.5 m -91.77 159.41 15.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 103.657 -2.72 . . . . 71.01 103.657 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 m -151.0 167.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.99 -2.226 . . . . 74.22 104.99 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -167.92 170.6 10.47 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.668 -2.345 . . . . 75.44 104.668 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.57 -148.88 21.42 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 107.421 -2.272 . . . . 61.22 107.421 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 115.1 -78.69 0.27 Allowed Glycine 0 CA--C 1.481 -2.048 0 N-CA-C 108.953 -1.659 . . . . 72.14 108.953 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.6 15.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 123.304 0.642 . . . . 71.35 109.819 -170.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 26' ' ' GLY . 63.0 m-80 83.81 7.05 0.65 Allowed 'General case' 0 CA--C 1.486 -1.494 0 C-N-CA 124.373 1.069 . . . . 74.11 108.182 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.8 p -47.52 -171.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.058 1.743 . . . . 74.43 113.114 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -34.99 -44.04 0.21 Allowed 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.545 1.938 . . . . 74.32 114.544 -164.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.9 m -58.39 126.44 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 122.281 1.038 . . . . 74.43 110.301 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -51.62 -52.64 46.06 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.463 -1.244 . . . . 74.15 113.833 -165.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.24 -18.88 61.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 119.088 -1.045 . . . . 63.51 109.509 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.22 54.83 2.9 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 108.271 -1.931 . . . . 72.12 108.271 172.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.43 -179.17 22.38 Favored Glycine 0 CA--C 1.461 -3.328 0 N-CA-C 104.051 -3.62 . . . . 75.33 104.051 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.0 mm -82.49 128.02 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.353 0 N-CA-C 104.409 -2.441 . . . . 74.41 104.409 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -106.37 150.91 25.54 Favored 'General case' 0 CA--C 1.459 -2.536 0 N-CA-C 104.432 -2.433 . . . . 75.32 104.432 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.95 103.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 N-CA-C 105.5 -2.037 . . . . 75.23 105.5 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -70.21 -33.99 72.35 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 114.393 -1.276 . . . . 75.13 109.3 -172.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.5 155.55 9.18 Favored 'General case' 0 CA--C 1.464 -2.348 0 N-CA-C 105.636 -1.987 . . . . 64.43 105.636 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.97 134.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 103.045 -2.946 . . . . 75.33 103.045 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 150.18 77.56 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 105.31 -2.108 . . . . 75.34 105.31 176.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.02 168.82 23.86 Favored 'Trans proline' 0 CA--C 1.465 -2.928 0 N-CA-C 105.528 -2.528 . . . . 74.4 105.528 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 62.93 -0.33 0.6 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.297 0.851 . . . . 73.15 113.297 167.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.5 173.81 49.89 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 106.712 -2.555 . . . . 73.43 106.712 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.79 73.95 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.961 -1.125 . . . . 61.32 107.961 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.95 -49.48 65.98 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 115.826 -0.624 . . . . 75.22 110.377 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -65.36 -56.15 14.19 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 122.145 -0.347 . . . . 71.34 110.072 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -63.73 -28.8 70.13 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 122.103 -0.373 . . . . 72.15 111.009 -170.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -83.93 -30.99 25.86 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 106.515 -1.661 . . . . 72.33 106.515 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.89 20.0 79.69 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.375 -1.09 . . . . 72.44 110.375 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -97.16 6.54 48.3 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.691 -1.596 . . . . 71.21 106.691 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.2 mt -140.96 141.66 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.451 -3.166 . . . . 62.11 102.451 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -142.3 153.5 43.93 Favored 'General case' 0 CA--C 1.46 -2.482 0 N-CA-C 105.205 -2.146 . . . . 65.44 105.205 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.68 141.9 56.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.273 -1.38 . . . . 73.42 107.273 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.21 -32.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 108.898 -1.681 . . . . 72.35 108.898 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.62 154.32 29.43 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 107.83 -1.174 . . . . 62.44 107.83 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.14 135.35 53.9 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.474 -1.676 . . . . 75.42 106.474 -167.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.0 129.57 41.56 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 105.454 -2.054 . . . . 72.23 105.454 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.3 mt -95.53 -60.5 1.65 Allowed 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.527 -1.286 . . . . 73.43 107.527 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.88 48.96 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 106.099 -1.815 . . . . 74.24 106.099 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.5 t -115.31 114.85 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 105.23 -2.137 . . . . 71.35 105.23 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 t30 44.09 47.25 7.4 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.046 1.338 . . . . 72.35 111.34 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.45 -32.96 6.9 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 108.301 -1.92 . . . . 61.22 108.301 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.52 118.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.751 0 N-CA-C 109.384 -0.599 . . . . 72.22 109.384 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -54.22 109.47 0.49 Allowed 'General case' 0 C--N 1.369 1.425 0 N-CA-C 106.976 -1.49 . . . . 70.13 106.976 168.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -100.49 -13.28 18.74 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.357 -1.72 . . . . 74.13 106.357 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.27 134.32 56.35 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.458 -0.941 . . . . 65.44 108.458 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.77 -17.69 58.12 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.172 -1.971 . . . . 72.52 108.172 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 151.71 28.06 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.607 -1.998 . . . . 71.32 105.607 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.3 p -79.54 178.41 8.15 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.813 0.816 . . . . 75.41 108.935 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -68.03 -45.17 74.72 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 108.533 -0.914 . . . . 71.32 108.533 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -56.37 -51.5 68.07 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 121.577 -0.702 . . . . 74.23 110.585 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -53.61 -41.49 66.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.831 -0.433 . . . . 63.21 109.831 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.16 64.09 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.975 -0.557 . . . . 64.42 110.02 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.38 -47.41 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 107.793 -1.188 . . . . 75.42 107.793 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.9 m -56.72 -35.59 68.72 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 107.38 -1.341 . . . . 53.41 107.38 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -69.9 -47.11 63.79 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 120.484 -1.385 . . . . 75.01 108.012 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.46 -32.94 72.95 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 109.126 -0.694 . . . . 71.33 109.126 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.55 -60.71 2.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.892 -1.151 . . . . 72.32 107.892 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -69.67 48.63 0.09 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 123.569 0.748 . . . . 71.31 111.706 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.8 p -102.5 -175.71 2.9 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.377 -2.083 . . . . 74.14 105.377 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.89 -148.12 22.75 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 106.799 -2.52 . . . . 70.2 106.799 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.44 -55.24 12.54 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.102 -1.073 . . . . 73.41 108.102 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.1 140.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.41 -1.7 . . . . 74.11 106.41 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -104.99 135.62 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.053 -1.832 . . . . 75.24 106.053 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -110.43 129.3 55.8 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 104.889 -2.263 . . . . 72.42 104.889 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.74 133.88 10.48 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.126 -1.435 . . . . 75.33 107.126 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -80.86 138.02 36.19 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 107.71 -1.219 . . . . 74.31 107.71 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.89 155.99 22.76 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.492 -2.41 . . . . 74.44 104.492 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.77 132.19 55.55 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 100.827 -3.768 . . . . 72.32 100.827 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.99 138.62 58.17 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.708 -0.849 . . . . 74.55 108.708 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.305 0 N-CA-C 106.858 -2.497 . . . . 74.05 106.858 -176.211 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.136 0 N-CA-C 109.344 -1.502 . . . . 64.14 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.28 141.84 31.54 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.358 -1.349 . . . . 63.33 107.358 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.5 mt -104.63 135.11 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.997 0 N-CA-C 109.069 -0.715 . . . . 75.43 109.069 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 2.8 p90 -130.84 149.27 52.55 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 106.56 -1.644 . . . . 74.14 106.56 169.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -103.64 146.13 29.02 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.88 -2.267 . . . . 64.41 104.88 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.75 152.37 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 106.596 -1.631 . . . . 73.21 106.596 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -106.99 131.69 53.77 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.737 -2.32 . . . . 71.13 104.737 168.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -142.98 142.37 31.62 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.207 -1.035 . . . . 63.25 108.207 -178.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.22 150.52 21.94 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 105.099 -2.186 . . . . 72.1 105.099 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.503 ' HG3' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -76.85 -35.1 57.74 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.744 -1.576 . . . . 64.25 106.744 175.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 77.54 109.91 0.07 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.466 -1.309 . . . . 75.14 107.466 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 t0 57.69 36.12 26.3 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 107.804 -1.184 . . . . 74.23 107.804 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.3 t30 52.05 2.03 0.02 OUTLIER 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.752 1.621 . . . . 75.34 112.985 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.0 m -116.54 114.04 23.6 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 120.369 -1.457 . . . . 74.33 109.027 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.503 ' HG ' ' HG3' ' A' ' 14' ' ' LYS . 49.8 mt -94.22 -153.94 0.39 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 102.468 -3.16 . . . . 63.0 102.468 162.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.07 42.19 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 107.752 -2.139 . . . . 71.15 107.752 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.3 176.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 105.428 -2.064 . . . . 74.32 105.428 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.62 158.33 21.87 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 104.681 -2.34 . . . . 65.15 104.681 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -145.9 172.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 N-CA-C 106.16 -1.792 . . . . 74.24 106.16 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -164.48 167.35 19.59 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 104.353 -2.462 . . . . 74.23 104.353 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 -160.12 29.11 Favored Glycine 0 CA--C 1.494 -1.272 0 N-CA-C 109.004 -1.638 . . . . 71.1 109.004 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.43 -91.38 0.31 Allowed Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 109.063 -1.615 . . . . 74.21 109.063 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.14 16.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.506 1.123 . . . . 63.11 113.975 -162.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 85.24 6.78 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.503 1.121 . . . . 74.53 108.716 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 p -37.97 -170.06 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 127.266 2.226 . . . . 61.21 113.895 161.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 m -57.77 -21.27 40.6 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.134 0.974 . . . . 73.42 112.333 -168.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.86 136.23 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 109.053 -0.721 . . . . 74.34 109.053 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -70.57 0.1 Allowed 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.437 1.095 . . . . 73.51 111.424 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -86.21 15.75 4.95 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.497 -0.752 . . . . 74.14 110.977 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 49.68 62.58 4.75 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 110.205 -1.158 . . . . 72.21 110.205 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.01 179.76 28.3 Favored Glycine 0 CA--C 1.454 -3.734 0 N-CA-C 103.843 -3.703 . . . . 61.41 103.843 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.87 132.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.882 0 N-CA-C 105.373 -2.084 . . . . 70.13 105.373 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -110.25 148.39 31.97 Favored 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.881 -2.637 . . . . 71.33 103.881 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -82.06 102.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.049 -1.834 . . . . 74.01 106.049 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -71.9 -33.8 68.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.459 -1.246 . . . . 63.33 110.365 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 146.97 20.49 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 106.247 -1.761 . . . . 74.21 106.247 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.5 125.98 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 N-CA-C 104.853 -2.277 . . . . 65.53 104.853 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -98.59 171.21 6.02 Favored Pre-proline 0 C--O 1.213 -0.817 0 N-CA-C 105.687 -1.968 . . . . 74.13 105.687 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 60.0 Cg_endo -84.43 179.62 4.38 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.398 1.399 . . . . 72.25 110.128 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 76.25 -14.15 0.83 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.184 1.394 . . . . 72.02 113.042 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.43 -179.51 45.16 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.58 -1.408 . . . . 74.11 109.58 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.12 -53.67 12.06 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.033 -0.584 . . . . 71.41 109.558 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.53 -50.83 66.93 Favored 'General case' 0 C--N 1.369 1.43 0 CA-C-O 121.08 0.467 . . . . 74.23 110.227 -170.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.607 ' HG2' ' H ' ' A' ' 49' ' ' SER . 3.8 pm0 -61.66 -55.88 25.73 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 123.907 0.883 . . . . 73.43 110.713 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.607 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 22.0 m -62.36 -25.13 67.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.958 0.503 . . . . 70.52 110.859 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -84.35 -28.28 27.14 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.917 -1.512 . . . . 71.13 106.917 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.22 15.15 81.43 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.052 -1.219 . . . . 52.33 110.052 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -99.11 6.71 46.4 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.274 -1.38 . . . . 74.44 107.274 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.423 HD12 HD11 ' A' ' 12' ' ' LEU . 1.3 mp -132.15 137.52 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 102.099 -3.297 . . . . 73.24 102.099 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -133.68 151.37 51.63 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.75 -2.315 . . . . 75.44 104.75 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -67.9 138.14 55.78 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.736 -1.579 . . . . 73.04 106.736 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.57 -27.79 11.49 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 109.496 -1.442 . . . . 75.42 109.496 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.39 154.61 35.0 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 107.141 -1.429 . . . . 73.42 107.141 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.489 HH21 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -117.63 139.01 51.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.472 -1.677 . . . . 64.14 106.472 -166.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.5 131.0 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 105.805 -1.924 . . . . 61.44 105.805 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mt -92.32 -60.08 1.93 Allowed 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.42 -1.696 . . . . 72.42 106.42 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.78 150.64 52.09 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 107.08 -1.452 . . . . 64.0 107.08 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -120.73 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 103.683 -2.71 . . . . 75.41 103.683 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.2 t30 60.58 30.07 19.47 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 121.636 0.732 . . . . 71.12 109.098 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.58 75.16 Favored Glycine 0 CA--C 1.483 -1.942 0 N-CA-C 109.326 -1.51 . . . . 54.23 109.326 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.33 122.29 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 106.77 -1.567 . . . . 74.33 106.77 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.68 111.65 0.86 Allowed 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.557 -1.275 . . . . 42.42 107.557 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -97.92 -10.99 23.64 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 106.477 -1.675 . . . . 74.31 106.477 -167.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.489 ' HB3' HH21 ' A' ' 58' ' ' ARG . 25.9 pt-20 -62.99 131.89 50.18 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.265 -0.897 . . . . 74.34 108.69 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.41 -19.72 38.31 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.336 -1.505 . . . . 73.22 109.336 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -81.44 154.62 26.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 105.78 -1.933 . . . . 74.22 105.78 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 p -86.04 178.87 7.1 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.682 0.753 . . . . 75.12 109.683 -166.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -64.14 -45.21 89.51 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.553 -0.906 . . . . 73.22 108.553 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -50.29 -56.06 12.82 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 109.939 -0.393 . . . . 74.1 109.939 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -57.43 -45.26 84.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 116.261 -0.427 . . . . 63.05 109.963 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.19 -56.47 12.65 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 122.603 0.361 . . . . 75.13 110.921 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.77 -39.3 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 109.514 -0.55 . . . . 75.12 109.514 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.69 -29.26 69.22 Favored 'General case' 0 C--O 1.186 -2.283 0 C-N-CA 117.021 -1.871 . . . . 74.44 106.503 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -67.77 -43.23 80.3 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.506 -1.371 . . . . 72.13 107.736 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.0 mt -65.97 -37.0 84.84 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.136 -0.69 . . . . 74.23 109.136 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -77.58 -61.79 1.88 Allowed 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.026 -0.731 . . . . 72.3 109.026 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.46 62.57 1.0 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.01 0.91 . . . . 54.34 110.75 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.07 -176.67 4.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.3 -1.741 . . . . 73.31 106.3 172.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.92 -138.4 4.22 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.758 -2.137 . . . . 60.23 107.758 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.0 -56.06 5.12 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.864 -0.791 . . . . 73.44 108.864 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.0 150.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 107.504 -1.295 . . . . 72.24 107.504 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.9 t -124.77 152.67 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.02 -2.215 . . . . 72.44 105.02 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -102.55 116.61 32.95 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 104.218 -2.512 . . . . 73.21 104.218 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.34 116.53 14.43 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 107.508 -1.293 . . . . 75.13 107.508 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.61 141.64 33.52 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 108.393 -0.965 . . . . 75.13 108.393 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -115.37 154.83 28.49 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.19 -2.152 . . . . 75.01 105.19 178.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.15 133.03 54.29 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 101.87 -3.382 . . . . 73.21 101.87 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.46 139.59 56.96 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.685 -0.857 . . . . 74.04 108.685 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.125 0 N-CA-C 108.093 -2.003 . . . . 71.35 108.093 -178.172 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.328 0 N-CA-C 109.424 -1.47 . . . . 61.02 109.424 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -73.73 134.65 43.53 Favored 'General case' 0 C--N 1.363 1.164 0 N-CA-C 106.855 -1.535 . . . . 73.0 106.855 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -104.31 136.49 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.515 0 N-CA-C 108.146 -1.057 . . . . 71.12 108.146 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.8 159.0 43.82 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.028 -1.471 . . . . 74.24 107.028 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.63 145.37 30.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 75.51 105.67 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.9 m -140.12 151.02 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.381 -1.34 . . . . 65.44 107.381 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -112.11 125.89 54.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.941 -1.874 . . . . 65.12 105.941 167.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.13 143.59 46.64 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 106.793 -1.558 . . . . 72.4 106.793 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.44 152.39 21.5 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.83 -1.915 . . . . 71.41 105.83 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -69.45 -36.01 76.21 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.846 -1.168 . . . . 73.31 107.846 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.24 112.84 0.07 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.44 -0.948 . . . . 71.45 108.44 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.3 32.95 21.39 Favored 'General case' 0 C--N 1.369 1.456 0 N-CA-C 108.603 -0.888 . . . . 75.03 108.603 -174.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.3 t30 48.6 -1.39 0.0 OUTLIER 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.284 1.834 . . . . 55.54 114.1 -174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -89.83 172.92 8.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.276 -1.379 . . . . 61.3 107.276 -170.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.88 -156.31 0.56 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 103.753 -2.684 . . . . 75.23 103.753 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.66 39.37 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.684 0 N-CA-C 105.912 -2.875 . . . . 65.0 105.912 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.99 177.11 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 104.309 -2.478 . . . . 71.31 104.309 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -141.83 166.52 24.51 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 104.905 -2.257 . . . . 53.43 104.905 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.65 172.13 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 N-CA-C 105.871 -1.9 . . . . 74.25 105.871 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -167.94 168.49 12.07 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 104.404 -2.443 . . . . 75.41 104.404 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.46 -141.42 20.46 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 108.733 -1.747 . . . . 51.13 108.733 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 100.07 -70.19 0.49 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 109.038 -1.625 . . . . 61.4 109.038 174.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.98 13.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 121.397 0.618 . . . . 75.33 109.475 -171.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 26' ' ' GLY . 2.3 m120 78.77 6.39 2.31 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.521 1.128 . . . . 65.23 109.333 176.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.6 t -53.0 -170.7 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 124.2 1.0 . . . . 74.23 111.378 167.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 m -30.81 -44.87 0.06 Allowed 'General case' 0 C--N 1.366 1.307 0 C-N-CA 127.448 2.299 . . . . 75.34 115.657 -162.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.07 132.68 21.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.513 0.673 . . . . 72.31 110.722 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -49.94 -57.66 7.04 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-N 115.138 -0.937 . . . . 73.54 112.677 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -72.81 -20.9 61.06 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.897 -0.721 . . . . 72.12 109.478 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.21 -14.81 62.12 Favored Glycine 0 C--N 1.359 1.835 0 N-CA-C 109.323 -1.511 . . . . 60.21 109.323 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.19 -178.96 48.24 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 109.09 -1.604 . . . . 75.34 109.09 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.7 mm -81.66 124.5 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 103.014 -2.958 . . . . 75.12 103.014 171.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -100.87 150.4 22.87 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 103.688 -2.708 . . . . 75.01 103.688 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.1 t -80.18 102.97 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.078 -2.193 . . . . 73.13 105.078 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -71.57 -32.87 68.56 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.752 -1.113 . . . . 72.4 109.933 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.82 147.9 22.0 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 106.273 -1.751 . . . . 71.21 106.273 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.13 133.05 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 N-CA-C 103.174 -2.898 . . . . 73.35 103.174 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.95 152.5 71.75 Favored Pre-proline 0 CA--C 1.511 -0.526 0 N-CA-C 106.502 -1.666 . . . . 73.02 106.502 176.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 58.8 Cg_endo -76.86 172.57 15.96 Favored 'Trans proline' 0 CA--C 1.463 -3.053 0 N-CA-C 105.909 -2.381 . . . . 74.3 105.909 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 66.21 -1.72 1.13 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 124.294 0.996 . . . . 74.12 111.994 163.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.65 -179.1 36.5 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 107.334 -2.306 . . . . 75.42 107.334 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.89 -52.94 45.83 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.268 -1.012 . . . . 71.43 108.268 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.37 65.24 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.379 -0.373 . . . . 75.22 110.838 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.0 -55.31 26.85 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 109.583 -0.525 . . . . 75.41 109.583 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 t -58.35 -32.51 68.6 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.045 0.538 . . . . 64.21 110.641 -171.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.91 -29.6 29.1 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.797 -1.186 . . . . 62.4 107.797 -172.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.25 83.65 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 110.36 -1.096 . . . . 64.05 110.36 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -99.31 6.39 46.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 106.709 -1.589 . . . . 72.54 106.709 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.0 mt -142.44 138.59 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 103.098 -2.927 . . . . 72.41 103.098 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.02 166.34 26.35 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.482 -2.414 . . . . 74.0 104.482 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.72 145.77 54.43 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 107.119 -1.437 . . . . 73.54 107.119 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.59 -33.01 5.97 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 107.982 -2.047 . . . . 64.44 107.982 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.92 149.08 45.52 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 106.941 -1.503 . . . . 71.54 106.941 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.79 143.86 47.62 Favored 'General case' 0 CA--C 1.473 -2.009 0 N-CA-C 107.259 -1.386 . . . . 72.53 107.259 -165.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.26 130.07 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 105.826 -1.916 . . . . 74.21 105.826 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.6 mt -95.27 -59.28 1.92 Allowed 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.275 -1.38 . . . . 73.44 107.275 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.95 51.17 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 105.946 -1.872 . . . . 74.44 105.946 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.73 121.45 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.376 -2.083 . . . . 75.31 105.376 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.47 30.5 13.01 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.524 0.678 . . . . 74.43 109.724 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.81 -18.2 57.2 Favored Glycine 0 CA--C 1.48 -2.152 0 N-CA-C 109.158 -1.577 . . . . 73.01 109.158 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.64 115.75 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 108.266 -1.013 . . . . 73.22 108.266 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 m -56.74 120.0 7.11 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 107.899 -1.148 . . . . 75.33 107.899 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -111.92 -11.83 13.84 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.663 -1.606 . . . . 71.02 106.663 -162.079 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -56.38 128.34 35.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.969 -0.752 . . . . 75.43 108.969 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.88 -13.03 68.31 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 108.773 -1.731 . . . . 65.43 108.773 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -85.74 157.04 20.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.56 -1.645 . . . . 63.23 106.56 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -85.68 179.08 7.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.735 0.778 . . . . 75.42 109.402 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -64.7 -45.22 87.51 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 115.392 -0.822 . . . . 73.53 108.97 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -54.5 -55.24 31.14 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 121.567 -0.708 . . . . 74.53 109.955 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -53.84 -43.76 69.74 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.696 -0.483 . . . . 75.24 109.696 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.35 27.25 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.811 0.444 . . . . 72.43 110.531 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 m -74.98 -35.47 35.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 O-C-N 121.976 -0.453 . . . . 75.43 109.835 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 12.6 t -69.11 -32.9 72.63 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 116.854 -1.938 . . . . 73.4 105.986 -169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -73.09 -45.14 58.87 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 106.996 -1.483 . . . . 73.23 106.996 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.0 -45.15 95.98 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.831 1.253 . . . . 74.31 109.562 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.444 ' C ' ' H ' ' A' ' 82' ' ' THR . 66.7 ttp85 -67.38 -56.2 10.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.517 -0.92 . . . . 75.04 108.517 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -71.47 52.16 0.19 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.75 0.42 . . . . 62.32 110.854 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 80' ' ' ARG . 6.2 p -101.69 -175.49 2.87 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.589 -2.004 . . . . 71.42 105.589 168.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.79 -152.72 17.45 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.222 -2.351 . . . . 61.11 107.222 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -63.33 -55.34 25.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.191 -1.04 . . . . 73.24 108.191 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.59 145.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 106.388 -1.708 . . . . 73.23 106.388 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 82' ' ' THR . 23.6 t -101.17 129.03 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 N-CA-C 105.242 -2.133 . . . . 74.43 105.242 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -111.98 121.63 45.54 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 104.063 -2.569 . . . . 70.34 104.063 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.68 133.61 12.28 Favored 'General case' 0 CA--C 1.46 -2.498 0 N-CA-C 106.518 -1.66 . . . . 72.41 106.518 -174.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -86.98 145.38 26.53 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 107.938 -1.134 . . . . 73.44 107.938 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.8 169.05 16.77 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.533 -2.025 . . . . 72.52 105.533 174.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.42 153.06 48.3 Favored 'General case' 0 N--CA 1.402 -2.843 0 N-CA-C 101.822 -3.399 . . . . 74.53 101.822 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -65.32 135.03 54.83 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.743 -1.206 . . . . 74.43 107.743 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.466 -2.969 0 N-CA-C 107.131 -2.388 . . . . 74.21 107.131 -176.514 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.642 0 N-CA-C 108.68 -1.768 . . . . 61.31 108.68 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -83.19 138.75 33.51 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.601 -1.629 . . . . 75.31 106.601 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 60' ' ' LEU . 23.4 mm -95.91 122.44 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 105.949 -1.871 . . . . 65.43 105.949 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.408 ' CD2' HD22 ' A' ' 90' ' ' LEU . 2.8 p90 -136.68 157.02 47.74 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.397 -0.964 . . . . 74.45 108.397 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.515 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 47.1 mt-10 -103.01 148.44 25.69 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 104.512 -2.403 . . . . 74.43 104.512 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.05 147.1 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.062 0 N-CA-C 106.078 -1.823 . . . . 64.31 106.078 170.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.63 118.18 35.95 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 104.671 -2.344 . . . . 74.25 104.671 168.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.407 HD11 HD12 ' A' ' 53' ' ' ILE . 59.3 mt -139.61 135.88 33.79 Favored 'General case' 0 CA--C 1.455 -2.7 0 N-CA-C 105.673 -1.973 . . . . 75.35 105.673 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.45 157.26 20.52 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 106.753 -1.573 . . . . 71.43 106.753 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.23 -40.72 98.24 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 106.747 -1.575 . . . . 74.24 106.747 167.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 78.36 108.32 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 107.828 -1.175 . . . . 72.34 107.828 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 18' ' ' SER . 68.4 m-20 56.81 39.09 29.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.79 0.836 . . . . 73.43 108.843 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.3 t30 55.03 -9.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.728 1.611 . . . . 71.14 113.634 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 16' ' ' ASP . 32.6 t -99.67 120.53 39.85 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.712 -1.959 . . . . 75.43 105.712 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -70.91 -56.18 6.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.904 -1.147 . . . . 72.22 107.904 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.72 85.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 109.91 -1.276 . . . . 63.23 109.91 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.553 HG23 ' H ' ' A' ' 22' ' ' CYS . 5.2 mm -86.7 176.57 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 105.262 -2.125 . . . . 74.44 105.262 -174.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.553 ' H ' HG23 ' A' ' 21' ' ' ILE . 60.0 m -138.64 164.38 29.66 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 103.754 -2.684 . . . . 74.14 103.754 174.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.65 171.93 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 105.772 -1.936 . . . . 72.14 105.772 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 t -164.15 170.64 16.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.399 -2.075 . . . . 72.34 105.399 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 -154.53 21.97 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 107.165 -2.374 . . . . 55.43 107.165 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.12 -99.0 0.65 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 109.435 -1.466 . . . . 60.4 109.435 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.36 16.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.211 1.189 . . . . 73.45 114.211 -161.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m120 85.24 6.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.267 1.027 . . . . 74.01 108.714 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -43.09 -168.34 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 126.737 2.015 . . . . 63.34 110.009 151.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 m -28.75 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.205 1.802 . . . . 74.22 114.942 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 131.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.207 -1.035 . . . . 74.54 108.207 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.13 -40.34 38.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.492 -0.929 . . . . 73.05 108.492 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -64.14 -18.01 64.03 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.916 -0.772 . . . . 74.54 108.916 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.69 2.31 64.07 Favored Glycine 0 C--O 1.208 -1.477 0 N-CA-C 110.722 -0.951 . . . . 71.2 110.722 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.93 177.68 52.15 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 106.614 -2.594 . . . . 62.1 106.614 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.78 136.55 23.78 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 N-CA-C 104.415 -2.439 . . . . 73.54 104.415 174.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -108.4 148.73 29.72 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 103.358 -2.83 . . . . 74.05 103.358 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.65 102.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 106.547 -1.649 . . . . 73.51 106.547 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -71.66 -36.3 70.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.665 -1.152 . . . . 75.21 110.45 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.97 148.94 22.77 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.061 -1.829 . . . . 74.12 106.061 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.49 138.01 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 103.936 -2.616 . . . . 75.44 103.936 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -79.17 155.52 77.06 Favored Pre-proline 0 CA--C 1.515 -0.386 0 N-CA-C 105.738 -1.949 . . . . 74.02 105.738 173.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 75.2 Cg_endo -74.39 171.7 17.57 Favored 'Trans proline' 0 CA--C 1.461 -3.168 0 N-CA-C 105.72 -2.454 . . . . 73.24 105.72 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 65.07 -0.2 1.11 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.012 0.82 . . . . 74.45 112.13 164.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.55 174.14 41.1 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 106.624 -2.59 . . . . 70.43 106.624 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.17 -52.87 36.17 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 107.854 -1.165 . . . . 63.41 107.854 -173.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.23 -50.66 64.3 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 116.068 -0.515 . . . . 71.45 111.008 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.04 -54.47 21.27 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 109.933 -0.395 . . . . 73.03 109.933 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.3 t -61.76 -28.58 69.54 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.792 0.437 . . . . 72.24 110.965 -170.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.29 -30.2 38.26 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.105 -1.813 . . . . 75.51 106.105 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.47 20.01 61.05 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 110.146 -1.182 . . . . 71.55 110.146 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -107.59 7.24 28.56 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.696 -1.224 . . . . 75.4 107.696 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.407 HD12 HD11 ' A' ' 12' ' ' LEU . 77.7 mt -144.55 145.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 102.359 -3.2 . . . . 72.3 102.359 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -151.26 176.19 11.46 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 104.77 -2.307 . . . . 74.53 104.77 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -67.23 143.29 56.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.671 -1.233 . . . . 72.1 107.671 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.44 -32.01 7.66 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.029 -1.628 . . . . 71.12 109.029 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.19 160.1 31.76 Favored 'General case' 0 C--N 1.372 1.563 0 N-CA-C 107.347 -1.353 . . . . 62.54 107.347 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -128.42 151.51 49.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 -168.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.92 135.78 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.525 -2.028 . . . . 72.14 105.525 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 7' ' ' ILE . 53.0 mt -98.5 -58.76 1.89 Allowed 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 107.391 -1.337 . . . . 62.44 107.391 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.97 148.99 48.7 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 106.149 -1.797 . . . . 71.14 106.149 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.46 122.2 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.376 -2.453 . . . . 75.01 104.376 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.31 6.2 p30 44.59 39.9 3.64 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.36 1.064 . . . . 75.42 111.161 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.87 -22.34 41.1 Favored Glycine 0 CA--C 1.471 -2.665 0 N-CA-C 108.936 -1.665 . . . . 74.12 108.936 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -78.25 114.83 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 N-CA-C 107.369 -1.345 . . . . 75.23 107.369 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 m -56.01 120.36 7.33 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.877 -0.786 . . . . 64.23 108.877 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -99.37 -17.29 18.08 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 106.916 -1.513 . . . . 75.44 106.916 -164.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -62.05 125.08 22.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.397 0.618 . . . . 72.42 109.878 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 -15.28 62.0 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 108.019 -2.032 . . . . 53.43 108.019 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 149.29 34.78 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 106.146 -1.798 . . . . 71.4 106.146 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.0 p -80.51 179.05 7.93 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.708 -0.849 . . . . 71.12 108.708 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -63.46 -50.18 70.7 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.117 -1.068 . . . . 74.22 108.117 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -54.2 -55.74 25.04 Favored 'General case' 0 C--N 1.362 1.148 0 O-C-N 121.66 -0.65 . . . . 74.15 110.601 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -54.59 -46.46 73.77 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 109.395 -0.594 . . . . 72.52 109.395 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.41 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.99 -52.47 50.32 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.163 0.585 . . . . 75.13 110.568 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.64 -40.11 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 108.025 -1.102 . . . . 75.22 108.025 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 t -63.95 -30.99 72.02 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 106.551 -1.648 . . . . 71.5 106.551 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.6 m -71.79 -45.79 60.43 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.602 -1.259 . . . . 74.35 107.602 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.99 -40.46 89.23 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 108.945 -0.761 . . . . 73.32 108.945 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.6 -60.56 3.35 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 108.2 -1.037 . . . . 75.21 108.2 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -71.36 53.37 0.2 Allowed 'General case' 0 C--N 1.373 1.605 0 C-N-CA 123.543 0.737 . . . . 61.01 110.572 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.44 HG23 HG11 ' A' ' 86' ' ' VAL . 16.1 p -112.38 -176.23 2.87 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.544 -2.021 . . . . 74.05 105.544 168.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.75 -159.69 32.4 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.195 -2.362 . . . . 63.32 107.195 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -56.86 -53.52 56.98 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.646 -0.872 . . . . 71.53 108.646 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.5 t -105.66 147.2 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 106.012 -1.847 . . . . 75.34 106.012 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.44 HG11 HG23 ' A' ' 82' ' ' THR . 39.6 t -100.37 129.53 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 106.66 -1.607 . . . . 74.24 106.66 -171.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.515 ' HE1' ' OE1' ' A' ' 9' ' ' GLU . 58.3 t60 -103.89 117.27 33.94 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 105.089 -2.189 . . . . 72.5 105.089 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.76 134.42 14.57 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 107.603 -1.258 . . . . 75.22 107.603 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.45 141.41 33.92 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.447 -1.316 . . . . 55.32 107.447 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.408 HD22 ' CD2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -117.11 163.51 16.15 Favored 'General case' 0 CA--C 1.473 -2.001 0 N-CA-C 105.605 -1.998 . . . . 71.21 105.605 175.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB2' HD13 ' A' ' 60' ' ' LEU . 33.9 tt0 -130.76 139.2 50.23 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 101.45 -3.537 . . . . 74.31 101.45 165.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -66.19 142.46 57.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.678 0 N-CA-C 105.859 -2.896 . . . . 72.33 105.859 179.592 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.744 0 N-CA-C 110.004 -1.239 . . . . 72.45 110.004 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.18 130.71 40.28 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.212 -1.403 . . . . 74.31 107.212 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.477 HD12 HD13 ' A' ' 60' ' ' LEU . 12.0 mm -98.45 136.16 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.19 -1.781 . . . . 73.34 106.19 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.79 160.09 43.11 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.68 -0.859 . . . . 73.24 108.68 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . 0.494 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 50.5 mt-10 -105.83 145.96 30.52 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 105.511 -2.033 . . . . 70.03 105.511 176.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.99 156.5 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 106.82 -1.548 . . . . 64.01 106.82 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -116.11 134.76 54.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.517 -2.031 . . . . 65.1 105.517 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.407 HD23 HD12 ' A' ' 53' ' ' ILE . 4.3 mp -135.61 145.82 47.28 Favored 'General case' 0 CA--C 1.454 -2.721 0 N-CA-C 107.755 -1.202 . . . . 74.44 107.755 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.06 142.33 28.0 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 105.206 -2.146 . . . . 73.32 105.206 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HG2' ' HB2' ' A' ' 19' ' ' LEU . 37.0 mtpt -77.68 -33.44 53.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 106.133 -1.803 . . . . 75.13 106.133 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 70.55 126.13 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.066 -1.424 . . . . 71.12 108.79 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 18' ' ' SER . 38.0 t70 59.71 34.82 22.16 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.075 -0.713 . . . . 74.02 109.075 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.1 t30 55.38 -9.18 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.009 1.724 . . . . 74.13 113.582 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' ASP . 42.4 m -99.2 130.68 45.52 Favored 'General case' 0 N--CA 1.424 -1.732 0 O-C-N 120.815 -1.178 . . . . 70.12 108.535 -168.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.415 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 24.7 tp -134.04 139.3 45.92 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 102.679 -3.082 . . . . 72.23 102.679 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.85 62.48 0.24 Allowed Glycine 0 CA--C 1.464 -3.137 0 N-CA-C 106.215 -2.754 . . . . 63.52 106.215 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 22' ' ' CYS . 1.1 mm -88.54 178.14 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.198 -2.519 . . . . 74.32 104.198 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.473 ' H ' HG22 ' A' ' 21' ' ' ILE . 8.2 m -118.43 160.35 21.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.016 -2.216 . . . . 75.01 105.016 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 m -152.05 173.03 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 106.1 -1.815 . . . . 65.11 106.1 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.418 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 12.4 t -167.22 170.54 11.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.115 -1.809 . . . . 61.3 106.115 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.57 -145.39 17.71 Favored Glycine 0 CA--C 1.485 -1.796 0 N-CA-C 109.857 -1.297 . . . . 65.44 109.857 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.67 -79.26 0.25 Allowed Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.784 -1.727 . . . . 61.23 108.784 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.07 15.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.817 0 N-CA-C 112.304 0.483 . . . . 75.11 112.304 -164.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 85.58 6.36 0.44 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 124.234 1.014 . . . . 62.41 109.35 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.1 p -46.94 -168.9 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.901 1.68 . . . . 73.43 112.188 165.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 m -35.13 -35.53 0.04 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.045 1.738 . . . . 74.53 113.596 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 10.4 m -58.84 113.28 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.412 1.101 . . . . 74.23 110.159 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -47.87 -58.97 3.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.812 -1.086 . . . . 75.03 112.626 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -69.18 -20.65 64.0 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.822 -0.548 . . . . 64.44 110.071 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 52.34 4.02 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 107.591 -2.204 . . . . 71.24 107.591 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.4 179.81 25.88 Favored Glycine 0 CA--C 1.459 -3.459 0 N-CA-C 103.108 -3.997 . . . . 74.04 103.108 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.9 mm -88.71 127.78 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.792 0 N-CA-C 105.236 -2.135 . . . . 73.2 105.236 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.406 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 5.3 m-85 -107.41 154.66 21.0 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 104.677 -2.342 . . . . 75.21 104.677 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.25 101.71 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 N-CA-C 105.089 -2.189 . . . . 72.14 105.089 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.418 ' HE2' ' HB ' ' A' ' 24' ' ' THR . 11.5 ttmm -71.62 -26.2 62.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.121 -0.945 . . . . 74.21 109.082 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 142.96 16.69 Favored 'General case' 0 CA--C 1.46 -2.495 0 N-CA-C 105.627 -1.99 . . . . 74.11 105.627 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.8 t -110.21 125.98 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 102.729 -3.064 . . . . 74.34 102.729 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -76.63 145.95 75.96 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.978 -1.86 . . . . 73.54 105.978 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 45' ' ' GLY . 55.7 Cg_endo -77.81 174.53 12.43 Favored 'Trans proline' 0 CA--C 1.469 -2.742 0 N-CA-C 105.813 -2.418 . . . . 74.33 105.813 -174.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 69.05 -11.85 0.43 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.238 0.961 . . . . 73.42 112.597 161.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -93.23 -177.69 40.34 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 108.275 -1.93 . . . . 74.24 108.275 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.59 60.53 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 108.167 -1.049 . . . . 61.13 108.167 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.48 65.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.174 -0.466 . . . . 72.42 110.675 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.62 -53.87 44.79 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 122.009 -0.432 . . . . 74.55 109.876 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 t -60.14 -33.53 72.29 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.288 -0.634 . . . . 72.55 109.288 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.97 -43.42 35.1 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.342 -1.355 . . . . 60.24 107.342 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.94 11.08 79.78 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.615 -0.994 . . . . 52.03 110.615 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -95.24 7.33 46.48 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.583 -1.265 . . . . 65.31 107.583 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.449 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 1.6 mp -134.32 139.4 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 102.537 -3.134 . . . . 73.02 102.537 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.449 ' CD2' ' O ' ' A' ' 53' ' ' ILE . 26.3 m170 -148.04 161.45 41.36 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 104.986 -2.227 . . . . 72.3 104.986 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -66.6 138.93 57.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.996 -1.112 . . . . 73.45 107.996 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.41 -32.51 7.48 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 108.069 -2.012 . . . . 70.34 108.069 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.97 154.23 41.65 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 107.011 -1.478 . . . . 74.45 107.011 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 91' ' ' GLU . 19.1 ptt-85 -131.38 155.16 47.76 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.369 -0.974 . . . . 72.21 108.369 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.28 139.44 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 105.908 -1.886 . . . . 74.31 105.908 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.477 HD13 HD12 ' A' ' 7' ' ' ILE . 93.6 mt -102.28 -57.97 1.96 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.832 -1.544 . . . . 64.14 106.832 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.24 148.34 49.56 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.549 -2.019 . . . . 55.43 105.549 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.6 119.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 105.233 -2.136 . . . . 75.12 105.233 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.8 t30 53.57 36.12 22.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.606 0.762 . . . . 74.24 109.841 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.87 -21.77 44.25 Favored Glycine 0 CA--C 1.474 -2.524 0 N-CA-C 108.777 -1.729 . . . . 70.3 108.777 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.8 115.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 108.082 -1.081 . . . . 71.4 108.082 -172.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -52.41 120.97 6.16 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.523 0.729 . . . . 64.1 109.122 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -109.94 -19.16 13.2 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 107.549 -1.278 . . . . 73.34 107.549 -167.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.9 127.37 31.11 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 120.787 -1.196 . . . . 73.43 108.38 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.86 62.06 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 108.553 -1.819 . . . . 65.22 108.553 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -79.76 151.24 30.48 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 105.311 -2.107 . . . . 73.2 105.311 174.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.6 p -81.68 179.39 7.85 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.712 -0.847 . . . . 72.33 108.712 -171.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.5 -45.32 69.21 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.197 -1.038 . . . . 73.34 108.197 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -52.49 -56.11 17.38 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 121.339 -0.851 . . . . 53.22 109.852 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -53.75 -41.63 67.32 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 109.746 -0.465 . . . . 74.23 109.746 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.0 -50.04 65.01 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 116.087 -0.506 . . . . 62.42 109.933 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.2 t -73.52 -42.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 108.067 -1.086 . . . . 72.31 108.067 -174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.4 m -57.97 -35.12 70.72 Favored 'General case' 0 N--CA 1.523 3.224 0 N-CA-C 106.177 -1.786 . . . . 64.34 106.177 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.6 m -73.24 -47.89 39.47 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.904 -1.043 . . . . 74.23 108.554 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.75 -37.67 82.46 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.379 -0.6 . . . . 53.24 109.379 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -69.12 -60.53 2.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.614 -1.254 . . . . 74.54 107.614 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -69.17 57.39 0.1 Allowed 'General case' 0 C--N 1.367 1.337 0 C-N-CA 123.595 0.758 . . . . 72.21 110.981 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -109.24 -176.38 3.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.775 -1.565 . . . . 63.02 106.775 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.27 -144.99 16.07 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.313 -2.315 . . . . 73.05 107.313 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -72.19 -55.58 7.01 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.666 -0.864 . . . . 74.23 108.666 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.52 146.84 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 106.19 -1.781 . . . . 75.32 106.19 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -105.08 132.85 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 105.241 -2.133 . . . . 75.41 105.241 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . 0.494 ' HE1' ' OE1' ' A' ' 9' ' ' GLU . 61.1 t-80 -113.21 132.55 55.46 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.73 -2.322 . . . . 74.12 104.73 173.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -159.49 143.5 14.88 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 108.582 -0.895 . . . . 75.31 108.582 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.08 137.88 35.98 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 107.267 -1.383 . . . . 73.21 107.267 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.69 161.9 36.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.531 -1.285 . . . . 74.24 107.531 176.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 58' ' ' ARG . 79.6 tt0 -133.69 141.76 47.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 104.183 -2.525 . . . . 75.1 104.183 -173.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -66.82 144.35 56.35 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.928 -0.767 . . . . 74.12 108.928 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.474 -2.485 0 N-CA-C 105.665 -2.974 . . . . 71.21 105.665 178.92 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 109.231 -1.547 . . . . 71.51 109.231 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -77.07 134.29 38.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.839 -1.541 . . . . 75.44 106.839 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.407 HD12 HD13 ' A' ' 60' ' ' LEU . 2.5 mt -105.25 138.12 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 N-CA-C 107.405 -1.332 . . . . 71.24 107.405 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -156.41 172.37 18.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.368 -1.345 . . . . 73.45 107.368 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.01 155.01 27.75 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 106.051 -1.833 . . . . 73.41 106.051 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.84 156.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 105.711 -1.959 . . . . 74.32 105.711 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.84 130.35 55.0 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.176 -1.787 . . . . 74.21 106.176 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.72 140.06 47.91 Favored 'General case' 0 CA--C 1.46 -2.501 0 N-CA-C 106.875 -1.528 . . . . 72.25 106.875 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 140.99 31.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.648 -1.982 . . . . 70.12 105.648 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -68.61 -28.2 66.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.648 -1.241 . . . . 75.21 107.648 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 t30 86.51 93.54 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.324 -1.361 . . . . 72.34 107.324 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.28 47.77 6.7 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.772 -1.195 . . . . 55.03 107.772 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 45.94 -0.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 127.588 2.355 . . . . 62.44 115.407 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -104.83 115.27 30.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.887 1.221 . . . . 73.35 108.03 -172.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.602 HD22 ' H ' ' A' ' 19' ' ' LEU . 1.6 pt? -89.48 -155.39 0.35 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.432 -1.692 . . . . 71.01 106.432 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.34 55.56 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.189 0 N-CA-C 106.275 -2.73 . . . . 71.3 106.275 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.3 mm -106.65 178.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.119 -2.919 . . . . 74.11 103.119 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.493 ' H ' HG22 ' A' ' 21' ' ' ILE . 56.0 m -133.01 163.79 28.43 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.176 -2.157 . . . . 75.2 105.176 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.35 175.86 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.827 -1.546 . . . . 73.12 106.827 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -164.21 167.0 20.54 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 104.816 -2.29 . . . . 73.23 104.816 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.49 23.28 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 108.479 -1.849 . . . . 64.24 108.479 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 107.68 -74.13 0.21 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 108.776 -1.729 . . . . 63.34 108.776 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.14 15.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.203 0.525 . . . . 73.22 109.659 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 26' ' ' GLY . 41.8 t30 84.46 5.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.962 1.305 . . . . 73.31 108.006 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -53.74 -170.69 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.53 1.132 . . . . 73.21 112.293 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 m -29.46 -45.73 0.05 OUTLIER 'General case' 0 C--N 1.367 1.366 0 C-N-CA 126.843 2.057 . . . . 74.2 115.934 -159.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.52 125.56 19.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 CA-C-O 122.05 0.929 . . . . 75.22 109.954 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -52.65 -44.31 66.07 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.583 -1.19 . . . . 74.23 112.884 -169.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.418 ' HD1' ' NE ' ' A' ' 58' ' ' ARG . 23.8 t-160 -75.45 -21.25 58.27 Favored 'General case' 0 C--N 1.37 1.486 0 O-C-N 120.823 -1.173 . . . . 73.51 108.719 -175.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -14.79 62.97 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 109.878 -1.289 . . . . 62.41 109.878 171.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.95 179.92 44.13 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 108.551 -1.82 . . . . 71.31 108.551 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mm -83.2 127.85 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 N-CA-C 104.336 -2.468 . . . . 74.44 104.336 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.53 152.27 23.9 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 104.567 -2.383 . . . . 75.11 104.567 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.27 100.29 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 104.785 -2.302 . . . . 74.34 104.785 170.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.64 -17.97 42.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.788 -1.096 . . . . 73.54 111.725 -176.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.86 19.53 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 106.997 -1.483 . . . . 72.51 106.997 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.89 132.02 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 103.581 -2.748 . . . . 75.23 103.581 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.93 145.6 81.44 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 106.252 -1.759 . . . . 74.33 106.252 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.01 167.02 27.95 Favored 'Trans proline' 0 CA--C 1.464 -2.996 0 N-CA-C 106.848 -2.02 . . . . 73.12 106.848 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 69.06 2.1 3.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 124.474 1.109 . . . . 73.52 110.884 165.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.68 -175.77 38.43 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 108.515 -1.834 . . . . 53.43 108.515 -174.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.58 55.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 108.123 -1.066 . . . . 65.0 108.123 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.72 -49.39 62.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.978 -0.556 . . . . 52.31 110.417 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.31 -52.64 31.25 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.875 -0.33 . . . . 64.35 110.407 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.8 t -65.73 -36.24 83.04 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.686 -0.634 . . . . 70.54 109.973 -169.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.57 -25.57 35.69 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 106.672 -1.603 . . . . 73.41 106.672 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.1 78.78 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.75 -0.94 . . . . 74.42 110.75 167.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -87.24 1.99 51.45 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.684 -1.228 . . . . 75.13 107.684 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.9 mt -143.6 140.89 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 103.832 -2.655 . . . . 75.33 103.832 -168.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -142.72 159.4 42.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.029 -2.582 . . . . 75.14 104.029 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.45 142.88 57.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.007 -1.109 . . . . 72.55 108.007 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.56 -31.87 8.14 Favored Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 107.467 -2.253 . . . . 73.21 107.467 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -58.86 147.86 32.24 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 109.039 -0.726 . . . . 62.31 109.039 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.418 ' NE ' ' HD1' ' A' ' 33' ' ' HIS . 31.0 mtm-85 -114.88 139.93 49.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.623 -1.251 . . . . 72.21 107.623 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.89 129.03 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.451 -2.055 . . . . 70.22 105.451 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.407 HD13 HD12 ' A' ' 7' ' ' ILE . 89.2 mt -97.33 -58.81 1.92 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 106.905 -1.517 . . . . 74.43 106.905 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.23 148.76 48.22 Favored 'General case' 0 CA--C 1.476 -1.865 0 N-CA-C 106.414 -1.699 . . . . 71.04 106.414 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.2 121.59 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 105.29 -2.115 . . . . 74.41 105.29 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.9 t30 53.16 37.32 24.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 71.14 110.046 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.49 -26.88 22.05 Favored Glycine 0 CA--C 1.471 -2.672 0 N-CA-C 108.513 -1.835 . . . . 61.32 108.513 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 83.4 t -79.4 116.69 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 107.809 -1.182 . . . . 75.11 107.809 -171.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 114.65 1.76 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 108.593 -0.892 . . . . 72.24 108.593 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -102.27 -18.82 15.29 Favored 'General case' 0 C--O 1.191 -1.992 0 N-CA-C 106.363 -1.717 . . . . 73.4 106.363 -167.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.16 129.14 39.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.193 -0.942 . . . . 64.45 108.473 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.56 -16.56 56.34 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 108.044 -2.022 . . . . 34.21 108.044 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.61 154.1 27.61 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.435 -1.691 . . . . 72.35 106.435 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.0 p -81.13 179.88 7.66 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.109 -0.7 . . . . 64.43 109.109 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -58.76 -53.33 59.56 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 107.936 -1.135 . . . . 71.45 107.936 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.57 -48.3 80.07 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 110.282 -0.266 . . . . 74.55 110.282 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -57.84 -41.08 81.6 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.767 -0.457 . . . . 75.13 109.767 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.67 -56.22 12.9 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 120.818 0.342 . . . . 74.24 110.714 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.7 m -74.64 -33.39 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 109.145 -0.687 . . . . 61.11 109.145 -173.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.9 t -68.79 -31.55 70.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 105.991 -1.855 . . . . 74.41 105.991 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.2 m -71.37 -41.83 69.22 Favored 'General case' 0 C--O 1.207 -1.133 0 O-C-N 120.319 -1.488 . . . . 75.45 107.464 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.3 -29.55 69.94 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 109.232 -0.655 . . . . 75.41 109.232 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -73.78 -61.21 1.92 Allowed 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.807 -1.183 . . . . 74.5 107.807 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.83 54.45 0.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.422 0.629 . . . . 64.43 111.548 -174.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.539 ' HG1' HG23 ' A' ' 86' ' ' VAL . 2.7 p -112.77 -175.06 2.58 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 104.956 -2.238 . . . . 75.22 104.956 167.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.78 -161.55 25.97 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 107.71 -2.156 . . . . 71.45 107.71 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -52.69 -53.34 48.87 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.8 -0.815 . . . . 55.24 108.8 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.5 t -102.99 148.8 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 105.465 -2.05 . . . . 73.12 105.465 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.539 HG23 ' HG1' ' A' ' 82' ' ' THR . 33.4 t -104.59 131.11 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 N-CA-C 105.42 -2.067 . . . . 61.44 105.42 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -112.92 128.91 56.6 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.048 -2.575 . . . . 73.41 104.048 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 142.97 17.75 Favored 'General case' 0 CA--C 1.467 -2.227 0 N-CA-C 108.087 -1.079 . . . . 74.24 108.087 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 135.67 35.93 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.839 -1.541 . . . . 74.12 106.839 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.65 160.43 33.36 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 106.353 -1.721 . . . . 71.13 106.353 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.6 135.03 48.77 Favored 'General case' 0 N--CA 1.397 -3.106 0 N-CA-C 102.102 -3.296 . . . . 72.2 102.102 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 6.8 mmpt? -62.48 136.86 58.1 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 107.813 -1.18 . . . . 74.11 107.813 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.461 -3.326 0 N-CA-C 106.78 -2.528 . . . . 74.23 106.78 -171.425 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.105 0 N-CA-C 109.25 -1.54 . . . . 74.12 109.25 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -81.77 140.34 34.3 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.613 -1.625 . . . . 60.13 106.613 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.86 137.75 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.467 0 N-CA-C 108.392 -0.966 . . . . 72.35 108.392 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 1.2 p90 -138.89 155.8 47.8 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 107.098 -1.445 . . . . 72.33 107.098 172.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -105.89 145.71 30.9 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.757 -1.942 . . . . 73.31 105.757 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.4 m -142.34 155.86 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 106.888 -1.523 . . . . 72.12 106.888 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.66 122.96 46.1 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 105.088 -2.19 . . . . 65.11 105.088 167.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.482 HD13 HD12 ' A' ' 53' ' ' ILE . 12.7 mt -131.97 133.12 44.13 Favored 'General case' 0 CA--C 1.458 -2.58 0 N-CA-C 105.018 -2.216 . . . . 73.11 105.018 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.02 22.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 105.805 -1.924 . . . . 72.43 105.805 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -70.04 -36.16 74.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.999 -1.852 . . . . 74.23 105.999 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 81.48 113.21 0.06 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 125.231 1.412 . . . . 65.32 108.117 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.57 36.21 25.01 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.791 -1.188 . . . . 75.1 107.791 -173.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 43.38 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 127.485 2.314 . . . . 63.4 115.25 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.7 m -97.24 124.52 41.35 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 119.985 1.266 . . . . 72.24 107.904 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.546 HD22 ' H ' ' A' ' 19' ' ' LEU . 1.9 pt? -97.03 -158.88 0.7 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 105.817 -1.92 . . . . 75.35 105.817 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.76 32.09 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 106.671 -2.571 . . . . 71.42 106.671 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.476 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.1 mm -88.16 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.863 -2.273 . . . . 61.24 104.863 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.476 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.2 m -140.56 167.23 22.66 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 103.849 -2.649 . . . . 51.53 103.849 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 m -148.38 173.18 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 106.985 -1.487 . . . . 74.22 106.985 -168.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 39' ' ' LYS . 8.2 t -159.32 164.01 35.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 104.037 -2.579 . . . . 71.14 104.037 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -139.16 18.31 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.356 -1.898 . . . . 71.01 108.356 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 104.61 -79.31 0.29 Allowed Glycine 0 CA--C 1.466 -3.001 0 N-CA-C 108.54 -1.824 . . . . 44.41 108.54 177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -76.11 16.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 122.731 0.413 . . . . 74.32 111.045 -171.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 26' ' ' GLY . 17.2 t-20 85.59 5.68 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.832 1.253 . . . . 70.52 108.099 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -55.85 -171.0 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.476 -0.784 . . . . 74.23 111.851 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 m -29.1 -45.03 0.04 OUTLIER 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.439 2.295 . . . . 65.31 116.009 -162.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.72 136.82 16.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-O 121.663 0.744 . . . . 72.22 111.855 -172.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -35.16 -71.53 0.07 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 126.17 1.788 . . . . 73.41 113.207 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -76.97 -15.6 59.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.26 -0.9 . . . . 72.43 110.104 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.38 61.79 2.16 Favored Glycine 0 CA--C 1.491 -1.449 0 N-CA-C 108.093 -2.003 . . . . 72.42 108.093 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.95 -178.81 25.23 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 104.376 -3.49 . . . . 72.41 104.376 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.0 mm -83.72 122.3 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.131 0 N-CA-C 104.427 -2.434 . . . . 74.12 104.427 172.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -107.17 153.13 23.13 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 103.809 -2.663 . . . . 73.32 103.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -83.55 102.32 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.154 -1.795 . . . . 75.32 106.154 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HD3' HG22 ' A' ' 24' ' ' THR . 13.5 tptm -72.91 -31.11 64.42 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.423 -0.808 . . . . 75.42 111.036 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.73 145.4 18.61 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 106.495 -1.668 . . . . 75.12 106.495 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -122.27 133.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.413 -2.81 . . . . 72.51 103.413 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -74.97 151.49 86.34 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 106.398 -1.705 . . . . 65.11 106.398 173.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.33 167.66 25.35 Favored 'Trans proline' 0 CA--C 1.457 -3.336 0 N-CA-C 105.735 -2.448 . . . . 74.31 105.735 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 68.38 1.98 3.13 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.769 0.668 . . . . 73.04 110.109 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.99 175.06 42.98 Favored Glycine 0 CA--C 1.472 -2.642 0 N-CA-C 107.571 -2.212 . . . . 72.32 107.571 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.13 -48.6 64.97 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 107.355 -1.35 . . . . 72.44 107.355 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.19 64.9 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 116.067 -0.515 . . . . 73.44 110.019 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.08 -56.22 14.25 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.975 -0.379 . . . . 74.24 109.975 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -65.44 -28.94 69.59 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.908 0.385 . . . . 70.34 110.515 -166.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -83.17 -31.28 27.22 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 106.764 -1.569 . . . . 71.42 106.764 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 16.91 65.88 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 111.025 -0.83 . . . . 70.41 111.025 170.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.1 mmp_? -91.71 5.65 48.93 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.523 -1.288 . . . . 74.54 107.523 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.482 HD12 HD13 ' A' ' 12' ' ' LEU . 58.9 mt -144.83 144.88 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 104.161 -2.533 . . . . 72.43 104.161 -171.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 55' ' ' LYS . 50.9 p-80 -149.3 168.24 23.88 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 101.871 -3.381 . . . . 73.42 101.871 172.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 39.5 mtmt -66.44 144.16 56.67 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.074 -1.084 . . . . 75.22 108.074 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.19 -32.5 7.47 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.07 -1.062 . . . . 54.42 110.839 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' CG ' ' CE1' ' A' ' 54' ' ' HIS . 34.8 m-20 -66.65 154.55 40.3 Favored 'General case' 0 C--N 1.378 1.822 0 CA-C-N 119.871 1.836 . . . . 72.43 107.859 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 137.41 51.92 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.047 -1.464 . . . . 74.35 107.047 -164.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.5 127.27 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 106.452 -1.684 . . . . 70.44 106.452 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.1 mt -95.12 -59.83 1.81 Allowed 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.017 -1.105 . . . . 72.41 108.017 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.38 148.66 47.94 Favored 'General case' 0 CA--C 1.467 -2.216 0 N-CA-C 106.254 -1.758 . . . . 64.44 106.254 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.6 t -119.92 119.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 105.864 -1.902 . . . . 75.21 105.864 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.9 t30 49.38 38.07 13.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.698 1.199 . . . . 71.43 110.318 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.22 -33.5 6.52 Favored Glycine 0 CA--C 1.469 -2.821 0 N-CA-C 108.212 -1.955 . . . . 63.14 108.212 171.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.0 114.98 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 107.753 -1.203 . . . . 74.41 107.753 -172.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.6 m -53.88 117.44 3.19 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 107.939 -1.134 . . . . 65.45 107.939 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 70' ' ' ALA . 1.1 tm? -99.88 -10.48 21.68 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.291 -2.114 . . . . 65.51 105.291 -168.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.45 137.18 48.87 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.914 -1.143 . . . . 70.25 107.914 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.6 62.04 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.46 -1.456 . . . . 74.41 109.46 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -80.47 148.96 30.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.837 -1.172 . . . . 61.12 107.837 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.0 p -81.99 -179.48 7.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.844 -0.798 . . . . 73.53 108.844 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -60.64 -52.02 66.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.981 -1.118 . . . . 74.33 107.981 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -57.1 -55.5 33.9 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 121.638 -0.664 . . . . 73.13 110.783 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -53.62 -40.7 65.99 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 120.772 0.32 . . . . 73.33 110.529 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.13 -54.46 24.97 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.023 0.529 . . . . 73.53 110.787 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.98 -37.43 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.801 -0.444 . . . . 73.01 109.801 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.02 -31.67 72.85 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 116.943 -1.903 . . . . 55.41 106.266 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 82' ' ' THR . 26.5 m -71.85 -45.16 62.34 Favored 'General case' 0 C--O 1.206 -1.232 0 O-C-N 120.654 -1.279 . . . . 64.13 107.901 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.5 mt -62.48 -29.66 70.7 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 110.181 -0.303 . . . . 71.31 110.181 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' A' ' 82' ' ' THR . 61.1 ttp85 -73.69 -59.0 2.92 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.194 -1.41 . . . . 74.53 107.194 176.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -70.51 46.77 0.09 Allowed 'General case' 0 C--N 1.362 1.139 0 C-N-CA 125.109 1.364 . . . . 75.35 111.441 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.459 ' HG1' HG23 ' A' ' 86' ' ' VAL . 2.7 p -105.22 -175.4 2.78 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.159 -1.793 . . . . 74.35 106.159 173.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.0 33.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 106.012 -2.835 . . . . 63.44 106.012 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.25 -54.54 44.6 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.22 -1.03 . . . . 72.32 108.22 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.0 t -101.79 145.18 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 105.995 -1.854 . . . . 62.42 105.995 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.459 HG23 ' HG1' ' A' ' 82' ' ' THR . 47.7 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 105.904 -1.887 . . . . 72.31 105.904 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -107.7 127.02 53.31 Favored 'General case' 0 CA--C 1.466 -2.271 0 N-CA-C 103.298 -2.853 . . . . 72.43 103.298 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.46 136.57 13.81 Favored 'General case' 0 CA--C 1.458 -2.583 0 N-CA-C 107.374 -1.343 . . . . 75.44 107.374 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.26 136.37 35.8 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.311 -1.366 . . . . 73.2 107.311 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -107.41 151.74 25.12 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 103.893 -2.632 . . . . 73.1 103.893 175.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.53 133.3 55.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 101.65 -3.463 . . . . 70.0 101.65 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.7 129.52 41.94 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.49 -0.929 . . . . 75.34 108.49 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.295 0 N-CA-C 105.177 -3.169 . . . . 71.4 105.177 179.407 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.522 0 N-CA-C 108.923 -1.671 . . . . 51.44 108.923 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -75.6 139.78 42.26 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.418 -1.327 . . . . 73.4 107.418 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.419 HD12 HD11 ' A' ' 60' ' ' LEU . 9.4 mm -100.68 131.64 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.128 -1.434 . . . . 74.44 107.128 -171.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -143.34 155.8 44.53 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.255 -1.387 . . . . 74.32 107.255 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -108.77 147.07 32.59 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.729 -1.952 . . . . 74.23 105.729 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.22 152.51 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 N-CA-C 107.272 -1.381 . . . . 74.41 107.272 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.58 127.07 53.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.117 -2.179 . . . . 74.53 105.117 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 mp -135.18 140.99 45.79 Favored 'General case' 0 CA--C 1.461 -2.445 0 N-CA-C 107.748 -1.204 . . . . 63.41 107.748 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.07 141.22 33.36 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.757 -1.571 . . . . 72.24 106.757 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -71.54 -25.88 62.4 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.333 -0.988 . . . . 73.13 108.333 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 72.64 108.05 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.25 -1.019 . . . . 73.51 108.25 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 51.94 53.1 13.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 109.549 -0.537 . . . . 71.41 109.549 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.1 t30 54.37 -9.09 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.043 1.737 . . . . 75.55 115.007 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.4 t -126.12 120.76 30.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 120.595 1.543 . . . . 75.03 108.317 -171.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -99.99 167.44 10.49 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.109 -2.182 . . . . 73.4 105.109 171.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.99 95.62 0.15 Allowed Glycine 0 CA--C 1.478 -2.232 0 N-CA-C 105.041 -3.223 . . . . 65.23 105.041 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.557 HG23 ' H ' ' A' ' 22' ' ' CYS . 4.7 mm -118.95 177.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.273 -2.862 . . . . 73.15 103.273 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.557 ' H ' HG23 ' A' ' 21' ' ' ILE . 4.1 t -127.79 154.74 45.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 102.987 -2.968 . . . . 72.52 102.987 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.0 m -149.46 169.55 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.818 -1.549 . . . . 74.23 106.818 -165.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.517 HG22 ' CE2' ' A' ' 37' ' ' TYR . 6.8 t -165.22 168.23 17.26 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.531 -2.396 . . . . 75.5 104.531 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.26 -167.03 22.33 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 105.573 -3.011 . . . . 64.43 105.573 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.91 -115.74 0.91 Allowed Glycine 0 CA--C 1.489 -1.55 0 C-N-CA 119.443 -1.361 . . . . 74.1 110.165 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -60.73 20.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.691 1.996 . . . . 74.25 116.32 -162.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 87.37 9.07 0.17 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.262 -1.014 . . . . 72.32 108.262 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.3 p -39.14 -166.96 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 126.283 1.833 . . . . 74.43 111.626 154.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -39.34 -29.11 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.9 0 O-C-N 120.458 -1.401 . . . . 74.51 114.616 -168.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG13 ' CE1' ' A' ' 37' ' ' TYR . 4.6 m -86.27 134.84 26.4 Favored 'Isoleucine or valine' 0 C--N 1.365 1.248 0 O-C-N 120.347 -1.471 . . . . 61.44 108.486 177.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -70.54 -24.17 62.76 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.857 -0.794 . . . . 72.51 108.857 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 60' ' ' LEU . 7.4 t-160 -83.69 -10.98 57.79 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.898 -0.721 . . . . 72.55 109.06 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.69 67.1 2.36 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 110.029 -1.229 . . . . 60.24 110.029 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.74 178.21 26.46 Favored Glycine 0 CA--C 1.472 -2.607 0 N-CA-C 105.348 -3.101 . . . . 74.12 105.348 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.76 141.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 N-CA-C 105.905 -1.887 . . . . 71.12 105.905 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.517 ' CE2' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -121.46 162.05 21.15 Favored 'General case' 0 CA--C 1.45 -2.898 0 N-CA-C 106.696 -1.594 . . . . 74.13 106.696 175.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.7 t -85.8 103.54 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 106.593 -1.632 . . . . 64.42 106.593 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -71.12 -30.48 66.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.535 -1.211 . . . . 75.12 108.949 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.7 151.16 10.69 Favored 'General case' 0 CA--C 1.467 -2.225 0 N-CA-C 105.869 -1.9 . . . . 73.42 105.869 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 t -118.33 134.15 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 103.657 -2.72 . . . . 72.31 103.657 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 148.68 84.01 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.826 -1.916 . . . . 75.04 105.826 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.26 168.12 25.34 Favored 'Trans proline' 0 CA--C 1.467 -2.84 0 N-CA-C 106.073 -2.318 . . . . 73.1 106.073 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 62.08 2.75 0.85 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.239 0.829 . . . . 74.12 113.239 164.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.19 -175.78 36.13 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 107.12 -2.392 . . . . 75.15 107.12 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.63 -53.01 38.76 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 108.579 -0.897 . . . . 74.41 108.579 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.49 -49.84 66.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 116.362 -0.381 . . . . 75.25 111.067 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.7 -53.1 59.6 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 109.616 -0.513 . . . . 73.53 109.616 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -55.71 -38.15 69.35 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.278 0.631 . . . . 71.14 109.962 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -77.48 -33.5 54.52 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.871 -1.159 . . . . 74.1 107.871 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.31 81.04 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.235 -1.146 . . . . 73.11 110.235 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -107.33 8.37 29.69 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.282 -1.006 . . . . 74.24 108.282 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mp -126.92 134.13 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 101.859 -3.386 . . . . 72.14 101.859 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -138.74 159.58 41.75 Favored 'General case' 0 CA--C 1.473 -2.0 0 N-CA-C 104.091 -2.559 . . . . 63.22 104.091 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -66.48 143.99 56.76 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.74 -1.207 . . . . 75.32 107.74 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -30.82 8.88 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 108.623 -1.791 . . . . 72.23 108.623 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -66.49 152.73 44.6 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 106.232 -1.766 . . . . 75.41 106.232 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.473 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 18.7 ptt-85 -132.23 157.67 43.75 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.954 -1.498 . . . . 75.14 106.954 -171.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.54 135.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.416 -1.698 . . . . 74.21 106.416 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.45 ' CD2' ' CE1' ' A' ' 33' ' ' HIS . 48.2 mt -96.92 -58.26 2.08 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.029 -1.471 . . . . 75.34 107.029 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.92 151.57 50.11 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.416 -1.698 . . . . 75.42 106.416 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.65 119.86 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 105.515 -2.031 . . . . 70.31 105.515 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.5 t30 54.71 32.85 18.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.133 0.973 . . . . 72.11 109.909 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.78 -28.99 13.42 Favored Glycine 0 CA--C 1.463 -3.183 0 N-CA-C 108.551 -1.82 . . . . 72.45 108.551 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.26 115.12 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 N-CA-C 107.533 -1.284 . . . . 74.33 107.533 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 t -55.65 130.56 43.62 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.689 -0.856 . . . . 75.45 108.689 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.98 -11.81 21.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.939 -1.874 . . . . 73.22 105.939 -170.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.77 126.13 20.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.863 -0.608 . . . . 64.53 109.634 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.17 -12.26 64.95 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 109.137 -1.585 . . . . 53.21 109.137 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.88 148.8 41.96 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 107.271 -1.381 . . . . 73.31 107.271 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 p -81.77 177.32 8.95 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 107.317 -1.364 . . . . 73.43 107.317 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -65.85 -43.93 86.98 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.541 -0.911 . . . . 70.54 108.541 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -54.59 -56.73 15.91 Favored 'General case' 0 C--N 1.362 1.125 0 O-C-N 121.881 -0.512 . . . . 64.34 110.176 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -56.46 -44.42 80.52 Favored 'General case' 0 C--N 1.365 1.246 0 N-CA-C 110.089 -0.337 . . . . 71.03 110.089 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.54 -52.76 35.85 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.792 0.437 . . . . 71.14 110.831 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.14 -42.12 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.775 -1.195 . . . . 74.12 107.775 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -53.23 -40.6 64.65 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 123.722 1.725 . . . . 61.22 106.442 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -65.5 -40.34 92.92 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 120.338 -1.476 . . . . 71.01 108.776 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.87 -29.57 70.28 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 109.813 -0.44 . . . . 74.42 109.813 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -73.26 -60.42 2.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.531 -0.544 . . . . 74.32 109.531 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -68.97 40.79 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 113.563 0.949 . . . . 73.22 113.563 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 p -106.72 -176.12 2.99 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 106.303 -1.74 . . . . 71.14 106.303 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.02 -153.87 28.97 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 108.415 -1.874 . . . . 73.53 108.415 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -61.14 -54.39 45.07 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.923 -0.769 . . . . 72.43 108.923 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.52 145.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 105.82 -1.919 . . . . 73.22 105.82 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.06 139.41 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.673 0 N-CA-C 105.592 -2.003 . . . . 72.23 105.592 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -114.08 135.8 53.62 Favored 'General case' 0 CA--C 1.463 -2.376 0 N-CA-C 104.608 -2.367 . . . . 72.42 104.608 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.54 135.69 9.92 Favored 'General case' 0 CA--C 1.461 -2.448 0 N-CA-C 106.975 -1.491 . . . . 74.52 106.975 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.411 ' HB3' HD13 ' A' ' 60' ' ' LEU . 6.5 mp -81.19 139.08 35.76 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 107.318 -1.364 . . . . 75.44 107.318 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.76 155.5 21.5 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 104.62 -2.363 . . . . 74.14 104.62 176.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.473 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.9 tt0 -120.74 128.75 53.21 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 101.604 -3.48 . . . . 72.21 101.604 165.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -61.93 146.83 48.76 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.736 -0.838 . . . . 73.14 108.736 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.411 0 N-CA-C 105.577 -3.009 . . . . 73.24 105.577 178.813 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.237 0 N-CA-C 108.713 -1.755 . . . . 71.44 108.713 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.36 133.48 42.5 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 108.131 -1.063 . . . . 74.24 108.131 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mt -99.27 128.08 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.522 -1.288 . . . . 71.35 107.522 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -138.25 159.58 41.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.793 -1.558 . . . . 72.33 106.793 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.86 152.12 22.3 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 105.172 -2.158 . . . . 75.34 105.172 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.5 m -131.79 142.75 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 N-CA-C 104.35 -2.463 . . . . 75.51 104.35 167.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -101.06 116.84 33.78 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 103.782 -2.673 . . . . 70.01 103.782 167.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -136.08 134.04 37.98 Favored 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.434 -1.691 . . . . 71.23 106.434 -172.156 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.44 148.59 25.49 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.831 -1.544 . . . . 51.5 106.831 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -75.1 -33.88 61.68 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.12 -1.807 . . . . 73.12 106.12 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.84 104.88 0.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.379 1.071 . . . . 71.13 108.164 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.66 37.59 19.06 Favored 'General case' 0 C--N 1.366 1.288 0 N-CA-C 107.85 -1.167 . . . . 75.42 107.85 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 47.75 2.41 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.36 1.864 . . . . 72.25 114.747 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -86.41 139.25 31.11 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 106.706 -1.591 . . . . 74.45 106.706 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.01 -144.66 0.29 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 104.675 -2.343 . . . . 72.32 104.675 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.21 74.66 0.63 Allowed Glycine 0 CA--C 1.467 -2.953 0 N-CA-C 105.056 -3.218 . . . . 61.13 105.056 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 22' ' ' CYS . 8.5 mm -103.57 177.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 101.584 -3.487 . . . . 74.41 101.584 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.531 ' H ' HG22 ' A' ' 21' ' ' ILE . 3.1 m -121.34 151.97 39.49 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 103.205 -2.887 . . . . 72.33 103.205 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -152.11 169.23 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 N-CA-C 106.828 -1.545 . . . . 72.4 106.828 -165.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -160.46 164.64 32.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 104.334 -2.469 . . . . 71.42 104.334 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.71 -162.74 26.74 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.083 -2.007 . . . . 73.05 108.083 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 126.3 -88.43 0.35 Allowed Glycine 0 C--N 1.356 1.686 0 N-CA-C 109.112 -1.595 . . . . 55.51 109.112 176.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.88 18.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 123.134 0.574 . . . . 72.13 112.251 -167.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 26' ' ' GLY . 5.2 t-20 85.98 7.05 0.36 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.313 -0.995 . . . . 65.44 108.313 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.7 p -45.51 -169.31 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.413 1.885 . . . . 64.31 112.466 167.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -49.92 -18.39 0.51 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.939 1.088 . . . . 74.23 113.939 -167.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.436 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 15.3 m -66.53 128.78 30.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.525 0 N-CA-C 107.868 -1.16 . . . . 74.44 107.868 172.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.36 -52.69 44.35 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.256 -0.902 . . . . 74.43 110.958 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.64 -20.37 59.92 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 119.543 -0.863 . . . . 73.35 110.174 -168.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.43 -6.86 55.83 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.804 -1.718 . . . . 74.34 108.804 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 179.26 53.38 Favored Glycine 0 CA--C 1.501 -0.833 0 N-CA-C 108.198 -1.961 . . . . 51.22 108.198 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 mm -88.97 132.24 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.215 0 N-CA-C 104.535 -2.395 . . . . 65.34 104.535 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.436 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 3.8 m-30 -107.16 150.23 26.82 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 105.129 -2.174 . . . . 74.53 105.129 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.6 t -82.85 103.43 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.194 -1.78 . . . . 73.31 106.194 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -73.04 -34.56 66.38 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.13 -1.396 . . . . 74.11 108.751 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.76 151.06 8.82 Favored 'General case' 0 CA--C 1.46 -2.486 0 N-CA-C 104.598 -2.371 . . . . 75.24 104.598 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.36 131.58 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 102.975 -2.972 . . . . 74.53 102.975 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.77 146.63 83.34 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 106.332 -1.729 . . . . 70.24 106.332 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.9 172.03 16.92 Favored 'Trans proline' 0 CA--C 1.468 -2.794 0 N-CA-C 105.965 -2.36 . . . . 65.22 105.965 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 49.55 51.99 15.37 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.312 1.053 . . . . 71.51 109.743 164.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.47 34.41 Favored Glycine 0 CA--C 1.472 -2.612 1 N-CA-C 102.899 -4.08 . . . . 73.13 102.899 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -53.58 26.78 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-N 117.781 0.791 . . . . 72.21 109.734 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.5 -50.48 65.31 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.987 -0.097 . . . . 73.11 111.122 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -63.37 -55.36 25.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.664 0.385 . . . . 73.42 110.058 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.1 m -65.33 -30.23 71.05 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.694 -0.629 . . . . 71.54 110.75 -172.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.42 -35.56 54.04 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 105.914 -1.884 . . . . 72.41 105.914 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.8 30.2 59.98 Favored Glycine 0 CA--C 1.476 -2.398 0 CA-C-N 115.318 -0.855 . . . . 54.21 111.738 167.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -98.48 -47.85 5.23 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.387 -1.709 . . . . 74.35 106.387 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.405 HD12 HD12 ' A' ' 12' ' ' LEU . 65.9 mt -66.07 148.06 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.53 0.681 . . . . 75.02 109.735 169.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 55' ' ' LYS . 27.5 p-80 -154.94 167.12 31.38 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 104.227 -2.509 . . . . 74.1 104.227 172.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 52.7 mtmt -66.73 143.16 57.1 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.156 0.503 . . . . 74.35 109.86 -176.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.94 -33.19 6.63 Favored Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 108.606 -1.797 . . . . 72.23 108.606 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -69.35 156.41 38.85 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 105.701 -1.963 . . . . 73.44 105.701 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -132.98 157.91 44.01 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.021 -1.103 . . . . 73.23 108.021 -168.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.26 135.27 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 106.177 -1.786 . . . . 75.32 106.177 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -99.57 -58.67 1.87 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.638 -1.616 . . . . 74.21 106.638 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.48 149.97 50.76 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 105.76 -1.941 . . . . 71.22 105.76 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.54 121.47 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 N-CA-C 105.069 -2.197 . . . . 75.23 105.069 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.56 32.88 21.69 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 123.46 0.704 . . . . 73.15 109.278 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.81 -5.59 84.65 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 109.562 -1.415 . . . . 61.02 109.562 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.1 t -94.92 130.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 107.023 -1.473 . . . . 74.42 107.023 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -47.62 147.33 1.85 Allowed 'General case' 0 C--N 1.367 1.332 0 C-N-CA 123.907 0.883 . . . . 65.51 110.501 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.74 -25.18 0.42 Allowed 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.717 -1.586 . . . . 63.22 106.717 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.9 pm0 -56.3 127.19 29.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.603 -0.888 . . . . 63.4 108.603 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.8 -11.47 66.52 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.43 -1.468 . . . . 74.22 109.43 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 157.36 25.64 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 105.66 -1.978 . . . . 64.54 105.66 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.2 p -87.64 179.49 6.51 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.146 -0.687 . . . . 71.11 109.146 -168.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.39 -51.34 69.16 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.638 -1.245 . . . . 73.02 107.638 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.72 -55.81 22.89 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 109.896 -0.409 . . . . 74.21 109.896 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -56.46 -42.38 78.1 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 122.169 -0.332 . . . . 70.32 110.623 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.16 -55.76 16.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 122.853 0.461 . . . . 72.44 110.311 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.5 m -74.72 -36.27 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 109.044 -0.724 . . . . 63.12 109.044 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -62.66 -34.66 77.55 Favored 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 106.055 -1.832 . . . . 72.34 106.055 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.7 m -71.83 -45.48 61.31 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 120.071 -1.643 . . . . 74.13 107.715 -175.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.46 -29.82 70.2 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.722 -0.473 . . . . 70.04 109.722 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -60.08 2.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.58 -1.637 . . . . 74.23 106.58 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -67.86 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.485 1.114 . . . . 73.12 112.219 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.3 p -101.81 -175.21 2.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.166 -1.79 . . . . 71.32 106.166 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.6 -150.89 26.95 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 107.694 -2.163 . . . . 74.53 107.694 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.61 -55.69 16.26 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.681 -0.859 . . . . 74.25 108.681 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.5 t -104.25 149.34 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 104.992 -2.225 . . . . 71.23 104.992 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -111.61 140.56 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.288 -1.745 . . . . 74.44 106.288 -174.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -110.62 130.8 55.48 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 103.657 -2.72 . . . . 62.33 103.657 167.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.97 132.49 12.1 Favored 'General case' 0 CA--C 1.456 -2.649 0 N-CA-C 106.786 -1.561 . . . . 70.41 106.786 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.65 136.01 36.14 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 106.82 -1.548 . . . . 75.54 106.82 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -109.68 159.45 17.13 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 103.968 -2.604 . . . . 74.51 103.968 174.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -120.37 134.1 55.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.77 -3.419 . . . . 74.25 101.77 167.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -62.89 138.18 58.47 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 107.945 -1.131 . . . . 72.03 107.945 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.471 -2.701 0 N-CA-C 106.459 -2.656 . . . . 71.1 106.459 -175.835 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.587 0 N-CA-C 109.328 -1.509 . . . . 74.54 109.328 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -80.84 143.33 32.86 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.037 -1.468 . . . . 72.02 107.037 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.443 HG21 ' CD1' ' A' ' 60' ' ' LEU . 12.9 mm -98.19 132.79 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 105.879 -1.897 . . . . 71.43 105.879 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.422 ' CD2' HD22 ' A' ' 90' ' ' LEU . 1.5 p90 -144.18 156.48 44.33 Favored 'General case' 0 CA--C 1.478 -1.803 0 C-N-CA 119.056 -1.057 . . . . 73.33 109.027 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.3 141.65 35.54 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 105.387 -2.079 . . . . 74.21 105.387 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.01 145.93 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 105.127 -2.175 . . . . 71.34 105.127 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -110.05 126.44 53.99 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.336 -2.098 . . . . 62.41 105.336 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 52' ' ' ARG . 58.1 mt -134.83 139.48 45.1 Favored 'General case' 0 CA--C 1.451 -2.836 0 N-CA-C 106.948 -1.501 . . . . 74.44 106.948 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.54 152.68 23.74 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.352 -2.092 . . . . 71.25 105.352 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -77.22 -28.58 53.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.221 -1.399 . . . . 73.05 107.221 172.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 81.38 104.93 0.06 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.442 1.097 . . . . 73.44 108.105 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 57.56 41.68 25.4 Favored 'General case' 0 C--N 1.366 1.293 0 N-CA-C 107.271 -1.381 . . . . 62.42 107.271 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 43.26 2.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 127.516 2.326 . . . . 65.01 115.504 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.0 m -100.23 114.69 28.32 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 120.34 1.427 . . . . 63.12 107.269 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.535 HD22 ' H ' ' A' ' 19' ' ' LEU . 1.8 pt? -89.63 -173.18 3.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 104.697 -2.334 . . . . 72.44 104.697 169.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 40.95 0.04 OUTLIER Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 104.43 -3.468 . . . . 45.24 104.43 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.508 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.6 mt -98.09 174.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.479 -2.786 . . . . 75.34 103.479 -176.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.508 ' H ' HG22 ' A' ' 21' ' ' ILE . 34.4 t -138.86 156.39 47.34 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 104.738 -2.319 . . . . 71.12 104.738 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.65 173.29 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.617 0 N-CA-C 104.716 -2.327 . . . . 73.41 104.716 -167.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.4 t -162.09 167.12 24.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.446 -1.686 . . . . 73.04 106.446 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.87 -154.08 30.36 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 108.578 -1.809 . . . . 75.22 108.578 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.55 -82.38 0.34 Allowed Glycine 0 CA--C 1.474 -2.497 0 N-CA-C 108.849 -1.7 . . . . 65.5 108.849 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.48 16.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.497 0 C-N-CA 123.438 0.695 . . . . 75.02 112.199 -165.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 85.71 5.54 0.46 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.954 1.301 . . . . 73.13 108.345 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.5 p -49.29 -170.82 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.237 1.415 . . . . 74.41 111.352 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 m -30.19 -41.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 126.268 1.827 . . . . 74.51 115.359 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 14.7 m -57.28 120.0 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 122.348 1.07 . . . . 73.54 110.774 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -49.27 -64.33 0.84 Allowed 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.786 -1.097 . . . . 71.35 111.824 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -73.99 -19.85 60.52 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 120.209 -0.597 . . . . 73.24 110.112 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.36 60.19 1.57 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 109.754 -1.338 . . . . 53.11 109.754 170.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.73 -178.76 29.39 Favored Glycine 0 CA--C 1.466 -3.015 0 N-CA-C 103.184 -3.966 . . . . 73.13 103.184 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.94 133.67 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 103.973 -2.603 . . . . 74.1 103.973 175.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.449 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 9.2 m-85 -106.47 150.58 25.94 Favored 'General case' 0 CA--C 1.463 -2.367 0 N-CA-C 104.755 -2.313 . . . . 74.22 104.755 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.15 102.28 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.179 -1.786 . . . . 74.21 106.179 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -71.89 -35.2 69.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.495 -1.23 . . . . 75.21 109.67 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.86 144.08 19.98 Favored 'General case' 0 CA--C 1.464 -2.355 0 N-CA-C 105.841 -1.911 . . . . 51.21 105.841 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.99 127.62 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 103.409 -2.812 . . . . 71.33 103.409 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.23 147.03 63.82 Favored Pre-proline 0 CA--C 1.51 -0.577 0 N-CA-C 106.365 -1.717 . . . . 75.3 106.365 176.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.466 ' C ' ' H ' ' A' ' 45' ' ' GLY . 65.5 Cg_endo -76.29 172.67 15.82 Favored 'Trans proline' 0 CA--C 1.473 -2.526 0 N-CA-C 106.063 -2.322 . . . . 73.41 106.063 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 70.35 -11.75 0.57 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 124.116 0.885 . . . . 72.44 111.132 167.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -91.19 178.91 42.09 Favored Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 107.198 -2.361 . . . . 74.05 107.198 -174.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.51 69.87 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.211 -1.033 . . . . 74.12 108.211 -174.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.54 63.61 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 116.056 -0.52 . . . . 73.44 110.41 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.08 -53.95 17.63 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.69 -0.485 . . . . 62.33 109.69 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -61.27 -34.89 75.92 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.118 0.567 . . . . 70.13 110.531 -169.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -90.39 -23.22 21.13 Favored 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.077 -1.453 . . . . 73.22 107.077 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.0 24.57 59.52 Favored Glycine 0 C--N 1.358 1.755 0 N-CA-C 110.5 -1.04 . . . . 72.22 110.5 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HB2' HD13 ' A' ' 12' ' ' LEU . 23.4 mmt180 -96.33 6.45 48.77 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.264 -1.013 . . . . 74.02 108.264 -174.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' A' ' 12' ' ' LEU . 47.4 mt -142.34 146.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.172 -2.529 . . . . 75.1 104.172 -173.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -147.2 156.41 42.93 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 103.984 -2.599 . . . . 75.3 103.984 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -66.86 146.14 54.73 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.685 -1.228 . . . . 74.43 107.685 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.11 -30.71 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 108.221 -1.952 . . . . 72.13 108.221 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.25 153.93 39.61 Favored 'General case' 0 C--N 1.364 1.221 0 N-CA-C 107.896 -1.149 . . . . 74.43 107.896 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.8 ttp85 -112.56 138.43 49.34 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 105.967 -1.864 . . . . 75.31 105.967 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.67 126.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 105.089 -2.189 . . . . 75.24 105.089 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' CD1' HG21 ' A' ' 7' ' ' ILE . 16.3 mt -92.31 -58.71 2.29 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 107.841 -1.17 . . . . 75.41 107.841 -173.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.49 148.68 46.22 Favored 'General case' 0 CA--C 1.472 -2.03 0 N-CA-C 105.534 -2.024 . . . . 73.52 105.534 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -121.55 127.01 75.52 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.604 0 N-CA-C 104.665 -2.346 . . . . 63.41 104.665 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 t30 57.48 29.63 17.36 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.89 -0.781 . . . . 71.3 108.89 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.17 -20.04 52.38 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 108.887 -1.685 . . . . 64.31 108.887 173.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.27 123.29 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.917 0 N-CA-C 108.529 -0.915 . . . . 74.31 108.529 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.4 m -52.92 122.91 10.18 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 123.273 0.629 . . . . 72.12 109.924 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 HD11 ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -101.79 -21.95 14.49 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.358 -1.349 . . . . 73.14 107.358 -171.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -65.65 129.04 38.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.39 -0.819 . . . . 71.11 109.467 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 -17.08 57.11 Favored Glycine 0 C--N 1.363 2.055 0 N-CA-C 108.614 -1.795 . . . . 70.03 108.614 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB3' ' CG ' ' A' ' 74' ' ' GLN . . . -79.67 154.78 28.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.495 -1.669 . . . . 72.44 106.495 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 p -82.74 176.43 9.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.528 0.68 . . . . 74.41 110.242 -165.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -62.79 -51.46 67.02 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.669 -1.234 . . . . 74.34 107.669 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -53.7 -56.16 19.82 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 122.406 0.283 . . . . 62.41 111.083 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.5 ' CG ' ' HB3' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -60.57 -35.67 76.63 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 109.26 -0.644 . . . . 64.02 109.26 -171.024 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.13 -48.83 61.68 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 123.144 0.577 . . . . 75.22 109.583 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.27 -40.35 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 108.296 -1.002 . . . . 74.55 108.296 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -54.9 -40.45 69.82 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.526 -1.657 . . . . 73.21 106.526 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.4 m -74.33 -36.73 63.67 Favored 'General case' 0 C--O 1.215 -0.762 0 O-C-N 120.564 -1.335 . . . . 73.44 109.207 -171.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 mt -71.2 -39.84 71.54 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.086 -0.709 . . . . 73.12 109.086 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -78.74 -60.59 2.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.816 -0.438 . . . . 74.43 109.816 -171.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -67.06 60.27 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.901 0.858 . . . . 74.05 110.928 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -127.41 -176.28 3.7 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.913 -1.514 . . . . 70.34 106.913 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.18 -149.44 20.58 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 107.159 -2.376 . . . . 65.25 107.159 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -67.08 -55.77 12.86 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.259 -0.645 . . . . 55.21 109.259 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.62 145.02 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 106.214 -1.773 . . . . 73.02 106.214 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.49 146.01 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 106.101 -1.814 . . . . 74.54 106.101 -171.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -106.79 128.91 54.65 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 105.919 -1.882 . . . . 70.34 105.919 173.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.07 125.49 19.0 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 105.831 -1.914 . . . . 63.13 105.831 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.08 138.36 36.95 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.834 -1.543 . . . . 75.23 106.834 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -111.05 154.24 24.5 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 104.974 -2.232 . . . . 75.23 104.974 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -120.75 134.0 55.31 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 101.2 -3.63 . . . . 70.14 101.2 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -61.76 128.06 34.43 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.997 -1.112 . . . . 71.33 107.997 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.471 -2.702 0 N-CA-C 106.752 -2.539 . . . . 52.21 106.752 -173.262 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.121 0 N-CA-C 109.584 -1.406 . . . . 62.21 109.584 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.38 136.85 36.45 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 118.822 1.311 . . . . 75.33 107.724 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mt -102.78 132.89 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.915 0 N-CA-C 107.249 -1.389 . . . . 74.21 107.249 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -140.83 157.18 45.76 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.673 -1.232 . . . . 74.35 107.673 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.84 146.06 29.2 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.46 -2.052 . . . . 70.15 105.46 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.7 148.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 N-CA-C 106.378 -1.712 . . . . 72.02 106.378 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -107.19 122.32 46.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.632 -1.988 . . . . 73.45 105.632 171.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.62 131.61 53.9 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 106.775 -1.565 . . . . 74.15 106.775 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.78 139.07 33.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 104.332 -2.47 . . . . 72.23 104.332 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -67.37 -34.54 77.52 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.354 -1.35 . . . . 74.45 107.354 175.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.7 t30 68.08 113.33 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.785 -0.82 . . . . 74.05 108.785 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.71 31.82 16.45 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.7 -1.222 . . . . 62.13 107.7 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 46.8 3.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 126.33 1.852 . . . . 72.13 114.117 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m -103.41 143.25 32.94 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.667 -1.235 . . . . 72.3 107.667 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.8 -143.75 0.35 Allowed 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.351 -2.833 . . . . 73.43 103.351 172.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.95 47.66 0.04 OUTLIER Glycine 0 CA--C 1.467 -2.954 0 N-CA-C 106.334 -2.706 . . . . 24.42 106.334 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mm -91.22 177.09 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 103.374 -2.825 . . . . 72.33 103.374 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.0 m -133.27 157.68 44.82 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.689 -2.708 . . . . 74.11 103.689 172.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' HG13 ' A' ' 36' ' ' ILE . 4.2 m -148.3 171.47 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 106.588 -1.634 . . . . 65.11 106.588 -168.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.6 t -165.25 168.12 17.31 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.25 -2.13 . . . . 65.34 105.25 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -145.19 17.68 Favored Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 107.746 -2.141 . . . . 54.13 107.746 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.9 -85.51 0.42 Allowed Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.417 -1.473 . . . . 71.15 109.417 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.02 17.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.247 0 O-C-N 121.88 -0.777 . . . . 75.01 113.056 -166.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.7 t30 86.24 6.38 0.37 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.251 -1.018 . . . . 73.01 108.251 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -45.71 -168.98 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 126.497 1.919 . . . . 75.33 111.696 159.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 m -33.7 -39.54 0.06 Allowed 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.663 1.585 . . . . 64.31 114.836 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 m -77.27 139.96 17.86 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 O-C-N 121.184 -0.948 . . . . 75.1 108.934 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -69.42 -52.29 28.25 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 122.031 -0.418 . . . . 74.5 111.854 -169.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -78.25 5.05 11.15 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.64 -0.663 . . . . 75.33 110.49 -169.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.6 7.36 14.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 111.228 -0.749 . . . . 64.11 111.228 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.28 178.93 50.69 Favored Glycine 0 CA--C 1.473 -2.583 0 N-CA-C 106.09 -2.804 . . . . 74.11 106.09 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.402 HG13 ' HB ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -88.9 136.65 22.9 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.4 0 N-CA-C 104.688 -2.338 . . . . 70.24 104.688 173.835 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -109.81 146.58 34.79 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 102.991 -2.966 . . . . 72.34 102.991 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.75 103.29 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 107.085 -1.45 . . . . 65.44 107.085 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -71.18 -35.15 71.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.271 -1.331 . . . . 75.43 109.758 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.77 153.9 12.96 Favored 'General case' 0 CA--C 1.465 -2.309 0 N-CA-C 105.935 -1.876 . . . . 72.12 105.935 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.37 139.58 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 103.317 -2.845 . . . . 70.02 103.317 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.444 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -75.88 151.8 84.47 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 106.279 -1.748 . . . . 73.15 106.279 174.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.7 174.3 13.04 Favored 'Trans proline' 0 CA--C 1.468 -2.807 0 N-CA-C 105.449 -2.558 . . . . 61.42 105.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 49.26 52.01 15.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.74 0.781 . . . . 74.22 110.02 166.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.73 171.27 30.53 Favored Glycine 0 CA--C 1.461 -3.324 0 N-CA-C 103.184 -3.966 . . . . 23.1 103.184 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.92 -53.11 43.53 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 118.182 0.991 . . . . 72.23 108.847 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.6 63.52 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 116.898 -0.137 . . . . 71.33 111.28 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -69.86 -54.19 14.62 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.971 -0.381 . . . . 73.44 109.971 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.7 m -61.45 -30.59 70.69 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.983 -0.448 . . . . 70.11 110.777 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -81.35 -35.5 30.79 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.298 -1.742 . . . . 74.02 106.298 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.48 63.01 Favored Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 109.827 -1.309 . . . . 65.42 109.827 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -93.28 1.28 57.07 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.292 -1.374 . . . . 74.33 107.292 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.8 mt -144.64 139.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.157 -2.905 . . . . 73.03 103.157 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -143.9 162.46 36.06 Favored 'General case' 0 CA--C 1.459 -2.548 0 N-CA-C 106.054 -1.832 . . . . 72.13 106.054 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -67.19 137.58 56.33 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.195 -1.409 . . . . 70.55 107.195 170.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.38 -33.03 6.67 Favored Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 108.151 -1.98 . . . . 74.31 108.151 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.41 155.0 38.68 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.48 -1.674 . . . . 74.53 106.48 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.34 148.33 51.26 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.336 -1.357 . . . . 72.43 107.336 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.92 129.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.831 -1.914 . . . . 75.1 105.831 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.5 mt -93.79 -58.66 2.19 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 106.937 -1.505 . . . . 74.24 106.937 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.25 150.63 51.03 Favored 'General case' 0 CA--C 1.475 -1.923 0 N-CA-C 106.455 -1.683 . . . . 72.12 106.455 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.66 122.38 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 104.929 -2.248 . . . . 72.53 104.929 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 56.11 33.43 21.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.976 0.893 . . . . 64.25 108.875 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.41 -21.62 41.73 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 108.143 -1.983 . . . . 70.5 108.143 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.91 118.73 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.132 0 N-CA-C 107.873 -1.158 . . . . 74.02 107.873 -172.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -49.21 116.97 1.9 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.814 -0.81 . . . . 74.43 108.814 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.85 -19.59 17.31 Favored 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 105.936 -1.876 . . . . 74.11 105.936 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.99 124.62 21.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.664 -0.865 . . . . 71.24 108.664 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.63 60.84 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.465 -1.854 . . . . 74.42 108.465 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.55 147.17 39.9 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.195 -1.78 . . . . 74.05 106.195 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.1 p -77.04 178.57 6.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.143 -1.058 . . . . 75.32 108.143 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -68.47 -46.96 68.34 Favored 'General case' 0 C--O 1.204 -1.314 0 N-CA-C 108.665 -0.865 . . . . 73.14 108.665 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.17 -54.39 45.79 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.366 -0.834 . . . . 74.31 110.518 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -57.92 -40.77 81.23 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 110.141 -0.318 . . . . 74.54 110.141 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.95 -52.15 52.26 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 122.604 0.362 . . . . 75.01 110.438 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -73.7 -39.72 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.621 -1.252 . . . . 72.43 107.621 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.0 t -57.14 -35.58 69.67 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 106.423 -1.695 . . . . 64.44 106.423 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.4 m -71.69 -43.82 65.3 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 120.388 -1.445 . . . . 74.21 107.829 -174.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.04 -39.35 94.48 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 109.069 -0.715 . . . . 72.04 109.069 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 82' ' ' THR . 3.0 tmm_? -68.28 -59.76 2.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.868 -1.16 . . . . 74.02 107.868 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.17 53.31 0.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.877 0.846 . . . . 75.25 110.723 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 80' ' ' ARG . 7.0 p -103.74 -175.97 2.95 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 105.161 -2.162 . . . . 65.45 105.161 169.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.21 -148.85 16.93 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 107.225 -2.35 . . . . 75.23 107.225 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -66.61 -54.99 17.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.55 -0.907 . . . . 74.41 108.55 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.6 t -99.29 144.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.67 -1.604 . . . . 74.35 106.67 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.415 HG12 HG21 ' A' ' 82' ' ' THR . 58.0 t -100.69 129.3 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 105.459 -2.052 . . . . 74.11 105.459 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -113.33 128.26 56.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.723 -2.325 . . . . 64.01 104.723 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.05 138.31 12.58 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.406 -1.331 . . . . 71.02 107.406 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -81.76 139.58 34.75 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.617 -1.253 . . . . 73.02 107.617 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.76 159.05 17.5 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 104.174 -2.528 . . . . 73.14 104.174 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.79 131.25 53.96 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 100.542 -3.873 . . . . 74.44 100.542 161.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -70.61 139.97 51.52 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 106.208 -1.775 . . . . 73.45 106.208 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.286 0 N-CA-C 107.737 -2.145 . . . . 75.2 107.737 -173.861 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.586 0 N-CA-C 108.385 -1.886 . . . . 62.4 108.385 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.99 131.34 42.03 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.237 -1.394 . . . . 65.5 107.237 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mt -94.8 136.31 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 N-CA-C 107.0 -1.482 . . . . 72.45 107.0 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 1.1 p90 -141.21 154.85 46.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.144 -1.428 . . . . 73.4 107.144 174.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -104.66 148.81 26.14 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 105.574 -2.01 . . . . 73.14 105.574 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.17 150.97 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 106.481 -1.674 . . . . 72.21 106.481 173.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -106.58 124.99 50.43 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 104.619 -2.363 . . . . 64.44 104.619 164.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.452 HD13 HD12 ' A' ' 53' ' ' ILE . 50.7 mt -139.46 137.42 35.56 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.599 -1.63 . . . . 64.23 106.599 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.48 161.18 17.15 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 106.416 -1.698 . . . . 74.54 106.416 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -43.68 63.03 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 105.919 -1.882 . . . . 64.21 105.919 168.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 70.13 117.35 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.325 1.05 . . . . 74.4 108.983 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 59.2 37.54 23.82 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-O 121.816 0.817 . . . . 62.11 109.021 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 55.1 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.253 1.821 . . . . 70.5 114.392 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.3 m -93.73 136.54 33.91 Favored 'General case' 0 CA--C 1.483 -1.606 0 O-C-N 120.51 -1.369 . . . . 63.32 108.759 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.544 HD11 ' H ' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.01 -165.01 1.22 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.725 -3.065 . . . . 74.53 102.725 172.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.441 ' H ' HD11 ' A' ' 19' ' ' LEU . . . 163.43 23.6 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.328 0 C-N-CA 117.315 -2.374 . . . . 63.25 110.339 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.544 ' H ' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -87.79 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 104.411 -2.44 . . . . 74.13 104.411 179.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 m -138.31 160.3 39.84 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.114 -2.18 . . . . 74.33 105.114 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 169.47 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.629 -0.878 . . . . 74.41 108.629 -163.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.2 t -160.41 165.45 31.08 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 104.805 -2.294 . . . . 70.45 104.805 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.18 -149.72 24.18 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 108.938 -1.665 . . . . 64.03 108.938 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 113.61 -75.85 0.24 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 109.46 -1.456 . . . . 75.5 109.46 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.39 15.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 O-C-N 122.579 -0.365 . . . . 64.3 110.953 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 26' ' ' GLY . 8.8 t30 83.8 5.15 0.76 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.619 1.168 . . . . 74.54 108.15 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.1 p -47.44 -170.11 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.542 1.937 . . . . 72.23 113.623 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 m -40.94 -37.58 0.82 Allowed 'General case' 0 C--N 1.373 1.597 0 C-N-CA 125.969 1.707 . . . . 70.01 113.853 -165.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 132.07 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.537 0.684 . . . . 73.44 110.171 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ptt85 -44.53 -63.63 0.86 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-N 114.79 -1.095 . . . . 74.31 113.397 -168.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -77.78 -19.92 54.22 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 118.708 0.686 . . . . 73.3 109.229 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.42 -12.54 43.47 Favored Glycine 0 C--N 1.361 1.949 0 N-CA-C 109.916 -1.274 . . . . 61.41 109.916 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.17 179.94 49.62 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 109.855 -1.298 . . . . 71.34 109.855 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 75' ' ' ALA . 2.8 mm -86.53 127.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 102.05 -3.315 . . . . 64.51 102.05 170.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -104.9 155.59 18.79 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 105.426 -2.065 . . . . 74.13 105.426 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -83.5 102.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 105.675 -1.972 . . . . 70.41 105.675 174.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.83 -31.28 66.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.497 -1.228 . . . . 74.14 110.163 -172.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.48 149.95 17.45 Favored 'General case' 0 CA--C 1.463 -2.387 0 N-CA-C 105.849 -1.908 . . . . 45.13 105.849 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.0 t -127.4 134.96 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 104.512 -2.403 . . . . 73.21 104.512 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -81.97 151.43 67.1 Favored Pre-proline 0 N--CA 1.445 -0.695 0 N-CA-C 106.669 -1.604 . . . . 72.43 106.669 176.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.45 -179.14 5.01 Favored 'Trans proline' 0 CA--C 1.479 -2.274 0 N-CA-C 105.928 -2.374 . . . . 72.25 105.928 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 49.43 52.24 14.86 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.023 0.827 . . . . 74.34 110.641 162.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.59 32.85 Favored Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 103.41 -3.876 . . . . 75.14 103.41 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.36 53.54 Favored 'General case' 0 C--O 1.205 -1.263 0 CA-C-N 117.632 0.716 . . . . 74.25 109.173 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.91 -50.26 64.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.547 -0.297 . . . . 44.1 110.99 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -68.79 -50.15 52.66 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.958 -0.464 . . . . 71.51 110.016 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.7 t -63.81 -33.69 76.25 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.754 -0.461 . . . . 71.32 109.754 -171.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -79.17 -32.0 44.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.074 -1.824 . . . . 70.12 106.074 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.29 60.98 Favored Glycine 0 C--N 1.359 1.818 0 N-CA-C 110.327 -1.109 . . . . 75.21 110.327 170.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -101.87 8.26 41.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.94 -1.133 . . . . 73.23 107.94 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.452 HD12 HD13 ' A' ' 12' ' ' LEU . 55.0 mt -144.27 145.75 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.009 -2.219 . . . . 74.44 105.009 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.504 ' CE1' ' OD1' ' A' ' 57' ' ' ASP . 54.0 p-80 -154.12 159.69 41.58 Favored 'General case' 0 N--CA 1.401 -2.911 0 N-CA-C 102.815 -3.031 . . . . 74.45 102.815 172.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 17.1 ptpt -66.5 147.0 53.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.57 -0.9 . . . . 73.52 108.57 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.54 -33.26 6.7 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 109.975 -1.25 . . . . 65.34 109.975 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 83.0 m-20 -69.75 155.95 39.76 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 105.32 -2.104 . . . . 62.34 105.32 172.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -132.66 157.89 43.69 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.633 -0.877 . . . . 73.14 108.633 -169.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.83 140.82 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 106.723 -1.584 . . . . 74.11 106.723 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.3 mt -101.11 -59.48 1.69 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.36 -1.718 . . . . 73.34 106.36 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.13 151.31 49.64 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 106.487 -1.672 . . . . 63.51 106.487 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.78 123.5 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.336 -2.098 . . . . 73.02 105.336 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.4 t30 50.99 35.35 12.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.874 1.27 . . . . 75.55 110.854 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.58 -22.04 38.75 Favored Glycine 0 CA--C 1.473 -2.566 0 N-CA-C 108.856 -1.698 . . . . 73.43 108.856 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.64 115.78 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 N-CA-C 108.095 -1.076 . . . . 74.3 108.095 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.0 m -54.12 112.92 1.06 Allowed 'General case' 0 C--N 1.371 1.537 0 N-CA-C 107.6 -1.259 . . . . 72.2 107.6 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.426 ' CD1' HG13 ' A' ' 36' ' ' ILE . 1.1 tm? -104.44 -11.79 16.87 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 106.882 -1.525 . . . . 75.34 106.882 -162.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -60.16 129.2 40.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.62 -0.881 . . . . 65.22 108.62 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.91 -14.5 65.16 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.64 -1.784 . . . . 74.42 108.64 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -81.6 150.91 27.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.399 -1.704 . . . . 73.22 106.399 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -83.58 178.84 7.81 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.795 -0.446 . . . . 73.12 109.795 -167.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -56.21 -52.0 66.01 Favored 'General case' 0 C--N 1.382 2.007 0 N-CA-C 107.093 -1.447 . . . . 71.14 107.093 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -58.72 -48.51 80.91 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 116.538 -0.301 . . . . 72.52 110.764 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -56.64 -42.71 79.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.7 -0.4 . . . . 65.4 110.543 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -52.06 -51.4 57.81 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 120.727 -0.389 . . . . 73.04 110.657 177.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.26 -39.98 49.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 C-N-CA 119.932 -0.707 . . . . 75.34 109.831 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.67 -33.25 74.67 Favored 'General case' 0 N--CA 1.521 3.077 0 N-CA-C 106.131 -1.803 . . . . 74.45 106.131 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 m -71.31 -42.93 68.0 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 120.242 -1.536 . . . . 74.2 108.209 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.5 mt -69.49 -35.26 75.39 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.409 -0.589 . . . . 73.42 109.409 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -61.86 1.61 Allowed 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.556 -1.276 . . . . 73.32 107.556 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -73.07 58.46 0.49 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.409 0.623 . . . . 74.34 110.67 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 p -102.68 -175.79 2.92 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.323 -1.362 . . . . 70.23 107.323 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.01 -154.28 30.35 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 106.224 -2.75 . . . . 64.24 106.224 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.61 -53.98 50.88 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.829 -0.434 . . . . 72.41 109.829 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.0 t -110.57 154.09 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 105.729 -1.952 . . . . 74.2 105.729 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.47 139.04 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.441 0 N-CA-C 105.912 -1.884 . . . . 65.13 105.912 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.87 123.99 49.42 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 104.418 -2.438 . . . . 72.11 104.418 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.8 133.31 11.97 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.052 -1.092 . . . . 72.41 108.052 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -84.86 144.34 28.47 Favored 'General case' 0 CA--C 1.474 -1.98 0 N-CA-C 108.832 -0.803 . . . . 74.41 108.832 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -117.79 162.71 17.65 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 104.711 -2.329 . . . . 65.1 104.711 175.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -124.39 137.38 54.47 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.233 -3.247 . . . . 73.13 102.233 165.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.8 145.75 54.2 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.006 -0.739 . . . . 71.21 109.006 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.904 0 N-CA-C 105.427 -3.069 . . . . 75.24 105.427 179.765 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.959 0 N-CA-C 109.569 -1.413 . . . . 64.31 109.569 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.86 145.52 26.55 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 106.604 -1.628 . . . . 71.53 106.604 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.2 mt -101.53 139.02 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.986 0 N-CA-C 108.083 -1.08 . . . . 75.35 108.083 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -144.67 162.27 37.1 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.012 -1.477 . . . . 75.03 107.012 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.59 150.38 24.02 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.003 -1.851 . . . . 74.34 106.003 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.89 140.27 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.543 0 N-CA-C 105.178 -2.156 . . . . 73.41 105.178 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.38 116.4 31.88 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.65 -2.352 . . . . 65.23 104.65 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 mt -138.46 138.24 37.94 Favored 'General case' 0 CA--C 1.454 -2.726 0 N-CA-C 107.615 -1.254 . . . . 73.4 107.615 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.1 159.58 17.47 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 105.746 -1.946 . . . . 74.22 105.746 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.85 -50.69 71.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.879 -1.526 . . . . 74.21 106.879 171.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 t30 74.62 119.24 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.446 -1.252 . . . . 72.41 107.954 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 18' ' ' SER . 68.8 m-20 57.16 34.48 24.9 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.734 0.814 . . . . 75.5 109.445 -173.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.1 t30 54.61 -5.11 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.746 1.618 . . . . 54.12 113.679 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 16' ' ' ASP . 61.5 m -95.66 136.99 35.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.894 -0.78 . . . . 73.54 108.894 -171.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -149.95 0.45 Allowed 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 103.008 -2.96 . . . . 64.31 103.008 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.12 76.17 0.86 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 106.542 -2.623 . . . . 73.43 106.542 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.3 mm -102.02 176.74 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 102.531 -3.137 . . . . 74.44 102.531 176.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.509 ' H ' HG22 ' A' ' 21' ' ' ILE . 7.0 m -106.11 152.71 23.06 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 103.843 -2.651 . . . . 71.22 103.843 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.35 165.0 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.98 -1.119 . . . . 72.33 107.98 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.9 t -160.2 165.96 30.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.683 -2.339 . . . . 74.15 104.683 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.431 ' O ' ' CE1' ' A' ' 72' ' ' HIS . . . 82.7 -141.25 20.94 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 107.292 -2.323 . . . . 73.5 107.292 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.51 -84.11 0.38 Allowed Glycine 0 CA--C 1.471 -2.664 0 N-CA-C 108.437 -1.865 . . . . 61.44 108.437 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -69.06 8.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.041 0 N-CA-C 112.396 0.517 . . . . 74.3 112.396 -166.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 68.66 68.08 0.3 Allowed 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 106.71 -1.589 . . . . 72.14 106.71 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 p -107.04 -164.66 1.0 Allowed 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 101.956 -3.35 . . . . 63.32 101.956 -172.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -44.84 -18.43 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.152 0.981 . . . . 73.15 113.152 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.67 150.85 8.49 Favored 'Isoleucine or valine' 0 C--N 1.38 1.934 0 N-CA-C 106.06 -1.83 . . . . 74.34 106.06 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -78.77 -72.17 0.4 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 120.403 -1.436 . . . . 72.14 110.121 -169.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -69.9 -21.55 63.3 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 120.29 -0.564 . . . . 73.33 110.944 -160.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.27 59.99 1.7 Allowed Glycine 0 CA--C 1.484 -1.897 0 C-N-CA 119.554 -1.307 . . . . 74.15 110.168 164.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.18 179.41 20.73 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 104.643 -3.383 . . . . 72.52 104.643 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.1 mm -82.17 127.91 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.428 0 N-CA-C 103.356 -2.831 . . . . 65.31 103.356 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -106.1 150.93 25.32 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 105.045 -2.206 . . . . 73.22 105.045 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -83.9 102.03 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.053 -1.832 . . . . 73.54 106.053 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.47 -25.97 63.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.054 -1.43 . . . . 72.12 109.861 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -173.62 161.38 3.95 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 104.642 -2.355 . . . . 71.12 104.642 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -116.88 132.57 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 103.134 -2.913 . . . . 74.4 103.134 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -82.35 151.0 65.1 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.964 -1.865 . . . . 63.54 105.964 175.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.95 177.47 8.76 Favored 'Trans proline' 0 CA--C 1.482 -2.084 0 N-CA-C 106.587 -2.12 . . . . 74.25 106.587 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 53.96 53.47 11.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.031 0.832 . . . . 73.04 109.157 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.55 166.89 33.43 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 105.447 -3.061 . . . . 71.34 105.447 -176.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.6 -50.74 70.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.508 -0.923 . . . . 71.22 108.508 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.97 66.04 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.857 -0.61 . . . . 75.54 110.688 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -65.85 -53.72 36.12 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.71 -0.478 . . . . 73.21 109.71 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -56.95 -29.12 62.87 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 122.226 -0.296 . . . . 75.11 111.271 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.55 -28.39 20.79 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.867 -1.16 . . . . 74.4 107.867 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.0 19.9 74.16 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.77 -0.932 . . . . 54.41 110.77 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -104.55 7.1 35.11 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 117.753 0.777 . . . . 65.51 108.94 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.471 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 1.5 mp -127.56 136.57 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.183 -3.266 . . . . 71.5 102.183 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 53' ' ' ILE . 40.8 m170 -145.34 162.72 36.56 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 106.118 -1.808 . . . . 74.01 106.118 -177.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -66.6 136.78 56.11 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.274 -1.01 . . . . 75.34 108.274 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.31 -29.25 12.31 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 108.338 -1.905 . . . . 64.32 108.338 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.92 155.03 41.0 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 106.91 -1.515 . . . . 72.33 106.91 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -124.76 153.81 41.87 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.216 -1.031 . . . . 74.02 108.216 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -92.59 132.32 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 N-CA-C 105.739 -1.949 . . . . 74.45 105.739 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.5 mt -95.36 -59.41 1.89 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.942 -1.503 . . . . 74.23 106.942 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.69 51.37 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.788 -1.56 . . . . 71.04 106.788 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.52 131.07 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 104.722 -2.325 . . . . 74.33 104.722 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 56.23 29.94 15.74 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 122.009 0.909 . . . . 75.43 109.489 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.39 -9.07 76.89 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.573 -1.811 . . . . 50.1 108.573 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.9 t -87.9 115.6 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 N-CA-C 106.507 -1.664 . . . . 72.11 106.507 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.46 119.82 5.76 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 107.898 -1.149 . . . . 61.13 107.898 172.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.1 tm? -108.97 -15.17 14.42 Favored 'General case' 0 C--O 1.2 -1.541 0 N-CA-C 107.262 -1.385 . . . . 72.34 107.262 -163.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.43 122.33 13.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.505 -0.924 . . . . 73.4 108.505 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.78 -16.63 57.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 108.635 -1.786 . . . . 61.45 108.635 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -80.39 151.45 29.37 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.606 -1.627 . . . . 75.31 106.606 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.486 ' HA ' HG23 ' A' ' 27' ' ' VAL . 68.6 p -79.96 179.78 7.41 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.202 0.525 . . . . 65.12 109.745 -170.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' HIS . . . . . 0.431 ' CE1' ' O ' ' A' ' 25' ' ' GLY . 14.4 m-70 -59.66 -51.31 70.35 Favored 'General case' 0 C--N 1.371 1.511 0 N-CA-C 107.589 -1.263 . . . . 73.32 107.589 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -55.7 -55.08 36.39 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 109.988 -0.375 . . . . 65.14 109.988 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -53.86 -43.95 69.97 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.775 -0.454 . . . . 74.14 109.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.49 23.11 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 122.663 0.385 . . . . 65.54 110.369 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 m -74.22 -37.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 C-N-CA 120.506 -0.478 . . . . 73.22 109.778 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 82.9 m -62.71 -32.23 73.29 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.305 -1.739 . . . . 73.01 106.305 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -73.62 -40.69 63.6 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.357 -1.464 . . . . 75.33 108.195 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.5 -28.4 69.81 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.242 -0.651 . . . . 74.52 109.242 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . 0.432 ' C ' ' H ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -80.06 -58.04 3.34 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 107.775 -1.194 . . . . 75.42 107.775 176.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -68.58 43.32 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 124.781 1.232 . . . . 63.22 112.212 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 80' ' ' ARG . 1.4 t -123.82 -174.61 3.02 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 102.942 -2.985 . . . . 72.31 102.942 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.34 -145.16 18.3 Favored Glycine 0 CA--C 1.49 -1.48 0 N-CA-C 107.7 -2.16 . . . . 53.34 107.7 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.78 -55.49 16.93 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.46 -0.941 . . . . 72.24 108.46 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.9 t -107.16 142.5 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 106.04 -1.837 . . . . 75.32 106.04 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.413 HG23 ' CG2' ' A' ' 82' ' ' THR . 45.8 t -115.08 144.82 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 105.634 -1.987 . . . . 74.53 105.634 -172.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.38 122.1 45.27 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 104.698 -2.334 . . . . 71.33 104.698 168.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.49 118.29 15.12 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.182 -2.155 . . . . 73.23 105.182 177.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.5 mp -83.94 143.62 29.71 Favored 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 106.624 -1.621 . . . . 75.01 106.624 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.34 156.23 22.8 Favored 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.96 -2.237 . . . . 73.04 104.96 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -123.54 135.44 54.01 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 101.08 -3.674 . . . . 72.52 101.08 162.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.29 137.11 58.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.618 -1.252 . . . . 73.23 107.618 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.464 -3.125 0 N-CA-C 110.233 -1.147 . . . . 64.52 110.233 -168.567 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.792 0 N-CA-C 108.211 -1.956 . . . . 35.24 108.211 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.24 143.91 66.44 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.885 2.39 . . . . 63.13 108.595 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.55 168.31 19.12 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 106.148 -1.797 . . . . 74.33 106.148 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.46 116.2 3.26 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.884 2.389 . . . . 72.3 109.679 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.65 8.83 63.46 Favored Glycine 0 C--N 1.344 0.988 0 N-CA-C 108.487 -1.845 . . . . 72.23 108.487 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -89.86 143.44 26.79 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.273 -1.751 . . . . 62.34 106.273 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.452 HG21 ' CD1' ' A' ' 60' ' ' LEU . 19.1 mm -95.95 129.51 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 105.524 -2.028 . . . . 73.1 105.524 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.4 ' CD2' HD22 ' A' ' 90' ' ' LEU . 2.2 p90 -137.07 152.41 50.03 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.81 -1.181 . . . . 73.35 107.81 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -106.53 146.34 30.74 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.044 -1.836 . . . . 74.4 106.044 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.1 m -142.26 152.66 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 105.958 -1.867 . . . . 73.31 105.958 174.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.85 132.04 56.04 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.381 -1.711 . . . . 74.15 106.381 172.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.03 139.13 49.9 Favored 'General case' 0 CA--C 1.457 -2.626 0 N-CA-C 106.833 -1.543 . . . . 70.24 106.833 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.49 131.36 38.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.927 -1.879 . . . . 73.01 105.927 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -67.28 -23.91 65.72 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.637 -0.875 . . . . 75.53 108.637 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 70.71 104.86 0.06 Allowed 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.171 0.988 . . . . 60.4 110.394 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 56.85 43.47 24.87 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-N 115.448 -0.796 . . . . 72.44 109.203 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 42.64 9.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.708 2.003 . . . . 73.23 116.031 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.1 m -126.88 129.78 48.89 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 106.437 -1.69 . . . . 75.22 106.437 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.3 167.34 12.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.836 -2.283 . . . . 74.41 104.836 168.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.56 68.62 0.27 Allowed Glycine 0 CA--C 1.47 -2.746 0 N-CA-C 104.507 -3.437 . . . . 72.22 104.507 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.552 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.4 mt -101.15 176.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.458 -2.793 . . . . 73.32 103.458 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.552 ' H ' HG22 ' A' ' 21' ' ' ILE . 70.9 m -138.28 165.07 27.65 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 106.402 -1.703 . . . . 73.13 106.402 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 m -152.33 177.15 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.085 -1.82 . . . . 64.4 106.085 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.442 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 10.0 t -160.95 166.21 28.71 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 104.0 -2.593 . . . . 62.32 104.0 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.97 -151.74 29.12 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.927 -1.669 . . . . 50.5 108.927 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 116.62 -70.64 0.28 Allowed Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.692 -1.363 . . . . 51.31 109.692 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 29' ' ' THR . 1.4 t -72.32 16.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.097 0.475 . . . . 64.22 111.252 -172.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.479 ' H ' ' C ' ' A' ' 26' ' ' GLY . 35.7 t30 78.41 5.14 2.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.597 1.159 . . . . 73.41 108.743 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 27' ' ' VAL . 6.3 t -49.77 -171.36 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 C-N-CA 125.337 1.455 . . . . 75.42 112.037 169.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.4 p -38.56 -38.22 0.37 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.63 1.972 . . . . 73.41 115.164 -164.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.7 m -59.71 140.77 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.544 0.688 . . . . 74.1 110.215 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HD3' ' H ' ' A' ' 97' ' ' THR . 96.1 mtt-85 -41.62 -70.28 0.11 Allowed 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.029 1.332 . . . . 74.11 112.824 -170.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -87.97 15.74 6.87 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.632 -0.877 . . . . 62.4 108.632 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.43 -7.98 2.42 Favored Glycine 0 C--N 1.359 1.842 0 O-C-N 121.792 -0.567 . . . . 71.41 113.149 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.11 -178.64 49.44 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.656 -1.378 . . . . 64.31 109.656 -170.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.1 mp -76.96 128.3 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 N-CA-C 101.922 -3.362 . . . . 52.24 101.922 170.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -107.08 147.56 29.85 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 104.089 -2.56 . . . . 72.25 104.089 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.47 102.22 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.724 -1.584 . . . . 74.52 106.724 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.442 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -72.82 -37.59 67.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.831 -1.531 . . . . 74.32 110.441 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.21 142.34 18.21 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 105.952 -1.87 . . . . 61.42 105.952 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -117.16 131.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 102.96 -2.978 . . . . 75.12 102.96 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.416 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -73.27 144.58 84.56 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 106.482 -1.673 . . . . 70.22 106.482 174.834 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.407 ' C ' ' H ' ' A' ' 45' ' ' GLY . 65.4 Cg_endo -75.43 169.55 22.17 Favored 'Trans proline' 0 CA--C 1.462 -3.088 0 N-CA-C 105.07 -2.704 . . . . 62.52 105.07 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 66.51 -3.94 0.79 Allowed 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 124.04 0.837 . . . . 73.13 111.317 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -92.48 -179.2 40.97 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 108.122 -1.991 . . . . 71.42 108.122 -177.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -51.74 63.09 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.118 -1.068 . . . . 75.24 108.118 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.97 65.18 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.277 -0.42 . . . . 73.43 110.882 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.61 -55.87 15.29 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.174 -0.328 . . . . 71.52 110.285 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.5 m -65.02 -31.24 72.37 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 122.056 -0.402 . . . . 64.14 111.256 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -81.3 -32.59 33.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.494 -1.669 . . . . 72.51 106.494 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.44 18.04 69.72 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 110.552 -1.019 . . . . 71.25 110.552 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -86.48 2.46 47.8 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.854 -1.165 . . . . 64.03 107.854 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -147.42 147.46 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 104.449 -2.426 . . . . 72.34 104.449 -168.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.97 167.11 30.87 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 104.186 -2.524 . . . . 74.32 104.186 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -66.3 145.41 55.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.121 -1.066 . . . . 74.25 108.121 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.7 -33.08 6.86 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 108.988 -1.645 . . . . 74.12 108.988 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.38 161.38 31.15 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 108.004 -1.11 . . . . 74.43 108.004 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.07 150.66 48.0 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 107.997 -1.112 . . . . 74.42 107.997 -172.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.01 139.24 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 105.705 -1.961 . . . . 74.24 105.705 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.452 ' CD1' HG21 ' A' ' 7' ' ' ILE . 16.3 mt -102.18 -59.49 1.69 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.992 -1.484 . . . . 74.44 106.992 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.55 150.4 50.74 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.199 -1.778 . . . . 71.33 106.199 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.44 120.33 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 105.015 -2.217 . . . . 75.11 105.015 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.4 t30 51.79 36.0 16.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.027 0.931 . . . . 75.44 109.979 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.34 -29.41 12.56 Favored Glycine 0 CA--C 1.474 -2.509 0 N-CA-C 108.134 -1.987 . . . . 44.14 108.134 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.69 115.32 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 108.383 -0.969 . . . . 72.45 108.383 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.9 m -55.4 115.54 2.35 Favored 'General case' 0 C--N 1.37 1.486 0 N-CA-C 107.193 -1.41 . . . . 44.13 107.193 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -101.33 -15.29 17.29 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 106.427 -1.694 . . . . 73.21 106.427 -165.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.09 128.77 37.37 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.498 -0.927 . . . . 75.22 108.498 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.98 57.78 Favored Glycine 0 CA--C 1.498 -0.977 0 N-CA-C 107.815 -2.114 . . . . 74.24 107.815 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.88 152.2 28.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.554 -2.017 . . . . 75.43 105.554 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.1 p -79.16 176.32 9.78 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.094 -0.706 . . . . 73.41 109.094 -172.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -70.34 -41.14 73.58 Favored 'General case' 0 C--O 1.21 -1.002 0 N-CA-C 108.726 -0.842 . . . . 75.43 108.726 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.67 -54.41 47.34 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.075 -1.015 . . . . 75.42 110.644 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -55.85 -34.96 65.91 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.441 -0.787 . . . . 75.1 111.294 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.72 -52.33 41.33 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.579 0.228 . . . . 73.02 111.282 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -74.95 -35.03 34.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 N-CA-C 108.276 -1.009 . . . . 74.5 108.276 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.41 -39.76 73.56 Favored 'General case' 0 N--CA 1.518 2.973 0 N-CA-C 105.775 -1.935 . . . . 72.03 105.775 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.2 m -69.3 -40.15 77.86 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.294 -1.503 . . . . 75.23 108.125 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.6 mt -64.71 -30.11 71.11 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.788 -0.449 . . . . 73.32 109.788 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -72.15 -57.67 4.06 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.529 -0.915 . . . . 74.52 108.529 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -69.14 48.11 0.07 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 122.918 0.487 . . . . 72.51 111.978 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.453 ' HG1' HG22 ' A' ' 86' ' ' VAL . 23.3 p -108.05 -175.58 2.82 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.21 -1.774 . . . . 74.2 106.21 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.06 -153.6 30.33 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 106.471 -2.652 . . . . 65.33 106.471 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.95 -54.86 20.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.75 -0.833 . . . . 73.13 108.75 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.9 t -95.07 142.74 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.335 -2.098 . . . . 75.44 105.335 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.453 HG22 ' HG1' ' A' ' 82' ' ' THR . 48.1 t -102.56 128.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 105.123 -2.177 . . . . 62.05 105.123 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -107.29 125.62 51.39 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 103.527 -2.768 . . . . 72.31 103.527 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.22 136.36 11.85 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.169 -1.048 . . . . 72.31 108.169 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -86.43 143.05 27.98 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 108.283 -1.006 . . . . 74.11 108.283 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.4 HD22 ' CD2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -120.32 165.42 14.89 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 104.878 -2.267 . . . . 72.5 104.878 177.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.48 145.79 51.44 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 102.608 -3.108 . . . . 72.24 102.608 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -64.82 131.11 45.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.839 -1.171 . . . . 74.42 107.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.09 10.45 33.99 Favored Glycine 0 CA--C 1.479 -2.196 0 N-CA-C 106.892 -2.483 . . . . 72.35 106.892 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -65.91 -40.02 91.11 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.621 -1.252 . . . . 71.34 107.621 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 1.8 m -45.09 112.47 1.55 Allowed Pre-proline 0 C--O 1.253 1.257 0 C-N-CA 124.286 1.035 . . . . 62.44 111.078 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.4 98.89 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.77 2.313 . . . . 74.11 107.325 173.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.404 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 26.8 m . . . . . 0 N--CA 1.418 -2.066 0 N-CA-C 105.376 -2.083 . . . . 70.32 105.376 -173.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.486 ' H20' ' H15' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.454 0 N-CA-C 108.288 -1.925 . . . . 70.43 108.288 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.78 149.94 78.68 Favored 'Trans proline' 0 CA--C 1.494 -1.485 0 C-N-CA 122.828 2.352 . . . . 74.44 108.068 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.43 161.47 48.48 Favored Pre-proline 0 N--CA 1.433 -1.311 0 N-CA-C 106.212 -1.773 . . . . 74.23 106.212 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.44 118.88 5.88 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.599 2.199 . . . . 74.35 108.938 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.496 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 88.7 9.09 69.14 Favored Glycine 0 CA--C 1.497 -1.034 0 N-CA-C 108.511 -1.836 . . . . 71.24 108.511 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.66 135.07 40.44 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.817 -1.549 . . . . 62.33 106.817 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.461 HD12 HD13 ' A' ' 60' ' ' LEU . 22.4 mm -98.8 130.07 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 106.1 -1.815 . . . . 74.33 106.1 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -141.91 153.77 44.62 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.054 -1.091 . . . . 73.31 108.054 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -107.81 144.09 35.46 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 105.07 -2.196 . . . . 65.02 105.07 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 27.6 m -141.6 153.71 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 107.068 -1.456 . . . . 64.24 107.068 176.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.428 ' HB2' HG13 ' A' ' 85' ' ' VAL . 7.4 pt-20 -112.08 130.71 55.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.892 -1.892 . . . . 64.24 105.892 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.468 HD13 HD12 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -135.17 134.1 39.79 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.865 -1.532 . . . . 75.22 106.865 -176.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 141.81 30.0 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 105.379 -2.082 . . . . 72.42 105.379 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HG2' HD22 ' A' ' 19' ' ' LEU . 42.3 mtpt -75.41 -31.83 60.53 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.178 -1.045 . . . . 73.4 108.178 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 68.4 110.59 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.122 -0.696 . . . . 75.05 109.122 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t70 58.3 32.15 21.72 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 107.992 -1.114 . . . . 73.33 107.992 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 43.13 19.04 0.01 OUTLIER 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.722 1.609 . . . . 62.31 113.324 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -90.56 119.36 30.75 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 106.215 -1.772 . . . . 65.53 106.215 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.586 ' CD1' ' H ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -111.6 -143.64 0.39 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 102.911 -2.996 . . . . 63.13 102.911 179.068 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.586 ' H ' ' CD1' ' A' ' 19' ' ' LEU . . . 103.36 66.25 0.73 Allowed Glycine 0 CA--C 1.474 -2.482 0 N-CA-C 106.855 -2.498 . . . . 74.24 106.855 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.528 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.6 mm -89.43 177.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 102.447 -3.168 . . . . 55.31 102.447 170.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.528 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.6 m -122.5 154.49 37.78 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.037 -2.579 . . . . 74.52 104.037 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.489 ' HA ' ' H ' ' A' ' 39' ' ' LYS . 30.9 m -149.25 176.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.424 -1.324 . . . . 71.34 107.424 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.15 -2.167 . . . . 71.52 105.15 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.53 -158.75 25.54 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 108.454 -1.858 . . . . 71.12 108.454 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.29 -95.06 0.3 Allowed Glycine 0 C--N 1.36 1.863 0 N-CA-C 109.08 -1.608 . . . . 63.44 109.08 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -68.31 17.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.433 1.093 . . . . 73.43 113.782 -165.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 85.79 6.04 0.43 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 124.437 1.095 . . . . 74.52 108.499 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.0 p -42.39 -169.44 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 127.044 2.138 . . . . 71.03 112.431 161.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -40.86 -33.1 0.27 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.126 1.37 . . . . 52.44 113.485 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 m -62.08 129.48 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 122.465 1.126 . . . . 73.43 110.318 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -51.17 -65.07 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.041 -1.436 . . . . 74.01 111.48 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -84.48 16.66 3.01 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.573 -0.704 . . . . 72.31 110.646 -171.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 47.36 65.51 2.3 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 111.372 -0.691 . . . . 62.03 111.372 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.83 -179.15 31.57 Favored Glycine 0 CA--C 1.457 -3.574 0 N-CA-C 103.98 -3.648 . . . . 73.31 103.98 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 131.72 35.44 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 N-CA-C 104.988 -2.227 . . . . 74.45 104.988 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.26 151.81 25.46 Favored 'General case' 0 CA--C 1.46 -2.503 0 N-CA-C 103.621 -2.733 . . . . 74.51 103.621 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.29 102.49 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 106.233 -1.766 . . . . 64.04 106.233 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.489 ' H ' ' HA ' ' A' ' 23' ' ' VAL . 46.9 tttp -71.82 -32.86 68.01 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.088 -0.96 . . . . 75.32 109.359 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.06 149.64 16.18 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 105.401 -2.074 . . . . 61.51 105.401 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.29 130.3 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 102.805 -3.035 . . . . 74.44 102.805 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.482 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 143.36 65.7 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 105.541 -2.022 . . . . 72.1 105.541 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.486 ' C ' ' H ' ' A' ' 45' ' ' GLY . 97.8 Cg_endo -75.59 173.58 14.26 Favored 'Trans proline' 0 CA--C 1.464 -2.984 0 N-CA-C 106.428 -2.181 . . . . 75.24 106.428 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 71.22 -12.1 0.63 Allowed 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.364 1.04 . . . . 73.4 111.674 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.486 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -90.11 -179.71 44.15 Favored Glycine 0 CA--C 1.476 -2.388 0 N-CA-C 107.439 -2.264 . . . . 75.02 107.439 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.06 -52.79 45.74 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.675 -0.861 . . . . 70.13 108.675 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -49.27 66.8 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 116.217 -0.447 . . . . 73.42 110.281 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.16 -55.66 29.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.59 -0.522 . . . . 65.51 109.59 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -64.85 -32.66 74.46 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.557 -0.292 . . . . 74.01 111.595 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -81.61 -25.22 35.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.236 -1.764 . . . . 55.05 106.236 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 19.4 77.42 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 110.518 -1.033 . . . . 72.55 110.518 167.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -94.44 6.46 48.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.891 -1.151 . . . . 74.04 107.891 -178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.468 HD12 HD13 ' A' ' 12' ' ' LEU . 66.5 mt -144.02 138.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 103.804 -2.665 . . . . 74.01 103.804 -169.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -149.94 159.96 43.98 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 105.196 -2.15 . . . . 72.22 105.196 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -67.22 144.14 56.14 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.171 -1.048 . . . . 75.31 108.171 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.22 -32.66 7.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 108.081 -2.008 . . . . 73.01 108.081 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.65 155.16 30.67 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.128 -1.064 . . . . 70.14 108.128 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -116.27 141.54 48.02 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.783 -1.562 . . . . 73.12 106.783 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.55 126.07 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.138 -2.171 . . . . 73.14 105.138 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.461 HD13 HD12 ' A' ' 7' ' ' ILE . 75.2 mt -91.17 -59.12 2.24 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 107.668 -1.234 . . . . 72.2 107.668 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.89 149.81 49.12 Favored 'General case' 0 CA--C 1.472 -2.046 0 N-CA-C 106.51 -1.663 . . . . 73.3 106.51 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.4 110.88 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.629 -1.989 . . . . 65.24 105.629 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.82 44.82 25.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.173 1.389 . . . . 63.13 110.622 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.22 -31.85 8.25 Favored Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 108.186 -1.966 . . . . 65.34 108.186 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -81.56 116.79 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 107.56 -1.274 . . . . 65.22 107.56 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 t -55.32 126.64 25.83 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 108.281 -1.007 . . . . 61.13 108.281 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.404 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -97.23 -13.43 22.04 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.099 -1.815 . . . . 74.42 106.099 -171.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.1 127.62 32.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.787 -0.819 . . . . 63.25 108.787 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.54 66.21 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.817 -1.713 . . . . 74.4 108.817 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.65 148.06 39.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.067 -1.457 . . . . 64.21 107.067 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 50.5 p -82.82 -179.93 7.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.824 -1.176 . . . . 70.21 107.824 -174.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.408 ' CE1' HG22 ' A' ' 23' ' ' VAL . 7.6 t60 -60.97 -51.39 69.47 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.213 -1.032 . . . . 71.44 108.213 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -52.95 -56.29 17.07 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 110.096 -0.335 . . . . 75.34 110.096 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.02 -47.63 77.45 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.509 -0.552 . . . . 74.33 109.509 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.404 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.42 -56.93 10.57 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.051 0.54 . . . . 75.34 111.242 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.24 -35.83 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 109.066 -0.716 . . . . 75.12 109.066 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.36 -32.54 74.24 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.338 -1.727 . . . . 74.4 106.338 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -74.22 -38.82 63.43 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.413 -1.429 . . . . 71.34 108.087 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.52 -48.67 74.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.61 -0.885 . . . . 75.44 108.61 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -55.88 13.58 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.582 -0.896 . . . . 74.24 108.582 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.24 60.95 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.97 0.891 . . . . 74.34 111.194 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 p -112.53 -176.11 2.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.54 -1.652 . . . . 72.22 106.54 171.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.59 -141.02 7.57 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 106.647 -2.581 . . . . 65.12 106.647 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 -55.13 12.89 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.785 -0.82 . . . . 74.53 108.785 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' A' ' 11' ' ' GLU . 73.6 t -99.32 144.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.775 -1.194 . . . . 70.21 107.775 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.9 t -97.62 125.57 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 105.731 -1.952 . . . . 74.12 105.731 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -97.67 117.8 32.78 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.931 -2.248 . . . . 71.43 104.931 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.12 130.32 11.2 Favored 'General case' 0 CA--C 1.482 -1.637 0 C-N-CA 119.281 -0.968 . . . . 71.02 108.474 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.401 ' HB3' HD12 ' A' ' 60' ' ' LEU . 8.5 mp -83.06 143.51 30.54 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.354 -0.98 . . . . 74.31 108.354 177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.08 158.92 22.43 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.438 -1.69 . . . . 75.14 106.438 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -126.72 131.51 51.35 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 102.47 -3.159 . . . . 73.43 102.47 169.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.496 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 30.1 mmmt -67.9 136.82 54.62 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 107.921 -1.14 . . . . 73.32 107.921 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.81 11.58 5.4 Favored Glycine 0 CA--C 1.488 -1.603 0 C-N-CA 119.9 -1.143 . . . . 72.5 110.725 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.7 mp0 -64.28 -37.06 86.13 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.578 -1.267 . . . . 74.14 107.578 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.0 m -116.04 97.03 48.62 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 104.722 -2.325 . . . . 73.15 104.722 170.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.38 106.37 1.58 Allowed 'Trans proline' 0 CA--C 1.5 -1.176 0 C-N-CA 122.068 1.845 . . . . 72.41 107.595 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.421 -1.893 0 N-CA-C 104.181 -2.526 . . . . 74.53 104.181 -176.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.437 ' H5 ' ' C1 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.639 0 N-CA-C 108.757 -1.737 . . . . 74.41 108.757 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.58 164.93 24.51 Favored 'Trans proline' 0 C--O 1.25 1.105 0 C-N-CA 123.235 2.623 . . . . 73.35 109.223 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -88.55 165.41 28.12 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.824 -1.176 . . . . 73.45 107.824 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -65.05 117.59 4.68 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.761 2.307 . . . . 71.54 108.181 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.41 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 91.82 5.71 66.16 Favored Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 109.73 -1.348 . . . . 75.51 109.73 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.09 146.96 23.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.472 -1.677 . . . . 73.13 106.472 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.4 mm -96.94 129.11 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 106.515 -1.661 . . . . 75.23 106.515 -173.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.459 ' CD2' HD22 ' A' ' 90' ' ' LEU . 6.2 p90 -131.87 148.36 52.54 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 106.655 -1.609 . . . . 74.25 106.655 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.404 ' HG2' ' HG ' ' A' ' 89' ' ' LEU . 36.8 mt-10 -108.22 148.64 29.67 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 106.454 -1.684 . . . . 71.24 106.454 -177.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 26.8 m -140.21 150.79 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.392 -1.707 . . . . 75.52 106.392 173.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -120.48 138.92 53.56 Favored 'General case' 0 CA--C 1.465 -2.315 0 N-CA-C 104.533 -2.395 . . . . 72.33 104.533 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.08 144.83 28.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.423 -1.325 . . . . 73.34 107.423 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.34 123.65 29.28 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 105.883 -1.895 . . . . 73.31 105.883 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -71.33 -22.52 61.91 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.023 -0.732 . . . . 73.34 109.023 -173.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 t30 73.61 109.19 0.07 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.706 0.802 . . . . 73.24 109.767 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.33 53.02 12.54 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.364 1.065 . . . . 63.12 110.685 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 53.31 -8.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.811 1.782 . . . . 71.44 115.811 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.6 m -131.39 130.22 42.32 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.379 -1.341 . . . . 75.21 107.379 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.5 179.84 3.84 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 104.242 -2.503 . . . . 75.23 104.242 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.02 53.57 0.46 Allowed Glycine 0 CA--C 1.475 -2.456 0 N-CA-C 106.644 -2.582 . . . . 42.41 106.644 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.551 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.9 mt -87.85 176.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 104.573 -2.381 . . . . 71.1 104.573 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.551 ' H ' HG22 ' A' ' 21' ' ' ILE . 77.1 m -141.78 167.28 22.52 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 106.312 -1.736 . . . . 63.23 106.312 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.476 ' HB ' HG21 ' A' ' 36' ' ' ILE . 6.2 m -148.79 172.92 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.073 -1.454 . . . . 64.12 107.073 -167.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.8 t -154.37 160.8 41.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 103.902 -2.629 . . . . 72.05 103.902 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.19 -164.95 31.22 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 108.02 -2.032 . . . . 63.44 108.02 -178.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 133.61 -88.69 0.26 Allowed Glycine 0 CA--C 1.479 -2.203 0 N-CA-C 108.418 -1.873 . . . . 61.03 108.418 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -72.63 16.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.028 0 C-N-CA 122.551 0.341 . . . . 71.2 111.446 -171.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 26' ' ' GLY . 7.1 t30 85.39 5.99 0.48 Allowed 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.483 1.113 . . . . 71.43 108.784 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -45.41 -171.05 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 126.279 1.832 . . . . 72.21 112.987 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 p -40.45 -40.71 1.26 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 127.272 2.229 . . . . 75.11 114.002 -164.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.6 m -56.46 135.82 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.64 0.733 . . . . 71.11 110.286 -173.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -39.69 -66.96 0.25 Allowed 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.017 1.327 . . . . 75.11 113.475 -171.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -77.72 -13.34 59.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.322 -0.951 . . . . 54.34 109.866 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.95 -14.62 64.77 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.361 -1.496 . . . . 65.13 109.361 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.78 -179.87 53.17 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.172 -1.571 . . . . 62.12 109.172 -173.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.476 HG21 ' HB ' ' A' ' 23' ' ' VAL . 19.3 mm -86.32 117.87 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 103.929 -2.619 . . . . 72.3 103.929 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.83 154.5 19.53 Favored 'General case' 0 CA--C 1.463 -2.399 0 N-CA-C 105.275 -2.12 . . . . 70.22 105.275 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.44 102.45 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 N-CA-C 106.206 -1.775 . . . . 74.01 106.206 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -71.16 -41.63 70.15 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 113.966 -1.47 . . . . 74.44 109.735 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.97 143.8 17.18 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 105.418 -2.067 . . . . 74.12 105.418 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.8 133.53 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.655 -2.72 . . . . 74.13 103.655 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.505 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.35 148.78 78.0 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 106.163 -1.791 . . . . 74.41 106.163 175.086 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 45' ' ' GLY . 68.1 Cg_endo -74.87 169.24 23.05 Favored 'Trans proline' 0 CA--C 1.458 -3.301 0 N-CA-C 105.438 -2.562 . . . . 61.33 105.438 -175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 65.04 -1.36 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.877 0.736 . . . . 75.33 111.942 166.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -86.75 171.59 43.34 Favored Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 106.702 -2.559 . . . . 72.04 106.702 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.95 67.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.405 -0.961 . . . . 75.44 108.405 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.443 ' HB2' ' HB ' ' A' ' 53' ' ' ILE . . . -53.78 -50.82 65.25 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.283 -0.872 . . . . 73.02 110.717 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -63.24 -56.27 17.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 120.872 0.368 . . . . 54.44 110.112 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -34.88 71.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.207 0.603 . . . . 71.2 110.982 -172.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.5 ' CG ' ' HE ' ' A' ' 52' ' ' ARG . 6.3 t70 -83.2 -34.52 25.9 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.698 -1.593 . . . . 74.12 106.698 -174.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.81 16.25 61.82 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 110.638 -0.985 . . . . 63.35 110.638 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.5 ' HE ' ' CG ' ' A' ' 50' ' ' ASP . 67.3 mtt180 -91.89 6.09 47.51 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 118.361 1.08 . . . . 74.43 108.201 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.443 ' HB ' ' HB2' ' A' ' 47' ' ' ALA . 2.9 mp -147.71 148.41 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.227 -2.509 . . . . 72.44 104.227 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -158.6 171.8 19.45 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 104.541 -2.392 . . . . 74.1 104.541 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -67.05 146.46 54.29 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.556 -0.905 . . . . 74.02 108.556 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.77 -32.95 6.98 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 109.263 -1.535 . . . . 74.21 109.263 169.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.434 ' CG ' ' HZ3' ' A' ' 92' ' ' LYS . 67.0 m-20 -73.43 158.52 34.82 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.662 -1.236 . . . . 72.35 107.662 176.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.471 HH22 ' CD ' ' A' ' 91' ' ' GLU . 24.6 ttp85 -123.88 143.79 50.15 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.741 -1.207 . . . . 61.11 107.741 -165.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.0 t -95.21 139.36 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.929 -1.878 . . . . 74.42 105.929 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.444 HD12 ' HB3' ' A' ' 89' ' ' LEU . 46.2 mt -102.01 -58.88 1.8 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.314 -1.365 . . . . 72.13 107.314 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.73 151.52 48.28 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.115 -1.809 . . . . 71.33 106.115 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.38 127.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.616 -2.365 . . . . 71.23 104.616 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.0 t30 59.04 31.28 21.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.91 0.862 . . . . 73.14 109.371 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.77 -8.14 73.96 Favored Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 109.156 -1.578 . . . . 43.43 109.156 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.77 118.52 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.572 0 N-CA-C 106.493 -1.669 . . . . 72.23 106.493 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 t -55.99 118.63 4.82 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.729 -1.211 . . . . 63.2 107.729 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.2 tm? -104.87 -13.47 15.81 Favored 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 106.552 -1.648 . . . . 70.34 106.552 -167.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.55 127.41 31.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.501 -0.749 . . . . 71.11 109.054 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.83 61.99 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.315 -1.914 . . . . 51.44 108.315 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.407 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -82.39 154.81 25.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.158 -1.793 . . . . 74.3 106.158 178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 22.8 p -81.29 176.83 9.41 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.781 0.801 . . . . 75.43 110.393 -168.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -58.48 -50.79 72.46 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.815 1.246 . . . . 74.0 107.906 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -55.13 -54.48 42.68 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 122.063 -0.398 . . . . 75.12 110.759 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -53.93 -41.34 67.62 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.864 -0.421 . . . . 74.21 109.864 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.33 -54.27 27.94 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 122.798 0.439 . . . . 73.43 110.33 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.62 -38.5 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 109.302 -0.629 . . . . 74.14 109.302 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.6 -32.74 72.87 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 105.801 -1.926 . . . . 73.41 105.801 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -70.69 -46.46 63.1 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.175 -1.578 . . . . 65.13 108.05 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.36 -30.3 69.47 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 109.388 -0.597 . . . . 72.23 109.388 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -59.9 2.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.139 -1.43 . . . . 61.33 107.139 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -48.73 -20.59 0.49 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 126.163 1.785 . . . . 72.21 114.019 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -74.13 171.84 12.83 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.35 -0.844 . . . . 74.32 109.422 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.23 -148.69 5.4 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.1 -1.2 . . . . 74.24 110.1 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -70.82 -55.93 7.43 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.839 -0.8 . . . . 62.44 108.839 -170.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.06 142.58 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.727 0 N-CA-C 104.428 -2.434 . . . . 75.13 104.428 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.65 134.9 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 104.987 -2.227 . . . . 64.43 104.987 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -103.46 121.32 42.59 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.085 -2.561 . . . . 65.41 104.085 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 125.91 14.4 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 107.914 -1.143 . . . . 64.14 107.914 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.444 ' HB3' HD12 ' A' ' 60' ' ' LEU . 4.3 mp -81.9 144.39 31.0 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 107.999 -1.111 . . . . 64.3 107.999 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.459 HD22 ' CD2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -117.28 162.18 18.31 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.105 -2.183 . . . . 75.34 105.105 174.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.471 ' CD ' HH22 ' A' ' 58' ' ' ARG . 41.5 tt0 -129.01 144.58 51.23 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 102.254 -3.239 . . . . 75.0 102.254 163.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.434 ' HZ3' ' CG ' ' A' ' 57' ' ' ASP . 26.2 mmmt -57.88 140.78 51.2 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.721 0.772 . . . . 74.42 110.389 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.75 -162.47 16.91 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 104.132 -3.587 . . . . 53.53 104.132 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 63.5 46.23 4.38 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.104 -1.443 . . . . 74.23 107.104 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.1 m -113.54 128.2 25.97 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 103.439 -2.8 . . . . 65.22 103.439 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.33 98.66 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.299 1.999 . . . . 74.23 107.972 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.425 -1.686 0 N-CA-C 105.131 -2.174 . . . . 74.4 105.131 -176.652 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.517 ' H20' ' H15' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.854 0 N-CA-C 108.617 -1.793 . . . . 71.22 108.617 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.22 156.87 52.94 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 123.608 2.872 . . . . 64.41 110.109 -169.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -96.25 167.44 12.37 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 106.573 -1.64 . . . . 74.03 106.573 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.69 118.39 5.27 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 122.792 2.328 . . . . 75.13 109.996 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.51 -0.52 68.15 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 108.819 -1.712 . . . . 43.52 108.819 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.66 139.9 38.45 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 106.691 -1.596 . . . . 74.54 106.691 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 54.0 mt -99.42 130.25 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 106.718 -1.586 . . . . 73.34 106.718 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -137.5 154.23 49.9 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 108.005 -1.109 . . . . 64.41 108.005 177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.66 143.56 33.65 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.232 -1.766 . . . . 71.24 106.232 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 29.1 m -142.54 151.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.511 -1.663 . . . . 62.5 106.511 177.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.82 129.21 56.52 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 106.213 -1.773 . . . . 72.41 106.213 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.51 140.21 50.5 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 108.493 -0.928 . . . . 75.52 108.493 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.04 137.76 32.02 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 105.818 -1.919 . . . . 64.32 105.818 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.43 -25.76 59.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.613 -0.884 . . . . 75.34 108.613 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 67.87 111.28 0.04 OUTLIER 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.184 -0.673 . . . . 62.31 109.184 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.12 40.29 30.2 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.35 -0.982 . . . . 73.31 108.35 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 t30 43.22 12.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.223 2.209 . . . . 73.24 114.649 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -97.11 129.17 44.55 Favored 'General case' 0 CA--C 1.494 -1.195 0 O-C-N 120.517 -1.364 . . . . 64.53 107.328 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 tp -124.78 142.51 51.37 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 102.738 -3.06 . . . . 75.31 102.738 173.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.51 64.34 0.27 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 106.406 -2.678 . . . . 54.13 106.406 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.549 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.0 mm -87.89 177.35 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 104.929 -2.248 . . . . 74.41 104.929 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.549 ' H ' HG22 ' A' ' 21' ' ' ILE . 16.8 m -124.78 156.85 37.08 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 103.662 -2.718 . . . . 74.13 103.662 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.7 m -150.53 171.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 108.092 -1.077 . . . . 73.55 108.092 -166.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -161.99 164.75 28.17 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.498 -2.408 . . . . 72.53 104.498 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.62 -160.84 22.76 Favored Glycine 0 CA--C 1.486 -1.774 0 N-CA-C 107.052 -2.419 . . . . 73.12 107.052 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.72 -104.84 0.56 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 108.89 -1.684 . . . . 70.11 108.89 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.82 16.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 113.374 0.879 . . . . 74.32 113.374 -164.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 86.64 12.96 0.14 Allowed 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.804 1.242 . . . . 73.42 108.877 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 p -46.15 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 124.334 1.054 . . . . 74.43 110.859 155.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.7 m -29.46 -44.02 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.487 1.662 . . . . 71.44 115.487 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.472 ' HB ' ' CZ ' ' A' ' 37' ' ' TYR . 30.0 m -76.12 140.22 17.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.22 -0.925 . . . . 74.31 108.517 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -68.31 -47.58 67.21 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.148 -0.97 . . . . 74.04 111.138 -171.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.418 ' HE1' ' CD ' ' A' ' 68' ' ' GLU . 8.3 t-80 -73.23 0.66 11.2 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.189 -0.319 . . . . 73.45 110.248 -166.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.97 61.21 7.11 Favored Glycine 0 C--N 1.362 1.991 0 N-CA-C 109.495 -1.442 . . . . 72.04 109.495 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.4 28.19 Favored Glycine 0 CA--C 1.454 -3.759 0 N-CA-C 103.721 -3.752 . . . . 63.4 103.721 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -90.61 131.17 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.707 0 N-CA-C 104.25 -2.5 . . . . 75.2 104.25 178.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.472 ' CZ ' ' HB ' ' A' ' 31' ' ' VAL . 3.7 m-30 -108.55 151.67 25.79 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 102.899 -3.0 . . . . 75.21 102.899 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.52 102.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 107.103 -1.443 . . . . 71.02 107.103 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -71.6 -36.61 70.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.196 -1.366 . . . . 74.42 110.113 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.71 152.7 14.08 Favored 'General case' 0 CA--C 1.466 -2.278 0 N-CA-C 105.464 -2.05 . . . . 70.03 105.464 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.71 136.16 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 104.308 -2.479 . . . . 63.45 104.308 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.421 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -75.24 145.22 79.83 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 106.259 -1.756 . . . . 74.22 106.259 174.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.83 168.38 24.36 Favored 'Trans proline' 0 CA--C 1.462 -3.09 0 N-CA-C 105.786 -2.428 . . . . 73.43 105.786 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 63.41 1.54 1.0 Allowed 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 123.665 0.603 . . . . 71.34 111.732 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.6 -178.22 41.11 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 106.667 -2.573 . . . . 65.34 106.667 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.67 -52.99 31.43 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 108.151 -1.055 . . . . 65.55 108.151 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.07 65.86 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.066 -0.516 . . . . 65.44 110.879 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -62.39 -56.11 21.44 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.56 -0.533 . . . . 75.42 109.56 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.7 m -62.79 -30.49 71.5 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.683 0.278 . . . . 62.14 111.232 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -77.21 -35.8 55.3 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.773 -1.566 . . . . 62.32 106.773 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.38 12.59 72.69 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.109 -1.596 . . . . 74.05 109.109 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -90.19 -1.93 57.99 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.275 -1.38 . . . . 73.1 107.275 -179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -142.77 145.26 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 102.857 -3.016 . . . . 72.22 102.857 -176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -156.79 173.03 17.58 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.699 -2.704 . . . . 73.43 103.699 170.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -66.35 145.62 55.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-O 121.391 0.615 . . . . 74.02 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -33.03 6.86 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.764 -1.734 . . . . 71.41 108.764 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -67.55 157.01 35.36 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.981 -0.748 . . . . 75.01 108.981 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -117.0 142.84 46.43 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.3 -1.37 . . . . 74.34 107.3 -166.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -93.01 126.71 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 105.761 -1.94 . . . . 74.22 105.761 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.9 mt -94.47 -58.64 2.14 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 107.417 -1.327 . . . . 60.24 107.417 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.36 147.62 47.45 Favored 'General case' 0 CA--C 1.471 -2.079 0 N-CA-C 106.379 -1.712 . . . . 72.01 106.379 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.43 119.12 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 104.897 -2.26 . . . . 72.43 104.897 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.3 t30 52.28 38.06 23.81 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.046 0.938 . . . . 75.33 110.618 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.7 -18.38 57.29 Favored Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 108.784 -1.726 . . . . 74.21 108.784 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.3 117.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.888 0 N-CA-C 106.78 -1.563 . . . . 73.11 106.78 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.0 t -56.02 122.73 12.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.243 -1.021 . . . . 65.12 108.243 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.42 -16.63 24.38 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.431 -2.063 . . . . 75.31 105.431 -172.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.418 ' CD ' ' HE1' ' A' ' 33' ' ' HIS . 53.3 mt-10 -59.85 123.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.816 -0.809 . . . . 73.2 108.816 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.56 -14.94 62.74 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 108.968 -1.653 . . . . 62.2 108.968 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.01 147.33 46.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.569 -1.271 . . . . 61.2 107.569 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 59.6 p -81.65 178.69 8.19 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.147 -1.427 . . . . 73.14 107.147 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 43.5 p-80 -62.26 -51.06 69.23 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.935 -0.765 . . . . 74.05 108.935 177.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.57 -56.07 24.62 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 121.707 -0.621 . . . . 74.21 110.12 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -60.9 -45.49 94.42 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 110.184 -0.302 . . . . 55.22 110.184 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.65 -51.29 63.62 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-O 120.918 0.389 . . . . 60.43 110.716 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.63 -36.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.827 -1.175 . . . . 75.33 107.827 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.6 -34.19 73.85 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.031 -1.84 . . . . 70.43 106.031 -176.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.9 m -73.14 -42.32 62.97 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 107.393 -1.336 . . . . 75.43 107.393 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.78 -39.58 94.66 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 110.109 -0.33 . . . . 65.02 110.109 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.467 ' C ' ' H ' ' A' ' 82' ' ' THR . 30.9 ttt180 -75.99 -54.64 6.56 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.662 -0.815 . . . . 71.25 109.139 -175.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -70.48 47.78 0.1 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.039 0.447 . . . . 72.11 111.591 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 80' ' ' ARG . 7.1 p -101.08 -176.07 3.05 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.702 -1.962 . . . . 72.31 105.702 172.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.65 -157.26 18.57 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 107.113 -2.395 . . . . 20.31 107.113 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.34 -54.02 39.57 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.088 -0.708 . . . . 65.11 109.088 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.27 141.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 105.928 -1.879 . . . . 72.33 105.928 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.2 130.68 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.491 0 N-CA-C 105.718 -1.956 . . . . 75.31 105.718 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -107.17 124.61 49.97 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 105.413 -2.069 . . . . 72.41 105.413 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -156.36 136.55 12.89 Favored 'General case' 0 CA--C 1.473 -2.004 0 C-N-CA 119.01 -1.076 . . . . 75.5 108.458 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.33 141.0 33.23 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.394 -1.336 . . . . 75.41 107.394 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.8 159.02 18.7 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 104.595 -2.372 . . . . 75.2 104.595 174.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -123.4 134.4 53.98 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 101.292 -3.596 . . . . 51.42 101.292 164.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.76 130.29 44.28 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.163 -1.421 . . . . 73.4 107.163 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.02 12.05 20.13 Favored Glycine 0 CA--C 1.463 -3.208 0 N-CA-C 107.303 -2.319 . . . . 23.15 107.303 -169.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -68.98 116.86 9.93 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.099 -1.815 . . . . 61.14 106.099 170.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.6 t -97.84 133.09 23.72 Favored Pre-proline 0 N--CA 1.422 -1.83 0 N-CA-C 106.465 -1.68 . . . . 51.33 106.465 -168.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.07 -179.04 4.29 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 N-CA-C 106.018 -2.339 . . . . 64.23 106.018 161.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 104.502 -2.407 . . . . 74.12 104.502 176.289 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.459 ' C15' H20A ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.665 0 N-CA-C 108.959 -1.656 . . . . 62.13 108.959 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.55 151.34 75.4 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 122.985 2.457 . . . . 75.21 109.057 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -83.33 165.24 41.68 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 105.975 -1.861 . . . . 74.43 105.975 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.28 128.87 23.76 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 122.716 2.277 . . . . 70.14 108.611 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.84 10.62 78.61 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 109.567 -1.413 . . . . 74.54 109.567 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -99.77 153.8 18.83 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.869 -1.901 . . . . 74.43 105.869 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.421 HG21 ' CD1' ' A' ' 60' ' ' LEU . 4.6 mm -99.63 137.51 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 106.59 -1.633 . . . . 75.32 106.59 -169.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.434 ' CD2' HD22 ' A' ' 90' ' ' LEU . 9.1 p90 -135.28 151.96 51.05 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.302 -1.37 . . . . 74.14 107.302 170.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.426 ' OE2' ' HE1' ' A' ' 87' ' ' HIS . 52.8 mt-10 -108.09 147.29 31.42 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.237 -1.764 . . . . 73.53 106.237 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.415 HG13 ' HB3' ' A' ' 52' ' ' ARG . 35.1 m -142.96 152.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 105.984 -1.858 . . . . 62.5 105.984 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -118.71 127.25 53.39 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.745 -1.946 . . . . 75.41 105.745 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 137.69 45.45 Favored 'General case' 0 CA--C 1.474 -1.961 0 N-CA-C 107.694 -1.224 . . . . 70.34 107.694 -169.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.29 142.3 28.63 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.693 -1.965 . . . . 70.01 105.693 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -69.88 -32.41 70.74 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.413 -0.958 . . . . 75.21 108.413 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 75.03 107.08 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.607 0.763 . . . . 64.13 109.299 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 50.84 45.38 27.43 Favored 'General case' 0 C--N 1.37 1.474 0 C-N-CA 124.576 1.151 . . . . 43.3 110.937 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 54.97 -9.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.549 1.94 . . . . 74.21 113.805 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -84.3 158.28 21.24 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 119.975 1.262 . . . . 71.11 108.341 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.96 -157.15 0.78 Allowed 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 102.952 -2.981 . . . . 61.01 102.952 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.36 40.79 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.657 0 N-CA-C 105.292 -3.123 . . . . 55.22 105.292 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mm -87.99 175.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 103.438 -2.801 . . . . 75.44 103.438 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.7 m -147.61 159.55 43.64 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.358 -2.09 . . . . 73.3 105.358 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.3 m -150.4 167.3 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 N-CA-C 107.766 -1.198 . . . . 73.13 107.766 -164.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -166.17 169.49 14.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.665 -2.346 . . . . 63.41 104.665 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -138.61 14.64 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.695 -2.162 . . . . 72.22 107.695 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 101.77 -88.17 0.68 Allowed Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 109.404 -1.478 . . . . 64.02 109.404 173.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 16.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 112.832 0.679 . . . . 71.23 112.832 -165.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 26' ' ' GLY . 17.7 t-20 82.55 6.92 0.9 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.677 0.791 . . . . 74.13 109.301 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 t -46.28 -170.23 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.427 1.491 . . . . 63.32 111.478 160.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -35.08 -40.33 0.12 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.071 1.748 . . . . 75.3 114.982 -166.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HB ' ' CZ ' ' A' ' 37' ' ' TYR . 34.6 m -72.25 142.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.559 -0.904 . . . . 62.23 108.559 -174.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 34' ' ' GLY . 98.4 mtt180 -66.19 -59.11 4.07 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 121.725 -0.609 . . . . 74.34 112.556 -167.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.537 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 22.8 t-160 -75.84 15.16 0.55 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.588 -0.695 . . . . 70.35 110.874 -164.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 32' ' ' ARG . . . 46.35 57.19 6.6 Favored Glycine 0 C--N 1.358 1.788 0 N-CA-C 109.559 -1.416 . . . . 64.14 109.559 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.95 178.27 23.78 Favored Glycine 1 CA--C 1.442 -4.49 0 N-CA-C 103.252 -3.939 . . . . 72.1 103.252 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.6 mm -92.63 132.09 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 106.214 -1.772 . . . . 71.2 106.214 -178.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.405 ' CZ ' ' HB ' ' A' ' 31' ' ' VAL . 2.7 m-85 -109.82 148.52 31.34 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.584 -2.747 . . . . 72.12 103.584 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.12 103.2 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 N-CA-C 106.702 -1.592 . . . . 74.44 106.702 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -70.58 -38.64 74.09 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.547 -1.206 . . . . 74.32 109.745 -174.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.35 155.56 17.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 N-CA-C 105.368 -2.086 . . . . 51.4 105.368 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.5 143.2 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 102.763 -3.051 . . . . 62.05 102.763 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -76.16 142.6 72.26 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 105.903 -1.888 . . . . 74.14 105.903 171.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.14 173.89 13.73 Favored 'Trans proline' 0 CA--C 1.472 -2.585 0 N-CA-C 105.896 -2.386 . . . . 64.14 105.896 -176.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 69.66 -2.73 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.024 0.828 . . . . 71.21 111.213 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.57 -176.25 38.6 Favored Glycine 0 CA--C 1.48 -2.139 0 N-CA-C 107.221 -2.352 . . . . 63.01 107.221 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -52.84 46.75 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.137 -1.061 . . . . 75.52 108.137 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.53 -49.65 64.42 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.224 -0.444 . . . . 74.02 110.589 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -64.54 -55.98 17.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.819 0.342 . . . . 54.05 110.124 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 m -64.04 -29.66 70.79 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 121.928 -0.482 . . . . 73.41 111.694 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -78.56 -34.15 47.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 105.773 -1.936 . . . . 74.35 105.773 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.49 63.97 Favored Glycine 0 CA--C 1.482 -2.02 0 N-CA-C 108.898 -1.681 . . . . 62.0 108.898 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HB3' HG13 ' A' ' 10' ' ' VAL . 13.4 mmt180 -89.89 -2.62 58.23 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 107.805 -1.183 . . . . 75.5 107.805 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.8 mt -146.64 143.9 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 N-CA-C 103.26 -2.867 . . . . 74.43 103.26 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.496 ' CE1' ' OD1' ' A' ' 57' ' ' ASP . 25.6 p80 -153.23 165.39 35.83 Favored 'General case' 0 CA--C 1.463 -2.375 0 N-CA-C 104.497 -2.409 . . . . 74.52 104.497 173.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HE3' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -67.93 145.08 54.9 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.612 -1.255 . . . . 73.43 107.612 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.74 -32.72 7.09 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.493 -1.443 . . . . 52.52 109.493 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 68.1 m-20 -66.4 158.0 30.47 Favored 'General case' 0 C--N 1.373 1.588 0 N-CA-C 108.292 -1.003 . . . . 73.5 108.292 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.473 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 52.5 mtm-85 -112.7 137.66 50.67 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.506 -1.294 . . . . 72.41 107.506 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.36 128.49 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 105.08 -2.193 . . . . 74.01 105.08 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.421 ' CD1' HG21 ' A' ' 7' ' ' ILE . 17.5 mt -99.28 -59.14 1.78 Allowed 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 107.467 -1.309 . . . . 73.42 107.467 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.06 146.53 51.77 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 106.433 -1.691 . . . . 64.54 106.433 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.78 125.42 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.213 -2.514 . . . . 74.12 104.213 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.64 29.84 17.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.114 0.959 . . . . 73.02 109.287 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.06 -12.06 68.85 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 109.26 -1.536 . . . . 72.51 109.26 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.04 118.54 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.557 -1.645 . . . . 74.11 106.557 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.5 m -56.7 118.38 4.82 Favored 'General case' 0 C--N 1.368 1.381 0 N-CA-C 108.435 -0.95 . . . . 64.43 108.435 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -104.52 -10.82 17.37 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.136 -1.802 . . . . 71.01 106.136 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.91 126.59 28.09 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.655 -0.868 . . . . 73.51 108.655 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -13.37 67.16 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 108.963 -1.655 . . . . 63.53 108.963 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.4 152.89 30.1 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.228 -1.767 . . . . 64.51 106.228 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -81.73 179.24 7.91 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.952 -0.758 . . . . 64.05 108.952 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -67.44 -46.15 73.93 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 108.202 -1.036 . . . . 74.35 108.202 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -52.19 -56.43 14.65 Favored 'General case' 0 C--N 1.362 1.136 0 O-C-N 121.733 -0.604 . . . . 65.44 110.07 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -53.96 -42.63 69.11 Favored 'General case' 0 C--N 1.369 1.452 0 N-CA-C 110.0 -0.37 . . . . 73.44 110.0 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.1 -53.9 36.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.096 0.558 . . . . 74.21 110.432 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.57 -40.57 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.657 -1.238 . . . . 73.43 107.657 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.05 -37.27 76.61 Favored 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 106.823 -1.547 . . . . 72.43 106.823 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.3 m -74.01 -48.06 32.79 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 120.355 -1.466 . . . . 73.45 107.627 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 124.024 0.929 . . . . 74.43 109.933 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -70.07 -55.47 9.41 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.998 -1.112 . . . . 72.53 107.998 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -70.84 55.26 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.875 0.845 . . . . 70.21 110.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.447 HG22 HG12 ' A' ' 86' ' ' VAL . 10.1 p -104.79 -175.53 2.82 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.226 -1.768 . . . . 75.55 106.226 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.12 -155.73 31.97 Favored Glycine 0 CA--C 1.485 -1.815 0 N-CA-C 107.189 -2.364 . . . . 50.0 107.189 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -63.24 -55.34 25.71 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.023 -1.103 . . . . 74.35 108.023 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.48 144.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.673 -1.973 . . . . 70.53 105.673 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.447 HG12 HG22 ' A' ' 82' ' ' THR . 46.8 t -103.01 131.84 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.715 0 N-CA-C 105.568 -2.012 . . . . 74.11 105.568 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.426 ' HE1' ' OE2' ' A' ' 9' ' ' GLU . 50.1 t-80 -112.5 124.18 51.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.089 -2.189 . . . . 63.45 105.089 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.29 136.4 14.74 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 107.781 -1.192 . . . . 73.51 107.781 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -81.29 140.14 35.0 Favored 'General case' 0 CA--C 1.469 -2.138 0 N-CA-C 107.712 -1.218 . . . . 74.52 107.712 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.434 HD22 ' CD2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -110.92 156.91 20.51 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.412 -2.44 . . . . 72.41 104.412 172.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.473 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.3 tt0 -118.75 129.82 55.47 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 101.566 -3.494 . . . . 71.1 101.566 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -66.89 129.24 39.23 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.225 -1.768 . . . . 71.21 106.225 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.08 -159.0 34.64 Favored Glycine 0 CA--C 1.475 -2.438 0 N-CA-C 107.835 -2.106 . . . . 42.44 107.835 -168.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -75.61 -47.87 24.69 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.735 -1.209 . . . . 73.21 107.735 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -65.94 127.67 93.3 Favored Pre-proline 0 C--N 1.361 1.103 0 N-CA-C 106.941 -1.503 . . . . 73.2 106.941 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.97 151.62 67.95 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.364 2.043 . . . . 70.42 109.458 -167.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.413 -2.309 0 N-CA-C 104.467 -2.42 . . . . 75.22 104.467 175.989 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.449 ' H5 ' ' C1 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.421 0 N-CA-C 107.935 -2.066 . . . . 72.3 107.935 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.76 169.42 20.22 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.164 2.576 . . . . 75.22 109.532 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -105.11 166.55 11.23 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 104.884 -2.265 . . . . 73.3 104.884 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.78 138.7 76.09 Favored 'Trans proline' 0 CA--C 1.499 -1.227 0 C-N-CA 122.324 2.016 . . . . 72.35 108.214 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.5 65.05 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 109.348 -1.501 . . . . 62.34 109.348 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.5 138.52 39.26 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.432 -1.322 . . . . 73.2 107.432 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.432 HG21 ' CD1' ' A' ' 60' ' ' LEU . 10.1 mm -97.53 133.28 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.321 -1.363 . . . . 74.11 107.321 -172.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -142.89 153.21 42.9 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.139 -1.06 . . . . 71.34 108.139 175.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -104.94 146.83 28.49 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 105.942 -1.873 . . . . 70.23 105.942 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 22.5 m -140.61 150.0 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.78 -1.563 . . . . 74.22 106.78 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -108.67 127.86 54.35 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 105.142 -2.17 . . . . 64.5 105.142 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mp -129.6 140.08 51.28 Favored 'General case' 0 CA--C 1.448 -2.967 0 N-CA-C 107.528 -1.286 . . . . 73.15 107.528 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.57 140.07 31.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 104.964 -2.236 . . . . 75.54 104.964 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.67 -31.97 67.37 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.539 -1.282 . . . . 71.34 107.539 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 74.83 102.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.251 -1.389 . . . . 74.35 107.251 -175.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.16 45.83 11.22 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.243 -0.89 . . . . 75.41 109.22 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.7 t30 45.34 3.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.816 2.046 . . . . 61.42 115.634 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -102.6 121.94 43.4 Favored 'General case' 0 CA--C 1.485 -1.548 0 O-C-N 120.358 -1.464 . . . . 61.34 107.049 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.9 tp -127.19 151.37 48.78 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 104.202 -2.518 . . . . 75.5 104.202 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.18 0.07 OUTLIER Glycine 0 CA--C 1.467 -2.934 0 N-CA-C 105.184 -3.166 . . . . 65.11 105.184 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.585 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.7 mm -89.22 178.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.415 -2.439 . . . . 64.42 104.415 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.585 ' H ' HG22 ' A' ' 21' ' ' ILE . 40.0 t -122.06 154.59 37.11 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 103.345 -2.835 . . . . 72.03 103.345 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.426 ' HB ' HG21 ' A' ' 36' ' ' ILE . 2.4 m -147.63 169.69 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 107.406 -1.331 . . . . 74.35 107.406 -164.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 t -162.67 165.88 25.16 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.884 -2.265 . . . . 64.34 104.884 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -152.67 31.24 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 107.067 -2.413 . . . . 42.34 107.067 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.493 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 118.48 -78.77 0.3 Allowed Glycine 0 CA--C 1.477 -2.332 0 N-CA-C 108.979 -1.649 . . . . 73.32 108.979 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -67.71 16.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 C-N-CA 124.557 1.143 . . . . 72.22 112.057 -168.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.493 ' H ' ' C ' ' A' ' 26' ' ' GLY . 12.5 t-20 81.32 5.14 1.38 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.213 1.405 . . . . 65.42 108.072 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.1 p -49.02 -170.86 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 126.071 1.748 . . . . 70.45 113.186 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 m -31.43 -42.41 0.05 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.63 2.372 . . . . 64.12 115.089 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -62.75 134.91 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.816 0.817 . . . . 74.32 109.967 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -52.44 -50.25 62.95 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 114.855 -1.066 . . . . 75.14 112.404 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -90.31 16.95 7.78 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.208 -0.933 . . . . 74.12 110.079 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.09 62.63 2.0 Favored Glycine 0 C--N 1.368 2.327 0 N-CA-C 111.206 -0.758 . . . . 72.33 111.206 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.1 179.73 24.73 Favored Glycine 0 CA--C 1.455 -3.681 0 N-CA-C 104.162 -3.575 . . . . 70.13 104.162 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.426 HG21 ' HB ' ' A' ' 23' ' ' VAL . 8.6 mm -88.87 125.54 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 105.479 -2.045 . . . . 73.14 105.479 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -109.32 152.86 24.71 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 103.84 -2.652 . . . . 64.52 103.84 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.81 104.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.464 -1.68 . . . . 75.2 106.464 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.37 -31.93 69.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.729 -0.841 . . . . 64.43 108.729 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.49 146.22 16.6 Favored 'General case' 0 CA--C 1.459 -2.525 0 N-CA-C 105.645 -1.983 . . . . 63.25 105.645 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.89 122.46 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.349 -3.204 . . . . 74.42 102.349 172.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.79 146.23 72.1 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 106.052 -1.833 . . . . 73.45 106.052 178.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.5 173.61 14.2 Favored 'Trans proline' 0 CA--C 1.47 -2.679 0 N-CA-C 107.109 -1.919 . . . . 72.41 107.109 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 63.65 53.98 1.94 Allowed 'General case' 0 N--CA 1.422 -1.829 0 O-C-N 124.664 1.228 . . . . 72.32 108.136 164.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.34 176.53 37.87 Favored Glycine 0 CA--C 1.466 -2.992 0 N-CA-C 106.659 -2.576 . . . . 75.25 106.659 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.43 -52.73 24.02 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.661 -0.866 . . . . 62.4 108.661 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -49.32 67.45 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.623 -0.262 . . . . 71.25 110.558 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -59.53 -57.5 12.67 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 122.104 -0.373 . . . . 73.12 110.129 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -63.58 -28.7 70.11 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.581 0.229 . . . . 62.15 110.948 -170.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.34 -40.37 58.38 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.146 -1.427 . . . . 64.44 107.146 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.56 9.61 78.39 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 109.794 -1.322 . . . . 62.44 109.794 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -100.22 7.07 44.73 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.594 -1.262 . . . . 74.11 107.594 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mp -134.5 140.75 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 102.987 -2.968 . . . . 72.51 102.987 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -140.83 158.71 43.56 Favored 'General case' 0 CA--C 1.465 -2.325 0 N-CA-C 104.666 -2.346 . . . . 75.54 104.666 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.21 140.48 57.43 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.487 -1.672 . . . . 72.24 106.487 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.5 -32.83 6.34 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 108.663 -1.775 . . . . 72.04 108.663 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -67.45 155.92 37.84 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.119 -1.808 . . . . 74.03 106.119 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.423 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 1.6 ppt_? -133.38 156.55 47.44 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.233 -0.987 . . . . 72.3 109.247 -169.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -93.02 138.73 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.474 -1.676 . . . . 60.51 106.474 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.432 ' CD1' HG21 ' A' ' 7' ' ' ILE . 7.0 mt -99.12 -59.29 1.75 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.216 -1.772 . . . . 64.33 106.216 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.56 152.28 50.3 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 106.474 -1.676 . . . . 64.12 106.474 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.91 121.14 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 104.522 -2.399 . . . . 72.44 104.522 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.96 36.48 22.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.937 0.895 . . . . 74.11 110.532 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.95 -19.95 52.24 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.694 -1.762 . . . . 75.35 108.694 169.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.4 116.09 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 107.565 -1.272 . . . . 72.13 107.565 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -55.52 117.91 4.0 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 107.664 -1.236 . . . . 71.15 107.664 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -102.12 -13.09 17.62 Favored 'General case' 0 C--O 1.202 -1.402 0 N-CA-C 106.608 -1.627 . . . . 64.43 106.608 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.84 128.72 37.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.523 -0.917 . . . . 64.52 108.523 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.41 -17.67 58.65 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 108.239 -1.945 . . . . 61.03 108.239 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 106.316 -1.735 . . . . 74.41 106.316 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -84.77 -179.37 7.09 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.384 0.611 . . . . 74.53 109.362 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -60.89 -52.44 65.05 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.073 -1.084 . . . . 70.44 108.073 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -60.27 -44.83 94.98 Favored 'General case' 0 C--N 1.372 1.564 0 O-C-N 121.859 -0.525 . . . . 74.15 110.37 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -55.44 -46.6 76.72 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 109.171 -0.677 . . . . 74.51 109.171 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' HB3' HG13 ' A' ' 36' ' ' ILE . . . -51.43 -53.83 32.9 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.893 -0.594 . . . . 63.04 110.722 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.16 -43.64 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.044 -1.095 . . . . 75.34 108.044 -171.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 t -68.04 -30.34 69.54 Favored 'General case' 0 C--O 1.193 -1.912 0 C-N-CA 116.924 -1.91 . . . . 75.14 107.253 -170.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -67.96 -43.42 79.06 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.876 -1.765 . . . . 74.42 106.892 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.68 -29.0 69.04 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 109.526 -0.546 . . . . 63.1 109.526 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.24 -60.39 2.29 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 107.77 -1.196 . . . . 75.12 107.77 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -58.85 -3.37 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.775 1.23 . . . . 74.34 113.607 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 p -73.97 -176.33 2.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.678 -0.86 . . . . 73.23 108.678 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.77 -149.17 24.42 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 109.432 -1.467 . . . . 64.42 109.432 -167.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -65.95 -55.18 18.15 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.177 -1.416 . . . . 75.5 107.177 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -100.68 144.36 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 N-CA-C 105.441 -2.059 . . . . 74.32 105.441 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -108.49 133.41 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 106.128 -1.804 . . . . 75.42 106.128 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -107.08 121.87 45.35 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 104.902 -2.259 . . . . 75.23 104.902 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.5 134.42 13.01 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.074 -1.084 . . . . 75.31 108.074 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -84.63 141.33 30.72 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 108.232 -1.025 . . . . 74.11 108.232 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.3 163.24 17.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.054 -2.202 . . . . 73.24 105.054 176.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.423 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 36.2 tt0 -124.17 137.28 54.56 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 102.25 -3.241 . . . . 64.42 102.25 166.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 11.8 mmmm -61.16 149.88 36.01 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.822 -0.807 . . . . 75.01 108.822 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.82 -144.96 8.97 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 105.654 -2.978 . . . . 72.33 105.654 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 84.13 57.98 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.437 -2.06 . . . . 75.44 105.437 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -68.8 124.15 89.54 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 107.525 -1.287 . . . . 44.42 107.525 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.13 -163.56 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.346 2.697 . . . . 74.34 108.555 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.426 -1.633 0 N-CA-C 103.424 -2.806 . . . . 74.53 103.424 174.088 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.493 ' H15' H20A ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.476 -2.345 0 N-CA-C 108.49 -1.844 . . . . 55.11 108.49 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.73 158.6 55.32 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.639 2.226 . . . . 73.21 108.313 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -91.07 165.55 21.36 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 105.91 -1.885 . . . . 75.21 105.91 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.19 113.43 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.712 2.274 . . . . 63.0 110.27 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.94 11.82 57.27 Favored Glycine 0 C--N 1.349 1.291 0 N-CA-C 108.598 -1.801 . . . . 73.02 108.598 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -78.91 132.37 36.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.435 -1.321 . . . . 74.2 107.435 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' A' ' 60' ' ' LEU . 18.5 mm -100.38 135.58 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 106.196 -1.779 . . . . 73.2 106.196 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -145.88 161.61 39.62 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 107.669 -1.234 . . . . 74.33 107.669 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.49 151.76 29.57 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 105.548 -2.019 . . . . 74.55 105.548 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -145.04 153.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 106.715 -1.587 . . . . 75.14 106.715 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -111.96 131.22 55.53 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 105.116 -2.179 . . . . 75.03 105.116 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.441 HD23 HD12 ' A' ' 53' ' ' ILE . 4.6 mp -136.76 145.15 44.27 Favored 'General case' 0 CA--C 1.462 -2.409 0 N-CA-C 107.881 -1.155 . . . . 74.14 107.881 174.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.15 144.83 26.67 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.139 -1.43 . . . . 74.33 107.139 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -75.22 -27.52 59.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.773 -1.195 . . . . 64.54 107.773 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 t30 71.02 96.89 0.07 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.831 0.852 . . . . 73.44 109.226 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 62.13 40.51 11.8 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.139 -1.06 . . . . 73.35 108.139 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 50.29 -8.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.067 2.547 . . . . 73.32 114.952 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.7 m -93.06 115.69 28.34 Favored 'General case' 0 CA--C 1.47 -2.105 0 N-CA-C 106.745 -1.576 . . . . 70.42 106.745 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.524 ' H ' HD21 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -87.12 -150.75 0.16 Allowed 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.516 -2.401 . . . . 74.45 104.516 173.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.79 29.89 0.02 OUTLIER Glycine 0 CA--C 1.463 -3.203 0 N-CA-C 107.169 -2.372 . . . . 71.2 107.169 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.38 176.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 103.14 -2.911 . . . . 62.21 103.14 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -151.04 166.48 30.6 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 104.166 -2.531 . . . . 54.4 104.166 172.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.06 177.32 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 107.827 -1.175 . . . . 74.32 107.827 -166.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 170.78 20.74 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.525 -2.398 . . . . 75.13 104.525 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.53 -153.16 24.81 Favored Glycine 0 CA--C 1.484 -1.854 0 N-CA-C 109.091 -1.604 . . . . 70.22 109.091 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.45 -80.93 0.32 Allowed Glycine 0 CA--C 1.477 -2.299 0 N-CA-C 108.864 -1.695 . . . . 61.44 108.864 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -76.71 16.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 122.755 0.422 . . . . 71.32 111.643 -166.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.3 t30 85.64 6.43 0.43 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.241 -1.022 . . . . 75.23 108.241 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -45.89 -168.39 0.0 OUTLIER 'General case' 0 C--O 1.192 -1.933 0 C-N-CA 126.821 2.048 . . . . 75.2 112.051 162.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.6 m -33.06 -43.58 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.568 1.547 . . . . 74.11 114.441 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.1 m -71.3 130.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 107.524 -1.287 . . . . 74.31 107.524 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -55.93 11.51 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 121.138 -0.976 . . . . 74.43 108.854 -166.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -61.74 -20.72 63.84 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 111.81 0.3 . . . . 61.43 111.81 -164.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 55.64 2.63 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 107.817 -2.113 . . . . 64.4 107.817 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.01 -179.77 29.62 Favored Glycine 0 CA--C 1.456 -3.629 1 N-CA-C 101.923 -4.471 . . . . 71.15 101.923 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.13 136.66 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.593 0 N-CA-C 104.734 -2.321 . . . . 65.31 104.734 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -105.48 151.43 24.27 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 103.487 -2.783 . . . . 71.34 103.487 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.95 101.41 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.724 -1.954 . . . . 74.21 105.724 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.09 -37.02 66.89 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.116 -1.402 . . . . 75.31 110.978 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.43 140.54 24.03 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.283 -1.747 . . . . 74.23 106.283 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.57 132.97 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 103.368 -2.827 . . . . 74.53 103.368 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 154.03 84.95 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 106.647 -1.612 . . . . 75.41 106.647 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.18 172.34 16.24 Favored 'Trans proline' 0 CA--C 1.472 -2.6 0 N-CA-C 107.079 -1.931 . . . . 55.11 107.079 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 53.41 55.67 8.38 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 124.612 1.195 . . . . 74.24 109.541 164.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.34 176.37 35.31 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 104.011 -3.635 . . . . 73.41 104.011 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.35 55.77 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 117.291 0.546 . . . . 74.43 109.765 -168.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.39 -49.79 63.73 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 122.542 -0.099 . . . . 70.23 111.115 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -62.86 -55.8 22.98 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 122.094 -0.379 . . . . 71.02 110.483 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 m -65.78 -29.03 69.46 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 110.051 -0.351 . . . . 73.13 110.051 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.14 -38.13 52.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.318 -1.734 . . . . 65.02 106.318 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 15.22 76.39 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 109.889 -1.285 . . . . 74.32 109.889 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -101.56 7.65 42.19 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.043 -1.465 . . . . 74.35 107.043 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.441 HD12 HD23 ' A' ' 12' ' ' LEU . 64.0 mt -141.49 143.72 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 103.756 -2.683 . . . . 75.2 103.756 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -141.63 169.31 17.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.089 -2.56 . . . . 75.31 104.089 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -68.09 138.47 55.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.569 -2.011 . . . . 62.02 105.569 164.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.04 -28.07 12.92 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 108.991 -1.644 . . . . 73.1 108.991 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.57 139.51 53.33 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 118.057 0.929 . . . . 72.12 108.708 178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.7 130.24 56.12 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 104.839 -2.282 . . . . 73.25 104.839 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.75 130.61 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.281 -2.118 . . . . 73.44 105.281 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.433 ' CD1' HG21 ' A' ' 7' ' ' ILE . 19.8 mt -97.79 -58.31 2.02 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 106.366 -1.716 . . . . 73.35 106.366 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.7 151.47 50.21 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.51 -1.663 . . . . 71.43 106.51 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.08 117.93 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 105.485 -2.043 . . . . 73.21 105.485 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 t30 49.42 40.39 18.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.246 1.018 . . . . 71.22 111.033 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.68 7.05 Favored Glycine 0 CA--C 1.472 -2.621 0 N-CA-C 108.157 -1.977 . . . . 73.3 108.157 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.15 117.04 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 N-CA-C 108.643 -0.873 . . . . 72.42 108.643 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -56.27 126.17 25.05 Favored 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.377 -0.971 . . . . 75.34 108.377 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.66 -12.09 17.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.237 -1.764 . . . . 75.35 106.237 -169.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.8 124.31 19.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.677 -0.861 . . . . 74.03 108.677 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.81 -16.53 61.07 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.764 -1.735 . . . . 62.15 108.764 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.31 154.01 31.25 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 106.814 -1.55 . . . . 44.54 106.814 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.7 p -85.57 179.38 7.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.56 -0.904 . . . . 75.35 108.56 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -68.83 -42.92 76.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.559 -0.904 . . . . 74.11 108.559 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -56.35 16.18 Favored 'General case' 0 C--N 1.367 1.352 0 O-C-N 121.915 -0.491 . . . . 73.11 110.085 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -54.79 -45.11 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 122.19 -0.319 . . . . 71.41 110.248 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.03 -54.48 29.51 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 116.085 -0.507 . . . . 75.23 110.488 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.64 -38.17 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 108.758 -0.83 . . . . 75.4 108.758 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.2 t -56.29 -40.03 73.63 Favored 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 105.935 -1.876 . . . . 64.52 105.935 -173.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 m -74.42 -48.84 25.24 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.054 -1.43 . . . . 72.23 109.194 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.11 -31.43 72.62 Favored 'General case' 0 C--N 1.368 1.391 0 N-CA-C 110.259 -0.274 . . . . 73.42 110.259 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -79.51 -53.71 6.61 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 108.246 -1.02 . . . . 74.05 108.246 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -68.79 53.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.295 1.045 . . . . 71.32 110.973 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.4 p -110.77 -175.74 2.79 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.384 -1.71 . . . . 74.1 106.384 176.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.1 -156.11 32.5 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.497 -2.641 . . . . 34.2 106.497 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -62.24 -54.69 37.23 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.784 -1.191 . . . . 73.5 107.784 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.46 142.36 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 106.461 -1.681 . . . . 75.41 106.461 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.9 t -103.71 132.17 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 N-CA-C 105.052 -2.203 . . . . 71.25 105.052 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -110.24 127.75 55.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.831 -2.285 . . . . 73.51 104.831 173.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 139.17 16.02 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.727 -1.212 . . . . 73.24 107.727 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.4 140.53 33.41 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 107.271 -1.381 . . . . 75.41 107.271 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.83 160.82 38.24 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.994 -1.457 . . . . 73.21 107.474 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -123.57 120.77 33.82 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.387 -2.079 . . . . 75.41 105.387 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.419 0.0 OUTLIER 34.79 -79.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 127.146 2.178 . . . . 75.33 116.195 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 100.74 -60.68 0.64 Allowed Glycine 0 CA--C 1.461 -3.285 0 N-CA-C 106.043 -2.823 . . . . 33.22 106.043 -173.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -64.8 109.58 2.11 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 107.152 -1.425 . . . . 63.01 107.152 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.6 m -102.66 129.41 25.94 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 106.614 -1.625 . . . . 55.41 106.614 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.5 177.83 7.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.365 2.044 . . . . 71.13 106.957 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.564 1.485 0 N-CA-C 107.834 -1.172 . . . . 75.05 107.834 -178.492 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.742 0 N-CA-C 108.192 -1.963 . . . . 63.4 108.192 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.87 128.79 20.55 Favored 'Trans proline' 0 CA--C 1.497 -1.337 0 C-N-CA 122.782 2.321 . . . . 71.22 108.582 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -96.09 162.1 24.96 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 106.243 -1.762 . . . . 65.54 106.243 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -64.33 127.42 19.06 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.679 2.253 . . . . 72.24 109.381 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.73 1.35 65.85 Favored Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 108.946 -1.661 . . . . 74.42 108.946 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -75.9 137.24 40.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.557 -1.275 . . . . 72.41 107.557 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.8 mt -101.11 128.82 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 N-CA-C 107.653 -1.24 . . . . 72.45 107.653 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -139.76 156.23 46.88 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.212 -1.403 . . . . 64.41 107.212 177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.1 145.93 31.86 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.483 -2.043 . . . . 62.21 105.483 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.1 m -140.39 151.69 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.038 -1.467 . . . . 72.43 107.038 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.58 128.54 54.91 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 105.35 -2.093 . . . . 64.13 105.35 168.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mp -132.27 143.93 50.25 Favored 'General case' 0 CA--C 1.454 -2.731 0 N-CA-C 107.438 -1.319 . . . . 72.0 107.438 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.66 142.18 28.4 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 105.521 -2.029 . . . . 72.31 105.521 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -71.72 -30.55 65.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.071 -1.085 . . . . 75.22 108.071 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 72.43 104.38 0.07 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.76 -0.83 . . . . 74.01 108.76 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 18' ' ' SER . 23.4 t70 62.27 46.47 6.05 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.817 0.847 . . . . 74.52 110.192 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 53.39 -9.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 127.12 2.168 . . . . 63.43 114.791 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 16' ' ' ASP . 14.7 m -109.61 149.69 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.203 -1.036 . . . . 63.24 108.203 -167.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.43 167.4 30.15 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 105.629 -1.989 . . . . 73.12 105.629 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.05 95.54 0.1 Allowed Glycine 0 CA--C 1.46 -3.356 0 N-CA-C 104.225 -3.55 . . . . 74.43 104.225 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.66 153.07 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.091 -2.929 . . . . 74.15 103.091 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.5 m -91.77 159.41 15.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 103.657 -2.72 . . . . 71.01 103.657 -177.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 m -151.0 167.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.99 -2.226 . . . . 74.22 104.99 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -167.92 170.6 10.47 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.668 -2.345 . . . . 75.44 104.668 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.57 -148.88 21.42 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 107.421 -2.272 . . . . 61.22 107.421 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 115.1 -78.69 0.27 Allowed Glycine 0 CA--C 1.481 -2.048 0 N-CA-C 108.953 -1.659 . . . . 72.14 108.953 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.3 t -75.6 15.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 123.304 0.642 . . . . 71.35 109.819 -170.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' H ' ' C ' ' A' ' 26' ' ' GLY . 63.0 m-80 83.81 7.05 0.65 Allowed 'General case' 0 CA--C 1.486 -1.494 0 C-N-CA 124.373 1.069 . . . . 74.11 108.182 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.8 p -47.52 -171.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.058 1.743 . . . . 74.43 113.114 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -34.99 -44.04 0.21 Allowed 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.545 1.938 . . . . 74.32 114.544 -164.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.9 m -58.39 126.44 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 122.281 1.038 . . . . 74.43 110.301 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -51.62 -52.64 46.06 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.463 -1.244 . . . . 74.15 113.833 -165.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.24 -18.88 61.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 119.088 -1.045 . . . . 63.51 109.509 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.22 54.83 2.9 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 108.271 -1.931 . . . . 72.12 108.271 172.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.43 -179.17 22.38 Favored Glycine 0 CA--C 1.461 -3.328 0 N-CA-C 104.051 -3.62 . . . . 75.33 104.051 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.0 mm -82.49 128.02 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.353 0 N-CA-C 104.409 -2.441 . . . . 74.41 104.409 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -106.37 150.91 25.54 Favored 'General case' 0 CA--C 1.459 -2.536 0 N-CA-C 104.432 -2.433 . . . . 75.32 104.432 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.95 103.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 N-CA-C 105.5 -2.037 . . . . 75.23 105.5 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -70.21 -33.99 72.35 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 114.393 -1.276 . . . . 75.13 109.3 -172.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.5 155.55 9.18 Favored 'General case' 0 CA--C 1.464 -2.348 0 N-CA-C 105.636 -1.987 . . . . 64.43 105.636 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.97 134.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 103.045 -2.946 . . . . 75.33 103.045 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 150.18 77.56 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 105.31 -2.108 . . . . 75.34 105.31 176.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.02 168.82 23.86 Favored 'Trans proline' 0 CA--C 1.465 -2.928 0 N-CA-C 105.528 -2.528 . . . . 74.4 105.528 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 62.93 -0.33 0.6 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.297 0.851 . . . . 73.15 113.297 167.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.5 173.81 49.89 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 106.712 -2.555 . . . . 73.43 106.712 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.79 73.95 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.961 -1.125 . . . . 61.32 107.961 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.95 -49.48 65.98 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 115.826 -0.624 . . . . 75.22 110.377 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -65.36 -56.15 14.19 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 122.145 -0.347 . . . . 71.34 110.072 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -63.73 -28.8 70.13 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 122.103 -0.373 . . . . 72.15 111.009 -170.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -83.93 -30.99 25.86 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 106.515 -1.661 . . . . 72.33 106.515 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.89 20.0 79.69 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.375 -1.09 . . . . 72.44 110.375 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -97.16 6.54 48.3 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.691 -1.596 . . . . 71.21 106.691 178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.2 mt -140.96 141.66 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.451 -3.166 . . . . 62.11 102.451 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -142.3 153.5 43.93 Favored 'General case' 0 CA--C 1.46 -2.482 0 N-CA-C 105.205 -2.146 . . . . 65.44 105.205 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.68 141.9 56.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.273 -1.38 . . . . 73.42 107.273 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.21 -32.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 108.898 -1.681 . . . . 72.35 108.898 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.62 154.32 29.43 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 107.83 -1.174 . . . . 62.44 107.83 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.14 135.35 53.9 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.474 -1.676 . . . . 75.42 106.474 -167.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.0 129.57 41.56 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 105.454 -2.054 . . . . 72.23 105.454 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 13.3 mt -95.53 -60.5 1.65 Allowed 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.527 -1.286 . . . . 73.43 107.527 -176.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.88 48.96 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 106.099 -1.815 . . . . 74.24 106.099 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.5 t -115.31 114.85 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 105.23 -2.137 . . . . 71.35 105.23 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 t30 44.09 47.25 7.4 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.046 1.338 . . . . 72.35 111.34 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.45 -32.96 6.9 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 108.301 -1.92 . . . . 61.22 108.301 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.52 118.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.751 0 N-CA-C 109.384 -0.599 . . . . 72.22 109.384 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -54.22 109.47 0.49 Allowed 'General case' 0 C--N 1.369 1.425 0 N-CA-C 106.976 -1.49 . . . . 70.13 106.976 168.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -100.49 -13.28 18.74 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.357 -1.72 . . . . 74.13 106.357 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.27 134.32 56.35 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.458 -0.941 . . . . 65.44 108.458 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.77 -17.69 58.12 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.172 -1.971 . . . . 72.52 108.172 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 151.71 28.06 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.607 -1.998 . . . . 71.32 105.607 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.3 p -79.54 178.41 8.15 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.813 0.816 . . . . 75.41 108.935 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -68.03 -45.17 74.72 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 108.533 -0.914 . . . . 71.32 108.533 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -56.37 -51.5 68.07 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 121.577 -0.702 . . . . 74.23 110.585 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -53.61 -41.49 66.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.831 -0.433 . . . . 63.21 109.831 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.16 64.09 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.975 -0.557 . . . . 64.42 110.02 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.38 -47.41 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 107.793 -1.188 . . . . 75.42 107.793 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.9 m -56.72 -35.59 68.72 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 107.38 -1.341 . . . . 53.41 107.38 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -69.9 -47.11 63.79 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 120.484 -1.385 . . . . 75.01 108.012 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.46 -32.94 72.95 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 109.126 -0.694 . . . . 71.33 109.126 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.55 -60.71 2.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.892 -1.151 . . . . 72.32 107.892 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -69.67 48.63 0.09 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 123.569 0.748 . . . . 71.31 111.706 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.8 p -102.5 -175.71 2.9 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.377 -2.083 . . . . 74.14 105.377 170.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.89 -148.12 22.75 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 106.799 -2.52 . . . . 70.2 106.799 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.44 -55.24 12.54 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.102 -1.073 . . . . 73.41 108.102 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.1 140.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.41 -1.7 . . . . 74.11 106.41 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -104.99 135.62 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.053 -1.832 . . . . 75.24 106.053 -177.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -110.43 129.3 55.8 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 104.889 -2.263 . . . . 72.42 104.889 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.74 133.88 10.48 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.126 -1.435 . . . . 75.33 107.126 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -80.86 138.02 36.19 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 107.71 -1.219 . . . . 74.31 107.71 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.89 155.99 22.76 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.492 -2.41 . . . . 74.44 104.492 177.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.77 132.19 55.55 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 100.827 -3.768 . . . . 72.32 100.827 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.99 138.62 58.17 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.708 -0.849 . . . . 74.55 108.708 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.09 -177.27 48.99 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 106.858 -2.497 . . . . 74.05 106.858 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 66.73 33.37 6.31 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.261 -1.755 . . . . 74.1 106.261 -173.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 p -91.42 124.23 61.69 Favored Pre-proline 0 N--CA 1.419 -2.011 0 N-CA-C 104.225 -2.509 . . . . 54.04 104.225 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.24 96.41 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.259 1.973 . . . . 71.22 109.274 -170.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.42 -1.928 0 N-CA-C 104.387 -2.449 . . . . 72.04 104.387 170.439 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.458 ' H20' ' H15' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.635 0 N-CA-C 107.801 -2.12 . . . . 63.22 107.801 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.74 175.4 7.28 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 123.137 2.558 . . . . 53.45 110.436 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.07 168.66 7.56 Favored Pre-proline 0 N--CA 1.423 -1.807 0 N-CA-C 103.907 -2.627 . . . . 63.12 103.907 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 92' ' ' LYS . 46.1 Cg_exo -61.3 145.33 98.51 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 122.811 2.34 . . . . 75.02 108.819 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.97 -12.79 57.61 Favored Glycine 0 CA--C 1.496 -1.136 0 N-CA-C 109.344 -1.502 . . . . 64.14 109.344 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.28 141.84 31.54 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.358 -1.349 . . . . 63.33 107.358 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.5 mt -104.63 135.11 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.997 0 N-CA-C 109.069 -0.715 . . . . 75.43 109.069 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 2.8 p90 -130.84 149.27 52.55 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 106.56 -1.644 . . . . 74.14 106.56 169.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -103.64 146.13 29.02 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.88 -2.267 . . . . 64.41 104.88 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.75 152.37 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 106.596 -1.631 . . . . 73.21 106.596 173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -106.99 131.69 53.77 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.737 -2.32 . . . . 71.13 104.737 168.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.423 HD11 HD12 ' A' ' 53' ' ' ILE . 0.3 OUTLIER -142.98 142.37 31.62 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.207 -1.035 . . . . 63.25 108.207 -178.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.22 150.52 21.94 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 105.099 -2.186 . . . . 72.1 105.099 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.503 ' HG3' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -76.85 -35.1 57.74 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.744 -1.576 . . . . 64.25 106.744 175.458 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 77.54 109.91 0.07 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.466 -1.309 . . . . 75.14 107.466 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 t0 57.69 36.12 26.3 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 107.804 -1.184 . . . . 74.23 107.804 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.3 t30 52.05 2.03 0.02 OUTLIER 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.752 1.621 . . . . 75.34 112.985 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.0 m -116.54 114.04 23.6 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 120.369 -1.457 . . . . 74.33 109.027 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.503 ' HG ' ' HG3' ' A' ' 14' ' ' LYS . 49.8 mt -94.22 -153.94 0.39 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 102.468 -3.16 . . . . 63.0 102.468 162.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.07 42.19 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 107.752 -2.139 . . . . 71.15 107.752 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -87.3 176.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 105.428 -2.064 . . . . 74.32 105.428 175.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.62 158.33 21.87 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 104.681 -2.34 . . . . 65.15 104.681 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -145.9 172.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 N-CA-C 106.16 -1.792 . . . . 74.24 106.16 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -164.48 167.35 19.59 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 104.353 -2.462 . . . . 74.23 104.353 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 -160.12 29.11 Favored Glycine 0 CA--C 1.494 -1.272 0 N-CA-C 109.004 -1.638 . . . . 71.1 109.004 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.43 -91.38 0.31 Allowed Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 109.063 -1.615 . . . . 74.21 109.063 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -67.14 16.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.506 1.123 . . . . 63.11 113.975 -162.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 85.24 6.78 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.503 1.121 . . . . 74.53 108.716 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 p -37.97 -170.06 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 127.266 2.226 . . . . 61.21 113.895 161.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 m -57.77 -21.27 40.6 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.134 0.974 . . . . 73.42 112.333 -168.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.86 136.23 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 109.053 -0.721 . . . . 74.34 109.053 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -70.57 0.1 Allowed 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.437 1.095 . . . . 73.51 111.424 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -86.21 15.75 4.95 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.497 -0.752 . . . . 74.14 110.977 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 49.68 62.58 4.75 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 110.205 -1.158 . . . . 72.21 110.205 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.01 179.76 28.3 Favored Glycine 0 CA--C 1.454 -3.734 0 N-CA-C 103.843 -3.703 . . . . 61.41 103.843 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.87 132.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.882 0 N-CA-C 105.373 -2.084 . . . . 70.13 105.373 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -110.25 148.39 31.97 Favored 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.881 -2.637 . . . . 71.33 103.881 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -82.06 102.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.049 -1.834 . . . . 74.01 106.049 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -71.9 -33.8 68.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.459 -1.246 . . . . 63.33 110.365 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 146.97 20.49 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 106.247 -1.761 . . . . 74.21 106.247 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 41.6 t -121.5 125.98 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 N-CA-C 104.853 -2.277 . . . . 65.53 104.853 178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.638 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -98.59 171.21 6.02 Favored Pre-proline 0 C--O 1.213 -0.817 0 N-CA-C 105.687 -1.968 . . . . 74.13 105.687 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.485 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 60.0 Cg_endo -84.43 179.62 4.38 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.398 1.399 . . . . 72.25 110.128 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 76.25 -14.15 0.83 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.184 1.394 . . . . 72.02 113.042 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.43 -179.51 45.16 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.58 -1.408 . . . . 74.11 109.58 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.12 -53.67 12.06 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.033 -0.584 . . . . 71.41 109.558 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.53 -50.83 66.93 Favored 'General case' 0 C--N 1.369 1.43 0 CA-C-O 121.08 0.467 . . . . 74.23 110.227 -170.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.607 ' HG2' ' H ' ' A' ' 49' ' ' SER . 3.8 pm0 -61.66 -55.88 25.73 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 123.907 0.883 . . . . 73.43 110.713 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.607 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 22.0 m -62.36 -25.13 67.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.958 0.503 . . . . 70.52 110.859 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -84.35 -28.28 27.14 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.917 -1.512 . . . . 71.13 106.917 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.22 15.15 81.43 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.052 -1.219 . . . . 52.33 110.052 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -99.11 6.71 46.4 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.274 -1.38 . . . . 74.44 107.274 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.423 HD12 HD11 ' A' ' 12' ' ' LEU . 1.3 mp -132.15 137.52 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 102.099 -3.297 . . . . 73.24 102.099 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -133.68 151.37 51.63 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.75 -2.315 . . . . 75.44 104.75 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -67.9 138.14 55.78 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.736 -1.579 . . . . 73.04 106.736 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.57 -27.79 11.49 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 109.496 -1.442 . . . . 75.42 109.496 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.39 154.61 35.0 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 107.141 -1.429 . . . . 73.42 107.141 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.489 HH21 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -117.63 139.01 51.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.472 -1.677 . . . . 64.14 106.472 -166.207 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.5 131.0 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 105.805 -1.924 . . . . 61.44 105.805 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mt -92.32 -60.08 1.93 Allowed 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.42 -1.696 . . . . 72.42 106.42 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.78 150.64 52.09 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 107.08 -1.452 . . . . 64.0 107.08 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -120.73 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 103.683 -2.71 . . . . 75.41 103.683 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.2 t30 60.58 30.07 19.47 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 121.636 0.732 . . . . 71.12 109.098 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.58 75.16 Favored Glycine 0 CA--C 1.483 -1.942 0 N-CA-C 109.326 -1.51 . . . . 54.23 109.326 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.33 122.29 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 106.77 -1.567 . . . . 74.33 106.77 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.68 111.65 0.86 Allowed 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.557 -1.275 . . . . 42.42 107.557 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.431 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -97.92 -10.99 23.64 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 106.477 -1.675 . . . . 74.31 106.477 -167.456 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.489 ' HB3' HH21 ' A' ' 58' ' ' ARG . 25.9 pt-20 -62.99 131.89 50.18 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.265 -0.897 . . . . 74.34 108.69 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.41 -19.72 38.31 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.336 -1.505 . . . . 73.22 109.336 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -81.44 154.62 26.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 105.78 -1.933 . . . . 74.22 105.78 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 p -86.04 178.87 7.1 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.682 0.753 . . . . 75.12 109.683 -166.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -64.14 -45.21 89.51 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.553 -0.906 . . . . 73.22 108.553 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -50.29 -56.06 12.82 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 109.939 -0.393 . . . . 74.1 109.939 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -57.43 -45.26 84.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 116.261 -0.427 . . . . 63.05 109.963 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.19 -56.47 12.65 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 122.603 0.361 . . . . 75.13 110.921 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.77 -39.3 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 109.514 -0.55 . . . . 75.12 109.514 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.69 -29.26 69.22 Favored 'General case' 0 C--O 1.186 -2.283 0 C-N-CA 117.021 -1.871 . . . . 74.44 106.503 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -67.77 -43.23 80.3 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.506 -1.371 . . . . 72.13 107.736 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.0 mt -65.97 -37.0 84.84 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.136 -0.69 . . . . 74.23 109.136 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -77.58 -61.79 1.88 Allowed 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.026 -0.731 . . . . 72.3 109.026 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.46 62.57 1.0 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.01 0.91 . . . . 54.34 110.75 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.07 -176.67 4.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.3 -1.741 . . . . 73.31 106.3 172.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.92 -138.4 4.22 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.758 -2.137 . . . . 60.23 107.758 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.0 -56.06 5.12 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.864 -0.791 . . . . 73.44 108.864 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.0 150.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 107.504 -1.295 . . . . 72.24 107.504 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.9 t -124.77 152.67 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.02 -2.215 . . . . 72.44 105.02 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -102.55 116.61 32.95 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 104.218 -2.512 . . . . 73.21 104.218 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.34 116.53 14.43 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 107.508 -1.293 . . . . 75.13 107.508 -176.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.61 141.64 33.52 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 108.393 -0.965 . . . . 75.13 108.393 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -115.37 154.83 28.49 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.19 -2.152 . . . . 75.01 105.19 178.193 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.15 133.03 54.29 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 101.87 -3.382 . . . . 73.21 101.87 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.41 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -59.46 139.59 56.96 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.685 -0.857 . . . . 74.04 108.685 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.89 -10.97 0.85 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 108.093 -2.003 . . . . 71.35 108.093 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -154.12 -103.96 0.04 OUTLIER 'General case' 0 C--N 1.363 1.167 0 N-CA-C 106.73 -1.582 . . . . 75.31 106.73 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.7 t -71.18 141.06 85.83 Favored Pre-proline 0 C--N 1.355 0.811 0 N-CA-C 106.973 -1.492 . . . . 71.21 106.973 -169.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.77 178.54 3.28 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.163 2.575 . . . . 71.01 109.47 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.423 -1.776 0 N-CA-C 102.812 -3.033 . . . . 74.2 102.812 174.466 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.455 ' C15' ' H20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.33 0 N-CA-C 108.088 -2.005 . . . . 55.14 108.088 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.9 148.35 89.8 Favored 'Trans proline' 0 CA--C 1.497 -1.349 0 C-N-CA 122.965 2.443 . . . . 63.23 108.664 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.8 167.35 13.26 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 105.383 -2.08 . . . . 74.41 105.383 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.32 128.56 22.94 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.288 1.992 . . . . 74.22 108.311 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.23 -2.72 65.87 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 109.424 -1.47 . . . . 61.02 109.424 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -73.73 134.65 43.53 Favored 'General case' 0 C--N 1.363 1.164 0 N-CA-C 106.855 -1.535 . . . . 73.0 106.855 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.4 mt -104.31 136.49 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.515 0 N-CA-C 108.146 -1.057 . . . . 71.12 108.146 -173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.8 159.0 43.82 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.028 -1.471 . . . . 74.24 107.028 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.63 145.37 30.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 75.51 105.67 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.9 m -140.12 151.02 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.381 -1.34 . . . . 65.44 107.381 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -112.11 125.89 54.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.941 -1.874 . . . . 65.12 105.941 167.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.13 143.59 46.64 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 106.793 -1.558 . . . . 72.4 106.793 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.44 152.39 21.5 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.83 -1.915 . . . . 71.41 105.83 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -69.45 -36.01 76.21 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.846 -1.168 . . . . 73.31 107.846 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.24 112.84 0.07 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.44 -0.948 . . . . 71.45 108.44 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.3 32.95 21.39 Favored 'General case' 0 C--N 1.369 1.456 0 N-CA-C 108.603 -0.888 . . . . 75.03 108.603 -174.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.3 t30 48.6 -1.39 0.0 OUTLIER 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.284 1.834 . . . . 55.54 114.1 -174.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -89.83 172.92 8.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.276 -1.379 . . . . 61.3 107.276 -170.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.88 -156.31 0.56 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 103.753 -2.684 . . . . 75.23 103.753 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.66 39.37 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.684 0 N-CA-C 105.912 -2.875 . . . . 65.0 105.912 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.99 177.11 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 104.309 -2.478 . . . . 71.31 104.309 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -141.83 166.52 24.51 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 104.905 -2.257 . . . . 53.43 104.905 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.6 m -147.65 172.13 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 N-CA-C 105.871 -1.9 . . . . 74.25 105.871 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -167.94 168.49 12.07 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 104.404 -2.443 . . . . 75.41 104.404 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.46 -141.42 20.46 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 108.733 -1.747 . . . . 51.13 108.733 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 100.07 -70.19 0.49 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 109.038 -1.625 . . . . 61.4 109.038 174.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.9 t -76.98 13.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 121.397 0.618 . . . . 75.33 109.475 -171.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.463 ' H ' ' C ' ' A' ' 26' ' ' GLY . 2.3 m120 78.77 6.39 2.31 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.521 1.128 . . . . 65.23 109.333 176.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.6 t -53.0 -170.7 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 124.2 1.0 . . . . 74.23 111.378 167.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 m -30.81 -44.87 0.06 Allowed 'General case' 0 C--N 1.366 1.307 0 C-N-CA 127.448 2.299 . . . . 75.34 115.657 -162.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.07 132.68 21.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.513 0.673 . . . . 72.31 110.722 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -49.94 -57.66 7.04 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-N 115.138 -0.937 . . . . 73.54 112.677 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -72.81 -20.9 61.06 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.897 -0.721 . . . . 72.12 109.478 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.21 -14.81 62.12 Favored Glycine 0 C--N 1.359 1.835 0 N-CA-C 109.323 -1.511 . . . . 60.21 109.323 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.19 -178.96 48.24 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 109.09 -1.604 . . . . 75.34 109.09 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.7 mm -81.66 124.5 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 103.014 -2.958 . . . . 75.12 103.014 171.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -100.87 150.4 22.87 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 103.688 -2.708 . . . . 75.01 103.688 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.1 t -80.18 102.97 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.078 -2.193 . . . . 73.13 105.078 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -71.57 -32.87 68.56 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.752 -1.113 . . . . 72.4 109.933 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.82 147.9 22.0 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 106.273 -1.751 . . . . 71.21 106.273 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.13 133.05 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 N-CA-C 103.174 -2.898 . . . . 73.35 103.174 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.502 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.95 152.5 71.75 Favored Pre-proline 0 CA--C 1.511 -0.526 0 N-CA-C 106.502 -1.666 . . . . 73.02 106.502 176.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 58.8 Cg_endo -76.86 172.57 15.96 Favored 'Trans proline' 0 CA--C 1.463 -3.053 0 N-CA-C 105.909 -2.381 . . . . 74.3 105.909 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 66.21 -1.72 1.13 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 124.294 0.996 . . . . 74.12 111.994 163.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.65 -179.1 36.5 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 107.334 -2.306 . . . . 75.42 107.334 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.89 -52.94 45.83 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.268 -1.012 . . . . 71.43 108.268 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.37 65.24 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.379 -0.373 . . . . 75.22 110.838 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.0 -55.31 26.85 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 109.583 -0.525 . . . . 75.41 109.583 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 t -58.35 -32.51 68.6 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.045 0.538 . . . . 64.21 110.641 -171.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.91 -29.6 29.1 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.797 -1.186 . . . . 62.4 107.797 -172.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.25 83.65 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 110.36 -1.096 . . . . 64.05 110.36 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -99.31 6.39 46.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 106.709 -1.589 . . . . 72.54 106.709 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.0 mt -142.44 138.59 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 103.098 -2.927 . . . . 72.41 103.098 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.02 166.34 26.35 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.482 -2.414 . . . . 74.0 104.482 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.72 145.77 54.43 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 107.119 -1.437 . . . . 73.54 107.119 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.59 -33.01 5.97 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 107.982 -2.047 . . . . 64.44 107.982 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.92 149.08 45.52 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 106.941 -1.503 . . . . 71.54 106.941 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.79 143.86 47.62 Favored 'General case' 0 CA--C 1.473 -2.009 0 N-CA-C 107.259 -1.386 . . . . 72.53 107.259 -165.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.26 130.07 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 105.826 -1.916 . . . . 74.21 105.826 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 78.6 mt -95.27 -59.28 1.92 Allowed 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.275 -1.38 . . . . 73.44 107.275 -179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.95 51.17 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 105.946 -1.872 . . . . 74.44 105.946 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.73 121.45 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.376 -2.083 . . . . 75.31 105.376 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.47 30.5 13.01 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.524 0.678 . . . . 74.43 109.724 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.81 -18.2 57.2 Favored Glycine 0 CA--C 1.48 -2.152 0 N-CA-C 109.158 -1.577 . . . . 73.01 109.158 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.64 115.75 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 108.266 -1.013 . . . . 73.22 108.266 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 m -56.74 120.0 7.11 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 107.899 -1.148 . . . . 75.33 107.899 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.432 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -111.92 -11.83 13.84 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.663 -1.606 . . . . 71.02 106.663 -162.079 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -56.38 128.34 35.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.969 -0.752 . . . . 75.43 108.969 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.88 -13.03 68.31 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 108.773 -1.731 . . . . 65.43 108.773 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.432 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -85.74 157.04 20.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.56 -1.645 . . . . 63.23 106.56 -179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -85.68 179.08 7.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.735 0.778 . . . . 75.42 109.402 -171.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -64.7 -45.22 87.51 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 115.392 -0.822 . . . . 73.53 108.97 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -54.5 -55.24 31.14 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 121.567 -0.708 . . . . 74.53 109.955 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -53.84 -43.76 69.74 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.696 -0.483 . . . . 75.24 109.696 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.35 27.25 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.811 0.444 . . . . 72.43 110.531 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 m -74.98 -35.47 35.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 O-C-N 121.976 -0.453 . . . . 75.43 109.835 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 12.6 t -69.11 -32.9 72.63 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 116.854 -1.938 . . . . 73.4 105.986 -169.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -73.09 -45.14 58.87 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 106.996 -1.483 . . . . 73.23 106.996 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.0 -45.15 95.98 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.831 1.253 . . . . 74.31 109.562 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.444 ' C ' ' H ' ' A' ' 82' ' ' THR . 66.7 ttp85 -67.38 -56.2 10.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.517 -0.92 . . . . 75.04 108.517 -178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -71.47 52.16 0.19 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.75 0.42 . . . . 62.32 110.854 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.444 ' H ' ' C ' ' A' ' 80' ' ' ARG . 6.2 p -101.69 -175.49 2.87 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.589 -2.004 . . . . 71.42 105.589 168.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.79 -152.72 17.45 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.222 -2.351 . . . . 61.11 107.222 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -63.33 -55.34 25.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.191 -1.04 . . . . 73.24 108.191 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.59 145.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 106.388 -1.708 . . . . 73.23 106.388 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 82' ' ' THR . 23.6 t -101.17 129.03 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 N-CA-C 105.242 -2.133 . . . . 74.43 105.242 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -111.98 121.63 45.54 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 104.063 -2.569 . . . . 70.34 104.063 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.68 133.61 12.28 Favored 'General case' 0 CA--C 1.46 -2.498 0 N-CA-C 106.518 -1.66 . . . . 72.41 106.518 -174.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -86.98 145.38 26.53 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 107.938 -1.134 . . . . 73.44 107.938 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -131.8 169.05 16.77 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.533 -2.025 . . . . 72.52 105.533 174.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.42 153.06 48.3 Favored 'General case' 0 N--CA 1.402 -2.843 0 N-CA-C 101.822 -3.399 . . . . 74.53 101.822 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 6.5 mmpt? -65.32 135.03 54.83 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.743 -1.206 . . . . 74.43 107.743 175.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.58 -8.04 2.3 Favored Glycine 0 CA--C 1.466 -2.969 0 N-CA-C 107.131 -2.388 . . . . 74.21 107.131 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 22.18 -88.09 0.0 OUTLIER 'General case' 0 C--N 1.373 1.62 0 C-N-CA 127.183 2.193 . . . . 71.04 114.465 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m -75.03 133.79 75.24 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.744 -1.206 . . . . 73.43 107.744 -173.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.54 3.74 2.49 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.363 2.709 . . . . 75.53 111.507 -167.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.391 -3.376 0 N-CA-C 102.488 -3.153 . . . . 64.51 102.488 176.111 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.55 0 N-CA-C 108.672 -1.771 . . . . 62.14 108.672 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.51 143.63 69.87 Favored 'Trans proline' 0 CA--C 1.495 -1.444 0 C-N-CA 122.905 2.403 . . . . 63.31 108.361 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -84.89 166.56 31.2 Favored Pre-proline 0 N--CA 1.427 -1.593 0 N-CA-C 106.916 -1.513 . . . . 73.4 106.916 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.9 106.51 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.662 2.242 . . . . 75.22 109.503 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.81 7.34 56.63 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 108.68 -1.768 . . . . 61.31 108.68 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -83.19 138.75 33.51 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.601 -1.629 . . . . 75.31 106.601 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.462 HG21 ' CD1' ' A' ' 60' ' ' LEU . 23.4 mm -95.91 122.44 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 105.949 -1.871 . . . . 65.43 105.949 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.408 ' CD2' HD22 ' A' ' 90' ' ' LEU . 2.8 p90 -136.68 157.02 47.74 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.397 -0.964 . . . . 74.45 108.397 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 47.1 mt-10 -103.01 148.44 25.69 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 104.512 -2.403 . . . . 74.43 104.512 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.9 m -137.05 147.1 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.062 0 N-CA-C 106.078 -1.823 . . . . 64.31 106.078 170.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.63 118.18 35.95 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 104.671 -2.344 . . . . 74.25 104.671 168.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.407 HD11 HD12 ' A' ' 53' ' ' ILE . 59.3 mt -139.61 135.88 33.79 Favored 'General case' 0 CA--C 1.455 -2.7 0 N-CA-C 105.673 -1.973 . . . . 75.35 105.673 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.45 157.26 20.52 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 106.753 -1.573 . . . . 71.43 106.753 -176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.23 -40.72 98.24 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 106.747 -1.575 . . . . 74.24 106.747 167.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 78.36 108.32 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 107.828 -1.175 . . . . 72.34 107.828 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.458 ' C ' ' H ' ' A' ' 18' ' ' SER . 68.4 m-20 56.81 39.09 29.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.79 0.836 . . . . 73.43 108.843 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.3 t30 55.03 -9.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.728 1.611 . . . . 71.14 113.634 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.458 ' H ' ' C ' ' A' ' 16' ' ' ASP . 32.6 t -99.67 120.53 39.85 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.712 -1.959 . . . . 75.43 105.712 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.626 HD22 ' H ' ' A' ' 19' ' ' LEU . 0.3 OUTLIER -70.91 -56.18 6.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.904 -1.147 . . . . 72.22 107.904 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.72 85.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 109.91 -1.276 . . . . 63.23 109.91 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.553 HG23 ' H ' ' A' ' 22' ' ' CYS . 5.2 mm -86.7 176.57 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 105.262 -2.125 . . . . 74.44 105.262 -174.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.553 ' H ' HG23 ' A' ' 21' ' ' ILE . 60.0 m -138.64 164.38 29.66 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 103.754 -2.684 . . . . 74.14 103.754 174.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.65 171.93 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 105.772 -1.936 . . . . 72.14 105.772 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 t -164.15 170.64 16.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.399 -2.075 . . . . 72.34 105.399 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 -154.53 21.97 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 107.165 -2.374 . . . . 55.43 107.165 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.12 -99.0 0.65 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 109.435 -1.466 . . . . 60.4 109.435 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -68.36 16.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.211 1.189 . . . . 73.45 114.211 -161.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m120 85.24 6.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.267 1.027 . . . . 74.01 108.714 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -43.09 -168.34 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 126.737 2.015 . . . . 63.34 110.009 151.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 m -28.75 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.205 1.802 . . . . 74.22 114.942 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 131.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.207 -1.035 . . . . 74.54 108.207 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.13 -40.34 38.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.492 -0.929 . . . . 73.05 108.492 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -64.14 -18.01 64.03 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.916 -0.772 . . . . 74.54 108.916 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.69 2.31 64.07 Favored Glycine 0 C--O 1.208 -1.477 0 N-CA-C 110.722 -0.951 . . . . 71.2 110.722 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.93 177.68 52.15 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 106.614 -2.594 . . . . 62.1 106.614 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.78 136.55 23.78 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 N-CA-C 104.415 -2.439 . . . . 73.54 104.415 174.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -108.4 148.73 29.72 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 103.358 -2.83 . . . . 74.05 103.358 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.65 102.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 106.547 -1.649 . . . . 73.51 106.547 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -71.66 -36.3 70.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.665 -1.152 . . . . 75.21 110.45 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.97 148.94 22.77 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.061 -1.829 . . . . 74.12 106.061 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.49 138.01 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 103.936 -2.616 . . . . 75.44 103.936 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.455 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -79.17 155.52 77.06 Favored Pre-proline 0 CA--C 1.515 -0.386 0 N-CA-C 105.738 -1.949 . . . . 74.02 105.738 173.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 75.2 Cg_endo -74.39 171.7 17.57 Favored 'Trans proline' 0 CA--C 1.461 -3.168 0 N-CA-C 105.72 -2.454 . . . . 73.24 105.72 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 65.07 -0.2 1.11 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.012 0.82 . . . . 74.45 112.13 164.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.55 174.14 41.1 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 106.624 -2.59 . . . . 70.43 106.624 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.17 -52.87 36.17 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 107.854 -1.165 . . . . 63.41 107.854 -173.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.23 -50.66 64.3 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 116.068 -0.515 . . . . 71.45 111.008 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.04 -54.47 21.27 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 109.933 -0.395 . . . . 73.03 109.933 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.3 t -61.76 -28.58 69.54 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.792 0.437 . . . . 72.24 110.965 -170.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.29 -30.2 38.26 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.105 -1.813 . . . . 75.51 106.105 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.47 20.01 61.05 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 110.146 -1.182 . . . . 71.55 110.146 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -107.59 7.24 28.56 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.696 -1.224 . . . . 75.4 107.696 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.407 HD12 HD11 ' A' ' 12' ' ' LEU . 77.7 mt -144.55 145.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 102.359 -3.2 . . . . 72.3 102.359 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -151.26 176.19 11.46 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 104.77 -2.307 . . . . 74.53 104.77 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -67.23 143.29 56.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.671 -1.233 . . . . 72.1 107.671 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.44 -32.01 7.66 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.029 -1.628 . . . . 71.12 109.029 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.19 160.1 31.76 Favored 'General case' 0 C--N 1.372 1.563 0 N-CA-C 107.347 -1.353 . . . . 62.54 107.347 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -128.42 151.51 49.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 -168.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.92 135.78 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.525 -2.028 . . . . 72.14 105.525 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.462 ' CD1' HG21 ' A' ' 7' ' ' ILE . 53.0 mt -98.5 -58.76 1.89 Allowed 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 107.391 -1.337 . . . . 62.44 107.391 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.97 148.99 48.7 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 106.149 -1.797 . . . . 71.14 106.149 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.46 122.2 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.376 -2.453 . . . . 75.01 104.376 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.31 6.2 p30 44.59 39.9 3.64 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.36 1.064 . . . . 75.42 111.161 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.87 -22.34 41.1 Favored Glycine 0 CA--C 1.471 -2.665 0 N-CA-C 108.936 -1.665 . . . . 74.12 108.936 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -78.25 114.83 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 N-CA-C 107.369 -1.345 . . . . 75.23 107.369 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 m -56.01 120.36 7.33 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.877 -0.786 . . . . 64.23 108.877 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -99.37 -17.29 18.08 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 106.916 -1.513 . . . . 75.44 106.916 -164.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -62.05 125.08 22.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.397 0.618 . . . . 72.42 109.878 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 -15.28 62.0 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 108.019 -2.032 . . . . 53.43 108.019 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 149.29 34.78 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 106.146 -1.798 . . . . 71.4 106.146 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.0 p -80.51 179.05 7.93 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.708 -0.849 . . . . 71.12 108.708 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -63.46 -50.18 70.7 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.117 -1.068 . . . . 74.22 108.117 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -54.2 -55.74 25.04 Favored 'General case' 0 C--N 1.362 1.148 0 O-C-N 121.66 -0.65 . . . . 74.15 110.601 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -54.59 -46.46 73.77 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 109.395 -0.594 . . . . 72.52 109.395 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.41 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.99 -52.47 50.32 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.163 0.585 . . . . 75.13 110.568 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.64 -40.11 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 108.025 -1.102 . . . . 75.22 108.025 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 t -63.95 -30.99 72.02 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 106.551 -1.648 . . . . 71.5 106.551 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.6 m -71.79 -45.79 60.43 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.602 -1.259 . . . . 74.35 107.602 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.99 -40.46 89.23 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 108.945 -0.761 . . . . 73.32 108.945 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.6 -60.56 3.35 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 108.2 -1.037 . . . . 75.21 108.2 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -71.36 53.37 0.2 Allowed 'General case' 0 C--N 1.373 1.605 0 C-N-CA 123.543 0.737 . . . . 61.01 110.572 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.44 HG23 HG11 ' A' ' 86' ' ' VAL . 16.1 p -112.38 -176.23 2.87 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.544 -2.021 . . . . 74.05 105.544 168.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.75 -159.69 32.4 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.195 -2.362 . . . . 63.32 107.195 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -56.86 -53.52 56.98 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.646 -0.872 . . . . 71.53 108.646 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 86.5 t -105.66 147.2 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 106.012 -1.847 . . . . 75.34 106.012 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.44 HG11 HG23 ' A' ' 82' ' ' THR . 39.6 t -100.37 129.53 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 106.66 -1.607 . . . . 74.24 106.66 -171.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.515 ' HE1' ' OE1' ' A' ' 9' ' ' GLU . 58.3 t60 -103.89 117.27 33.94 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 105.089 -2.189 . . . . 72.5 105.089 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.76 134.42 14.57 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 107.603 -1.258 . . . . 75.22 107.603 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.45 141.41 33.92 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.447 -1.316 . . . . 55.32 107.447 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.408 HD22 ' CD2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -117.11 163.51 16.15 Favored 'General case' 0 CA--C 1.473 -2.001 0 N-CA-C 105.605 -1.998 . . . . 71.21 105.605 175.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' HB2' HD13 ' A' ' 60' ' ' LEU . 33.9 tt0 -130.76 139.2 50.23 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 101.45 -3.537 . . . . 74.31 101.45 165.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -66.19 142.46 57.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.8 14.6 52.96 Favored Glycine 0 CA--C 1.487 -1.678 0 N-CA-C 105.859 -2.896 . . . . 72.33 105.859 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -60.75 -51.46 69.23 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 125.38 1.472 . . . . 61.11 108.476 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.9 p -67.89 122.93 85.73 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 106.196 -1.779 . . . . 74.31 106.196 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.45 157.97 59.05 Favored 'Trans proline' 0 CA--C 1.492 -1.594 0 C-N-CA 122.422 2.081 . . . . 74.22 108.701 -169.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.255 1.359 0 N-CA-C 105.528 -2.027 . . . . 75.32 105.528 -177.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.463 0 N-CA-C 108.882 -1.687 . . . . 74.53 108.882 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.32 169.55 12.22 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 123.348 2.698 . . . . 63.54 109.13 -175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -109.46 163.43 17.07 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 105.398 -2.075 . . . . 72.11 105.398 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.03 133.46 41.32 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.387 2.058 . . . . 64.14 108.343 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.61 -7.06 57.63 Favored Glycine 0 CA--C 1.486 -1.744 0 N-CA-C 110.004 -1.239 . . . . 72.45 110.004 171.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.18 130.71 40.28 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.212 -1.403 . . . . 74.31 107.212 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.477 HD12 HD13 ' A' ' 60' ' ' LEU . 12.0 mm -98.45 136.16 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.19 -1.781 . . . . 73.34 106.19 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.79 160.09 43.11 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.68 -0.859 . . . . 73.24 108.68 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 50.5 mt-10 -105.83 145.96 30.52 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 105.511 -2.033 . . . . 70.03 105.511 176.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.99 156.5 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 106.82 -1.548 . . . . 64.01 106.82 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -116.11 134.76 54.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.517 -2.031 . . . . 65.1 105.517 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.407 HD23 HD12 ' A' ' 53' ' ' ILE . 4.3 mp -135.61 145.82 47.28 Favored 'General case' 0 CA--C 1.454 -2.721 0 N-CA-C 107.755 -1.202 . . . . 74.44 107.755 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.06 142.33 28.0 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 105.206 -2.146 . . . . 73.32 105.206 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.415 ' HG2' ' HB2' ' A' ' 19' ' ' LEU . 37.0 mtpt -77.68 -33.44 53.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 106.133 -1.803 . . . . 75.13 106.133 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 70.55 126.13 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.066 -1.424 . . . . 71.12 108.79 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 18' ' ' SER . 38.0 t70 59.71 34.82 22.16 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.075 -0.713 . . . . 74.02 109.075 173.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.1 t30 55.38 -9.18 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.009 1.724 . . . . 74.13 113.582 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 16' ' ' ASP . 42.4 m -99.2 130.68 45.52 Favored 'General case' 0 N--CA 1.424 -1.732 0 O-C-N 120.815 -1.178 . . . . 70.12 108.535 -168.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.415 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 24.7 tp -134.04 139.3 45.92 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 102.679 -3.082 . . . . 72.23 102.679 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.85 62.48 0.24 Allowed Glycine 0 CA--C 1.464 -3.137 0 N-CA-C 106.215 -2.754 . . . . 63.52 106.215 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 22' ' ' CYS . 1.1 mm -88.54 178.14 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.198 -2.519 . . . . 74.32 104.198 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' H ' HG22 ' A' ' 21' ' ' ILE . 8.2 m -118.43 160.35 21.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.016 -2.216 . . . . 75.01 105.016 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 m -152.05 173.03 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 106.1 -1.815 . . . . 65.11 106.1 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.418 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 12.4 t -167.22 170.54 11.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.115 -1.809 . . . . 61.3 106.115 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.57 -145.39 17.71 Favored Glycine 0 CA--C 1.485 -1.796 0 N-CA-C 109.857 -1.297 . . . . 65.44 109.857 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.67 -79.26 0.25 Allowed Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.784 -1.727 . . . . 61.23 108.784 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.07 15.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.817 0 N-CA-C 112.304 0.483 . . . . 75.11 112.304 -164.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 85.58 6.36 0.44 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 124.234 1.014 . . . . 62.41 109.35 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.1 p -46.94 -168.9 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.901 1.68 . . . . 73.43 112.188 165.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 m -35.13 -35.53 0.04 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.045 1.738 . . . . 74.53 113.596 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.406 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 10.4 m -58.84 113.28 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.412 1.101 . . . . 74.23 110.159 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -47.87 -58.97 3.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.812 -1.086 . . . . 75.03 112.626 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -69.18 -20.65 64.0 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.822 -0.548 . . . . 64.44 110.071 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 52.34 4.02 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 107.591 -2.204 . . . . 71.24 107.591 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.4 179.81 25.88 Favored Glycine 0 CA--C 1.459 -3.459 0 N-CA-C 103.108 -3.997 . . . . 74.04 103.108 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 14.9 mm -88.71 127.78 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.792 0 N-CA-C 105.236 -2.135 . . . . 73.2 105.236 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 5.3 m-85 -107.41 154.66 21.0 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 104.677 -2.342 . . . . 75.21 104.677 -178.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -87.25 101.71 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 N-CA-C 105.089 -2.189 . . . . 72.14 105.089 171.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.418 ' HE2' ' HB ' ' A' ' 24' ' ' THR . 11.5 ttmm -71.62 -26.2 62.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.121 -0.945 . . . . 74.21 109.082 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 142.96 16.69 Favored 'General case' 0 CA--C 1.46 -2.495 0 N-CA-C 105.627 -1.99 . . . . 74.11 105.627 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 84.8 t -110.21 125.98 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 102.729 -3.064 . . . . 74.34 102.729 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.4 pp -76.63 145.95 75.96 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.978 -1.86 . . . . 73.54 105.978 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 45' ' ' GLY . 55.7 Cg_endo -77.81 174.53 12.43 Favored 'Trans proline' 0 CA--C 1.469 -2.742 0 N-CA-C 105.813 -2.418 . . . . 74.33 105.813 -174.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 69.05 -11.85 0.43 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.238 0.961 . . . . 73.42 112.597 161.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -93.23 -177.69 40.34 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 108.275 -1.93 . . . . 74.24 108.275 -175.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.59 60.53 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 108.167 -1.049 . . . . 61.13 108.167 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.48 65.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.174 -0.466 . . . . 72.42 110.675 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.62 -53.87 44.79 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 122.009 -0.432 . . . . 74.55 109.876 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 t -60.14 -33.53 72.29 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.288 -0.634 . . . . 72.55 109.288 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.97 -43.42 35.1 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.342 -1.355 . . . . 60.24 107.342 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.94 11.08 79.78 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.615 -0.994 . . . . 52.03 110.615 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -95.24 7.33 46.48 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.583 -1.265 . . . . 65.31 107.583 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.449 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 1.6 mp -134.32 139.4 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 102.537 -3.134 . . . . 73.02 102.537 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.449 ' CD2' ' O ' ' A' ' 53' ' ' ILE . 26.3 m170 -148.04 161.45 41.36 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 104.986 -2.227 . . . . 72.3 104.986 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -66.6 138.93 57.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.996 -1.112 . . . . 73.45 107.996 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.41 -32.51 7.48 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 108.069 -2.012 . . . . 70.34 108.069 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.97 154.23 41.65 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 107.011 -1.478 . . . . 74.45 107.011 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 91' ' ' GLU . 19.1 ptt-85 -131.38 155.16 47.76 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.369 -0.974 . . . . 72.21 108.369 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.28 139.44 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 105.908 -1.886 . . . . 74.31 105.908 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.477 HD13 HD12 ' A' ' 7' ' ' ILE . 93.6 mt -102.28 -57.97 1.96 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.832 -1.544 . . . . 64.14 106.832 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.24 148.34 49.56 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.549 -2.019 . . . . 55.43 105.549 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.6 119.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 105.233 -2.136 . . . . 75.12 105.233 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.8 t30 53.57 36.12 22.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.606 0.762 . . . . 74.24 109.841 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.87 -21.77 44.25 Favored Glycine 0 CA--C 1.474 -2.524 0 N-CA-C 108.777 -1.729 . . . . 70.3 108.777 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.8 115.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 108.082 -1.081 . . . . 71.4 108.082 -172.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -52.41 120.97 6.16 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.523 0.729 . . . . 64.1 109.122 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.413 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -109.94 -19.16 13.2 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 107.549 -1.278 . . . . 73.34 107.549 -167.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.9 127.37 31.11 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 120.787 -1.196 . . . . 73.43 108.38 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.86 62.06 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 108.553 -1.819 . . . . 65.22 108.553 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.413 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -79.76 151.24 30.48 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 105.311 -2.107 . . . . 73.2 105.311 174.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 58.6 p -81.68 179.39 7.85 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.712 -0.847 . . . . 72.33 108.712 -171.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.5 -45.32 69.21 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.197 -1.038 . . . . 73.34 108.197 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -52.49 -56.11 17.38 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 121.339 -0.851 . . . . 53.22 109.852 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -53.75 -41.63 67.32 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 109.746 -0.465 . . . . 74.23 109.746 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -53.0 -50.04 65.01 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 116.087 -0.506 . . . . 62.42 109.933 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.2 t -73.52 -42.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 108.067 -1.086 . . . . 72.31 108.067 -174.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.4 m -57.97 -35.12 70.72 Favored 'General case' 0 N--CA 1.523 3.224 0 N-CA-C 106.177 -1.786 . . . . 64.34 106.177 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.6 m -73.24 -47.89 39.47 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.904 -1.043 . . . . 74.23 108.554 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.75 -37.67 82.46 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.379 -0.6 . . . . 53.24 109.379 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -69.12 -60.53 2.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.614 -1.254 . . . . 74.54 107.614 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -69.17 57.39 0.1 Allowed 'General case' 0 C--N 1.367 1.337 0 C-N-CA 123.595 0.758 . . . . 72.21 110.981 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -109.24 -176.38 3.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.775 -1.565 . . . . 63.02 106.775 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.27 -144.99 16.07 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.313 -2.315 . . . . 73.05 107.313 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -72.19 -55.58 7.01 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.666 -0.864 . . . . 74.23 108.666 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.52 146.84 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 106.19 -1.781 . . . . 75.32 106.19 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -105.08 132.85 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 105.241 -2.133 . . . . 75.41 105.241 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.494 ' HE1' ' OE1' ' A' ' 9' ' ' GLU . 61.1 t-80 -113.21 132.55 55.46 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.73 -2.322 . . . . 74.12 104.73 173.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -159.49 143.5 14.88 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 108.582 -0.895 . . . . 75.31 108.582 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.08 137.88 35.98 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 107.267 -1.383 . . . . 73.21 107.267 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.69 161.9 36.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.531 -1.285 . . . . 74.24 107.531 176.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 58' ' ' ARG . 79.6 tt0 -133.69 141.76 47.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 104.183 -2.525 . . . . 75.1 104.183 -173.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -66.82 144.35 56.35 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.928 -0.767 . . . . 74.12 108.928 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.17 -161.22 22.6 Favored Glycine 0 CA--C 1.474 -2.485 0 N-CA-C 105.665 -2.974 . . . . 71.21 105.665 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -112.63 158.31 20.16 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 104.105 -2.554 . . . . 73.04 104.105 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.9 m -64.2 130.61 94.67 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 108.904 -0.776 . . . . 70.23 108.904 -175.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.44 -172.84 0.83 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.344 2.696 . . . . 74.34 108.159 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.426 -1.647 0 N-CA-C 106.392 -1.707 . . . . 71.02 106.392 -178.827 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.478 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.897 0 N-CA-C 107.831 -2.108 . . . . 75.03 107.831 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.1 164.32 36.01 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 N-CA-C 106.795 -2.04 . . . . 62.54 106.795 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -107.51 157.76 34.93 Favored Pre-proline 0 N--CA 1.445 -0.69 0 N-CA-C 106.386 -1.709 . . . . 72.13 106.386 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.89 130.24 28.65 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 C-N-CA 122.603 2.202 . . . . 61.32 108.94 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.57 -8.08 59.92 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 109.231 -1.547 . . . . 71.51 109.231 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -77.07 134.29 38.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.839 -1.541 . . . . 75.44 106.839 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.407 HD12 HD13 ' A' ' 60' ' ' LEU . 2.5 mt -105.25 138.12 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 N-CA-C 107.405 -1.332 . . . . 71.24 107.405 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -156.41 172.37 18.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.368 -1.345 . . . . 73.45 107.368 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.01 155.01 27.75 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 106.051 -1.833 . . . . 73.41 106.051 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.84 156.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 105.711 -1.959 . . . . 74.32 105.711 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.84 130.35 55.0 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.176 -1.787 . . . . 74.21 106.176 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.72 140.06 47.91 Favored 'General case' 0 CA--C 1.46 -2.501 0 N-CA-C 106.875 -1.528 . . . . 72.25 106.875 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 140.99 31.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.648 -1.982 . . . . 70.12 105.648 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -68.61 -28.2 66.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.648 -1.241 . . . . 75.21 107.648 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 t30 86.51 93.54 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.324 -1.361 . . . . 72.34 107.324 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.28 47.77 6.7 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.772 -1.195 . . . . 55.03 107.772 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 45.94 -0.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 127.588 2.355 . . . . 62.44 115.407 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -104.83 115.27 30.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.887 1.221 . . . . 73.35 108.03 -172.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.602 HD22 ' H ' ' A' ' 19' ' ' LEU . 1.6 pt? -89.48 -155.39 0.35 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.432 -1.692 . . . . 71.01 106.432 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.34 55.56 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.189 0 N-CA-C 106.275 -2.73 . . . . 71.3 106.275 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.493 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.3 mm -106.65 178.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.119 -2.919 . . . . 74.11 103.119 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.493 ' H ' HG22 ' A' ' 21' ' ' ILE . 56.0 m -133.01 163.79 28.43 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.176 -2.157 . . . . 75.2 105.176 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.35 175.86 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.827 -1.546 . . . . 73.12 106.827 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -164.21 167.0 20.54 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 104.816 -2.29 . . . . 73.23 104.816 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.49 23.28 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 108.479 -1.849 . . . . 64.24 108.479 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 107.68 -74.13 0.21 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 108.776 -1.729 . . . . 63.34 108.776 174.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.14 15.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.203 0.525 . . . . 73.22 109.659 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.448 ' H ' ' C ' ' A' ' 26' ' ' GLY . 41.8 t30 84.46 5.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.962 1.305 . . . . 73.31 108.006 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -53.74 -170.69 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.53 1.132 . . . . 73.21 112.293 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 m -29.46 -45.73 0.05 OUTLIER 'General case' 0 C--N 1.367 1.366 0 C-N-CA 126.843 2.057 . . . . 74.2 115.934 -159.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.52 125.56 19.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 CA-C-O 122.05 0.929 . . . . 75.22 109.954 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.424 ' HD2' HE22 ' A' ' 94' ' ' GLN . 11.3 ptp85 -52.65 -44.31 66.07 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.583 -1.19 . . . . 74.23 112.884 -169.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.418 ' HD1' ' NE ' ' A' ' 58' ' ' ARG . 23.8 t-160 -75.45 -21.25 58.27 Favored 'General case' 0 C--N 1.37 1.486 0 O-C-N 120.823 -1.173 . . . . 73.51 108.719 -175.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -14.79 62.97 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 109.878 -1.289 . . . . 62.41 109.878 171.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.95 179.92 44.13 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 108.551 -1.82 . . . . 71.31 108.551 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.1 mm -83.2 127.85 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 N-CA-C 104.336 -2.468 . . . . 74.44 104.336 171.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.53 152.27 23.9 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 104.567 -2.383 . . . . 75.11 104.567 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.27 100.29 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 104.785 -2.302 . . . . 74.34 104.785 170.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.64 -17.97 42.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.788 -1.096 . . . . 73.54 111.725 -176.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.86 19.53 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 106.997 -1.483 . . . . 72.51 106.997 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.89 132.02 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 103.581 -2.748 . . . . 75.23 103.581 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.93 145.6 81.44 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 106.252 -1.759 . . . . 74.33 106.252 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.01 167.02 27.95 Favored 'Trans proline' 0 CA--C 1.464 -2.996 0 N-CA-C 106.848 -2.02 . . . . 73.12 106.848 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 69.06 2.1 3.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 124.474 1.109 . . . . 73.52 110.884 165.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.68 -175.77 38.43 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 108.515 -1.834 . . . . 53.43 108.515 -174.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.58 55.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 108.123 -1.066 . . . . 65.0 108.123 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.72 -49.39 62.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.978 -0.556 . . . . 52.31 110.417 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.31 -52.64 31.25 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.875 -0.33 . . . . 64.35 110.407 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.8 t -65.73 -36.24 83.04 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.686 -0.634 . . . . 70.54 109.973 -169.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.57 -25.57 35.69 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 106.672 -1.603 . . . . 73.41 106.672 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.1 78.78 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.75 -0.94 . . . . 74.42 110.75 167.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -87.24 1.99 51.45 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.684 -1.228 . . . . 75.13 107.684 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.9 mt -143.6 140.89 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 103.832 -2.655 . . . . 75.33 103.832 -168.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -142.72 159.4 42.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.029 -2.582 . . . . 75.14 104.029 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.45 142.88 57.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.007 -1.109 . . . . 72.55 108.007 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.56 -31.87 8.14 Favored Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 107.467 -2.253 . . . . 73.21 107.467 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -58.86 147.86 32.24 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 109.039 -0.726 . . . . 62.31 109.039 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.418 ' NE ' ' HD1' ' A' ' 33' ' ' HIS . 31.0 mtm-85 -114.88 139.93 49.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.623 -1.251 . . . . 72.21 107.623 -172.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.89 129.03 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.451 -2.055 . . . . 70.22 105.451 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.407 HD13 HD12 ' A' ' 7' ' ' ILE . 89.2 mt -97.33 -58.81 1.92 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 106.905 -1.517 . . . . 74.43 106.905 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.23 148.76 48.22 Favored 'General case' 0 CA--C 1.476 -1.865 0 N-CA-C 106.414 -1.699 . . . . 71.04 106.414 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.2 121.59 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 105.29 -2.115 . . . . 74.41 105.29 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.9 t30 53.16 37.32 24.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 71.14 110.046 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.49 -26.88 22.05 Favored Glycine 0 CA--C 1.471 -2.672 0 N-CA-C 108.513 -1.835 . . . . 61.32 108.513 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 83.4 t -79.4 116.69 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 107.809 -1.182 . . . . 75.11 107.809 -171.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 114.65 1.76 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 108.593 -0.892 . . . . 72.24 108.593 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -102.27 -18.82 15.29 Favored 'General case' 0 C--O 1.191 -1.992 0 N-CA-C 106.363 -1.717 . . . . 73.4 106.363 -167.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.16 129.14 39.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.193 -0.942 . . . . 64.45 108.473 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.56 -16.56 56.34 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 108.044 -2.022 . . . . 34.21 108.044 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.61 154.1 27.61 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.435 -1.691 . . . . 72.35 106.435 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.0 p -81.13 179.88 7.66 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.109 -0.7 . . . . 64.43 109.109 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -58.76 -53.33 59.56 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 107.936 -1.135 . . . . 71.45 107.936 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.57 -48.3 80.07 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 110.282 -0.266 . . . . 74.55 110.282 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -57.84 -41.08 81.6 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.767 -0.457 . . . . 75.13 109.767 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.67 -56.22 12.9 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 120.818 0.342 . . . . 74.24 110.714 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.7 m -74.64 -33.39 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 109.145 -0.687 . . . . 61.11 109.145 -173.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.9 t -68.79 -31.55 70.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 105.991 -1.855 . . . . 74.41 105.991 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.2 m -71.37 -41.83 69.22 Favored 'General case' 0 C--O 1.207 -1.133 0 O-C-N 120.319 -1.488 . . . . 75.45 107.464 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.3 -29.55 69.94 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 109.232 -0.655 . . . . 75.41 109.232 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -73.78 -61.21 1.92 Allowed 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.807 -1.183 . . . . 74.5 107.807 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.83 54.45 0.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.422 0.629 . . . . 64.43 111.548 -174.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.539 ' HG1' HG23 ' A' ' 86' ' ' VAL . 2.7 p -112.77 -175.06 2.58 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 104.956 -2.238 . . . . 75.22 104.956 167.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.78 -161.55 25.97 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 107.71 -2.156 . . . . 71.45 107.71 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -52.69 -53.34 48.87 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.8 -0.815 . . . . 55.24 108.8 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.5 t -102.99 148.8 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 105.465 -2.05 . . . . 73.12 105.465 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.539 HG23 ' HG1' ' A' ' 82' ' ' THR . 33.4 t -104.59 131.11 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 N-CA-C 105.42 -2.067 . . . . 61.44 105.42 -177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -112.92 128.91 56.6 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.048 -2.575 . . . . 73.41 104.048 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 142.97 17.75 Favored 'General case' 0 CA--C 1.467 -2.227 0 N-CA-C 108.087 -1.079 . . . . 74.24 108.087 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 135.67 35.93 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.839 -1.541 . . . . 74.12 106.839 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.65 160.43 33.36 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 106.353 -1.721 . . . . 71.13 106.353 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.6 135.03 48.77 Favored 'General case' 0 N--CA 1.397 -3.106 0 N-CA-C 102.102 -3.296 . . . . 72.2 102.102 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.434 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 6.8 mmpt? -62.48 136.86 58.1 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 107.813 -1.18 . . . . 74.11 107.813 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.88 -173.3 48.82 Favored Glycine 0 CA--C 1.461 -3.326 0 N-CA-C 106.78 -2.528 . . . . 74.23 106.78 -171.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.424 HE22 ' HD2' ' A' ' 32' ' ' ARG . 36.0 mt-30 -82.91 136.8 34.46 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 105.035 -2.209 . . . . 73.32 105.035 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 m -46.61 121.39 6.52 Favored Pre-proline 0 C--N 1.348 0.528 0 O-C-N 123.855 0.722 . . . . 72.24 110.734 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.24 159.72 50.92 Favored 'Trans proline' 0 CA--C 1.498 -1.291 0 C-N-CA 122.985 2.456 . . . . 73.12 108.646 -169.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.42 -1.953 0 N-CA-C 104.077 -2.564 . . . . 63.45 104.077 178.878 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.48 ' H15' H20A ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.239 0 N-CA-C 108.087 -2.005 . . . . 44.03 108.087 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.25 149.47 88.54 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.649 2.233 . . . . 73.43 108.449 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -102.78 165.33 13.9 Favored Pre-proline 0 N--CA 1.437 -1.104 0 N-CA-C 106.556 -1.646 . . . . 75.13 106.556 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.17 127.67 19.83 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.54 2.16 . . . . 74.53 108.207 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.46 1.92 65.99 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 109.25 -1.54 . . . . 74.12 109.25 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -81.77 140.34 34.3 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.613 -1.625 . . . . 60.13 106.613 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.8 mt -104.86 137.75 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.467 0 N-CA-C 108.392 -0.966 . . . . 72.35 108.392 -173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 1.2 p90 -138.89 155.8 47.8 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 107.098 -1.445 . . . . 72.33 107.098 172.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -105.89 145.71 30.9 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.757 -1.942 . . . . 73.31 105.757 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.4 m -142.34 155.86 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 106.888 -1.523 . . . . 72.12 106.888 175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.66 122.96 46.1 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 105.088 -2.19 . . . . 65.11 105.088 167.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.482 HD13 HD12 ' A' ' 53' ' ' ILE . 12.7 mt -131.97 133.12 44.13 Favored 'General case' 0 CA--C 1.458 -2.58 0 N-CA-C 105.018 -2.216 . . . . 73.11 105.018 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.02 22.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 105.805 -1.924 . . . . 72.43 105.805 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -70.04 -36.16 74.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.999 -1.852 . . . . 74.23 105.999 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 81.48 113.21 0.06 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 125.231 1.412 . . . . 65.32 108.117 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.57 36.21 25.01 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.791 -1.188 . . . . 75.1 107.791 -173.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 43.38 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 127.485 2.314 . . . . 63.4 115.25 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.7 m -97.24 124.52 41.35 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 119.985 1.266 . . . . 72.24 107.904 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.546 ' H ' HD22 ' A' ' 19' ' ' LEU . 1.9 pt? -97.03 -158.88 0.7 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 105.817 -1.92 . . . . 75.35 105.817 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.76 32.09 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 106.671 -2.571 . . . . 71.42 106.671 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.476 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.1 mm -88.16 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.863 -2.273 . . . . 61.24 104.863 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.476 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.2 m -140.56 167.23 22.66 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 103.849 -2.649 . . . . 51.53 103.849 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 m -148.38 173.18 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 106.985 -1.487 . . . . 74.22 106.985 -168.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.437 HG22 ' HD3' ' A' ' 39' ' ' LYS . 8.2 t -159.32 164.01 35.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 104.037 -2.579 . . . . 71.14 104.037 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -139.16 18.31 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.356 -1.898 . . . . 71.01 108.356 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.468 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 104.61 -79.31 0.29 Allowed Glycine 0 CA--C 1.466 -3.001 0 N-CA-C 108.54 -1.824 . . . . 44.41 108.54 177.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -76.11 16.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 122.731 0.413 . . . . 74.32 111.045 -171.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' H ' ' C ' ' A' ' 26' ' ' GLY . 17.2 t-20 85.59 5.68 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.832 1.253 . . . . 70.52 108.099 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -55.85 -171.0 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.476 -0.784 . . . . 74.23 111.851 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 m -29.1 -45.03 0.04 OUTLIER 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.439 2.295 . . . . 65.31 116.009 -162.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.72 136.82 16.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-O 121.663 0.744 . . . . 72.22 111.855 -172.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -35.16 -71.53 0.07 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 126.17 1.788 . . . . 73.41 113.207 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -76.97 -15.6 59.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.26 -0.9 . . . . 72.43 110.104 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.38 61.79 2.16 Favored Glycine 0 CA--C 1.491 -1.449 0 N-CA-C 108.093 -2.003 . . . . 72.42 108.093 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.95 -178.81 25.23 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 104.376 -3.49 . . . . 72.41 104.376 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 7.0 mm -83.72 122.3 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.131 0 N-CA-C 104.427 -2.434 . . . . 74.12 104.427 172.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -107.17 153.13 23.13 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 103.809 -2.663 . . . . 73.32 103.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -83.55 102.32 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.154 -1.795 . . . . 75.32 106.154 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.437 ' HD3' HG22 ' A' ' 24' ' ' THR . 13.5 tptm -72.91 -31.11 64.42 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.423 -0.808 . . . . 75.42 111.036 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.73 145.4 18.61 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 106.495 -1.668 . . . . 75.12 106.495 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -122.27 133.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.413 -2.81 . . . . 72.51 103.413 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.439 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -74.97 151.49 86.34 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 106.398 -1.705 . . . . 65.11 106.398 173.526 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.33 167.66 25.35 Favored 'Trans proline' 0 CA--C 1.457 -3.336 0 N-CA-C 105.735 -2.448 . . . . 74.31 105.735 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 68.38 1.98 3.13 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.769 0.668 . . . . 73.04 110.109 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.99 175.06 42.98 Favored Glycine 0 CA--C 1.472 -2.642 0 N-CA-C 107.571 -2.212 . . . . 72.32 107.571 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.13 -48.6 64.97 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 107.355 -1.35 . . . . 72.44 107.355 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.19 64.9 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 116.067 -0.515 . . . . 73.44 110.019 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.08 -56.22 14.25 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.975 -0.379 . . . . 74.24 109.975 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -65.44 -28.94 69.59 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.908 0.385 . . . . 70.34 110.515 -166.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -83.17 -31.28 27.22 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 106.764 -1.569 . . . . 71.42 106.764 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 16.91 65.88 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 111.025 -0.83 . . . . 70.41 111.025 170.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.1 mmp_? -91.71 5.65 48.93 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.523 -1.288 . . . . 74.54 107.523 -179.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.482 HD12 HD13 ' A' ' 12' ' ' LEU . 58.9 mt -144.83 144.88 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 104.161 -2.533 . . . . 72.43 104.161 -171.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 55' ' ' LYS . 50.9 p-80 -149.3 168.24 23.88 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 101.871 -3.381 . . . . 73.42 101.871 172.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 39.5 mtmt -66.44 144.16 56.67 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.074 -1.084 . . . . 75.22 108.074 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.19 -32.5 7.47 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.07 -1.062 . . . . 54.42 110.839 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' CG ' ' CE1' ' A' ' 54' ' ' HIS . 34.8 m-20 -66.65 154.55 40.3 Favored 'General case' 0 C--N 1.378 1.822 0 CA-C-N 119.871 1.836 . . . . 72.43 107.859 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 137.41 51.92 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.047 -1.464 . . . . 74.35 107.047 -164.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.5 127.27 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 106.452 -1.684 . . . . 70.44 106.452 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.1 mt -95.12 -59.83 1.81 Allowed 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.017 -1.105 . . . . 72.41 108.017 -177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.38 148.66 47.94 Favored 'General case' 0 CA--C 1.467 -2.216 0 N-CA-C 106.254 -1.758 . . . . 64.44 106.254 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.6 t -119.92 119.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 105.864 -1.902 . . . . 75.21 105.864 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.9 t30 49.38 38.07 13.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.698 1.199 . . . . 71.43 110.318 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.22 -33.5 6.52 Favored Glycine 0 CA--C 1.469 -2.821 0 N-CA-C 108.212 -1.955 . . . . 63.14 108.212 171.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.0 114.98 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 107.753 -1.203 . . . . 74.41 107.753 -172.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.6 m -53.88 117.44 3.19 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 107.939 -1.134 . . . . 65.45 107.939 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 70' ' ' ALA . 1.1 tm? -99.88 -10.48 21.68 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.291 -2.114 . . . . 65.51 105.291 -168.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.45 137.18 48.87 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.914 -1.143 . . . . 70.25 107.914 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.6 62.04 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.46 -1.456 . . . . 74.41 109.46 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.41 ' HB2' HD13 ' A' ' 67' ' ' LEU . . . -80.47 148.96 30.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.837 -1.172 . . . . 61.12 107.837 -177.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 39.0 p -81.99 -179.48 7.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.844 -0.798 . . . . 73.53 108.844 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -60.64 -52.02 66.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.981 -1.118 . . . . 74.33 107.981 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -57.1 -55.5 33.9 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 121.638 -0.664 . . . . 73.13 110.783 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -53.62 -40.7 65.99 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 120.772 0.32 . . . . 73.33 110.529 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.13 -54.46 24.97 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.023 0.529 . . . . 73.53 110.787 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.98 -37.43 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.801 -0.444 . . . . 73.01 109.801 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.02 -31.67 72.85 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 116.943 -1.903 . . . . 55.41 106.266 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.408 ' O ' HG22 ' A' ' 82' ' ' THR . 26.5 m -71.85 -45.16 62.34 Favored 'General case' 0 C--O 1.206 -1.232 0 O-C-N 120.654 -1.279 . . . . 64.13 107.901 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.5 mt -62.48 -29.66 70.7 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 110.181 -0.303 . . . . 71.31 110.181 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' A' ' 82' ' ' THR . 61.1 ttp85 -73.69 -59.0 2.92 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.194 -1.41 . . . . 74.53 107.194 176.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -70.51 46.77 0.09 Allowed 'General case' 0 C--N 1.362 1.139 0 C-N-CA 125.109 1.364 . . . . 75.35 111.441 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.459 ' HG1' HG23 ' A' ' 86' ' ' VAL . 2.7 p -105.22 -175.4 2.78 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.159 -1.793 . . . . 74.35 106.159 173.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.0 33.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 106.012 -2.835 . . . . 63.44 106.012 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.25 -54.54 44.6 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.22 -1.03 . . . . 72.32 108.22 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.0 t -101.79 145.18 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 105.995 -1.854 . . . . 62.42 105.995 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.459 HG23 ' HG1' ' A' ' 82' ' ' THR . 47.7 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 105.904 -1.887 . . . . 72.31 105.904 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -107.7 127.02 53.31 Favored 'General case' 0 CA--C 1.466 -2.271 0 N-CA-C 103.298 -2.853 . . . . 72.43 103.298 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.46 136.57 13.81 Favored 'General case' 0 CA--C 1.458 -2.583 0 N-CA-C 107.374 -1.343 . . . . 75.44 107.374 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.26 136.37 35.8 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.311 -1.366 . . . . 73.2 107.311 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.45 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -107.41 151.74 25.12 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 103.893 -2.632 . . . . 73.1 103.893 175.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.53 133.3 55.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 101.65 -3.463 . . . . 70.0 101.65 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.7 129.52 41.94 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.49 -0.929 . . . . 75.34 108.49 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.15 0.41 25.38 Favored Glycine 0 CA--C 1.477 -2.295 0 N-CA-C 105.177 -3.169 . . . . 71.4 105.177 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.446 ' CD ' ' H ' ' A' ' 95' ' ' SER . 0.0 OUTLIER 67.19 -172.08 0.19 Allowed 'General case' 0 C--N 1.38 1.929 0 N-CA-C 107.446 -1.316 . . . . 74.32 107.446 178.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.446 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 53.4 m -102.44 97.51 8.98 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 104.751 -2.314 . . . . 75.3 104.751 167.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.83 124.13 11.52 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.813 2.342 . . . . 71.03 109.081 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.408 -2.567 0 N-CA-C 103.604 -2.739 . . . . 75.14 103.604 175.824 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.421 ' H5 ' ' H1A' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.041 0 N-CA-C 108.368 -1.893 . . . . 74.41 108.368 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.05 155.96 68.5 Favored 'Trans proline' 0 CA--C 1.5 -1.182 0 C-N-CA 122.636 2.224 . . . . 71.5 108.654 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.79 166.82 12.81 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 104.737 -2.32 . . . . 74.22 104.737 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.26 129.91 31.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.749 2.299 . . . . 74.45 109.123 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.37 -8.86 72.14 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 108.923 -1.671 . . . . 51.44 108.923 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -75.6 139.78 42.26 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.418 -1.327 . . . . 73.4 107.418 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.419 HD12 HD11 ' A' ' 60' ' ' LEU . 9.4 mm -100.68 131.64 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.128 -1.434 . . . . 74.44 107.128 -171.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -143.34 155.8 44.53 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.255 -1.387 . . . . 74.32 107.255 175.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -108.77 147.07 32.59 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.729 -1.952 . . . . 74.23 105.729 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.8 m -141.22 152.51 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 N-CA-C 107.272 -1.381 . . . . 74.41 107.272 177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.58 127.07 53.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.117 -2.179 . . . . 74.53 105.117 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.0 mp -135.18 140.99 45.79 Favored 'General case' 0 CA--C 1.461 -2.445 0 N-CA-C 107.748 -1.204 . . . . 63.41 107.748 175.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.07 141.22 33.36 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.757 -1.571 . . . . 72.24 106.757 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -71.54 -25.88 62.4 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.333 -0.988 . . . . 73.13 108.333 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 72.64 108.05 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.25 -1.019 . . . . 73.51 108.25 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 51.94 53.1 13.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 109.549 -0.537 . . . . 71.41 109.549 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.1 t30 54.37 -9.09 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.043 1.737 . . . . 75.55 115.007 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.4 t -126.12 120.76 30.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 120.595 1.543 . . . . 75.03 108.317 -171.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -99.99 167.44 10.49 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.109 -2.182 . . . . 73.4 105.109 171.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.99 95.62 0.15 Allowed Glycine 0 CA--C 1.478 -2.232 0 N-CA-C 105.041 -3.223 . . . . 65.23 105.041 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.557 HG23 ' H ' ' A' ' 22' ' ' CYS . 4.7 mm -118.95 177.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.273 -2.862 . . . . 73.15 103.273 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.557 ' H ' HG23 ' A' ' 21' ' ' ILE . 4.1 t -127.79 154.74 45.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 102.987 -2.968 . . . . 72.52 102.987 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.0 m -149.46 169.55 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.818 -1.549 . . . . 74.23 106.818 -165.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.517 HG22 ' CE2' ' A' ' 37' ' ' TYR . 6.8 t -165.22 168.23 17.26 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.531 -2.396 . . . . 75.5 104.531 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.26 -167.03 22.33 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 105.573 -3.011 . . . . 64.43 105.573 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.91 -115.74 0.91 Allowed Glycine 0 CA--C 1.489 -1.55 0 C-N-CA 119.443 -1.361 . . . . 74.1 110.165 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -60.73 20.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.691 1.996 . . . . 74.25 116.32 -162.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 87.37 9.07 0.17 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.262 -1.014 . . . . 72.32 108.262 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.3 p -39.14 -166.96 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 126.283 1.833 . . . . 74.43 111.626 154.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -39.34 -29.11 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.9 0 O-C-N 120.458 -1.401 . . . . 74.51 114.616 -168.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG13 ' CE1' ' A' ' 37' ' ' TYR . 4.6 m -86.27 134.84 26.4 Favored 'Isoleucine or valine' 0 C--N 1.365 1.248 0 O-C-N 120.347 -1.471 . . . . 61.44 108.486 177.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -70.54 -24.17 62.76 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.857 -0.794 . . . . 72.51 108.857 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 60' ' ' LEU . 7.4 t-160 -83.69 -10.98 57.79 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.898 -0.721 . . . . 72.55 109.06 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.69 67.1 2.36 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 110.029 -1.229 . . . . 60.24 110.029 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.74 178.21 26.46 Favored Glycine 0 CA--C 1.472 -2.607 0 N-CA-C 105.348 -3.101 . . . . 74.12 105.348 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.76 141.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 N-CA-C 105.905 -1.887 . . . . 71.12 105.905 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.517 ' CE2' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -121.46 162.05 21.15 Favored 'General case' 0 CA--C 1.45 -2.898 0 N-CA-C 106.696 -1.594 . . . . 74.13 106.696 175.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 99.7 t -85.8 103.54 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 106.593 -1.632 . . . . 64.42 106.593 -176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -71.12 -30.48 66.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.535 -1.211 . . . . 75.12 108.949 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.7 151.16 10.69 Favored 'General case' 0 CA--C 1.467 -2.225 0 N-CA-C 105.869 -1.9 . . . . 73.42 105.869 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.0 t -118.33 134.15 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 103.657 -2.72 . . . . 72.31 103.657 178.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 148.68 84.01 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.826 -1.916 . . . . 75.04 105.826 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.26 168.12 25.34 Favored 'Trans proline' 0 CA--C 1.467 -2.84 0 N-CA-C 106.073 -2.318 . . . . 73.1 106.073 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 62.08 2.75 0.85 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.239 0.829 . . . . 74.12 113.239 164.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.19 -175.78 36.13 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 107.12 -2.392 . . . . 75.15 107.12 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.63 -53.01 38.76 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 108.579 -0.897 . . . . 74.41 108.579 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.49 -49.84 66.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 116.362 -0.381 . . . . 75.25 111.067 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.7 -53.1 59.6 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 109.616 -0.513 . . . . 73.53 109.616 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -55.71 -38.15 69.35 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.278 0.631 . . . . 71.14 109.962 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -77.48 -33.5 54.52 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.871 -1.159 . . . . 74.1 107.871 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.31 81.04 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.235 -1.146 . . . . 73.11 110.235 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -107.33 8.37 29.69 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.282 -1.006 . . . . 74.24 108.282 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 mp -126.92 134.13 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 101.859 -3.386 . . . . 72.14 101.859 175.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -138.74 159.58 41.75 Favored 'General case' 0 CA--C 1.473 -2.0 0 N-CA-C 104.091 -2.559 . . . . 63.22 104.091 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -66.48 143.99 56.76 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.74 -1.207 . . . . 75.32 107.74 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -30.82 8.88 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 108.623 -1.791 . . . . 72.23 108.623 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -66.49 152.73 44.6 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 106.232 -1.766 . . . . 75.41 106.232 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.473 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 18.7 ptt-85 -132.23 157.67 43.75 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.954 -1.498 . . . . 75.14 106.954 -171.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.54 135.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.416 -1.698 . . . . 74.21 106.416 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.45 ' CD2' ' CE1' ' A' ' 33' ' ' HIS . 48.2 mt -96.92 -58.26 2.08 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.029 -1.471 . . . . 75.34 107.029 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.92 151.57 50.11 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.416 -1.698 . . . . 75.42 106.416 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.65 119.86 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 105.515 -2.031 . . . . 70.31 105.515 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.5 t30 54.71 32.85 18.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.133 0.973 . . . . 72.11 109.909 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.78 -28.99 13.42 Favored Glycine 0 CA--C 1.463 -3.183 0 N-CA-C 108.551 -1.82 . . . . 72.45 108.551 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.26 115.12 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 N-CA-C 107.533 -1.284 . . . . 74.33 107.533 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 t -55.65 130.56 43.62 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.689 -0.856 . . . . 75.45 108.689 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.98 -11.81 21.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.939 -1.874 . . . . 73.22 105.939 -170.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.77 126.13 20.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.863 -0.608 . . . . 64.53 109.634 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.17 -12.26 64.95 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 109.137 -1.585 . . . . 53.21 109.137 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.88 148.8 41.96 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 107.271 -1.381 . . . . 73.31 107.271 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 p -81.77 177.32 8.95 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 107.317 -1.364 . . . . 73.43 107.317 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -65.85 -43.93 86.98 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.541 -0.911 . . . . 70.54 108.541 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -54.59 -56.73 15.91 Favored 'General case' 0 C--N 1.362 1.125 0 O-C-N 121.881 -0.512 . . . . 64.34 110.176 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -56.46 -44.42 80.52 Favored 'General case' 0 C--N 1.365 1.246 0 N-CA-C 110.089 -0.337 . . . . 71.03 110.089 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.54 -52.76 35.85 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.792 0.437 . . . . 71.14 110.831 -178.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.14 -42.12 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.775 -1.195 . . . . 74.12 107.775 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -53.23 -40.6 64.65 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 123.722 1.725 . . . . 61.22 106.442 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -65.5 -40.34 92.92 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 120.338 -1.476 . . . . 71.01 108.776 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.87 -29.57 70.28 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 109.813 -0.44 . . . . 74.42 109.813 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -73.26 -60.42 2.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.531 -0.544 . . . . 74.32 109.531 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -68.97 40.79 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 113.563 0.949 . . . . 73.22 113.563 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 p -106.72 -176.12 2.99 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 106.303 -1.74 . . . . 71.14 106.303 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.02 -153.87 28.97 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 108.415 -1.874 . . . . 73.53 108.415 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -61.14 -54.39 45.07 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.923 -0.769 . . . . 72.43 108.923 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.52 145.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 105.82 -1.919 . . . . 73.22 105.82 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.06 139.41 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.673 0 N-CA-C 105.592 -2.003 . . . . 72.23 105.592 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -114.08 135.8 53.62 Favored 'General case' 0 CA--C 1.463 -2.376 0 N-CA-C 104.608 -2.367 . . . . 72.42 104.608 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.54 135.69 9.92 Favored 'General case' 0 CA--C 1.461 -2.448 0 N-CA-C 106.975 -1.491 . . . . 74.52 106.975 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.411 ' HB3' HD13 ' A' ' 60' ' ' LEU . 6.5 mp -81.19 139.08 35.76 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 107.318 -1.364 . . . . 75.44 107.318 178.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.76 155.5 21.5 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 104.62 -2.363 . . . . 74.14 104.62 176.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.473 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.9 tt0 -120.74 128.75 53.21 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 101.604 -3.48 . . . . 72.21 101.604 165.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -61.93 146.83 48.76 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.736 -0.838 . . . . 73.14 108.736 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.96 -166.03 18.81 Favored Glycine 0 N--CA 1.42 -2.411 0 N-CA-C 105.577 -3.009 . . . . 73.24 105.577 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 168.42 -78.82 0.0 OUTLIER 'General case' 0 CA--C 1.448 -2.972 0 N-CA-C 101.343 -3.577 . . . . 63.42 101.343 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -88.4 152.47 49.88 Favored Pre-proline 0 N--CA 1.397 -3.114 0 N-CA-C 104.543 -2.391 . . . . 74.33 104.543 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.86 -174.08 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.872 2.381 . . . . 70.23 109.122 170.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.559 1.324 0 CA-C-O 118.209 -0.901 . . . . 61.21 109.18 176.526 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.538 0 N-CA-C 109.122 -1.591 . . . . 74.31 109.122 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.15 158.32 57.97 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 122.964 2.443 . . . . 73.14 108.251 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -117.99 161.24 35.5 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 106.356 -1.72 . . . . 55.32 106.356 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.91 132.59 40.33 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.011 2.474 . . . . 55.32 109.367 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.21 -15.83 35.91 Favored Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 108.713 -1.755 . . . . 71.44 108.713 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.36 133.48 42.5 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 108.131 -1.063 . . . . 74.24 108.131 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mt -99.27 128.08 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.522 -1.288 . . . . 71.35 107.522 -178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 0.9 OUTLIER -138.25 159.58 41.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.793 -1.558 . . . . 72.33 106.793 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.86 152.12 22.3 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 105.172 -2.158 . . . . 75.34 105.172 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 11.5 m -131.79 142.75 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 N-CA-C 104.35 -2.463 . . . . 75.51 104.35 167.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -101.06 116.84 33.78 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 103.782 -2.673 . . . . 70.01 103.782 167.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.405 HD12 HD12 ' A' ' 53' ' ' ILE . 0.2 OUTLIER -136.08 134.04 37.98 Favored 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.434 -1.691 . . . . 71.23 106.434 -172.156 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.44 148.59 25.49 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.831 -1.544 . . . . 51.5 106.831 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -75.1 -33.88 61.68 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.12 -1.807 . . . . 73.12 106.12 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.84 104.88 0.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.379 1.071 . . . . 71.13 108.164 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.66 37.59 19.06 Favored 'General case' 0 C--N 1.366 1.288 0 N-CA-C 107.85 -1.167 . . . . 75.42 107.85 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 47.75 2.41 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.36 1.864 . . . . 72.25 114.747 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -86.41 139.25 31.11 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 106.706 -1.591 . . . . 74.45 106.706 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -128.01 -144.66 0.29 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 104.675 -2.343 . . . . 72.32 104.675 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.21 74.66 0.63 Allowed Glycine 0 CA--C 1.467 -2.953 0 N-CA-C 105.056 -3.218 . . . . 61.13 105.056 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.531 HG22 ' H ' ' A' ' 22' ' ' CYS . 8.5 mm -103.57 177.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 101.584 -3.487 . . . . 74.41 101.584 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.531 ' H ' HG22 ' A' ' 21' ' ' ILE . 3.1 m -121.34 151.97 39.49 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 103.205 -2.887 . . . . 72.33 103.205 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -152.11 169.23 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 N-CA-C 106.828 -1.545 . . . . 72.4 106.828 -165.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -160.46 164.64 32.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 104.334 -2.469 . . . . 71.42 104.334 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.71 -162.74 26.74 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.083 -2.007 . . . . 73.05 108.083 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.447 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 126.3 -88.43 0.35 Allowed Glycine 0 C--N 1.356 1.686 0 N-CA-C 109.112 -1.595 . . . . 55.51 109.112 176.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.88 18.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 123.134 0.574 . . . . 72.13 112.251 -167.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.447 ' H ' ' C ' ' A' ' 26' ' ' GLY . 5.2 t-20 85.98 7.05 0.36 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.313 -0.995 . . . . 65.44 108.313 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.7 p -45.51 -169.31 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.413 1.885 . . . . 64.31 112.466 167.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -49.92 -18.39 0.51 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.939 1.088 . . . . 74.23 113.939 -167.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.436 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 15.3 m -66.53 128.78 30.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.525 0 N-CA-C 107.868 -1.16 . . . . 74.44 107.868 172.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.36 -52.69 44.35 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.256 -0.902 . . . . 74.43 110.958 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.64 -20.37 59.92 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 119.543 -0.863 . . . . 73.35 110.174 -168.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.43 -6.86 55.83 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.804 -1.718 . . . . 74.34 108.804 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 179.26 53.38 Favored Glycine 0 CA--C 1.501 -0.833 0 N-CA-C 108.198 -1.961 . . . . 51.22 108.198 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.8 mm -88.97 132.24 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.215 0 N-CA-C 104.535 -2.395 . . . . 65.34 104.535 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.436 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 3.8 m-30 -107.16 150.23 26.82 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 105.129 -2.174 . . . . 74.53 105.129 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.6 t -82.85 103.43 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.194 -1.78 . . . . 73.31 106.194 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -73.04 -34.56 66.38 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.13 -1.396 . . . . 74.11 108.751 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.76 151.06 8.82 Favored 'General case' 0 CA--C 1.46 -2.486 0 N-CA-C 104.598 -2.371 . . . . 75.24 104.598 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.36 131.58 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 102.975 -2.972 . . . . 74.53 102.975 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.77 146.63 83.34 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 106.332 -1.729 . . . . 70.24 106.332 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.9 172.03 16.92 Favored 'Trans proline' 0 CA--C 1.468 -2.794 0 N-CA-C 105.965 -2.36 . . . . 65.22 105.965 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 49.55 51.99 15.37 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.312 1.053 . . . . 71.51 109.743 164.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.47 34.41 Favored Glycine 0 CA--C 1.472 -2.612 1 N-CA-C 102.899 -4.08 . . . . 73.13 102.899 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -53.58 26.78 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-N 117.781 0.791 . . . . 72.21 109.734 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.5 -50.48 65.31 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.987 -0.097 . . . . 73.11 111.122 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -63.37 -55.36 25.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.664 0.385 . . . . 73.42 110.058 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.1 m -65.33 -30.23 71.05 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.694 -0.629 . . . . 71.54 110.75 -172.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.42 -35.56 54.04 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 105.914 -1.884 . . . . 72.41 105.914 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.8 30.2 59.98 Favored Glycine 0 CA--C 1.476 -2.398 0 CA-C-N 115.318 -0.855 . . . . 54.21 111.738 167.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -98.48 -47.85 5.23 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.387 -1.709 . . . . 74.35 106.387 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.405 HD12 HD12 ' A' ' 12' ' ' LEU . 65.9 mt -66.07 148.06 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.53 0.681 . . . . 75.02 109.735 169.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 55' ' ' LYS . 27.5 p-80 -154.94 167.12 31.38 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 104.227 -2.509 . . . . 74.1 104.227 172.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 52.7 mtmt -66.73 143.16 57.1 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.156 0.503 . . . . 74.35 109.86 -176.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.94 -33.19 6.63 Favored Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 108.606 -1.797 . . . . 72.23 108.606 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -69.35 156.41 38.85 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 105.701 -1.963 . . . . 73.44 105.701 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -132.98 157.91 44.01 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.021 -1.103 . . . . 73.23 108.021 -168.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.26 135.27 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 106.177 -1.786 . . . . 75.32 106.177 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -99.57 -58.67 1.87 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.638 -1.616 . . . . 74.21 106.638 178.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.48 149.97 50.76 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 105.76 -1.941 . . . . 71.22 105.76 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.54 121.47 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 N-CA-C 105.069 -2.197 . . . . 75.23 105.069 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.56 32.88 21.69 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 123.46 0.704 . . . . 73.15 109.278 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.81 -5.59 84.65 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 109.562 -1.415 . . . . 61.02 109.562 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.1 t -94.92 130.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 107.023 -1.473 . . . . 74.42 107.023 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -47.62 147.33 1.85 Allowed 'General case' 0 C--N 1.367 1.332 0 C-N-CA 123.907 0.883 . . . . 65.51 110.501 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.74 -25.18 0.42 Allowed 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.717 -1.586 . . . . 63.22 106.717 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.9 pm0 -56.3 127.19 29.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.603 -0.888 . . . . 63.4 108.603 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.8 -11.47 66.52 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.43 -1.468 . . . . 74.22 109.43 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 157.36 25.64 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 105.66 -1.978 . . . . 64.54 105.66 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 29.2 p -87.64 179.49 6.51 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.146 -0.687 . . . . 71.11 109.146 -168.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.39 -51.34 69.16 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.638 -1.245 . . . . 73.02 107.638 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.72 -55.81 22.89 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 109.896 -0.409 . . . . 74.21 109.896 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -56.46 -42.38 78.1 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 122.169 -0.332 . . . . 70.32 110.623 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.16 -55.76 16.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 122.853 0.461 . . . . 72.44 110.311 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.5 m -74.72 -36.27 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 109.044 -0.724 . . . . 63.12 109.044 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -62.66 -34.66 77.55 Favored 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 106.055 -1.832 . . . . 72.34 106.055 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.7 m -71.83 -45.48 61.31 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 120.071 -1.643 . . . . 74.13 107.715 -175.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.46 -29.82 70.2 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.722 -0.473 . . . . 70.04 109.722 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -60.08 2.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.58 -1.637 . . . . 74.23 106.58 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -67.86 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.485 1.114 . . . . 73.12 112.219 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.3 p -101.81 -175.21 2.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.166 -1.79 . . . . 71.32 106.166 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.6 -150.89 26.95 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 107.694 -2.163 . . . . 74.53 107.694 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.61 -55.69 16.26 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.681 -0.859 . . . . 74.25 108.681 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.5 t -104.25 149.34 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 104.992 -2.225 . . . . 71.23 104.992 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 42.9 t -111.61 140.56 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.288 -1.745 . . . . 74.44 106.288 -174.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -110.62 130.8 55.48 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 103.657 -2.72 . . . . 62.33 103.657 167.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.97 132.49 12.1 Favored 'General case' 0 CA--C 1.456 -2.649 0 N-CA-C 106.786 -1.561 . . . . 70.41 106.786 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.65 136.01 36.14 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 106.82 -1.548 . . . . 75.54 106.82 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.529 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -109.68 159.45 17.13 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 103.968 -2.604 . . . . 74.51 103.968 174.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -120.37 134.1 55.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.77 -3.419 . . . . 74.25 101.77 167.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -62.89 138.18 58.47 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 107.945 -1.131 . . . . 72.03 107.945 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.32 -156.61 9.95 Favored Glycine 0 CA--C 1.471 -2.701 0 N-CA-C 106.459 -2.656 . . . . 71.1 106.459 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -144.11 166.65 24.4 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.535 -2.024 . . . . 74.5 105.535 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.0 m -98.17 124.37 47.52 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 105.375 -2.083 . . . . 71.1 105.375 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.95 112.71 3.18 Favored 'Trans proline' 0 CA--C 1.502 -1.081 0 C-N-CA 122.338 2.025 . . . . 72.02 108.431 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.576 1.965 0 O-C-N 124.969 1.418 . . . . 71.22 111.54 -179.862 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.444 0 N-CA-C 108.922 -1.671 . . . . 72.41 108.922 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.23 156.56 64.35 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 122.79 2.327 . . . . 63.11 108.133 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -85.54 165.5 35.26 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 107.027 -1.472 . . . . 53.44 107.027 -175.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.66 121.45 9.74 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.425 2.084 . . . . 74.43 110.147 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.73 11.99 69.89 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 109.328 -1.509 . . . . 74.54 109.328 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -80.84 143.33 32.86 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.037 -1.468 . . . . 72.02 107.037 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.443 HG21 ' CD1' ' A' ' 60' ' ' LEU . 12.9 mm -98.19 132.79 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 105.879 -1.897 . . . . 71.43 105.879 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.422 ' CD2' HD22 ' A' ' 90' ' ' LEU . 1.5 p90 -144.18 156.48 44.33 Favored 'General case' 0 CA--C 1.478 -1.803 0 C-N-CA 119.056 -1.057 . . . . 73.33 109.027 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -103.3 141.65 35.54 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 105.387 -2.079 . . . . 74.21 105.387 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.01 145.93 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 105.127 -2.175 . . . . 71.34 105.127 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -110.05 126.44 53.99 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.336 -2.098 . . . . 62.41 105.336 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.47 HD13 ' HB2' ' A' ' 52' ' ' ARG . 58.1 mt -134.83 139.48 45.1 Favored 'General case' 0 CA--C 1.451 -2.836 0 N-CA-C 106.948 -1.501 . . . . 74.44 106.948 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.54 152.68 23.74 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.352 -2.092 . . . . 71.25 105.352 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -77.22 -28.58 53.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.221 -1.399 . . . . 73.05 107.221 172.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 81.38 104.93 0.06 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.442 1.097 . . . . 73.44 108.105 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 57.56 41.68 25.4 Favored 'General case' 0 C--N 1.366 1.293 0 N-CA-C 107.271 -1.381 . . . . 62.42 107.271 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 43.26 2.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 127.516 2.326 . . . . 65.01 115.504 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.0 m -100.23 114.69 28.32 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 120.34 1.427 . . . . 63.12 107.269 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.535 HD22 ' H ' ' A' ' 19' ' ' LEU . 1.8 pt? -89.63 -173.18 3.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 104.697 -2.334 . . . . 72.44 104.697 169.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 40.95 0.04 OUTLIER Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 104.43 -3.468 . . . . 45.24 104.43 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.508 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.6 mt -98.09 174.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.479 -2.786 . . . . 75.34 103.479 -176.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.508 ' H ' HG22 ' A' ' 21' ' ' ILE . 34.4 t -138.86 156.39 47.34 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 104.738 -2.319 . . . . 71.12 104.738 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.65 173.29 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.617 0 N-CA-C 104.716 -2.327 . . . . 73.41 104.716 -167.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.4 t -162.09 167.12 24.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.446 -1.686 . . . . 73.04 106.446 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.87 -154.08 30.36 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 108.578 -1.809 . . . . 75.22 108.578 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.55 -82.38 0.34 Allowed Glycine 0 CA--C 1.474 -2.497 0 N-CA-C 108.849 -1.7 . . . . 65.5 108.849 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.48 16.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.497 0 C-N-CA 123.438 0.695 . . . . 75.02 112.199 -165.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 85.71 5.54 0.46 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.954 1.301 . . . . 73.13 108.345 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.5 p -49.29 -170.82 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.237 1.415 . . . . 74.41 111.352 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 m -30.19 -41.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 126.268 1.827 . . . . 74.51 115.359 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.449 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 14.7 m -57.28 120.0 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 122.348 1.07 . . . . 73.54 110.774 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -49.27 -64.33 0.84 Allowed 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.786 -1.097 . . . . 71.35 111.824 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -73.99 -19.85 60.52 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 120.209 -0.597 . . . . 73.24 110.112 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.36 60.19 1.57 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 109.754 -1.338 . . . . 53.11 109.754 170.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.73 -178.76 29.39 Favored Glycine 0 CA--C 1.466 -3.015 0 N-CA-C 103.184 -3.966 . . . . 73.13 103.184 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.94 133.67 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 103.973 -2.603 . . . . 74.1 103.973 175.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.449 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 9.2 m-85 -106.47 150.58 25.94 Favored 'General case' 0 CA--C 1.463 -2.367 0 N-CA-C 104.755 -2.313 . . . . 74.22 104.755 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.15 102.28 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.179 -1.786 . . . . 74.21 106.179 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -71.89 -35.2 69.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.495 -1.23 . . . . 75.21 109.67 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.86 144.08 19.98 Favored 'General case' 0 CA--C 1.464 -2.355 0 N-CA-C 105.841 -1.911 . . . . 51.21 105.841 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.99 127.62 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 103.409 -2.812 . . . . 71.33 103.409 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.23 147.03 63.82 Favored Pre-proline 0 CA--C 1.51 -0.577 0 N-CA-C 106.365 -1.717 . . . . 75.3 106.365 176.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.466 ' C ' ' H ' ' A' ' 45' ' ' GLY . 65.5 Cg_endo -76.29 172.67 15.82 Favored 'Trans proline' 0 CA--C 1.473 -2.526 0 N-CA-C 106.063 -2.322 . . . . 73.41 106.063 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 70.35 -11.75 0.57 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 124.116 0.885 . . . . 72.44 111.132 167.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.466 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -91.19 178.91 42.09 Favored Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 107.198 -2.361 . . . . 74.05 107.198 -174.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.51 69.87 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.211 -1.033 . . . . 74.12 108.211 -174.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.54 63.61 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 116.056 -0.52 . . . . 73.44 110.41 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.08 -53.95 17.63 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.69 -0.485 . . . . 62.33 109.69 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -61.27 -34.89 75.92 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.118 0.567 . . . . 70.13 110.531 -169.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -90.39 -23.22 21.13 Favored 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.077 -1.453 . . . . 73.22 107.077 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.0 24.57 59.52 Favored Glycine 0 C--N 1.358 1.755 0 N-CA-C 110.5 -1.04 . . . . 72.22 110.5 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HB2' HD13 ' A' ' 12' ' ' LEU . 23.4 mmt180 -96.33 6.45 48.77 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.264 -1.013 . . . . 74.02 108.264 -174.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.467 HD12 ' CD1' ' A' ' 12' ' ' LEU . 47.4 mt -142.34 146.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.172 -2.529 . . . . 75.1 104.172 -173.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -147.2 156.41 42.93 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 103.984 -2.599 . . . . 75.3 103.984 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -66.86 146.14 54.73 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.685 -1.228 . . . . 74.43 107.685 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.11 -30.71 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 108.221 -1.952 . . . . 72.13 108.221 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.25 153.93 39.61 Favored 'General case' 0 C--N 1.364 1.221 0 N-CA-C 107.896 -1.149 . . . . 74.43 107.896 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.8 ttp85 -112.56 138.43 49.34 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 105.967 -1.864 . . . . 75.31 105.967 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.67 126.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 105.089 -2.189 . . . . 75.24 105.089 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' CD1' HG21 ' A' ' 7' ' ' ILE . 16.3 mt -92.31 -58.71 2.29 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 107.841 -1.17 . . . . 75.41 107.841 -173.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.49 148.68 46.22 Favored 'General case' 0 CA--C 1.472 -2.03 0 N-CA-C 105.534 -2.024 . . . . 73.52 105.534 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -121.55 127.01 75.52 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.604 0 N-CA-C 104.665 -2.346 . . . . 63.41 104.665 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 t30 57.48 29.63 17.36 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.89 -0.781 . . . . 71.3 108.89 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.17 -20.04 52.38 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 108.887 -1.685 . . . . 64.31 108.887 173.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.27 123.29 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.917 0 N-CA-C 108.529 -0.915 . . . . 74.31 108.529 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.4 m -52.92 122.91 10.18 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 123.273 0.629 . . . . 72.12 109.924 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 HD11 ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -101.79 -21.95 14.49 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.358 -1.349 . . . . 73.14 107.358 -171.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -65.65 129.04 38.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.39 -0.819 . . . . 71.11 109.467 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 -17.08 57.11 Favored Glycine 0 C--N 1.363 2.055 0 N-CA-C 108.614 -1.795 . . . . 70.03 108.614 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.5 ' HB3' ' CG ' ' A' ' 74' ' ' GLN . . . -79.67 154.78 28.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.495 -1.669 . . . . 72.44 106.495 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 p -82.74 176.43 9.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.528 0.68 . . . . 74.41 110.242 -165.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -62.79 -51.46 67.02 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.669 -1.234 . . . . 74.34 107.669 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -53.7 -56.16 19.82 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 122.406 0.283 . . . . 62.41 111.083 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.5 ' CG ' ' HB3' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -60.57 -35.67 76.63 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 109.26 -0.644 . . . . 64.02 109.26 -171.024 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.13 -48.83 61.68 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 123.144 0.577 . . . . 75.22 109.583 176.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.27 -40.35 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 108.296 -1.002 . . . . 74.55 108.296 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -54.9 -40.45 69.82 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.526 -1.657 . . . . 73.21 106.526 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.4 m -74.33 -36.73 63.67 Favored 'General case' 0 C--O 1.215 -0.762 0 O-C-N 120.564 -1.335 . . . . 73.44 109.207 -171.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 mt -71.2 -39.84 71.54 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.086 -0.709 . . . . 73.12 109.086 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -78.74 -60.59 2.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.816 -0.438 . . . . 74.43 109.816 -171.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -67.06 60.27 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.901 0.858 . . . . 74.05 110.928 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -127.41 -176.28 3.7 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.913 -1.514 . . . . 70.34 106.913 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.18 -149.44 20.58 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 107.159 -2.376 . . . . 65.25 107.159 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -67.08 -55.77 12.86 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.259 -0.645 . . . . 55.21 109.259 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.62 145.02 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 106.214 -1.773 . . . . 73.02 106.214 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.49 146.01 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 106.101 -1.814 . . . . 74.54 106.101 -171.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -106.79 128.91 54.65 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 105.919 -1.882 . . . . 70.34 105.919 173.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.07 125.49 19.0 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 105.831 -1.914 . . . . 63.13 105.831 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -80.08 138.36 36.95 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.834 -1.543 . . . . 75.23 106.834 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.422 HD22 ' CD2' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -111.05 154.24 24.5 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 104.974 -2.232 . . . . 75.23 104.974 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -120.75 134.0 55.31 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 101.2 -3.63 . . . . 70.14 101.2 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -61.76 128.06 34.43 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.997 -1.112 . . . . 71.33 107.997 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.25 13.0 67.56 Favored Glycine 0 CA--C 1.471 -2.702 0 N-CA-C 106.752 -2.539 . . . . 52.21 106.752 -173.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -55.05 -46.21 75.34 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.53 -1.655 . . . . 74.02 106.53 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.6 m -86.44 127.61 60.26 Favored Pre-proline 0 N--CA 1.427 -1.581 0 N-CA-C 105.746 -1.946 . . . . 65.1 105.746 170.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.9 -14.46 29.5 Favored 'Trans proline' 0 CA--C 1.485 -1.93 0 C-N-CA 122.611 2.207 . . . . 72.12 109.27 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.404 -2.737 0 N-CA-C 102.573 -3.121 . . . . 73.33 102.573 -179.453 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.544 0 N-CA-C 109.104 -1.598 . . . . 52.11 109.104 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.95 139.05 55.01 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.592 2.195 . . . . 75.33 108.804 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -96.43 169.53 8.78 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 103.543 -2.762 . . . . 71.23 103.543 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -58.31 115.61 2.66 Favored 'Trans proline' 0 CA--C 1.512 -0.592 0 C-N-CA 122.46 2.107 . . . . 74.13 109.032 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.05 -11.69 37.49 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.584 -1.406 . . . . 62.21 109.584 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.38 136.85 36.45 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 118.822 1.311 . . . . 75.33 107.724 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 3.9 mt -102.78 132.89 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.915 0 N-CA-C 107.249 -1.389 . . . . 74.21 107.249 -178.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -140.83 157.18 45.76 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.673 -1.232 . . . . 74.35 107.673 178.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.84 146.06 29.2 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.46 -2.052 . . . . 70.15 105.46 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.3 m -140.7 148.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 N-CA-C 106.378 -1.712 . . . . 72.02 106.378 174.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -107.19 122.32 46.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.632 -1.988 . . . . 73.45 105.632 171.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.62 131.61 53.9 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 106.775 -1.565 . . . . 74.15 106.775 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.78 139.07 33.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 104.332 -2.47 . . . . 72.23 104.332 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -67.37 -34.54 77.52 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.354 -1.35 . . . . 74.45 107.354 175.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.7 t30 68.08 113.33 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.785 -0.82 . . . . 74.05 108.785 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.71 31.82 16.45 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.7 -1.222 . . . . 62.13 107.7 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 46.8 3.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 126.33 1.852 . . . . 72.13 114.117 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m -103.41 143.25 32.94 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.667 -1.235 . . . . 72.3 107.667 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.8 -143.75 0.35 Allowed 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.351 -2.833 . . . . 73.43 103.351 172.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.95 47.66 0.04 OUTLIER Glycine 0 CA--C 1.467 -2.954 0 N-CA-C 106.334 -2.706 . . . . 24.42 106.334 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mm -91.22 177.09 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 103.374 -2.825 . . . . 72.33 103.374 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.0 m -133.27 157.68 44.82 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.689 -2.708 . . . . 74.11 103.689 172.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.402 ' HB ' HG13 ' A' ' 36' ' ' ILE . 4.2 m -148.3 171.47 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 106.588 -1.634 . . . . 65.11 106.588 -168.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.6 t -165.25 168.12 17.31 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.25 -2.13 . . . . 65.34 105.25 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -145.19 17.68 Favored Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 107.746 -2.141 . . . . 54.13 107.746 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.9 -85.51 0.42 Allowed Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.417 -1.473 . . . . 71.15 109.417 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.02 17.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.247 0 O-C-N 121.88 -0.777 . . . . 75.01 113.056 -166.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.7 t30 86.24 6.38 0.37 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.251 -1.018 . . . . 73.01 108.251 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -45.71 -168.98 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 126.497 1.919 . . . . 75.33 111.696 159.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 m -33.7 -39.54 0.06 Allowed 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.663 1.585 . . . . 64.31 114.836 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.2 m -77.27 139.96 17.86 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 O-C-N 121.184 -0.948 . . . . 75.1 108.934 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -69.42 -52.29 28.25 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 122.031 -0.418 . . . . 74.5 111.854 -169.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -78.25 5.05 11.15 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.64 -0.663 . . . . 75.33 110.49 -169.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.6 7.36 14.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 111.228 -0.749 . . . . 64.11 111.228 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.28 178.93 50.69 Favored Glycine 0 CA--C 1.473 -2.583 0 N-CA-C 106.09 -2.804 . . . . 74.11 106.09 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.402 HG13 ' HB ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -88.9 136.65 22.9 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.4 0 N-CA-C 104.688 -2.338 . . . . 70.24 104.688 173.835 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -109.81 146.58 34.79 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 102.991 -2.966 . . . . 72.34 102.991 -178.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.75 103.29 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 107.085 -1.45 . . . . 65.44 107.085 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -71.18 -35.15 71.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.271 -1.331 . . . . 75.43 109.758 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.77 153.9 12.96 Favored 'General case' 0 CA--C 1.465 -2.309 0 N-CA-C 105.935 -1.876 . . . . 72.12 105.935 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.37 139.58 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 103.317 -2.845 . . . . 70.02 103.317 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.444 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -75.88 151.8 84.47 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 106.279 -1.748 . . . . 73.15 106.279 174.433 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.7 174.3 13.04 Favored 'Trans proline' 0 CA--C 1.468 -2.807 0 N-CA-C 105.449 -2.558 . . . . 61.42 105.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 49.26 52.01 15.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.74 0.781 . . . . 74.22 110.02 166.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.73 171.27 30.53 Favored Glycine 0 CA--C 1.461 -3.324 0 N-CA-C 103.184 -3.966 . . . . 23.1 103.184 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.92 -53.11 43.53 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 118.182 0.991 . . . . 72.23 108.847 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.6 63.52 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 116.898 -0.137 . . . . 71.33 111.28 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -69.86 -54.19 14.62 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.971 -0.381 . . . . 73.44 109.971 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.7 m -61.45 -30.59 70.69 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.983 -0.448 . . . . 70.11 110.777 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -81.35 -35.5 30.79 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.298 -1.742 . . . . 74.02 106.298 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.48 63.01 Favored Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 109.827 -1.309 . . . . 65.42 109.827 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -93.28 1.28 57.07 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.292 -1.374 . . . . 74.33 107.292 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.8 mt -144.64 139.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.157 -2.905 . . . . 73.03 103.157 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -143.9 162.46 36.06 Favored 'General case' 0 CA--C 1.459 -2.548 0 N-CA-C 106.054 -1.832 . . . . 72.13 106.054 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -67.19 137.58 56.33 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.195 -1.409 . . . . 70.55 107.195 170.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.38 -33.03 6.67 Favored Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 108.151 -1.98 . . . . 74.31 108.151 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.41 155.0 38.68 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.48 -1.674 . . . . 74.53 106.48 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.34 148.33 51.26 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.336 -1.357 . . . . 72.43 107.336 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.92 129.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.831 -1.914 . . . . 75.1 105.831 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.5 mt -93.79 -58.66 2.19 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 106.937 -1.505 . . . . 74.24 106.937 -178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.25 150.63 51.03 Favored 'General case' 0 CA--C 1.475 -1.923 0 N-CA-C 106.455 -1.683 . . . . 72.12 106.455 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.66 122.38 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 104.929 -2.248 . . . . 72.53 104.929 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 56.11 33.43 21.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.976 0.893 . . . . 64.25 108.875 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.41 -21.62 41.73 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 108.143 -1.983 . . . . 70.5 108.143 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.91 118.73 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.132 0 N-CA-C 107.873 -1.158 . . . . 74.02 107.873 -172.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -49.21 116.97 1.9 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.814 -0.81 . . . . 74.43 108.814 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.85 -19.59 17.31 Favored 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 105.936 -1.876 . . . . 74.11 105.936 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.99 124.62 21.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.664 -0.865 . . . . 71.24 108.664 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.63 60.84 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.465 -1.854 . . . . 74.42 108.465 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.55 147.17 39.9 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.195 -1.78 . . . . 74.05 106.195 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.1 p -77.04 178.57 6.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.143 -1.058 . . . . 75.32 108.143 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -68.47 -46.96 68.34 Favored 'General case' 0 C--O 1.204 -1.314 0 N-CA-C 108.665 -0.865 . . . . 73.14 108.665 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.17 -54.39 45.79 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.366 -0.834 . . . . 74.31 110.518 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -57.92 -40.77 81.23 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 110.141 -0.318 . . . . 74.54 110.141 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.95 -52.15 52.26 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 122.604 0.362 . . . . 75.01 110.438 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -73.7 -39.72 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.621 -1.252 . . . . 72.43 107.621 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.0 t -57.14 -35.58 69.67 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 106.423 -1.695 . . . . 64.44 106.423 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.4 m -71.69 -43.82 65.3 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 120.388 -1.445 . . . . 74.21 107.829 -174.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.04 -39.35 94.48 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 109.069 -0.715 . . . . 72.04 109.069 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 82' ' ' THR . 3.0 tmm_? -68.28 -59.76 2.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.868 -1.16 . . . . 74.02 107.868 -177.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.17 53.31 0.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.877 0.846 . . . . 75.25 110.723 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.424 ' H ' ' C ' ' A' ' 80' ' ' ARG . 7.0 p -103.74 -175.97 2.95 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 105.161 -2.162 . . . . 65.45 105.161 169.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.21 -148.85 16.93 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 107.225 -2.35 . . . . 75.23 107.225 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -66.61 -54.99 17.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.55 -0.907 . . . . 74.41 108.55 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.6 t -99.29 144.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.67 -1.604 . . . . 74.35 106.67 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.415 HG12 HG21 ' A' ' 82' ' ' THR . 58.0 t -100.69 129.3 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 105.459 -2.052 . . . . 74.11 105.459 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -113.33 128.26 56.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.723 -2.325 . . . . 64.01 104.723 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.05 138.31 12.58 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.406 -1.331 . . . . 71.02 107.406 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -81.76 139.58 34.75 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.617 -1.253 . . . . 73.02 107.617 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.76 159.05 17.5 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 104.174 -2.528 . . . . 73.14 104.174 175.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.79 131.25 53.96 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 100.542 -3.873 . . . . 74.44 100.542 161.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.43 ' HD2' ' H ' ' A' ' 95' ' ' SER . 1.5 tppp? -70.61 139.97 51.52 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 106.208 -1.775 . . . . 73.45 106.208 -174.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.42 2.15 0.11 Allowed Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 107.737 -2.145 . . . . 75.2 107.737 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -74.15 -54.57 7.49 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.509 -1.663 . . . . 74.31 106.509 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.43 ' H ' ' HD2' ' A' ' 92' ' ' LYS . 6.4 m -60.98 126.2 85.27 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 106.597 -1.631 . . . . 72.24 106.597 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.91 121.77 8.83 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.888 2.392 . . . . 73.14 109.407 -165.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.561 1.401 0 N-CA-C 107.343 -1.354 . . . . 62.44 107.343 176.55 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . 0.496 ' H15' H20A ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.349 0 N-CA-C 107.026 -2.43 . . . . 71.04 107.026 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.38 163.53 38.77 Favored 'Trans proline' 0 CA--C 1.496 -1.406 0 C-N-CA 122.437 2.091 . . . . 62.55 108.695 -170.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -116.28 162.29 27.06 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 104.965 -2.235 . . . . 74.0 104.965 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.4 131.87 43.13 Favored 'Trans proline' 0 CA--C 1.495 -1.47 0 C-N-CA 122.83 2.354 . . . . 72.33 108.928 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.62 -22.07 20.18 Favored Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 108.385 -1.886 . . . . 62.4 108.385 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.99 131.34 42.03 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.237 -1.394 . . . . 65.5 107.237 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.6 mt -94.8 136.31 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 N-CA-C 107.0 -1.482 . . . . 72.45 107.0 -177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 90' ' ' LEU . 1.1 p90 -141.21 154.85 46.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.144 -1.428 . . . . 73.4 107.144 174.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -104.66 148.81 26.14 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 105.574 -2.01 . . . . 73.14 105.574 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 17.1 m -138.17 150.97 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 106.481 -1.674 . . . . 72.21 106.481 173.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -106.58 124.99 50.43 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 104.619 -2.363 . . . . 64.44 104.619 164.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.452 HD13 HD12 ' A' ' 53' ' ' ILE . 50.7 mt -139.46 137.42 35.56 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.599 -1.63 . . . . 64.23 106.599 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.48 161.18 17.15 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 106.416 -1.698 . . . . 74.54 106.416 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -43.68 63.03 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 105.919 -1.882 . . . . 64.21 105.919 168.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 70.13 117.35 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.325 1.05 . . . . 74.4 108.983 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 59.2 37.54 23.82 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-O 121.816 0.817 . . . . 62.11 109.021 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 55.1 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.253 1.821 . . . . 70.5 114.392 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.3 m -93.73 136.54 33.91 Favored 'General case' 0 CA--C 1.483 -1.606 0 O-C-N 120.51 -1.369 . . . . 63.32 108.759 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.544 HD11 ' H ' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.01 -165.01 1.22 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.725 -3.065 . . . . 74.53 102.725 172.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.441 ' H ' HD11 ' A' ' 19' ' ' LEU . . . 163.43 23.6 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.328 0 C-N-CA 117.315 -2.374 . . . . 63.25 110.339 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.544 ' H ' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -87.79 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 104.411 -2.44 . . . . 74.13 104.411 179.21 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 m -138.31 160.3 39.84 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.114 -2.18 . . . . 74.33 105.114 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 169.47 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.629 -0.878 . . . . 74.41 108.629 -163.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.2 t -160.41 165.45 31.08 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 104.805 -2.294 . . . . 70.45 104.805 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.18 -149.72 24.18 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 108.938 -1.665 . . . . 64.03 108.938 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.43 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 113.61 -75.85 0.24 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 109.46 -1.456 . . . . 75.5 109.46 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.39 15.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 O-C-N 122.579 -0.365 . . . . 64.3 110.953 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 26' ' ' GLY . 8.8 t30 83.8 5.15 0.76 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.619 1.168 . . . . 74.54 108.15 177.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.1 p -47.44 -170.11 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.542 1.937 . . . . 72.23 113.623 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 m -40.94 -37.58 0.82 Allowed 'General case' 0 C--N 1.373 1.597 0 C-N-CA 125.969 1.707 . . . . 70.01 113.853 -165.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 132.07 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.537 0.684 . . . . 73.44 110.171 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ptt85 -44.53 -63.63 0.86 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-N 114.79 -1.095 . . . . 74.31 113.397 -168.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -77.78 -19.92 54.22 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 118.708 0.686 . . . . 73.3 109.229 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.42 -12.54 43.47 Favored Glycine 0 C--N 1.361 1.949 0 N-CA-C 109.916 -1.274 . . . . 61.41 109.916 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.17 179.94 49.62 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 109.855 -1.298 . . . . 71.34 109.855 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.428 ' CD1' ' HB3' ' A' ' 75' ' ' ALA . 2.8 mm -86.53 127.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 102.05 -3.315 . . . . 64.51 102.05 170.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -104.9 155.59 18.79 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 105.426 -2.065 . . . . 74.13 105.426 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -83.5 102.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 105.675 -1.972 . . . . 70.41 105.675 174.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.83 -31.28 66.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.497 -1.228 . . . . 74.14 110.163 -172.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.48 149.95 17.45 Favored 'General case' 0 CA--C 1.463 -2.387 0 N-CA-C 105.849 -1.908 . . . . 45.13 105.849 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.0 t -127.4 134.96 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 104.512 -2.403 . . . . 73.21 104.512 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -81.97 151.43 67.1 Favored Pre-proline 0 N--CA 1.445 -0.695 0 N-CA-C 106.669 -1.604 . . . . 72.43 106.669 176.353 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.45 -179.14 5.01 Favored 'Trans proline' 0 CA--C 1.479 -2.274 0 N-CA-C 105.928 -2.374 . . . . 72.25 105.928 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 49.43 52.24 14.86 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.023 0.827 . . . . 74.34 110.641 162.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.59 32.85 Favored Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 103.41 -3.876 . . . . 75.14 103.41 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.36 53.54 Favored 'General case' 0 C--O 1.205 -1.263 0 CA-C-N 117.632 0.716 . . . . 74.25 109.173 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.91 -50.26 64.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.547 -0.297 . . . . 44.1 110.99 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -68.79 -50.15 52.66 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.958 -0.464 . . . . 71.51 110.016 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.7 t -63.81 -33.69 76.25 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.754 -0.461 . . . . 71.32 109.754 -171.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -79.17 -32.0 44.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.074 -1.824 . . . . 70.12 106.074 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.29 60.98 Favored Glycine 0 C--N 1.359 1.818 0 N-CA-C 110.327 -1.109 . . . . 75.21 110.327 170.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -101.87 8.26 41.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.94 -1.133 . . . . 73.23 107.94 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.452 HD12 HD13 ' A' ' 12' ' ' LEU . 55.0 mt -144.27 145.75 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.009 -2.219 . . . . 74.44 105.009 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.504 ' CE1' ' OD1' ' A' ' 57' ' ' ASP . 54.0 p-80 -154.12 159.69 41.58 Favored 'General case' 0 N--CA 1.401 -2.911 0 N-CA-C 102.815 -3.031 . . . . 74.45 102.815 172.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 17.1 ptpt -66.5 147.0 53.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.57 -0.9 . . . . 73.52 108.57 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.54 -33.26 6.7 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 109.975 -1.25 . . . . 65.34 109.975 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 83.0 m-20 -69.75 155.95 39.76 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 105.32 -2.104 . . . . 62.34 105.32 172.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -132.66 157.89 43.69 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.633 -0.877 . . . . 73.14 108.633 -169.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.83 140.82 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 106.723 -1.584 . . . . 74.11 106.723 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.3 mt -101.11 -59.48 1.69 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.36 -1.718 . . . . 73.34 106.36 174.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.13 151.31 49.64 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 106.487 -1.672 . . . . 63.51 106.487 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.78 123.5 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.336 -2.098 . . . . 73.02 105.336 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.4 t30 50.99 35.35 12.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.874 1.27 . . . . 75.55 110.854 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.58 -22.04 38.75 Favored Glycine 0 CA--C 1.473 -2.566 0 N-CA-C 108.856 -1.698 . . . . 73.43 108.856 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.64 115.78 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 N-CA-C 108.095 -1.076 . . . . 74.3 108.095 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.0 m -54.12 112.92 1.06 Allowed 'General case' 0 C--N 1.371 1.537 0 N-CA-C 107.6 -1.259 . . . . 72.2 107.6 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.426 ' CD1' HG13 ' A' ' 36' ' ' ILE . 1.1 tm? -104.44 -11.79 16.87 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 106.882 -1.525 . . . . 75.34 106.882 -162.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -60.16 129.2 40.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.62 -0.881 . . . . 65.22 108.62 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.91 -14.5 65.16 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.64 -1.784 . . . . 74.42 108.64 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.415 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -81.6 150.91 27.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.399 -1.704 . . . . 73.22 106.399 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -83.58 178.84 7.81 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.795 -0.446 . . . . 73.12 109.795 -167.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -56.21 -52.0 66.01 Favored 'General case' 0 C--N 1.382 2.007 0 N-CA-C 107.093 -1.447 . . . . 71.14 107.093 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -58.72 -48.51 80.91 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 116.538 -0.301 . . . . 72.52 110.764 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -56.64 -42.71 79.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.7 -0.4 . . . . 65.4 110.543 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' A' ' 36' ' ' ILE . . . -52.06 -51.4 57.81 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 120.727 -0.389 . . . . 73.04 110.657 177.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.26 -39.98 49.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 C-N-CA 119.932 -0.707 . . . . 75.34 109.831 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.67 -33.25 74.67 Favored 'General case' 0 N--CA 1.521 3.077 0 N-CA-C 106.131 -1.803 . . . . 74.45 106.131 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 m -71.31 -42.93 68.0 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 120.242 -1.536 . . . . 74.2 108.209 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.5 mt -69.49 -35.26 75.39 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.409 -0.589 . . . . 73.42 109.409 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -61.86 1.61 Allowed 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.556 -1.276 . . . . 73.32 107.556 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -73.07 58.46 0.49 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.409 0.623 . . . . 74.34 110.67 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.2 p -102.68 -175.79 2.92 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.323 -1.362 . . . . 70.23 107.323 175.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.01 -154.28 30.35 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 106.224 -2.75 . . . . 64.24 106.224 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.61 -53.98 50.88 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.829 -0.434 . . . . 72.41 109.829 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.0 t -110.57 154.09 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 105.729 -1.952 . . . . 74.2 105.729 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.47 139.04 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.441 0 N-CA-C 105.912 -1.884 . . . . 65.13 105.912 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.87 123.99 49.42 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 104.418 -2.438 . . . . 72.11 104.418 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.8 133.31 11.97 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.052 -1.092 . . . . 72.41 108.052 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -84.86 144.34 28.47 Favored 'General case' 0 CA--C 1.474 -1.98 0 N-CA-C 108.832 -0.803 . . . . 74.41 108.832 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.491 ' HB2' ' CE1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -117.79 162.71 17.65 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 104.711 -2.329 . . . . 65.1 104.711 175.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -124.39 137.38 54.47 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.233 -3.247 . . . . 73.13 102.233 165.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.8 145.75 54.2 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.006 -0.739 . . . . 71.21 109.006 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.94 -150.7 7.4 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 105.427 -3.069 . . . . 75.24 105.427 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 77.94 147.15 0.09 Allowed 'General case' 0 C--N 1.361 1.079 0 C-N-CA 124.343 1.057 . . . . 74.24 108.149 -173.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.3 m -68.15 127.56 93.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 108.173 -1.047 . . . . 64.43 108.173 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.23 151.91 76.37 Favored 'Trans proline' 0 CA--C 1.5 -1.224 0 C-N-CA 122.743 2.295 . . . . 73.23 110.94 -172.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.421 -1.902 0 N-CA-C 105.247 -2.131 . . . . 72.54 105.247 172.906 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.906 0 N-CA-C 108.03 -2.028 . . . . 73.43 108.03 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.49 151.67 84.64 Favored 'Trans proline' 0 CA--C 1.502 -1.104 0 C-N-CA 122.663 2.242 . . . . 72.53 108.207 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -82.58 166.5 35.87 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 106.192 -1.781 . . . . 64.41 106.192 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.98 123.23 11.58 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.444 2.096 . . . . 74.13 107.688 172.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.62 8.59 76.71 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.569 -1.413 . . . . 64.31 109.569 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.86 145.52 26.55 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 106.604 -1.628 . . . . 71.53 106.604 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 12.2 mt -101.53 139.02 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.986 0 N-CA-C 108.083 -1.08 . . . . 75.35 108.083 -175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -144.67 162.27 37.1 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.012 -1.477 . . . . 75.03 107.012 171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.59 150.38 24.02 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.003 -1.851 . . . . 74.34 106.003 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.89 140.27 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.543 0 N-CA-C 105.178 -2.156 . . . . 73.41 105.178 168.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.38 116.4 31.88 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.65 -2.352 . . . . 65.23 104.65 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.1 mt -138.46 138.24 37.94 Favored 'General case' 0 CA--C 1.454 -2.726 0 N-CA-C 107.615 -1.254 . . . . 73.4 107.615 -173.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.1 159.58 17.47 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 105.746 -1.946 . . . . 74.22 105.746 -177.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.85 -50.69 71.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.879 -1.526 . . . . 74.21 106.879 171.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 t30 74.62 119.24 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.446 -1.252 . . . . 72.41 107.954 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 18' ' ' SER . 68.8 m-20 57.16 34.48 24.9 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.734 0.814 . . . . 75.5 109.445 -173.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.1 t30 54.61 -5.11 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.746 1.618 . . . . 54.12 113.679 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 16' ' ' ASP . 61.5 m -95.66 136.99 35.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.894 -0.78 . . . . 73.54 108.894 -171.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -149.95 0.45 Allowed 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 103.008 -2.96 . . . . 64.31 103.008 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.12 76.17 0.86 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 106.542 -2.623 . . . . 73.43 106.542 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.509 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.3 mm -102.02 176.74 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 102.531 -3.137 . . . . 74.44 102.531 176.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.509 ' H ' HG22 ' A' ' 21' ' ' ILE . 7.0 m -106.11 152.71 23.06 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 103.843 -2.651 . . . . 71.22 103.843 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.35 165.0 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.98 -1.119 . . . . 72.33 107.98 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.9 t -160.2 165.96 30.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.683 -2.339 . . . . 74.15 104.683 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.431 ' O ' ' CE1' ' A' ' 72' ' ' HIS . . . 82.7 -141.25 20.94 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 107.292 -2.323 . . . . 73.5 107.292 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.51 -84.11 0.38 Allowed Glycine 0 CA--C 1.471 -2.664 0 N-CA-C 108.437 -1.865 . . . . 61.44 108.437 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.486 HG23 ' HA ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -69.06 8.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.041 0 N-CA-C 112.396 0.517 . . . . 74.3 112.396 -166.79 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 68.66 68.08 0.3 Allowed 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 106.71 -1.589 . . . . 72.14 106.71 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 p -107.04 -164.66 1.0 Allowed 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 101.956 -3.35 . . . . 63.32 101.956 -172.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -44.84 -18.43 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.152 0.981 . . . . 73.15 113.152 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.67 150.85 8.49 Favored 'Isoleucine or valine' 0 C--N 1.38 1.934 0 N-CA-C 106.06 -1.83 . . . . 74.34 106.06 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -78.77 -72.17 0.4 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 120.403 -1.436 . . . . 72.14 110.121 -169.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -69.9 -21.55 63.3 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 120.29 -0.564 . . . . 73.33 110.944 -160.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.27 59.99 1.7 Allowed Glycine 0 CA--C 1.484 -1.897 0 C-N-CA 119.554 -1.307 . . . . 74.15 110.168 164.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.18 179.41 20.73 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 104.643 -3.383 . . . . 72.52 104.643 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 8.1 mm -82.17 127.91 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.428 0 N-CA-C 103.356 -2.831 . . . . 65.31 103.356 169.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -106.1 150.93 25.32 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 105.045 -2.206 . . . . 73.22 105.045 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -83.9 102.03 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.053 -1.832 . . . . 73.54 106.053 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.47 -25.97 63.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.054 -1.43 . . . . 72.12 109.861 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -173.62 161.38 3.95 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 104.642 -2.355 . . . . 71.12 104.642 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -116.88 132.57 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 103.134 -2.913 . . . . 74.4 103.134 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.481 ' H ' HD12 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -82.35 151.0 65.1 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.964 -1.865 . . . . 63.54 105.964 175.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.95 177.47 8.76 Favored 'Trans proline' 0 CA--C 1.482 -2.084 0 N-CA-C 106.587 -2.12 . . . . 74.25 106.587 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 53.96 53.47 11.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.031 0.832 . . . . 73.04 109.157 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.55 166.89 33.43 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 105.447 -3.061 . . . . 71.34 105.447 -176.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.6 -50.74 70.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.508 -0.923 . . . . 71.22 108.508 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.97 66.04 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.857 -0.61 . . . . 75.54 110.688 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -65.85 -53.72 36.12 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.71 -0.478 . . . . 73.21 109.71 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -56.95 -29.12 62.87 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 122.226 -0.296 . . . . 75.11 111.271 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.55 -28.39 20.79 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.867 -1.16 . . . . 74.4 107.867 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.0 19.9 74.16 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.77 -0.932 . . . . 54.41 110.77 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 85.0 mtt-85 -104.55 7.1 35.11 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 117.753 0.777 . . . . 65.51 108.94 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.471 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 1.5 mp -127.56 136.57 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.183 -3.266 . . . . 71.5 102.183 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 53' ' ' ILE . 40.8 m170 -145.34 162.72 36.56 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 106.118 -1.808 . . . . 74.01 106.118 -177.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -66.6 136.78 56.11 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.274 -1.01 . . . . 75.34 108.274 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.31 -29.25 12.31 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 108.338 -1.905 . . . . 64.32 108.338 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.92 155.03 41.0 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 106.91 -1.515 . . . . 72.33 106.91 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -124.76 153.81 41.87 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.216 -1.031 . . . . 74.02 108.216 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -92.59 132.32 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 N-CA-C 105.739 -1.949 . . . . 74.45 105.739 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.5 mt -95.36 -59.41 1.89 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.942 -1.503 . . . . 74.23 106.942 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.69 51.37 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.788 -1.56 . . . . 71.04 106.788 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.52 131.07 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 104.722 -2.325 . . . . 74.33 104.722 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 56.23 29.94 15.74 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 122.009 0.909 . . . . 75.43 109.489 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.39 -9.07 76.89 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.573 -1.811 . . . . 50.1 108.573 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.9 t -87.9 115.6 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 N-CA-C 106.507 -1.664 . . . . 72.11 106.507 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.46 119.82 5.76 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 107.898 -1.149 . . . . 61.13 107.898 172.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.401 HD11 ' HB2' ' A' ' 70' ' ' ALA . 1.1 tm? -108.97 -15.17 14.42 Favored 'General case' 0 C--O 1.2 -1.541 0 N-CA-C 107.262 -1.385 . . . . 72.34 107.262 -163.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.43 122.33 13.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.505 -0.924 . . . . 73.4 108.505 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.78 -16.63 57.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 108.635 -1.786 . . . . 61.45 108.635 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 67' ' ' LEU . . . -80.39 151.45 29.37 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.606 -1.627 . . . . 75.31 106.606 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.486 ' HA ' HG23 ' A' ' 27' ' ' VAL . 68.6 p -79.96 179.78 7.41 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.202 0.525 . . . . 65.12 109.745 -170.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.431 ' CE1' ' O ' ' A' ' 25' ' ' GLY . 14.4 m-70 -59.66 -51.31 70.35 Favored 'General case' 0 C--N 1.371 1.511 0 N-CA-C 107.589 -1.263 . . . . 73.32 107.589 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -55.7 -55.08 36.39 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 109.988 -0.375 . . . . 65.14 109.988 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -53.86 -43.95 69.97 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.775 -0.454 . . . . 74.14 109.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -50.78 -54.49 23.11 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 122.663 0.385 . . . . 65.54 110.369 178.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 m -74.22 -37.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 C-N-CA 120.506 -0.478 . . . . 73.22 109.778 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 82.9 m -62.71 -32.23 73.29 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.305 -1.739 . . . . 73.01 106.305 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -73.62 -40.69 63.6 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.357 -1.464 . . . . 75.33 108.195 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.5 -28.4 69.81 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.242 -0.651 . . . . 74.52 109.242 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . 0.432 ' C ' ' H ' ' A' ' 82' ' ' THR . 0.0 OUTLIER -80.06 -58.04 3.34 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 107.775 -1.194 . . . . 75.42 107.775 176.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -68.58 43.32 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 124.781 1.232 . . . . 63.22 112.212 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.432 ' H ' ' C ' ' A' ' 80' ' ' ARG . 1.4 t -123.82 -174.61 3.02 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 102.942 -2.985 . . . . 72.31 102.942 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.34 -145.16 18.3 Favored Glycine 0 CA--C 1.49 -1.48 0 N-CA-C 107.7 -2.16 . . . . 53.34 107.7 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.78 -55.49 16.93 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.46 -0.941 . . . . 72.24 108.46 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 94.9 t -107.16 142.5 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 106.04 -1.837 . . . . 75.32 106.04 -178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.413 HG23 ' CG2' ' A' ' 82' ' ' THR . 45.8 t -115.08 144.82 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 105.634 -1.987 . . . . 74.53 105.634 -172.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.38 122.1 45.27 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 104.698 -2.334 . . . . 71.33 104.698 168.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.49 118.29 15.12 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.182 -2.155 . . . . 73.23 105.182 177.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.5 mp -83.94 143.62 29.71 Favored 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 106.624 -1.621 . . . . 75.01 106.624 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -112.34 156.23 22.8 Favored 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.96 -2.237 . . . . 73.04 104.96 -179.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -123.54 135.44 54.01 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 101.08 -3.674 . . . . 72.52 101.08 162.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.29 137.11 58.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.618 -1.252 . . . . 73.23 107.618 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.23 172.32 17.23 Favored Glycine 0 CA--C 1.464 -3.125 0 N-CA-C 110.233 -1.147 . . . . 64.52 110.233 -168.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -79.57 137.03 37.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 105.265 -2.124 . . . . 73.25 105.265 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.3 m -55.39 122.23 42.66 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.686 -1.227 . . . . 72.35 107.686 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.22 161.96 40.6 Favored 'Trans proline' 0 CA--C 1.491 -1.657 0 C-N-CA 122.599 2.199 . . . . 75.31 109.237 -165.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.406 -2.673 0 N-CA-C 103.589 -2.745 . . . . 74.41 103.589 172.982 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.983 0 N-CA-C 108.487 -1.845 . . . . 54.11 108.487 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -89.86 143.44 26.79 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.273 -1.751 . . . . 62.34 106.273 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.53 HG23 ' CD1' ' A' ' 60' ' ' LEU . 19.1 mm -95.95 129.51 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 105.524 -2.028 . . . . 73.1 105.524 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.621 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.2 p90 -137.07 152.41 50.03 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.81 -1.181 . . . . 73.35 107.81 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -106.53 146.34 30.74 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.044 -1.836 . . . . 72.54 106.044 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.722 HG22 HD21 ' A' ' 90' ' ' LEU . 30.1 m -142.26 152.66 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 105.958 -1.867 . . . . 50.32 105.958 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.85 132.04 56.04 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.381 -1.711 . . . . 73.32 106.381 172.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.03 139.13 49.9 Favored 'General case' 0 CA--C 1.457 -2.626 0 N-CA-C 106.833 -1.543 . . . . 43.23 106.833 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.49 131.36 38.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.927 -1.879 . . . . 73.01 105.927 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -67.28 -23.91 65.72 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.637 -0.875 . . . . 71.01 108.637 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 70.71 104.86 0.06 Allowed 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.171 0.988 . . . . 55.43 110.394 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 56.85 43.47 24.87 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-N 115.448 -0.796 . . . . 72.11 109.203 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 42.64 9.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.708 2.003 . . . . 73.23 116.031 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.1 m -126.88 129.78 48.89 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 106.437 -1.69 . . . . 52.01 106.437 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.3 167.34 12.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.836 -2.283 . . . . 55.14 104.836 168.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.56 68.62 0.27 Allowed Glycine 0 CA--C 1.47 -2.746 0 N-CA-C 104.507 -3.437 . . . . 72.22 104.507 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.4 mt -101.15 176.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.458 -2.793 . . . . 73.32 103.458 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.513 ' H ' HG22 ' A' ' 21' ' ' ILE . 70.9 m -138.28 165.07 27.65 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 106.402 -1.703 . . . . 73.13 106.402 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 m -152.33 177.15 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.085 -1.82 . . . . 43.24 106.085 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.471 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 10.0 t -160.95 166.21 28.71 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 104.0 -2.593 . . . . 62.15 104.0 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.97 -151.74 29.12 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.927 -1.669 . . . . 50.5 108.927 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.444 ' CA ' HD12 ' A' ' 36' ' ' ILE . . . 116.62 -70.64 0.28 Allowed Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.692 -1.363 . . . . 44.34 109.692 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 71' ' ' THR . 1.4 t -72.32 16.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.097 0.475 . . . . 61.33 111.252 -172.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 26' ' ' GLY . 35.7 t30 78.41 5.14 2.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.597 1.159 . . . . 73.41 108.743 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.3 t -49.77 -171.36 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 C-N-CA 125.337 1.455 . . . . 62.33 112.037 169.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.4 p -38.56 -38.22 0.37 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.63 1.972 . . . . 73.41 115.164 -164.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.7 m -59.71 140.77 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.544 0.688 . . . . 74.1 110.215 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -41.62 -70.28 0.11 Allowed 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.029 1.332 . . . . 74.11 112.824 -170.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -87.97 15.74 6.87 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.632 -0.877 . . . . 62.4 108.632 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.43 -7.98 2.42 Favored Glycine 0 C--N 1.359 1.842 0 O-C-N 121.792 -0.567 . . . . 71.41 113.149 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.11 -178.64 49.44 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.656 -1.378 . . . . 64.31 109.656 -170.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.444 HD12 ' CA ' ' A' ' 26' ' ' GLY . 1.1 mp -76.96 128.3 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 N-CA-C 101.922 -3.362 . . . . 42.13 101.922 170.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -107.08 147.56 29.85 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 104.089 -2.56 . . . . 72.25 104.089 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.47 102.22 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.724 -1.584 . . . . 60.3 106.724 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -72.82 -37.59 67.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.831 -1.531 . . . . 64.3 110.441 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.21 142.34 18.21 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 105.952 -1.87 . . . . 61.42 105.952 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -117.16 131.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 102.96 -2.978 . . . . 75.12 102.96 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.27 144.58 84.56 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 106.482 -1.673 . . . . 70.22 106.482 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.43 169.55 22.17 Favored 'Trans proline' 0 CA--C 1.462 -3.088 0 N-CA-C 105.07 -2.704 . . . . 62.52 105.07 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 66.51 -3.94 0.79 Allowed 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 124.04 0.837 . . . . 73.13 111.317 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.48 -179.2 40.97 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 108.122 -1.991 . . . . 71.42 108.122 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -51.74 63.09 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.118 -1.068 . . . . 72.32 108.118 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.97 65.18 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.277 -0.42 . . . . 50.54 110.882 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.61 -55.87 15.29 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.174 -0.328 . . . . 71.52 110.285 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.5 m -65.02 -31.24 72.37 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 122.056 -0.402 . . . . 64.14 111.256 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -81.3 -32.59 33.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.494 -1.669 . . . . 72.51 106.494 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.44 18.04 69.72 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 110.552 -1.019 . . . . 71.25 110.552 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -86.48 2.46 47.8 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.854 -1.165 . . . . 60.12 107.854 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -147.42 147.46 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 104.449 -2.426 . . . . 72.34 104.449 -168.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.97 167.11 30.87 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 104.186 -2.524 . . . . 74.32 104.186 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -66.3 145.41 55.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.121 -1.066 . . . . 55.4 108.121 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.7 -33.08 6.86 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 108.988 -1.645 . . . . 74.12 108.988 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.38 161.38 31.15 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 108.004 -1.11 . . . . 74.43 108.004 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.07 150.66 48.0 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 107.997 -1.112 . . . . 74.42 107.997 -172.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.01 139.24 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 105.705 -1.961 . . . . 61.12 105.705 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.53 ' CD1' HG23 ' A' ' 7' ' ' ILE . 16.3 mt -102.18 -59.49 1.69 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.992 -1.484 . . . . 74.44 106.992 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.55 150.4 50.74 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.199 -1.778 . . . . 61.54 106.199 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.44 120.33 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 105.015 -2.217 . . . . 75.11 105.015 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.4 t30 51.79 36.0 16.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.027 0.931 . . . . 75.44 109.979 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.34 -29.41 12.56 Favored Glycine 0 CA--C 1.474 -2.509 0 N-CA-C 108.134 -1.987 . . . . 44.14 108.134 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.69 115.32 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 108.383 -0.969 . . . . 72.23 108.383 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.9 m -55.4 115.54 2.35 Favored 'General case' 0 C--N 1.37 1.486 0 N-CA-C 107.193 -1.41 . . . . 43.3 107.193 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -101.33 -15.29 17.29 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 106.427 -1.694 . . . . 71.41 106.427 -165.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.09 128.77 37.37 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.498 -0.927 . . . . 75.22 108.498 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.98 57.78 Favored Glycine 0 CA--C 1.498 -0.977 0 N-CA-C 107.815 -2.114 . . . . 54.11 107.815 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.88 152.2 28.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.554 -2.017 . . . . 75.43 105.554 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.422 HG22 HG22 ' A' ' 27' ' ' VAL . 31.1 p -79.16 176.32 9.78 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.094 -0.706 . . . . 73.41 109.094 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -70.34 -41.14 73.58 Favored 'General case' 0 C--O 1.21 -1.002 0 N-CA-C 108.726 -0.842 . . . . 75.43 108.726 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.67 -54.41 47.34 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.075 -1.015 . . . . 73.12 110.644 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -55.85 -34.96 65.91 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.441 -0.787 . . . . 64.51 111.294 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.41 ' CB ' HG12 ' A' ' 36' ' ' ILE . . . -50.72 -52.33 41.33 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.579 0.228 . . . . 73.02 111.282 176.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -74.95 -35.03 34.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 N-CA-C 108.276 -1.009 . . . . 74.5 108.276 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.41 -39.76 73.56 Favored 'General case' 0 N--CA 1.518 2.973 0 N-CA-C 105.775 -1.935 . . . . 72.03 105.775 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.2 m -69.3 -40.15 77.86 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.294 -1.503 . . . . 75.23 108.125 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.6 mt -64.71 -30.11 71.11 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.788 -0.449 . . . . 73.32 109.788 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -72.15 -57.67 4.06 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.529 -0.915 . . . . 74.35 108.529 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -69.14 48.11 0.07 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 122.918 0.487 . . . . 72.51 111.978 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.417 HG21 HG13 ' A' ' 86' ' ' VAL . 23.3 p -108.05 -175.58 2.82 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.21 -1.774 . . . . 72.34 106.21 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.06 -153.6 30.33 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 106.471 -2.652 . . . . 65.33 106.471 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.95 -54.86 20.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.75 -0.833 . . . . 73.13 108.75 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.9 t -95.07 142.74 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.335 -2.098 . . . . 75.44 105.335 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.417 HG13 HG21 ' A' ' 82' ' ' THR . 48.1 t -102.56 128.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 105.123 -2.177 . . . . 62.05 105.123 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -107.29 125.62 51.39 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 103.527 -2.768 . . . . 72.31 103.527 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.22 136.36 11.85 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.169 -1.048 . . . . 72.31 108.169 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.4 ' HB3' HD12 ' A' ' 60' ' ' LEU . 5.7 mp -86.43 143.05 27.98 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 108.283 -1.006 . . . . 74.11 108.283 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.722 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -120.32 165.42 14.89 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 104.878 -2.267 . . . . 72.5 104.878 177.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.48 145.79 51.44 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 102.608 -3.108 . . . . 72.24 102.608 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -64.82 131.11 45.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.839 -1.171 . . . . 72.43 107.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.196 0 N-CA-C 106.892 -2.483 . . . . 72.35 106.892 -174.258 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.034 0 N-CA-C 108.511 -1.836 . . . . 71.24 108.511 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.66 135.07 40.44 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.817 -1.549 . . . . 62.33 106.817 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 60' ' ' LEU . 22.4 mm -98.8 130.07 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 106.1 -1.815 . . . . 74.33 106.1 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.612 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -141.91 153.77 44.62 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.054 -1.091 . . . . 71.33 108.054 -177.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -107.81 144.09 35.46 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 105.07 -2.196 . . . . 65.02 105.07 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.698 HG22 HD21 ' A' ' 90' ' ' LEU . 27.6 m -141.6 153.71 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 107.068 -1.456 . . . . 64.24 107.068 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HB2' HG11 ' A' ' 85' ' ' VAL . 7.4 pt-20 -112.08 130.71 55.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.892 -1.892 . . . . 64.24 105.892 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.17 134.1 39.79 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.865 -1.532 . . . . 75.22 106.865 -176.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 141.81 30.0 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 105.379 -2.082 . . . . 72.42 105.379 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HG2' HD23 ' A' ' 19' ' ' LEU . 42.3 mtpt -75.41 -31.83 60.53 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.178 -1.045 . . . . 73.4 108.178 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 68.4 110.59 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.122 -0.696 . . . . 74.31 109.122 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t70 58.3 32.15 21.72 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 107.992 -1.114 . . . . 73.33 107.992 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 43.13 19.04 0.01 OUTLIER 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.722 1.609 . . . . 62.31 113.324 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -90.56 119.36 30.75 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 106.215 -1.772 . . . . 65.53 106.215 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' H ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -111.6 -143.64 0.39 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 102.911 -2.996 . . . . 63.13 102.911 179.068 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.742 ' H ' HD13 ' A' ' 19' ' ' LEU . . . 103.36 66.25 0.73 Allowed Glycine 0 CA--C 1.474 -2.482 0 N-CA-C 106.855 -2.498 . . . . 74.24 106.855 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.6 mm -89.43 177.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 102.447 -3.168 . . . . 55.31 102.447 170.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.6 m -122.5 154.49 37.78 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.037 -2.579 . . . . 61.43 104.037 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.464 ' HA ' ' H ' ' A' ' 39' ' ' LYS . 30.9 m -149.25 176.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.424 -1.324 . . . . 61.3 107.424 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.15 -2.167 . . . . 71.31 105.15 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.53 -158.75 25.54 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 108.454 -1.858 . . . . 45.13 108.454 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.29 -95.06 0.3 Allowed Glycine 0 C--N 1.36 1.863 0 N-CA-C 109.08 -1.608 . . . . 63.44 109.08 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -68.31 17.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.433 1.093 . . . . 63.43 113.782 -165.461 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 85.79 6.04 0.43 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 124.437 1.095 . . . . 74.52 108.499 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.0 p -42.39 -169.44 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 127.044 2.138 . . . . 71.03 112.431 161.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -40.86 -33.1 0.27 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.126 1.37 . . . . 44.01 113.485 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 m -62.08 129.48 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 122.465 1.126 . . . . 73.43 110.318 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -51.17 -65.07 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.041 -1.436 . . . . 74.01 111.48 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -84.48 16.66 3.01 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.573 -0.704 . . . . 72.31 110.646 -171.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 47.36 65.51 2.3 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 111.372 -0.691 . . . . 62.03 111.372 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.83 -179.15 31.57 Favored Glycine 0 CA--C 1.457 -3.574 0 N-CA-C 103.98 -3.648 . . . . 73.31 103.98 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 131.72 35.44 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 N-CA-C 104.988 -2.227 . . . . 60.12 104.988 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.26 151.81 25.46 Favored 'General case' 0 CA--C 1.46 -2.503 0 N-CA-C 103.621 -2.733 . . . . 74.51 103.621 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.29 102.49 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 106.233 -1.766 . . . . 55.33 106.233 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' H ' ' HA ' ' A' ' 23' ' ' VAL . 46.9 tttp -71.82 -32.86 68.01 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.088 -0.96 . . . . 75.32 109.359 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.06 149.64 16.18 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 105.401 -2.074 . . . . 61.51 105.401 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.29 130.3 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 102.805 -3.035 . . . . 74.44 102.805 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.427 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 143.36 65.7 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 105.541 -2.022 . . . . 72.1 105.541 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 45' ' ' GLY . 97.8 Cg_endo -75.59 173.58 14.26 Favored 'Trans proline' 0 CA--C 1.464 -2.984 0 N-CA-C 106.428 -2.181 . . . . 62.04 106.428 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 71.22 -12.1 0.63 Allowed 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.364 1.04 . . . . 72.53 111.674 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -90.11 -179.71 44.15 Favored Glycine 0 CA--C 1.476 -2.388 0 N-CA-C 107.439 -2.264 . . . . 75.02 107.439 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.06 -52.79 45.74 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.675 -0.861 . . . . 70.13 108.675 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -49.27 66.8 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 116.217 -0.447 . . . . 55.11 110.281 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.16 -55.66 29.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.59 -0.522 . . . . 65.51 109.59 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -64.85 -32.66 74.46 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.557 -0.292 . . . . 74.01 111.595 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -81.61 -25.22 35.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.236 -1.764 . . . . 55.05 106.236 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 19.4 77.42 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 110.518 -1.033 . . . . 72.55 110.518 167.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' HG11 ' A' ' 10' ' ' VAL . 6.6 mmp_? -94.44 6.46 48.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.891 -1.151 . . . . 73.54 107.891 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.5 mt -144.02 138.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 103.804 -2.665 . . . . 74.01 103.804 -169.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -149.94 159.96 43.98 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 105.196 -2.15 . . . . 61.41 105.196 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -67.22 144.14 56.14 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.171 -1.048 . . . . 75.31 108.171 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.22 -32.66 7.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 108.081 -2.008 . . . . 73.01 108.081 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.65 155.16 30.67 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.128 -1.064 . . . . 33.32 108.128 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -116.27 141.54 48.02 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.783 -1.562 . . . . 54.41 106.783 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.55 126.07 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.138 -2.171 . . . . 73.14 105.138 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.539 HD11 HD12 ' A' ' 7' ' ' ILE . 75.2 mt -91.17 -59.12 2.24 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 107.668 -1.234 . . . . 72.04 107.668 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.89 149.81 49.12 Favored 'General case' 0 CA--C 1.472 -2.046 0 N-CA-C 106.51 -1.663 . . . . 63.41 106.51 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.4 110.88 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.629 -1.989 . . . . 65.24 105.629 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.82 44.82 25.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.173 1.389 . . . . 63.13 110.622 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.22 -31.85 8.25 Favored Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 108.186 -1.966 . . . . 65.34 108.186 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -81.56 116.79 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 107.56 -1.274 . . . . 65.22 107.56 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 t -55.32 126.64 25.83 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 108.281 -1.007 . . . . 61.13 108.281 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -97.23 -13.43 22.04 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.099 -1.815 . . . . 74.42 106.099 -171.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.1 127.62 32.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.787 -0.819 . . . . 63.25 108.787 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.54 66.21 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.817 -1.713 . . . . 74.4 108.817 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.65 148.06 39.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.067 -1.457 . . . . 64.21 107.067 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 27' ' ' VAL . 50.5 p -82.82 -179.93 7.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.824 -1.176 . . . . 44.21 107.824 -174.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -60.97 -51.39 69.47 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.213 -1.032 . . . . 64.33 108.213 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -52.95 -56.29 17.07 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 110.096 -0.335 . . . . 75.34 110.096 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.02 -47.63 77.45 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.509 -0.552 . . . . 74.33 109.509 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.42 -56.93 10.57 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.051 0.54 . . . . 70.42 111.242 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.24 -35.83 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 109.066 -0.716 . . . . 72.43 109.066 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.36 -32.54 74.24 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.338 -1.727 . . . . 74.4 106.338 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -74.22 -38.82 63.43 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.413 -1.429 . . . . 71.34 108.087 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.52 -48.67 74.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.61 -0.885 . . . . 62.41 108.61 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -55.88 13.58 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.582 -0.896 . . . . 30.12 108.582 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.24 60.95 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.97 0.891 . . . . 53.02 111.194 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 p -112.53 -176.11 2.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.54 -1.652 . . . . 70.43 106.54 171.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.59 -141.02 7.57 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 106.647 -2.581 . . . . 65.12 106.647 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 -55.13 12.89 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.785 -0.82 . . . . 74.34 108.785 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' ' 11' ' ' GLU . 73.6 t -99.32 144.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.775 -1.194 . . . . 55.32 107.775 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.9 t -97.62 125.57 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 105.731 -1.952 . . . . 73.41 105.731 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -97.67 117.8 32.78 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.931 -2.248 . . . . 63.1 104.931 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.12 130.32 11.2 Favored 'General case' 0 CA--C 1.482 -1.637 0 C-N-CA 119.281 -0.968 . . . . 65.5 108.474 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.06 143.51 30.54 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.354 -0.98 . . . . 42.43 108.354 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.698 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -116.08 158.92 22.43 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.438 -1.69 . . . . 75.14 106.438 178.43 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -126.72 131.51 51.35 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 102.47 -3.159 . . . . 52.01 102.47 169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -67.9 136.82 54.62 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 107.921 -1.14 . . . . 54.22 107.921 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.603 0 C-N-CA 119.9 -1.143 . . . . 72.5 110.725 -168.364 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.329 0 N-CA-C 109.73 -1.348 . . . . 75.51 109.73 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.09 146.96 23.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.472 -1.677 . . . . 73.13 106.472 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.622 HD12 HD11 ' A' ' 60' ' ' LEU . 11.4 mm -96.94 129.11 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 106.515 -1.661 . . . . 75.23 106.515 -173.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.59 ' CD2' HD23 ' A' ' 90' ' ' LEU . 6.2 p90 -131.87 148.36 52.54 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 106.655 -1.609 . . . . 74.25 106.655 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.22 148.64 29.67 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 106.454 -1.684 . . . . 71.24 106.454 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.708 HG22 HD21 ' A' ' 90' ' ' LEU . 26.8 m -140.21 150.79 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.392 -1.707 . . . . 62.14 106.392 173.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -120.48 138.92 53.56 Favored 'General case' 0 CA--C 1.465 -2.315 0 N-CA-C 104.533 -2.395 . . . . 72.33 104.533 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.08 144.83 28.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.423 -1.325 . . . . 73.34 107.423 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.34 123.65 29.28 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 105.883 -1.895 . . . . 73.31 105.883 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -71.33 -22.52 61.91 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.023 -0.732 . . . . 60.33 109.023 -173.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 t30 73.61 109.19 0.07 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.706 0.802 . . . . 73.24 109.767 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.33 53.02 12.54 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.364 1.065 . . . . 63.12 110.685 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 53.31 -8.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.811 1.782 . . . . 71.44 115.811 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.6 m -131.39 130.22 42.32 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.379 -1.341 . . . . 75.21 107.379 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.5 179.84 3.84 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 104.242 -2.503 . . . . 72.31 104.242 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.02 53.57 0.46 Allowed Glycine 0 CA--C 1.475 -2.456 0 N-CA-C 106.644 -2.582 . . . . 34.54 106.644 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.9 mt -87.85 176.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 104.573 -2.381 . . . . 63.04 104.573 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.506 ' H ' HG22 ' A' ' 21' ' ' ILE . 77.1 m -141.78 167.28 22.52 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 106.312 -1.736 . . . . 42.31 106.312 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.487 ' HB ' HG23 ' A' ' 36' ' ' ILE . 6.2 m -148.79 172.92 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.073 -1.454 . . . . 42.05 107.073 -167.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.8 t -154.37 160.8 41.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 103.902 -2.629 . . . . 72.05 103.902 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 31' ' ' VAL . . . 90.19 -164.95 31.22 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 108.02 -2.032 . . . . 53.4 108.02 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 133.61 -88.69 0.26 Allowed Glycine 0 CA--C 1.479 -2.203 0 N-CA-C 108.418 -1.873 . . . . 61.03 108.418 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.481 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -72.63 16.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.028 0 C-N-CA 122.551 0.341 . . . . 41.32 111.446 -171.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 26' ' ' GLY . 7.1 t30 85.39 5.99 0.48 Allowed 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.483 1.113 . . . . 71.43 108.784 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -45.41 -171.05 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 126.279 1.832 . . . . 63.11 112.987 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 p -40.45 -40.71 1.26 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 127.272 2.229 . . . . 73.15 114.002 -164.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG21 ' HA3' ' A' ' 25' ' ' GLY . 27.6 m -56.46 135.82 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.64 0.733 . . . . 64.41 110.286 -173.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -39.69 -66.96 0.25 Allowed 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.017 1.327 . . . . 64.21 113.475 -171.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -77.72 -13.34 59.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.322 -0.951 . . . . 54.34 109.866 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.95 -14.62 64.77 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.361 -1.496 . . . . 53.35 109.361 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.78 -179.87 53.17 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.172 -1.571 . . . . 61.21 109.172 -173.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 HG23 ' HB ' ' A' ' 23' ' ' VAL . 19.3 mm -86.32 117.87 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 103.929 -2.619 . . . . 72.3 103.929 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.83 154.5 19.53 Favored 'General case' 0 CA--C 1.463 -2.399 0 N-CA-C 105.275 -2.12 . . . . 64.45 105.275 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.44 102.45 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 N-CA-C 106.206 -1.775 . . . . 74.01 106.206 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -71.16 -41.63 70.15 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 113.966 -1.47 . . . . 72.5 109.735 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.97 143.8 17.18 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 105.418 -2.067 . . . . 74.12 105.418 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.8 133.53 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.655 -2.72 . . . . 74.13 103.655 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.35 148.78 78.0 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 106.163 -1.791 . . . . 71.12 106.163 175.086 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.87 169.24 23.05 Favored 'Trans proline' 0 CA--C 1.458 -3.301 0 N-CA-C 105.438 -2.562 . . . . 52.45 105.438 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 65.04 -1.36 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.877 0.736 . . . . 75.33 111.942 166.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.75 171.59 43.34 Favored Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 106.702 -2.559 . . . . 72.04 106.702 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.95 67.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.405 -0.961 . . . . 63.13 108.405 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB1' ' HB ' ' A' ' 53' ' ' ILE . . . -53.78 -50.82 65.25 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.283 -0.872 . . . . 63.45 110.717 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -63.24 -56.27 17.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 120.872 0.368 . . . . 43.44 110.112 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -34.88 71.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.207 0.603 . . . . 71.2 110.982 -172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.446 ' CG ' ' HE ' ' A' ' 52' ' ' ARG . 6.3 t70 -83.2 -34.52 25.9 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.698 -1.593 . . . . 54.24 106.698 -174.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.81 16.25 61.82 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 110.638 -0.985 . . . . 63.35 110.638 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.446 ' HE ' ' CG ' ' A' ' 50' ' ' ASP . 67.3 mtt180 -91.89 6.09 47.51 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 118.361 1.08 . . . . 74.43 108.201 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.434 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 2.9 mp -147.71 148.41 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.227 -2.509 . . . . 72.44 104.227 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -158.6 171.8 19.45 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 104.541 -2.392 . . . . 74.1 104.541 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -67.05 146.46 54.29 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.556 -0.905 . . . . 71.34 108.556 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.77 -32.95 6.98 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 109.263 -1.535 . . . . 74.21 109.263 169.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.43 158.52 34.82 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.662 -1.236 . . . . 53.11 107.662 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.459 HH22 ' CD ' ' A' ' 91' ' ' GLU . 24.6 ttp85 -123.88 143.79 50.15 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.741 -1.207 . . . . 61.04 107.741 -165.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.0 t -95.21 139.36 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.929 -1.878 . . . . 74.42 105.929 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.622 HD11 HD12 ' A' ' 7' ' ' ILE . 46.2 mt -102.01 -58.88 1.8 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.314 -1.365 . . . . 72.13 107.314 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.73 151.52 48.28 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.115 -1.809 . . . . 54.1 106.115 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.38 127.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.616 -2.365 . . . . 71.23 104.616 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.0 t30 59.04 31.28 21.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.91 0.862 . . . . 73.1 109.371 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.77 -8.14 73.96 Favored Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 109.156 -1.578 . . . . 43.43 109.156 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.77 118.52 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.572 0 N-CA-C 106.493 -1.669 . . . . 72.23 106.493 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 t -55.99 118.63 4.82 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.729 -1.211 . . . . 63.2 107.729 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD12 HG13 ' A' ' 36' ' ' ILE . 1.2 tm? -104.87 -13.47 15.81 Favored 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 106.552 -1.648 . . . . 70.34 106.552 -167.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.55 127.41 31.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.501 -0.749 . . . . 71.11 109.054 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.83 61.99 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.315 -1.914 . . . . 51.44 108.315 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.39 154.81 25.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.158 -1.793 . . . . 63.42 106.158 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.481 HG22 HG22 ' A' ' 27' ' ' VAL . 22.8 p -81.29 176.83 9.41 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.781 0.801 . . . . 75.43 110.393 -168.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -58.48 -50.79 72.46 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.815 1.246 . . . . 74.0 107.906 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -55.13 -54.48 42.68 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 122.063 -0.398 . . . . 75.12 110.759 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -53.93 -41.34 67.62 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.864 -0.421 . . . . 74.21 109.864 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.33 -54.27 27.94 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 122.798 0.439 . . . . 73.43 110.33 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.62 -38.5 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 109.302 -0.629 . . . . 63.3 109.302 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.6 -32.74 72.87 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 105.801 -1.926 . . . . 73.41 105.801 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -70.69 -46.46 63.1 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.175 -1.578 . . . . 65.13 108.05 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.36 -30.3 69.47 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 109.388 -0.597 . . . . 72.23 109.388 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -59.9 2.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.139 -1.43 . . . . 55.52 107.139 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -48.73 -20.59 0.49 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 126.163 1.785 . . . . 72.21 114.019 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -74.13 171.84 12.83 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.35 -0.844 . . . . 74.32 109.422 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.23 -148.69 5.4 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.1 -1.2 . . . . 74.24 110.1 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -70.82 -55.93 7.43 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.839 -0.8 . . . . 62.44 108.839 -170.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.06 142.58 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.727 0 N-CA-C 104.428 -2.434 . . . . 73.34 104.428 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.65 134.9 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 104.987 -2.227 . . . . 61.32 104.987 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -103.46 121.32 42.59 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.085 -2.561 . . . . 65.41 104.085 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 125.91 14.4 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 107.914 -1.143 . . . . 61.33 107.914 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.432 ' HB3' HD12 ' A' ' 60' ' ' LEU . 4.3 mp -81.9 144.39 31.0 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 107.999 -1.111 . . . . 63.05 107.999 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.708 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.28 162.18 18.31 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.105 -2.183 . . . . 55.21 105.105 174.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HG3' HD13 ' A' ' 7' ' ' ILE . 41.5 tt0 -129.01 144.58 51.23 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 102.254 -3.239 . . . . 75.0 102.254 163.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.88 140.78 51.2 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.721 0.772 . . . . 73.04 110.389 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.83 0 N-CA-C 104.132 -3.587 . . . . 53.53 104.132 174.51 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.033 0 N-CA-C 108.819 -1.712 . . . . 43.52 108.819 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.66 139.9 38.45 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 106.691 -1.596 . . . . 74.54 106.691 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.408 HG12 HD11 ' A' ' 60' ' ' LEU . 54.0 mt -99.42 130.25 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 106.718 -1.586 . . . . 72.01 106.718 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.1 p90 -137.5 154.23 49.9 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 108.005 -1.109 . . . . 62.34 108.005 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.66 143.56 33.65 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.232 -1.766 . . . . 71.24 106.232 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.634 HG22 HD21 ' A' ' 90' ' ' LEU . 29.1 m -142.54 151.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.511 -1.663 . . . . 53.45 106.511 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.82 129.21 56.52 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 106.213 -1.773 . . . . 63.44 106.213 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.51 140.21 50.5 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 108.493 -0.928 . . . . 75.52 108.493 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.04 137.76 32.02 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 105.818 -1.919 . . . . 64.32 105.818 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.43 -25.76 59.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.613 -0.884 . . . . 72.35 108.613 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 67.87 111.28 0.04 OUTLIER 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.184 -0.673 . . . . 62.31 109.184 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.12 40.29 30.2 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.35 -0.982 . . . . 73.31 108.35 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 t30 43.22 12.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.223 2.209 . . . . 63.24 114.649 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -97.11 129.17 44.55 Favored 'General case' 0 CA--C 1.494 -1.195 0 O-C-N 120.517 -1.364 . . . . 61.52 107.328 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 tp -124.78 142.51 51.37 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 102.738 -3.06 . . . . 75.31 102.738 173.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.51 64.34 0.27 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 106.406 -2.678 . . . . 51.23 106.406 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.0 mm -87.89 177.35 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 104.929 -2.248 . . . . 74.13 104.929 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.516 ' H ' HG22 ' A' ' 21' ' ' ILE . 16.8 m -124.78 156.85 37.08 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 103.662 -2.718 . . . . 74.13 103.662 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.7 m -150.53 171.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 108.092 -1.077 . . . . 72.11 108.092 -166.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -161.99 164.75 28.17 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.498 -2.408 . . . . 71.24 104.498 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.62 -160.84 22.76 Favored Glycine 0 CA--C 1.486 -1.774 0 N-CA-C 107.052 -2.419 . . . . 73.12 107.052 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.72 -104.84 0.56 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 108.89 -1.684 . . . . 70.11 108.89 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.82 16.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 113.374 0.879 . . . . 74.32 113.374 -164.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 86.64 12.96 0.14 Allowed 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.804 1.242 . . . . 73.42 108.877 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 p -46.15 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 124.334 1.054 . . . . 74.43 110.859 155.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.7 m -29.46 -44.02 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.487 1.662 . . . . 71.44 115.487 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 37' ' ' TYR . 30.0 m -76.12 140.22 17.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.22 -0.925 . . . . 53.15 108.517 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -68.31 -47.58 67.21 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.148 -0.97 . . . . 74.04 111.138 -171.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.424 ' HE1' ' CD ' ' A' ' 68' ' ' GLU . 8.3 t-80 -73.23 0.66 11.2 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.189 -0.319 . . . . 73.45 110.248 -166.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.97 61.21 7.11 Favored Glycine 0 C--N 1.362 1.991 0 N-CA-C 109.495 -1.442 . . . . 72.04 109.495 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.4 28.19 Favored Glycine 0 CA--C 1.454 -3.759 0 N-CA-C 103.721 -3.752 . . . . 42.23 103.721 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 72' ' ' HIS . 0.7 OUTLIER -90.61 131.17 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.707 0 N-CA-C 104.25 -2.5 . . . . 75.2 104.25 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.466 ' CZ ' ' HB ' ' A' ' 31' ' ' VAL . 3.7 m-30 -108.55 151.67 25.79 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 102.899 -3.0 . . . . 75.21 102.899 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.52 102.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 107.103 -1.443 . . . . 71.02 107.103 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -71.6 -36.61 70.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.196 -1.366 . . . . 74.42 110.113 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.71 152.7 14.08 Favored 'General case' 0 CA--C 1.466 -2.278 0 N-CA-C 105.464 -2.05 . . . . 70.03 105.464 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.71 136.16 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 104.308 -2.479 . . . . 62.41 104.308 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.24 145.22 79.83 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 106.259 -1.756 . . . . 74.22 106.259 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.83 168.38 24.36 Favored 'Trans proline' 0 CA--C 1.462 -3.09 0 N-CA-C 105.786 -2.428 . . . . 73.11 105.786 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 63.41 1.54 1.0 Allowed 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 123.665 0.603 . . . . 71.34 111.732 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.6 -178.22 41.11 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 106.667 -2.573 . . . . 65.34 106.667 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.67 -52.99 31.43 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 108.151 -1.055 . . . . 63.44 108.151 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.07 65.86 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.066 -0.516 . . . . 65.44 110.879 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -62.39 -56.11 21.44 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.56 -0.533 . . . . 74.53 109.56 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.7 m -62.79 -30.49 71.5 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.683 0.278 . . . . 61.12 111.232 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -77.21 -35.8 55.3 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.773 -1.566 . . . . 62.32 106.773 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.38 12.59 72.69 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.109 -1.596 . . . . 74.05 109.109 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB2' HD12 ' A' ' 53' ' ' ILE . 23.8 mmt180 -90.19 -1.93 57.99 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.275 -1.38 . . . . 73.1 107.275 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 52' ' ' ARG . 2.1 mp -142.77 145.26 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 102.857 -3.016 . . . . 72.22 102.857 -176.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -156.79 173.03 17.58 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.699 -2.704 . . . . 72.2 103.699 170.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -66.35 145.62 55.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-O 121.391 0.615 . . . . 74.02 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -33.03 6.86 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.764 -1.734 . . . . 45.32 108.764 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -67.55 157.01 35.36 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.981 -0.748 . . . . 75.01 108.981 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -117.0 142.84 46.43 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.3 -1.37 . . . . 74.34 107.3 -166.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -93.01 126.71 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 105.761 -1.94 . . . . 74.22 105.761 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.408 HD11 HG12 ' A' ' 7' ' ' ILE . 19.9 mt -94.47 -58.64 2.14 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 107.417 -1.327 . . . . 60.24 107.417 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.36 147.62 47.45 Favored 'General case' 0 CA--C 1.471 -2.079 0 N-CA-C 106.379 -1.712 . . . . 72.01 106.379 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.43 119.12 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 104.897 -2.26 . . . . 71.33 104.897 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.3 t30 52.28 38.06 23.81 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.046 0.938 . . . . 64.42 110.618 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.7 -18.38 57.29 Favored Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 108.784 -1.726 . . . . 53.52 108.784 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.3 117.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.888 0 N-CA-C 106.78 -1.563 . . . . 73.11 106.78 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.0 t -56.02 122.73 12.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.243 -1.021 . . . . 65.12 108.243 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.6 tm? -93.42 -16.63 24.38 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.431 -2.063 . . . . 74.13 105.431 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CD ' ' HE1' ' A' ' 33' ' ' HIS . 53.3 mt-10 -59.85 123.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.816 -0.809 . . . . 62.33 108.816 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.56 -14.94 62.74 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 108.968 -1.653 . . . . 62.2 108.968 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.01 147.33 46.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.569 -1.271 . . . . 61.2 107.569 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 59.6 p -81.65 178.69 8.19 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.147 -1.427 . . . . 73.14 107.147 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' HIS . . . . . 0.401 ' HA ' HD11 ' A' ' 36' ' ' ILE . 43.5 p-80 -62.26 -51.06 69.23 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.935 -0.765 . . . . 63.23 108.935 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.57 -56.07 24.62 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 121.707 -0.621 . . . . 73.22 110.12 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -60.9 -45.49 94.42 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 110.184 -0.302 . . . . 55.22 110.184 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -53.65 -51.29 63.62 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-O 120.918 0.389 . . . . 60.43 110.716 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.63 -36.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.827 -1.175 . . . . 75.33 107.827 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.6 -34.19 73.85 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.031 -1.84 . . . . 70.43 106.031 -176.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.9 m -73.14 -42.32 62.97 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 107.393 -1.336 . . . . 74.55 107.393 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.78 -39.58 94.66 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 110.109 -0.33 . . . . 64.45 110.109 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -75.99 -54.64 6.56 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.662 -0.815 . . . . 63.13 109.139 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -70.48 47.78 0.1 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.039 0.447 . . . . 72.11 111.591 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -101.08 -176.07 3.05 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.702 -1.962 . . . . 72.31 105.702 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.65 -157.26 18.57 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 107.113 -2.395 . . . . 13.2 107.113 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.34 -54.02 39.57 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.088 -0.708 . . . . 63.45 109.088 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.27 141.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 105.928 -1.879 . . . . 71.44 105.928 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.2 130.68 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.491 0 N-CA-C 105.718 -1.956 . . . . 75.31 105.718 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -107.17 124.61 49.97 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 105.413 -2.069 . . . . 72.41 105.413 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -156.36 136.55 12.89 Favored 'General case' 0 CA--C 1.473 -2.004 0 C-N-CA 119.01 -1.076 . . . . 75.5 108.458 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.33 141.0 33.23 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.394 -1.336 . . . . 72.51 107.394 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.634 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.8 159.02 18.7 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 104.595 -2.372 . . . . 75.2 104.595 174.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -123.4 134.4 53.98 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 101.292 -3.596 . . . . 51.42 101.292 164.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.76 130.29 44.28 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.163 -1.421 . . . . 73.14 107.163 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.463 -3.208 0 N-CA-C 107.303 -2.319 . . . . 21.11 107.303 -169.806 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.204 0 N-CA-C 109.567 -1.413 . . . . 74.54 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -99.77 153.8 18.83 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.869 -1.901 . . . . 74.43 105.869 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 60' ' ' LEU . 4.6 mm -99.63 137.51 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 106.59 -1.633 . . . . 63.22 106.59 -169.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.563 ' CD2' HD23 ' A' ' 90' ' ' LEU . 9.1 p90 -135.28 151.96 51.05 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.302 -1.37 . . . . 74.14 107.302 170.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -108.09 147.29 31.42 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.237 -1.764 . . . . 64.24 106.237 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.73 HG22 HD21 ' A' ' 90' ' ' LEU . 35.1 m -142.96 152.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 105.984 -1.858 . . . . 62.5 105.984 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -118.71 127.25 53.39 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.745 -1.946 . . . . 73.13 105.745 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 137.69 45.45 Favored 'General case' 0 CA--C 1.474 -1.961 0 N-CA-C 107.694 -1.224 . . . . 70.34 107.694 -169.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.29 142.3 28.63 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.693 -1.965 . . . . 64.32 105.693 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -69.88 -32.41 70.74 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.413 -0.958 . . . . 75.21 108.413 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 75.03 107.08 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.607 0.763 . . . . 64.13 109.299 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 50.84 45.38 27.43 Favored 'General case' 0 C--N 1.37 1.474 0 C-N-CA 124.576 1.151 . . . . 43.3 110.937 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 54.97 -9.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.549 1.94 . . . . 74.21 113.805 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -84.3 158.28 21.24 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 119.975 1.262 . . . . 71.11 108.341 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.96 -157.15 0.78 Allowed 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 102.952 -2.981 . . . . 53.44 102.952 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.36 40.79 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.657 0 N-CA-C 105.292 -3.123 . . . . 55.22 105.292 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mm -87.99 175.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 103.438 -2.801 . . . . 70.23 103.438 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.7 m -147.61 159.55 43.64 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.358 -2.09 . . . . 73.3 105.358 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.3 m -150.4 167.3 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 N-CA-C 107.766 -1.198 . . . . 73.13 107.766 -164.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -166.17 169.49 14.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.665 -2.346 . . . . 63.41 104.665 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -138.61 14.64 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.695 -2.162 . . . . 25.43 107.695 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.77 -88.17 0.68 Allowed Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 109.404 -1.478 . . . . 64.02 109.404 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 16.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 112.832 0.679 . . . . 71.22 112.832 -165.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 17.7 t-20 82.55 6.92 0.9 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.677 0.791 . . . . 74.13 109.301 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 t -46.28 -170.23 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.427 1.491 . . . . 54.42 111.478 160.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -35.08 -40.33 0.12 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.071 1.748 . . . . 72.54 114.982 -166.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 34.6 m -72.25 142.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.559 -0.904 . . . . 34.13 108.559 -174.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.19 -59.11 4.07 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 121.725 -0.609 . . . . 72.33 112.556 -167.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.537 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 22.8 t-160 -75.84 15.16 0.55 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.588 -0.695 . . . . 70.35 110.874 -164.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 28' ' ' ASN . . . 46.35 57.19 6.6 Favored Glycine 0 C--N 1.358 1.788 0 N-CA-C 109.559 -1.416 . . . . 54.41 109.559 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.95 178.27 23.78 Favored Glycine 1 CA--C 1.442 -4.49 0 N-CA-C 103.252 -3.939 . . . . 61.23 103.252 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.493 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.6 mm -92.63 132.09 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 106.214 -1.772 . . . . 71.2 106.214 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.429 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 2.7 m-85 -109.82 148.52 31.34 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.584 -2.747 . . . . 72.12 103.584 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.12 103.2 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 N-CA-C 106.702 -1.592 . . . . 71.52 106.702 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -70.58 -38.64 74.09 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.547 -1.206 . . . . 63.23 109.745 -174.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.35 155.56 17.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 N-CA-C 105.368 -2.086 . . . . 43.32 105.368 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.5 143.2 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 102.763 -3.051 . . . . 54.42 102.763 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.16 142.6 72.26 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 105.903 -1.888 . . . . 74.14 105.903 171.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.14 173.89 13.73 Favored 'Trans proline' 0 CA--C 1.472 -2.585 0 N-CA-C 105.896 -2.386 . . . . 64.14 105.896 -176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 69.66 -2.73 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.024 0.828 . . . . 71.21 111.213 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.57 -176.25 38.6 Favored Glycine 0 CA--C 1.48 -2.139 0 N-CA-C 107.221 -2.352 . . . . 63.01 107.221 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -52.84 46.75 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.137 -1.061 . . . . 75.52 108.137 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.53 -49.65 64.42 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.224 -0.444 . . . . 74.02 110.589 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -64.54 -55.98 17.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.819 0.342 . . . . 52.45 110.124 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 m -64.04 -29.66 70.79 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 121.928 -0.482 . . . . 73.41 111.694 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -78.56 -34.15 47.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 105.773 -1.936 . . . . 74.35 105.773 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.49 63.97 Favored Glycine 0 CA--C 1.482 -2.02 0 N-CA-C 108.898 -1.681 . . . . 61.21 108.898 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.505 ' HB3' HG11 ' A' ' 10' ' ' VAL . 13.4 mmt180 -89.89 -2.62 58.23 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 107.805 -1.183 . . . . 75.5 107.805 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.8 mt -146.64 143.9 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 N-CA-C 103.26 -2.867 . . . . 74.43 103.26 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.496 ' CE1' ' OD1' ' A' ' 57' ' ' ASP . 25.6 p80 -153.23 165.39 35.83 Favored 'General case' 0 CA--C 1.463 -2.375 0 N-CA-C 104.497 -2.409 . . . . 74.52 104.497 173.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.716 ' H ' ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -67.93 145.08 54.9 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.612 -1.255 . . . . 72.43 107.612 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.74 -32.72 7.09 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.493 -1.443 . . . . 52.52 109.493 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 68.1 m-20 -66.4 158.0 30.47 Favored 'General case' 0 C--N 1.373 1.588 0 N-CA-C 108.292 -1.003 . . . . 73.5 108.292 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 52.5 mtm-85 -112.7 137.66 50.67 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.506 -1.294 . . . . 72.41 107.506 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.36 128.49 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 105.08 -2.193 . . . . 74.01 105.08 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.521 ' CD1' HG23 ' A' ' 7' ' ' ILE . 17.5 mt -99.28 -59.14 1.78 Allowed 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 107.467 -1.309 . . . . 73.42 107.467 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.06 146.53 51.77 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 106.433 -1.691 . . . . 64.54 106.433 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.78 125.42 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.213 -2.514 . . . . 74.12 104.213 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.64 29.84 17.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.114 0.959 . . . . 73.02 109.287 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.06 -12.06 68.85 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 109.26 -1.536 . . . . 72.51 109.26 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.04 118.54 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.557 -1.645 . . . . 74.11 106.557 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.5 m -56.7 118.38 4.82 Favored 'General case' 0 C--N 1.368 1.381 0 N-CA-C 108.435 -0.95 . . . . 55.44 108.435 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -104.52 -10.82 17.37 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.136 -1.802 . . . . 54.41 106.136 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.91 126.59 28.09 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.655 -0.868 . . . . 73.51 108.655 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -13.37 67.16 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 108.963 -1.655 . . . . 63.15 108.963 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.4 152.89 30.1 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.228 -1.767 . . . . 64.51 106.228 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -81.73 179.24 7.91 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.952 -0.758 . . . . 64.05 108.952 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -67.44 -46.15 73.93 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 108.202 -1.036 . . . . 74.35 108.202 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -52.19 -56.43 14.65 Favored 'General case' 0 C--N 1.362 1.136 0 O-C-N 121.733 -0.604 . . . . 53.22 110.07 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -53.96 -42.63 69.11 Favored 'General case' 0 C--N 1.369 1.452 0 N-CA-C 110.0 -0.37 . . . . 73.44 110.0 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -52.1 -53.9 36.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.096 0.558 . . . . 73.23 110.432 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.57 -40.57 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.657 -1.238 . . . . 73.43 107.657 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.05 -37.27 76.61 Favored 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 106.823 -1.547 . . . . 72.43 106.823 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.3 m -74.01 -48.06 32.79 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 120.355 -1.466 . . . . 73.44 107.627 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 124.024 0.929 . . . . 74.43 109.933 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -70.07 -55.47 9.41 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.998 -1.112 . . . . 72.53 107.998 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -70.84 55.26 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.875 0.845 . . . . 54.31 110.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.562 HG21 HG13 ' A' ' 86' ' ' VAL . 10.1 p -104.79 -175.53 2.82 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.226 -1.768 . . . . 74.11 106.226 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.12 -155.73 31.97 Favored Glycine 0 CA--C 1.485 -1.815 0 N-CA-C 107.189 -2.364 . . . . 50.0 107.189 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -63.24 -55.34 25.71 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.023 -1.103 . . . . 74.35 108.023 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.48 144.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.673 -1.973 . . . . 70.22 105.673 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.562 HG13 HG21 ' A' ' 82' ' ' THR . 46.8 t -103.01 131.84 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.715 0 N-CA-C 105.568 -2.012 . . . . 74.11 105.568 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -112.5 124.18 51.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.089 -2.189 . . . . 63.34 105.089 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.29 136.4 14.74 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 107.781 -1.192 . . . . 73.51 107.781 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -81.29 140.14 35.0 Favored 'General case' 0 CA--C 1.469 -2.138 0 N-CA-C 107.712 -1.218 . . . . 70.23 107.712 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.73 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.92 156.91 20.51 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.412 -2.44 . . . . 45.53 104.412 172.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.3 tt0 -118.75 129.82 55.47 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 101.566 -3.494 . . . . 71.1 101.566 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -66.89 129.24 39.23 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.225 -1.768 . . . . 71.21 106.225 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.475 -2.438 0 N-CA-C 107.835 -2.106 . . . . 30.14 107.835 -168.119 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.33 0 N-CA-C 109.348 -1.501 . . . . 62.34 109.348 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.5 138.52 39.26 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.432 -1.322 . . . . 73.2 107.432 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 60' ' ' LEU . 10.1 mm -97.53 133.28 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.321 -1.363 . . . . 74.11 107.321 -172.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.586 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -142.89 153.21 42.9 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.139 -1.06 . . . . 61.41 108.139 175.154 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -104.94 146.83 28.49 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 105.942 -1.873 . . . . 70.23 105.942 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.648 HG22 HD21 ' A' ' 90' ' ' LEU . 22.5 m -140.61 150.0 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.78 -1.563 . . . . 74.22 106.78 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -108.67 127.86 54.35 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 105.142 -2.17 . . . . 64.5 105.142 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 53' ' ' ILE . 3.6 mp -129.6 140.08 51.28 Favored 'General case' 0 CA--C 1.448 -2.967 0 N-CA-C 107.528 -1.286 . . . . 73.15 107.528 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.57 140.07 31.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 104.964 -2.236 . . . . 64.43 104.964 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.67 -31.97 67.37 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.539 -1.282 . . . . 71.1 107.539 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 74.83 102.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.251 -1.389 . . . . 74.35 107.251 -175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.16 45.83 11.22 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.243 -0.89 . . . . 75.41 109.22 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.7 t30 45.34 3.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.816 2.046 . . . . 61.42 115.634 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -102.6 121.94 43.4 Favored 'General case' 0 CA--C 1.485 -1.548 0 O-C-N 120.358 -1.464 . . . . 61.34 107.049 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.9 tp -127.19 151.37 48.78 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 104.202 -2.518 . . . . 54.31 104.202 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.18 0.07 OUTLIER Glycine 0 CA--C 1.467 -2.934 0 N-CA-C 105.184 -3.166 . . . . 65.11 105.184 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.7 mm -89.22 178.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.415 -2.439 . . . . 64.21 104.415 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.534 ' H ' HG22 ' A' ' 21' ' ' ILE . 40.0 t -122.06 154.59 37.11 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 103.345 -2.835 . . . . 53.1 103.345 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.481 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.4 m -147.63 169.69 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 107.406 -1.331 . . . . 74.35 107.406 -164.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 t -162.67 165.88 25.16 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.884 -2.265 . . . . 55.44 104.884 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -152.67 31.24 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 107.067 -2.413 . . . . 42.34 107.067 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 118.48 -78.77 0.3 Allowed Glycine 0 CA--C 1.477 -2.332 0 N-CA-C 108.979 -1.649 . . . . 73.22 108.979 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -67.71 16.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 C-N-CA 124.557 1.143 . . . . 72.22 112.057 -168.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 26' ' ' GLY . 12.5 t-20 81.32 5.14 1.38 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.213 1.405 . . . . 65.42 108.072 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.1 p -49.02 -170.86 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 126.071 1.748 . . . . 70.45 113.186 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 m -31.43 -42.41 0.05 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.63 2.372 . . . . 64.12 115.089 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -62.75 134.91 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.816 0.817 . . . . 62.22 109.967 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -52.44 -50.25 62.95 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 114.855 -1.066 . . . . 73.12 112.404 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -90.31 16.95 7.78 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.208 -0.933 . . . . 74.12 110.079 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.09 62.63 2.0 Favored Glycine 0 C--N 1.368 2.327 0 N-CA-C 111.206 -0.758 . . . . 72.33 111.206 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.1 179.73 24.73 Favored Glycine 0 CA--C 1.455 -3.681 0 N-CA-C 104.162 -3.575 . . . . 70.13 104.162 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.564 HG13 ' HB2' ' A' ' 75' ' ' ALA . 8.6 mm -88.87 125.54 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 105.479 -2.045 . . . . 73.14 105.479 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -109.32 152.86 24.71 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 103.84 -2.652 . . . . 64.52 103.84 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.81 104.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.464 -1.68 . . . . 75.2 106.464 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.37 -31.93 69.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.729 -0.841 . . . . 64.43 108.729 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.49 146.22 16.6 Favored 'General case' 0 CA--C 1.459 -2.525 0 N-CA-C 105.645 -1.983 . . . . 63.25 105.645 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.89 122.46 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.349 -3.204 . . . . 73.04 102.349 172.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.406 ' H ' ' CD1' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.79 146.23 72.1 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 106.052 -1.833 . . . . 73.13 106.052 178.002 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.5 173.61 14.2 Favored 'Trans proline' 0 CA--C 1.47 -2.679 0 N-CA-C 107.109 -1.919 . . . . 72.41 107.109 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 63.65 53.98 1.94 Allowed 'General case' 0 N--CA 1.422 -1.829 0 O-C-N 124.664 1.228 . . . . 72.32 108.136 164.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.34 176.53 37.87 Favored Glycine 0 CA--C 1.466 -2.992 0 N-CA-C 106.659 -2.576 . . . . 75.25 106.659 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.43 -52.73 24.02 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.661 -0.866 . . . . 62.4 108.661 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -49.32 67.45 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.623 -0.262 . . . . 71.25 110.558 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -59.53 -57.5 12.67 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 122.104 -0.373 . . . . 73.12 110.129 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -63.58 -28.7 70.11 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.581 0.229 . . . . 42.04 110.948 -170.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.34 -40.37 58.38 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.146 -1.427 . . . . 64.44 107.146 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.56 9.61 78.39 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 109.794 -1.322 . . . . 62.44 109.794 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -100.22 7.07 44.73 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.594 -1.262 . . . . 72.11 107.594 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 12' ' ' LEU . 1.4 mp -134.5 140.75 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 102.987 -2.968 . . . . 43.55 102.987 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -140.83 158.71 43.56 Favored 'General case' 0 CA--C 1.465 -2.325 0 N-CA-C 104.666 -2.346 . . . . 74.41 104.666 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.21 140.48 57.43 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.487 -1.672 . . . . 72.24 106.487 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.5 -32.83 6.34 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 108.663 -1.775 . . . . 72.04 108.663 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -67.45 155.92 37.84 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.119 -1.808 . . . . 74.03 106.119 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.426 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 1.6 ppt_? -133.38 156.55 47.44 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.233 -0.987 . . . . 64.43 109.247 -169.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -93.02 138.73 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.474 -1.676 . . . . 60.51 106.474 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.527 ' CD1' HG23 ' A' ' 7' ' ' ILE . 7.0 mt -99.12 -59.29 1.75 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.216 -1.772 . . . . 64.33 106.216 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.56 152.28 50.3 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 106.474 -1.676 . . . . 64.12 106.474 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.91 121.14 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 104.522 -2.399 . . . . 62.34 104.522 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.96 36.48 22.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.937 0.895 . . . . 74.11 110.532 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.95 -19.95 52.24 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.694 -1.762 . . . . 75.35 108.694 169.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.4 116.09 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 107.565 -1.272 . . . . 62.42 107.565 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -55.52 117.91 4.0 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 107.664 -1.236 . . . . 71.15 107.664 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -102.12 -13.09 17.62 Favored 'General case' 0 C--O 1.202 -1.402 0 N-CA-C 106.608 -1.627 . . . . 54.33 106.608 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.84 128.72 37.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.523 -0.917 . . . . 64.52 108.523 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.41 -17.67 58.65 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 108.239 -1.945 . . . . 61.03 108.239 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 106.316 -1.735 . . . . 62.43 106.316 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -84.77 -179.37 7.09 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.384 0.611 . . . . 62.54 109.362 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -60.89 -52.44 65.05 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.073 -1.084 . . . . 70.44 108.073 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -60.27 -44.83 94.98 Favored 'General case' 0 C--N 1.372 1.564 0 O-C-N 121.859 -0.525 . . . . 63.01 110.37 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -55.44 -46.6 76.72 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 109.171 -0.677 . . . . 54.41 109.171 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -51.43 -53.83 32.9 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.893 -0.594 . . . . 55.43 110.722 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.16 -43.64 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.044 -1.095 . . . . 74.22 108.044 -171.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 t -68.04 -30.34 69.54 Favored 'General case' 0 C--O 1.193 -1.912 0 C-N-CA 116.924 -1.91 . . . . 75.14 107.253 -170.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -67.96 -43.42 79.06 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.876 -1.765 . . . . 74.22 106.892 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.68 -29.0 69.04 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 109.526 -0.546 . . . . 63.1 109.526 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.24 -60.39 2.29 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 107.77 -1.196 . . . . 74.35 107.77 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -58.85 -3.37 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.775 1.23 . . . . 74.34 113.607 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 p -73.97 -176.33 2.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.678 -0.86 . . . . 72.44 108.678 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.77 -149.17 24.42 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 109.432 -1.467 . . . . 64.42 109.432 -167.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.95 -55.18 18.15 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.177 -1.416 . . . . 75.41 107.177 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -100.68 144.36 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 N-CA-C 105.441 -2.059 . . . . 72.4 105.441 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -108.49 133.41 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 106.128 -1.804 . . . . 75.42 106.128 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -107.08 121.87 45.35 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 104.902 -2.259 . . . . 75.23 104.902 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.5 134.42 13.01 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.074 -1.084 . . . . 74.43 108.074 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -84.63 141.33 30.72 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 108.232 -1.025 . . . . 71.4 108.232 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.648 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -118.3 163.24 17.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.054 -2.202 . . . . 64.04 105.054 176.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.426 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 36.2 tt0 -124.17 137.28 54.56 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 102.25 -3.241 . . . . 62.12 102.25 166.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 8' ' ' PHE . 11.8 mmmm -61.16 149.88 36.01 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.822 -0.807 . . . . 75.01 108.822 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.678 0 N-CA-C 105.654 -2.978 . . . . 72.33 105.654 175.708 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.958 0 N-CA-C 108.598 -1.801 . . . . 73.02 108.598 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -78.91 132.37 36.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.435 -1.321 . . . . 74.2 107.435 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.513 HG23 ' CD1' ' A' ' 60' ' ' LEU . 18.5 mm -100.38 135.58 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 106.196 -1.779 . . . . 73.2 106.196 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -145.88 161.61 39.62 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 107.669 -1.234 . . . . 74.32 107.669 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.49 151.76 29.57 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 105.548 -2.019 . . . . 72.34 105.548 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -145.04 153.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 106.715 -1.587 . . . . 74.01 106.715 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -111.96 131.22 55.53 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 105.116 -2.179 . . . . 75.03 105.116 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.424 HD22 HD12 ' A' ' 53' ' ' ILE . 4.6 mp -136.76 145.15 44.27 Favored 'General case' 0 CA--C 1.462 -2.409 0 N-CA-C 107.881 -1.155 . . . . 72.1 107.881 174.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.15 144.83 26.67 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.139 -1.43 . . . . 52.12 107.139 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -75.22 -27.52 59.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.773 -1.195 . . . . 63.53 107.773 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 t30 71.02 96.89 0.07 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.831 0.852 . . . . 73.44 109.226 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 62.13 40.51 11.8 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.139 -1.06 . . . . 73.35 108.139 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 50.29 -8.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.067 2.547 . . . . 62.02 114.952 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.7 m -93.06 115.69 28.34 Favored 'General case' 0 CA--C 1.47 -2.105 0 N-CA-C 106.745 -1.576 . . . . 70.42 106.745 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -87.12 -150.75 0.16 Allowed 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.516 -2.401 . . . . 73.01 104.516 173.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.79 29.89 0.02 OUTLIER Glycine 0 CA--C 1.463 -3.203 0 N-CA-C 107.169 -2.372 . . . . 71.2 107.169 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.38 176.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 103.14 -2.911 . . . . 62.21 103.14 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -151.04 166.48 30.6 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 104.166 -2.531 . . . . 54.4 104.166 172.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.06 177.32 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 107.827 -1.175 . . . . 74.32 107.827 -166.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 170.78 20.74 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.525 -2.398 . . . . 73.52 104.525 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.53 -153.16 24.81 Favored Glycine 0 CA--C 1.484 -1.854 0 N-CA-C 109.091 -1.604 . . . . 70.22 109.091 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.45 -80.93 0.32 Allowed Glycine 0 CA--C 1.477 -2.299 0 N-CA-C 108.864 -1.695 . . . . 61.44 108.864 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -76.71 16.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 122.755 0.422 . . . . 63.11 111.643 -166.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.3 t30 85.64 6.43 0.43 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.241 -1.022 . . . . 75.23 108.241 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -45.89 -168.39 0.0 OUTLIER 'General case' 0 C--O 1.192 -1.933 0 C-N-CA 126.821 2.048 . . . . 75.2 112.051 162.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.6 m -33.06 -43.58 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.568 1.547 . . . . 74.11 114.441 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.1 m -71.3 130.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 107.524 -1.287 . . . . 65.34 107.524 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -55.93 11.51 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 121.138 -0.976 . . . . 74.43 108.854 -166.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -61.74 -20.72 63.84 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 111.81 0.3 . . . . 61.43 111.81 -164.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 55.64 2.63 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 107.817 -2.113 . . . . 64.4 107.817 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.01 -179.77 29.62 Favored Glycine 0 CA--C 1.456 -3.629 1 N-CA-C 101.923 -4.471 . . . . 54.12 101.923 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.13 136.66 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.593 0 N-CA-C 104.734 -2.321 . . . . 65.31 104.734 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -105.48 151.43 24.27 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 103.487 -2.783 . . . . 63.12 103.487 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.95 101.41 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.724 -1.954 . . . . 74.21 105.724 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.09 -37.02 66.89 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.116 -1.402 . . . . 72.4 110.978 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.43 140.54 24.03 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.283 -1.747 . . . . 74.23 106.283 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.57 132.97 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 103.368 -2.827 . . . . 74.53 103.368 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 154.03 84.95 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 106.647 -1.612 . . . . 75.41 106.647 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.18 172.34 16.24 Favored 'Trans proline' 0 CA--C 1.472 -2.6 0 N-CA-C 107.079 -1.931 . . . . 51.13 107.079 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 53.41 55.67 8.38 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 124.612 1.195 . . . . 73.21 109.541 164.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.34 176.37 35.31 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 104.011 -3.635 . . . . 73.41 104.011 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.35 55.77 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 117.291 0.546 . . . . 74.43 109.765 -168.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.39 -49.79 63.73 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 122.542 -0.099 . . . . 70.23 111.115 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -62.86 -55.8 22.98 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 122.094 -0.379 . . . . 64.43 110.483 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 m -65.78 -29.03 69.46 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 110.051 -0.351 . . . . 73.13 110.051 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.14 -38.13 52.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.318 -1.734 . . . . 65.02 106.318 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 15.22 76.39 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 109.889 -1.285 . . . . 74.32 109.889 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -101.56 7.65 42.19 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.043 -1.465 . . . . 74.35 107.043 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.424 HD12 HD22 ' A' ' 12' ' ' LEU . 64.0 mt -141.49 143.72 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 103.756 -2.683 . . . . 75.2 103.756 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -141.63 169.31 17.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.089 -2.56 . . . . 75.31 104.089 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -68.09 138.47 55.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.569 -2.011 . . . . 60.33 105.569 164.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.04 -28.07 12.92 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 108.991 -1.644 . . . . 73.1 108.991 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 1.1 m-20 -57.57 139.51 53.33 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 118.057 0.929 . . . . 72.12 108.708 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.7 130.24 56.12 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 104.839 -2.282 . . . . 73.25 104.839 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.75 130.61 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.281 -2.118 . . . . 73.44 105.281 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' CD1' HG23 ' A' ' 7' ' ' ILE . 19.8 mt -97.79 -58.31 2.02 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 106.366 -1.716 . . . . 73.35 106.366 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.7 151.47 50.21 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.51 -1.663 . . . . 71.43 106.51 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.08 117.93 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 105.485 -2.043 . . . . 61.3 105.485 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 t30 49.42 40.39 18.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.246 1.018 . . . . 53.33 111.033 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.68 7.05 Favored Glycine 0 CA--C 1.472 -2.621 0 N-CA-C 108.157 -1.977 . . . . 73.3 108.157 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.15 117.04 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 N-CA-C 108.643 -0.873 . . . . 72.42 108.643 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -56.27 126.17 25.05 Favored 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.377 -0.971 . . . . 75.34 108.377 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.469 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -103.66 -12.09 17.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.237 -1.764 . . . . 55.1 106.237 -169.512 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.8 124.31 19.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.677 -0.861 . . . . 74.03 108.677 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.81 -16.53 61.07 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.764 -1.735 . . . . 62.15 108.764 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.31 154.01 31.25 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 106.814 -1.55 . . . . 44.43 106.814 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.7 p -85.57 179.38 7.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.56 -0.904 . . . . 75.35 108.56 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -68.83 -42.92 76.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.559 -0.904 . . . . 74.11 108.559 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -56.35 16.18 Favored 'General case' 0 C--N 1.367 1.352 0 O-C-N 121.915 -0.491 . . . . 70.43 110.085 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -54.79 -45.11 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 122.19 -0.319 . . . . 42.52 110.248 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -52.03 -54.48 29.51 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 116.085 -0.507 . . . . 75.23 110.488 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.64 -38.17 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 108.758 -0.83 . . . . 54.34 108.758 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.2 t -56.29 -40.03 73.63 Favored 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 105.935 -1.876 . . . . 64.52 105.935 -173.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 m -74.42 -48.84 25.24 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.054 -1.43 . . . . 72.23 109.194 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.11 -31.43 72.62 Favored 'General case' 0 C--N 1.368 1.391 0 N-CA-C 110.259 -0.274 . . . . 73.42 110.259 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -79.51 -53.71 6.61 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 108.246 -1.02 . . . . 73.4 108.246 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -68.79 53.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.295 1.045 . . . . 63.31 110.973 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.47 HG21 HG13 ' A' ' 86' ' ' VAL . 10.4 p -110.77 -175.74 2.79 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.384 -1.71 . . . . 71.54 106.384 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.1 -156.11 32.5 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.497 -2.641 . . . . 34.2 106.497 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -62.24 -54.69 37.23 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.784 -1.191 . . . . 72.25 107.784 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.46 142.36 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 106.461 -1.681 . . . . 75.41 106.461 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 HG21 ' A' ' 82' ' ' THR . 48.9 t -103.71 132.17 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 N-CA-C 105.052 -2.203 . . . . 64.34 105.052 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -110.24 127.75 55.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.831 -2.285 . . . . 73.51 104.831 173.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 139.17 16.02 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.727 -1.212 . . . . 73.24 107.727 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.4 140.53 33.41 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 107.271 -1.381 . . . . 75.41 107.271 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.83 160.82 38.24 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.994 -1.457 . . . . 71.14 107.474 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -123.57 120.77 33.82 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.387 -2.079 . . . . 75.41 105.387 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.419 0.0 OUTLIER 34.79 -79.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 127.146 2.178 . . . . 75.33 116.195 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 57' ' ' ASP . . . . . . . . 0 CA--C 1.461 -3.285 0 N-CA-C 106.043 -2.823 . . . . 33.22 106.043 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.244 0 N-CA-C 108.946 -1.661 . . . . 74.42 108.946 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -75.9 137.24 40.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.557 -1.275 . . . . 72.41 107.557 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.472 HG23 ' CD1' ' A' ' 60' ' ' LEU . 11.8 mt -101.11 128.82 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 N-CA-C 107.653 -1.24 . . . . 72.45 107.653 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.3 p90 -139.76 156.23 46.88 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.212 -1.403 . . . . 54.55 107.212 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.1 145.93 31.86 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.483 -2.043 . . . . 62.21 105.483 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 90' ' ' LEU . 16.1 m -140.39 151.69 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.038 -1.467 . . . . 54.24 107.038 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.58 128.54 54.91 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 105.35 -2.093 . . . . 64.13 105.35 168.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mp -132.27 143.93 50.25 Favored 'General case' 0 CA--C 1.454 -2.731 0 N-CA-C 107.438 -1.319 . . . . 72.0 107.438 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.66 142.18 28.4 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 105.521 -2.029 . . . . 72.31 105.521 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -71.72 -30.55 65.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.071 -1.085 . . . . 65.2 108.071 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 72.43 104.38 0.07 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.76 -0.83 . . . . 63.41 108.76 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 62.27 46.47 6.05 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.817 0.847 . . . . 74.52 110.192 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 53.39 -9.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 127.12 2.168 . . . . 63.43 114.791 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 m -109.61 149.69 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.203 -1.036 . . . . 63.24 108.203 -167.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.43 167.4 30.15 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 105.629 -1.989 . . . . 54.45 105.629 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.05 95.54 0.1 Allowed Glycine 0 CA--C 1.46 -3.356 0 N-CA-C 104.225 -3.55 . . . . 74.43 104.225 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.66 153.07 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.091 -2.929 . . . . 74.15 103.091 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 6.5 m -91.77 159.41 15.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 103.657 -2.72 . . . . 71.01 103.657 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 m -151.0 167.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.99 -2.226 . . . . 73.5 104.99 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -167.92 170.6 10.47 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.668 -2.345 . . . . 65.02 104.668 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.57 -148.88 21.42 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 107.421 -2.272 . . . . 61.22 107.421 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 115.1 -78.69 0.27 Allowed Glycine 0 CA--C 1.481 -2.048 0 N-CA-C 108.953 -1.659 . . . . 72.14 108.953 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 27' ' ' VAL . 2.3 t -75.6 15.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 123.304 0.642 . . . . 53.21 109.819 -170.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 26' ' ' GLY . 63.0 m-80 83.81 7.05 0.65 Allowed 'General case' 0 CA--C 1.486 -1.494 0 C-N-CA 124.373 1.069 . . . . 74.11 108.182 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.8 p -47.52 -171.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.058 1.743 . . . . 74.24 113.114 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -34.99 -44.04 0.21 Allowed 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.545 1.938 . . . . 72.55 114.544 -164.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.9 m -58.39 126.44 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 122.281 1.038 . . . . 64.11 110.301 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -51.62 -52.64 46.06 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.463 -1.244 . . . . 63.5 113.833 -165.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.24 -18.88 61.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 119.088 -1.045 . . . . 63.51 109.509 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.22 54.83 2.9 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 108.271 -1.931 . . . . 72.12 108.271 172.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.43 -179.17 22.38 Favored Glycine 0 CA--C 1.461 -3.328 0 N-CA-C 104.051 -3.62 . . . . 75.33 104.051 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 36' ' ' ILE . 10.0 mm -82.49 128.02 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.353 0 N-CA-C 104.409 -2.441 . . . . 53.24 104.409 171.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -106.37 150.91 25.54 Favored 'General case' 0 CA--C 1.459 -2.536 0 N-CA-C 104.432 -2.433 . . . . 64.34 104.432 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.95 103.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 N-CA-C 105.5 -2.037 . . . . 75.23 105.5 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 84.9 tttt -70.21 -33.99 72.35 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 114.393 -1.276 . . . . 72.02 109.3 -172.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.5 155.55 9.18 Favored 'General case' 0 CA--C 1.464 -2.348 0 N-CA-C 105.636 -1.987 . . . . 64.43 105.636 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.97 134.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 103.045 -2.946 . . . . 75.33 103.045 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.402 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 150.18 77.56 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 105.31 -2.108 . . . . 75.34 105.31 176.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.02 168.82 23.86 Favored 'Trans proline' 0 CA--C 1.465 -2.928 0 N-CA-C 105.528 -2.528 . . . . 74.4 105.528 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 62.93 -0.33 0.6 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.297 0.851 . . . . 73.15 113.297 167.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.5 173.81 49.89 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 106.712 -2.555 . . . . 73.43 106.712 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.79 73.95 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.961 -1.125 . . . . 51.24 107.961 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.95 -49.48 65.98 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 115.826 -0.624 . . . . 75.22 110.377 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -65.36 -56.15 14.19 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 122.145 -0.347 . . . . 71.34 110.072 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -63.73 -28.8 70.13 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 122.103 -0.373 . . . . 72.15 111.009 -170.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -83.93 -30.99 25.86 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 106.515 -1.661 . . . . 71.24 106.515 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.89 20.0 79.69 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.375 -1.09 . . . . 72.44 110.375 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB3' HG11 ' A' ' 10' ' ' VAL . 90.6 mtt-85 -97.16 6.54 48.3 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.691 -1.596 . . . . 71.04 106.691 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.2 mt -140.96 141.66 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.451 -3.166 . . . . 62.11 102.451 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -142.3 153.5 43.93 Favored 'General case' 0 CA--C 1.46 -2.482 0 N-CA-C 105.205 -2.146 . . . . 65.44 105.205 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.68 141.9 56.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.273 -1.38 . . . . 64.44 107.273 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.21 -32.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 108.898 -1.681 . . . . 72.35 108.898 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.62 154.32 29.43 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 107.83 -1.174 . . . . 62.44 107.83 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.14 135.35 53.9 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.474 -1.676 . . . . 75.42 106.474 -167.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.0 129.57 41.56 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 105.454 -2.054 . . . . 70.43 105.454 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' CD1' HG23 ' A' ' 7' ' ' ILE . 13.3 mt -95.53 -60.5 1.65 Allowed 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.527 -1.286 . . . . 62.3 107.527 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.88 48.96 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 106.099 -1.815 . . . . 74.24 106.099 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.5 t -115.31 114.85 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 105.23 -2.137 . . . . 71.35 105.23 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 t30 44.09 47.25 7.4 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.046 1.338 . . . . 64.12 111.34 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.45 -32.96 6.9 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 108.301 -1.92 . . . . 33.23 108.301 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.52 118.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.751 0 N-CA-C 109.384 -0.599 . . . . 62.42 109.384 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -54.22 109.47 0.49 Allowed 'General case' 0 C--N 1.369 1.425 0 N-CA-C 106.976 -1.49 . . . . 70.13 106.976 168.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -100.49 -13.28 18.74 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.357 -1.72 . . . . 74.13 106.357 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.27 134.32 56.35 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.458 -0.941 . . . . 65.44 108.458 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.77 -17.69 58.12 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.172 -1.971 . . . . 72.52 108.172 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 151.71 28.06 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.607 -1.998 . . . . 51.4 105.607 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.3 p -79.54 178.41 8.15 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.813 0.816 . . . . 60.33 108.935 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -68.03 -45.17 74.72 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 108.533 -0.914 . . . . 71.32 108.533 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -56.37 -51.5 68.07 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 121.577 -0.702 . . . . 74.23 110.585 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -53.61 -41.49 66.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.831 -0.433 . . . . 63.21 109.831 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.16 64.09 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.975 -0.557 . . . . 64.42 110.02 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.38 -47.41 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 107.793 -1.188 . . . . 73.05 107.793 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.9 m -56.72 -35.59 68.72 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 107.38 -1.341 . . . . 53.41 107.38 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -69.9 -47.11 63.79 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 120.484 -1.385 . . . . 75.01 108.012 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.46 -32.94 72.95 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 109.126 -0.694 . . . . 71.33 109.126 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.55 -60.71 2.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.892 -1.151 . . . . 71.22 107.892 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -69.67 48.63 0.09 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 123.569 0.748 . . . . 63.53 111.706 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.488 HG21 HG13 ' A' ' 86' ' ' VAL . 12.8 p -102.5 -175.71 2.9 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.377 -2.083 . . . . 73.41 105.377 170.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.89 -148.12 22.75 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 106.799 -2.52 . . . . 42.23 106.799 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -68.44 -55.24 12.54 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.102 -1.073 . . . . 73.41 108.102 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.1 140.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.41 -1.7 . . . . 73.44 106.41 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.488 HG13 HG21 ' A' ' 82' ' ' THR . 48.8 t -104.99 135.62 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.053 -1.832 . . . . 75.24 106.053 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -110.43 129.3 55.8 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 104.889 -2.263 . . . . 72.42 104.889 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.74 133.88 10.48 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.126 -1.435 . . . . 75.33 107.126 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -80.86 138.02 36.19 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 107.71 -1.219 . . . . 74.31 107.71 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.666 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.89 155.99 22.76 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.492 -2.41 . . . . 74.44 104.492 177.011 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.77 132.19 55.55 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 100.827 -3.768 . . . . 72.32 100.827 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.99 138.62 58.17 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.708 -0.849 . . . . 74.55 108.708 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.305 0 N-CA-C 106.858 -2.497 . . . . 74.05 106.858 -176.211 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.136 0 N-CA-C 109.344 -1.502 . . . . 64.14 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.28 141.84 31.54 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.358 -1.349 . . . . 63.33 107.358 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.5 mt -104.63 135.11 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.997 0 N-CA-C 109.069 -0.715 . . . . 75.43 109.069 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.542 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.8 p90 -130.84 149.27 52.55 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 106.56 -1.644 . . . . 72.13 106.56 169.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -103.64 146.13 29.02 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.88 -2.267 . . . . 64.41 104.88 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.633 HG22 HD21 ' A' ' 90' ' ' LEU . 28.7 m -140.75 152.37 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 106.596 -1.631 . . . . 73.21 106.596 173.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -106.99 131.69 53.77 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.737 -2.32 . . . . 71.13 104.737 168.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.98 142.37 31.62 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.207 -1.035 . . . . 63.25 108.207 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.22 150.52 21.94 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 105.099 -2.186 . . . . 72.1 105.099 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HG3' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -76.85 -35.1 57.74 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.744 -1.576 . . . . 52.41 106.744 175.458 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 77.54 109.91 0.07 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.466 -1.309 . . . . 70.44 107.466 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 t0 57.69 36.12 26.3 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 107.804 -1.184 . . . . 74.23 107.804 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.3 t30 52.05 2.03 0.02 OUTLIER 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.752 1.621 . . . . 75.34 112.985 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.0 m -116.54 114.04 23.6 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 120.369 -1.457 . . . . 74.33 109.027 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' HG ' ' HG3' ' A' ' 14' ' ' LYS . 49.8 mt -94.22 -153.94 0.39 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 102.468 -3.16 . . . . 52.11 102.468 162.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.07 42.19 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 107.752 -2.139 . . . . 71.15 107.752 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.418 ' H ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.3 176.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 105.428 -2.064 . . . . 74.32 105.428 175.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.62 158.33 21.87 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 104.681 -2.34 . . . . 65.15 104.681 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -145.9 172.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 N-CA-C 106.16 -1.792 . . . . 65.2 106.16 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -164.48 167.35 19.59 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 104.353 -2.462 . . . . 63.42 104.353 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 -160.12 29.11 Favored Glycine 0 CA--C 1.494 -1.272 0 N-CA-C 109.004 -1.638 . . . . 71.1 109.004 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.43 -91.38 0.31 Allowed Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 109.063 -1.615 . . . . 60.0 109.063 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -67.14 16.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.506 1.123 . . . . 63.11 113.975 -162.438 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 85.24 6.78 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.503 1.121 . . . . 74.53 108.716 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 p -37.97 -170.06 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 127.266 2.226 . . . . 61.21 113.895 161.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 m -57.77 -21.27 40.6 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.134 0.974 . . . . 73.42 112.333 -168.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.86 136.23 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 109.053 -0.721 . . . . 70.24 109.053 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -70.57 0.1 Allowed 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.437 1.095 . . . . 65.0 111.424 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -86.21 15.75 4.95 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.497 -0.752 . . . . 63.03 110.977 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 49.68 62.58 4.75 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 110.205 -1.158 . . . . 62.33 110.205 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.01 179.76 28.3 Favored Glycine 0 CA--C 1.454 -3.734 0 N-CA-C 103.843 -3.703 . . . . 61.41 103.843 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.87 132.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.882 0 N-CA-C 105.373 -2.084 . . . . 64.43 105.373 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -110.25 148.39 31.97 Favored 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.881 -2.637 . . . . 71.33 103.881 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -82.06 102.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.049 -1.834 . . . . 62.43 106.049 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -71.9 -33.8 68.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.459 -1.246 . . . . 63.33 110.365 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 146.97 20.49 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 106.247 -1.761 . . . . 74.21 106.247 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 48' ' ' GLU . 41.6 t -121.5 125.98 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 N-CA-C 104.853 -2.277 . . . . 65.53 104.853 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.676 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -98.59 171.21 6.02 Favored Pre-proline 0 C--O 1.213 -0.817 0 N-CA-C 105.687 -1.968 . . . . 74.13 105.687 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 60.0 Cg_endo -84.43 179.62 4.38 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.398 1.399 . . . . 72.25 110.128 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 76.25 -14.15 0.83 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.184 1.394 . . . . 72.02 113.042 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.43 -179.51 45.16 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.58 -1.408 . . . . 74.11 109.58 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.12 -53.67 12.06 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.033 -0.584 . . . . 41.04 109.558 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.53 -50.83 66.93 Favored 'General case' 0 C--N 1.369 1.43 0 CA-C-O 121.08 0.467 . . . . 54.05 110.227 -170.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 49' ' ' SER . 3.8 pm0 -61.66 -55.88 25.73 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 123.907 0.883 . . . . 70.43 110.713 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.509 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 22.0 m -62.36 -25.13 67.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.958 0.503 . . . . 65.21 110.859 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -84.35 -28.28 27.14 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.917 -1.512 . . . . 71.13 106.917 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.22 15.15 81.43 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.052 -1.219 . . . . 52.33 110.052 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -99.11 6.71 46.4 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.274 -1.38 . . . . 74.44 107.274 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 mp -132.15 137.52 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 102.099 -3.297 . . . . 73.24 102.099 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -133.68 151.37 51.63 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.75 -2.315 . . . . 71.01 104.75 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -67.9 138.14 55.78 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.736 -1.579 . . . . 73.04 106.736 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.57 -27.79 11.49 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 109.496 -1.442 . . . . 75.42 109.496 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.39 154.61 35.0 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 107.141 -1.429 . . . . 73.42 107.141 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.546 HH21 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -117.63 139.01 51.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.472 -1.677 . . . . 64.14 106.472 -166.207 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.5 131.0 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 105.805 -1.924 . . . . 61.44 105.805 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mt -92.32 -60.08 1.93 Allowed 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.42 -1.696 . . . . 71.22 106.42 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.78 150.64 52.09 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 107.08 -1.452 . . . . 64.0 107.08 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -120.73 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 103.683 -2.71 . . . . 75.41 103.683 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.2 t30 60.58 30.07 19.47 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 121.636 0.732 . . . . 64.3 109.098 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.58 75.16 Favored Glycine 0 CA--C 1.483 -1.942 0 N-CA-C 109.326 -1.51 . . . . 51.24 109.326 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.33 122.29 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 106.77 -1.567 . . . . 71.31 106.77 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.68 111.65 0.86 Allowed 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.557 -1.275 . . . . 25.45 107.557 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -97.92 -10.99 23.64 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 106.477 -1.675 . . . . 74.31 106.477 -167.456 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HB3' HH21 ' A' ' 58' ' ' ARG . 25.9 pt-20 -62.99 131.89 50.18 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.265 -0.897 . . . . 74.34 108.69 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.41 -19.72 38.31 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.336 -1.505 . . . . 73.22 109.336 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 67' ' ' LEU . . . -81.44 154.62 26.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 105.78 -1.933 . . . . 74.22 105.78 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.445 HG22 HG22 ' A' ' 27' ' ' VAL . 14.2 p -86.04 178.87 7.1 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.682 0.753 . . . . 75.12 109.683 -166.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -64.14 -45.21 89.51 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.553 -0.906 . . . . 73.22 108.553 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -50.29 -56.06 12.82 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 109.939 -0.393 . . . . 73.44 109.939 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -57.43 -45.26 84.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 116.261 -0.427 . . . . 63.05 109.963 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.19 -56.47 12.65 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 122.603 0.361 . . . . 75.13 110.921 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.77 -39.3 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 109.514 -0.55 . . . . 75.12 109.514 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.69 -29.26 69.22 Favored 'General case' 0 C--O 1.186 -2.283 0 C-N-CA 117.021 -1.871 . . . . 74.44 106.503 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -67.77 -43.23 80.3 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.506 -1.371 . . . . 33.43 107.736 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.0 mt -65.97 -37.0 84.84 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.136 -0.69 . . . . 74.01 109.136 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -77.58 -61.79 1.88 Allowed 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.026 -0.731 . . . . 72.3 109.026 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.46 62.57 1.0 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.01 0.91 . . . . 54.34 110.75 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.07 -176.67 4.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.3 -1.741 . . . . 73.31 106.3 172.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.92 -138.4 4.22 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.758 -2.137 . . . . 60.23 107.758 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.0 -56.06 5.12 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.864 -0.791 . . . . 72.22 108.864 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.0 150.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 107.504 -1.295 . . . . 71.25 107.504 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.9 t -124.77 152.67 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.02 -2.215 . . . . 65.43 105.02 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -102.55 116.61 32.95 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 104.218 -2.512 . . . . 73.12 104.218 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -135.34 116.53 14.43 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 107.508 -1.293 . . . . 64.13 107.508 -176.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.61 141.64 33.52 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 108.393 -0.965 . . . . 62.5 108.393 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.633 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -115.37 154.83 28.49 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.19 -2.152 . . . . 75.01 105.19 178.193 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.15 133.03 54.29 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 101.87 -3.382 . . . . 73.21 101.87 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.46 139.59 56.96 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.685 -0.857 . . . . 74.04 108.685 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.125 0 N-CA-C 108.093 -2.003 . . . . 54.21 108.093 -178.172 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.328 0 N-CA-C 109.424 -1.47 . . . . 61.02 109.424 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -73.73 134.65 43.53 Favored 'General case' 0 C--N 1.363 1.164 0 N-CA-C 106.855 -1.535 . . . . 73.0 106.855 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.494 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.4 mt -104.31 136.49 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.515 0 N-CA-C 108.146 -1.057 . . . . 71.12 108.146 -173.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.8 159.0 43.82 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.028 -1.471 . . . . 74.24 107.028 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.63 145.37 30.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 75.51 105.67 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 90' ' ' LEU . 15.9 m -140.12 151.02 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.381 -1.34 . . . . 65.44 107.381 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -112.11 125.89 54.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.941 -1.874 . . . . 44.12 105.941 167.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.13 143.59 46.64 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 106.793 -1.558 . . . . 72.4 106.793 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.44 152.39 21.5 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.83 -1.915 . . . . 51.23 105.83 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -69.45 -36.01 76.21 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.846 -1.168 . . . . 73.31 107.846 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.24 112.84 0.07 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.44 -0.948 . . . . 71.04 108.44 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.3 32.95 21.39 Favored 'General case' 0 C--N 1.369 1.456 0 N-CA-C 108.603 -0.888 . . . . 53.35 108.603 -174.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.3 t30 48.6 -1.39 0.0 OUTLIER 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.284 1.834 . . . . 51.41 114.1 -174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -89.83 172.92 8.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.276 -1.379 . . . . 61.3 107.276 -170.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.88 -156.31 0.56 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 103.753 -2.684 . . . . 73.25 103.753 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.66 39.37 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.684 0 N-CA-C 105.912 -2.875 . . . . 65.0 105.912 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.99 177.11 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 104.309 -2.478 . . . . 71.31 104.309 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -141.83 166.52 24.51 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 104.905 -2.257 . . . . 53.43 104.905 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.6 m -147.65 172.13 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 N-CA-C 105.871 -1.9 . . . . 53.31 105.871 -172.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -167.94 168.49 12.07 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 104.404 -2.443 . . . . 71.51 104.404 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.46 -141.42 20.46 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 108.733 -1.747 . . . . 51.13 108.733 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 100.07 -70.19 0.49 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 109.038 -1.625 . . . . 61.4 109.038 174.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 71' ' ' THR . 1.9 t -76.98 13.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 121.397 0.618 . . . . 74.14 109.475 -171.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 26' ' ' GLY . 36.2 m-20 78.77 6.39 2.31 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.521 1.128 . . . . 65.23 109.333 176.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.6 t -53.0 -170.7 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 124.2 1.0 . . . . 74.23 111.378 167.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 m -30.81 -44.87 0.06 Allowed 'General case' 0 C--N 1.366 1.307 0 C-N-CA 127.448 2.299 . . . . 75.34 115.657 -162.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.07 132.68 21.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.513 0.673 . . . . 72.31 110.722 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -49.94 -57.66 7.04 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-N 115.138 -0.937 . . . . 73.54 112.677 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -72.81 -20.9 61.06 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.897 -0.721 . . . . 72.12 109.478 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.21 -14.81 62.12 Favored Glycine 0 C--N 1.359 1.835 0 N-CA-C 109.323 -1.511 . . . . 60.21 109.323 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.19 -178.96 48.24 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 109.09 -1.604 . . . . 61.41 109.09 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.418 HG13 HD12 ' A' ' 67' ' ' LEU . 13.7 mm -81.66 124.5 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 103.014 -2.958 . . . . 65.33 103.014 171.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -100.87 150.4 22.87 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 103.688 -2.708 . . . . 73.24 103.688 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.1 t -80.18 102.97 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.078 -2.193 . . . . 64.2 105.078 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -71.57 -32.87 68.56 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.752 -1.113 . . . . 72.4 109.933 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.82 147.9 22.0 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 106.273 -1.751 . . . . 71.21 106.273 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.13 133.05 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 N-CA-C 103.174 -2.898 . . . . 64.1 103.174 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.476 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.95 152.5 71.75 Favored Pre-proline 0 CA--C 1.511 -0.526 0 N-CA-C 106.502 -1.666 . . . . 60.35 106.502 176.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 58.8 Cg_endo -76.86 172.57 15.96 Favored 'Trans proline' 0 CA--C 1.463 -3.053 0 N-CA-C 105.909 -2.381 . . . . 71.42 105.909 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 66.21 -1.72 1.13 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 124.294 0.996 . . . . 54.33 111.994 163.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.65 -179.1 36.5 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 107.334 -2.306 . . . . 63.34 107.334 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.89 -52.94 45.83 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.268 -1.012 . . . . 62.0 108.268 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.37 65.24 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.379 -0.373 . . . . 75.22 110.838 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.0 -55.31 26.85 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 109.583 -0.525 . . . . 75.41 109.583 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 t -58.35 -32.51 68.6 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.045 0.538 . . . . 64.21 110.641 -171.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.91 -29.6 29.1 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.797 -1.186 . . . . 62.4 107.797 -172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.25 83.65 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 110.36 -1.096 . . . . 64.05 110.36 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -99.31 6.39 46.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 106.709 -1.589 . . . . 72.54 106.709 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.0 mt -142.44 138.59 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 103.098 -2.927 . . . . 72.41 103.098 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.02 166.34 26.35 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.482 -2.414 . . . . 74.0 104.482 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.72 145.77 54.43 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 107.119 -1.437 . . . . 64.2 107.119 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.59 -33.01 5.97 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 107.982 -2.047 . . . . 64.44 107.982 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.92 149.08 45.52 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 106.941 -1.503 . . . . 70.44 106.941 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.79 143.86 47.62 Favored 'General case' 0 CA--C 1.473 -2.009 0 N-CA-C 107.259 -1.386 . . . . 72.2 107.259 -165.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.26 130.07 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 105.826 -1.916 . . . . 62.21 105.826 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.494 ' CD1' HG23 ' A' ' 7' ' ' ILE . 78.6 mt -95.27 -59.28 1.92 Allowed 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.275 -1.38 . . . . 72.12 107.275 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.95 51.17 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 105.946 -1.872 . . . . 62.53 105.946 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.73 121.45 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.376 -2.083 . . . . 63.31 105.376 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.47 30.5 13.01 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.524 0.678 . . . . 70.04 109.724 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.81 -18.2 57.2 Favored Glycine 0 CA--C 1.48 -2.152 0 N-CA-C 109.158 -1.577 . . . . 73.01 109.158 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.64 115.75 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 108.266 -1.013 . . . . 73.22 108.266 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 m -56.74 120.0 7.11 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 107.899 -1.148 . . . . 75.33 107.899 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.418 HD12 HG13 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -111.92 -11.83 13.84 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.663 -1.606 . . . . 63.53 106.663 -162.079 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -56.38 128.34 35.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.969 -0.752 . . . . 75.43 108.969 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.88 -13.03 68.31 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 108.773 -1.731 . . . . 65.43 108.773 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.74 157.04 20.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.56 -1.645 . . . . 63.23 106.56 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.421 HG22 HG22 ' A' ' 27' ' ' VAL . 41.1 p -85.68 179.08 7.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.735 0.778 . . . . 75.42 109.402 -171.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -64.7 -45.22 87.51 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 115.392 -0.822 . . . . 73.53 108.97 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -54.5 -55.24 31.14 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 121.567 -0.708 . . . . 62.14 109.955 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -53.84 -43.76 69.74 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.696 -0.483 . . . . 70.24 109.696 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.35 27.25 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.811 0.444 . . . . 42.04 110.531 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 m -74.98 -35.47 35.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 O-C-N 121.976 -0.453 . . . . 73.42 109.835 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 12.6 t -69.11 -32.9 72.63 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 116.854 -1.938 . . . . 63.31 105.986 -169.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -73.09 -45.14 58.87 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 106.996 -1.483 . . . . 61.34 106.996 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.0 -45.15 95.98 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.831 1.253 . . . . 74.31 109.562 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -67.38 -56.2 10.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.517 -0.92 . . . . 73.44 108.517 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -71.47 52.16 0.19 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.75 0.42 . . . . 54.51 110.854 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 86' ' ' VAL . 6.2 p -101.69 -175.49 2.87 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.589 -2.004 . . . . 71.15 105.589 168.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.79 -152.72 17.45 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.222 -2.351 . . . . 61.11 107.222 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -63.33 -55.34 25.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.191 -1.04 . . . . 73.24 108.191 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.59 145.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 106.388 -1.708 . . . . 73.23 106.388 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 82' ' ' THR . 23.6 t -101.17 129.03 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 N-CA-C 105.242 -2.133 . . . . 74.43 105.242 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -111.98 121.63 45.54 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 104.063 -2.569 . . . . 61.43 104.063 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.68 133.61 12.28 Favored 'General case' 0 CA--C 1.46 -2.498 0 N-CA-C 106.518 -1.66 . . . . 71.5 106.518 -174.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -86.98 145.38 26.53 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 107.938 -1.134 . . . . 54.3 107.938 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.568 HD22 ' H ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -131.8 169.05 16.77 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.533 -2.025 . . . . 65.4 105.533 174.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.42 153.06 48.3 Favored 'General case' 0 N--CA 1.402 -2.843 0 N-CA-C 101.822 -3.399 . . . . 74.53 101.822 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 6.5 mmpt? -65.32 135.03 54.83 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.743 -1.206 . . . . 74.23 107.743 175.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.466 -2.969 0 N-CA-C 107.131 -2.388 . . . . 74.21 107.131 -176.514 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.642 0 N-CA-C 108.68 -1.768 . . . . 61.31 108.68 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -83.19 138.75 33.51 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.601 -1.629 . . . . 75.31 106.601 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.546 HG23 ' CD1' ' A' ' 60' ' ' LEU . 23.4 mm -95.91 122.44 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 105.949 -1.871 . . . . 65.43 105.949 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.63 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.8 p90 -136.68 157.02 47.74 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.397 -0.964 . . . . 74.45 108.397 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -103.01 148.44 25.69 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 104.512 -2.403 . . . . 74.43 104.512 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.779 HG22 HD21 ' A' ' 90' ' ' LEU . 15.9 m -137.05 147.1 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.062 0 N-CA-C 106.078 -1.823 . . . . 51.42 106.078 170.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.63 118.18 35.95 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 104.671 -2.344 . . . . 74.25 104.671 168.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.416 HD13 HD12 ' A' ' 53' ' ' ILE . 59.3 mt -139.61 135.88 33.79 Favored 'General case' 0 CA--C 1.455 -2.7 0 N-CA-C 105.673 -1.973 . . . . 74.05 105.673 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . . . -85.45 157.26 20.52 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 106.753 -1.573 . . . . 71.43 106.753 -176.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.23 -40.72 98.24 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 106.747 -1.575 . . . . 74.24 106.747 167.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 78.36 108.32 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 107.828 -1.175 . . . . 72.34 107.828 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 18' ' ' SER . 68.4 m-20 56.81 39.09 29.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.79 0.836 . . . . 73.43 108.843 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.3 t30 55.03 -9.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.728 1.611 . . . . 53.42 113.634 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 16' ' ' ASP . 32.6 t -99.67 120.53 39.85 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.712 -1.959 . . . . 75.43 105.712 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.714 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -70.91 -56.18 6.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.904 -1.147 . . . . 54.1 107.904 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.72 85.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 109.91 -1.276 . . . . 63.23 109.91 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 22' ' ' CYS . 5.2 mm -86.7 176.57 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 105.262 -2.125 . . . . 61.01 105.262 -174.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 21' ' ' ILE . 60.0 m -138.64 164.38 29.66 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 103.754 -2.684 . . . . 72.42 103.754 174.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.65 171.93 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 105.772 -1.936 . . . . 72.14 105.772 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 t -164.15 170.64 16.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.399 -2.075 . . . . 72.34 105.399 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 -154.53 21.97 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 107.165 -2.374 . . . . 55.43 107.165 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.12 -99.0 0.65 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 109.435 -1.466 . . . . 60.4 109.435 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -68.36 16.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.211 1.189 . . . . 63.53 114.211 -161.687 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m120 85.24 6.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.267 1.027 . . . . 51.4 108.714 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -43.09 -168.34 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 126.737 2.015 . . . . 63.34 110.009 151.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 m -28.75 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.205 1.802 . . . . 64.31 114.942 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 131.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.207 -1.035 . . . . 74.54 108.207 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.13 -40.34 38.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.492 -0.929 . . . . 73.05 108.492 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -64.14 -18.01 64.03 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.916 -0.772 . . . . 73.22 108.916 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.69 2.31 64.07 Favored Glycine 0 C--O 1.208 -1.477 0 N-CA-C 110.722 -0.951 . . . . 71.2 110.722 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.93 177.68 52.15 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 106.614 -2.594 . . . . 62.1 106.614 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -90.78 136.55 23.78 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 N-CA-C 104.415 -2.439 . . . . 73.51 104.415 174.539 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -108.4 148.73 29.72 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 103.358 -2.83 . . . . 71.32 103.358 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.65 102.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 106.547 -1.649 . . . . 63.15 106.547 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -71.66 -36.3 70.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.665 -1.152 . . . . 75.21 110.45 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.97 148.94 22.77 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.061 -1.829 . . . . 74.12 106.061 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.49 138.01 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 103.936 -2.616 . . . . 75.44 103.936 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -79.17 155.52 77.06 Favored Pre-proline 0 CA--C 1.515 -0.386 0 N-CA-C 105.738 -1.949 . . . . 74.02 105.738 173.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 75.2 Cg_endo -74.39 171.7 17.57 Favored 'Trans proline' 0 CA--C 1.461 -3.168 0 N-CA-C 105.72 -2.454 . . . . 61.43 105.72 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 65.07 -0.2 1.11 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.012 0.82 . . . . 74.45 112.13 164.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.55 174.14 41.1 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 106.624 -2.59 . . . . 70.43 106.624 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.17 -52.87 36.17 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 107.854 -1.165 . . . . 42.22 107.854 -173.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.23 -50.66 64.3 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 116.068 -0.515 . . . . 71.45 111.008 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.04 -54.47 21.27 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 109.933 -0.395 . . . . 73.03 109.933 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.3 t -61.76 -28.58 69.54 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.792 0.437 . . . . 72.24 110.965 -170.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.29 -30.2 38.26 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.105 -1.813 . . . . 75.51 106.105 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.47 20.01 61.05 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 110.146 -1.182 . . . . 71.55 110.146 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -107.59 7.24 28.56 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.696 -1.224 . . . . 75.4 107.696 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.416 HD12 HD13 ' A' ' 12' ' ' LEU . 77.7 mt -144.55 145.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 102.359 -3.2 . . . . 71.45 102.359 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -151.26 176.19 11.46 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 104.77 -2.307 . . . . 74.53 104.77 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -67.23 143.29 56.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.671 -1.233 . . . . 72.1 107.671 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.44 -32.01 7.66 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.029 -1.628 . . . . 64.25 109.029 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.19 160.1 31.76 Favored 'General case' 0 C--N 1.372 1.563 0 N-CA-C 107.347 -1.353 . . . . 62.54 107.347 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -128.42 151.51 49.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 -168.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.92 135.78 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.525 -2.028 . . . . 64.14 105.525 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.546 ' CD1' HG23 ' A' ' 7' ' ' ILE . 53.0 mt -98.5 -58.76 1.89 Allowed 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 107.391 -1.337 . . . . 54.22 107.391 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.97 148.99 48.7 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 106.149 -1.797 . . . . 71.14 106.149 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.46 122.2 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.376 -2.453 . . . . 72.02 104.376 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.31 3.5 p-10 44.59 39.9 3.64 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.36 1.064 . . . . 61.11 111.161 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.87 -22.34 41.1 Favored Glycine 0 CA--C 1.471 -2.665 0 N-CA-C 108.936 -1.665 . . . . 74.12 108.936 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -78.25 114.83 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 N-CA-C 107.369 -1.345 . . . . 74.12 107.369 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 m -56.01 120.36 7.33 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.877 -0.786 . . . . 64.23 108.877 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -99.37 -17.29 18.08 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 106.916 -1.513 . . . . 75.44 106.916 -164.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -62.05 125.08 22.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.397 0.618 . . . . 72.42 109.878 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 -15.28 62.0 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 108.019 -2.032 . . . . 53.43 108.019 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 149.29 34.78 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 106.146 -1.798 . . . . 43.33 106.146 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.0 p -80.51 179.05 7.93 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.708 -0.849 . . . . 71.12 108.708 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -63.46 -50.18 70.7 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.117 -1.068 . . . . 74.22 108.117 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -54.2 -55.74 25.04 Favored 'General case' 0 C--N 1.362 1.148 0 O-C-N 121.66 -0.65 . . . . 73.33 110.601 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -54.59 -46.46 73.77 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 109.395 -0.594 . . . . 63.3 109.395 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.99 -52.47 50.32 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.163 0.585 . . . . 75.13 110.568 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.64 -40.11 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 108.025 -1.102 . . . . 75.22 108.025 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 t -63.95 -30.99 72.02 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 106.551 -1.648 . . . . 71.5 106.551 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.6 m -71.79 -45.79 60.43 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.602 -1.259 . . . . 74.35 107.602 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.99 -40.46 89.23 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 108.945 -0.761 . . . . 71.34 108.945 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.6 -60.56 3.35 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 108.2 -1.037 . . . . 63.34 108.2 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -71.36 53.37 0.2 Allowed 'General case' 0 C--N 1.373 1.605 0 C-N-CA 123.543 0.737 . . . . 53.44 110.572 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.469 HG21 HG13 ' A' ' 86' ' ' VAL . 16.1 p -112.38 -176.23 2.87 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.544 -2.021 . . . . 63.12 105.544 168.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.75 -159.69 32.4 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.195 -2.362 . . . . 63.32 107.195 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -56.86 -53.52 56.98 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.646 -0.872 . . . . 71.53 108.646 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' ALA . 86.5 t -105.66 147.2 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 106.012 -1.847 . . . . 45.02 106.012 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 82' ' ' THR . 39.6 t -100.37 129.53 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 106.66 -1.607 . . . . 74.24 106.66 -171.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -103.89 117.27 33.94 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 105.089 -2.189 . . . . 64.31 105.089 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.76 134.42 14.57 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 107.603 -1.258 . . . . 71.01 107.603 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.45 141.41 33.92 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.447 -1.316 . . . . 55.32 107.447 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.779 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.11 163.51 16.15 Favored 'General case' 0 CA--C 1.473 -2.001 0 N-CA-C 105.605 -1.998 . . . . 71.21 105.605 175.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HB2' HD11 ' A' ' 60' ' ' LEU . 33.9 tt0 -130.76 139.2 50.23 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 101.45 -3.537 . . . . 71.52 101.45 165.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -66.19 142.46 57.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.678 0 N-CA-C 105.859 -2.896 . . . . 72.33 105.859 179.592 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.744 0 N-CA-C 110.004 -1.239 . . . . 72.45 110.004 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.18 130.71 40.28 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.212 -1.403 . . . . 74.31 107.212 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 HD11 ' A' ' 60' ' ' LEU . 12.0 mm -98.45 136.16 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.19 -1.781 . . . . 73.34 106.19 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.79 160.09 43.11 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.68 -0.859 . . . . 73.24 108.68 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -105.83 145.96 30.52 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 105.511 -2.033 . . . . 70.03 105.511 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.99 156.5 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 106.82 -1.548 . . . . 54.41 106.82 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -116.11 134.76 54.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.517 -2.031 . . . . 65.1 105.517 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.409 HD22 HD13 ' A' ' 53' ' ' ILE . 4.3 mp -135.61 145.82 47.28 Favored 'General case' 0 CA--C 1.454 -2.721 0 N-CA-C 107.755 -1.202 . . . . 74.02 107.755 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.06 142.33 28.0 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 105.206 -2.146 . . . . 54.32 105.206 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HG2' ' HB2' ' A' ' 19' ' ' LEU . 37.0 mtpt -77.68 -33.44 53.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 106.133 -1.803 . . . . 73.11 106.133 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 70.55 126.13 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.066 -1.424 . . . . 65.34 108.79 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.0 t70 59.71 34.82 22.16 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.075 -0.713 . . . . 74.02 109.075 173.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.1 t30 55.38 -9.18 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.009 1.724 . . . . 74.13 113.582 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.4 m -99.2 130.68 45.52 Favored 'General case' 0 N--CA 1.424 -1.732 0 O-C-N 120.815 -1.178 . . . . 70.12 108.535 -168.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 24.7 tp -134.04 139.3 45.92 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 102.679 -3.082 . . . . 71.51 102.679 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.85 62.48 0.24 Allowed Glycine 0 CA--C 1.464 -3.137 0 N-CA-C 106.215 -2.754 . . . . 63.52 106.215 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 22' ' ' CYS . 1.1 mm -88.54 178.14 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.198 -2.519 . . . . 74.32 104.198 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' H ' HG22 ' A' ' 21' ' ' ILE . 8.2 m -118.43 160.35 21.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.016 -2.216 . . . . 75.01 105.016 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 m -152.05 173.03 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 106.1 -1.815 . . . . 60.23 106.1 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.404 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 12.4 t -167.22 170.54 11.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.115 -1.809 . . . . 61.3 106.115 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.57 -145.39 17.71 Favored Glycine 0 CA--C 1.485 -1.796 0 N-CA-C 109.857 -1.297 . . . . 65.44 109.857 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.67 -79.26 0.25 Allowed Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.784 -1.727 . . . . 61.23 108.784 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -77.07 15.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.817 0 N-CA-C 112.304 0.483 . . . . 72.02 112.304 -164.528 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 85.58 6.36 0.44 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 124.234 1.014 . . . . 54.2 109.35 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.1 p -46.94 -168.9 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.901 1.68 . . . . 71.42 112.188 165.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 m -35.13 -35.53 0.04 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.045 1.738 . . . . 74.53 113.596 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 m -58.84 113.28 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.412 1.101 . . . . 74.23 110.159 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -47.87 -58.97 3.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.812 -1.086 . . . . 73.42 112.626 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -69.18 -20.65 64.0 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.822 -0.548 . . . . 64.34 110.071 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 52.34 4.02 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 107.591 -2.204 . . . . 71.24 107.591 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.4 179.81 25.88 Favored Glycine 0 CA--C 1.459 -3.459 0 N-CA-C 103.108 -3.997 . . . . 74.04 103.108 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.9 mm -88.71 127.78 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.792 0 N-CA-C 105.236 -2.135 . . . . 73.2 105.236 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -107.41 154.66 21.0 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 104.677 -2.342 . . . . 75.21 104.677 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 41' ' ' VAL . 60.6 t -87.25 101.71 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 N-CA-C 105.089 -2.189 . . . . 72.14 105.089 171.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HE2' ' HB ' ' A' ' 24' ' ' THR . 11.5 ttmm -71.62 -26.2 62.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.121 -0.945 . . . . 74.02 109.082 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 142.96 16.69 Favored 'General case' 0 CA--C 1.46 -2.495 0 N-CA-C 105.627 -1.99 . . . . 64.45 105.627 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 38' ' ' VAL . 84.8 t -110.21 125.98 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 102.729 -3.064 . . . . 62.12 102.729 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.566 ' O ' HD12 ' A' ' 42' ' ' ILE . 2.4 pp -76.63 145.95 75.96 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.978 -1.86 . . . . 73.54 105.978 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.81 174.53 12.43 Favored 'Trans proline' 0 CA--C 1.469 -2.742 0 N-CA-C 105.813 -2.418 . . . . 74.33 105.813 -174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 69.05 -11.85 0.43 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.238 0.961 . . . . 73.42 112.597 161.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.23 -177.69 40.34 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 108.275 -1.93 . . . . 65.41 108.275 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.59 60.53 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 108.167 -1.049 . . . . 61.13 108.167 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.48 65.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.174 -0.466 . . . . 52.14 110.675 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.62 -53.87 44.79 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 122.009 -0.432 . . . . 74.55 109.876 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 t -60.14 -33.53 72.29 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.288 -0.634 . . . . 72.55 109.288 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.97 -43.42 35.1 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.342 -1.355 . . . . 60.24 107.342 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.94 11.08 79.78 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.615 -0.994 . . . . 52.03 110.615 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -95.24 7.33 46.48 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.583 -1.265 . . . . 64.41 107.583 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.409 HD13 HD22 ' A' ' 12' ' ' LEU . 1.6 mp -134.32 139.4 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 102.537 -3.134 . . . . 64.41 102.537 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -148.04 161.45 41.36 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 104.986 -2.227 . . . . 70.03 104.986 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -66.6 138.93 57.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.996 -1.112 . . . . 60.43 107.996 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.41 -32.51 7.48 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 108.069 -2.012 . . . . 70.34 108.069 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.97 154.23 41.65 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 107.011 -1.478 . . . . 73.15 107.011 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 91' ' ' GLU . 19.1 ptt-85 -131.38 155.16 47.76 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.369 -0.974 . . . . 61.5 108.369 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.28 139.44 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 105.908 -1.886 . . . . 74.31 105.908 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD11 HD12 ' A' ' 7' ' ' ILE . 93.6 mt -102.28 -57.97 1.96 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.832 -1.544 . . . . 63.53 106.832 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.24 148.34 49.56 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.549 -2.019 . . . . 54.34 105.549 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.6 119.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 105.233 -2.136 . . . . 73.44 105.233 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.8 t30 53.57 36.12 22.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.606 0.762 . . . . 73.14 109.841 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.87 -21.77 44.25 Favored Glycine 0 CA--C 1.474 -2.524 0 N-CA-C 108.777 -1.729 . . . . 70.3 108.777 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.8 115.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 108.082 -1.081 . . . . 64.12 108.082 -172.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -52.41 120.97 6.16 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.523 0.729 . . . . 60.43 109.122 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -109.94 -19.16 13.2 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 107.549 -1.278 . . . . 64.34 107.549 -167.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.9 127.37 31.11 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 120.787 -1.196 . . . . 73.43 108.38 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.86 62.06 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 108.553 -1.819 . . . . 65.22 108.553 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.76 151.24 30.48 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 105.311 -2.107 . . . . 62.41 105.311 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.401 ' HA ' HG22 ' A' ' 27' ' ' VAL . 58.6 p -81.68 179.39 7.85 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.712 -0.847 . . . . 72.33 108.712 -171.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.5 -45.32 69.21 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.197 -1.038 . . . . 73.34 108.197 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -52.49 -56.11 17.38 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 121.339 -0.851 . . . . 53.22 109.852 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -53.75 -41.63 67.32 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 109.746 -0.465 . . . . 74.23 109.746 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -53.0 -50.04 65.01 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 116.087 -0.506 . . . . 62.42 109.933 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.2 t -73.52 -42.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 108.067 -1.086 . . . . 72.31 108.067 -174.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.4 m -57.97 -35.12 70.72 Favored 'General case' 0 N--CA 1.523 3.224 0 N-CA-C 106.177 -1.786 . . . . 64.34 106.177 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.6 m -73.24 -47.89 39.47 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.904 -1.043 . . . . 74.23 108.554 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.75 -37.67 82.46 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.379 -0.6 . . . . 53.24 109.379 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -69.12 -60.53 2.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.614 -1.254 . . . . 72.11 107.614 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -69.17 57.39 0.1 Allowed 'General case' 0 C--N 1.367 1.337 0 C-N-CA 123.595 0.758 . . . . 72.21 110.981 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -109.24 -176.38 3.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.775 -1.565 . . . . 55.4 106.775 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.27 -144.99 16.07 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.313 -2.315 . . . . 73.05 107.313 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -72.19 -55.58 7.01 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.666 -0.864 . . . . 74.23 108.666 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.52 146.84 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 106.19 -1.781 . . . . 75.32 106.19 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -105.08 132.85 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 105.241 -2.133 . . . . 64.24 105.241 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -113.21 132.55 55.46 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.73 -2.322 . . . . 63.23 104.73 173.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -159.49 143.5 14.88 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 108.582 -0.895 . . . . 74.51 108.582 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.08 137.88 35.98 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 107.267 -1.383 . . . . 61.03 107.267 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.69 161.9 36.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.531 -1.285 . . . . 74.24 107.531 176.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 58' ' ' ARG . 79.6 tt0 -133.69 141.76 47.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 104.183 -2.525 . . . . 64.4 104.183 -173.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -66.82 144.35 56.35 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.928 -0.767 . . . . 74.12 108.928 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.474 -2.485 0 N-CA-C 105.665 -2.974 . . . . 71.21 105.665 178.92 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 109.231 -1.547 . . . . 71.51 109.231 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -77.07 134.29 38.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.839 -1.541 . . . . 75.44 106.839 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.407 HD13 HD11 ' A' ' 60' ' ' LEU . 2.5 mt -105.25 138.12 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 N-CA-C 107.405 -1.332 . . . . 71.24 107.405 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -156.41 172.37 18.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.368 -1.345 . . . . 73.45 107.368 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.01 155.01 27.75 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 106.051 -1.833 . . . . 73.41 106.051 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.84 156.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 105.711 -1.959 . . . . 54.51 105.711 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.84 130.35 55.0 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.176 -1.787 . . . . 63.13 106.176 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.72 140.06 47.91 Favored 'General case' 0 CA--C 1.46 -2.501 0 N-CA-C 106.875 -1.528 . . . . 55.31 106.875 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 140.99 31.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.648 -1.982 . . . . 62.12 105.648 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -68.61 -28.2 66.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.648 -1.241 . . . . 73.0 107.648 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 t30 86.51 93.54 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.324 -1.361 . . . . 72.34 107.324 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.28 47.77 6.7 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.772 -1.195 . . . . 52.45 107.772 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 45.94 -0.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 127.588 2.355 . . . . 62.44 115.407 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -104.83 115.27 30.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.887 1.221 . . . . 62.31 108.03 -172.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.718 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.6 pt? -89.48 -155.39 0.35 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.432 -1.692 . . . . 71.01 106.432 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.34 55.56 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.189 0 N-CA-C 106.275 -2.73 . . . . 71.3 106.275 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.3 mm -106.65 178.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.119 -2.919 . . . . 72.42 103.119 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.417 ' H ' HG22 ' A' ' 21' ' ' ILE . 56.0 m -133.01 163.79 28.43 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.176 -2.157 . . . . 75.2 105.176 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.35 175.86 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.827 -1.546 . . . . 64.31 106.827 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -164.21 167.0 20.54 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 104.816 -2.29 . . . . 73.23 104.816 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.49 23.28 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 108.479 -1.849 . . . . 64.24 108.479 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.68 -74.13 0.21 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 108.776 -1.729 . . . . 63.34 108.776 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.14 15.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.203 0.525 . . . . 73.22 109.659 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.8 t30 84.46 5.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.962 1.305 . . . . 73.31 108.006 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -53.74 -170.69 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.53 1.132 . . . . 73.21 112.293 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 m -29.46 -45.73 0.05 OUTLIER 'General case' 0 C--N 1.367 1.366 0 C-N-CA 126.843 2.057 . . . . 52.14 115.934 -159.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.52 125.56 19.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 CA-C-O 122.05 0.929 . . . . 75.22 109.954 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -52.65 -44.31 66.07 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.583 -1.19 . . . . 63.15 112.884 -169.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.411 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 23.8 t-160 -75.45 -21.25 58.27 Favored 'General case' 0 C--N 1.37 1.486 0 O-C-N 120.823 -1.173 . . . . 73.51 108.719 -175.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -14.79 62.97 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 109.878 -1.289 . . . . 62.41 109.878 171.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.95 179.92 44.13 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 108.551 -1.82 . . . . 71.31 108.551 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.1 mm -83.2 127.85 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 N-CA-C 104.336 -2.468 . . . . 74.44 104.336 171.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.53 152.27 23.9 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 104.567 -2.383 . . . . 74.03 104.567 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.27 100.29 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 104.785 -2.302 . . . . 74.34 104.785 170.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.64 -17.97 42.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.788 -1.096 . . . . 73.54 111.725 -176.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.86 19.53 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 106.997 -1.483 . . . . 72.51 106.997 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.89 132.02 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 103.581 -2.748 . . . . 75.23 103.581 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.93 145.6 81.44 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 106.252 -1.759 . . . . 73.21 106.252 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.01 167.02 27.95 Favored 'Trans proline' 0 CA--C 1.464 -2.996 0 N-CA-C 106.848 -2.02 . . . . 64.42 106.848 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 69.06 2.1 3.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 124.474 1.109 . . . . 73.52 110.884 165.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.68 -175.77 38.43 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 108.515 -1.834 . . . . 53.43 108.515 -174.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.58 55.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 108.123 -1.066 . . . . 65.0 108.123 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.72 -49.39 62.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.978 -0.556 . . . . 52.31 110.417 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.31 -52.64 31.25 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.875 -0.33 . . . . 64.35 110.407 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.8 t -65.73 -36.24 83.04 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.686 -0.634 . . . . 70.54 109.973 -169.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.57 -25.57 35.69 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 106.672 -1.603 . . . . 62.42 106.672 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.1 78.78 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.75 -0.94 . . . . 74.42 110.75 167.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -87.24 1.99 51.45 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.684 -1.228 . . . . 74.31 107.684 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.9 mt -143.6 140.89 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 103.832 -2.655 . . . . 74.34 103.832 -168.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -142.72 159.4 42.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.029 -2.582 . . . . 75.14 104.029 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.45 142.88 57.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.007 -1.109 . . . . 72.55 108.007 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.56 -31.87 8.14 Favored Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 107.467 -2.253 . . . . 73.21 107.467 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -58.86 147.86 32.24 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 109.039 -0.726 . . . . 62.31 109.039 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -114.88 139.93 49.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.623 -1.251 . . . . 72.21 107.623 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.89 129.03 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.451 -2.055 . . . . 64.44 105.451 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.407 HD11 HD13 ' A' ' 7' ' ' ILE . 89.2 mt -97.33 -58.81 1.92 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 106.905 -1.517 . . . . 54.03 106.905 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.23 148.76 48.22 Favored 'General case' 0 CA--C 1.476 -1.865 0 N-CA-C 106.414 -1.699 . . . . 71.04 106.414 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.2 121.59 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 105.29 -2.115 . . . . 64.34 105.29 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.9 t30 53.16 37.32 24.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 71.14 110.046 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.49 -26.88 22.05 Favored Glycine 0 CA--C 1.471 -2.672 0 N-CA-C 108.513 -1.835 . . . . 61.32 108.513 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 83.4 t -79.4 116.69 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 107.809 -1.182 . . . . 74.4 107.809 -171.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 114.65 1.76 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 108.593 -0.892 . . . . 72.24 108.593 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 75' ' ' ALA . 2.1 tm? -102.27 -18.82 15.29 Favored 'General case' 0 C--O 1.191 -1.992 0 N-CA-C 106.363 -1.717 . . . . 73.4 106.363 -167.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.16 129.14 39.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.193 -0.942 . . . . 64.45 108.473 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.56 -16.56 56.34 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 108.044 -2.022 . . . . 34.21 108.044 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.61 154.1 27.61 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.435 -1.691 . . . . 54.25 106.435 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.0 p -81.13 179.88 7.66 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.109 -0.7 . . . . 64.43 109.109 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -58.76 -53.33 59.56 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 107.936 -1.135 . . . . 71.45 107.936 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.57 -48.3 80.07 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 110.282 -0.266 . . . . 74.55 110.282 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -57.84 -41.08 81.6 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.767 -0.457 . . . . 75.13 109.767 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' HD11 ' A' ' 67' ' ' LEU . . . -50.67 -56.22 12.9 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 120.818 0.342 . . . . 65.51 110.714 177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.7 m -74.64 -33.39 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 109.145 -0.687 . . . . 34.33 109.145 -173.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.9 t -68.79 -31.55 70.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 105.991 -1.855 . . . . 74.41 105.991 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.2 m -71.37 -41.83 69.22 Favored 'General case' 0 C--O 1.207 -1.133 0 O-C-N 120.319 -1.488 . . . . 74.3 107.464 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.3 -29.55 69.94 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 109.232 -0.655 . . . . 75.41 109.232 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -73.78 -61.21 1.92 Allowed 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.807 -1.183 . . . . 74.5 107.807 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.83 54.45 0.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.422 0.629 . . . . 64.43 111.548 -174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 p -112.77 -175.06 2.58 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 104.956 -2.238 . . . . 75.22 104.956 167.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.78 -161.55 25.97 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 107.71 -2.156 . . . . 63.4 107.71 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -52.69 -53.34 48.87 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.8 -0.815 . . . . 55.24 108.8 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.5 t -102.99 148.8 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 105.465 -2.05 . . . . 63.51 105.465 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.4 t -104.59 131.11 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 N-CA-C 105.42 -2.067 . . . . 43.11 105.42 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -112.92 128.91 56.6 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.048 -2.575 . . . . 61.31 104.048 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 142.97 17.75 Favored 'General case' 0 CA--C 1.467 -2.227 0 N-CA-C 108.087 -1.079 . . . . 74.24 108.087 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 135.67 35.93 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.839 -1.541 . . . . 72.0 106.839 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.65 160.43 33.36 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 106.353 -1.721 . . . . 71.12 106.353 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.6 135.03 48.77 Favored 'General case' 0 N--CA 1.397 -3.106 0 N-CA-C 102.102 -3.296 . . . . 72.2 102.102 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.654 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 6.8 mmpt? -62.48 136.86 58.1 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 107.813 -1.18 . . . . 74.01 107.813 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.461 -3.326 0 N-CA-C 106.78 -2.528 . . . . 74.23 106.78 -171.425 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.105 0 N-CA-C 109.25 -1.54 . . . . 74.12 109.25 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -81.77 140.34 34.3 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.613 -1.625 . . . . 60.13 106.613 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.47 HG23 ' CD1' ' A' ' 60' ' ' LEU . 10.8 mt -104.86 137.75 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.467 0 N-CA-C 108.392 -0.966 . . . . 72.35 108.392 -173.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.488 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.2 p90 -138.89 155.8 47.8 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 107.098 -1.445 . . . . 51.21 107.098 172.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -105.89 145.71 30.9 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.757 -1.942 . . . . 73.31 105.757 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.677 HG22 HD21 ' A' ' 90' ' ' LEU . 30.4 m -142.34 155.86 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 106.888 -1.523 . . . . 63.41 106.888 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.66 122.96 46.1 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 105.088 -2.19 . . . . 65.11 105.088 167.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 52' ' ' ARG . 12.7 mt -131.97 133.12 44.13 Favored 'General case' 0 CA--C 1.458 -2.58 0 N-CA-C 105.018 -2.216 . . . . 63.24 105.018 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.02 22.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 105.805 -1.924 . . . . 53.23 105.805 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -70.04 -36.16 74.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.999 -1.852 . . . . 74.23 105.999 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 81.48 113.21 0.06 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 125.231 1.412 . . . . 61.11 108.117 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.57 36.21 25.01 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.791 -1.188 . . . . 75.1 107.791 -173.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 43.38 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 127.485 2.314 . . . . 63.4 115.25 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.7 m -97.24 124.52 41.35 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 119.985 1.266 . . . . 72.24 107.904 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.625 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -97.03 -158.88 0.7 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 105.817 -1.92 . . . . 73.22 105.817 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.76 32.09 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 106.671 -2.571 . . . . 71.42 106.671 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.1 mm -88.16 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.863 -2.273 . . . . 61.24 104.863 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.2 m -140.56 167.23 22.66 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 103.849 -2.649 . . . . 51.53 103.849 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 36' ' ' ILE . 9.0 m -148.38 173.18 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 106.985 -1.487 . . . . 74.22 106.985 -168.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 39' ' ' LYS . 8.2 t -159.32 164.01 35.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 104.037 -2.579 . . . . 44.55 104.037 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -139.16 18.31 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.356 -1.898 . . . . 71.01 108.356 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.61 -79.31 0.29 Allowed Glycine 0 CA--C 1.466 -3.001 0 N-CA-C 108.54 -1.824 . . . . 33.44 108.54 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -76.11 16.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 122.731 0.413 . . . . 74.32 111.045 -171.163 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 85.59 5.68 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.832 1.253 . . . . 70.52 108.099 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -55.85 -171.0 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.476 -0.784 . . . . 74.23 111.851 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 m -29.1 -45.03 0.04 OUTLIER 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.439 2.295 . . . . 63.33 116.009 -162.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.72 136.82 16.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-O 121.663 0.744 . . . . 72.22 111.855 -172.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -35.16 -71.53 0.07 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 126.17 1.788 . . . . 73.41 113.207 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -76.97 -15.6 59.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.26 -0.9 . . . . 72.43 110.104 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.38 61.79 2.16 Favored Glycine 0 CA--C 1.491 -1.449 0 N-CA-C 108.093 -2.003 . . . . 72.42 108.093 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.95 -178.81 25.23 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 104.376 -3.49 . . . . 72.41 104.376 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 36' ' ' ILE . 7.0 mm -83.72 122.3 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.131 0 N-CA-C 104.427 -2.434 . . . . 71.42 104.427 172.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -107.17 153.13 23.13 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 103.809 -2.663 . . . . 63.45 103.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -83.55 102.32 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.154 -1.795 . . . . 62.23 106.154 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HB2' HG22 ' A' ' 24' ' ' THR . 13.5 tptm -72.91 -31.11 64.42 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.423 -0.808 . . . . 75.42 111.036 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.73 145.4 18.61 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 106.495 -1.668 . . . . 75.12 106.495 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -122.27 133.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.413 -2.81 . . . . 65.43 103.413 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.97 151.49 86.34 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 106.398 -1.705 . . . . 65.11 106.398 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.33 167.66 25.35 Favored 'Trans proline' 0 CA--C 1.457 -3.336 0 N-CA-C 105.735 -2.448 . . . . 74.31 105.735 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 68.38 1.98 3.13 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.769 0.668 . . . . 73.04 110.109 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.99 175.06 42.98 Favored Glycine 0 CA--C 1.472 -2.642 0 N-CA-C 107.571 -2.212 . . . . 72.32 107.571 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.13 -48.6 64.97 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 107.355 -1.35 . . . . 64.01 107.355 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.19 64.9 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 116.067 -0.515 . . . . 73.44 110.019 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.08 -56.22 14.25 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.975 -0.379 . . . . 74.24 109.975 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -65.44 -28.94 69.59 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.908 0.385 . . . . 70.34 110.515 -166.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -83.17 -31.28 27.22 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 106.764 -1.569 . . . . 64.31 106.764 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 16.91 65.88 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 111.025 -0.83 . . . . 54.1 111.025 170.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HB2' HD11 ' A' ' 12' ' ' LEU . 17.1 mmp_? -91.71 5.65 48.93 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.523 -1.288 . . . . 70.21 107.523 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.9 mt -144.83 144.88 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 104.161 -2.533 . . . . 72.43 104.161 -171.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -149.3 168.24 23.88 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 101.871 -3.381 . . . . 73.42 101.871 172.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -66.44 144.16 56.67 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.074 -1.084 . . . . 75.22 108.074 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.19 -32.5 7.47 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.07 -1.062 . . . . 54.42 110.839 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -66.65 154.55 40.3 Favored 'General case' 0 C--N 1.378 1.822 0 CA-C-N 119.871 1.836 . . . . 72.43 107.859 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 137.41 51.92 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.047 -1.464 . . . . 74.35 107.047 -164.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.5 127.27 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 106.452 -1.684 . . . . 70.44 106.452 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.47 ' CD1' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -95.12 -59.83 1.81 Allowed 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.017 -1.105 . . . . 72.04 108.017 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.38 148.66 47.94 Favored 'General case' 0 CA--C 1.467 -2.216 0 N-CA-C 106.254 -1.758 . . . . 64.44 106.254 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.6 t -119.92 119.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 105.864 -1.902 . . . . 74.34 105.864 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.9 t30 49.38 38.07 13.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.698 1.199 . . . . 71.43 110.318 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.22 -33.5 6.52 Favored Glycine 0 CA--C 1.469 -2.821 0 N-CA-C 108.212 -1.955 . . . . 63.14 108.212 171.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.0 114.98 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 107.753 -1.203 . . . . 61.43 107.753 -172.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.6 m -53.88 117.44 3.19 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 107.939 -1.134 . . . . 55.52 107.939 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -99.88 -10.48 21.68 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.291 -2.114 . . . . 61.14 105.291 -168.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.45 137.18 48.87 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.914 -1.143 . . . . 70.25 107.914 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.6 62.04 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.46 -1.456 . . . . 74.41 109.46 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.47 148.96 30.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.837 -1.172 . . . . 60.3 107.837 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.414 ' HA ' HG22 ' A' ' 27' ' ' VAL . 39.0 p -81.99 -179.48 7.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.844 -0.798 . . . . 73.53 108.844 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.64 -52.02 66.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.981 -1.118 . . . . 74.33 107.981 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -57.1 -55.5 33.9 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 121.638 -0.664 . . . . 72.21 110.783 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -53.62 -40.7 65.99 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 120.772 0.32 . . . . 73.33 110.529 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.13 -54.46 24.97 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.023 0.529 . . . . 72.54 110.787 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.98 -37.43 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.801 -0.444 . . . . 72.43 109.801 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.02 -31.67 72.85 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 116.943 -1.903 . . . . 55.41 106.266 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 82' ' ' THR . 26.5 m -71.85 -45.16 62.34 Favored 'General case' 0 C--O 1.206 -1.232 0 O-C-N 120.654 -1.279 . . . . 64.13 107.901 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.5 mt -62.48 -29.66 70.7 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 110.181 -0.303 . . . . 71.11 110.181 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -73.69 -59.0 2.92 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.194 -1.41 . . . . 74.53 107.194 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -70.51 46.77 0.09 Allowed 'General case' 0 C--N 1.362 1.139 0 C-N-CA 125.109 1.364 . . . . 63.44 111.441 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.572 HG21 HG13 ' A' ' 86' ' ' VAL . 2.7 p -105.22 -175.4 2.78 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.159 -1.793 . . . . 74.35 106.159 173.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.0 33.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 106.012 -2.835 . . . . 63.44 106.012 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.25 -54.54 44.6 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.22 -1.03 . . . . 72.32 108.22 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.0 t -101.79 145.18 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 105.995 -1.854 . . . . 61.24 105.995 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.572 HG13 HG21 ' A' ' 82' ' ' THR . 47.7 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 105.904 -1.887 . . . . 71.34 105.904 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -107.7 127.02 53.31 Favored 'General case' 0 CA--C 1.466 -2.271 0 N-CA-C 103.298 -2.853 . . . . 72.43 103.298 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.46 136.57 13.81 Favored 'General case' 0 CA--C 1.458 -2.583 0 N-CA-C 107.374 -1.343 . . . . 75.24 107.374 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.26 136.37 35.8 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.311 -1.366 . . . . 61.31 107.311 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.677 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -107.41 151.74 25.12 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 103.893 -2.632 . . . . 71.44 103.893 175.107 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.53 133.3 55.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 101.65 -3.463 . . . . 61.42 101.65 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.7 129.52 41.94 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.49 -0.929 . . . . 75.34 108.49 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.295 0 N-CA-C 105.177 -3.169 . . . . 71.4 105.177 179.407 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.522 0 N-CA-C 108.923 -1.671 . . . . 51.44 108.923 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -75.6 139.78 42.26 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.418 -1.327 . . . . 64.21 107.418 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' LEU . 9.4 mm -100.68 131.64 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.128 -1.434 . . . . 74.44 107.128 -171.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.582 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.8 p90 -143.34 155.8 44.53 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.255 -1.387 . . . . 74.22 107.255 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -108.77 147.07 32.59 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.729 -1.952 . . . . 74.23 105.729 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.67 HG22 HD21 ' A' ' 90' ' ' LEU . 18.8 m -141.22 152.51 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 N-CA-C 107.272 -1.381 . . . . 74.41 107.272 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.58 127.07 53.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.117 -2.179 . . . . 72.13 105.117 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 53' ' ' ILE . 3.0 mp -135.18 140.99 45.79 Favored 'General case' 0 CA--C 1.461 -2.445 0 N-CA-C 107.748 -1.204 . . . . 63.41 107.748 175.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.07 141.22 33.36 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.757 -1.571 . . . . 64.41 106.757 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -71.54 -25.88 62.4 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.333 -0.988 . . . . 72.33 108.333 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 72.64 108.05 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.25 -1.019 . . . . 73.51 108.25 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 51.94 53.1 13.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 109.549 -0.537 . . . . 71.41 109.549 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.1 t30 54.37 -9.09 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.043 1.737 . . . . 75.55 115.007 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.4 t -126.12 120.76 30.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 120.595 1.543 . . . . 72.12 108.317 -171.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.0 pt? -99.99 167.44 10.49 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.109 -2.182 . . . . 73.4 105.109 171.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.99 95.62 0.15 Allowed Glycine 0 CA--C 1.478 -2.232 0 N-CA-C 105.041 -3.223 . . . . 52.53 105.041 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.7 mm -118.95 177.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.273 -2.862 . . . . 73.15 103.273 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.473 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.1 t -127.79 154.74 45.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 102.987 -2.968 . . . . 72.52 102.987 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.0 m -149.46 169.55 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.818 -1.549 . . . . 54.34 106.818 -165.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.533 HG23 ' CE2' ' A' ' 37' ' ' TYR . 6.8 t -165.22 168.23 17.26 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.531 -2.396 . . . . 72.1 104.531 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.26 -167.03 22.33 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 105.573 -3.011 . . . . 64.43 105.573 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.91 -115.74 0.91 Allowed Glycine 0 CA--C 1.489 -1.55 0 C-N-CA 119.443 -1.361 . . . . 74.1 110.165 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -60.73 20.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.691 1.996 . . . . 71.31 116.32 -162.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 87.37 9.07 0.17 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.262 -1.014 . . . . 72.32 108.262 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.3 p -39.14 -166.96 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 126.283 1.833 . . . . 74.43 111.626 154.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -39.34 -29.11 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.9 0 O-C-N 120.458 -1.401 . . . . 74.51 114.616 -168.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG11 ' CE1' ' A' ' 37' ' ' TYR . 4.6 m -86.27 134.84 26.4 Favored 'Isoleucine or valine' 0 C--N 1.365 1.248 0 O-C-N 120.347 -1.471 . . . . 53.44 108.486 177.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -70.54 -24.17 62.76 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.857 -0.794 . . . . 72.51 108.857 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 60' ' ' LEU . 7.4 t-160 -83.69 -10.98 57.79 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.898 -0.721 . . . . 72.41 109.06 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.69 67.1 2.36 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 110.029 -1.229 . . . . 34.24 110.029 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.74 178.21 26.46 Favored Glycine 0 CA--C 1.472 -2.607 0 N-CA-C 105.348 -3.101 . . . . 74.12 105.348 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.76 141.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 N-CA-C 105.905 -1.887 . . . . 71.12 105.905 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -121.46 162.05 21.15 Favored 'General case' 0 CA--C 1.45 -2.898 0 N-CA-C 106.696 -1.594 . . . . 65.22 106.696 175.064 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.416 HG11 HG22 ' A' ' 41' ' ' VAL . 99.7 t -85.8 103.54 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 106.593 -1.632 . . . . 64.42 106.593 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -71.12 -30.48 66.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.535 -1.211 . . . . 75.12 108.949 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.7 151.16 10.69 Favored 'General case' 0 CA--C 1.467 -2.225 0 N-CA-C 105.869 -1.9 . . . . 73.42 105.869 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.416 HG22 HG11 ' A' ' 38' ' ' VAL . 7.0 t -118.33 134.15 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 103.657 -2.72 . . . . 63.32 103.657 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 148.68 84.01 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.826 -1.916 . . . . 75.04 105.826 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.26 168.12 25.34 Favored 'Trans proline' 0 CA--C 1.467 -2.84 0 N-CA-C 106.073 -2.318 . . . . 73.1 106.073 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 62.08 2.75 0.85 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.239 0.829 . . . . 73.32 113.239 164.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.19 -175.78 36.13 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 107.12 -2.392 . . . . 55.11 107.12 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.63 -53.01 38.76 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 108.579 -0.897 . . . . 74.41 108.579 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.49 -49.84 66.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 116.362 -0.381 . . . . 41.01 111.067 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.7 -53.1 59.6 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 109.616 -0.513 . . . . 73.53 109.616 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -55.71 -38.15 69.35 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.278 0.631 . . . . 71.14 109.962 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -77.48 -33.5 54.52 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.871 -1.159 . . . . 74.1 107.871 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.31 81.04 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.235 -1.146 . . . . 73.11 110.235 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -107.33 8.37 29.69 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.282 -1.006 . . . . 72.14 108.282 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 12' ' ' LEU . 1.4 mp -126.92 134.13 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 101.859 -3.386 . . . . 72.14 101.859 175.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -138.74 159.58 41.75 Favored 'General case' 0 CA--C 1.473 -2.0 0 N-CA-C 104.091 -2.559 . . . . 63.22 104.091 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -66.48 143.99 56.76 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.74 -1.207 . . . . 75.32 107.74 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -30.82 8.88 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 108.623 -1.791 . . . . 64.4 108.623 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -66.49 152.73 44.6 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 106.232 -1.766 . . . . 75.41 106.232 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.666 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 18.7 ptt-85 -132.23 157.67 43.75 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.954 -1.498 . . . . 75.14 106.954 -171.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.54 135.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.416 -1.698 . . . . 74.21 106.416 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.529 HD11 HD12 ' A' ' 7' ' ' ILE . 48.2 mt -96.92 -58.26 2.08 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.029 -1.471 . . . . 72.14 107.029 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.92 151.57 50.11 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.416 -1.698 . . . . 60.3 106.416 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.65 119.86 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 105.515 -2.031 . . . . 70.31 105.515 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.5 t30 54.71 32.85 18.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.133 0.973 . . . . 62.34 109.909 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.78 -28.99 13.42 Favored Glycine 0 CA--C 1.463 -3.183 0 N-CA-C 108.551 -1.82 . . . . 72.45 108.551 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.26 115.12 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 N-CA-C 107.533 -1.284 . . . . 34.32 107.533 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 t -55.65 130.56 43.62 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.689 -0.856 . . . . 75.45 108.689 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -98.98 -11.81 21.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.939 -1.874 . . . . 71.15 105.939 -170.47 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.77 126.13 20.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.863 -0.608 . . . . 63.5 109.634 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.17 -12.26 64.95 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 109.137 -1.585 . . . . 53.21 109.137 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.88 148.8 41.96 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 107.271 -1.381 . . . . 73.31 107.271 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 p -81.77 177.32 8.95 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 107.317 -1.364 . . . . 73.43 107.317 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -65.85 -43.93 86.98 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.541 -0.911 . . . . 45.01 108.541 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -54.59 -56.73 15.91 Favored 'General case' 0 C--N 1.362 1.125 0 O-C-N 121.881 -0.512 . . . . 53.43 110.176 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -56.46 -44.42 80.52 Favored 'General case' 0 C--N 1.365 1.246 0 N-CA-C 110.089 -0.337 . . . . 71.03 110.089 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -50.54 -52.76 35.85 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.792 0.437 . . . . 42.13 110.831 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.14 -42.12 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.775 -1.195 . . . . 71.13 107.775 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -53.23 -40.6 64.65 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 123.722 1.725 . . . . 40.42 106.442 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -65.5 -40.34 92.92 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 120.338 -1.476 . . . . 71.01 108.776 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.87 -29.57 70.28 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 109.813 -0.44 . . . . 74.42 109.813 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -73.26 -60.42 2.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.531 -0.544 . . . . 64.41 109.531 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.97 40.79 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 113.563 0.949 . . . . 73.22 113.563 -174.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 p -106.72 -176.12 2.99 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 106.303 -1.74 . . . . 71.14 106.303 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.02 -153.87 28.97 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 108.415 -1.874 . . . . 73.43 108.415 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -61.14 -54.39 45.07 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.923 -0.769 . . . . 72.43 108.923 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.52 145.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 105.82 -1.919 . . . . 54.24 105.82 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.06 139.41 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.673 0 N-CA-C 105.592 -2.003 . . . . 72.23 105.592 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -114.08 135.8 53.62 Favored 'General case' 0 CA--C 1.463 -2.376 0 N-CA-C 104.608 -2.367 . . . . 72.42 104.608 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.54 135.69 9.92 Favored 'General case' 0 CA--C 1.461 -2.448 0 N-CA-C 106.975 -1.491 . . . . 74.52 106.975 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.19 139.08 35.76 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 107.318 -1.364 . . . . 75.44 107.318 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.67 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.76 155.5 21.5 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 104.62 -2.363 . . . . 74.14 104.62 176.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.425 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.9 tt0 -120.74 128.75 53.21 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 101.604 -3.48 . . . . 70.24 101.604 165.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -61.93 146.83 48.76 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.736 -0.838 . . . . 73.14 108.736 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.411 0 N-CA-C 105.577 -3.009 . . . . 44.31 105.577 178.813 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.237 0 N-CA-C 108.713 -1.755 . . . . 64.51 108.713 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.36 133.48 42.5 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 108.131 -1.063 . . . . 74.24 108.131 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.485 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.9 mt -99.27 128.08 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.522 -1.288 . . . . 71.35 107.522 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -138.25 159.58 41.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.793 -1.558 . . . . 72.21 106.793 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.86 152.12 22.3 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 105.172 -2.158 . . . . 74.43 105.172 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.712 HG22 HD21 ' A' ' 90' ' ' LEU . 11.5 m -131.79 142.75 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 N-CA-C 104.35 -2.463 . . . . 71.43 104.35 167.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -101.06 116.84 33.78 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 103.782 -2.673 . . . . 70.01 103.782 167.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.08 134.04 37.98 Favored 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.434 -1.691 . . . . 71.23 106.434 -172.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.44 148.59 25.49 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.831 -1.544 . . . . 51.5 106.831 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -75.1 -33.88 61.68 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.12 -1.807 . . . . 73.12 106.12 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.84 104.88 0.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.379 1.071 . . . . 71.13 108.164 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.66 37.59 19.06 Favored 'General case' 0 C--N 1.366 1.288 0 N-CA-C 107.85 -1.167 . . . . 75.42 107.85 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 47.75 2.41 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.36 1.864 . . . . 72.25 114.747 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -86.41 139.25 31.11 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 106.706 -1.591 . . . . 74.45 106.706 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.2 pt? -128.01 -144.66 0.29 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 104.675 -2.343 . . . . 72.32 104.675 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.21 74.66 0.63 Allowed Glycine 0 CA--C 1.467 -2.953 0 N-CA-C 105.056 -3.218 . . . . 54.1 105.056 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 22' ' ' CYS . 8.5 mm -103.57 177.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 101.584 -3.487 . . . . 74.41 101.584 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.473 ' H ' HG22 ' A' ' 21' ' ' ILE . 3.1 m -121.34 151.97 39.49 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 103.205 -2.887 . . . . 72.33 103.205 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -152.11 169.23 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 N-CA-C 106.828 -1.545 . . . . 71.3 106.828 -165.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -160.46 164.64 32.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 104.334 -2.469 . . . . 71.34 104.334 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.71 -162.74 26.74 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.083 -2.007 . . . . 73.05 108.083 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.3 -88.43 0.35 Allowed Glycine 0 C--N 1.356 1.686 0 N-CA-C 109.112 -1.595 . . . . 30.21 109.112 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 71' ' ' THR . 0.8 OUTLIER -71.88 18.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 123.134 0.574 . . . . 62.32 112.251 -167.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 85.98 7.05 0.36 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.313 -0.995 . . . . 65.44 108.313 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.7 p -45.51 -169.31 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.413 1.885 . . . . 53.45 112.466 167.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -49.92 -18.39 0.51 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.939 1.088 . . . . 72.51 113.939 -167.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 15.3 m -66.53 128.78 30.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.525 0 N-CA-C 107.868 -1.16 . . . . 70.33 107.868 172.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.36 -52.69 44.35 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.256 -0.902 . . . . 74.43 110.958 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.64 -20.37 59.92 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 119.543 -0.863 . . . . 73.35 110.174 -168.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.43 -6.86 55.83 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.804 -1.718 . . . . 74.34 108.804 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 179.26 53.38 Favored Glycine 0 CA--C 1.501 -0.833 0 N-CA-C 108.198 -1.961 . . . . 51.22 108.198 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 75' ' ' ALA . 8.8 mm -88.97 132.24 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.215 0 N-CA-C 104.535 -2.395 . . . . 65.34 104.535 174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 3.8 m-30 -107.16 150.23 26.82 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 105.129 -2.174 . . . . 73.52 105.129 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.6 t -82.85 103.43 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.194 -1.78 . . . . 73.31 106.194 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -73.04 -34.56 66.38 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.13 -1.396 . . . . 74.11 108.751 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.76 151.06 8.82 Favored 'General case' 0 CA--C 1.46 -2.486 0 N-CA-C 104.598 -2.371 . . . . 73.04 104.598 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.36 131.58 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 102.975 -2.972 . . . . 74.53 102.975 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.77 146.63 83.34 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 106.332 -1.729 . . . . 70.24 106.332 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.9 172.03 16.92 Favored 'Trans proline' 0 CA--C 1.468 -2.794 0 N-CA-C 105.965 -2.36 . . . . 65.22 105.965 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 49.55 51.99 15.37 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.312 1.053 . . . . 71.51 109.743 164.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.47 34.41 Favored Glycine 0 CA--C 1.472 -2.612 1 N-CA-C 102.899 -4.08 . . . . 61.25 102.899 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -53.58 26.78 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-N 117.781 0.791 . . . . 72.04 109.734 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.5 -50.48 65.31 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.987 -0.097 . . . . 73.11 111.122 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -63.37 -55.36 25.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.664 0.385 . . . . 73.42 110.058 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.1 m -65.33 -30.23 71.05 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.694 -0.629 . . . . 71.54 110.75 -172.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.42 -35.56 54.04 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 105.914 -1.884 . . . . 72.41 105.914 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.8 30.2 59.98 Favored Glycine 0 CA--C 1.476 -2.398 0 CA-C-N 115.318 -0.855 . . . . 54.21 111.738 167.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -98.48 -47.85 5.23 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.387 -1.709 . . . . 74.35 106.387 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.07 148.06 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.53 0.681 . . . . 74.22 109.735 169.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -154.94 167.12 31.38 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 104.227 -2.509 . . . . 63.02 104.227 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -66.73 143.16 57.1 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.156 0.503 . . . . 74.35 109.86 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.94 -33.19 6.63 Favored Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 108.606 -1.797 . . . . 72.23 108.606 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -69.35 156.41 38.85 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 105.701 -1.963 . . . . 73.44 105.701 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -132.98 157.91 44.01 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.021 -1.103 . . . . 73.23 108.021 -168.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.26 135.27 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 106.177 -1.786 . . . . 52.54 106.177 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.485 ' CD1' HG23 ' A' ' 7' ' ' ILE . 15.2 mt -99.57 -58.67 1.87 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.638 -1.616 . . . . 74.21 106.638 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.48 149.97 50.76 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 105.76 -1.941 . . . . 62.33 105.76 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.54 121.47 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 N-CA-C 105.069 -2.197 . . . . 75.23 105.069 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.56 32.88 21.69 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 123.46 0.704 . . . . 52.15 109.278 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.81 -5.59 84.65 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 109.562 -1.415 . . . . 61.02 109.562 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.1 t -94.92 130.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 107.023 -1.473 . . . . 74.42 107.023 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -47.62 147.33 1.85 Allowed 'General case' 0 C--N 1.367 1.332 0 C-N-CA 123.907 0.883 . . . . 65.51 110.501 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.74 -25.18 0.42 Allowed 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.717 -1.586 . . . . 41.31 106.717 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.9 pm0 -56.3 127.19 29.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.603 -0.888 . . . . 63.4 108.603 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.8 -11.47 66.52 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.43 -1.468 . . . . 74.22 109.43 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 157.36 25.64 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 105.66 -1.978 . . . . 64.54 105.66 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 27' ' ' VAL . 29.2 p -87.64 179.49 6.51 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.146 -0.687 . . . . 63.41 109.146 -168.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.39 -51.34 69.16 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.638 -1.245 . . . . 72.12 107.638 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.72 -55.81 22.89 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 109.896 -0.409 . . . . 74.21 109.896 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -56.46 -42.38 78.1 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 122.169 -0.332 . . . . 60.41 110.623 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -51.16 -55.76 16.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 122.853 0.461 . . . . 72.44 110.311 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.5 m -74.72 -36.27 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 109.044 -0.724 . . . . 52.22 109.044 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -62.66 -34.66 77.55 Favored 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 106.055 -1.832 . . . . 72.34 106.055 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 82' ' ' THR . 28.7 m -71.83 -45.48 61.31 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 120.071 -1.643 . . . . 74.13 107.715 -175.167 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.46 -29.82 70.2 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.722 -0.473 . . . . 70.04 109.722 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -60.08 2.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.58 -1.637 . . . . 54.41 106.58 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -67.86 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.485 1.114 . . . . 64.23 112.219 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.422 HG21 HG13 ' A' ' 86' ' ' VAL . 19.3 p -101.81 -175.21 2.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.166 -1.79 . . . . 52.31 106.166 171.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.6 -150.89 26.95 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 107.694 -2.163 . . . . 74.32 107.694 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.61 -55.69 16.26 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.681 -0.859 . . . . 74.25 108.681 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.5 t -104.25 149.34 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 104.992 -2.225 . . . . 55.11 104.992 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 82' ' ' THR . 42.9 t -111.61 140.56 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.288 -1.745 . . . . 62.41 106.288 -174.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -110.62 130.8 55.48 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 103.657 -2.72 . . . . 62.33 103.657 167.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.97 132.49 12.1 Favored 'General case' 0 CA--C 1.456 -2.649 0 N-CA-C 106.786 -1.561 . . . . 64.42 106.786 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.65 136.01 36.14 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 106.82 -1.548 . . . . 44.34 106.82 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.68 159.45 17.13 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 103.968 -2.604 . . . . 74.51 103.968 174.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -120.37 134.1 55.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.77 -3.419 . . . . 74.25 101.77 167.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -62.89 138.18 58.47 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 107.945 -1.131 . . . . 72.03 107.945 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.471 -2.701 0 N-CA-C 106.459 -2.656 . . . . 71.1 106.459 -175.835 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.587 0 N-CA-C 109.328 -1.509 . . . . 74.54 109.328 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -80.84 143.33 32.86 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.037 -1.468 . . . . 61.41 107.037 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 60' ' ' LEU . 12.9 mm -98.19 132.79 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 105.879 -1.897 . . . . 71.43 105.879 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CD2' HD23 ' A' ' 90' ' ' LEU . 1.5 p90 -144.18 156.48 44.33 Favored 'General case' 0 CA--C 1.478 -1.803 0 C-N-CA 119.056 -1.057 . . . . 73.33 109.027 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' HD11 ' A' ' 89' ' ' LEU . 46.0 mt-10 -103.3 141.65 35.54 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 105.387 -2.079 . . . . 74.21 105.387 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.621 HG22 HD21 ' A' ' 90' ' ' LEU . 34.9 m -141.01 145.93 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 105.127 -2.175 . . . . 71.34 105.127 172.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -110.05 126.44 53.99 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.336 -2.098 . . . . 62.33 105.336 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 52' ' ' ARG . 58.1 mt -134.83 139.48 45.1 Favored 'General case' 0 CA--C 1.451 -2.836 0 N-CA-C 106.948 -1.501 . . . . 74.44 106.948 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.54 152.68 23.74 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.352 -2.092 . . . . 71.25 105.352 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -77.22 -28.58 53.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.221 -1.399 . . . . 62.45 107.221 172.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 81.38 104.93 0.06 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.442 1.097 . . . . 73.44 108.105 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 57.56 41.68 25.4 Favored 'General case' 0 C--N 1.366 1.293 0 N-CA-C 107.271 -1.381 . . . . 62.42 107.271 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 43.26 2.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 127.516 2.326 . . . . 65.01 115.504 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.0 m -100.23 114.69 28.32 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 120.34 1.427 . . . . 63.12 107.269 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.622 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -89.63 -173.18 3.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 104.697 -2.334 . . . . 72.44 104.697 169.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 40.95 0.04 OUTLIER Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 104.43 -3.468 . . . . 45.24 104.43 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.6 mt -98.09 174.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.479 -2.786 . . . . 75.34 103.479 -176.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.438 ' H ' HG22 ' A' ' 21' ' ' ILE . 34.4 t -138.86 156.39 47.34 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 104.738 -2.319 . . . . 71.12 104.738 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.65 173.29 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.617 0 N-CA-C 104.716 -2.327 . . . . 70.44 104.716 -167.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.4 t -162.09 167.12 24.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.446 -1.686 . . . . 73.04 106.446 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.87 -154.08 30.36 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 108.578 -1.809 . . . . 75.22 108.578 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.55 -82.38 0.34 Allowed Glycine 0 CA--C 1.474 -2.497 0 N-CA-C 108.849 -1.7 . . . . 65.5 108.849 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.48 16.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.497 0 C-N-CA 123.438 0.695 . . . . 51.51 112.199 -165.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 85.71 5.54 0.46 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.954 1.301 . . . . 73.13 108.345 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.5 p -49.29 -170.82 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.237 1.415 . . . . 74.41 111.352 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 m -30.19 -41.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 126.268 1.827 . . . . 74.51 115.359 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 14.7 m -57.28 120.0 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 122.348 1.07 . . . . 54.44 110.774 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -49.27 -64.33 0.84 Allowed 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.786 -1.097 . . . . 71.32 111.824 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -73.99 -19.85 60.52 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 120.209 -0.597 . . . . 73.24 110.112 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.36 60.19 1.57 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 109.754 -1.338 . . . . 53.11 109.754 170.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.73 -178.76 29.39 Favored Glycine 0 CA--C 1.466 -3.015 0 N-CA-C 103.184 -3.966 . . . . 73.13 103.184 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.94 133.67 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 103.973 -2.603 . . . . 74.1 103.973 175.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.443 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 9.2 m-85 -106.47 150.58 25.94 Favored 'General case' 0 CA--C 1.463 -2.367 0 N-CA-C 104.755 -2.313 . . . . 74.22 104.755 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.15 102.28 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.179 -1.786 . . . . 60.31 106.179 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -71.89 -35.2 69.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.495 -1.23 . . . . 75.21 109.67 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.86 144.08 19.98 Favored 'General case' 0 CA--C 1.464 -2.355 0 N-CA-C 105.841 -1.911 . . . . 51.21 105.841 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.99 127.62 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 103.409 -2.812 . . . . 63.13 103.409 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.23 147.03 63.82 Favored Pre-proline 0 CA--C 1.51 -0.577 0 N-CA-C 106.365 -1.717 . . . . 75.3 106.365 176.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 45' ' ' GLY . 65.5 Cg_endo -76.29 172.67 15.82 Favored 'Trans proline' 0 CA--C 1.473 -2.526 0 N-CA-C 106.063 -2.322 . . . . 73.41 106.063 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 70.35 -11.75 0.57 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 124.116 0.885 . . . . 64.55 111.132 167.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -91.19 178.91 42.09 Favored Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 107.198 -2.361 . . . . 71.13 107.198 -174.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.51 69.87 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.211 -1.033 . . . . 74.12 108.211 -174.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.54 63.61 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 116.056 -0.52 . . . . 61.21 110.41 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.08 -53.95 17.63 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.69 -0.485 . . . . 62.33 109.69 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -61.27 -34.89 75.92 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.118 0.567 . . . . 70.13 110.531 -169.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -90.39 -23.22 21.13 Favored 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.077 -1.453 . . . . 73.22 107.077 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.0 24.57 59.52 Favored Glycine 0 C--N 1.358 1.755 0 N-CA-C 110.5 -1.04 . . . . 72.22 110.5 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.522 ' HB2' HD11 ' A' ' 12' ' ' LEU . 23.4 mmt180 -96.33 6.45 48.77 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.264 -1.013 . . . . 73.33 108.264 -174.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.4 mt -142.34 146.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.172 -2.529 . . . . 75.1 104.172 -173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -147.2 156.41 42.93 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 103.984 -2.599 . . . . 75.3 103.984 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -66.86 146.14 54.73 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.685 -1.228 . . . . 74.43 107.685 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.11 -30.71 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 108.221 -1.952 . . . . 72.13 108.221 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.25 153.93 39.61 Favored 'General case' 0 C--N 1.364 1.221 0 N-CA-C 107.896 -1.149 . . . . 74.43 107.896 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.8 ttp85 -112.56 138.43 49.34 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 105.967 -1.864 . . . . 75.31 105.967 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.67 126.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 105.089 -2.189 . . . . 64.34 105.089 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.521 ' CD1' HG23 ' A' ' 7' ' ' ILE . 16.3 mt -92.31 -58.71 2.29 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 107.841 -1.17 . . . . 55.14 107.841 -173.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.49 148.68 46.22 Favored 'General case' 0 CA--C 1.472 -2.03 0 N-CA-C 105.534 -2.024 . . . . 51.21 105.534 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -121.55 127.01 75.52 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.604 0 N-CA-C 104.665 -2.346 . . . . 52.21 104.665 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 t30 57.48 29.63 17.36 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.89 -0.781 . . . . 71.3 108.89 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.17 -20.04 52.38 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 108.887 -1.685 . . . . 64.31 108.887 173.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.27 123.29 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.917 0 N-CA-C 108.529 -0.915 . . . . 72.14 108.529 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.4 m -52.92 122.91 10.18 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 123.273 0.629 . . . . 72.12 109.924 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.79 -21.95 14.49 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.358 -1.349 . . . . 73.14 107.358 -171.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -65.65 129.04 38.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.39 -0.819 . . . . 64.02 109.467 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 -17.08 57.11 Favored Glycine 0 C--N 1.363 2.055 0 N-CA-C 108.614 -1.795 . . . . 70.03 108.614 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.796 ' HB1' ' CG ' ' A' ' 74' ' ' GLN . . . -79.67 154.78 28.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.495 -1.669 . . . . 72.44 106.495 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 p -82.74 176.43 9.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.528 0.68 . . . . 64.31 110.242 -165.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -62.79 -51.46 67.02 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.669 -1.234 . . . . 72.12 107.669 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -53.7 -56.16 19.82 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 122.406 0.283 . . . . 62.41 111.083 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.796 ' CG ' ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -60.57 -35.67 76.63 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 109.26 -0.644 . . . . 63.2 109.26 -171.024 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 74' ' ' GLN . . . -51.13 -48.83 61.68 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 123.144 0.577 . . . . 72.42 109.583 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.27 -40.35 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 108.296 -1.002 . . . . 74.55 108.296 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -54.9 -40.45 69.82 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.526 -1.657 . . . . 51.53 106.526 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.4 m -74.33 -36.73 63.67 Favored 'General case' 0 C--O 1.215 -0.762 0 O-C-N 120.564 -1.335 . . . . 51.45 109.207 -171.023 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 mt -71.2 -39.84 71.54 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.086 -0.709 . . . . 61.22 109.086 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -78.74 -60.59 2.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.816 -0.438 . . . . 74.43 109.816 -171.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -67.06 60.27 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.901 0.858 . . . . 74.05 110.928 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -127.41 -176.28 3.7 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.913 -1.514 . . . . 55.02 106.913 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.18 -149.44 20.58 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 107.159 -2.376 . . . . 65.25 107.159 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -67.08 -55.77 12.86 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.259 -0.645 . . . . 51.11 109.259 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.62 145.02 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 106.214 -1.773 . . . . 71.41 106.214 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.49 146.01 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 106.101 -1.814 . . . . 74.54 106.101 -171.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -106.79 128.91 54.65 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 105.919 -1.882 . . . . 70.34 105.919 173.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.07 125.49 19.0 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 105.831 -1.914 . . . . 63.13 105.831 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.416 HD11 ' HG2' ' A' ' 9' ' ' GLU . 3.1 mm? -80.08 138.36 36.95 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.834 -1.543 . . . . 74.02 106.834 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.621 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.05 154.24 24.5 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 104.974 -2.232 . . . . 73.12 104.974 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -120.75 134.0 55.31 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 101.2 -3.63 . . . . 70.14 101.2 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -61.76 128.06 34.43 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.997 -1.112 . . . . 71.33 107.997 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.471 -2.702 0 N-CA-C 106.752 -2.539 . . . . 52.21 106.752 -173.262 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.121 0 N-CA-C 109.584 -1.406 . . . . 62.21 109.584 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.38 136.85 36.45 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 118.822 1.311 . . . . 75.33 107.724 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.525 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.9 mt -102.78 132.89 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.915 0 N-CA-C 107.249 -1.389 . . . . 74.21 107.249 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.497 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.7 p90 -140.83 157.18 45.76 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.673 -1.232 . . . . 74.35 107.673 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.84 146.06 29.2 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.46 -2.052 . . . . 70.15 105.46 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.644 HG22 HD21 ' A' ' 90' ' ' LEU . 31.3 m -140.7 148.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 N-CA-C 106.378 -1.712 . . . . 72.02 106.378 174.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -107.19 122.32 46.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.632 -1.988 . . . . 62.35 105.632 171.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.62 131.61 53.9 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 106.775 -1.565 . . . . 72.02 106.775 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.78 139.07 33.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 104.332 -2.47 . . . . 55.14 104.332 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -67.37 -34.54 77.52 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.354 -1.35 . . . . 74.45 107.354 175.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.7 t30 68.08 113.33 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.785 -0.82 . . . . 41.13 108.785 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.71 31.82 16.45 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.7 -1.222 . . . . 62.13 107.7 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 46.8 3.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 126.33 1.852 . . . . 72.13 114.117 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m -103.41 143.25 32.94 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.667 -1.235 . . . . 72.3 107.667 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.8 -143.75 0.35 Allowed 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.351 -2.833 . . . . 73.43 103.351 172.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.95 47.66 0.04 OUTLIER Glycine 0 CA--C 1.467 -2.954 0 N-CA-C 106.334 -2.706 . . . . 24.42 106.334 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mm -91.22 177.09 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 103.374 -2.825 . . . . 72.33 103.374 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.0 m -133.27 157.68 44.82 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.689 -2.708 . . . . 74.11 103.689 172.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 36' ' ' ILE . 4.2 m -148.3 171.47 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 106.588 -1.634 . . . . 65.11 106.588 -168.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.6 t -165.25 168.12 17.31 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.25 -2.13 . . . . 65.34 105.25 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -145.19 17.68 Favored Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 107.746 -2.141 . . . . 54.13 107.746 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.9 -85.51 0.42 Allowed Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.417 -1.473 . . . . 71.15 109.417 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.02 17.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.247 0 O-C-N 121.88 -0.777 . . . . 72.1 113.056 -166.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.7 t30 86.24 6.38 0.37 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.251 -1.018 . . . . 64.14 108.251 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -45.71 -168.98 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 126.497 1.919 . . . . 75.33 111.696 159.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 m -33.7 -39.54 0.06 Allowed 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.663 1.585 . . . . 64.31 114.836 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 20.2 m -77.27 139.96 17.86 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 O-C-N 121.184 -0.948 . . . . 63.11 108.934 -175.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -69.42 -52.29 28.25 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 122.031 -0.418 . . . . 74.31 111.854 -169.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -78.25 5.05 11.15 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.64 -0.663 . . . . 75.33 110.49 -169.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.6 7.36 14.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 111.228 -0.749 . . . . 64.11 111.228 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.28 178.93 50.69 Favored Glycine 0 CA--C 1.473 -2.583 0 N-CA-C 106.09 -2.804 . . . . 74.11 106.09 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.445 HG13 ' HB ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -88.9 136.65 22.9 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.4 0 N-CA-C 104.688 -2.338 . . . . 70.24 104.688 173.835 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.405 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 3.1 m-85 -109.81 146.58 34.79 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 102.991 -2.966 . . . . 72.34 102.991 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.75 103.29 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 107.085 -1.45 . . . . 64.52 107.085 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -71.18 -35.15 71.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.271 -1.331 . . . . 71.2 109.758 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.77 153.9 12.96 Favored 'General case' 0 CA--C 1.465 -2.309 0 N-CA-C 105.935 -1.876 . . . . 72.12 105.935 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.37 139.58 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 103.317 -2.845 . . . . 64.14 103.317 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.402 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -75.88 151.8 84.47 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 106.279 -1.748 . . . . 73.12 106.279 174.433 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.7 174.3 13.04 Favored 'Trans proline' 0 CA--C 1.468 -2.807 0 N-CA-C 105.449 -2.558 . . . . 61.42 105.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 49.26 52.01 15.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.74 0.781 . . . . 54.33 110.02 166.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.73 171.27 30.53 Favored Glycine 0 CA--C 1.461 -3.324 0 N-CA-C 103.184 -3.966 . . . . 23.1 103.184 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.92 -53.11 43.53 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 118.182 0.991 . . . . 72.23 108.847 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.6 63.52 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 116.898 -0.137 . . . . 71.33 111.28 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -69.86 -54.19 14.62 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.971 -0.381 . . . . 73.44 109.971 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.7 m -61.45 -30.59 70.69 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.983 -0.448 . . . . 70.11 110.777 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -81.35 -35.5 30.79 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.298 -1.742 . . . . 65.33 106.298 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.48 63.01 Favored Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 109.827 -1.309 . . . . 65.42 109.827 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -93.28 1.28 57.07 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.292 -1.374 . . . . 64.24 107.292 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.8 mt -144.64 139.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.157 -2.905 . . . . 73.03 103.157 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -143.9 162.46 36.06 Favored 'General case' 0 CA--C 1.459 -2.548 0 N-CA-C 106.054 -1.832 . . . . 72.13 106.054 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -67.19 137.58 56.33 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.195 -1.409 . . . . 62.31 107.195 170.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.38 -33.03 6.67 Favored Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 108.151 -1.98 . . . . 74.31 108.151 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.41 155.0 38.68 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.48 -1.674 . . . . 72.31 106.48 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.34 148.33 51.26 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.336 -1.357 . . . . 72.43 107.336 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.92 129.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.831 -1.914 . . . . 73.11 105.831 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.525 ' CD1' HG23 ' A' ' 7' ' ' ILE . 32.5 mt -93.79 -58.66 2.19 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 106.937 -1.505 . . . . 70.12 106.937 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.25 150.63 51.03 Favored 'General case' 0 CA--C 1.475 -1.923 0 N-CA-C 106.455 -1.683 . . . . 72.12 106.455 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.66 122.38 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 104.929 -2.248 . . . . 35.23 104.929 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 56.11 33.43 21.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.976 0.893 . . . . 55.01 108.875 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.41 -21.62 41.73 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 108.143 -1.983 . . . . 42.35 108.143 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.91 118.73 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.132 0 N-CA-C 107.873 -1.158 . . . . 55.14 107.873 -172.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -49.21 116.97 1.9 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.814 -0.81 . . . . 74.43 108.814 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.472 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -98.85 -19.59 17.31 Favored 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 105.936 -1.876 . . . . 74.11 105.936 -173.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.99 124.62 21.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.664 -0.865 . . . . 71.24 108.664 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.63 60.84 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.465 -1.854 . . . . 42.32 108.465 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.55 147.17 39.9 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.195 -1.78 . . . . 73.33 106.195 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.1 p -77.04 178.57 6.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.143 -1.058 . . . . 51.44 108.143 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -68.47 -46.96 68.34 Favored 'General case' 0 C--O 1.204 -1.314 0 N-CA-C 108.665 -0.865 . . . . 62.51 108.665 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.17 -54.39 45.79 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.366 -0.834 . . . . 74.31 110.518 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -57.92 -40.77 81.23 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 110.141 -0.318 . . . . 74.54 110.141 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.95 -52.15 52.26 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 122.604 0.362 . . . . 75.01 110.438 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -73.7 -39.72 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.621 -1.252 . . . . 72.43 107.621 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.0 t -57.14 -35.58 69.67 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 106.423 -1.695 . . . . 64.44 106.423 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.4 m -71.69 -43.82 65.3 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 120.388 -1.445 . . . . 71.43 107.829 -174.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.04 -39.35 94.48 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 109.069 -0.715 . . . . 72.04 109.069 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -68.28 -59.76 2.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.868 -1.16 . . . . 74.02 107.868 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.17 53.31 0.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.877 0.846 . . . . 75.25 110.723 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.435 HG21 HG13 ' A' ' 86' ' ' VAL . 7.0 p -103.74 -175.97 2.95 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 105.161 -2.162 . . . . 53.41 105.161 169.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.21 -148.85 16.93 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 107.225 -2.35 . . . . 75.23 107.225 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -66.61 -54.99 17.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.55 -0.907 . . . . 74.41 108.55 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.6 t -99.29 144.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.67 -1.604 . . . . 74.35 106.67 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.435 HG13 HG21 ' A' ' 82' ' ' THR . 58.0 t -100.69 129.3 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 105.459 -2.052 . . . . 61.54 105.459 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -113.33 128.26 56.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.723 -2.325 . . . . 64.01 104.723 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.05 138.31 12.58 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.406 -1.331 . . . . 63.41 107.406 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -81.76 139.58 34.75 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.617 -1.253 . . . . 64.21 107.617 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.644 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.76 159.05 17.5 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 104.174 -2.528 . . . . 73.14 104.174 175.392 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.79 131.25 53.96 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 100.542 -3.873 . . . . 74.44 100.542 161.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -70.61 139.97 51.52 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 106.208 -1.775 . . . . 73.45 106.208 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.286 0 N-CA-C 107.737 -2.145 . . . . 52.34 107.737 -173.861 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.586 0 N-CA-C 108.385 -1.886 . . . . 62.4 108.385 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.99 131.34 42.03 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.237 -1.394 . . . . 65.5 107.237 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.488 HG23 ' CD1' ' A' ' 60' ' ' LEU . 4.6 mt -94.8 136.31 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 N-CA-C 107.0 -1.482 . . . . 53.22 107.0 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.1 p90 -141.21 154.85 46.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.144 -1.428 . . . . 73.24 107.144 174.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -104.66 148.81 26.14 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 105.574 -2.01 . . . . 73.14 105.574 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.621 HG22 HD21 ' A' ' 90' ' ' LEU . 17.1 m -138.17 150.97 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 106.481 -1.674 . . . . 54.13 106.481 173.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -106.58 124.99 50.43 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 104.619 -2.363 . . . . 64.44 104.619 164.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.7 mt -139.46 137.42 35.56 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.599 -1.63 . . . . 64.23 106.599 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.48 161.18 17.15 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 106.416 -1.698 . . . . 55.51 106.416 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -43.68 63.03 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 105.919 -1.882 . . . . 44.43 105.919 168.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 70.13 117.35 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.325 1.05 . . . . 62.23 108.983 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 59.2 37.54 23.82 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-O 121.816 0.817 . . . . 50.0 109.021 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 55.1 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.253 1.821 . . . . 70.5 114.392 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.3 m -93.73 136.54 33.91 Favored 'General case' 0 CA--C 1.483 -1.606 0 O-C-N 120.51 -1.369 . . . . 63.32 108.759 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.01 -165.01 1.22 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.725 -3.065 . . . . 72.14 102.725 172.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.468 ' H ' HD13 ' A' ' 19' ' ' LEU . . . 163.43 23.6 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.328 0 C-N-CA 117.315 -2.374 . . . . 63.25 110.339 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.505 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -87.79 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 104.411 -2.44 . . . . 64.03 104.411 179.21 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 m -138.31 160.3 39.84 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.114 -2.18 . . . . 74.33 105.114 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 169.47 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.629 -0.878 . . . . 74.41 108.629 -163.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.2 t -160.41 165.45 31.08 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 104.805 -2.294 . . . . 70.45 104.805 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.18 -149.72 24.18 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 108.938 -1.665 . . . . 64.03 108.938 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' HA2' HG12 ' A' ' 36' ' ' ILE . . . 113.61 -75.85 0.24 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 109.46 -1.456 . . . . 75.5 109.46 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.39 15.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 O-C-N 122.579 -0.365 . . . . 62.52 110.953 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.8 t30 83.8 5.15 0.76 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.619 1.168 . . . . 74.54 108.15 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.1 p -47.44 -170.11 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.542 1.937 . . . . 72.23 113.623 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 m -40.94 -37.58 0.82 Allowed 'General case' 0 C--N 1.373 1.597 0 C-N-CA 125.969 1.707 . . . . 70.01 113.853 -165.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 132.07 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.537 0.684 . . . . 70.1 110.171 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ptt85 -44.53 -63.63 0.86 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-N 114.79 -1.095 . . . . 74.31 113.397 -168.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -77.78 -19.92 54.22 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 118.708 0.686 . . . . 73.3 109.229 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.42 -12.54 43.47 Favored Glycine 0 C--N 1.361 1.949 0 N-CA-C 109.916 -1.274 . . . . 53.21 109.916 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.17 179.94 49.62 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 109.855 -1.298 . . . . 64.02 109.855 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.514 HG13 ' CD1' ' A' ' 67' ' ' LEU . 2.8 mm -86.53 127.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 102.05 -3.315 . . . . 64.51 102.05 170.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -104.9 155.59 18.79 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 105.426 -2.065 . . . . 74.13 105.426 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -83.5 102.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 105.675 -1.972 . . . . 70.41 105.675 174.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.83 -31.28 66.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.497 -1.228 . . . . 74.14 110.163 -172.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.48 149.95 17.45 Favored 'General case' 0 CA--C 1.463 -2.387 0 N-CA-C 105.849 -1.908 . . . . 45.13 105.849 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.0 t -127.4 134.96 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 104.512 -2.403 . . . . 73.21 104.512 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -81.97 151.43 67.1 Favored Pre-proline 0 N--CA 1.445 -0.695 0 N-CA-C 106.669 -1.604 . . . . 72.43 106.669 176.353 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.45 -179.14 5.01 Favored 'Trans proline' 0 CA--C 1.479 -2.274 0 N-CA-C 105.928 -2.374 . . . . 72.25 105.928 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 49.43 52.24 14.86 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.023 0.827 . . . . 72.51 110.641 162.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.59 32.85 Favored Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 103.41 -3.876 . . . . 75.14 103.41 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.36 53.54 Favored 'General case' 0 C--O 1.205 -1.263 0 CA-C-N 117.632 0.716 . . . . 72.13 109.173 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.91 -50.26 64.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.547 -0.297 . . . . 32.13 110.99 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -68.79 -50.15 52.66 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.958 -0.464 . . . . 71.51 110.016 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.7 t -63.81 -33.69 76.25 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.754 -0.461 . . . . 71.32 109.754 -171.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -79.17 -32.0 44.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.074 -1.824 . . . . 70.12 106.074 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.29 60.98 Favored Glycine 0 C--N 1.359 1.818 0 N-CA-C 110.327 -1.109 . . . . 75.21 110.327 170.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -101.87 8.26 41.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.94 -1.133 . . . . 63.13 107.94 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.0 mt -144.27 145.75 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.009 -2.219 . . . . 64.32 105.009 -171.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -154.12 159.69 41.58 Favored 'General case' 0 N--CA 1.401 -2.911 0 N-CA-C 102.815 -3.031 . . . . 62.44 102.815 172.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -66.5 147.0 53.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.57 -0.9 . . . . 72.31 108.57 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.54 -33.26 6.7 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 109.975 -1.25 . . . . 62.22 109.975 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.75 155.95 39.76 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 105.32 -2.104 . . . . 62.34 105.32 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -132.66 157.89 43.69 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.633 -0.877 . . . . 73.14 108.633 -169.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.83 140.82 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 106.723 -1.584 . . . . 71.41 106.723 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.488 ' CD1' HG23 ' A' ' 7' ' ' ILE . 10.3 mt -101.11 -59.48 1.69 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.36 -1.718 . . . . 73.34 106.36 174.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.13 151.31 49.64 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 106.487 -1.672 . . . . 63.51 106.487 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.78 123.5 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.336 -2.098 . . . . 73.02 105.336 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.4 t30 50.99 35.35 12.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.874 1.27 . . . . 75.55 110.854 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.58 -22.04 38.75 Favored Glycine 0 CA--C 1.473 -2.566 0 N-CA-C 108.856 -1.698 . . . . 73.43 108.856 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.64 115.78 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 N-CA-C 108.095 -1.076 . . . . 72.42 108.095 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.0 m -54.12 112.92 1.06 Allowed 'General case' 0 C--N 1.371 1.537 0 N-CA-C 107.6 -1.259 . . . . 72.2 107.6 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 36' ' ' ILE . 1.1 tm? -104.44 -11.79 16.87 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 106.882 -1.525 . . . . 75.34 106.882 -162.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -60.16 129.2 40.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.62 -0.881 . . . . 65.22 108.62 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.91 -14.5 65.16 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.64 -1.784 . . . . 74.42 108.64 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.6 150.91 27.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.399 -1.704 . . . . 73.22 106.399 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -83.58 178.84 7.81 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.795 -0.446 . . . . 70.22 109.795 -167.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -56.21 -52.0 66.01 Favored 'General case' 0 C--N 1.382 2.007 0 N-CA-C 107.093 -1.447 . . . . 62.53 107.093 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -58.72 -48.51 80.91 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 116.538 -0.301 . . . . 45.14 110.764 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -56.64 -42.71 79.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.7 -0.4 . . . . 65.4 110.543 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -52.06 -51.4 57.81 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 120.727 -0.389 . . . . 73.04 110.657 177.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.26 -39.98 49.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 C-N-CA 119.932 -0.707 . . . . 75.03 109.831 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.67 -33.25 74.67 Favored 'General case' 0 N--CA 1.521 3.077 0 N-CA-C 106.131 -1.803 . . . . 74.45 106.131 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 m -71.31 -42.93 68.0 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 120.242 -1.536 . . . . 60.41 108.209 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.5 mt -69.49 -35.26 75.39 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.409 -0.589 . . . . 60.44 109.409 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -61.86 1.61 Allowed 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.556 -1.276 . . . . 61.54 107.556 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -73.07 58.46 0.49 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.409 0.623 . . . . 74.34 110.67 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 86' ' ' VAL . 3.2 p -102.68 -175.79 2.92 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.323 -1.362 . . . . 62.15 107.323 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.01 -154.28 30.35 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 106.224 -2.75 . . . . 64.24 106.224 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.61 -53.98 50.88 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.829 -0.434 . . . . 72.41 109.829 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.0 t -110.57 154.09 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 105.729 -1.952 . . . . 70.11 105.729 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 82' ' ' THR . 21.8 t -107.47 139.04 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.441 0 N-CA-C 105.912 -1.884 . . . . 62.23 105.912 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.87 123.99 49.42 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 104.418 -2.438 . . . . 65.34 104.418 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.8 133.31 11.97 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.052 -1.092 . . . . 53.14 108.052 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -84.86 144.34 28.47 Favored 'General case' 0 CA--C 1.474 -1.98 0 N-CA-C 108.832 -0.803 . . . . 74.22 108.832 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.621 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.79 162.71 17.65 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 104.711 -2.329 . . . . 63.14 104.711 175.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -124.39 137.38 54.47 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.233 -3.247 . . . . 71.32 102.233 165.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.8 145.75 54.2 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.006 -0.739 . . . . 64.3 109.006 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.904 0 N-CA-C 105.427 -3.069 . . . . 74.01 105.427 179.765 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.959 0 N-CA-C 109.569 -1.413 . . . . 64.31 109.569 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.86 145.52 26.55 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 106.604 -1.628 . . . . 71.53 106.604 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.436 HG23 ' CD1' ' A' ' 60' ' ' LEU . 12.2 mt -101.53 139.02 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.986 0 N-CA-C 108.083 -1.08 . . . . 75.35 108.083 -175.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.541 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.5 p90 -144.67 162.27 37.1 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.012 -1.477 . . . . 75.03 107.012 171.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.59 150.38 24.02 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.003 -1.851 . . . . 74.34 106.003 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.624 HG22 HD21 ' A' ' 90' ' ' LEU . 15.7 m -132.89 140.27 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.543 0 N-CA-C 105.178 -2.156 . . . . 72.14 105.178 168.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.38 116.4 31.88 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.65 -2.352 . . . . 65.23 104.65 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 12' ' ' LEU . 8.1 mt -138.46 138.24 37.94 Favored 'General case' 0 CA--C 1.454 -2.726 0 N-CA-C 107.615 -1.254 . . . . 73.4 107.615 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . . . -89.1 159.58 17.47 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 105.746 -1.946 . . . . 74.22 105.746 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.85 -50.69 71.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.879 -1.526 . . . . 74.21 106.879 171.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 t30 74.62 119.24 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.446 -1.252 . . . . 72.41 107.954 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 57.16 34.48 24.9 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.734 0.814 . . . . 75.5 109.445 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.1 t30 54.61 -5.11 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.746 1.618 . . . . 54.12 113.679 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 m -95.66 136.99 35.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.894 -0.78 . . . . 73.54 108.894 -171.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -149.95 0.45 Allowed 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 103.008 -2.96 . . . . 63.42 103.008 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.12 76.17 0.86 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 106.542 -2.623 . . . . 73.43 106.542 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.3 mm -102.02 176.74 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 102.531 -3.137 . . . . 74.31 102.531 176.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.403 ' H ' HG22 ' A' ' 21' ' ' ILE . 7.0 m -106.11 152.71 23.06 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 103.843 -2.651 . . . . 55.24 103.843 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.35 165.0 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.98 -1.119 . . . . 64.44 107.98 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.9 t -160.2 165.96 30.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.683 -2.339 . . . . 74.15 104.683 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.7 -141.25 20.94 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 107.292 -2.323 . . . . 73.5 107.292 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.51 -84.11 0.38 Allowed Glycine 0 CA--C 1.471 -2.664 0 N-CA-C 108.437 -1.865 . . . . 53.31 108.437 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -69.06 8.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.041 0 N-CA-C 112.396 0.517 . . . . 65.31 112.396 -166.79 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 68.66 68.08 0.3 Allowed 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 106.71 -1.589 . . . . 72.14 106.71 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 p -107.04 -164.66 1.0 Allowed 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 101.956 -3.35 . . . . 63.32 101.956 -172.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -44.84 -18.43 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.152 0.981 . . . . 73.15 113.152 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.67 150.85 8.49 Favored 'Isoleucine or valine' 0 C--N 1.38 1.934 0 N-CA-C 106.06 -1.83 . . . . 74.34 106.06 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -78.77 -72.17 0.4 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 120.403 -1.436 . . . . 61.51 110.121 -169.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -21.55 63.3 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 120.29 -0.564 . . . . 61.12 110.944 -160.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.27 59.99 1.7 Allowed Glycine 0 CA--C 1.484 -1.897 0 C-N-CA 119.554 -1.307 . . . . 74.15 110.168 164.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.18 179.41 20.73 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 104.643 -3.383 . . . . 70.32 104.643 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 36' ' ' ILE . 8.1 mm -82.17 127.91 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.428 0 N-CA-C 103.356 -2.831 . . . . 65.31 103.356 169.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -106.1 150.93 25.32 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 105.045 -2.206 . . . . 73.22 105.045 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -83.9 102.03 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.053 -1.832 . . . . 73.41 106.053 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.47 -25.97 63.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.054 -1.43 . . . . 53.03 109.861 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -173.62 161.38 3.95 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 104.642 -2.355 . . . . 71.12 104.642 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -116.88 132.57 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 103.134 -2.913 . . . . 54.02 103.134 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.412 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -82.35 151.0 65.1 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.964 -1.865 . . . . 63.54 105.964 175.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.95 177.47 8.76 Favored 'Trans proline' 0 CA--C 1.482 -2.084 0 N-CA-C 106.587 -2.12 . . . . 64.15 106.587 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 53.96 53.47 11.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.031 0.832 . . . . 73.04 109.157 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.55 166.89 33.43 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 105.447 -3.061 . . . . 55.45 105.447 -176.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.6 -50.74 70.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.508 -0.923 . . . . 51.25 108.508 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.97 66.04 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.857 -0.61 . . . . 72.44 110.688 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -65.85 -53.72 36.12 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.71 -0.478 . . . . 73.21 109.71 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -56.95 -29.12 62.87 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 122.226 -0.296 . . . . 75.11 111.271 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.55 -28.39 20.79 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.867 -1.16 . . . . 74.4 107.867 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.0 19.9 74.16 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.77 -0.932 . . . . 54.41 110.77 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HB3' HG11 ' A' ' 10' ' ' VAL . 85.0 mtt-85 -104.55 7.1 35.11 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 117.753 0.777 . . . . 64.42 108.94 -176.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.5 mp -127.56 136.57 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.183 -3.266 . . . . 71.5 102.183 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -145.34 162.72 36.56 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 106.118 -1.808 . . . . 72.42 106.118 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -66.6 136.78 56.11 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.274 -1.01 . . . . 75.34 108.274 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.31 -29.25 12.31 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 108.338 -1.905 . . . . 51.03 108.338 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.92 155.03 41.0 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 106.91 -1.515 . . . . 72.33 106.91 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -124.76 153.81 41.87 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.216 -1.031 . . . . 74.02 108.216 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -92.59 132.32 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 N-CA-C 105.739 -1.949 . . . . 74.45 105.739 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.436 ' CD1' HG23 ' A' ' 7' ' ' ILE . 11.5 mt -95.36 -59.41 1.89 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.942 -1.503 . . . . 74.23 106.942 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.69 51.37 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.788 -1.56 . . . . 34.54 106.788 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.52 131.07 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 104.722 -2.325 . . . . 62.11 104.722 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 56.23 29.94 15.74 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 122.009 0.909 . . . . 75.43 109.489 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.39 -9.07 76.89 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.573 -1.811 . . . . 50.1 108.573 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.9 t -87.9 115.6 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 N-CA-C 106.507 -1.664 . . . . 72.11 106.507 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.46 119.82 5.76 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 107.898 -1.149 . . . . 61.13 107.898 172.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -108.97 -15.17 14.42 Favored 'General case' 0 C--O 1.2 -1.541 0 N-CA-C 107.262 -1.385 . . . . 54.11 107.262 -163.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.43 122.33 13.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.505 -0.924 . . . . 73.4 108.505 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.78 -16.63 57.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 108.635 -1.786 . . . . 60.42 108.635 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.39 151.45 29.37 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.606 -1.627 . . . . 75.31 106.606 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.547 ' HA ' HG22 ' A' ' 27' ' ' VAL . 68.6 p -79.96 179.78 7.41 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.202 0.525 . . . . 65.12 109.745 -170.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -59.66 -51.31 70.35 Favored 'General case' 0 C--N 1.371 1.511 0 N-CA-C 107.589 -1.263 . . . . 62.32 107.589 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -55.7 -55.08 36.39 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 109.988 -0.375 . . . . 65.14 109.988 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -53.86 -43.95 69.97 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.775 -0.454 . . . . 63.51 109.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -50.78 -54.49 23.11 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 122.663 0.385 . . . . 34.04 110.369 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 m -74.22 -37.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 C-N-CA 120.506 -0.478 . . . . 71.21 109.778 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 82.9 m -62.71 -32.23 73.29 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.305 -1.739 . . . . 73.01 106.305 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -73.62 -40.69 63.6 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.357 -1.464 . . . . 71.15 108.195 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.5 -28.4 69.81 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.242 -0.651 . . . . 74.22 109.242 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -58.04 3.34 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 107.775 -1.194 . . . . 75.42 107.775 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -68.58 43.32 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 124.781 1.232 . . . . 55.54 112.212 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.452 ' CG2' HG22 ' A' ' 86' ' ' VAL . 1.4 t -123.82 -174.61 3.02 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 102.942 -2.985 . . . . 72.1 102.942 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.34 -145.16 18.3 Favored Glycine 0 CA--C 1.49 -1.48 0 N-CA-C 107.7 -2.16 . . . . 53.34 107.7 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.78 -55.49 16.93 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.46 -0.941 . . . . 62.04 108.46 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' ALA . 94.9 t -107.16 142.5 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 106.04 -1.837 . . . . 55.03 106.04 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.452 HG22 ' CG2' ' A' ' 82' ' ' THR . 45.8 t -115.08 144.82 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 105.634 -1.987 . . . . 62.44 105.634 -172.087 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.38 122.1 45.27 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 104.698 -2.334 . . . . 71.33 104.698 168.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -136.49 118.29 15.12 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.182 -2.155 . . . . 73.23 105.182 177.142 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.5 mp -83.94 143.62 29.71 Favored 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 106.624 -1.621 . . . . 73.13 106.624 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.624 HD21 HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -112.34 156.23 22.8 Favored 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.96 -2.237 . . . . 43.32 104.96 -179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -123.54 135.44 54.01 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 101.08 -3.674 . . . . 71.22 101.08 162.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.29 137.11 58.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.618 -1.252 . . . . 73.13 107.618 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.464 -3.125 0 N-CA-C 110.233 -1.147 . . . . 64.52 110.233 -168.567 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.792 0 N-CA-C 108.211 -1.956 . . . . 20.52 108.211 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.24 143.91 66.44 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.885 2.39 . . . . 63.13 108.595 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.55 168.31 19.12 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 106.148 -1.797 . . . . 65.33 106.148 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.46 116.2 3.26 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.884 2.389 . . . . 72.3 109.679 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.65 8.83 63.46 Favored Glycine 0 C--N 1.344 0.988 0 N-CA-C 108.487 -1.845 . . . . 54.11 108.487 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -89.86 143.44 26.79 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.273 -1.751 . . . . 62.34 106.273 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.53 HG23 ' CD1' ' A' ' 60' ' ' LEU . 19.1 mm -95.95 129.51 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 105.524 -2.028 . . . . 73.1 105.524 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.621 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.2 p90 -137.07 152.41 50.03 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.81 -1.181 . . . . 73.35 107.81 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -106.53 146.34 30.74 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.044 -1.836 . . . . 72.54 106.044 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.722 HG22 HD21 ' A' ' 90' ' ' LEU . 30.1 m -142.26 152.66 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 105.958 -1.867 . . . . 50.32 105.958 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.85 132.04 56.04 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.381 -1.711 . . . . 73.32 106.381 172.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.03 139.13 49.9 Favored 'General case' 0 CA--C 1.457 -2.626 0 N-CA-C 106.833 -1.543 . . . . 43.23 106.833 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.49 131.36 38.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.927 -1.879 . . . . 73.01 105.927 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -67.28 -23.91 65.72 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.637 -0.875 . . . . 71.01 108.637 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 70.71 104.86 0.06 Allowed 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.171 0.988 . . . . 55.43 110.394 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 56.85 43.47 24.87 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-N 115.448 -0.796 . . . . 72.11 109.203 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 42.64 9.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.708 2.003 . . . . 73.23 116.031 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.1 m -126.88 129.78 48.89 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 106.437 -1.69 . . . . 52.01 106.437 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.3 167.34 12.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.836 -2.283 . . . . 55.14 104.836 168.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.56 68.62 0.27 Allowed Glycine 0 CA--C 1.47 -2.746 0 N-CA-C 104.507 -3.437 . . . . 72.22 104.507 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.4 mt -101.15 176.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.458 -2.793 . . . . 73.32 103.458 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.513 ' H ' HG22 ' A' ' 21' ' ' ILE . 70.9 m -138.28 165.07 27.65 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 106.402 -1.703 . . . . 73.13 106.402 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 m -152.33 177.15 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.085 -1.82 . . . . 43.24 106.085 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.471 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 10.0 t -160.95 166.21 28.71 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 104.0 -2.593 . . . . 62.15 104.0 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.97 -151.74 29.12 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.927 -1.669 . . . . 50.5 108.927 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.444 ' CA ' HD12 ' A' ' 36' ' ' ILE . . . 116.62 -70.64 0.28 Allowed Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.692 -1.363 . . . . 44.34 109.692 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 71' ' ' THR . 1.4 t -72.32 16.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.097 0.475 . . . . 61.33 111.252 -172.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 26' ' ' GLY . 35.7 t30 78.41 5.14 2.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.597 1.159 . . . . 73.41 108.743 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.3 t -49.77 -171.36 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 C-N-CA 125.337 1.455 . . . . 62.33 112.037 169.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.4 p -38.56 -38.22 0.37 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.63 1.972 . . . . 73.41 115.164 -164.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.7 m -59.71 140.77 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.544 0.688 . . . . 74.1 110.215 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.407 ' HD3' ' H ' ' A' ' 97' ' ' THR . 96.1 mtt-85 -41.62 -70.28 0.11 Allowed 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.029 1.332 . . . . 74.11 112.824 -170.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -87.97 15.74 6.87 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.632 -0.877 . . . . 62.4 108.632 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.43 -7.98 2.42 Favored Glycine 0 C--N 1.359 1.842 0 O-C-N 121.792 -0.567 . . . . 71.41 113.149 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.11 -178.64 49.44 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.656 -1.378 . . . . 64.31 109.656 -170.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.444 HD12 ' CA ' ' A' ' 26' ' ' GLY . 1.1 mp -76.96 128.3 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 N-CA-C 101.922 -3.362 . . . . 42.13 101.922 170.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -107.08 147.56 29.85 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 104.089 -2.56 . . . . 72.25 104.089 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.47 102.22 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.724 -1.584 . . . . 60.3 106.724 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -72.82 -37.59 67.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.831 -1.531 . . . . 64.3 110.441 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.21 142.34 18.21 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 105.952 -1.87 . . . . 61.42 105.952 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -117.16 131.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 102.96 -2.978 . . . . 75.12 102.96 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.27 144.58 84.56 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 106.482 -1.673 . . . . 70.22 106.482 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.43 169.55 22.17 Favored 'Trans proline' 0 CA--C 1.462 -3.088 0 N-CA-C 105.07 -2.704 . . . . 62.52 105.07 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 66.51 -3.94 0.79 Allowed 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 124.04 0.837 . . . . 73.13 111.317 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.48 -179.2 40.97 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 108.122 -1.991 . . . . 71.42 108.122 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -51.74 63.09 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.118 -1.068 . . . . 72.32 108.118 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.97 65.18 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.277 -0.42 . . . . 50.54 110.882 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.61 -55.87 15.29 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.174 -0.328 . . . . 71.52 110.285 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.5 m -65.02 -31.24 72.37 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 122.056 -0.402 . . . . 64.14 111.256 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -81.3 -32.59 33.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.494 -1.669 . . . . 72.51 106.494 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.44 18.04 69.72 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 110.552 -1.019 . . . . 71.25 110.552 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -86.48 2.46 47.8 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.854 -1.165 . . . . 60.12 107.854 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -147.42 147.46 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 104.449 -2.426 . . . . 72.34 104.449 -168.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.97 167.11 30.87 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 104.186 -2.524 . . . . 74.32 104.186 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -66.3 145.41 55.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.121 -1.066 . . . . 55.4 108.121 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.7 -33.08 6.86 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 108.988 -1.645 . . . . 74.12 108.988 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.38 161.38 31.15 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 108.004 -1.11 . . . . 74.43 108.004 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.07 150.66 48.0 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 107.997 -1.112 . . . . 74.42 107.997 -172.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.01 139.24 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 105.705 -1.961 . . . . 61.12 105.705 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.53 ' CD1' HG23 ' A' ' 7' ' ' ILE . 16.3 mt -102.18 -59.49 1.69 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.992 -1.484 . . . . 74.44 106.992 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.55 150.4 50.74 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.199 -1.778 . . . . 61.54 106.199 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.44 120.33 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 105.015 -2.217 . . . . 75.11 105.015 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.4 t30 51.79 36.0 16.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.027 0.931 . . . . 75.44 109.979 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.34 -29.41 12.56 Favored Glycine 0 CA--C 1.474 -2.509 0 N-CA-C 108.134 -1.987 . . . . 44.14 108.134 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.69 115.32 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 108.383 -0.969 . . . . 72.23 108.383 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.9 m -55.4 115.54 2.35 Favored 'General case' 0 C--N 1.37 1.486 0 N-CA-C 107.193 -1.41 . . . . 43.3 107.193 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -101.33 -15.29 17.29 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 106.427 -1.694 . . . . 71.41 106.427 -165.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.09 128.77 37.37 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.498 -0.927 . . . . 75.22 108.498 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.98 57.78 Favored Glycine 0 CA--C 1.498 -0.977 0 N-CA-C 107.815 -2.114 . . . . 54.11 107.815 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.88 152.2 28.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.554 -2.017 . . . . 75.43 105.554 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.422 HG22 HG22 ' A' ' 27' ' ' VAL . 31.1 p -79.16 176.32 9.78 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.094 -0.706 . . . . 73.41 109.094 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 10.1 p-80 -70.34 -41.14 73.58 Favored 'General case' 0 C--O 1.21 -1.002 0 N-CA-C 108.726 -0.842 . . . . 75.43 108.726 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.67 -54.41 47.34 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.075 -1.015 . . . . 73.12 110.644 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -55.85 -34.96 65.91 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.441 -0.787 . . . . 64.51 111.294 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.41 ' CB ' HG12 ' A' ' 36' ' ' ILE . . . -50.72 -52.33 41.33 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.579 0.228 . . . . 73.02 111.282 176.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -74.95 -35.03 34.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 N-CA-C 108.276 -1.009 . . . . 74.5 108.276 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.41 -39.76 73.56 Favored 'General case' 0 N--CA 1.518 2.973 0 N-CA-C 105.775 -1.935 . . . . 72.03 105.775 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.2 m -69.3 -40.15 77.86 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.294 -1.503 . . . . 75.23 108.125 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.6 mt -64.71 -30.11 71.11 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.788 -0.449 . . . . 73.32 109.788 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -72.15 -57.67 4.06 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.529 -0.915 . . . . 74.35 108.529 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -69.14 48.11 0.07 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 122.918 0.487 . . . . 72.51 111.978 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.417 HG21 HG13 ' A' ' 86' ' ' VAL . 23.3 p -108.05 -175.58 2.82 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.21 -1.774 . . . . 72.34 106.21 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.06 -153.6 30.33 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 106.471 -2.652 . . . . 65.33 106.471 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.95 -54.86 20.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.75 -0.833 . . . . 73.13 108.75 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.9 t -95.07 142.74 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.335 -2.098 . . . . 75.44 105.335 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.417 HG13 HG21 ' A' ' 82' ' ' THR . 48.1 t -102.56 128.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 105.123 -2.177 . . . . 62.05 105.123 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -107.29 125.62 51.39 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 103.527 -2.768 . . . . 72.31 103.527 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.22 136.36 11.85 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.169 -1.048 . . . . 72.31 108.169 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.4 ' HB3' HD12 ' A' ' 60' ' ' LEU . 5.7 mp -86.43 143.05 27.98 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 108.283 -1.006 . . . . 74.11 108.283 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.722 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -120.32 165.42 14.89 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 104.878 -2.267 . . . . 72.5 104.878 177.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.48 145.79 51.44 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 102.608 -3.108 . . . . 72.24 102.608 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -64.82 131.11 45.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.839 -1.171 . . . . 72.43 107.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.09 10.45 33.99 Favored Glycine 0 CA--C 1.479 -2.196 0 N-CA-C 106.892 -2.483 . . . . 72.35 106.892 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -65.91 -40.02 91.11 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.621 -1.252 . . . . 71.05 107.621 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 96' ' ' PRO . 1.8 m -45.09 112.47 1.55 Allowed Pre-proline 0 C--O 1.253 1.257 0 C-N-CA 124.286 1.035 . . . . 62.44 111.078 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 95' ' ' SER . 44.4 Cg_endo -68.4 98.89 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.77 2.313 . . . . 63.32 107.325 173.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.407 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 26.8 m . . . . . 0 N--CA 1.418 -2.066 0 N-CA-C 105.376 -2.083 . . . . 70.32 105.376 -173.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.579 ' H5 ' ' C1 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.454 0 N-CA-C 108.288 -1.925 . . . . 70.43 108.288 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.78 149.94 78.68 Favored 'Trans proline' 0 CA--C 1.494 -1.485 0 C-N-CA 122.828 2.352 . . . . 65.35 108.068 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.43 161.47 48.48 Favored Pre-proline 0 N--CA 1.433 -1.311 0 N-CA-C 106.212 -1.773 . . . . 73.34 106.212 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.44 118.88 5.88 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.599 2.199 . . . . 74.35 108.938 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 88.7 9.09 69.14 Favored Glycine 0 CA--C 1.497 -1.034 0 N-CA-C 108.511 -1.836 . . . . 71.24 108.511 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.66 135.07 40.44 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.817 -1.549 . . . . 62.33 106.817 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 60' ' ' LEU . 22.4 mm -98.8 130.07 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 106.1 -1.815 . . . . 74.33 106.1 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.612 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -141.91 153.77 44.62 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.054 -1.091 . . . . 71.33 108.054 -177.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -107.81 144.09 35.46 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 105.07 -2.196 . . . . 65.02 105.07 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.698 HG22 HD21 ' A' ' 90' ' ' LEU . 27.6 m -141.6 153.71 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 107.068 -1.456 . . . . 64.24 107.068 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HB2' HG11 ' A' ' 85' ' ' VAL . 7.4 pt-20 -112.08 130.71 55.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.892 -1.892 . . . . 64.24 105.892 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.17 134.1 39.79 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.865 -1.532 . . . . 75.22 106.865 -176.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 141.81 30.0 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 105.379 -2.082 . . . . 72.42 105.379 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HG2' HD23 ' A' ' 19' ' ' LEU . 42.3 mtpt -75.41 -31.83 60.53 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.178 -1.045 . . . . 73.4 108.178 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 68.4 110.59 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.122 -0.696 . . . . 74.31 109.122 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t70 58.3 32.15 21.72 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 107.992 -1.114 . . . . 73.33 107.992 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 43.13 19.04 0.01 OUTLIER 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.722 1.609 . . . . 62.31 113.324 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -90.56 119.36 30.75 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 106.215 -1.772 . . . . 65.53 106.215 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' H ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -111.6 -143.64 0.39 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 102.911 -2.996 . . . . 63.13 102.911 179.068 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.742 ' H ' HD13 ' A' ' 19' ' ' LEU . . . 103.36 66.25 0.73 Allowed Glycine 0 CA--C 1.474 -2.482 0 N-CA-C 106.855 -2.498 . . . . 74.24 106.855 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.6 mm -89.43 177.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 102.447 -3.168 . . . . 55.31 102.447 170.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.6 m -122.5 154.49 37.78 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.037 -2.579 . . . . 61.43 104.037 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' HA ' ' H ' ' A' ' 39' ' ' LYS . 30.9 m -149.25 176.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.424 -1.324 . . . . 61.3 107.424 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.15 -2.167 . . . . 71.31 105.15 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.53 -158.75 25.54 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 108.454 -1.858 . . . . 45.13 108.454 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.29 -95.06 0.3 Allowed Glycine 0 C--N 1.36 1.863 0 N-CA-C 109.08 -1.608 . . . . 63.44 109.08 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -68.31 17.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.433 1.093 . . . . 63.43 113.782 -165.461 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 85.79 6.04 0.43 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 124.437 1.095 . . . . 74.52 108.499 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.0 p -42.39 -169.44 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 127.044 2.138 . . . . 71.03 112.431 161.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -40.86 -33.1 0.27 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.126 1.37 . . . . 44.01 113.485 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 m -62.08 129.48 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 122.465 1.126 . . . . 73.43 110.318 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -51.17 -65.07 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.041 -1.436 . . . . 74.01 111.48 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -84.48 16.66 3.01 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.573 -0.704 . . . . 72.31 110.646 -171.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 47.36 65.51 2.3 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 111.372 -0.691 . . . . 62.03 111.372 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.83 -179.15 31.57 Favored Glycine 0 CA--C 1.457 -3.574 0 N-CA-C 103.98 -3.648 . . . . 73.31 103.98 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 131.72 35.44 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 N-CA-C 104.988 -2.227 . . . . 60.12 104.988 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.26 151.81 25.46 Favored 'General case' 0 CA--C 1.46 -2.503 0 N-CA-C 103.621 -2.733 . . . . 74.51 103.621 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.29 102.49 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 106.233 -1.766 . . . . 55.33 106.233 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' H ' ' HA ' ' A' ' 23' ' ' VAL . 46.9 tttp -71.82 -32.86 68.01 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.088 -0.96 . . . . 75.32 109.359 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.06 149.64 16.18 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 105.401 -2.074 . . . . 61.51 105.401 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.29 130.3 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 102.805 -3.035 . . . . 74.44 102.805 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.427 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 143.36 65.7 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 105.541 -2.022 . . . . 72.1 105.541 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 45' ' ' GLY . 97.8 Cg_endo -75.59 173.58 14.26 Favored 'Trans proline' 0 CA--C 1.464 -2.984 0 N-CA-C 106.428 -2.181 . . . . 62.04 106.428 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 71.22 -12.1 0.63 Allowed 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.364 1.04 . . . . 72.53 111.674 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -90.11 -179.71 44.15 Favored Glycine 0 CA--C 1.476 -2.388 0 N-CA-C 107.439 -2.264 . . . . 75.02 107.439 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.06 -52.79 45.74 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.675 -0.861 . . . . 70.13 108.675 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -49.27 66.8 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 116.217 -0.447 . . . . 55.11 110.281 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.16 -55.66 29.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.59 -0.522 . . . . 65.51 109.59 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -64.85 -32.66 74.46 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.557 -0.292 . . . . 74.01 111.595 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -81.61 -25.22 35.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.236 -1.764 . . . . 55.05 106.236 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 19.4 77.42 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 110.518 -1.033 . . . . 72.55 110.518 167.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' HG11 ' A' ' 10' ' ' VAL . 6.6 mmp_? -94.44 6.46 48.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.891 -1.151 . . . . 73.54 107.891 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.5 mt -144.02 138.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 103.804 -2.665 . . . . 74.01 103.804 -169.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -149.94 159.96 43.98 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 105.196 -2.15 . . . . 61.41 105.196 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -67.22 144.14 56.14 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.171 -1.048 . . . . 75.31 108.171 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.22 -32.66 7.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 108.081 -2.008 . . . . 73.01 108.081 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.65 155.16 30.67 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.128 -1.064 . . . . 33.32 108.128 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -116.27 141.54 48.02 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.783 -1.562 . . . . 54.41 106.783 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.55 126.07 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.138 -2.171 . . . . 73.14 105.138 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.539 HD11 HD12 ' A' ' 7' ' ' ILE . 75.2 mt -91.17 -59.12 2.24 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 107.668 -1.234 . . . . 72.04 107.668 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.89 149.81 49.12 Favored 'General case' 0 CA--C 1.472 -2.046 0 N-CA-C 106.51 -1.663 . . . . 63.41 106.51 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.4 110.88 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.629 -1.989 . . . . 65.24 105.629 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.82 44.82 25.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.173 1.389 . . . . 63.13 110.622 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.22 -31.85 8.25 Favored Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 108.186 -1.966 . . . . 65.34 108.186 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -81.56 116.79 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 107.56 -1.274 . . . . 65.22 107.56 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 t -55.32 126.64 25.83 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 108.281 -1.007 . . . . 61.13 108.281 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -97.23 -13.43 22.04 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.099 -1.815 . . . . 74.42 106.099 -171.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.1 127.62 32.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.787 -0.819 . . . . 63.25 108.787 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.54 66.21 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.817 -1.713 . . . . 74.4 108.817 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.65 148.06 39.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.067 -1.457 . . . . 64.21 107.067 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 27' ' ' VAL . 50.5 p -82.82 -179.93 7.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.824 -1.176 . . . . 44.21 107.824 -174.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -60.97 -51.39 69.47 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.213 -1.032 . . . . 64.33 108.213 178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -52.95 -56.29 17.07 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 110.096 -0.335 . . . . 75.34 110.096 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.02 -47.63 77.45 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.509 -0.552 . . . . 74.33 109.509 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.42 -56.93 10.57 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.051 0.54 . . . . 70.42 111.242 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.24 -35.83 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 109.066 -0.716 . . . . 72.43 109.066 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.36 -32.54 74.24 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.338 -1.727 . . . . 74.4 106.338 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -74.22 -38.82 63.43 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.413 -1.429 . . . . 71.34 108.087 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.52 -48.67 74.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.61 -0.885 . . . . 62.41 108.61 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -55.88 13.58 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.582 -0.896 . . . . 30.12 108.582 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.24 60.95 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.97 0.891 . . . . 53.02 111.194 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 p -112.53 -176.11 2.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.54 -1.652 . . . . 70.43 106.54 171.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.59 -141.02 7.57 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 106.647 -2.581 . . . . 65.12 106.647 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 -55.13 12.89 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.785 -0.82 . . . . 74.34 108.785 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' ' 11' ' ' GLU . 73.6 t -99.32 144.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.775 -1.194 . . . . 55.32 107.775 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.9 t -97.62 125.57 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 105.731 -1.952 . . . . 73.41 105.731 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -97.67 117.8 32.78 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.931 -2.248 . . . . 63.1 104.931 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.12 130.32 11.2 Favored 'General case' 0 CA--C 1.482 -1.637 0 C-N-CA 119.281 -0.968 . . . . 65.5 108.474 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.06 143.51 30.54 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.354 -0.98 . . . . 42.43 108.354 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.698 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -116.08 158.92 22.43 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.438 -1.69 . . . . 75.14 106.438 178.43 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -126.72 131.51 51.35 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 102.47 -3.159 . . . . 52.01 102.47 169.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.513 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 30.1 mmmt -67.9 136.82 54.62 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 107.921 -1.14 . . . . 54.22 107.921 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.81 11.58 5.4 Favored Glycine 0 CA--C 1.488 -1.603 0 C-N-CA 119.9 -1.143 . . . . 72.5 110.725 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.42 ' OE1' ' HE3' ' A' ' 92' ' ' LYS . 24.7 mp0 -64.28 -37.06 86.13 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.578 -1.267 . . . . 74.14 107.578 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.0 m -116.04 97.03 48.62 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 104.722 -2.325 . . . . 73.15 104.722 170.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.38 106.37 1.58 Allowed 'Trans proline' 0 CA--C 1.5 -1.176 0 C-N-CA 122.068 1.845 . . . . 61.12 107.595 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.421 -1.893 0 N-CA-C 104.181 -2.526 . . . . 71.42 104.181 -176.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.535 ' C1 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.639 0 N-CA-C 108.757 -1.737 . . . . 74.41 108.757 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.58 164.93 24.51 Favored 'Trans proline' 0 C--O 1.25 1.105 0 C-N-CA 123.235 2.623 . . . . 73.33 109.223 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -88.55 165.41 28.12 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.824 -1.176 . . . . 65.21 107.824 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -65.05 117.59 4.68 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.761 2.307 . . . . 62.4 108.181 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 91.82 5.71 66.16 Favored Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 109.73 -1.348 . . . . 75.51 109.73 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.09 146.96 23.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.472 -1.677 . . . . 73.13 106.472 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.622 HD12 HD11 ' A' ' 60' ' ' LEU . 11.4 mm -96.94 129.11 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 106.515 -1.661 . . . . 75.23 106.515 -173.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.59 ' CD2' HD23 ' A' ' 90' ' ' LEU . 6.2 p90 -131.87 148.36 52.54 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 106.655 -1.609 . . . . 74.25 106.655 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.22 148.64 29.67 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 106.454 -1.684 . . . . 71.24 106.454 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.708 HG22 HD21 ' A' ' 90' ' ' LEU . 26.8 m -140.21 150.79 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.392 -1.707 . . . . 62.14 106.392 173.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -120.48 138.92 53.56 Favored 'General case' 0 CA--C 1.465 -2.315 0 N-CA-C 104.533 -2.395 . . . . 72.33 104.533 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.08 144.83 28.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.423 -1.325 . . . . 73.34 107.423 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.34 123.65 29.28 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 105.883 -1.895 . . . . 73.31 105.883 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -71.33 -22.52 61.91 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.023 -0.732 . . . . 60.33 109.023 -173.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 t30 73.61 109.19 0.07 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.706 0.802 . . . . 73.24 109.767 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.33 53.02 12.54 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.364 1.065 . . . . 63.12 110.685 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 53.31 -8.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.811 1.782 . . . . 71.44 115.811 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.6 m -131.39 130.22 42.32 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.379 -1.341 . . . . 75.21 107.379 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.5 179.84 3.84 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 104.242 -2.503 . . . . 72.31 104.242 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.02 53.57 0.46 Allowed Glycine 0 CA--C 1.475 -2.456 0 N-CA-C 106.644 -2.582 . . . . 34.54 106.644 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.9 mt -87.85 176.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 104.573 -2.381 . . . . 63.04 104.573 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.506 ' H ' HG22 ' A' ' 21' ' ' ILE . 77.1 m -141.78 167.28 22.52 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 106.312 -1.736 . . . . 42.31 106.312 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.487 ' HB ' HG23 ' A' ' 36' ' ' ILE . 6.2 m -148.79 172.92 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.073 -1.454 . . . . 42.05 107.073 -167.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.8 t -154.37 160.8 41.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 103.902 -2.629 . . . . 72.05 103.902 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 31' ' ' VAL . . . 90.19 -164.95 31.22 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 108.02 -2.032 . . . . 53.4 108.02 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 133.61 -88.69 0.26 Allowed Glycine 0 CA--C 1.479 -2.203 0 N-CA-C 108.418 -1.873 . . . . 61.03 108.418 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.481 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -72.63 16.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.028 0 C-N-CA 122.551 0.341 . . . . 41.32 111.446 -171.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 26' ' ' GLY . 7.1 t30 85.39 5.99 0.48 Allowed 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.483 1.113 . . . . 71.43 108.784 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -45.41 -171.05 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 126.279 1.832 . . . . 63.11 112.987 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 p -40.45 -40.71 1.26 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 127.272 2.229 . . . . 73.15 114.002 -164.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG21 ' HA3' ' A' ' 25' ' ' GLY . 27.6 m -56.46 135.82 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.64 0.733 . . . . 64.41 110.286 -173.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -39.69 -66.96 0.25 Allowed 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.017 1.327 . . . . 64.21 113.475 -171.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -77.72 -13.34 59.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.322 -0.951 . . . . 54.34 109.866 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.95 -14.62 64.77 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.361 -1.496 . . . . 53.35 109.361 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.78 -179.87 53.17 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.172 -1.571 . . . . 61.21 109.172 -173.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 HG23 ' HB ' ' A' ' 23' ' ' VAL . 19.3 mm -86.32 117.87 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 103.929 -2.619 . . . . 72.3 103.929 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.83 154.5 19.53 Favored 'General case' 0 CA--C 1.463 -2.399 0 N-CA-C 105.275 -2.12 . . . . 64.45 105.275 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.44 102.45 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 N-CA-C 106.206 -1.775 . . . . 74.01 106.206 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -71.16 -41.63 70.15 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 113.966 -1.47 . . . . 72.5 109.735 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.97 143.8 17.18 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 105.418 -2.067 . . . . 74.12 105.418 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.8 133.53 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.655 -2.72 . . . . 74.13 103.655 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.35 148.78 78.0 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 106.163 -1.791 . . . . 71.12 106.163 175.086 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.87 169.24 23.05 Favored 'Trans proline' 0 CA--C 1.458 -3.301 0 N-CA-C 105.438 -2.562 . . . . 52.45 105.438 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 65.04 -1.36 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.877 0.736 . . . . 75.33 111.942 166.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.75 171.59 43.34 Favored Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 106.702 -2.559 . . . . 72.04 106.702 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.95 67.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.405 -0.961 . . . . 63.13 108.405 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB1' ' HB ' ' A' ' 53' ' ' ILE . . . -53.78 -50.82 65.25 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.283 -0.872 . . . . 63.45 110.717 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -63.24 -56.27 17.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 120.872 0.368 . . . . 43.44 110.112 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -34.88 71.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.207 0.603 . . . . 71.2 110.982 -172.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.446 ' CG ' ' HE ' ' A' ' 52' ' ' ARG . 6.3 t70 -83.2 -34.52 25.9 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.698 -1.593 . . . . 54.24 106.698 -174.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.81 16.25 61.82 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 110.638 -0.985 . . . . 63.35 110.638 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.446 ' HE ' ' CG ' ' A' ' 50' ' ' ASP . 67.3 mtt180 -91.89 6.09 47.51 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 118.361 1.08 . . . . 74.43 108.201 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.434 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 2.9 mp -147.71 148.41 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.227 -2.509 . . . . 72.44 104.227 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -158.6 171.8 19.45 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 104.541 -2.392 . . . . 74.1 104.541 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -67.05 146.46 54.29 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.556 -0.905 . . . . 71.34 108.556 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.77 -32.95 6.98 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 109.263 -1.535 . . . . 74.21 109.263 169.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.43 158.52 34.82 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.662 -1.236 . . . . 53.11 107.662 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.459 HH22 ' CD ' ' A' ' 91' ' ' GLU . 24.6 ttp85 -123.88 143.79 50.15 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.741 -1.207 . . . . 61.04 107.741 -165.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.0 t -95.21 139.36 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.929 -1.878 . . . . 74.42 105.929 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.622 HD11 HD12 ' A' ' 7' ' ' ILE . 46.2 mt -102.01 -58.88 1.8 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.314 -1.365 . . . . 72.13 107.314 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.73 151.52 48.28 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.115 -1.809 . . . . 54.1 106.115 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.38 127.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.616 -2.365 . . . . 71.23 104.616 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.0 t30 59.04 31.28 21.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.91 0.862 . . . . 73.1 109.371 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.77 -8.14 73.96 Favored Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 109.156 -1.578 . . . . 43.43 109.156 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.77 118.52 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.572 0 N-CA-C 106.493 -1.669 . . . . 72.23 106.493 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 t -55.99 118.63 4.82 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.729 -1.211 . . . . 63.2 107.729 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD12 HG13 ' A' ' 36' ' ' ILE . 1.2 tm? -104.87 -13.47 15.81 Favored 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 106.552 -1.648 . . . . 70.34 106.552 -167.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.55 127.41 31.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.501 -0.749 . . . . 71.11 109.054 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.83 61.99 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.315 -1.914 . . . . 51.44 108.315 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.39 154.81 25.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.158 -1.793 . . . . 63.42 106.158 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.481 HG22 HG22 ' A' ' 27' ' ' VAL . 22.8 p -81.29 176.83 9.41 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.781 0.801 . . . . 75.43 110.393 -168.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.3 t-80 -58.48 -50.79 72.46 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.815 1.246 . . . . 74.0 107.906 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -55.13 -54.48 42.68 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 122.063 -0.398 . . . . 75.12 110.759 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -53.93 -41.34 67.62 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.864 -0.421 . . . . 74.21 109.864 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.33 -54.27 27.94 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 122.798 0.439 . . . . 73.43 110.33 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.62 -38.5 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 109.302 -0.629 . . . . 63.3 109.302 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.6 -32.74 72.87 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 105.801 -1.926 . . . . 73.41 105.801 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -70.69 -46.46 63.1 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.175 -1.578 . . . . 65.13 108.05 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.36 -30.3 69.47 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 109.388 -0.597 . . . . 72.23 109.388 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -59.9 2.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.139 -1.43 . . . . 55.52 107.139 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -48.73 -20.59 0.49 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 126.163 1.785 . . . . 72.21 114.019 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -74.13 171.84 12.83 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.35 -0.844 . . . . 74.32 109.422 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.23 -148.69 5.4 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.1 -1.2 . . . . 74.24 110.1 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -70.82 -55.93 7.43 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.839 -0.8 . . . . 62.44 108.839 -170.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.06 142.58 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.727 0 N-CA-C 104.428 -2.434 . . . . 73.34 104.428 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.65 134.9 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 104.987 -2.227 . . . . 61.32 104.987 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -103.46 121.32 42.59 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.085 -2.561 . . . . 65.41 104.085 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 125.91 14.4 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 107.914 -1.143 . . . . 61.33 107.914 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.432 ' HB3' HD12 ' A' ' 60' ' ' LEU . 4.3 mp -81.9 144.39 31.0 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 107.999 -1.111 . . . . 63.05 107.999 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.708 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.28 162.18 18.31 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.105 -2.183 . . . . 55.21 105.105 174.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HG3' HD13 ' A' ' 7' ' ' ILE . 41.5 tt0 -129.01 144.58 51.23 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 102.254 -3.239 . . . . 75.0 102.254 163.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 26.2 mmmt -57.88 140.78 51.2 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.721 0.772 . . . . 73.04 110.389 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.75 -162.47 16.91 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 104.132 -3.587 . . . . 53.53 104.132 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 63.5 46.23 4.38 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.104 -1.443 . . . . 50.23 107.104 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.1 m -113.54 128.2 25.97 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 103.439 -2.8 . . . . 65.22 103.439 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.33 98.66 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.299 1.999 . . . . 74.23 107.972 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.425 -1.686 0 N-CA-C 105.131 -2.174 . . . . 64.24 105.131 -176.652 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.572 ' C1 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.854 0 N-CA-C 108.617 -1.793 . . . . 71.22 108.617 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.22 156.87 52.94 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 123.608 2.872 . . . . 62.15 110.109 -169.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -96.25 167.44 12.37 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 106.573 -1.64 . . . . 73.15 106.573 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.69 118.39 5.27 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 122.792 2.328 . . . . 54.51 109.996 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.51 -0.52 68.15 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 108.819 -1.712 . . . . 43.52 108.819 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.66 139.9 38.45 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 106.691 -1.596 . . . . 74.54 106.691 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.408 HG12 HD11 ' A' ' 60' ' ' LEU . 54.0 mt -99.42 130.25 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 106.718 -1.586 . . . . 72.01 106.718 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.1 p90 -137.5 154.23 49.9 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 108.005 -1.109 . . . . 62.34 108.005 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.66 143.56 33.65 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.232 -1.766 . . . . 71.24 106.232 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.634 HG22 HD21 ' A' ' 90' ' ' LEU . 29.1 m -142.54 151.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.511 -1.663 . . . . 53.45 106.511 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.82 129.21 56.52 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 106.213 -1.773 . . . . 63.44 106.213 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.51 140.21 50.5 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 108.493 -0.928 . . . . 75.52 108.493 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.04 137.76 32.02 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 105.818 -1.919 . . . . 64.32 105.818 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.43 -25.76 59.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.613 -0.884 . . . . 72.35 108.613 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 67.87 111.28 0.04 OUTLIER 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.184 -0.673 . . . . 62.31 109.184 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.12 40.29 30.2 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.35 -0.982 . . . . 73.31 108.35 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 t30 43.22 12.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.223 2.209 . . . . 63.24 114.649 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -97.11 129.17 44.55 Favored 'General case' 0 CA--C 1.494 -1.195 0 O-C-N 120.517 -1.364 . . . . 61.52 107.328 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 tp -124.78 142.51 51.37 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 102.738 -3.06 . . . . 75.31 102.738 173.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.51 64.34 0.27 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 106.406 -2.678 . . . . 51.23 106.406 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.0 mm -87.89 177.35 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 104.929 -2.248 . . . . 74.13 104.929 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.516 ' H ' HG22 ' A' ' 21' ' ' ILE . 16.8 m -124.78 156.85 37.08 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 103.662 -2.718 . . . . 74.13 103.662 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.7 m -150.53 171.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 108.092 -1.077 . . . . 72.11 108.092 -166.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -161.99 164.75 28.17 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.498 -2.408 . . . . 71.24 104.498 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.62 -160.84 22.76 Favored Glycine 0 CA--C 1.486 -1.774 0 N-CA-C 107.052 -2.419 . . . . 73.12 107.052 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.72 -104.84 0.56 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 108.89 -1.684 . . . . 70.11 108.89 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.82 16.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 113.374 0.879 . . . . 74.32 113.374 -164.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 86.64 12.96 0.14 Allowed 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.804 1.242 . . . . 73.42 108.877 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 p -46.15 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 124.334 1.054 . . . . 74.43 110.859 155.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.7 m -29.46 -44.02 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.487 1.662 . . . . 71.44 115.487 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 37' ' ' TYR . 30.0 m -76.12 140.22 17.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.22 -0.925 . . . . 53.15 108.517 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -68.31 -47.58 67.21 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.148 -0.97 . . . . 74.04 111.138 -171.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.424 ' HE1' ' CD ' ' A' ' 68' ' ' GLU . 8.3 t-80 -73.23 0.66 11.2 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.189 -0.319 . . . . 73.45 110.248 -166.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.97 61.21 7.11 Favored Glycine 0 C--N 1.362 1.991 0 N-CA-C 109.495 -1.442 . . . . 72.04 109.495 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.4 28.19 Favored Glycine 0 CA--C 1.454 -3.759 0 N-CA-C 103.721 -3.752 . . . . 42.23 103.721 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 72' ' ' HIS . 0.7 OUTLIER -90.61 131.17 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.707 0 N-CA-C 104.25 -2.5 . . . . 75.2 104.25 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.466 ' CZ ' ' HB ' ' A' ' 31' ' ' VAL . 3.7 m-30 -108.55 151.67 25.79 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 102.899 -3.0 . . . . 75.21 102.899 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.52 102.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 107.103 -1.443 . . . . 71.02 107.103 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -71.6 -36.61 70.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.196 -1.366 . . . . 74.42 110.113 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.71 152.7 14.08 Favored 'General case' 0 CA--C 1.466 -2.278 0 N-CA-C 105.464 -2.05 . . . . 70.03 105.464 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.71 136.16 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 104.308 -2.479 . . . . 62.41 104.308 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.24 145.22 79.83 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 106.259 -1.756 . . . . 74.22 106.259 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.83 168.38 24.36 Favored 'Trans proline' 0 CA--C 1.462 -3.09 0 N-CA-C 105.786 -2.428 . . . . 73.11 105.786 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 63.41 1.54 1.0 Allowed 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 123.665 0.603 . . . . 71.34 111.732 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.6 -178.22 41.11 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 106.667 -2.573 . . . . 65.34 106.667 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.67 -52.99 31.43 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 108.151 -1.055 . . . . 63.44 108.151 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.07 65.86 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.066 -0.516 . . . . 65.44 110.879 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -62.39 -56.11 21.44 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.56 -0.533 . . . . 74.53 109.56 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.7 m -62.79 -30.49 71.5 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.683 0.278 . . . . 61.12 111.232 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -77.21 -35.8 55.3 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.773 -1.566 . . . . 62.32 106.773 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.38 12.59 72.69 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.109 -1.596 . . . . 74.05 109.109 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB2' HD12 ' A' ' 53' ' ' ILE . 23.8 mmt180 -90.19 -1.93 57.99 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.275 -1.38 . . . . 73.1 107.275 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 52' ' ' ARG . 2.1 mp -142.77 145.26 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 102.857 -3.016 . . . . 72.22 102.857 -176.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.577 ' HE1' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -156.79 173.03 17.58 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.699 -2.704 . . . . 72.2 103.699 170.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -66.35 145.62 55.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-O 121.391 0.615 . . . . 74.02 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -33.03 6.86 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.764 -1.734 . . . . 45.32 108.764 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.577 ' OD1' ' HE1' ' A' ' 54' ' ' HIS . 84.6 m-20 -67.55 157.01 35.36 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.981 -0.748 . . . . 75.01 108.981 -177.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -117.0 142.84 46.43 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.3 -1.37 . . . . 74.34 107.3 -166.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -93.01 126.71 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 105.761 -1.94 . . . . 74.22 105.761 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.408 HD11 HG12 ' A' ' 7' ' ' ILE . 19.9 mt -94.47 -58.64 2.14 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 107.417 -1.327 . . . . 60.24 107.417 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.36 147.62 47.45 Favored 'General case' 0 CA--C 1.471 -2.079 0 N-CA-C 106.379 -1.712 . . . . 72.01 106.379 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.43 119.12 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 104.897 -2.26 . . . . 71.33 104.897 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.3 t30 52.28 38.06 23.81 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.046 0.938 . . . . 64.42 110.618 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.7 -18.38 57.29 Favored Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 108.784 -1.726 . . . . 53.52 108.784 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.3 117.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.888 0 N-CA-C 106.78 -1.563 . . . . 73.11 106.78 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.0 t -56.02 122.73 12.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.243 -1.021 . . . . 65.12 108.243 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.6 tm? -93.42 -16.63 24.38 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.431 -2.063 . . . . 74.13 105.431 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CD ' ' HE1' ' A' ' 33' ' ' HIS . 53.3 mt-10 -59.85 123.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.816 -0.809 . . . . 62.33 108.816 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.56 -14.94 62.74 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 108.968 -1.653 . . . . 62.2 108.968 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.01 147.33 46.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.569 -1.271 . . . . 61.2 107.569 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 59.6 p -81.65 178.69 8.19 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.147 -1.427 . . . . 73.14 107.147 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . 0.401 ' HA ' HD11 ' A' ' 36' ' ' ILE . 43.5 p-80 -62.26 -51.06 69.23 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.935 -0.765 . . . . 63.23 108.935 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.57 -56.07 24.62 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 121.707 -0.621 . . . . 73.22 110.12 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -60.9 -45.49 94.42 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 110.184 -0.302 . . . . 55.22 110.184 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -53.65 -51.29 63.62 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-O 120.918 0.389 . . . . 60.43 110.716 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.63 -36.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.827 -1.175 . . . . 75.33 107.827 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.6 -34.19 73.85 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.031 -1.84 . . . . 70.43 106.031 -176.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.9 m -73.14 -42.32 62.97 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 107.393 -1.336 . . . . 74.55 107.393 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.78 -39.58 94.66 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 110.109 -0.33 . . . . 64.45 110.109 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -75.99 -54.64 6.56 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.662 -0.815 . . . . 63.13 109.139 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -70.48 47.78 0.1 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.039 0.447 . . . . 72.11 111.591 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -101.08 -176.07 3.05 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.702 -1.962 . . . . 72.31 105.702 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.65 -157.26 18.57 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 107.113 -2.395 . . . . 13.2 107.113 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.34 -54.02 39.57 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.088 -0.708 . . . . 63.45 109.088 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.27 141.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 105.928 -1.879 . . . . 71.44 105.928 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.2 130.68 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.491 0 N-CA-C 105.718 -1.956 . . . . 75.31 105.718 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -107.17 124.61 49.97 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 105.413 -2.069 . . . . 72.41 105.413 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -156.36 136.55 12.89 Favored 'General case' 0 CA--C 1.473 -2.004 0 C-N-CA 119.01 -1.076 . . . . 75.5 108.458 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.33 141.0 33.23 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.394 -1.336 . . . . 72.51 107.394 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.634 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.8 159.02 18.7 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 104.595 -2.372 . . . . 75.2 104.595 174.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -123.4 134.4 53.98 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 101.292 -3.596 . . . . 51.42 101.292 164.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.76 130.29 44.28 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.163 -1.421 . . . . 73.14 107.163 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.02 12.05 20.13 Favored Glycine 0 CA--C 1.463 -3.208 0 N-CA-C 107.303 -2.319 . . . . 21.11 107.303 -169.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -68.98 116.86 9.93 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.099 -1.815 . . . . 60.24 106.099 170.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.6 t -97.84 133.09 23.72 Favored Pre-proline 0 N--CA 1.422 -1.83 0 N-CA-C 106.465 -1.68 . . . . 51.33 106.465 -168.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.07 -179.04 4.29 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 N-CA-C 106.018 -2.339 . . . . 64.23 106.018 161.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 104.502 -2.407 . . . . 74.12 104.502 176.289 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.451 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.665 0 N-CA-C 108.959 -1.656 . . . . 62.13 108.959 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.55 151.34 75.4 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 122.985 2.457 . . . . 72.51 109.057 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -83.33 165.24 41.68 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 105.975 -1.861 . . . . 74.43 105.975 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.28 128.87 23.76 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 122.716 2.277 . . . . 62.12 108.611 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.84 10.62 78.61 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 109.567 -1.413 . . . . 74.54 109.567 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -99.77 153.8 18.83 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.869 -1.901 . . . . 74.43 105.869 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 60' ' ' LEU . 4.6 mm -99.63 137.51 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 106.59 -1.633 . . . . 63.22 106.59 -169.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.563 ' CD2' HD23 ' A' ' 90' ' ' LEU . 9.1 p90 -135.28 151.96 51.05 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.302 -1.37 . . . . 74.14 107.302 170.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -108.09 147.29 31.42 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.237 -1.764 . . . . 64.24 106.237 -178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.73 HG22 HD21 ' A' ' 90' ' ' LEU . 35.1 m -142.96 152.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 105.984 -1.858 . . . . 62.5 105.984 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -118.71 127.25 53.39 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.745 -1.946 . . . . 73.13 105.745 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 137.69 45.45 Favored 'General case' 0 CA--C 1.474 -1.961 0 N-CA-C 107.694 -1.224 . . . . 70.34 107.694 -169.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.29 142.3 28.63 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.693 -1.965 . . . . 64.32 105.693 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -69.88 -32.41 70.74 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.413 -0.958 . . . . 75.21 108.413 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 75.03 107.08 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.607 0.763 . . . . 64.13 109.299 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 50.84 45.38 27.43 Favored 'General case' 0 C--N 1.37 1.474 0 C-N-CA 124.576 1.151 . . . . 43.3 110.937 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 54.97 -9.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.549 1.94 . . . . 74.21 113.805 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -84.3 158.28 21.24 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 119.975 1.262 . . . . 71.11 108.341 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.96 -157.15 0.78 Allowed 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 102.952 -2.981 . . . . 53.44 102.952 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.36 40.79 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.657 0 N-CA-C 105.292 -3.123 . . . . 55.22 105.292 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mm -87.99 175.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 103.438 -2.801 . . . . 70.23 103.438 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.7 m -147.61 159.55 43.64 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.358 -2.09 . . . . 73.3 105.358 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.3 m -150.4 167.3 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 N-CA-C 107.766 -1.198 . . . . 73.13 107.766 -164.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -166.17 169.49 14.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.665 -2.346 . . . . 63.41 104.665 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -138.61 14.64 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.695 -2.162 . . . . 25.43 107.695 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.77 -88.17 0.68 Allowed Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 109.404 -1.478 . . . . 64.02 109.404 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 16.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 112.832 0.679 . . . . 71.22 112.832 -165.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 17.7 t-20 82.55 6.92 0.9 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.677 0.791 . . . . 74.13 109.301 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 t -46.28 -170.23 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.427 1.491 . . . . 54.42 111.478 160.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -35.08 -40.33 0.12 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.071 1.748 . . . . 72.54 114.982 -166.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 34.6 m -72.25 142.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.559 -0.904 . . . . 34.13 108.559 -174.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.19 -59.11 4.07 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 121.725 -0.609 . . . . 72.33 112.556 -167.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.537 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 22.8 t-160 -75.84 15.16 0.55 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.588 -0.695 . . . . 70.35 110.874 -164.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 28' ' ' ASN . . . 46.35 57.19 6.6 Favored Glycine 0 C--N 1.358 1.788 0 N-CA-C 109.559 -1.416 . . . . 54.41 109.559 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.95 178.27 23.78 Favored Glycine 1 CA--C 1.442 -4.49 0 N-CA-C 103.252 -3.939 . . . . 61.23 103.252 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.493 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.6 mm -92.63 132.09 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 106.214 -1.772 . . . . 71.2 106.214 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.429 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 2.7 m-85 -109.82 148.52 31.34 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.584 -2.747 . . . . 72.12 103.584 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.12 103.2 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 N-CA-C 106.702 -1.592 . . . . 71.52 106.702 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -70.58 -38.64 74.09 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.547 -1.206 . . . . 63.23 109.745 -174.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.35 155.56 17.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 N-CA-C 105.368 -2.086 . . . . 43.32 105.368 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.5 143.2 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 102.763 -3.051 . . . . 54.42 102.763 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.16 142.6 72.26 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 105.903 -1.888 . . . . 74.14 105.903 171.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.14 173.89 13.73 Favored 'Trans proline' 0 CA--C 1.472 -2.585 0 N-CA-C 105.896 -2.386 . . . . 64.14 105.896 -176.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 69.66 -2.73 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.024 0.828 . . . . 71.21 111.213 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.57 -176.25 38.6 Favored Glycine 0 CA--C 1.48 -2.139 0 N-CA-C 107.221 -2.352 . . . . 63.01 107.221 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -52.84 46.75 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.137 -1.061 . . . . 75.52 108.137 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.53 -49.65 64.42 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.224 -0.444 . . . . 74.02 110.589 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -64.54 -55.98 17.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.819 0.342 . . . . 52.45 110.124 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 m -64.04 -29.66 70.79 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 121.928 -0.482 . . . . 73.41 111.694 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -78.56 -34.15 47.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 105.773 -1.936 . . . . 74.35 105.773 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.49 63.97 Favored Glycine 0 CA--C 1.482 -2.02 0 N-CA-C 108.898 -1.681 . . . . 61.21 108.898 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.505 ' HB3' HG11 ' A' ' 10' ' ' VAL . 13.4 mmt180 -89.89 -2.62 58.23 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 107.805 -1.183 . . . . 75.5 107.805 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.8 mt -146.64 143.9 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 N-CA-C 103.26 -2.867 . . . . 74.43 103.26 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.496 ' CE1' ' OD1' ' A' ' 57' ' ' ASP . 25.6 p80 -153.23 165.39 35.83 Favored 'General case' 0 CA--C 1.463 -2.375 0 N-CA-C 104.497 -2.409 . . . . 74.52 104.497 173.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.716 ' H ' ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -67.93 145.08 54.9 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.612 -1.255 . . . . 72.43 107.612 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.74 -32.72 7.09 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.493 -1.443 . . . . 52.52 109.493 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 68.1 m-20 -66.4 158.0 30.47 Favored 'General case' 0 C--N 1.373 1.588 0 N-CA-C 108.292 -1.003 . . . . 73.5 108.292 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 52.5 mtm-85 -112.7 137.66 50.67 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.506 -1.294 . . . . 72.41 107.506 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.36 128.49 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 105.08 -2.193 . . . . 74.01 105.08 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' CD1' HG23 ' A' ' 7' ' ' ILE . 17.5 mt -99.28 -59.14 1.78 Allowed 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 107.467 -1.309 . . . . 73.42 107.467 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.06 146.53 51.77 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 106.433 -1.691 . . . . 64.54 106.433 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.78 125.42 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.213 -2.514 . . . . 74.12 104.213 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.64 29.84 17.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.114 0.959 . . . . 73.02 109.287 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.06 -12.06 68.85 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 109.26 -1.536 . . . . 72.51 109.26 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.04 118.54 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.557 -1.645 . . . . 74.11 106.557 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.5 m -56.7 118.38 4.82 Favored 'General case' 0 C--N 1.368 1.381 0 N-CA-C 108.435 -0.95 . . . . 55.44 108.435 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -104.52 -10.82 17.37 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.136 -1.802 . . . . 54.41 106.136 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.91 126.59 28.09 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.655 -0.868 . . . . 73.51 108.655 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -13.37 67.16 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 108.963 -1.655 . . . . 63.15 108.963 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.4 152.89 30.1 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.228 -1.767 . . . . 64.51 106.228 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -81.73 179.24 7.91 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.952 -0.758 . . . . 64.05 108.952 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 28.8 p80 -67.44 -46.15 73.93 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 108.202 -1.036 . . . . 74.35 108.202 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -52.19 -56.43 14.65 Favored 'General case' 0 C--N 1.362 1.136 0 O-C-N 121.733 -0.604 . . . . 53.22 110.07 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -53.96 -42.63 69.11 Favored 'General case' 0 C--N 1.369 1.452 0 N-CA-C 110.0 -0.37 . . . . 73.44 110.0 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -52.1 -53.9 36.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.096 0.558 . . . . 73.23 110.432 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.57 -40.57 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.657 -1.238 . . . . 73.43 107.657 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.05 -37.27 76.61 Favored 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 106.823 -1.547 . . . . 72.43 106.823 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.3 m -74.01 -48.06 32.79 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 120.355 -1.466 . . . . 73.44 107.627 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 124.024 0.929 . . . . 74.43 109.933 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -70.07 -55.47 9.41 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.998 -1.112 . . . . 72.53 107.998 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -70.84 55.26 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.875 0.845 . . . . 54.31 110.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.562 HG21 HG13 ' A' ' 86' ' ' VAL . 10.1 p -104.79 -175.53 2.82 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.226 -1.768 . . . . 74.11 106.226 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.12 -155.73 31.97 Favored Glycine 0 CA--C 1.485 -1.815 0 N-CA-C 107.189 -2.364 . . . . 50.0 107.189 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -63.24 -55.34 25.71 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.023 -1.103 . . . . 74.35 108.023 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.48 144.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.673 -1.973 . . . . 70.22 105.673 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.562 HG13 HG21 ' A' ' 82' ' ' THR . 46.8 t -103.01 131.84 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.715 0 N-CA-C 105.568 -2.012 . . . . 74.11 105.568 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 31.7 t60 -112.5 124.18 51.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.089 -2.189 . . . . 63.34 105.089 173.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.29 136.4 14.74 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 107.781 -1.192 . . . . 73.51 107.781 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -81.29 140.14 35.0 Favored 'General case' 0 CA--C 1.469 -2.138 0 N-CA-C 107.712 -1.218 . . . . 70.23 107.712 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.73 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.92 156.91 20.51 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.412 -2.44 . . . . 45.53 104.412 172.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.3 tt0 -118.75 129.82 55.47 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 101.566 -3.494 . . . . 71.1 101.566 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -66.89 129.24 39.23 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.225 -1.768 . . . . 71.21 106.225 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.08 -159.0 34.64 Favored Glycine 0 CA--C 1.475 -2.438 0 N-CA-C 107.835 -2.106 . . . . 30.14 107.835 -168.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -75.61 -47.87 24.69 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.735 -1.209 . . . . 73.21 107.735 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -65.94 127.67 93.3 Favored Pre-proline 0 C--N 1.361 1.103 0 N-CA-C 106.941 -1.503 . . . . 73.2 106.941 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.97 151.62 67.95 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.364 2.043 . . . . 70.4 109.458 -167.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.413 -2.309 0 N-CA-C 104.467 -2.42 . . . . 75.22 104.467 175.989 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.551 ' C1 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.421 0 N-CA-C 107.935 -2.066 . . . . 72.3 107.935 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.76 169.42 20.22 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.164 2.576 . . . . 73.43 109.532 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -105.11 166.55 11.23 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 104.884 -2.265 . . . . 73.3 104.884 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.78 138.7 76.09 Favored 'Trans proline' 0 CA--C 1.499 -1.227 0 C-N-CA 122.324 2.016 . . . . 65.2 108.214 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.5 65.05 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 109.348 -1.501 . . . . 62.34 109.348 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.5 138.52 39.26 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.432 -1.322 . . . . 73.2 107.432 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 60' ' ' LEU . 10.1 mm -97.53 133.28 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.321 -1.363 . . . . 74.11 107.321 -172.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.586 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -142.89 153.21 42.9 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.139 -1.06 . . . . 61.41 108.139 175.154 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -104.94 146.83 28.49 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 105.942 -1.873 . . . . 70.23 105.942 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.648 HG22 HD21 ' A' ' 90' ' ' LEU . 22.5 m -140.61 150.0 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.78 -1.563 . . . . 74.22 106.78 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -108.67 127.86 54.35 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 105.142 -2.17 . . . . 64.5 105.142 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 53' ' ' ILE . 3.6 mp -129.6 140.08 51.28 Favored 'General case' 0 CA--C 1.448 -2.967 0 N-CA-C 107.528 -1.286 . . . . 73.15 107.528 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.57 140.07 31.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 104.964 -2.236 . . . . 64.43 104.964 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.67 -31.97 67.37 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.539 -1.282 . . . . 71.1 107.539 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 74.83 102.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.251 -1.389 . . . . 74.35 107.251 -175.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.16 45.83 11.22 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.243 -0.89 . . . . 75.41 109.22 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.7 t30 45.34 3.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.816 2.046 . . . . 61.42 115.634 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -102.6 121.94 43.4 Favored 'General case' 0 CA--C 1.485 -1.548 0 O-C-N 120.358 -1.464 . . . . 61.34 107.049 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.9 tp -127.19 151.37 48.78 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 104.202 -2.518 . . . . 54.31 104.202 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.18 0.07 OUTLIER Glycine 0 CA--C 1.467 -2.934 0 N-CA-C 105.184 -3.166 . . . . 65.11 105.184 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.7 mm -89.22 178.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.415 -2.439 . . . . 64.21 104.415 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.534 ' H ' HG22 ' A' ' 21' ' ' ILE . 40.0 t -122.06 154.59 37.11 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 103.345 -2.835 . . . . 53.1 103.345 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.481 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.4 m -147.63 169.69 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 107.406 -1.331 . . . . 74.35 107.406 -164.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 t -162.67 165.88 25.16 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.884 -2.265 . . . . 55.44 104.884 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -152.67 31.24 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 107.067 -2.413 . . . . 42.34 107.067 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 118.48 -78.77 0.3 Allowed Glycine 0 CA--C 1.477 -2.332 0 N-CA-C 108.979 -1.649 . . . . 73.22 108.979 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -67.71 16.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 C-N-CA 124.557 1.143 . . . . 72.22 112.057 -168.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 26' ' ' GLY . 12.5 t-20 81.32 5.14 1.38 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.213 1.405 . . . . 65.42 108.072 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.1 p -49.02 -170.86 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 126.071 1.748 . . . . 70.45 113.186 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 m -31.43 -42.41 0.05 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.63 2.372 . . . . 64.12 115.089 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -62.75 134.91 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.816 0.817 . . . . 62.22 109.967 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -52.44 -50.25 62.95 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 114.855 -1.066 . . . . 73.12 112.404 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -90.31 16.95 7.78 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.208 -0.933 . . . . 74.12 110.079 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.09 62.63 2.0 Favored Glycine 0 C--N 1.368 2.327 0 N-CA-C 111.206 -0.758 . . . . 72.33 111.206 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.1 179.73 24.73 Favored Glycine 0 CA--C 1.455 -3.681 0 N-CA-C 104.162 -3.575 . . . . 70.13 104.162 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.564 HG13 ' HB2' ' A' ' 75' ' ' ALA . 8.6 mm -88.87 125.54 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 105.479 -2.045 . . . . 73.14 105.479 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -109.32 152.86 24.71 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 103.84 -2.652 . . . . 64.52 103.84 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.81 104.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.464 -1.68 . . . . 75.2 106.464 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.37 -31.93 69.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.729 -0.841 . . . . 64.43 108.729 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.49 146.22 16.6 Favored 'General case' 0 CA--C 1.459 -2.525 0 N-CA-C 105.645 -1.983 . . . . 63.25 105.645 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.89 122.46 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.349 -3.204 . . . . 73.04 102.349 172.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.406 ' H ' ' CD1' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.79 146.23 72.1 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 106.052 -1.833 . . . . 73.13 106.052 178.002 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.5 173.61 14.2 Favored 'Trans proline' 0 CA--C 1.47 -2.679 0 N-CA-C 107.109 -1.919 . . . . 72.41 107.109 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 63.65 53.98 1.94 Allowed 'General case' 0 N--CA 1.422 -1.829 0 O-C-N 124.664 1.228 . . . . 72.32 108.136 164.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.34 176.53 37.87 Favored Glycine 0 CA--C 1.466 -2.992 0 N-CA-C 106.659 -2.576 . . . . 75.25 106.659 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.43 -52.73 24.02 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.661 -0.866 . . . . 62.4 108.661 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -49.32 67.45 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.623 -0.262 . . . . 71.25 110.558 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -59.53 -57.5 12.67 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 122.104 -0.373 . . . . 73.12 110.129 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -63.58 -28.7 70.11 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.581 0.229 . . . . 42.04 110.948 -170.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.34 -40.37 58.38 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.146 -1.427 . . . . 64.44 107.146 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.56 9.61 78.39 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 109.794 -1.322 . . . . 62.44 109.794 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -100.22 7.07 44.73 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.594 -1.262 . . . . 72.11 107.594 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 12' ' ' LEU . 1.4 mp -134.5 140.75 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 102.987 -2.968 . . . . 43.55 102.987 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -140.83 158.71 43.56 Favored 'General case' 0 CA--C 1.465 -2.325 0 N-CA-C 104.666 -2.346 . . . . 74.41 104.666 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.21 140.48 57.43 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.487 -1.672 . . . . 72.24 106.487 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.5 -32.83 6.34 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 108.663 -1.775 . . . . 72.04 108.663 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -67.45 155.92 37.84 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.119 -1.808 . . . . 74.03 106.119 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.426 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 1.6 ppt_? -133.38 156.55 47.44 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.233 -0.987 . . . . 64.43 109.247 -169.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -93.02 138.73 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.474 -1.676 . . . . 60.51 106.474 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.527 ' CD1' HG23 ' A' ' 7' ' ' ILE . 7.0 mt -99.12 -59.29 1.75 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.216 -1.772 . . . . 64.33 106.216 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.56 152.28 50.3 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 106.474 -1.676 . . . . 64.12 106.474 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.91 121.14 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 104.522 -2.399 . . . . 62.34 104.522 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.96 36.48 22.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.937 0.895 . . . . 74.11 110.532 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.95 -19.95 52.24 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.694 -1.762 . . . . 75.35 108.694 169.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.4 116.09 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 107.565 -1.272 . . . . 62.42 107.565 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -55.52 117.91 4.0 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 107.664 -1.236 . . . . 71.15 107.664 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -102.12 -13.09 17.62 Favored 'General case' 0 C--O 1.202 -1.402 0 N-CA-C 106.608 -1.627 . . . . 54.33 106.608 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.84 128.72 37.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.523 -0.917 . . . . 64.52 108.523 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.41 -17.67 58.65 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 108.239 -1.945 . . . . 61.03 108.239 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 106.316 -1.735 . . . . 62.43 106.316 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -84.77 -179.37 7.09 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.384 0.611 . . . . 62.54 109.362 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -60.89 -52.44 65.05 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.073 -1.084 . . . . 70.44 108.073 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -60.27 -44.83 94.98 Favored 'General case' 0 C--N 1.372 1.564 0 O-C-N 121.859 -0.525 . . . . 63.01 110.37 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -55.44 -46.6 76.72 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 109.171 -0.677 . . . . 54.41 109.171 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -51.43 -53.83 32.9 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.893 -0.594 . . . . 55.43 110.722 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.16 -43.64 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.044 -1.095 . . . . 74.22 108.044 -171.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 t -68.04 -30.34 69.54 Favored 'General case' 0 C--O 1.193 -1.912 0 C-N-CA 116.924 -1.91 . . . . 75.14 107.253 -170.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -67.96 -43.42 79.06 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.876 -1.765 . . . . 74.22 106.892 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.68 -29.0 69.04 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 109.526 -0.546 . . . . 63.1 109.526 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.24 -60.39 2.29 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 107.77 -1.196 . . . . 74.35 107.77 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -58.85 -3.37 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.775 1.23 . . . . 74.34 113.607 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 p -73.97 -176.33 2.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.678 -0.86 . . . . 72.44 108.678 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.77 -149.17 24.42 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 109.432 -1.467 . . . . 64.42 109.432 -167.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -65.95 -55.18 18.15 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.177 -1.416 . . . . 75.41 107.177 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -100.68 144.36 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 N-CA-C 105.441 -2.059 . . . . 72.4 105.441 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -108.49 133.41 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 106.128 -1.804 . . . . 75.42 106.128 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -107.08 121.87 45.35 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 104.902 -2.259 . . . . 75.23 104.902 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.5 134.42 13.01 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.074 -1.084 . . . . 74.43 108.074 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -84.63 141.33 30.72 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 108.232 -1.025 . . . . 71.4 108.232 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.648 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -118.3 163.24 17.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.054 -2.202 . . . . 64.04 105.054 176.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.426 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 36.2 tt0 -124.17 137.28 54.56 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 102.25 -3.241 . . . . 62.12 102.25 166.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 8' ' ' PHE . 11.8 mmmm -61.16 149.88 36.01 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.822 -0.807 . . . . 75.01 108.822 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.82 -144.96 8.97 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 105.654 -2.978 . . . . 72.33 105.654 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 84.13 57.98 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.437 -2.06 . . . . 75.44 105.437 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -68.8 124.15 89.54 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 107.525 -1.287 . . . . 44.42 107.525 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.13 -163.56 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.346 2.697 . . . . 74.34 108.555 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.426 -1.633 0 N-CA-C 103.424 -2.806 . . . . 74.53 103.424 174.088 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.408 ' H5 ' ' O2 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.476 -2.345 0 N-CA-C 108.49 -1.844 . . . . 55.11 108.49 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.73 158.6 55.32 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.639 2.226 . . . . 73.21 108.313 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -91.07 165.55 21.36 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 105.91 -1.885 . . . . 75.21 105.91 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.19 113.43 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.712 2.274 . . . . 63.0 110.27 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.94 11.82 57.27 Favored Glycine 0 C--N 1.349 1.291 0 N-CA-C 108.598 -1.801 . . . . 73.02 108.598 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -78.91 132.37 36.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.435 -1.321 . . . . 74.2 107.435 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.513 HG23 ' CD1' ' A' ' 60' ' ' LEU . 18.5 mm -100.38 135.58 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 106.196 -1.779 . . . . 73.2 106.196 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -145.88 161.61 39.62 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 107.669 -1.234 . . . . 74.32 107.669 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.49 151.76 29.57 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 105.548 -2.019 . . . . 72.34 105.548 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -145.04 153.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 106.715 -1.587 . . . . 74.01 106.715 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -111.96 131.22 55.53 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 105.116 -2.179 . . . . 75.03 105.116 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.424 HD22 HD12 ' A' ' 53' ' ' ILE . 4.6 mp -136.76 145.15 44.27 Favored 'General case' 0 CA--C 1.462 -2.409 0 N-CA-C 107.881 -1.155 . . . . 72.1 107.881 174.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.15 144.83 26.67 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.139 -1.43 . . . . 52.12 107.139 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -75.22 -27.52 59.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.773 -1.195 . . . . 63.53 107.773 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 t30 71.02 96.89 0.07 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.831 0.852 . . . . 73.44 109.226 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 62.13 40.51 11.8 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.139 -1.06 . . . . 73.35 108.139 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 50.29 -8.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.067 2.547 . . . . 62.02 114.952 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.7 m -93.06 115.69 28.34 Favored 'General case' 0 CA--C 1.47 -2.105 0 N-CA-C 106.745 -1.576 . . . . 70.42 106.745 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -87.12 -150.75 0.16 Allowed 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.516 -2.401 . . . . 73.01 104.516 173.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.79 29.89 0.02 OUTLIER Glycine 0 CA--C 1.463 -3.203 0 N-CA-C 107.169 -2.372 . . . . 71.2 107.169 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.38 176.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 103.14 -2.911 . . . . 62.21 103.14 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -151.04 166.48 30.6 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 104.166 -2.531 . . . . 54.4 104.166 172.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.06 177.32 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 107.827 -1.175 . . . . 74.32 107.827 -166.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 170.78 20.74 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.525 -2.398 . . . . 73.52 104.525 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.53 -153.16 24.81 Favored Glycine 0 CA--C 1.484 -1.854 0 N-CA-C 109.091 -1.604 . . . . 70.22 109.091 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.45 -80.93 0.32 Allowed Glycine 0 CA--C 1.477 -2.299 0 N-CA-C 108.864 -1.695 . . . . 61.44 108.864 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -76.71 16.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 122.755 0.422 . . . . 63.11 111.643 -166.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.3 t30 85.64 6.43 0.43 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.241 -1.022 . . . . 75.23 108.241 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -45.89 -168.39 0.0 OUTLIER 'General case' 0 C--O 1.192 -1.933 0 C-N-CA 126.821 2.048 . . . . 75.2 112.051 162.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.6 m -33.06 -43.58 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.568 1.547 . . . . 74.11 114.441 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.1 m -71.3 130.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 107.524 -1.287 . . . . 65.34 107.524 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -55.93 11.51 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 121.138 -0.976 . . . . 74.43 108.854 -166.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -61.74 -20.72 63.84 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 111.81 0.3 . . . . 61.43 111.81 -164.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 55.64 2.63 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 107.817 -2.113 . . . . 64.4 107.817 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.01 -179.77 29.62 Favored Glycine 0 CA--C 1.456 -3.629 1 N-CA-C 101.923 -4.471 . . . . 54.12 101.923 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.13 136.66 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.593 0 N-CA-C 104.734 -2.321 . . . . 65.31 104.734 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -105.48 151.43 24.27 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 103.487 -2.783 . . . . 63.12 103.487 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.95 101.41 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.724 -1.954 . . . . 74.21 105.724 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.09 -37.02 66.89 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.116 -1.402 . . . . 72.4 110.978 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.43 140.54 24.03 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.283 -1.747 . . . . 74.23 106.283 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.57 132.97 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 103.368 -2.827 . . . . 74.53 103.368 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 154.03 84.95 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 106.647 -1.612 . . . . 75.41 106.647 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.18 172.34 16.24 Favored 'Trans proline' 0 CA--C 1.472 -2.6 0 N-CA-C 107.079 -1.931 . . . . 51.13 107.079 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 53.41 55.67 8.38 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 124.612 1.195 . . . . 73.21 109.541 164.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.34 176.37 35.31 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 104.011 -3.635 . . . . 73.41 104.011 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.35 55.77 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 117.291 0.546 . . . . 74.43 109.765 -168.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.39 -49.79 63.73 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 122.542 -0.099 . . . . 70.23 111.115 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -62.86 -55.8 22.98 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 122.094 -0.379 . . . . 64.43 110.483 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 m -65.78 -29.03 69.46 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 110.051 -0.351 . . . . 73.13 110.051 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.14 -38.13 52.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.318 -1.734 . . . . 65.02 106.318 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 15.22 76.39 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 109.889 -1.285 . . . . 74.32 109.889 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -101.56 7.65 42.19 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.043 -1.465 . . . . 74.35 107.043 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.424 HD12 HD22 ' A' ' 12' ' ' LEU . 64.0 mt -141.49 143.72 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 103.756 -2.683 . . . . 75.2 103.756 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -141.63 169.31 17.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.089 -2.56 . . . . 75.31 104.089 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -68.09 138.47 55.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.569 -2.011 . . . . 60.33 105.569 164.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.04 -28.07 12.92 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 108.991 -1.644 . . . . 73.1 108.991 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 1.1 m-20 -57.57 139.51 53.33 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 118.057 0.929 . . . . 72.12 108.708 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.7 130.24 56.12 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 104.839 -2.282 . . . . 73.25 104.839 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.75 130.61 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.281 -2.118 . . . . 73.44 105.281 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' CD1' HG23 ' A' ' 7' ' ' ILE . 19.8 mt -97.79 -58.31 2.02 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 106.366 -1.716 . . . . 73.35 106.366 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.7 151.47 50.21 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.51 -1.663 . . . . 71.43 106.51 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.08 117.93 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 105.485 -2.043 . . . . 61.3 105.485 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 t30 49.42 40.39 18.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.246 1.018 . . . . 53.33 111.033 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.68 7.05 Favored Glycine 0 CA--C 1.472 -2.621 0 N-CA-C 108.157 -1.977 . . . . 73.3 108.157 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.15 117.04 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 N-CA-C 108.643 -0.873 . . . . 72.42 108.643 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -56.27 126.17 25.05 Favored 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.377 -0.971 . . . . 75.34 108.377 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.469 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -103.66 -12.09 17.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.237 -1.764 . . . . 55.1 106.237 -169.512 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.8 124.31 19.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.677 -0.861 . . . . 74.03 108.677 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.81 -16.53 61.07 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.764 -1.735 . . . . 62.15 108.764 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.31 154.01 31.25 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 106.814 -1.55 . . . . 44.43 106.814 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.7 p -85.57 179.38 7.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.56 -0.904 . . . . 75.35 108.56 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -68.83 -42.92 76.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.559 -0.904 . . . . 74.11 108.559 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -56.35 16.18 Favored 'General case' 0 C--N 1.367 1.352 0 O-C-N 121.915 -0.491 . . . . 70.43 110.085 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -54.79 -45.11 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 122.19 -0.319 . . . . 42.52 110.248 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -52.03 -54.48 29.51 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 116.085 -0.507 . . . . 75.23 110.488 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.64 -38.17 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 108.758 -0.83 . . . . 54.34 108.758 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.44 ' SG ' ' H15' ' A' ' 101' ' ' 33B . 8.2 t -56.29 -40.03 73.63 Favored 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 105.935 -1.876 . . . . 64.52 105.935 -173.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 m -74.42 -48.84 25.24 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.054 -1.43 . . . . 72.23 109.194 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.11 -31.43 72.62 Favored 'General case' 0 C--N 1.368 1.391 0 N-CA-C 110.259 -0.274 . . . . 73.42 110.259 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -79.51 -53.71 6.61 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 108.246 -1.02 . . . . 73.4 108.246 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -68.79 53.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.295 1.045 . . . . 63.31 110.973 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.47 HG21 HG13 ' A' ' 86' ' ' VAL . 10.4 p -110.77 -175.74 2.79 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.384 -1.71 . . . . 71.54 106.384 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.1 -156.11 32.5 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.497 -2.641 . . . . 34.2 106.497 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -62.24 -54.69 37.23 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.784 -1.191 . . . . 72.25 107.784 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.46 142.36 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 106.461 -1.681 . . . . 75.41 106.461 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 HG21 ' A' ' 82' ' ' THR . 48.9 t -103.71 132.17 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 N-CA-C 105.052 -2.203 . . . . 64.34 105.052 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -110.24 127.75 55.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.831 -2.285 . . . . 73.51 104.831 173.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 139.17 16.02 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.727 -1.212 . . . . 73.24 107.727 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.4 140.53 33.41 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 107.271 -1.381 . . . . 75.41 107.271 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.83 160.82 38.24 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.994 -1.457 . . . . 71.14 107.474 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -123.57 120.77 33.82 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.387 -2.079 . . . . 75.41 105.387 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.419 0.0 OUTLIER 34.79 -79.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 127.146 2.178 . . . . 75.33 116.195 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 57' ' ' ASP . . . 100.74 -60.68 0.64 Allowed Glycine 0 CA--C 1.461 -3.285 0 N-CA-C 106.043 -2.823 . . . . 33.22 106.043 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -64.8 109.58 2.11 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 107.152 -1.425 . . . . 63.01 107.152 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.6 m -102.66 129.41 25.94 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 106.614 -1.625 . . . . 55.41 106.614 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.5 177.83 7.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.365 2.044 . . . . 71.13 106.957 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.564 1.485 0 N-CA-C 107.834 -1.172 . . . . 75.05 107.834 -178.492 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.44 ' H15' ' SG ' ' A' ' 77' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.742 0 N-CA-C 108.192 -1.963 . . . . 63.4 108.192 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.87 128.79 20.55 Favored 'Trans proline' 0 CA--C 1.497 -1.337 0 C-N-CA 122.782 2.321 . . . . 71.22 108.582 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -96.09 162.1 24.96 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 106.243 -1.762 . . . . 65.54 106.243 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -64.33 127.42 19.06 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.679 2.253 . . . . 53.32 109.381 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.73 1.35 65.85 Favored Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 108.946 -1.661 . . . . 74.42 108.946 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -75.9 137.24 40.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.557 -1.275 . . . . 72.41 107.557 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.472 HG23 ' CD1' ' A' ' 60' ' ' LEU . 11.8 mt -101.11 128.82 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 N-CA-C 107.653 -1.24 . . . . 72.45 107.653 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.3 p90 -139.76 156.23 46.88 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.212 -1.403 . . . . 54.55 107.212 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.1 145.93 31.86 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.483 -2.043 . . . . 62.21 105.483 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 90' ' ' LEU . 16.1 m -140.39 151.69 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.038 -1.467 . . . . 54.24 107.038 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.58 128.54 54.91 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 105.35 -2.093 . . . . 64.13 105.35 168.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mp -132.27 143.93 50.25 Favored 'General case' 0 CA--C 1.454 -2.731 0 N-CA-C 107.438 -1.319 . . . . 72.0 107.438 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.66 142.18 28.4 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 105.521 -2.029 . . . . 72.31 105.521 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -71.72 -30.55 65.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.071 -1.085 . . . . 65.2 108.071 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 72.43 104.38 0.07 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.76 -0.83 . . . . 63.41 108.76 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 62.27 46.47 6.05 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.817 0.847 . . . . 74.52 110.192 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 53.39 -9.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 127.12 2.168 . . . . 63.43 114.791 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 m -109.61 149.69 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.203 -1.036 . . . . 63.24 108.203 -167.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.43 167.4 30.15 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 105.629 -1.989 . . . . 54.45 105.629 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.05 95.54 0.1 Allowed Glycine 0 CA--C 1.46 -3.356 0 N-CA-C 104.225 -3.55 . . . . 74.43 104.225 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.66 153.07 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.091 -2.929 . . . . 74.15 103.091 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 6.5 m -91.77 159.41 15.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 103.657 -2.72 . . . . 71.01 103.657 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 m -151.0 167.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.99 -2.226 . . . . 73.5 104.99 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -167.92 170.6 10.47 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.668 -2.345 . . . . 65.02 104.668 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.57 -148.88 21.42 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 107.421 -2.272 . . . . 61.22 107.421 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 115.1 -78.69 0.27 Allowed Glycine 0 CA--C 1.481 -2.048 0 N-CA-C 108.953 -1.659 . . . . 72.14 108.953 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 27' ' ' VAL . 2.3 t -75.6 15.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 123.304 0.642 . . . . 53.21 109.819 -170.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 26' ' ' GLY . 63.0 m-80 83.81 7.05 0.65 Allowed 'General case' 0 CA--C 1.486 -1.494 0 C-N-CA 124.373 1.069 . . . . 74.11 108.182 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.8 p -47.52 -171.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.058 1.743 . . . . 74.24 113.114 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -34.99 -44.04 0.21 Allowed 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.545 1.938 . . . . 72.55 114.544 -164.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.9 m -58.39 126.44 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 122.281 1.038 . . . . 64.11 110.301 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -51.62 -52.64 46.06 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.463 -1.244 . . . . 63.5 113.833 -165.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.24 -18.88 61.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 119.088 -1.045 . . . . 63.51 109.509 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.22 54.83 2.9 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 108.271 -1.931 . . . . 72.12 108.271 172.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.43 -179.17 22.38 Favored Glycine 0 CA--C 1.461 -3.328 0 N-CA-C 104.051 -3.62 . . . . 75.33 104.051 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.463 HD13 ' HA ' ' A' ' 36' ' ' ILE . 10.0 mm -82.49 128.02 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.353 0 N-CA-C 104.409 -2.441 . . . . 53.24 104.409 171.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -106.37 150.91 25.54 Favored 'General case' 0 CA--C 1.459 -2.536 0 N-CA-C 104.432 -2.433 . . . . 64.34 104.432 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.95 103.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 N-CA-C 105.5 -2.037 . . . . 75.23 105.5 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 84.9 tttt -70.21 -33.99 72.35 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 114.393 -1.276 . . . . 72.02 109.3 -172.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.5 155.55 9.18 Favored 'General case' 0 CA--C 1.464 -2.348 0 N-CA-C 105.636 -1.987 . . . . 64.43 105.636 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.97 134.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 103.045 -2.946 . . . . 75.33 103.045 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.402 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 150.18 77.56 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 105.31 -2.108 . . . . 75.34 105.31 176.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.02 168.82 23.86 Favored 'Trans proline' 0 CA--C 1.465 -2.928 0 N-CA-C 105.528 -2.528 . . . . 74.4 105.528 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 62.93 -0.33 0.6 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.297 0.851 . . . . 73.15 113.297 167.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.5 173.81 49.89 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 106.712 -2.555 . . . . 73.43 106.712 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.79 73.95 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.961 -1.125 . . . . 51.24 107.961 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.95 -49.48 65.98 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 115.826 -0.624 . . . . 75.22 110.377 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -65.36 -56.15 14.19 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 122.145 -0.347 . . . . 71.34 110.072 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -63.73 -28.8 70.13 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 122.103 -0.373 . . . . 72.15 111.009 -170.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -83.93 -30.99 25.86 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 106.515 -1.661 . . . . 71.24 106.515 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.89 20.0 79.69 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.375 -1.09 . . . . 72.44 110.375 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB3' HG11 ' A' ' 10' ' ' VAL . 90.6 mtt-85 -97.16 6.54 48.3 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.691 -1.596 . . . . 71.04 106.691 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.2 mt -140.96 141.66 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.451 -3.166 . . . . 62.11 102.451 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -142.3 153.5 43.93 Favored 'General case' 0 CA--C 1.46 -2.482 0 N-CA-C 105.205 -2.146 . . . . 65.44 105.205 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.68 141.9 56.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.273 -1.38 . . . . 64.44 107.273 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.21 -32.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 108.898 -1.681 . . . . 72.35 108.898 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.62 154.32 29.43 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 107.83 -1.174 . . . . 62.44 107.83 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.14 135.35 53.9 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.474 -1.676 . . . . 75.42 106.474 -167.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.0 129.57 41.56 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 105.454 -2.054 . . . . 70.43 105.454 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' CD1' HG23 ' A' ' 7' ' ' ILE . 13.3 mt -95.53 -60.5 1.65 Allowed 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.527 -1.286 . . . . 62.3 107.527 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.88 48.96 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 106.099 -1.815 . . . . 74.24 106.099 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.5 t -115.31 114.85 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 105.23 -2.137 . . . . 71.35 105.23 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 t30 44.09 47.25 7.4 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.046 1.338 . . . . 64.12 111.34 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.45 -32.96 6.9 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 108.301 -1.92 . . . . 33.23 108.301 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.52 118.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.751 0 N-CA-C 109.384 -0.599 . . . . 62.42 109.384 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -54.22 109.47 0.49 Allowed 'General case' 0 C--N 1.369 1.425 0 N-CA-C 106.976 -1.49 . . . . 70.13 106.976 168.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -100.49 -13.28 18.74 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.357 -1.72 . . . . 74.13 106.357 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.27 134.32 56.35 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.458 -0.941 . . . . 65.44 108.458 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.77 -17.69 58.12 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.172 -1.971 . . . . 72.52 108.172 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 151.71 28.06 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.607 -1.998 . . . . 51.4 105.607 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.3 p -79.54 178.41 8.15 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.813 0.816 . . . . 60.33 108.935 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -68.03 -45.17 74.72 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 108.533 -0.914 . . . . 71.32 108.533 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -56.37 -51.5 68.07 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 121.577 -0.702 . . . . 74.23 110.585 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -53.61 -41.49 66.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.831 -0.433 . . . . 63.21 109.831 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.16 64.09 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.975 -0.557 . . . . 64.42 110.02 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.38 -47.41 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 107.793 -1.188 . . . . 73.05 107.793 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.9 m -56.72 -35.59 68.72 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 107.38 -1.341 . . . . 53.41 107.38 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -69.9 -47.11 63.79 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 120.484 -1.385 . . . . 75.01 108.012 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.46 -32.94 72.95 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 109.126 -0.694 . . . . 71.33 109.126 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.55 -60.71 2.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.892 -1.151 . . . . 71.22 107.892 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -69.67 48.63 0.09 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 123.569 0.748 . . . . 63.53 111.706 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.488 HG21 HG13 ' A' ' 86' ' ' VAL . 12.8 p -102.5 -175.71 2.9 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.377 -2.083 . . . . 73.41 105.377 170.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.89 -148.12 22.75 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 106.799 -2.52 . . . . 42.23 106.799 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -68.44 -55.24 12.54 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.102 -1.073 . . . . 73.41 108.102 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.1 140.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.41 -1.7 . . . . 73.44 106.41 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.488 HG13 HG21 ' A' ' 82' ' ' THR . 48.8 t -104.99 135.62 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.053 -1.832 . . . . 75.24 106.053 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -110.43 129.3 55.8 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 104.889 -2.263 . . . . 72.42 104.889 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.74 133.88 10.48 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.126 -1.435 . . . . 75.33 107.126 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -80.86 138.02 36.19 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 107.71 -1.219 . . . . 74.31 107.71 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.666 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.89 155.99 22.76 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.492 -2.41 . . . . 74.44 104.492 177.011 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.77 132.19 55.55 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 100.827 -3.768 . . . . 72.32 100.827 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.99 138.62 58.17 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.708 -0.849 . . . . 74.55 108.708 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.09 -177.27 48.99 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 106.858 -2.497 . . . . 74.05 106.858 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 66.73 33.37 6.31 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.261 -1.755 . . . . 74.1 106.261 -173.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 p -91.42 124.23 61.69 Favored Pre-proline 0 N--CA 1.419 -2.011 0 N-CA-C 104.225 -2.509 . . . . 54.04 104.225 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.24 96.41 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.259 1.973 . . . . 71.22 109.274 -170.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.42 -1.928 0 N-CA-C 104.387 -2.449 . . . . 63.0 104.387 170.439 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.495 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.635 0 N-CA-C 107.801 -2.12 . . . . 63.22 107.801 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.74 175.4 7.28 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 123.137 2.558 . . . . 53.45 110.436 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.07 168.66 7.56 Favored Pre-proline 0 N--CA 1.423 -1.807 0 N-CA-C 103.907 -2.627 . . . . 63.12 103.907 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 92' ' ' LYS . 46.1 Cg_exo -61.3 145.33 98.51 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 122.811 2.34 . . . . 74.3 108.819 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.97 -12.79 57.61 Favored Glycine 0 CA--C 1.496 -1.136 0 N-CA-C 109.344 -1.502 . . . . 64.14 109.344 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.28 141.84 31.54 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.358 -1.349 . . . . 63.33 107.358 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.5 mt -104.63 135.11 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.997 0 N-CA-C 109.069 -0.715 . . . . 75.43 109.069 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.542 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.8 p90 -130.84 149.27 52.55 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 106.56 -1.644 . . . . 72.13 106.56 169.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -103.64 146.13 29.02 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.88 -2.267 . . . . 64.41 104.88 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.633 HG22 HD21 ' A' ' 90' ' ' LEU . 28.7 m -140.75 152.37 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 106.596 -1.631 . . . . 73.21 106.596 173.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -106.99 131.69 53.77 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.737 -2.32 . . . . 71.13 104.737 168.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.98 142.37 31.62 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.207 -1.035 . . . . 63.25 108.207 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.22 150.52 21.94 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 105.099 -2.186 . . . . 72.1 105.099 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HG3' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -76.85 -35.1 57.74 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.744 -1.576 . . . . 52.41 106.744 175.458 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 77.54 109.91 0.07 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.466 -1.309 . . . . 70.44 107.466 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 t0 57.69 36.12 26.3 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 107.804 -1.184 . . . . 74.23 107.804 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.3 t30 52.05 2.03 0.02 OUTLIER 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.752 1.621 . . . . 75.34 112.985 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.0 m -116.54 114.04 23.6 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 120.369 -1.457 . . . . 74.33 109.027 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' HG ' ' HG3' ' A' ' 14' ' ' LYS . 49.8 mt -94.22 -153.94 0.39 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 102.468 -3.16 . . . . 52.11 102.468 162.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.07 42.19 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 107.752 -2.139 . . . . 71.15 107.752 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.418 ' H ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.3 176.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 105.428 -2.064 . . . . 74.32 105.428 175.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.62 158.33 21.87 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 104.681 -2.34 . . . . 65.15 104.681 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -145.9 172.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 N-CA-C 106.16 -1.792 . . . . 65.2 106.16 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -164.48 167.35 19.59 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 104.353 -2.462 . . . . 63.42 104.353 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 -160.12 29.11 Favored Glycine 0 CA--C 1.494 -1.272 0 N-CA-C 109.004 -1.638 . . . . 71.1 109.004 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.43 -91.38 0.31 Allowed Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 109.063 -1.615 . . . . 60.0 109.063 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -67.14 16.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.506 1.123 . . . . 63.11 113.975 -162.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 85.24 6.78 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.503 1.121 . . . . 74.53 108.716 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 p -37.97 -170.06 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 127.266 2.226 . . . . 61.21 113.895 161.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 m -57.77 -21.27 40.6 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.134 0.974 . . . . 73.42 112.333 -168.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.86 136.23 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 109.053 -0.721 . . . . 70.24 109.053 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -70.57 0.1 Allowed 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.437 1.095 . . . . 65.0 111.424 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -86.21 15.75 4.95 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.497 -0.752 . . . . 63.03 110.977 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 49.68 62.58 4.75 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 110.205 -1.158 . . . . 62.33 110.205 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.01 179.76 28.3 Favored Glycine 0 CA--C 1.454 -3.734 0 N-CA-C 103.843 -3.703 . . . . 61.41 103.843 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.87 132.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.882 0 N-CA-C 105.373 -2.084 . . . . 64.43 105.373 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -110.25 148.39 31.97 Favored 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.881 -2.637 . . . . 71.33 103.881 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -82.06 102.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.049 -1.834 . . . . 62.43 106.049 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -71.9 -33.8 68.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.459 -1.246 . . . . 63.33 110.365 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 146.97 20.49 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 106.247 -1.761 . . . . 74.21 106.247 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 48' ' ' GLU . 41.6 t -121.5 125.98 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 N-CA-C 104.853 -2.277 . . . . 65.53 104.853 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.676 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -98.59 171.21 6.02 Favored Pre-proline 0 C--O 1.213 -0.817 0 N-CA-C 105.687 -1.968 . . . . 74.13 105.687 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 60.0 Cg_endo -84.43 179.62 4.38 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.398 1.399 . . . . 72.25 110.128 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 76.25 -14.15 0.83 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.184 1.394 . . . . 72.02 113.042 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.43 -179.51 45.16 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.58 -1.408 . . . . 74.11 109.58 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.12 -53.67 12.06 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.033 -0.584 . . . . 41.04 109.558 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.53 -50.83 66.93 Favored 'General case' 0 C--N 1.369 1.43 0 CA-C-O 121.08 0.467 . . . . 54.05 110.227 -170.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 49' ' ' SER . 3.8 pm0 -61.66 -55.88 25.73 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 123.907 0.883 . . . . 70.43 110.713 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.509 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 22.0 m -62.36 -25.13 67.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.958 0.503 . . . . 65.21 110.859 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -84.35 -28.28 27.14 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.917 -1.512 . . . . 71.13 106.917 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.22 15.15 81.43 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.052 -1.219 . . . . 52.33 110.052 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -99.11 6.71 46.4 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.274 -1.38 . . . . 74.44 107.274 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 mp -132.15 137.52 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 102.099 -3.297 . . . . 73.24 102.099 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -133.68 151.37 51.63 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.75 -2.315 . . . . 71.01 104.75 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -67.9 138.14 55.78 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.736 -1.579 . . . . 73.04 106.736 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.57 -27.79 11.49 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 109.496 -1.442 . . . . 75.42 109.496 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.39 154.61 35.0 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 107.141 -1.429 . . . . 73.42 107.141 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.546 HH21 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -117.63 139.01 51.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.472 -1.677 . . . . 64.14 106.472 -166.207 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.5 131.0 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 105.805 -1.924 . . . . 61.44 105.805 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mt -92.32 -60.08 1.93 Allowed 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.42 -1.696 . . . . 71.22 106.42 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.78 150.64 52.09 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 107.08 -1.452 . . . . 64.0 107.08 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -120.73 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 103.683 -2.71 . . . . 75.41 103.683 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.2 t30 60.58 30.07 19.47 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 121.636 0.732 . . . . 64.3 109.098 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.58 75.16 Favored Glycine 0 CA--C 1.483 -1.942 0 N-CA-C 109.326 -1.51 . . . . 51.24 109.326 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.33 122.29 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 106.77 -1.567 . . . . 71.31 106.77 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.68 111.65 0.86 Allowed 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.557 -1.275 . . . . 25.45 107.557 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -97.92 -10.99 23.64 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 106.477 -1.675 . . . . 74.31 106.477 -167.456 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HB3' HH21 ' A' ' 58' ' ' ARG . 25.9 pt-20 -62.99 131.89 50.18 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.265 -0.897 . . . . 74.34 108.69 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.41 -19.72 38.31 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.336 -1.505 . . . . 73.22 109.336 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 67' ' ' LEU . . . -81.44 154.62 26.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 105.78 -1.933 . . . . 74.22 105.78 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.445 HG22 HG22 ' A' ' 27' ' ' VAL . 14.2 p -86.04 178.87 7.1 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.682 0.753 . . . . 75.12 109.683 -166.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -64.14 -45.21 89.51 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.553 -0.906 . . . . 73.22 108.553 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -50.29 -56.06 12.82 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 109.939 -0.393 . . . . 73.44 109.939 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -57.43 -45.26 84.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 116.261 -0.427 . . . . 63.05 109.963 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.19 -56.47 12.65 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 122.603 0.361 . . . . 75.13 110.921 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.77 -39.3 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 109.514 -0.55 . . . . 75.12 109.514 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.69 -29.26 69.22 Favored 'General case' 0 C--O 1.186 -2.283 0 C-N-CA 117.021 -1.871 . . . . 74.44 106.503 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -67.77 -43.23 80.3 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.506 -1.371 . . . . 33.43 107.736 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.0 mt -65.97 -37.0 84.84 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.136 -0.69 . . . . 74.01 109.136 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -77.58 -61.79 1.88 Allowed 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.026 -0.731 . . . . 72.3 109.026 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.46 62.57 1.0 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.01 0.91 . . . . 54.34 110.75 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.07 -176.67 4.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.3 -1.741 . . . . 73.31 106.3 172.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.92 -138.4 4.22 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.758 -2.137 . . . . 60.23 107.758 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.0 -56.06 5.12 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.864 -0.791 . . . . 72.22 108.864 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.0 150.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 107.504 -1.295 . . . . 71.25 107.504 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.9 t -124.77 152.67 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.02 -2.215 . . . . 65.43 105.02 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -102.55 116.61 32.95 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 104.218 -2.512 . . . . 73.12 104.218 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -135.34 116.53 14.43 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 107.508 -1.293 . . . . 64.13 107.508 -176.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.61 141.64 33.52 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 108.393 -0.965 . . . . 62.5 108.393 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.633 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -115.37 154.83 28.49 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.19 -2.152 . . . . 75.01 105.19 178.193 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.15 133.03 54.29 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 101.87 -3.382 . . . . 73.21 101.87 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -59.46 139.59 56.96 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.685 -0.857 . . . . 74.04 108.685 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.89 -10.97 0.85 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 108.093 -2.003 . . . . 54.21 108.093 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -154.12 -103.96 0.04 OUTLIER 'General case' 0 C--N 1.363 1.167 0 N-CA-C 106.73 -1.582 . . . . 75.31 106.73 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.7 t -71.18 141.06 85.83 Favored Pre-proline 0 C--N 1.355 0.811 0 N-CA-C 106.973 -1.492 . . . . 71.21 106.973 -169.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.77 178.54 3.28 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.163 2.575 . . . . 71.01 109.47 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.423 -1.776 0 N-CA-C 102.812 -3.033 . . . . 55.42 102.812 174.466 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.33 0 N-CA-C 108.088 -2.005 . . . . 55.14 108.088 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.9 148.35 89.8 Favored 'Trans proline' 0 CA--C 1.497 -1.349 0 C-N-CA 122.965 2.443 . . . . 63.14 108.664 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.8 167.35 13.26 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 105.383 -2.08 . . . . 42.53 105.383 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.32 128.56 22.94 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.288 1.992 . . . . 74.22 108.311 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.23 -2.72 65.87 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 109.424 -1.47 . . . . 61.02 109.424 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -73.73 134.65 43.53 Favored 'General case' 0 C--N 1.363 1.164 0 N-CA-C 106.855 -1.535 . . . . 73.0 106.855 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.494 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.4 mt -104.31 136.49 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.515 0 N-CA-C 108.146 -1.057 . . . . 71.12 108.146 -173.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.8 159.0 43.82 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.028 -1.471 . . . . 74.24 107.028 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.63 145.37 30.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 75.51 105.67 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 90' ' ' LEU . 15.9 m -140.12 151.02 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.381 -1.34 . . . . 65.44 107.381 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -112.11 125.89 54.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.941 -1.874 . . . . 44.12 105.941 167.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.13 143.59 46.64 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 106.793 -1.558 . . . . 72.4 106.793 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.44 152.39 21.5 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.83 -1.915 . . . . 51.23 105.83 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -69.45 -36.01 76.21 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.846 -1.168 . . . . 73.31 107.846 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.24 112.84 0.07 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.44 -0.948 . . . . 71.04 108.44 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.3 32.95 21.39 Favored 'General case' 0 C--N 1.369 1.456 0 N-CA-C 108.603 -0.888 . . . . 53.35 108.603 -174.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.3 t30 48.6 -1.39 0.0 OUTLIER 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.284 1.834 . . . . 51.41 114.1 -174.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -89.83 172.92 8.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.276 -1.379 . . . . 61.3 107.276 -170.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.88 -156.31 0.56 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 103.753 -2.684 . . . . 73.25 103.753 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.66 39.37 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.684 0 N-CA-C 105.912 -2.875 . . . . 65.0 105.912 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.99 177.11 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 104.309 -2.478 . . . . 71.31 104.309 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -141.83 166.52 24.51 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 104.905 -2.257 . . . . 53.43 104.905 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.6 m -147.65 172.13 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 N-CA-C 105.871 -1.9 . . . . 53.31 105.871 -172.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -167.94 168.49 12.07 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 104.404 -2.443 . . . . 71.51 104.404 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.46 -141.42 20.46 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 108.733 -1.747 . . . . 51.13 108.733 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 100.07 -70.19 0.49 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 109.038 -1.625 . . . . 61.4 109.038 174.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 71' ' ' THR . 1.9 t -76.98 13.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 121.397 0.618 . . . . 74.14 109.475 -171.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 26' ' ' GLY . 36.2 m-20 78.77 6.39 2.31 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.521 1.128 . . . . 65.23 109.333 176.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.6 t -53.0 -170.7 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 124.2 1.0 . . . . 74.23 111.378 167.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 m -30.81 -44.87 0.06 Allowed 'General case' 0 C--N 1.366 1.307 0 C-N-CA 127.448 2.299 . . . . 75.34 115.657 -162.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.07 132.68 21.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.513 0.673 . . . . 72.31 110.722 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -49.94 -57.66 7.04 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-N 115.138 -0.937 . . . . 73.54 112.677 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -72.81 -20.9 61.06 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.897 -0.721 . . . . 72.12 109.478 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.21 -14.81 62.12 Favored Glycine 0 C--N 1.359 1.835 0 N-CA-C 109.323 -1.511 . . . . 60.21 109.323 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.19 -178.96 48.24 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 109.09 -1.604 . . . . 61.41 109.09 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.418 HG13 HD12 ' A' ' 67' ' ' LEU . 13.7 mm -81.66 124.5 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 103.014 -2.958 . . . . 65.33 103.014 171.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -100.87 150.4 22.87 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 103.688 -2.708 . . . . 73.24 103.688 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.1 t -80.18 102.97 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.078 -2.193 . . . . 64.2 105.078 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -71.57 -32.87 68.56 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.752 -1.113 . . . . 72.4 109.933 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.82 147.9 22.0 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 106.273 -1.751 . . . . 71.21 106.273 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.13 133.05 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 N-CA-C 103.174 -2.898 . . . . 64.1 103.174 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.476 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.95 152.5 71.75 Favored Pre-proline 0 CA--C 1.511 -0.526 0 N-CA-C 106.502 -1.666 . . . . 60.35 106.502 176.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 58.8 Cg_endo -76.86 172.57 15.96 Favored 'Trans proline' 0 CA--C 1.463 -3.053 0 N-CA-C 105.909 -2.381 . . . . 71.42 105.909 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 66.21 -1.72 1.13 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 124.294 0.996 . . . . 54.33 111.994 163.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.65 -179.1 36.5 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 107.334 -2.306 . . . . 63.34 107.334 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.89 -52.94 45.83 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.268 -1.012 . . . . 62.0 108.268 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.37 65.24 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.379 -0.373 . . . . 75.22 110.838 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.0 -55.31 26.85 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 109.583 -0.525 . . . . 75.41 109.583 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 t -58.35 -32.51 68.6 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.045 0.538 . . . . 64.21 110.641 -171.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.91 -29.6 29.1 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.797 -1.186 . . . . 62.4 107.797 -172.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.25 83.65 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 110.36 -1.096 . . . . 64.05 110.36 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -99.31 6.39 46.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 106.709 -1.589 . . . . 72.54 106.709 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.0 mt -142.44 138.59 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 103.098 -2.927 . . . . 72.41 103.098 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.02 166.34 26.35 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.482 -2.414 . . . . 74.0 104.482 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.72 145.77 54.43 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 107.119 -1.437 . . . . 64.2 107.119 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.59 -33.01 5.97 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 107.982 -2.047 . . . . 64.44 107.982 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.92 149.08 45.52 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 106.941 -1.503 . . . . 70.44 106.941 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.79 143.86 47.62 Favored 'General case' 0 CA--C 1.473 -2.009 0 N-CA-C 107.259 -1.386 . . . . 72.2 107.259 -165.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.26 130.07 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 105.826 -1.916 . . . . 62.21 105.826 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' CD1' HG23 ' A' ' 7' ' ' ILE . 78.6 mt -95.27 -59.28 1.92 Allowed 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.275 -1.38 . . . . 72.12 107.275 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.95 51.17 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 105.946 -1.872 . . . . 62.53 105.946 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.73 121.45 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.376 -2.083 . . . . 63.31 105.376 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.47 30.5 13.01 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.524 0.678 . . . . 70.04 109.724 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.81 -18.2 57.2 Favored Glycine 0 CA--C 1.48 -2.152 0 N-CA-C 109.158 -1.577 . . . . 73.01 109.158 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.64 115.75 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 108.266 -1.013 . . . . 73.22 108.266 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 m -56.74 120.0 7.11 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 107.899 -1.148 . . . . 75.33 107.899 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.418 HD12 HG13 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -111.92 -11.83 13.84 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.663 -1.606 . . . . 63.53 106.663 -162.079 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -56.38 128.34 35.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.969 -0.752 . . . . 75.43 108.969 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.88 -13.03 68.31 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 108.773 -1.731 . . . . 65.43 108.773 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.74 157.04 20.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.56 -1.645 . . . . 63.23 106.56 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.421 HG22 HG22 ' A' ' 27' ' ' VAL . 41.1 p -85.68 179.08 7.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.735 0.778 . . . . 75.42 109.402 -171.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -64.7 -45.22 87.51 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 115.392 -0.822 . . . . 73.53 108.97 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -54.5 -55.24 31.14 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 121.567 -0.708 . . . . 62.14 109.955 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -53.84 -43.76 69.74 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.696 -0.483 . . . . 70.24 109.696 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.35 27.25 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.811 0.444 . . . . 42.04 110.531 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 m -74.98 -35.47 35.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 O-C-N 121.976 -0.453 . . . . 73.42 109.835 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CYS . . . . . 0.45 ' SG ' ' H15' ' A' ' 101' ' ' 33B . 12.6 t -69.11 -32.9 72.63 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 116.854 -1.938 . . . . 63.31 105.986 -169.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -73.09 -45.14 58.87 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 106.996 -1.483 . . . . 61.34 106.996 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.0 -45.15 95.98 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.831 1.253 . . . . 74.31 109.562 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -67.38 -56.2 10.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.517 -0.92 . . . . 73.44 108.517 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -71.47 52.16 0.19 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.75 0.42 . . . . 54.51 110.854 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 86' ' ' VAL . 6.2 p -101.69 -175.49 2.87 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.589 -2.004 . . . . 71.15 105.589 168.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.79 -152.72 17.45 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.222 -2.351 . . . . 61.11 107.222 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -63.33 -55.34 25.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.191 -1.04 . . . . 73.24 108.191 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.59 145.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 106.388 -1.708 . . . . 73.23 106.388 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 82' ' ' THR . 23.6 t -101.17 129.03 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 N-CA-C 105.242 -2.133 . . . . 74.43 105.242 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -111.98 121.63 45.54 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 104.063 -2.569 . . . . 61.43 104.063 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.68 133.61 12.28 Favored 'General case' 0 CA--C 1.46 -2.498 0 N-CA-C 106.518 -1.66 . . . . 71.5 106.518 -174.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -86.98 145.38 26.53 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 107.938 -1.134 . . . . 54.3 107.938 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.568 HD22 ' H ' ' A' ' 90' ' ' LEU . 0.0 OUTLIER -131.8 169.05 16.77 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.533 -2.025 . . . . 65.4 105.533 174.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.42 153.06 48.3 Favored 'General case' 0 N--CA 1.402 -2.843 0 N-CA-C 101.822 -3.399 . . . . 74.53 101.822 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 6.5 mmpt? -65.32 135.03 54.83 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.743 -1.206 . . . . 74.23 107.743 175.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.58 -8.04 2.3 Favored Glycine 0 CA--C 1.466 -2.969 0 N-CA-C 107.131 -2.388 . . . . 74.21 107.131 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 61.3 mt-30 22.18 -88.09 0.0 OUTLIER 'General case' 0 C--N 1.373 1.62 0 C-N-CA 127.183 2.193 . . . . 60.14 114.465 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m -75.03 133.79 75.24 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.744 -1.206 . . . . 71.13 107.744 -173.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.54 3.74 2.49 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.363 2.709 . . . . 72.43 111.507 -167.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.391 -3.376 0 N-CA-C 102.488 -3.153 . . . . 63.04 102.488 176.111 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.479 ' H5 ' ' O2 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.55 0 N-CA-C 108.672 -1.771 . . . . 62.14 108.672 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.51 143.63 69.87 Favored 'Trans proline' 0 CA--C 1.495 -1.444 0 C-N-CA 122.905 2.403 . . . . 63.31 108.361 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -84.89 166.56 31.2 Favored Pre-proline 0 N--CA 1.427 -1.593 0 N-CA-C 106.916 -1.513 . . . . 73.4 106.916 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.9 106.51 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.662 2.242 . . . . 72.24 109.503 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.81 7.34 56.63 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 108.68 -1.768 . . . . 61.31 108.68 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -83.19 138.75 33.51 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.601 -1.629 . . . . 75.31 106.601 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.546 HG23 ' CD1' ' A' ' 60' ' ' LEU . 23.4 mm -95.91 122.44 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 105.949 -1.871 . . . . 65.43 105.949 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.63 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.8 p90 -136.68 157.02 47.74 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.397 -0.964 . . . . 74.45 108.397 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -103.01 148.44 25.69 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 104.512 -2.403 . . . . 74.43 104.512 177.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.779 HG22 HD21 ' A' ' 90' ' ' LEU . 15.9 m -137.05 147.1 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.062 0 N-CA-C 106.078 -1.823 . . . . 51.42 106.078 170.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.63 118.18 35.95 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 104.671 -2.344 . . . . 74.25 104.671 168.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.416 HD13 HD12 ' A' ' 53' ' ' ILE . 59.3 mt -139.61 135.88 33.79 Favored 'General case' 0 CA--C 1.455 -2.7 0 N-CA-C 105.673 -1.973 . . . . 74.05 105.673 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . . . -85.45 157.26 20.52 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 106.753 -1.573 . . . . 71.43 106.753 -176.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.23 -40.72 98.24 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 106.747 -1.575 . . . . 74.24 106.747 167.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 78.36 108.32 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 107.828 -1.175 . . . . 72.34 107.828 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 18' ' ' SER . 68.4 m-20 56.81 39.09 29.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.79 0.836 . . . . 73.43 108.843 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.3 t30 55.03 -9.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.728 1.611 . . . . 53.42 113.634 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 16' ' ' ASP . 32.6 t -99.67 120.53 39.85 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.712 -1.959 . . . . 75.43 105.712 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.714 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -70.91 -56.18 6.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.904 -1.147 . . . . 54.1 107.904 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.72 85.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 109.91 -1.276 . . . . 63.23 109.91 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 22' ' ' CYS . 5.2 mm -86.7 176.57 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 105.262 -2.125 . . . . 61.01 105.262 -174.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 21' ' ' ILE . 60.0 m -138.64 164.38 29.66 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 103.754 -2.684 . . . . 72.42 103.754 174.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.65 171.93 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 105.772 -1.936 . . . . 72.14 105.772 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 t -164.15 170.64 16.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.399 -2.075 . . . . 72.34 105.399 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 -154.53 21.97 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 107.165 -2.374 . . . . 55.43 107.165 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.12 -99.0 0.65 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 109.435 -1.466 . . . . 60.4 109.435 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -68.36 16.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.211 1.189 . . . . 63.53 114.211 -161.687 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m120 85.24 6.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.267 1.027 . . . . 51.4 108.714 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -43.09 -168.34 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 126.737 2.015 . . . . 63.34 110.009 151.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 m -28.75 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.205 1.802 . . . . 64.31 114.942 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 131.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.207 -1.035 . . . . 74.54 108.207 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.13 -40.34 38.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.492 -0.929 . . . . 73.05 108.492 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -64.14 -18.01 64.03 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.916 -0.772 . . . . 73.22 108.916 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.69 2.31 64.07 Favored Glycine 0 C--O 1.208 -1.477 0 N-CA-C 110.722 -0.951 . . . . 71.2 110.722 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.93 177.68 52.15 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 106.614 -2.594 . . . . 62.1 106.614 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -90.78 136.55 23.78 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 N-CA-C 104.415 -2.439 . . . . 73.51 104.415 174.539 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -108.4 148.73 29.72 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 103.358 -2.83 . . . . 71.32 103.358 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.65 102.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 106.547 -1.649 . . . . 63.15 106.547 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -71.66 -36.3 70.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.665 -1.152 . . . . 75.21 110.45 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.97 148.94 22.77 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.061 -1.829 . . . . 74.12 106.061 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.49 138.01 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 103.936 -2.616 . . . . 75.44 103.936 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -79.17 155.52 77.06 Favored Pre-proline 0 CA--C 1.515 -0.386 0 N-CA-C 105.738 -1.949 . . . . 74.02 105.738 173.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 75.2 Cg_endo -74.39 171.7 17.57 Favored 'Trans proline' 0 CA--C 1.461 -3.168 0 N-CA-C 105.72 -2.454 . . . . 61.43 105.72 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 65.07 -0.2 1.11 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.012 0.82 . . . . 74.45 112.13 164.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.55 174.14 41.1 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 106.624 -2.59 . . . . 70.43 106.624 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.17 -52.87 36.17 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 107.854 -1.165 . . . . 42.22 107.854 -173.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.23 -50.66 64.3 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 116.068 -0.515 . . . . 71.45 111.008 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.04 -54.47 21.27 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 109.933 -0.395 . . . . 73.03 109.933 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.3 t -61.76 -28.58 69.54 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.792 0.437 . . . . 72.24 110.965 -170.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.29 -30.2 38.26 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.105 -1.813 . . . . 75.51 106.105 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.47 20.01 61.05 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 110.146 -1.182 . . . . 71.55 110.146 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -107.59 7.24 28.56 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.696 -1.224 . . . . 75.4 107.696 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.416 HD12 HD13 ' A' ' 12' ' ' LEU . 77.7 mt -144.55 145.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 102.359 -3.2 . . . . 71.45 102.359 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -151.26 176.19 11.46 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 104.77 -2.307 . . . . 74.53 104.77 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -67.23 143.29 56.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.671 -1.233 . . . . 72.1 107.671 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.44 -32.01 7.66 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.029 -1.628 . . . . 64.25 109.029 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.19 160.1 31.76 Favored 'General case' 0 C--N 1.372 1.563 0 N-CA-C 107.347 -1.353 . . . . 62.54 107.347 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -128.42 151.51 49.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.829 -0.804 . . . . 74.44 108.829 -168.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.92 135.78 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.525 -2.028 . . . . 64.14 105.525 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.546 ' CD1' HG23 ' A' ' 7' ' ' ILE . 53.0 mt -98.5 -58.76 1.89 Allowed 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 107.391 -1.337 . . . . 54.22 107.391 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.97 148.99 48.7 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 106.149 -1.797 . . . . 71.14 106.149 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.46 122.2 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.376 -2.453 . . . . 72.02 104.376 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.31 3.5 p-10 44.59 39.9 3.64 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.36 1.064 . . . . 61.11 111.161 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.87 -22.34 41.1 Favored Glycine 0 CA--C 1.471 -2.665 0 N-CA-C 108.936 -1.665 . . . . 74.12 108.936 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -78.25 114.83 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 N-CA-C 107.369 -1.345 . . . . 74.12 107.369 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 m -56.01 120.36 7.33 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.877 -0.786 . . . . 64.23 108.877 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -99.37 -17.29 18.08 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 106.916 -1.513 . . . . 75.44 106.916 -164.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -62.05 125.08 22.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.397 0.618 . . . . 72.42 109.878 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 -15.28 62.0 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 108.019 -2.032 . . . . 53.43 108.019 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 149.29 34.78 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 106.146 -1.798 . . . . 43.33 106.146 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.0 p -80.51 179.05 7.93 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.708 -0.849 . . . . 71.12 108.708 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -63.46 -50.18 70.7 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.117 -1.068 . . . . 74.22 108.117 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -54.2 -55.74 25.04 Favored 'General case' 0 C--N 1.362 1.148 0 O-C-N 121.66 -0.65 . . . . 73.33 110.601 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -54.59 -46.46 73.77 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 109.395 -0.594 . . . . 63.3 109.395 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.99 -52.47 50.32 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.163 0.585 . . . . 75.13 110.568 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.64 -40.11 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 108.025 -1.102 . . . . 75.22 108.025 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 t -63.95 -30.99 72.02 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 106.551 -1.648 . . . . 71.5 106.551 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.6 m -71.79 -45.79 60.43 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.602 -1.259 . . . . 74.35 107.602 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.99 -40.46 89.23 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 108.945 -0.761 . . . . 71.34 108.945 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.6 -60.56 3.35 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 108.2 -1.037 . . . . 63.34 108.2 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -71.36 53.37 0.2 Allowed 'General case' 0 C--N 1.373 1.605 0 C-N-CA 123.543 0.737 . . . . 53.44 110.572 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.469 HG21 HG13 ' A' ' 86' ' ' VAL . 16.1 p -112.38 -176.23 2.87 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.544 -2.021 . . . . 63.12 105.544 168.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.75 -159.69 32.4 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.195 -2.362 . . . . 63.32 107.195 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -56.86 -53.52 56.98 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.646 -0.872 . . . . 71.53 108.646 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' ALA . 86.5 t -105.66 147.2 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 106.012 -1.847 . . . . 45.02 106.012 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 82' ' ' THR . 39.6 t -100.37 129.53 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 106.66 -1.607 . . . . 74.24 106.66 -171.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -103.89 117.27 33.94 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 105.089 -2.189 . . . . 64.31 105.089 174.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.76 134.42 14.57 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 107.603 -1.258 . . . . 71.01 107.603 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.45 141.41 33.92 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.447 -1.316 . . . . 55.32 107.447 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.779 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.11 163.51 16.15 Favored 'General case' 0 CA--C 1.473 -2.001 0 N-CA-C 105.605 -1.998 . . . . 71.21 105.605 175.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HB2' HD11 ' A' ' 60' ' ' LEU . 33.9 tt0 -130.76 139.2 50.23 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 101.45 -3.537 . . . . 71.52 101.45 165.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -66.19 142.46 57.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.176 -1.046 . . . . 73.33 108.176 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.8 14.6 52.96 Favored Glycine 0 CA--C 1.487 -1.678 0 N-CA-C 105.859 -2.896 . . . . 72.33 105.859 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -60.75 -51.46 69.23 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 125.38 1.472 . . . . 55.51 108.476 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.9 p -67.89 122.93 85.73 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 106.196 -1.779 . . . . 74.31 106.196 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.45 157.97 59.05 Favored 'Trans proline' 0 CA--C 1.492 -1.594 0 C-N-CA 122.422 2.081 . . . . 74.22 108.701 -169.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.255 1.359 0 N-CA-C 105.528 -2.027 . . . . 75.32 105.528 -177.941 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.463 0 N-CA-C 108.882 -1.687 . . . . 74.53 108.882 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.32 169.55 12.22 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 123.348 2.698 . . . . 42.02 109.13 -175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -109.46 163.43 17.07 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 105.398 -2.075 . . . . 63.4 105.398 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.03 133.46 41.32 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.387 2.058 . . . . 61.1 108.343 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.61 -7.06 57.63 Favored Glycine 0 CA--C 1.486 -1.744 0 N-CA-C 110.004 -1.239 . . . . 72.45 110.004 171.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.18 130.71 40.28 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.212 -1.403 . . . . 74.31 107.212 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 HD11 ' A' ' 60' ' ' LEU . 12.0 mm -98.45 136.16 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.19 -1.781 . . . . 73.34 106.19 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.79 160.09 43.11 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.68 -0.859 . . . . 73.24 108.68 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -105.83 145.96 30.52 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 105.511 -2.033 . . . . 70.03 105.511 176.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.99 156.5 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 106.82 -1.548 . . . . 54.41 106.82 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -116.11 134.76 54.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.517 -2.031 . . . . 65.1 105.517 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.409 HD22 HD13 ' A' ' 53' ' ' ILE . 4.3 mp -135.61 145.82 47.28 Favored 'General case' 0 CA--C 1.454 -2.721 0 N-CA-C 107.755 -1.202 . . . . 74.02 107.755 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.06 142.33 28.0 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 105.206 -2.146 . . . . 54.32 105.206 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HG2' ' HB2' ' A' ' 19' ' ' LEU . 37.0 mtpt -77.68 -33.44 53.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 106.133 -1.803 . . . . 73.11 106.133 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 70.55 126.13 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.066 -1.424 . . . . 65.34 108.79 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.0 t70 59.71 34.82 22.16 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.075 -0.713 . . . . 74.02 109.075 173.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.1 t30 55.38 -9.18 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.009 1.724 . . . . 74.13 113.582 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.4 m -99.2 130.68 45.52 Favored 'General case' 0 N--CA 1.424 -1.732 0 O-C-N 120.815 -1.178 . . . . 70.12 108.535 -168.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 24.7 tp -134.04 139.3 45.92 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 102.679 -3.082 . . . . 71.51 102.679 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.85 62.48 0.24 Allowed Glycine 0 CA--C 1.464 -3.137 0 N-CA-C 106.215 -2.754 . . . . 63.52 106.215 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 22' ' ' CYS . 1.1 mm -88.54 178.14 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.198 -2.519 . . . . 74.32 104.198 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' H ' HG22 ' A' ' 21' ' ' ILE . 8.2 m -118.43 160.35 21.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.016 -2.216 . . . . 75.01 105.016 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 m -152.05 173.03 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 106.1 -1.815 . . . . 60.23 106.1 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.404 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 12.4 t -167.22 170.54 11.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.115 -1.809 . . . . 61.3 106.115 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.57 -145.39 17.71 Favored Glycine 0 CA--C 1.485 -1.796 0 N-CA-C 109.857 -1.297 . . . . 65.44 109.857 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.67 -79.26 0.25 Allowed Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.784 -1.727 . . . . 61.23 108.784 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -77.07 15.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.817 0 N-CA-C 112.304 0.483 . . . . 72.02 112.304 -164.528 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 85.58 6.36 0.44 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 124.234 1.014 . . . . 54.2 109.35 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.1 p -46.94 -168.9 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.901 1.68 . . . . 71.42 112.188 165.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 m -35.13 -35.53 0.04 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.045 1.738 . . . . 74.53 113.596 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 m -58.84 113.28 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.412 1.101 . . . . 74.23 110.159 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -47.87 -58.97 3.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.812 -1.086 . . . . 73.42 112.626 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -69.18 -20.65 64.0 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.822 -0.548 . . . . 64.34 110.071 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 52.34 4.02 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 107.591 -2.204 . . . . 71.24 107.591 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.4 179.81 25.88 Favored Glycine 0 CA--C 1.459 -3.459 0 N-CA-C 103.108 -3.997 . . . . 74.04 103.108 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.9 mm -88.71 127.78 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.792 0 N-CA-C 105.236 -2.135 . . . . 73.2 105.236 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -107.41 154.66 21.0 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 104.677 -2.342 . . . . 75.21 104.677 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 41' ' ' VAL . 60.6 t -87.25 101.71 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 N-CA-C 105.089 -2.189 . . . . 72.14 105.089 171.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HE2' ' HB ' ' A' ' 24' ' ' THR . 11.5 ttmm -71.62 -26.2 62.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.121 -0.945 . . . . 74.02 109.082 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 142.96 16.69 Favored 'General case' 0 CA--C 1.46 -2.495 0 N-CA-C 105.627 -1.99 . . . . 64.45 105.627 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 38' ' ' VAL . 84.8 t -110.21 125.98 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 102.729 -3.064 . . . . 62.12 102.729 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.566 ' O ' HD12 ' A' ' 42' ' ' ILE . 2.4 pp -76.63 145.95 75.96 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.978 -1.86 . . . . 73.54 105.978 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.81 174.53 12.43 Favored 'Trans proline' 0 CA--C 1.469 -2.742 0 N-CA-C 105.813 -2.418 . . . . 74.33 105.813 -174.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 69.05 -11.85 0.43 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.238 0.961 . . . . 73.42 112.597 161.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.23 -177.69 40.34 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 108.275 -1.93 . . . . 65.41 108.275 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.59 60.53 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 108.167 -1.049 . . . . 61.13 108.167 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.48 65.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.174 -0.466 . . . . 52.14 110.675 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.62 -53.87 44.79 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 122.009 -0.432 . . . . 74.55 109.876 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 t -60.14 -33.53 72.29 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.288 -0.634 . . . . 72.55 109.288 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.97 -43.42 35.1 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.342 -1.355 . . . . 60.24 107.342 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.94 11.08 79.78 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.615 -0.994 . . . . 52.03 110.615 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -95.24 7.33 46.48 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.583 -1.265 . . . . 64.41 107.583 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.409 HD13 HD22 ' A' ' 12' ' ' LEU . 1.6 mp -134.32 139.4 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 102.537 -3.134 . . . . 64.41 102.537 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -148.04 161.45 41.36 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 104.986 -2.227 . . . . 70.03 104.986 176.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -66.6 138.93 57.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.996 -1.112 . . . . 60.43 107.996 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.41 -32.51 7.48 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 108.069 -2.012 . . . . 70.34 108.069 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.97 154.23 41.65 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 107.011 -1.478 . . . . 73.15 107.011 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 91' ' ' GLU . 19.1 ptt-85 -131.38 155.16 47.76 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.369 -0.974 . . . . 61.5 108.369 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.28 139.44 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 105.908 -1.886 . . . . 74.31 105.908 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD11 HD12 ' A' ' 7' ' ' ILE . 93.6 mt -102.28 -57.97 1.96 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.832 -1.544 . . . . 63.53 106.832 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.24 148.34 49.56 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.549 -2.019 . . . . 54.34 105.549 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.6 119.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 105.233 -2.136 . . . . 73.44 105.233 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.8 t30 53.57 36.12 22.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.606 0.762 . . . . 73.14 109.841 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.87 -21.77 44.25 Favored Glycine 0 CA--C 1.474 -2.524 0 N-CA-C 108.777 -1.729 . . . . 70.3 108.777 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.8 115.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 108.082 -1.081 . . . . 64.12 108.082 -172.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -52.41 120.97 6.16 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.523 0.729 . . . . 60.43 109.122 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -109.94 -19.16 13.2 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 107.549 -1.278 . . . . 64.34 107.549 -167.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.9 127.37 31.11 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 120.787 -1.196 . . . . 73.43 108.38 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.86 62.06 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 108.553 -1.819 . . . . 65.22 108.553 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.76 151.24 30.48 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 105.311 -2.107 . . . . 62.41 105.311 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.401 ' HA ' HG22 ' A' ' 27' ' ' VAL . 58.6 p -81.68 179.39 7.85 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.712 -0.847 . . . . 72.33 108.712 -171.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.5 -45.32 69.21 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.197 -1.038 . . . . 73.34 108.197 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -52.49 -56.11 17.38 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 121.339 -0.851 . . . . 53.22 109.852 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -53.75 -41.63 67.32 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 109.746 -0.465 . . . . 74.23 109.746 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -53.0 -50.04 65.01 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 116.087 -0.506 . . . . 62.42 109.933 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.2 t -73.52 -42.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 108.067 -1.086 . . . . 72.31 108.067 -174.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.4 m -57.97 -35.12 70.72 Favored 'General case' 0 N--CA 1.523 3.224 0 N-CA-C 106.177 -1.786 . . . . 64.34 106.177 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.6 m -73.24 -47.89 39.47 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.904 -1.043 . . . . 74.23 108.554 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.75 -37.67 82.46 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.379 -0.6 . . . . 53.24 109.379 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -69.12 -60.53 2.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.614 -1.254 . . . . 72.11 107.614 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -69.17 57.39 0.1 Allowed 'General case' 0 C--N 1.367 1.337 0 C-N-CA 123.595 0.758 . . . . 72.21 110.981 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -109.24 -176.38 3.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.775 -1.565 . . . . 55.4 106.775 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.27 -144.99 16.07 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.313 -2.315 . . . . 73.05 107.313 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -72.19 -55.58 7.01 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.666 -0.864 . . . . 74.23 108.666 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.52 146.84 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 106.19 -1.781 . . . . 75.32 106.19 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -105.08 132.85 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 105.241 -2.133 . . . . 64.24 105.241 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.6 t60 -113.21 132.55 55.46 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.73 -2.322 . . . . 63.23 104.73 173.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -159.49 143.5 14.88 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 108.582 -0.895 . . . . 74.51 108.582 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.08 137.88 35.98 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 107.267 -1.383 . . . . 61.03 107.267 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.69 161.9 36.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.531 -1.285 . . . . 74.24 107.531 176.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 58' ' ' ARG . 79.6 tt0 -133.69 141.76 47.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 104.183 -2.525 . . . . 64.4 104.183 -173.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -66.82 144.35 56.35 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.928 -0.767 . . . . 74.12 108.928 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.17 -161.22 22.6 Favored Glycine 0 CA--C 1.474 -2.485 0 N-CA-C 105.665 -2.974 . . . . 71.21 105.665 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -112.63 158.31 20.16 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 104.105 -2.554 . . . . 73.04 104.105 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.9 m -64.2 130.61 94.67 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 108.904 -0.776 . . . . 70.23 108.904 -175.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.44 -172.84 0.83 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.344 2.696 . . . . 74.34 108.159 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.426 -1.647 0 N-CA-C 106.392 -1.707 . . . . 71.02 106.392 -178.827 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.58 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.897 0 N-CA-C 107.831 -2.108 . . . . 75.03 107.831 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.1 164.32 36.01 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 N-CA-C 106.795 -2.04 . . . . 62.54 106.795 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -107.51 157.76 34.93 Favored Pre-proline 0 N--CA 1.445 -0.69 0 N-CA-C 106.386 -1.709 . . . . 72.13 106.386 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.89 130.24 28.65 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 C-N-CA 122.603 2.202 . . . . 43.43 108.94 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.57 -8.08 59.92 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 109.231 -1.547 . . . . 71.51 109.231 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -77.07 134.29 38.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.839 -1.541 . . . . 75.44 106.839 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.407 HD13 HD11 ' A' ' 60' ' ' LEU . 2.5 mt -105.25 138.12 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 N-CA-C 107.405 -1.332 . . . . 71.24 107.405 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -156.41 172.37 18.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.368 -1.345 . . . . 73.45 107.368 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.01 155.01 27.75 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 106.051 -1.833 . . . . 73.41 106.051 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.84 156.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 105.711 -1.959 . . . . 54.51 105.711 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.84 130.35 55.0 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.176 -1.787 . . . . 63.13 106.176 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.72 140.06 47.91 Favored 'General case' 0 CA--C 1.46 -2.501 0 N-CA-C 106.875 -1.528 . . . . 55.31 106.875 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 140.99 31.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.648 -1.982 . . . . 62.12 105.648 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -68.61 -28.2 66.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.648 -1.241 . . . . 73.0 107.648 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 t30 86.51 93.54 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.324 -1.361 . . . . 72.34 107.324 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.28 47.77 6.7 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.772 -1.195 . . . . 52.45 107.772 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 45.94 -0.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 127.588 2.355 . . . . 62.44 115.407 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -104.83 115.27 30.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.887 1.221 . . . . 62.31 108.03 -172.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.718 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.6 pt? -89.48 -155.39 0.35 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.432 -1.692 . . . . 71.01 106.432 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.34 55.56 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.189 0 N-CA-C 106.275 -2.73 . . . . 71.3 106.275 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.3 mm -106.65 178.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.119 -2.919 . . . . 72.42 103.119 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.417 ' H ' HG22 ' A' ' 21' ' ' ILE . 56.0 m -133.01 163.79 28.43 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.176 -2.157 . . . . 75.2 105.176 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.35 175.86 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.827 -1.546 . . . . 64.31 106.827 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -164.21 167.0 20.54 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 104.816 -2.29 . . . . 73.23 104.816 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.49 23.28 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 108.479 -1.849 . . . . 64.24 108.479 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.68 -74.13 0.21 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 108.776 -1.729 . . . . 63.34 108.776 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.14 15.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.203 0.525 . . . . 73.22 109.659 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.8 t30 84.46 5.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.962 1.305 . . . . 73.31 108.006 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -53.74 -170.69 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.53 1.132 . . . . 73.21 112.293 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 m -29.46 -45.73 0.05 OUTLIER 'General case' 0 C--N 1.367 1.366 0 C-N-CA 126.843 2.057 . . . . 52.14 115.934 -159.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.52 125.56 19.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 CA-C-O 122.05 0.929 . . . . 75.22 109.954 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HD2' HE22 ' A' ' 94' ' ' GLN . 11.3 ptp85 -52.65 -44.31 66.07 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.583 -1.19 . . . . 63.15 112.884 -169.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.411 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 23.8 t-160 -75.45 -21.25 58.27 Favored 'General case' 0 C--N 1.37 1.486 0 O-C-N 120.823 -1.173 . . . . 73.51 108.719 -175.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -14.79 62.97 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 109.878 -1.289 . . . . 62.41 109.878 171.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.95 179.92 44.13 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 108.551 -1.82 . . . . 71.31 108.551 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.1 mm -83.2 127.85 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 N-CA-C 104.336 -2.468 . . . . 74.44 104.336 171.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.53 152.27 23.9 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 104.567 -2.383 . . . . 74.03 104.567 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.27 100.29 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 104.785 -2.302 . . . . 74.34 104.785 170.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.64 -17.97 42.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.788 -1.096 . . . . 73.54 111.725 -176.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.86 19.53 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 106.997 -1.483 . . . . 72.51 106.997 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.89 132.02 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 103.581 -2.748 . . . . 75.23 103.581 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.93 145.6 81.44 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 106.252 -1.759 . . . . 73.21 106.252 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.01 167.02 27.95 Favored 'Trans proline' 0 CA--C 1.464 -2.996 0 N-CA-C 106.848 -2.02 . . . . 64.42 106.848 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 69.06 2.1 3.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 124.474 1.109 . . . . 73.52 110.884 165.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.68 -175.77 38.43 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 108.515 -1.834 . . . . 53.43 108.515 -174.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.58 55.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 108.123 -1.066 . . . . 65.0 108.123 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.72 -49.39 62.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.978 -0.556 . . . . 52.31 110.417 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.31 -52.64 31.25 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.875 -0.33 . . . . 64.35 110.407 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.8 t -65.73 -36.24 83.04 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.686 -0.634 . . . . 70.54 109.973 -169.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.57 -25.57 35.69 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 106.672 -1.603 . . . . 62.42 106.672 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.1 78.78 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.75 -0.94 . . . . 74.42 110.75 167.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -87.24 1.99 51.45 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.684 -1.228 . . . . 74.31 107.684 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.9 mt -143.6 140.89 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 103.832 -2.655 . . . . 74.34 103.832 -168.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -142.72 159.4 42.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.029 -2.582 . . . . 75.14 104.029 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.45 142.88 57.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.007 -1.109 . . . . 72.55 108.007 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.56 -31.87 8.14 Favored Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 107.467 -2.253 . . . . 73.21 107.467 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -58.86 147.86 32.24 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 109.039 -0.726 . . . . 62.31 109.039 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -114.88 139.93 49.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.623 -1.251 . . . . 72.21 107.623 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.89 129.03 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.451 -2.055 . . . . 64.44 105.451 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.407 HD11 HD13 ' A' ' 7' ' ' ILE . 89.2 mt -97.33 -58.81 1.92 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 106.905 -1.517 . . . . 54.03 106.905 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.23 148.76 48.22 Favored 'General case' 0 CA--C 1.476 -1.865 0 N-CA-C 106.414 -1.699 . . . . 71.04 106.414 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.2 121.59 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 105.29 -2.115 . . . . 64.34 105.29 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.9 t30 53.16 37.32 24.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 71.14 110.046 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.49 -26.88 22.05 Favored Glycine 0 CA--C 1.471 -2.672 0 N-CA-C 108.513 -1.835 . . . . 61.32 108.513 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 83.4 t -79.4 116.69 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 107.809 -1.182 . . . . 74.4 107.809 -171.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 114.65 1.76 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 108.593 -0.892 . . . . 72.24 108.593 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 75' ' ' ALA . 2.1 tm? -102.27 -18.82 15.29 Favored 'General case' 0 C--O 1.191 -1.992 0 N-CA-C 106.363 -1.717 . . . . 73.4 106.363 -167.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.16 129.14 39.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.193 -0.942 . . . . 64.45 108.473 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.56 -16.56 56.34 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 108.044 -2.022 . . . . 34.21 108.044 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.61 154.1 27.61 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.435 -1.691 . . . . 54.25 106.435 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.0 p -81.13 179.88 7.66 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.109 -0.7 . . . . 64.43 109.109 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -58.76 -53.33 59.56 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 107.936 -1.135 . . . . 71.45 107.936 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.57 -48.3 80.07 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 110.282 -0.266 . . . . 74.55 110.282 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -57.84 -41.08 81.6 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.767 -0.457 . . . . 75.13 109.767 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' HD11 ' A' ' 67' ' ' LEU . . . -50.67 -56.22 12.9 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 120.818 0.342 . . . . 65.51 110.714 177.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.7 m -74.64 -33.39 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 109.145 -0.687 . . . . 34.33 109.145 -173.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.9 t -68.79 -31.55 70.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 105.991 -1.855 . . . . 74.41 105.991 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.2 m -71.37 -41.83 69.22 Favored 'General case' 0 C--O 1.207 -1.133 0 O-C-N 120.319 -1.488 . . . . 74.3 107.464 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.3 -29.55 69.94 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 109.232 -0.655 . . . . 75.41 109.232 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -73.78 -61.21 1.92 Allowed 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.807 -1.183 . . . . 74.5 107.807 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.83 54.45 0.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.422 0.629 . . . . 64.43 111.548 -174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 p -112.77 -175.06 2.58 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 104.956 -2.238 . . . . 75.22 104.956 167.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.78 -161.55 25.97 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 107.71 -2.156 . . . . 63.4 107.71 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -52.69 -53.34 48.87 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.8 -0.815 . . . . 55.24 108.8 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.5 t -102.99 148.8 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 105.465 -2.05 . . . . 63.51 105.465 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.4 t -104.59 131.11 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 N-CA-C 105.42 -2.067 . . . . 43.11 105.42 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -112.92 128.91 56.6 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.048 -2.575 . . . . 61.31 104.048 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 142.97 17.75 Favored 'General case' 0 CA--C 1.467 -2.227 0 N-CA-C 108.087 -1.079 . . . . 74.24 108.087 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 135.67 35.93 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.839 -1.541 . . . . 72.0 106.839 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.65 160.43 33.36 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 106.353 -1.721 . . . . 71.12 106.353 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.6 135.03 48.77 Favored 'General case' 0 N--CA 1.397 -3.106 0 N-CA-C 102.102 -3.296 . . . . 72.2 102.102 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.654 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 6.8 mmpt? -62.48 136.86 58.1 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 107.813 -1.18 . . . . 74.01 107.813 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.88 -173.3 48.82 Favored Glycine 0 CA--C 1.461 -3.326 0 N-CA-C 106.78 -2.528 . . . . 74.23 106.78 -171.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.437 HE22 ' HD2' ' A' ' 32' ' ' ARG . 36.0 mt-30 -82.91 136.8 34.46 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 105.035 -2.209 . . . . 62.43 105.035 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 m -46.61 121.39 6.52 Favored Pre-proline 0 C--N 1.348 0.528 0 O-C-N 123.855 0.722 . . . . 72.24 110.734 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.24 159.72 50.92 Favored 'Trans proline' 0 CA--C 1.498 -1.291 0 C-N-CA 122.985 2.456 . . . . 73.12 108.646 -169.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.42 -1.953 0 N-CA-C 104.077 -2.564 . . . . 63.45 104.077 178.878 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.409 ' H5 ' ' O2 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.239 0 N-CA-C 108.087 -2.005 . . . . 41.35 108.087 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.25 149.47 88.54 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.649 2.233 . . . . 73.43 108.449 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -102.78 165.33 13.9 Favored Pre-proline 0 N--CA 1.437 -1.104 0 N-CA-C 106.556 -1.646 . . . . 75.13 106.556 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.17 127.67 19.83 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.54 2.16 . . . . 74.53 108.207 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.46 1.92 65.99 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 109.25 -1.54 . . . . 74.12 109.25 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -81.77 140.34 34.3 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.613 -1.625 . . . . 60.13 106.613 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.47 HG23 ' CD1' ' A' ' 60' ' ' LEU . 10.8 mt -104.86 137.75 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.467 0 N-CA-C 108.392 -0.966 . . . . 72.35 108.392 -173.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.488 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.2 p90 -138.89 155.8 47.8 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 107.098 -1.445 . . . . 51.21 107.098 172.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -105.89 145.71 30.9 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.757 -1.942 . . . . 73.31 105.757 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.677 HG22 HD21 ' A' ' 90' ' ' LEU . 30.4 m -142.34 155.86 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 106.888 -1.523 . . . . 63.41 106.888 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.66 122.96 46.1 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 105.088 -2.19 . . . . 65.11 105.088 167.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 52' ' ' ARG . 12.7 mt -131.97 133.12 44.13 Favored 'General case' 0 CA--C 1.458 -2.58 0 N-CA-C 105.018 -2.216 . . . . 63.24 105.018 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.02 22.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 105.805 -1.924 . . . . 53.23 105.805 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -70.04 -36.16 74.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.999 -1.852 . . . . 74.23 105.999 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 81.48 113.21 0.06 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 125.231 1.412 . . . . 61.11 108.117 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.57 36.21 25.01 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.791 -1.188 . . . . 75.1 107.791 -173.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 43.38 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 127.485 2.314 . . . . 63.4 115.25 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.7 m -97.24 124.52 41.35 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 119.985 1.266 . . . . 72.24 107.904 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.625 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.9 pt? -97.03 -158.88 0.7 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 105.817 -1.92 . . . . 73.22 105.817 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.76 32.09 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 106.671 -2.571 . . . . 71.42 106.671 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.1 mm -88.16 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.863 -2.273 . . . . 61.24 104.863 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.2 m -140.56 167.23 22.66 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 103.849 -2.649 . . . . 51.53 103.849 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 36' ' ' ILE . 9.0 m -148.38 173.18 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 106.985 -1.487 . . . . 74.22 106.985 -168.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 39' ' ' LYS . 8.2 t -159.32 164.01 35.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 104.037 -2.579 . . . . 44.55 104.037 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -139.16 18.31 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.356 -1.898 . . . . 71.01 108.356 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.61 -79.31 0.29 Allowed Glycine 0 CA--C 1.466 -3.001 0 N-CA-C 108.54 -1.824 . . . . 33.44 108.54 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -76.11 16.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 122.731 0.413 . . . . 74.32 111.045 -171.163 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 85.59 5.68 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.832 1.253 . . . . 70.52 108.099 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -55.85 -171.0 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.476 -0.784 . . . . 74.23 111.851 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 m -29.1 -45.03 0.04 OUTLIER 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.439 2.295 . . . . 63.33 116.009 -162.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.72 136.82 16.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-O 121.663 0.744 . . . . 72.22 111.855 -172.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -35.16 -71.53 0.07 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 126.17 1.788 . . . . 73.41 113.207 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -76.97 -15.6 59.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.26 -0.9 . . . . 72.43 110.104 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.38 61.79 2.16 Favored Glycine 0 CA--C 1.491 -1.449 0 N-CA-C 108.093 -2.003 . . . . 72.42 108.093 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.95 -178.81 25.23 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 104.376 -3.49 . . . . 72.41 104.376 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 36' ' ' ILE . 7.0 mm -83.72 122.3 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.131 0 N-CA-C 104.427 -2.434 . . . . 71.42 104.427 172.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -107.17 153.13 23.13 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 103.809 -2.663 . . . . 63.45 103.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -83.55 102.32 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.154 -1.795 . . . . 62.23 106.154 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HB2' HG22 ' A' ' 24' ' ' THR . 13.5 tptm -72.91 -31.11 64.42 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.423 -0.808 . . . . 75.42 111.036 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.73 145.4 18.61 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 106.495 -1.668 . . . . 75.12 106.495 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -122.27 133.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.413 -2.81 . . . . 65.43 103.413 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.97 151.49 86.34 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 106.398 -1.705 . . . . 65.11 106.398 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.33 167.66 25.35 Favored 'Trans proline' 0 CA--C 1.457 -3.336 0 N-CA-C 105.735 -2.448 . . . . 74.31 105.735 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 68.38 1.98 3.13 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.769 0.668 . . . . 73.04 110.109 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.99 175.06 42.98 Favored Glycine 0 CA--C 1.472 -2.642 0 N-CA-C 107.571 -2.212 . . . . 72.32 107.571 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.13 -48.6 64.97 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 107.355 -1.35 . . . . 64.01 107.355 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.19 64.9 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 116.067 -0.515 . . . . 73.44 110.019 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.08 -56.22 14.25 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.975 -0.379 . . . . 74.24 109.975 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -65.44 -28.94 69.59 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.908 0.385 . . . . 70.34 110.515 -166.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -83.17 -31.28 27.22 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 106.764 -1.569 . . . . 64.31 106.764 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 16.91 65.88 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 111.025 -0.83 . . . . 54.1 111.025 170.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HB2' HD11 ' A' ' 12' ' ' LEU . 17.1 mmp_? -91.71 5.65 48.93 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.523 -1.288 . . . . 70.21 107.523 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.9 mt -144.83 144.88 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 104.161 -2.533 . . . . 72.43 104.161 -171.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.601 ' HE1' ' O ' ' A' ' 94' ' ' GLN . 14.5 p80 -149.3 168.24 23.88 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 101.871 -3.381 . . . . 73.42 101.871 172.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -66.44 144.16 56.67 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.074 -1.084 . . . . 75.22 108.074 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.19 -32.5 7.47 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.07 -1.062 . . . . 54.42 110.839 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -66.65 154.55 40.3 Favored 'General case' 0 C--N 1.378 1.822 0 CA-C-N 119.871 1.836 . . . . 72.43 107.859 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 137.41 51.92 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.047 -1.464 . . . . 74.35 107.047 -164.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.5 127.27 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 106.452 -1.684 . . . . 70.44 106.452 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.47 ' CD1' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -95.12 -59.83 1.81 Allowed 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.017 -1.105 . . . . 72.04 108.017 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.38 148.66 47.94 Favored 'General case' 0 CA--C 1.467 -2.216 0 N-CA-C 106.254 -1.758 . . . . 64.44 106.254 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.6 t -119.92 119.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 105.864 -1.902 . . . . 74.34 105.864 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.9 t30 49.38 38.07 13.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.698 1.199 . . . . 71.43 110.318 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.22 -33.5 6.52 Favored Glycine 0 CA--C 1.469 -2.821 0 N-CA-C 108.212 -1.955 . . . . 63.14 108.212 171.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.0 114.98 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 107.753 -1.203 . . . . 61.43 107.753 -172.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.6 m -53.88 117.44 3.19 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 107.939 -1.134 . . . . 55.52 107.939 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -99.88 -10.48 21.68 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.291 -2.114 . . . . 61.14 105.291 -168.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.45 137.18 48.87 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.914 -1.143 . . . . 70.25 107.914 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.6 62.04 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.46 -1.456 . . . . 74.41 109.46 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.47 148.96 30.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.837 -1.172 . . . . 60.3 107.837 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.414 ' HA ' HG22 ' A' ' 27' ' ' VAL . 39.0 p -81.99 -179.48 7.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.844 -0.798 . . . . 73.53 108.844 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.64 -52.02 66.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.981 -1.118 . . . . 74.33 107.981 178.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -57.1 -55.5 33.9 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 121.638 -0.664 . . . . 72.21 110.783 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -53.62 -40.7 65.99 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 120.772 0.32 . . . . 73.33 110.529 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.13 -54.46 24.97 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.023 0.529 . . . . 72.54 110.787 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.98 -37.43 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.801 -0.444 . . . . 72.43 109.801 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.02 -31.67 72.85 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 116.943 -1.903 . . . . 55.41 106.266 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 82' ' ' THR . 26.5 m -71.85 -45.16 62.34 Favored 'General case' 0 C--O 1.206 -1.232 0 O-C-N 120.654 -1.279 . . . . 64.13 107.901 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.5 mt -62.48 -29.66 70.7 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 110.181 -0.303 . . . . 71.11 110.181 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -73.69 -59.0 2.92 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.194 -1.41 . . . . 74.53 107.194 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -70.51 46.77 0.09 Allowed 'General case' 0 C--N 1.362 1.139 0 C-N-CA 125.109 1.364 . . . . 63.44 111.441 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.572 HG21 HG13 ' A' ' 86' ' ' VAL . 2.7 p -105.22 -175.4 2.78 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.159 -1.793 . . . . 74.35 106.159 173.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.0 33.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 106.012 -2.835 . . . . 63.44 106.012 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.25 -54.54 44.6 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.22 -1.03 . . . . 72.32 108.22 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.0 t -101.79 145.18 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 105.995 -1.854 . . . . 61.24 105.995 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.572 HG13 HG21 ' A' ' 82' ' ' THR . 47.7 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 105.904 -1.887 . . . . 71.34 105.904 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -107.7 127.02 53.31 Favored 'General case' 0 CA--C 1.466 -2.271 0 N-CA-C 103.298 -2.853 . . . . 72.43 103.298 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.46 136.57 13.81 Favored 'General case' 0 CA--C 1.458 -2.583 0 N-CA-C 107.374 -1.343 . . . . 75.24 107.374 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.26 136.37 35.8 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.311 -1.366 . . . . 61.31 107.311 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.677 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -107.41 151.74 25.12 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 103.893 -2.632 . . . . 71.44 103.893 175.107 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.53 133.3 55.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 101.65 -3.463 . . . . 61.42 101.65 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.7 129.52 41.94 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.49 -0.929 . . . . 75.34 108.49 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.15 0.41 25.38 Favored Glycine 0 CA--C 1.477 -2.295 0 N-CA-C 105.177 -3.169 . . . . 71.4 105.177 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.601 ' O ' ' HE1' ' A' ' 54' ' ' HIS . 0.0 OUTLIER 67.19 -172.08 0.19 Allowed 'General case' 0 C--N 1.38 1.929 0 N-CA-C 107.446 -1.316 . . . . 74.31 107.446 178.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.433 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 53.4 m -102.44 97.51 8.98 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 104.751 -2.314 . . . . 75.3 104.751 167.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.83 124.13 11.52 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.813 2.342 . . . . 61.12 109.081 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.408 -2.567 0 N-CA-C 103.604 -2.739 . . . . 75.14 103.604 175.824 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.525 ' C20' ' H15' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.041 0 N-CA-C 108.368 -1.893 . . . . 74.41 108.368 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.05 155.96 68.5 Favored 'Trans proline' 0 CA--C 1.5 -1.182 0 C-N-CA 122.636 2.224 . . . . 71.5 108.654 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.79 166.82 12.81 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 104.737 -2.32 . . . . 74.22 104.737 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.26 129.91 31.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.749 2.299 . . . . 63.42 109.123 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.37 -8.86 72.14 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 108.923 -1.671 . . . . 51.44 108.923 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -75.6 139.78 42.26 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.418 -1.327 . . . . 64.21 107.418 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' LEU . 9.4 mm -100.68 131.64 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.128 -1.434 . . . . 74.44 107.128 -171.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.582 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.8 p90 -143.34 155.8 44.53 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.255 -1.387 . . . . 74.22 107.255 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -108.77 147.07 32.59 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.729 -1.952 . . . . 74.23 105.729 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.67 HG22 HD21 ' A' ' 90' ' ' LEU . 18.8 m -141.22 152.51 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 N-CA-C 107.272 -1.381 . . . . 74.41 107.272 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.58 127.07 53.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.117 -2.179 . . . . 72.13 105.117 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 53' ' ' ILE . 3.0 mp -135.18 140.99 45.79 Favored 'General case' 0 CA--C 1.461 -2.445 0 N-CA-C 107.748 -1.204 . . . . 63.41 107.748 175.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.07 141.22 33.36 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.757 -1.571 . . . . 64.41 106.757 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -71.54 -25.88 62.4 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.333 -0.988 . . . . 72.33 108.333 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 72.64 108.05 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.25 -1.019 . . . . 73.51 108.25 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 51.94 53.1 13.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 109.549 -0.537 . . . . 71.41 109.549 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.1 t30 54.37 -9.09 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.043 1.737 . . . . 75.55 115.007 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.4 t -126.12 120.76 30.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 120.595 1.543 . . . . 72.12 108.317 -171.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.0 pt? -99.99 167.44 10.49 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.109 -2.182 . . . . 73.4 105.109 171.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.99 95.62 0.15 Allowed Glycine 0 CA--C 1.478 -2.232 0 N-CA-C 105.041 -3.223 . . . . 52.53 105.041 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.7 mm -118.95 177.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.273 -2.862 . . . . 73.15 103.273 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.1 t -127.79 154.74 45.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 102.987 -2.968 . . . . 72.52 102.987 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.0 m -149.46 169.55 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.818 -1.549 . . . . 54.34 106.818 -165.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.533 HG23 ' CE2' ' A' ' 37' ' ' TYR . 6.8 t -165.22 168.23 17.26 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.531 -2.396 . . . . 72.1 104.531 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.26 -167.03 22.33 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 105.573 -3.011 . . . . 64.43 105.573 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.91 -115.74 0.91 Allowed Glycine 0 CA--C 1.489 -1.55 0 C-N-CA 119.443 -1.361 . . . . 74.1 110.165 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -60.73 20.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.691 1.996 . . . . 71.31 116.32 -162.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 87.37 9.07 0.17 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.262 -1.014 . . . . 72.32 108.262 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.3 p -39.14 -166.96 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 126.283 1.833 . . . . 74.43 111.626 154.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -39.34 -29.11 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.9 0 O-C-N 120.458 -1.401 . . . . 74.51 114.616 -168.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG11 ' CE1' ' A' ' 37' ' ' TYR . 4.6 m -86.27 134.84 26.4 Favored 'Isoleucine or valine' 0 C--N 1.365 1.248 0 O-C-N 120.347 -1.471 . . . . 53.44 108.486 177.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -70.54 -24.17 62.76 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.857 -0.794 . . . . 72.51 108.857 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 60' ' ' LEU . 7.4 t-160 -83.69 -10.98 57.79 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.898 -0.721 . . . . 72.41 109.06 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.69 67.1 2.36 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 110.029 -1.229 . . . . 34.24 110.029 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.74 178.21 26.46 Favored Glycine 0 CA--C 1.472 -2.607 0 N-CA-C 105.348 -3.101 . . . . 74.12 105.348 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.76 141.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 N-CA-C 105.905 -1.887 . . . . 71.12 105.905 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -121.46 162.05 21.15 Favored 'General case' 0 CA--C 1.45 -2.898 0 N-CA-C 106.696 -1.594 . . . . 65.22 106.696 175.064 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.416 HG11 HG22 ' A' ' 41' ' ' VAL . 99.7 t -85.8 103.54 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 106.593 -1.632 . . . . 64.42 106.593 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -71.12 -30.48 66.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.535 -1.211 . . . . 75.12 108.949 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.7 151.16 10.69 Favored 'General case' 0 CA--C 1.467 -2.225 0 N-CA-C 105.869 -1.9 . . . . 73.42 105.869 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.416 HG22 HG11 ' A' ' 38' ' ' VAL . 7.0 t -118.33 134.15 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 103.657 -2.72 . . . . 63.32 103.657 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 148.68 84.01 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.826 -1.916 . . . . 75.04 105.826 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.26 168.12 25.34 Favored 'Trans proline' 0 CA--C 1.467 -2.84 0 N-CA-C 106.073 -2.318 . . . . 73.1 106.073 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 62.08 2.75 0.85 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.239 0.829 . . . . 73.32 113.239 164.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.19 -175.78 36.13 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 107.12 -2.392 . . . . 55.11 107.12 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.63 -53.01 38.76 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 108.579 -0.897 . . . . 74.41 108.579 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.49 -49.84 66.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 116.362 -0.381 . . . . 41.01 111.067 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.7 -53.1 59.6 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 109.616 -0.513 . . . . 73.53 109.616 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -55.71 -38.15 69.35 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.278 0.631 . . . . 71.14 109.962 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -77.48 -33.5 54.52 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.871 -1.159 . . . . 74.1 107.871 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.31 81.04 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.235 -1.146 . . . . 73.11 110.235 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -107.33 8.37 29.69 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.282 -1.006 . . . . 72.14 108.282 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 12' ' ' LEU . 1.4 mp -126.92 134.13 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 101.859 -3.386 . . . . 72.14 101.859 175.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -138.74 159.58 41.75 Favored 'General case' 0 CA--C 1.473 -2.0 0 N-CA-C 104.091 -2.559 . . . . 63.22 104.091 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -66.48 143.99 56.76 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.74 -1.207 . . . . 75.32 107.74 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -30.82 8.88 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 108.623 -1.791 . . . . 64.4 108.623 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -66.49 152.73 44.6 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 106.232 -1.766 . . . . 75.41 106.232 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.666 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 18.7 ptt-85 -132.23 157.67 43.75 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.954 -1.498 . . . . 75.14 106.954 -171.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.54 135.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.416 -1.698 . . . . 74.21 106.416 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.529 HD11 HD12 ' A' ' 7' ' ' ILE . 48.2 mt -96.92 -58.26 2.08 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.029 -1.471 . . . . 72.14 107.029 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.92 151.57 50.11 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.416 -1.698 . . . . 60.3 106.416 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.65 119.86 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 105.515 -2.031 . . . . 70.31 105.515 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.5 t30 54.71 32.85 18.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.133 0.973 . . . . 62.34 109.909 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.78 -28.99 13.42 Favored Glycine 0 CA--C 1.463 -3.183 0 N-CA-C 108.551 -1.82 . . . . 72.45 108.551 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.26 115.12 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 N-CA-C 107.533 -1.284 . . . . 34.32 107.533 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 t -55.65 130.56 43.62 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.689 -0.856 . . . . 75.45 108.689 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -98.98 -11.81 21.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.939 -1.874 . . . . 71.15 105.939 -170.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.77 126.13 20.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.863 -0.608 . . . . 63.5 109.634 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.17 -12.26 64.95 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 109.137 -1.585 . . . . 53.21 109.137 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.88 148.8 41.96 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 107.271 -1.381 . . . . 73.31 107.271 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 p -81.77 177.32 8.95 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 107.317 -1.364 . . . . 73.43 107.317 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -65.85 -43.93 86.98 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.541 -0.911 . . . . 45.01 108.541 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -54.59 -56.73 15.91 Favored 'General case' 0 C--N 1.362 1.125 0 O-C-N 121.881 -0.512 . . . . 53.43 110.176 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -56.46 -44.42 80.52 Favored 'General case' 0 C--N 1.365 1.246 0 N-CA-C 110.089 -0.337 . . . . 71.03 110.089 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -50.54 -52.76 35.85 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.792 0.437 . . . . 42.13 110.831 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.14 -42.12 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.775 -1.195 . . . . 71.13 107.775 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -53.23 -40.6 64.65 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 123.722 1.725 . . . . 40.42 106.442 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -65.5 -40.34 92.92 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 120.338 -1.476 . . . . 71.01 108.776 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.87 -29.57 70.28 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 109.813 -0.44 . . . . 74.42 109.813 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -73.26 -60.42 2.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.531 -0.544 . . . . 64.41 109.531 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.97 40.79 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 113.563 0.949 . . . . 73.22 113.563 -174.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 p -106.72 -176.12 2.99 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 106.303 -1.74 . . . . 71.14 106.303 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.02 -153.87 28.97 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 108.415 -1.874 . . . . 73.43 108.415 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -61.14 -54.39 45.07 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.923 -0.769 . . . . 72.43 108.923 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.52 145.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 105.82 -1.919 . . . . 54.24 105.82 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.06 139.41 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.673 0 N-CA-C 105.592 -2.003 . . . . 72.23 105.592 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -114.08 135.8 53.62 Favored 'General case' 0 CA--C 1.463 -2.376 0 N-CA-C 104.608 -2.367 . . . . 72.42 104.608 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.54 135.69 9.92 Favored 'General case' 0 CA--C 1.461 -2.448 0 N-CA-C 106.975 -1.491 . . . . 74.52 106.975 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.19 139.08 35.76 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 107.318 -1.364 . . . . 75.44 107.318 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.67 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.76 155.5 21.5 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 104.62 -2.363 . . . . 74.14 104.62 176.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.425 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.9 tt0 -120.74 128.75 53.21 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 101.604 -3.48 . . . . 70.24 101.604 165.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -61.93 146.83 48.76 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.736 -0.838 . . . . 73.14 108.736 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.96 -166.03 18.81 Favored Glycine 0 N--CA 1.42 -2.411 0 N-CA-C 105.577 -3.009 . . . . 44.31 105.577 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 168.42 -78.82 0.0 OUTLIER 'General case' 0 CA--C 1.448 -2.972 0 N-CA-C 101.343 -3.577 . . . . 52.52 101.343 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -88.4 152.47 49.88 Favored Pre-proline 0 N--CA 1.397 -3.114 0 N-CA-C 104.543 -2.391 . . . . 74.33 104.543 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.86 -174.08 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.872 2.381 . . . . 70.23 109.122 170.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.559 1.324 0 CA-C-O 118.209 -0.901 . . . . 61.21 109.18 176.526 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.538 0 N-CA-C 109.122 -1.591 . . . . 74.31 109.122 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.15 158.32 57.97 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 122.964 2.443 . . . . 73.14 108.251 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -117.99 161.24 35.5 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 106.356 -1.72 . . . . 55.32 106.356 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.91 132.59 40.33 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.011 2.474 . . . . 55.32 109.367 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.21 -15.83 35.91 Favored Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 108.713 -1.755 . . . . 64.51 108.713 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.36 133.48 42.5 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 108.131 -1.063 . . . . 74.24 108.131 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.485 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.9 mt -99.27 128.08 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.522 -1.288 . . . . 71.35 107.522 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -138.25 159.58 41.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.793 -1.558 . . . . 72.21 106.793 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.86 152.12 22.3 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 105.172 -2.158 . . . . 74.43 105.172 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.712 HG22 HD21 ' A' ' 90' ' ' LEU . 11.5 m -131.79 142.75 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 N-CA-C 104.35 -2.463 . . . . 71.43 104.35 167.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -101.06 116.84 33.78 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 103.782 -2.673 . . . . 70.01 103.782 167.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.08 134.04 37.98 Favored 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.434 -1.691 . . . . 71.23 106.434 -172.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.44 148.59 25.49 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.831 -1.544 . . . . 51.5 106.831 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -75.1 -33.88 61.68 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.12 -1.807 . . . . 73.12 106.12 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.84 104.88 0.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.379 1.071 . . . . 71.13 108.164 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.66 37.59 19.06 Favored 'General case' 0 C--N 1.366 1.288 0 N-CA-C 107.85 -1.167 . . . . 75.42 107.85 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 47.75 2.41 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.36 1.864 . . . . 72.25 114.747 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -86.41 139.25 31.11 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 106.706 -1.591 . . . . 74.45 106.706 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.2 pt? -128.01 -144.66 0.29 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 104.675 -2.343 . . . . 72.32 104.675 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.21 74.66 0.63 Allowed Glycine 0 CA--C 1.467 -2.953 0 N-CA-C 105.056 -3.218 . . . . 54.1 105.056 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 22' ' ' CYS . 8.5 mm -103.57 177.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 101.584 -3.487 . . . . 74.41 101.584 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' H ' HG22 ' A' ' 21' ' ' ILE . 3.1 m -121.34 151.97 39.49 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 103.205 -2.887 . . . . 72.33 103.205 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -152.11 169.23 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 N-CA-C 106.828 -1.545 . . . . 71.3 106.828 -165.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -160.46 164.64 32.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 104.334 -2.469 . . . . 71.34 104.334 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.71 -162.74 26.74 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.083 -2.007 . . . . 73.05 108.083 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.3 -88.43 0.35 Allowed Glycine 0 C--N 1.356 1.686 0 N-CA-C 109.112 -1.595 . . . . 30.21 109.112 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 71' ' ' THR . 0.8 OUTLIER -71.88 18.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 123.134 0.574 . . . . 62.32 112.251 -167.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 85.98 7.05 0.36 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.313 -0.995 . . . . 65.44 108.313 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.7 p -45.51 -169.31 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.413 1.885 . . . . 53.45 112.466 167.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -49.92 -18.39 0.51 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.939 1.088 . . . . 72.51 113.939 -167.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 15.3 m -66.53 128.78 30.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.525 0 N-CA-C 107.868 -1.16 . . . . 70.33 107.868 172.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.36 -52.69 44.35 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.256 -0.902 . . . . 74.43 110.958 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.64 -20.37 59.92 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 119.543 -0.863 . . . . 73.35 110.174 -168.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.43 -6.86 55.83 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.804 -1.718 . . . . 74.34 108.804 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 179.26 53.38 Favored Glycine 0 CA--C 1.501 -0.833 0 N-CA-C 108.198 -1.961 . . . . 51.22 108.198 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 75' ' ' ALA . 8.8 mm -88.97 132.24 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.215 0 N-CA-C 104.535 -2.395 . . . . 65.34 104.535 174.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 3.8 m-30 -107.16 150.23 26.82 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 105.129 -2.174 . . . . 73.52 105.129 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.6 t -82.85 103.43 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.194 -1.78 . . . . 73.31 106.194 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -73.04 -34.56 66.38 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.13 -1.396 . . . . 74.11 108.751 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.76 151.06 8.82 Favored 'General case' 0 CA--C 1.46 -2.486 0 N-CA-C 104.598 -2.371 . . . . 73.04 104.598 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.36 131.58 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 102.975 -2.972 . . . . 74.53 102.975 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.77 146.63 83.34 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 106.332 -1.729 . . . . 70.24 106.332 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.9 172.03 16.92 Favored 'Trans proline' 0 CA--C 1.468 -2.794 0 N-CA-C 105.965 -2.36 . . . . 65.22 105.965 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 49.55 51.99 15.37 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.312 1.053 . . . . 71.51 109.743 164.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.47 34.41 Favored Glycine 0 CA--C 1.472 -2.612 1 N-CA-C 102.899 -4.08 . . . . 61.25 102.899 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -53.58 26.78 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-N 117.781 0.791 . . . . 72.04 109.734 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.5 -50.48 65.31 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.987 -0.097 . . . . 73.11 111.122 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -63.37 -55.36 25.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.664 0.385 . . . . 73.42 110.058 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.1 m -65.33 -30.23 71.05 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.694 -0.629 . . . . 71.54 110.75 -172.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.42 -35.56 54.04 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 105.914 -1.884 . . . . 72.41 105.914 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.8 30.2 59.98 Favored Glycine 0 CA--C 1.476 -2.398 0 CA-C-N 115.318 -0.855 . . . . 54.21 111.738 167.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -98.48 -47.85 5.23 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.387 -1.709 . . . . 74.35 106.387 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.07 148.06 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.53 0.681 . . . . 74.22 109.735 169.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -154.94 167.12 31.38 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 104.227 -2.509 . . . . 63.02 104.227 172.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -66.73 143.16 57.1 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.156 0.503 . . . . 74.35 109.86 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.94 -33.19 6.63 Favored Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 108.606 -1.797 . . . . 72.23 108.606 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -69.35 156.41 38.85 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 105.701 -1.963 . . . . 73.44 105.701 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -132.98 157.91 44.01 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.021 -1.103 . . . . 73.23 108.021 -168.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.26 135.27 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 106.177 -1.786 . . . . 52.54 106.177 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.485 ' CD1' HG23 ' A' ' 7' ' ' ILE . 15.2 mt -99.57 -58.67 1.87 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.638 -1.616 . . . . 74.21 106.638 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.48 149.97 50.76 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 105.76 -1.941 . . . . 62.33 105.76 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.54 121.47 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 N-CA-C 105.069 -2.197 . . . . 75.23 105.069 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.56 32.88 21.69 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 123.46 0.704 . . . . 52.15 109.278 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.81 -5.59 84.65 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 109.562 -1.415 . . . . 61.02 109.562 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.1 t -94.92 130.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 107.023 -1.473 . . . . 74.42 107.023 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -47.62 147.33 1.85 Allowed 'General case' 0 C--N 1.367 1.332 0 C-N-CA 123.907 0.883 . . . . 65.51 110.501 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.74 -25.18 0.42 Allowed 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.717 -1.586 . . . . 41.31 106.717 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.9 pm0 -56.3 127.19 29.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.603 -0.888 . . . . 63.4 108.603 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.8 -11.47 66.52 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.43 -1.468 . . . . 74.22 109.43 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 157.36 25.64 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 105.66 -1.978 . . . . 64.54 105.66 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 27' ' ' VAL . 29.2 p -87.64 179.49 6.51 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.146 -0.687 . . . . 63.41 109.146 -168.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.39 -51.34 69.16 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.638 -1.245 . . . . 72.12 107.638 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.72 -55.81 22.89 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 109.896 -0.409 . . . . 74.21 109.896 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -56.46 -42.38 78.1 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 122.169 -0.332 . . . . 60.41 110.623 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -51.16 -55.76 16.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 122.853 0.461 . . . . 72.44 110.311 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.5 m -74.72 -36.27 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 109.044 -0.724 . . . . 52.22 109.044 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -62.66 -34.66 77.55 Favored 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 106.055 -1.832 . . . . 72.34 106.055 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 82' ' ' THR . 28.7 m -71.83 -45.48 61.31 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 120.071 -1.643 . . . . 74.13 107.715 -175.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.46 -29.82 70.2 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.722 -0.473 . . . . 70.04 109.722 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -60.08 2.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.58 -1.637 . . . . 54.41 106.58 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -67.86 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.485 1.114 . . . . 64.23 112.219 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.422 HG21 HG13 ' A' ' 86' ' ' VAL . 19.3 p -101.81 -175.21 2.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.166 -1.79 . . . . 52.31 106.166 171.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.6 -150.89 26.95 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 107.694 -2.163 . . . . 74.32 107.694 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.61 -55.69 16.26 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.681 -0.859 . . . . 74.25 108.681 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.5 t -104.25 149.34 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 104.992 -2.225 . . . . 55.11 104.992 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 82' ' ' THR . 42.9 t -111.61 140.56 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.288 -1.745 . . . . 62.41 106.288 -174.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -110.62 130.8 55.48 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 103.657 -2.72 . . . . 62.33 103.657 167.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.97 132.49 12.1 Favored 'General case' 0 CA--C 1.456 -2.649 0 N-CA-C 106.786 -1.561 . . . . 64.42 106.786 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.65 136.01 36.14 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 106.82 -1.548 . . . . 44.34 106.82 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.68 159.45 17.13 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 103.968 -2.604 . . . . 74.51 103.968 174.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -120.37 134.1 55.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.77 -3.419 . . . . 74.25 101.77 167.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -62.89 138.18 58.47 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 107.945 -1.131 . . . . 72.03 107.945 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.32 -156.61 9.95 Favored Glycine 0 CA--C 1.471 -2.701 0 N-CA-C 106.459 -2.656 . . . . 71.1 106.459 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -144.11 166.65 24.4 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.535 -2.024 . . . . 53.34 105.535 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.0 m -98.17 124.37 47.52 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 105.375 -2.083 . . . . 71.1 105.375 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.95 112.71 3.18 Favored 'Trans proline' 0 CA--C 1.502 -1.081 0 C-N-CA 122.338 2.025 . . . . 72.02 108.431 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.576 1.965 0 O-C-N 124.969 1.418 . . . . 71.22 111.54 -179.862 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.444 0 N-CA-C 108.922 -1.671 . . . . 72.41 108.922 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.23 156.56 64.35 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 122.79 2.327 . . . . 62.55 108.133 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -85.54 165.5 35.26 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 107.027 -1.472 . . . . 53.44 107.027 -175.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.66 121.45 9.74 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.425 2.084 . . . . 74.43 110.147 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.73 11.99 69.89 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 109.328 -1.509 . . . . 74.54 109.328 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -80.84 143.33 32.86 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.037 -1.468 . . . . 61.41 107.037 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 60' ' ' LEU . 12.9 mm -98.19 132.79 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 105.879 -1.897 . . . . 71.43 105.879 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CD2' HD23 ' A' ' 90' ' ' LEU . 1.5 p90 -144.18 156.48 44.33 Favored 'General case' 0 CA--C 1.478 -1.803 0 C-N-CA 119.056 -1.057 . . . . 73.33 109.027 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' HD11 ' A' ' 89' ' ' LEU . 46.0 mt-10 -103.3 141.65 35.54 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 105.387 -2.079 . . . . 74.21 105.387 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.621 HG22 HD21 ' A' ' 90' ' ' LEU . 34.9 m -141.01 145.93 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 105.127 -2.175 . . . . 71.34 105.127 172.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -110.05 126.44 53.99 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.336 -2.098 . . . . 62.33 105.336 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 52' ' ' ARG . 58.1 mt -134.83 139.48 45.1 Favored 'General case' 0 CA--C 1.451 -2.836 0 N-CA-C 106.948 -1.501 . . . . 74.44 106.948 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.54 152.68 23.74 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.352 -2.092 . . . . 71.25 105.352 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -77.22 -28.58 53.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.221 -1.399 . . . . 62.45 107.221 172.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 81.38 104.93 0.06 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.442 1.097 . . . . 73.44 108.105 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 57.56 41.68 25.4 Favored 'General case' 0 C--N 1.366 1.293 0 N-CA-C 107.271 -1.381 . . . . 62.42 107.271 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 43.26 2.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 127.516 2.326 . . . . 65.01 115.504 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.0 m -100.23 114.69 28.32 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 120.34 1.427 . . . . 63.12 107.269 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.622 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -89.63 -173.18 3.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 104.697 -2.334 . . . . 72.44 104.697 169.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 40.95 0.04 OUTLIER Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 104.43 -3.468 . . . . 45.24 104.43 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.6 mt -98.09 174.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.479 -2.786 . . . . 75.34 103.479 -176.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.438 ' H ' HG22 ' A' ' 21' ' ' ILE . 34.4 t -138.86 156.39 47.34 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 104.738 -2.319 . . . . 71.12 104.738 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.65 173.29 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.617 0 N-CA-C 104.716 -2.327 . . . . 70.44 104.716 -167.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.4 t -162.09 167.12 24.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.446 -1.686 . . . . 73.04 106.446 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.87 -154.08 30.36 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 108.578 -1.809 . . . . 75.22 108.578 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.55 -82.38 0.34 Allowed Glycine 0 CA--C 1.474 -2.497 0 N-CA-C 108.849 -1.7 . . . . 65.5 108.849 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.48 16.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.497 0 C-N-CA 123.438 0.695 . . . . 51.51 112.199 -165.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 85.71 5.54 0.46 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.954 1.301 . . . . 73.13 108.345 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.5 p -49.29 -170.82 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.237 1.415 . . . . 74.41 111.352 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 m -30.19 -41.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 126.268 1.827 . . . . 74.51 115.359 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 14.7 m -57.28 120.0 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 122.348 1.07 . . . . 54.44 110.774 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -49.27 -64.33 0.84 Allowed 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.786 -1.097 . . . . 71.32 111.824 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -73.99 -19.85 60.52 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 120.209 -0.597 . . . . 73.24 110.112 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.36 60.19 1.57 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 109.754 -1.338 . . . . 53.11 109.754 170.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.73 -178.76 29.39 Favored Glycine 0 CA--C 1.466 -3.015 0 N-CA-C 103.184 -3.966 . . . . 73.13 103.184 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.94 133.67 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 103.973 -2.603 . . . . 74.1 103.973 175.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.443 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 9.2 m-85 -106.47 150.58 25.94 Favored 'General case' 0 CA--C 1.463 -2.367 0 N-CA-C 104.755 -2.313 . . . . 74.22 104.755 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.15 102.28 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.179 -1.786 . . . . 60.31 106.179 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -71.89 -35.2 69.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.495 -1.23 . . . . 75.21 109.67 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.86 144.08 19.98 Favored 'General case' 0 CA--C 1.464 -2.355 0 N-CA-C 105.841 -1.911 . . . . 51.21 105.841 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.99 127.62 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 103.409 -2.812 . . . . 63.13 103.409 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.426 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.23 147.03 63.82 Favored Pre-proline 0 CA--C 1.51 -0.577 0 N-CA-C 106.365 -1.717 . . . . 75.3 106.365 176.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 45' ' ' GLY . 65.5 Cg_endo -76.29 172.67 15.82 Favored 'Trans proline' 0 CA--C 1.473 -2.526 0 N-CA-C 106.063 -2.322 . . . . 73.41 106.063 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 70.35 -11.75 0.57 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 124.116 0.885 . . . . 64.55 111.132 167.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -91.19 178.91 42.09 Favored Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 107.198 -2.361 . . . . 71.13 107.198 -174.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.51 69.87 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.211 -1.033 . . . . 74.12 108.211 -174.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.54 63.61 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 116.056 -0.52 . . . . 61.21 110.41 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.08 -53.95 17.63 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.69 -0.485 . . . . 62.33 109.69 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -61.27 -34.89 75.92 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.118 0.567 . . . . 70.13 110.531 -169.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -90.39 -23.22 21.13 Favored 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.077 -1.453 . . . . 73.22 107.077 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.0 24.57 59.52 Favored Glycine 0 C--N 1.358 1.755 0 N-CA-C 110.5 -1.04 . . . . 72.22 110.5 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.522 ' HB2' HD11 ' A' ' 12' ' ' LEU . 23.4 mmt180 -96.33 6.45 48.77 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.264 -1.013 . . . . 73.33 108.264 -174.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.4 mt -142.34 146.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.172 -2.529 . . . . 75.1 104.172 -173.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -147.2 156.41 42.93 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 103.984 -2.599 . . . . 75.3 103.984 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -66.86 146.14 54.73 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.685 -1.228 . . . . 74.43 107.685 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.11 -30.71 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 108.221 -1.952 . . . . 72.13 108.221 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.25 153.93 39.61 Favored 'General case' 0 C--N 1.364 1.221 0 N-CA-C 107.896 -1.149 . . . . 74.43 107.896 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.8 ttp85 -112.56 138.43 49.34 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 105.967 -1.864 . . . . 75.31 105.967 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.67 126.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 105.089 -2.189 . . . . 64.34 105.089 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' CD1' HG23 ' A' ' 7' ' ' ILE . 16.3 mt -92.31 -58.71 2.29 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 107.841 -1.17 . . . . 55.14 107.841 -173.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.49 148.68 46.22 Favored 'General case' 0 CA--C 1.472 -2.03 0 N-CA-C 105.534 -2.024 . . . . 51.21 105.534 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -121.55 127.01 75.52 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.604 0 N-CA-C 104.665 -2.346 . . . . 52.21 104.665 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 t30 57.48 29.63 17.36 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.89 -0.781 . . . . 71.3 108.89 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.17 -20.04 52.38 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 108.887 -1.685 . . . . 64.31 108.887 173.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.27 123.29 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.917 0 N-CA-C 108.529 -0.915 . . . . 72.14 108.529 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.4 m -52.92 122.91 10.18 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 123.273 0.629 . . . . 72.12 109.924 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.79 -21.95 14.49 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.358 -1.349 . . . . 73.14 107.358 -171.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -65.65 129.04 38.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.39 -0.819 . . . . 64.02 109.467 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 -17.08 57.11 Favored Glycine 0 C--N 1.363 2.055 0 N-CA-C 108.614 -1.795 . . . . 70.03 108.614 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.796 ' HB1' ' CG ' ' A' ' 74' ' ' GLN . . . -79.67 154.78 28.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.495 -1.669 . . . . 72.44 106.495 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 p -82.74 176.43 9.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.528 0.68 . . . . 64.31 110.242 -165.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -62.79 -51.46 67.02 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.669 -1.234 . . . . 72.12 107.669 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -53.7 -56.16 19.82 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 122.406 0.283 . . . . 62.41 111.083 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.796 ' CG ' ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -60.57 -35.67 76.63 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 109.26 -0.644 . . . . 63.2 109.26 -171.024 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 74' ' ' GLN . . . -51.13 -48.83 61.68 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 123.144 0.577 . . . . 72.42 109.583 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.27 -40.35 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 108.296 -1.002 . . . . 74.55 108.296 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -54.9 -40.45 69.82 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.526 -1.657 . . . . 51.53 106.526 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.4 m -74.33 -36.73 63.67 Favored 'General case' 0 C--O 1.215 -0.762 0 O-C-N 120.564 -1.335 . . . . 51.45 109.207 -171.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 mt -71.2 -39.84 71.54 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.086 -0.709 . . . . 61.22 109.086 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -78.74 -60.59 2.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.816 -0.438 . . . . 74.43 109.816 -171.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -67.06 60.27 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.901 0.858 . . . . 74.05 110.928 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -127.41 -176.28 3.7 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.913 -1.514 . . . . 55.02 106.913 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.18 -149.44 20.58 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 107.159 -2.376 . . . . 65.25 107.159 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -67.08 -55.77 12.86 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.259 -0.645 . . . . 51.11 109.259 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.62 145.02 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 106.214 -1.773 . . . . 71.41 106.214 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.49 146.01 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 106.101 -1.814 . . . . 74.54 106.101 -171.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -106.79 128.91 54.65 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 105.919 -1.882 . . . . 70.34 105.919 173.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.07 125.49 19.0 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 105.831 -1.914 . . . . 63.13 105.831 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.416 HD11 ' HG2' ' A' ' 9' ' ' GLU . 3.1 mm? -80.08 138.36 36.95 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.834 -1.543 . . . . 74.02 106.834 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.621 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.05 154.24 24.5 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 104.974 -2.232 . . . . 73.12 104.974 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -120.75 134.0 55.31 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 101.2 -3.63 . . . . 70.14 101.2 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -61.76 128.06 34.43 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.997 -1.112 . . . . 71.33 107.997 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.25 13.0 67.56 Favored Glycine 0 CA--C 1.471 -2.702 0 N-CA-C 106.752 -2.539 . . . . 52.21 106.752 -173.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -55.05 -46.21 75.34 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.53 -1.655 . . . . 64.15 106.53 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.6 m -86.44 127.61 60.26 Favored Pre-proline 0 N--CA 1.427 -1.581 0 N-CA-C 105.746 -1.946 . . . . 65.1 105.746 170.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.9 -14.46 29.5 Favored 'Trans proline' 0 CA--C 1.485 -1.93 0 C-N-CA 122.611 2.207 . . . . 72.12 109.27 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.404 -2.737 0 N-CA-C 102.573 -3.121 . . . . 71.23 102.573 -179.453 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.544 0 N-CA-C 109.104 -1.598 . . . . 43.43 109.104 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.95 139.05 55.01 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.592 2.195 . . . . 75.33 108.804 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -96.43 169.53 8.78 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 103.543 -2.762 . . . . 60.51 103.543 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -58.31 115.61 2.66 Favored 'Trans proline' 0 CA--C 1.512 -0.592 0 C-N-CA 122.46 2.107 . . . . 74.13 109.032 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.05 -11.69 37.49 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.584 -1.406 . . . . 62.21 109.584 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.38 136.85 36.45 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 118.822 1.311 . . . . 75.33 107.724 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.525 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.9 mt -102.78 132.89 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.915 0 N-CA-C 107.249 -1.389 . . . . 74.21 107.249 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.497 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.7 p90 -140.83 157.18 45.76 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.673 -1.232 . . . . 74.35 107.673 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.84 146.06 29.2 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.46 -2.052 . . . . 70.15 105.46 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.644 HG22 HD21 ' A' ' 90' ' ' LEU . 31.3 m -140.7 148.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 N-CA-C 106.378 -1.712 . . . . 72.02 106.378 174.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -107.19 122.32 46.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.632 -1.988 . . . . 62.35 105.632 171.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.62 131.61 53.9 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 106.775 -1.565 . . . . 72.02 106.775 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.78 139.07 33.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 104.332 -2.47 . . . . 55.14 104.332 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -67.37 -34.54 77.52 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.354 -1.35 . . . . 74.45 107.354 175.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.7 t30 68.08 113.33 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.785 -0.82 . . . . 41.13 108.785 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.71 31.82 16.45 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.7 -1.222 . . . . 62.13 107.7 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 46.8 3.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 126.33 1.852 . . . . 72.13 114.117 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m -103.41 143.25 32.94 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.667 -1.235 . . . . 72.3 107.667 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.8 -143.75 0.35 Allowed 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.351 -2.833 . . . . 73.43 103.351 172.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.95 47.66 0.04 OUTLIER Glycine 0 CA--C 1.467 -2.954 0 N-CA-C 106.334 -2.706 . . . . 24.42 106.334 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mm -91.22 177.09 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 103.374 -2.825 . . . . 72.33 103.374 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.0 m -133.27 157.68 44.82 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.689 -2.708 . . . . 74.11 103.689 172.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 36' ' ' ILE . 4.2 m -148.3 171.47 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 106.588 -1.634 . . . . 65.11 106.588 -168.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.6 t -165.25 168.12 17.31 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.25 -2.13 . . . . 65.34 105.25 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -145.19 17.68 Favored Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 107.746 -2.141 . . . . 54.13 107.746 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.9 -85.51 0.42 Allowed Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.417 -1.473 . . . . 71.15 109.417 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.02 17.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.247 0 O-C-N 121.88 -0.777 . . . . 72.1 113.056 -166.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.7 t30 86.24 6.38 0.37 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.251 -1.018 . . . . 64.14 108.251 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -45.71 -168.98 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 126.497 1.919 . . . . 75.33 111.696 159.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 m -33.7 -39.54 0.06 Allowed 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.663 1.585 . . . . 64.31 114.836 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 20.2 m -77.27 139.96 17.86 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 O-C-N 121.184 -0.948 . . . . 63.11 108.934 -175.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -69.42 -52.29 28.25 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 122.031 -0.418 . . . . 74.31 111.854 -169.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -78.25 5.05 11.15 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.64 -0.663 . . . . 75.33 110.49 -169.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.6 7.36 14.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 111.228 -0.749 . . . . 64.11 111.228 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.28 178.93 50.69 Favored Glycine 0 CA--C 1.473 -2.583 0 N-CA-C 106.09 -2.804 . . . . 74.11 106.09 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.445 HG13 ' HB ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -88.9 136.65 22.9 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.4 0 N-CA-C 104.688 -2.338 . . . . 70.24 104.688 173.835 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.405 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 3.1 m-85 -109.81 146.58 34.79 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 102.991 -2.966 . . . . 72.34 102.991 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.75 103.29 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 107.085 -1.45 . . . . 64.52 107.085 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -71.18 -35.15 71.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.271 -1.331 . . . . 71.2 109.758 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.77 153.9 12.96 Favored 'General case' 0 CA--C 1.465 -2.309 0 N-CA-C 105.935 -1.876 . . . . 72.12 105.935 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.37 139.58 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 103.317 -2.845 . . . . 64.14 103.317 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.402 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -75.88 151.8 84.47 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 106.279 -1.748 . . . . 73.12 106.279 174.433 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.7 174.3 13.04 Favored 'Trans proline' 0 CA--C 1.468 -2.807 0 N-CA-C 105.449 -2.558 . . . . 61.42 105.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 49.26 52.01 15.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.74 0.781 . . . . 54.33 110.02 166.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.73 171.27 30.53 Favored Glycine 0 CA--C 1.461 -3.324 0 N-CA-C 103.184 -3.966 . . . . 23.1 103.184 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.92 -53.11 43.53 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 118.182 0.991 . . . . 72.23 108.847 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.6 63.52 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 116.898 -0.137 . . . . 71.33 111.28 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -69.86 -54.19 14.62 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.971 -0.381 . . . . 73.44 109.971 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.7 m -61.45 -30.59 70.69 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.983 -0.448 . . . . 70.11 110.777 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -81.35 -35.5 30.79 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.298 -1.742 . . . . 65.33 106.298 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.48 63.01 Favored Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 109.827 -1.309 . . . . 65.42 109.827 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -93.28 1.28 57.07 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.292 -1.374 . . . . 64.24 107.292 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.8 mt -144.64 139.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.157 -2.905 . . . . 73.03 103.157 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -143.9 162.46 36.06 Favored 'General case' 0 CA--C 1.459 -2.548 0 N-CA-C 106.054 -1.832 . . . . 72.13 106.054 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -67.19 137.58 56.33 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.195 -1.409 . . . . 62.31 107.195 170.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.38 -33.03 6.67 Favored Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 108.151 -1.98 . . . . 74.31 108.151 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.41 155.0 38.68 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.48 -1.674 . . . . 72.31 106.48 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.34 148.33 51.26 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.336 -1.357 . . . . 72.43 107.336 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.92 129.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.831 -1.914 . . . . 73.11 105.831 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.525 ' CD1' HG23 ' A' ' 7' ' ' ILE . 32.5 mt -93.79 -58.66 2.19 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 106.937 -1.505 . . . . 70.12 106.937 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.25 150.63 51.03 Favored 'General case' 0 CA--C 1.475 -1.923 0 N-CA-C 106.455 -1.683 . . . . 72.12 106.455 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.66 122.38 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 104.929 -2.248 . . . . 35.23 104.929 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 56.11 33.43 21.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.976 0.893 . . . . 55.01 108.875 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.41 -21.62 41.73 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 108.143 -1.983 . . . . 42.35 108.143 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.91 118.73 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.132 0 N-CA-C 107.873 -1.158 . . . . 55.14 107.873 -172.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -49.21 116.97 1.9 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.814 -0.81 . . . . 74.43 108.814 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.472 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -98.85 -19.59 17.31 Favored 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 105.936 -1.876 . . . . 74.11 105.936 -173.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.99 124.62 21.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.664 -0.865 . . . . 71.24 108.664 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.63 60.84 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.465 -1.854 . . . . 42.32 108.465 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.55 147.17 39.9 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.195 -1.78 . . . . 73.33 106.195 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.1 p -77.04 178.57 6.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.143 -1.058 . . . . 51.44 108.143 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -68.47 -46.96 68.34 Favored 'General case' 0 C--O 1.204 -1.314 0 N-CA-C 108.665 -0.865 . . . . 62.51 108.665 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.17 -54.39 45.79 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.366 -0.834 . . . . 74.31 110.518 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -57.92 -40.77 81.23 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 110.141 -0.318 . . . . 74.54 110.141 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.95 -52.15 52.26 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 122.604 0.362 . . . . 75.01 110.438 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -73.7 -39.72 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.621 -1.252 . . . . 72.43 107.621 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.0 t -57.14 -35.58 69.67 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 106.423 -1.695 . . . . 64.44 106.423 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.4 m -71.69 -43.82 65.3 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 120.388 -1.445 . . . . 71.43 107.829 -174.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.04 -39.35 94.48 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 109.069 -0.715 . . . . 72.04 109.069 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -68.28 -59.76 2.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.868 -1.16 . . . . 74.02 107.868 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.17 53.31 0.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.877 0.846 . . . . 75.25 110.723 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.435 HG21 HG13 ' A' ' 86' ' ' VAL . 7.0 p -103.74 -175.97 2.95 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 105.161 -2.162 . . . . 53.41 105.161 169.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.21 -148.85 16.93 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 107.225 -2.35 . . . . 75.23 107.225 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -66.61 -54.99 17.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.55 -0.907 . . . . 74.41 108.55 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.6 t -99.29 144.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.67 -1.604 . . . . 74.35 106.67 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.435 HG13 HG21 ' A' ' 82' ' ' THR . 58.0 t -100.69 129.3 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 105.459 -2.052 . . . . 61.54 105.459 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -113.33 128.26 56.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.723 -2.325 . . . . 64.01 104.723 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.05 138.31 12.58 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.406 -1.331 . . . . 63.41 107.406 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -81.76 139.58 34.75 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.617 -1.253 . . . . 64.21 107.617 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.644 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.76 159.05 17.5 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 104.174 -2.528 . . . . 73.14 104.174 175.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.79 131.25 53.96 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 100.542 -3.873 . . . . 74.44 100.542 161.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 95' ' ' SER . 1.5 tppp? -70.61 139.97 51.52 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 106.208 -1.775 . . . . 73.45 106.208 -174.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.42 2.15 0.11 Allowed Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 107.737 -2.145 . . . . 52.34 107.737 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -74.15 -54.57 7.49 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.509 -1.663 . . . . 74.31 106.509 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.472 ' H ' ' HD2' ' A' ' 92' ' ' LYS . 6.4 m -60.98 126.2 85.27 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 106.597 -1.631 . . . . 72.24 106.597 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.91 121.77 8.83 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.888 2.392 . . . . 73.14 109.407 -165.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.561 1.401 0 N-CA-C 107.343 -1.354 . . . . 62.44 107.343 176.55 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.44 ' H5 ' ' O2 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.349 0 N-CA-C 107.026 -2.43 . . . . 34.44 107.026 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.38 163.53 38.77 Favored 'Trans proline' 0 CA--C 1.496 -1.406 0 C-N-CA 122.437 2.091 . . . . 53.44 108.695 -170.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -116.28 162.29 27.06 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 104.965 -2.235 . . . . 74.0 104.965 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.4 131.87 43.13 Favored 'Trans proline' 0 CA--C 1.495 -1.47 0 C-N-CA 122.83 2.354 . . . . 72.33 108.928 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.62 -22.07 20.18 Favored Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 108.385 -1.886 . . . . 62.4 108.385 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.99 131.34 42.03 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.237 -1.394 . . . . 65.5 107.237 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.488 HG23 ' CD1' ' A' ' 60' ' ' LEU . 4.6 mt -94.8 136.31 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 N-CA-C 107.0 -1.482 . . . . 53.22 107.0 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.1 p90 -141.21 154.85 46.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.144 -1.428 . . . . 73.24 107.144 174.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -104.66 148.81 26.14 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 105.574 -2.01 . . . . 73.14 105.574 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.621 HG22 HD21 ' A' ' 90' ' ' LEU . 17.1 m -138.17 150.97 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 106.481 -1.674 . . . . 54.13 106.481 173.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -106.58 124.99 50.43 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 104.619 -2.363 . . . . 64.44 104.619 164.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.7 mt -139.46 137.42 35.56 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.599 -1.63 . . . . 64.23 106.599 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.48 161.18 17.15 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 106.416 -1.698 . . . . 55.51 106.416 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -43.68 63.03 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 105.919 -1.882 . . . . 44.43 105.919 168.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 70.13 117.35 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.325 1.05 . . . . 62.23 108.983 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 59.2 37.54 23.82 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-O 121.816 0.817 . . . . 50.0 109.021 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 55.1 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.253 1.821 . . . . 70.5 114.392 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.3 m -93.73 136.54 33.91 Favored 'General case' 0 CA--C 1.483 -1.606 0 O-C-N 120.51 -1.369 . . . . 63.32 108.759 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.01 -165.01 1.22 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.725 -3.065 . . . . 72.14 102.725 172.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.468 ' H ' HD13 ' A' ' 19' ' ' LEU . . . 163.43 23.6 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.328 0 C-N-CA 117.315 -2.374 . . . . 63.25 110.339 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.505 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -87.79 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 104.411 -2.44 . . . . 64.03 104.411 179.21 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 m -138.31 160.3 39.84 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.114 -2.18 . . . . 74.33 105.114 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 169.47 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.629 -0.878 . . . . 74.41 108.629 -163.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.2 t -160.41 165.45 31.08 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 104.805 -2.294 . . . . 70.45 104.805 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.18 -149.72 24.18 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 108.938 -1.665 . . . . 64.03 108.938 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' HA2' HG12 ' A' ' 36' ' ' ILE . . . 113.61 -75.85 0.24 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 109.46 -1.456 . . . . 75.5 109.46 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.39 15.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 O-C-N 122.579 -0.365 . . . . 62.52 110.953 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.8 t30 83.8 5.15 0.76 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.619 1.168 . . . . 74.54 108.15 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.1 p -47.44 -170.11 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.542 1.937 . . . . 72.23 113.623 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 m -40.94 -37.58 0.82 Allowed 'General case' 0 C--N 1.373 1.597 0 C-N-CA 125.969 1.707 . . . . 70.01 113.853 -165.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 132.07 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.537 0.684 . . . . 70.1 110.171 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ptt85 -44.53 -63.63 0.86 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-N 114.79 -1.095 . . . . 74.31 113.397 -168.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -77.78 -19.92 54.22 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 118.708 0.686 . . . . 73.3 109.229 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.42 -12.54 43.47 Favored Glycine 0 C--N 1.361 1.949 0 N-CA-C 109.916 -1.274 . . . . 53.21 109.916 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.17 179.94 49.62 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 109.855 -1.298 . . . . 64.02 109.855 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.514 HG13 ' CD1' ' A' ' 67' ' ' LEU . 2.8 mm -86.53 127.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 102.05 -3.315 . . . . 64.51 102.05 170.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -104.9 155.59 18.79 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 105.426 -2.065 . . . . 74.13 105.426 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -83.5 102.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 105.675 -1.972 . . . . 70.41 105.675 174.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.83 -31.28 66.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.497 -1.228 . . . . 74.14 110.163 -172.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.48 149.95 17.45 Favored 'General case' 0 CA--C 1.463 -2.387 0 N-CA-C 105.849 -1.908 . . . . 45.13 105.849 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.0 t -127.4 134.96 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 104.512 -2.403 . . . . 73.21 104.512 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -81.97 151.43 67.1 Favored Pre-proline 0 N--CA 1.445 -0.695 0 N-CA-C 106.669 -1.604 . . . . 72.43 106.669 176.353 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.45 -179.14 5.01 Favored 'Trans proline' 0 CA--C 1.479 -2.274 0 N-CA-C 105.928 -2.374 . . . . 72.25 105.928 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 49.43 52.24 14.86 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.023 0.827 . . . . 72.51 110.641 162.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.59 32.85 Favored Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 103.41 -3.876 . . . . 75.14 103.41 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.36 53.54 Favored 'General case' 0 C--O 1.205 -1.263 0 CA-C-N 117.632 0.716 . . . . 72.13 109.173 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.91 -50.26 64.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.547 -0.297 . . . . 32.13 110.99 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -68.79 -50.15 52.66 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.958 -0.464 . . . . 71.51 110.016 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.7 t -63.81 -33.69 76.25 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.754 -0.461 . . . . 71.32 109.754 -171.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -79.17 -32.0 44.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.074 -1.824 . . . . 70.12 106.074 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.29 60.98 Favored Glycine 0 C--N 1.359 1.818 0 N-CA-C 110.327 -1.109 . . . . 75.21 110.327 170.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -101.87 8.26 41.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.94 -1.133 . . . . 63.13 107.94 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.0 mt -144.27 145.75 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.009 -2.219 . . . . 64.32 105.009 -171.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -154.12 159.69 41.58 Favored 'General case' 0 N--CA 1.401 -2.911 0 N-CA-C 102.815 -3.031 . . . . 62.44 102.815 172.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -66.5 147.0 53.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.57 -0.9 . . . . 72.31 108.57 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.54 -33.26 6.7 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 109.975 -1.25 . . . . 62.22 109.975 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -69.75 155.95 39.76 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 105.32 -2.104 . . . . 62.34 105.32 172.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -132.66 157.89 43.69 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.633 -0.877 . . . . 73.14 108.633 -169.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.83 140.82 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 106.723 -1.584 . . . . 71.41 106.723 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.488 ' CD1' HG23 ' A' ' 7' ' ' ILE . 10.3 mt -101.11 -59.48 1.69 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.36 -1.718 . . . . 73.34 106.36 174.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.13 151.31 49.64 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 106.487 -1.672 . . . . 63.51 106.487 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.78 123.5 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.336 -2.098 . . . . 73.02 105.336 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.4 t30 50.99 35.35 12.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.874 1.27 . . . . 75.55 110.854 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.58 -22.04 38.75 Favored Glycine 0 CA--C 1.473 -2.566 0 N-CA-C 108.856 -1.698 . . . . 73.43 108.856 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.64 115.78 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 N-CA-C 108.095 -1.076 . . . . 72.42 108.095 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.0 m -54.12 112.92 1.06 Allowed 'General case' 0 C--N 1.371 1.537 0 N-CA-C 107.6 -1.259 . . . . 72.2 107.6 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 36' ' ' ILE . 1.1 tm? -104.44 -11.79 16.87 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 106.882 -1.525 . . . . 75.34 106.882 -162.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -60.16 129.2 40.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.62 -0.881 . . . . 65.22 108.62 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.91 -14.5 65.16 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.64 -1.784 . . . . 74.42 108.64 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.6 150.91 27.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.399 -1.704 . . . . 73.22 106.399 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -83.58 178.84 7.81 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.795 -0.446 . . . . 70.22 109.795 -167.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -56.21 -52.0 66.01 Favored 'General case' 0 C--N 1.382 2.007 0 N-CA-C 107.093 -1.447 . . . . 62.53 107.093 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -58.72 -48.51 80.91 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 116.538 -0.301 . . . . 45.14 110.764 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -56.64 -42.71 79.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.7 -0.4 . . . . 65.4 110.543 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -52.06 -51.4 57.81 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 120.727 -0.389 . . . . 73.04 110.657 177.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.26 -39.98 49.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 C-N-CA 119.932 -0.707 . . . . 75.03 109.831 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.67 -33.25 74.67 Favored 'General case' 0 N--CA 1.521 3.077 0 N-CA-C 106.131 -1.803 . . . . 74.45 106.131 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 m -71.31 -42.93 68.0 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 120.242 -1.536 . . . . 60.41 108.209 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.5 mt -69.49 -35.26 75.39 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.409 -0.589 . . . . 60.44 109.409 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -61.86 1.61 Allowed 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.556 -1.276 . . . . 61.54 107.556 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -73.07 58.46 0.49 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.409 0.623 . . . . 74.34 110.67 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 86' ' ' VAL . 3.2 p -102.68 -175.79 2.92 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.323 -1.362 . . . . 62.15 107.323 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.01 -154.28 30.35 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 106.224 -2.75 . . . . 64.24 106.224 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.61 -53.98 50.88 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.829 -0.434 . . . . 72.41 109.829 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.0 t -110.57 154.09 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 105.729 -1.952 . . . . 70.11 105.729 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 82' ' ' THR . 21.8 t -107.47 139.04 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.441 0 N-CA-C 105.912 -1.884 . . . . 62.23 105.912 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.87 123.99 49.42 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 104.418 -2.438 . . . . 65.34 104.418 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.8 133.31 11.97 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.052 -1.092 . . . . 53.14 108.052 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -84.86 144.34 28.47 Favored 'General case' 0 CA--C 1.474 -1.98 0 N-CA-C 108.832 -0.803 . . . . 74.22 108.832 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.621 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.79 162.71 17.65 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 104.711 -2.329 . . . . 63.14 104.711 175.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -124.39 137.38 54.47 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.233 -3.247 . . . . 71.32 102.233 165.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.8 145.75 54.2 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.006 -0.739 . . . . 64.3 109.006 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.94 -150.7 7.4 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 105.427 -3.069 . . . . 74.01 105.427 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 77.94 147.15 0.09 Allowed 'General case' 0 C--N 1.361 1.079 0 C-N-CA 124.343 1.057 . . . . 74.24 108.149 -173.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.3 m -68.15 127.56 93.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 108.173 -1.047 . . . . 64.43 108.173 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.23 151.91 76.37 Favored 'Trans proline' 0 CA--C 1.5 -1.224 0 C-N-CA 122.743 2.295 . . . . 73.23 110.94 -172.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.421 -1.902 0 N-CA-C 105.247 -2.131 . . . . 70.2 105.247 172.906 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.412 ' H15' ' O19' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.906 0 N-CA-C 108.03 -2.028 . . . . 73.43 108.03 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.49 151.67 84.64 Favored 'Trans proline' 0 CA--C 1.502 -1.104 0 C-N-CA 122.663 2.242 . . . . 72.53 108.207 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -82.58 166.5 35.87 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 106.192 -1.781 . . . . 64.41 106.192 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.98 123.23 11.58 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.444 2.096 . . . . 73.25 107.688 172.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.62 8.59 76.71 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.569 -1.413 . . . . 64.31 109.569 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.86 145.52 26.55 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 106.604 -1.628 . . . . 71.53 106.604 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.436 HG23 ' CD1' ' A' ' 60' ' ' LEU . 12.2 mt -101.53 139.02 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.986 0 N-CA-C 108.083 -1.08 . . . . 75.35 108.083 -175.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.541 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.5 p90 -144.67 162.27 37.1 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.012 -1.477 . . . . 75.03 107.012 171.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.59 150.38 24.02 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.003 -1.851 . . . . 74.34 106.003 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.624 HG22 HD21 ' A' ' 90' ' ' LEU . 15.7 m -132.89 140.27 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.543 0 N-CA-C 105.178 -2.156 . . . . 72.14 105.178 168.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.38 116.4 31.88 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.65 -2.352 . . . . 65.23 104.65 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 12' ' ' LEU . 8.1 mt -138.46 138.24 37.94 Favored 'General case' 0 CA--C 1.454 -2.726 0 N-CA-C 107.615 -1.254 . . . . 73.4 107.615 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . . . -89.1 159.58 17.47 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 105.746 -1.946 . . . . 74.22 105.746 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.85 -50.69 71.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.879 -1.526 . . . . 74.21 106.879 171.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 t30 74.62 119.24 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.446 -1.252 . . . . 72.41 107.954 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 57.16 34.48 24.9 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.734 0.814 . . . . 75.5 109.445 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.1 t30 54.61 -5.11 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.746 1.618 . . . . 54.12 113.679 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 m -95.66 136.99 35.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.894 -0.78 . . . . 73.54 108.894 -171.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -149.95 0.45 Allowed 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 103.008 -2.96 . . . . 63.42 103.008 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.12 76.17 0.86 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 106.542 -2.623 . . . . 73.43 106.542 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.3 mm -102.02 176.74 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 102.531 -3.137 . . . . 74.31 102.531 176.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.403 ' H ' HG22 ' A' ' 21' ' ' ILE . 7.0 m -106.11 152.71 23.06 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 103.843 -2.651 . . . . 55.24 103.843 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.35 165.0 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.98 -1.119 . . . . 64.44 107.98 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.9 t -160.2 165.96 30.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.683 -2.339 . . . . 74.15 104.683 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.7 -141.25 20.94 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 107.292 -2.323 . . . . 73.5 107.292 179.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.51 -84.11 0.38 Allowed Glycine 0 CA--C 1.471 -2.664 0 N-CA-C 108.437 -1.865 . . . . 53.31 108.437 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -69.06 8.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.041 0 N-CA-C 112.396 0.517 . . . . 65.31 112.396 -166.79 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 68.66 68.08 0.3 Allowed 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 106.71 -1.589 . . . . 72.14 106.71 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 p -107.04 -164.66 1.0 Allowed 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 101.956 -3.35 . . . . 63.32 101.956 -172.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -44.84 -18.43 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.152 0.981 . . . . 73.15 113.152 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.67 150.85 8.49 Favored 'Isoleucine or valine' 0 C--N 1.38 1.934 0 N-CA-C 106.06 -1.83 . . . . 74.34 106.06 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -78.77 -72.17 0.4 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 120.403 -1.436 . . . . 61.51 110.121 -169.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -69.9 -21.55 63.3 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 120.29 -0.564 . . . . 61.12 110.944 -160.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.27 59.99 1.7 Allowed Glycine 0 CA--C 1.484 -1.897 0 C-N-CA 119.554 -1.307 . . . . 74.15 110.168 164.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.18 179.41 20.73 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 104.643 -3.383 . . . . 70.32 104.643 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 36' ' ' ILE . 8.1 mm -82.17 127.91 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.428 0 N-CA-C 103.356 -2.831 . . . . 65.31 103.356 169.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -106.1 150.93 25.32 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 105.045 -2.206 . . . . 73.22 105.045 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -83.9 102.03 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.053 -1.832 . . . . 73.41 106.053 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.47 -25.97 63.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.054 -1.43 . . . . 53.03 109.861 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -173.62 161.38 3.95 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 104.642 -2.355 . . . . 71.12 104.642 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -116.88 132.57 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 103.134 -2.913 . . . . 54.02 103.134 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.412 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -82.35 151.0 65.1 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.964 -1.865 . . . . 63.54 105.964 175.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.95 177.47 8.76 Favored 'Trans proline' 0 CA--C 1.482 -2.084 0 N-CA-C 106.587 -2.12 . . . . 64.15 106.587 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 53.96 53.47 11.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.031 0.832 . . . . 73.04 109.157 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.55 166.89 33.43 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 105.447 -3.061 . . . . 55.45 105.447 -176.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.6 -50.74 70.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.508 -0.923 . . . . 51.25 108.508 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.97 66.04 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.857 -0.61 . . . . 72.44 110.688 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -65.85 -53.72 36.12 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.71 -0.478 . . . . 73.21 109.71 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -56.95 -29.12 62.87 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 122.226 -0.296 . . . . 75.11 111.271 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.55 -28.39 20.79 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.867 -1.16 . . . . 74.4 107.867 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.0 19.9 74.16 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.77 -0.932 . . . . 54.41 110.77 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HB3' HG11 ' A' ' 10' ' ' VAL . 85.0 mtt-85 -104.55 7.1 35.11 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 117.753 0.777 . . . . 64.42 108.94 -176.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.5 mp -127.56 136.57 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.183 -3.266 . . . . 71.5 102.183 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -145.34 162.72 36.56 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 106.118 -1.808 . . . . 72.42 106.118 -177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -66.6 136.78 56.11 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.274 -1.01 . . . . 75.34 108.274 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.31 -29.25 12.31 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 108.338 -1.905 . . . . 51.03 108.338 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.92 155.03 41.0 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 106.91 -1.515 . . . . 72.33 106.91 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -124.76 153.81 41.87 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.216 -1.031 . . . . 74.02 108.216 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -92.59 132.32 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 N-CA-C 105.739 -1.949 . . . . 74.45 105.739 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.436 ' CD1' HG23 ' A' ' 7' ' ' ILE . 11.5 mt -95.36 -59.41 1.89 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.942 -1.503 . . . . 74.23 106.942 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.69 51.37 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.788 -1.56 . . . . 34.54 106.788 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.52 131.07 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 104.722 -2.325 . . . . 62.11 104.722 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 56.23 29.94 15.74 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 122.009 0.909 . . . . 75.43 109.489 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.39 -9.07 76.89 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.573 -1.811 . . . . 50.1 108.573 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.9 t -87.9 115.6 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 N-CA-C 106.507 -1.664 . . . . 72.11 106.507 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.46 119.82 5.76 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 107.898 -1.149 . . . . 61.13 107.898 172.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -108.97 -15.17 14.42 Favored 'General case' 0 C--O 1.2 -1.541 0 N-CA-C 107.262 -1.385 . . . . 54.11 107.262 -163.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.43 122.33 13.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.505 -0.924 . . . . 73.4 108.505 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.78 -16.63 57.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 108.635 -1.786 . . . . 60.42 108.635 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.39 151.45 29.37 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.606 -1.627 . . . . 75.31 106.606 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.547 ' HA ' HG22 ' A' ' 27' ' ' VAL . 68.6 p -79.96 179.78 7.41 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.202 0.525 . . . . 65.12 109.745 -170.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.5 m170 -59.66 -51.31 70.35 Favored 'General case' 0 C--N 1.371 1.511 0 N-CA-C 107.589 -1.263 . . . . 62.32 107.589 176.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -55.7 -55.08 36.39 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 109.988 -0.375 . . . . 65.14 109.988 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -53.86 -43.95 69.97 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.775 -0.454 . . . . 63.51 109.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -50.78 -54.49 23.11 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 122.663 0.385 . . . . 34.04 110.369 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 m -74.22 -37.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 C-N-CA 120.506 -0.478 . . . . 71.21 109.778 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 82.9 m -62.71 -32.23 73.29 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.305 -1.739 . . . . 73.01 106.305 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -73.62 -40.69 63.6 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.357 -1.464 . . . . 71.15 108.195 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.5 -28.4 69.81 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.242 -0.651 . . . . 74.22 109.242 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -58.04 3.34 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 107.775 -1.194 . . . . 75.42 107.775 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -68.58 43.32 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 124.781 1.232 . . . . 55.54 112.212 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.452 ' CG2' HG22 ' A' ' 86' ' ' VAL . 1.4 t -123.82 -174.61 3.02 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 102.942 -2.985 . . . . 72.1 102.942 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.34 -145.16 18.3 Favored Glycine 0 CA--C 1.49 -1.48 0 N-CA-C 107.7 -2.16 . . . . 53.34 107.7 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.78 -55.49 16.93 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.46 -0.941 . . . . 62.04 108.46 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' ALA . 94.9 t -107.16 142.5 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 106.04 -1.837 . . . . 55.03 106.04 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.452 HG22 ' CG2' ' A' ' 82' ' ' THR . 45.8 t -115.08 144.82 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 105.634 -1.987 . . . . 62.44 105.634 -172.087 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.38 122.1 45.27 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 104.698 -2.334 . . . . 71.33 104.698 168.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -136.49 118.29 15.12 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.182 -2.155 . . . . 73.23 105.182 177.142 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.5 mp -83.94 143.62 29.71 Favored 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 106.624 -1.621 . . . . 73.13 106.624 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.624 HD21 HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -112.34 156.23 22.8 Favored 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.96 -2.237 . . . . 43.32 104.96 -179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -123.54 135.44 54.01 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 101.08 -3.674 . . . . 71.22 101.08 162.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.29 137.11 58.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.618 -1.252 . . . . 73.13 107.618 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.23 172.32 17.23 Favored Glycine 0 CA--C 1.464 -3.125 0 N-CA-C 110.233 -1.147 . . . . 64.52 110.233 -168.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -79.57 137.03 37.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 105.265 -2.124 . . . . 73.25 105.265 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.3 m -55.39 122.23 42.66 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.686 -1.227 . . . . 72.35 107.686 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.22 161.96 40.6 Favored 'Trans proline' 0 CA--C 1.491 -1.657 0 C-N-CA 122.599 2.199 . . . . 75.31 109.237 -165.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.406 -2.673 0 N-CA-C 103.589 -2.745 . . . . 72.51 103.589 172.982 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' 33B . . . . . 0.436 ' H5 ' ' O2 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.983 0 N-CA-C 108.487 -1.845 . . . . 54.109999999999999 108.487 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -89.86 143.44 26.79 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.273 -1.751 . . . . 62.340000000000003 106.273 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.53 HG23 ' CD1' ' A' ' 60' ' ' LEU . 19.1 mm -95.95 129.51 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 105.524 -2.028 . . . . 73.099999999999994 105.524 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.621 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.2 p90 -137.07 152.41 50.03 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.81 -1.181 . . . . 73.349999999999994 107.81 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -106.53 146.34 30.74 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.044 -1.836 . . . . 72.540000000000006 106.044 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.722 HG22 HD21 ' A' ' 90' ' ' LEU . 30.1 m -142.26 152.66 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 105.958 -1.867 . . . . 50.32 105.958 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.85 132.04 56.04 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.381 -1.711 . . . . 73.319999999999993 106.381 172.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.03 139.13 49.9 Favored 'General case' 0 CA--C 1.457 -2.626 0 N-CA-C 106.833 -1.543 . . . . 43.229999999999997 106.833 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.49 131.36 38.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.927 -1.879 . . . . 73.010000000000005 105.927 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -67.28 -23.91 65.72 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.637 -0.875 . . . . 71.010000000000005 108.637 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 70.71 104.86 0.06 Allowed 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.171 0.988 . . . . 55.43 110.394 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 56.85 43.47 24.87 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-N 115.448 -0.796 . . . . 72.109999999999999 109.203 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 42.64 9.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.708 2.003 . . . . 73.230000000000004 116.031 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.1 m -126.88 129.78 48.89 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 106.437 -1.69 . . . . 52.009999999999998 106.437 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.3 167.34 12.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.836 -2.283 . . . . 55.140000000000001 104.836 168.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.56 68.62 0.27 Allowed Glycine 0 CA--C 1.47 -2.746 0 N-CA-C 104.507 -3.437 . . . . 72.219999999999999 104.507 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.4 mt -101.15 176.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.458 -2.793 . . . . 73.319999999999993 103.458 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.513 ' H ' HG22 ' A' ' 21' ' ' ILE . 70.9 m -138.28 165.07 27.65 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 106.402 -1.703 . . . . 73.129999999999995 106.402 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 m -152.33 177.15 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.085 -1.82 . . . . 43.240000000000002 106.085 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.471 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 10.0 t -160.95 166.21 28.71 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 104.0 -2.593 . . . . 62.149999999999999 104.0 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.97 -151.74 29.12 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.927 -1.669 . . . . 50.5 108.927 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.444 ' CA ' HD12 ' A' ' 36' ' ' ILE . . . 116.62 -70.64 0.28 Allowed Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.692 -1.363 . . . . 44.340000000000003 109.692 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 71' ' ' THR . 1.4 t -72.32 16.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.097 0.475 . . . . 61.329999999999998 111.252 -172.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 26' ' ' GLY . 35.7 t30 78.41 5.14 2.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.597 1.159 . . . . 73.409999999999997 108.743 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.3 t -49.77 -171.36 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 C-N-CA 125.337 1.455 . . . . 62.329999999999998 112.037 169.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.4 p -38.56 -38.22 0.37 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.63 1.972 . . . . 73.409999999999997 115.164 -164.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.7 m -59.71 140.77 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.544 0.688 . . . . 74.099999999999994 110.215 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -41.62 -70.28 0.11 Allowed 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.029 1.332 . . . . 74.109999999999999 112.824 -170.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -87.97 15.74 6.87 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.632 -0.877 . . . . 62.399999999999999 108.632 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.43 -7.98 2.42 Favored Glycine 0 C--N 1.359 1.842 0 O-C-N 121.792 -0.567 . . . . 71.409999999999997 113.149 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.11 -178.64 49.44 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.656 -1.378 . . . . 64.310000000000002 109.656 -170.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.444 HD12 ' CA ' ' A' ' 26' ' ' GLY . 1.1 mp -76.96 128.3 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 N-CA-C 101.922 -3.362 . . . . 42.130000000000003 101.922 170.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -107.08 147.56 29.85 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 104.089 -2.56 . . . . 72.25 104.089 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.47 102.22 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.724 -1.584 . . . . 60.299999999999997 106.724 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.471 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -72.82 -37.59 67.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.831 -1.531 . . . . 64.299999999999997 110.441 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.21 142.34 18.21 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 105.952 -1.87 . . . . 61.420000000000002 105.952 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -117.16 131.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 102.96 -2.978 . . . . 75.120000000000005 102.96 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.27 144.58 84.56 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 106.482 -1.673 . . . . 70.219999999999999 106.482 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.43 169.55 22.17 Favored 'Trans proline' 0 CA--C 1.462 -3.088 0 N-CA-C 105.07 -2.704 . . . . 62.520000000000003 105.07 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 66.51 -3.94 0.79 Allowed 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 124.04 0.837 . . . . 73.129999999999995 111.317 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.48 -179.2 40.97 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 108.122 -1.991 . . . . 71.420000000000002 108.122 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -51.74 63.09 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.118 -1.068 . . . . 72.319999999999993 108.118 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.97 65.18 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.277 -0.42 . . . . 50.539999999999999 110.882 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.61 -55.87 15.29 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.174 -0.328 . . . . 71.519999999999996 110.285 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.5 m -65.02 -31.24 72.37 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 122.056 -0.402 . . . . 64.140000000000001 111.256 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -81.3 -32.59 33.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.494 -1.669 . . . . 72.510000000000005 106.494 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.44 18.04 69.72 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 110.552 -1.019 . . . . 71.25 110.552 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -86.48 2.46 47.8 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.854 -1.165 . . . . 60.119999999999997 107.854 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -147.42 147.46 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 104.449 -2.426 . . . . 72.340000000000003 104.449 -168.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.97 167.11 30.87 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 104.186 -2.524 . . . . 74.319999999999993 104.186 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -66.3 145.41 55.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.121 -1.066 . . . . 55.399999999999999 108.121 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.7 -33.08 6.86 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 108.988 -1.645 . . . . 74.120000000000005 108.988 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.38 161.38 31.15 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 108.004 -1.11 . . . . 74.430000000000007 108.004 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.07 150.66 48.0 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 107.997 -1.112 . . . . 74.420000000000002 107.997 -172.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.01 139.24 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 105.705 -1.961 . . . . 61.119999999999997 105.705 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.53 ' CD1' HG23 ' A' ' 7' ' ' ILE . 16.3 mt -102.18 -59.49 1.69 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.992 -1.484 . . . . 74.439999999999998 106.992 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.55 150.4 50.74 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.199 -1.778 . . . . 61.539999999999999 106.199 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.44 120.33 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 105.015 -2.217 . . . . 75.109999999999999 105.015 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.4 t30 51.79 36.0 16.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.027 0.931 . . . . 75.439999999999998 109.979 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.34 -29.41 12.56 Favored Glycine 0 CA--C 1.474 -2.509 0 N-CA-C 108.134 -1.987 . . . . 44.140000000000001 108.134 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.69 115.32 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 108.383 -0.969 . . . . 72.230000000000004 108.383 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.9 m -55.4 115.54 2.35 Favored 'General case' 0 C--N 1.37 1.486 0 N-CA-C 107.193 -1.41 . . . . 43.299999999999997 107.193 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -101.33 -15.29 17.29 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 106.427 -1.694 . . . . 71.409999999999997 106.427 -165.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.09 128.77 37.37 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.498 -0.927 . . . . 75.219999999999999 108.498 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.98 57.78 Favored Glycine 0 CA--C 1.498 -0.977 0 N-CA-C 107.815 -2.114 . . . . 54.109999999999999 107.815 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.88 152.2 28.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.554 -2.017 . . . . 75.430000000000007 105.554 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.422 HG22 HG22 ' A' ' 27' ' ' VAL . 31.1 p -79.16 176.32 9.78 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.094 -0.706 . . . . 73.409999999999997 109.094 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -70.34 -41.14 73.58 Favored 'General case' 0 C--O 1.21 -1.002 0 N-CA-C 108.726 -0.842 . . . . 75.430000000000007 108.726 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.67 -54.41 47.34 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.075 -1.015 . . . . 73.120000000000005 110.644 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -55.85 -34.96 65.91 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.441 -0.787 . . . . 64.510000000000005 111.294 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.41 ' CB ' HG12 ' A' ' 36' ' ' ILE . . . -50.72 -52.33 41.33 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.579 0.228 . . . . 73.019999999999996 111.282 176.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -74.95 -35.03 34.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 N-CA-C 108.276 -1.009 . . . . 74.5 108.276 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.41 -39.76 73.56 Favored 'General case' 0 N--CA 1.518 2.973 0 N-CA-C 105.775 -1.935 . . . . 72.030000000000001 105.775 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.2 m -69.3 -40.15 77.86 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.294 -1.503 . . . . 75.230000000000004 108.125 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.6 mt -64.71 -30.11 71.11 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.788 -0.449 . . . . 73.319999999999993 109.788 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -72.15 -57.67 4.06 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.529 -0.915 . . . . 74.349999999999994 108.529 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -69.14 48.11 0.07 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 122.918 0.487 . . . . 72.510000000000005 111.978 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.417 HG21 HG13 ' A' ' 86' ' ' VAL . 23.3 p -108.05 -175.58 2.82 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.21 -1.774 . . . . 72.340000000000003 106.21 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.06 -153.6 30.33 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 106.471 -2.652 . . . . 65.329999999999998 106.471 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.95 -54.86 20.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.75 -0.833 . . . . 73.129999999999995 108.75 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.9 t -95.07 142.74 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.335 -2.098 . . . . 75.439999999999998 105.335 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.417 HG13 HG21 ' A' ' 82' ' ' THR . 48.1 t -102.56 128.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 105.123 -2.177 . . . . 62.049999999999997 105.123 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -107.29 125.62 51.39 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 103.527 -2.768 . . . . 72.310000000000002 103.527 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.22 136.36 11.85 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.169 -1.048 . . . . 72.310000000000002 108.169 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.4 ' HB3' HD12 ' A' ' 60' ' ' LEU . 5.7 mp -86.43 143.05 27.98 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 108.283 -1.006 . . . . 74.109999999999999 108.283 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.722 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -120.32 165.42 14.89 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 104.878 -2.267 . . . . 72.5 104.878 177.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.48 145.79 51.44 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 102.608 -3.108 . . . . 72.239999999999995 102.608 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -64.82 131.11 45.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.839 -1.171 . . . . 72.430000000000007 107.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.479 -2.196 0 N-CA-C 106.892 -2.483 . . . . 72.349999999999994 106.892 -174.258 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.034 0 N-CA-C 108.511 -1.836 . . . . 71.239999999999995 108.511 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.66 135.07 40.44 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.817 -1.549 . . . . 62.329999999999998 106.817 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 60' ' ' LEU . 22.4 mm -98.8 130.07 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 106.1 -1.815 . . . . 74.329999999999998 106.1 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.612 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -141.91 153.77 44.62 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.054 -1.091 . . . . 71.329999999999998 108.054 -177.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -107.81 144.09 35.46 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 105.07 -2.196 . . . . 65.019999999999996 105.07 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.698 HG22 HD21 ' A' ' 90' ' ' LEU . 27.6 m -141.6 153.71 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 107.068 -1.456 . . . . 64.239999999999995 107.068 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HB2' HG11 ' A' ' 85' ' ' VAL . 7.4 pt-20 -112.08 130.71 55.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.892 -1.892 . . . . 64.239999999999995 105.892 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.17 134.1 39.79 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.865 -1.532 . . . . 75.219999999999999 106.865 -176.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 141.81 30.0 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 105.379 -2.082 . . . . 72.420000000000002 105.379 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HG2' HD23 ' A' ' 19' ' ' LEU . 42.3 mtpt -75.41 -31.83 60.53 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.178 -1.045 . . . . 73.400000000000006 108.178 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 68.4 110.59 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.122 -0.696 . . . . 74.310000000000002 109.122 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t70 58.3 32.15 21.72 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 107.992 -1.114 . . . . 73.329999999999998 107.992 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 43.13 19.04 0.01 OUTLIER 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.722 1.609 . . . . 62.310000000000002 113.324 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -90.56 119.36 30.75 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 106.215 -1.772 . . . . 65.530000000000001 106.215 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' H ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -111.6 -143.64 0.39 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 102.911 -2.996 . . . . 63.130000000000003 102.911 179.068 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.742 ' H ' HD13 ' A' ' 19' ' ' LEU . . . 103.36 66.25 0.73 Allowed Glycine 0 CA--C 1.474 -2.482 0 N-CA-C 106.855 -2.498 . . . . 74.239999999999995 106.855 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.6 mm -89.43 177.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 102.447 -3.168 . . . . 55.310000000000002 102.447 170.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.442 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.6 m -122.5 154.49 37.78 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.037 -2.579 . . . . 61.43 104.037 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.464 ' HA ' ' H ' ' A' ' 39' ' ' LYS . 30.9 m -149.25 176.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.424 -1.324 . . . . 61.299999999999997 107.424 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.15 -2.167 . . . . 71.310000000000002 105.15 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.53 -158.75 25.54 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 108.454 -1.858 . . . . 45.130000000000003 108.454 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.29 -95.06 0.3 Allowed Glycine 0 C--N 1.36 1.863 0 N-CA-C 109.08 -1.608 . . . . 63.439999999999998 109.08 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -68.31 17.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.433 1.093 . . . . 63.43 113.782 -165.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 85.79 6.04 0.43 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 124.437 1.095 . . . . 74.519999999999996 108.499 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.0 p -42.39 -169.44 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 127.044 2.138 . . . . 71.030000000000001 112.431 161.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -40.86 -33.1 0.27 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.126 1.37 . . . . 44.009999999999998 113.485 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 m -62.08 129.48 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 122.465 1.126 . . . . 73.430000000000007 110.318 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -51.17 -65.07 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.041 -1.436 . . . . 74.010000000000005 111.48 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -84.48 16.66 3.01 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.573 -0.704 . . . . 72.310000000000002 110.646 -171.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 47.36 65.51 2.3 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 111.372 -0.691 . . . . 62.030000000000001 111.372 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.83 -179.15 31.57 Favored Glycine 0 CA--C 1.457 -3.574 0 N-CA-C 103.98 -3.648 . . . . 73.310000000000002 103.98 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 131.72 35.44 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 N-CA-C 104.988 -2.227 . . . . 60.119999999999997 104.988 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.26 151.81 25.46 Favored 'General case' 0 CA--C 1.46 -2.503 0 N-CA-C 103.621 -2.733 . . . . 74.510000000000005 103.621 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.29 102.49 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 106.233 -1.766 . . . . 55.329999999999998 106.233 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' H ' ' HA ' ' A' ' 23' ' ' VAL . 46.9 tttp -71.82 -32.86 68.01 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.088 -0.96 . . . . 75.319999999999993 109.359 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.06 149.64 16.18 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 105.401 -2.074 . . . . 61.509999999999998 105.401 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.29 130.3 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 102.805 -3.035 . . . . 74.439999999999998 102.805 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.427 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 143.36 65.7 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 105.541 -2.022 . . . . 72.099999999999994 105.541 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 45' ' ' GLY . 97.8 Cg_endo -75.59 173.58 14.26 Favored 'Trans proline' 0 CA--C 1.464 -2.984 0 N-CA-C 106.428 -2.181 . . . . 62.039999999999999 106.428 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 71.22 -12.1 0.63 Allowed 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.364 1.04 . . . . 72.530000000000001 111.674 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -90.11 -179.71 44.15 Favored Glycine 0 CA--C 1.476 -2.388 0 N-CA-C 107.439 -2.264 . . . . 75.019999999999996 107.439 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.06 -52.79 45.74 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.675 -0.861 . . . . 70.129999999999995 108.675 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -49.27 66.8 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 116.217 -0.447 . . . . 55.109999999999999 110.281 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.16 -55.66 29.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.59 -0.522 . . . . 65.510000000000005 109.59 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -64.85 -32.66 74.46 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.557 -0.292 . . . . 74.010000000000005 111.595 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -81.61 -25.22 35.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.236 -1.764 . . . . 55.049999999999997 106.236 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 19.4 77.42 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 110.518 -1.033 . . . . 72.549999999999997 110.518 167.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' HG11 ' A' ' 10' ' ' VAL . 6.6 mmp_? -94.44 6.46 48.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.891 -1.151 . . . . 73.540000000000006 107.891 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.5 mt -144.02 138.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 103.804 -2.665 . . . . 74.010000000000005 103.804 -169.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -149.94 159.96 43.98 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 105.196 -2.15 . . . . 61.409999999999997 105.196 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -67.22 144.14 56.14 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.171 -1.048 . . . . 75.310000000000002 108.171 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.22 -32.66 7.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 108.081 -2.008 . . . . 73.010000000000005 108.081 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.65 155.16 30.67 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.128 -1.064 . . . . 33.32 108.128 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -116.27 141.54 48.02 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.783 -1.562 . . . . 54.409999999999997 106.783 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.55 126.07 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.138 -2.171 . . . . 73.140000000000001 105.138 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.539 HD11 HD12 ' A' ' 7' ' ' ILE . 75.2 mt -91.17 -59.12 2.24 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 107.668 -1.234 . . . . 72.040000000000006 107.668 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.89 149.81 49.12 Favored 'General case' 0 CA--C 1.472 -2.046 0 N-CA-C 106.51 -1.663 . . . . 63.409999999999997 106.51 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.4 110.88 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.629 -1.989 . . . . 65.239999999999995 105.629 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.82 44.82 25.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.173 1.389 . . . . 63.130000000000003 110.622 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.22 -31.85 8.25 Favored Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 108.186 -1.966 . . . . 65.340000000000003 108.186 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -81.56 116.79 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 107.56 -1.274 . . . . 65.219999999999999 107.56 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 t -55.32 126.64 25.83 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 108.281 -1.007 . . . . 61.130000000000003 108.281 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -97.23 -13.43 22.04 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.099 -1.815 . . . . 74.420000000000002 106.099 -171.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.1 127.62 32.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.787 -0.819 . . . . 63.25 108.787 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.54 66.21 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.817 -1.713 . . . . 74.400000000000006 108.817 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.65 148.06 39.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.067 -1.457 . . . . 64.209999999999994 107.067 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 27' ' ' VAL . 50.5 p -82.82 -179.93 7.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.824 -1.176 . . . . 44.210000000000001 107.824 -174.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.417 ' CE1' HG23 ' A' ' 23' ' ' VAL . 7.6 t60 -60.97 -51.39 69.47 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.213 -1.032 . . . . 64.329999999999998 108.213 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -52.95 -56.29 17.07 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 110.096 -0.335 . . . . 75.340000000000003 110.096 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.02 -47.63 77.45 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.509 -0.552 . . . . 74.329999999999998 109.509 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.42 -56.93 10.57 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.051 0.54 . . . . 70.420000000000002 111.242 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.24 -35.83 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 109.066 -0.716 . . . . 72.430000000000007 109.066 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.36 -32.54 74.24 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.338 -1.727 . . . . 74.400000000000006 106.338 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -74.22 -38.82 63.43 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.413 -1.429 . . . . 71.340000000000003 108.087 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.52 -48.67 74.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.61 -0.885 . . . . 62.409999999999997 108.61 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -55.88 13.58 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.582 -0.896 . . . . 30.120000000000001 108.582 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.24 60.95 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.97 0.891 . . . . 53.020000000000003 111.194 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 p -112.53 -176.11 2.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.54 -1.652 . . . . 70.430000000000007 106.54 171.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.59 -141.02 7.57 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 106.647 -2.581 . . . . 65.120000000000005 106.647 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 -55.13 12.89 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.785 -0.82 . . . . 74.340000000000003 108.785 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' ' 11' ' ' GLU . 73.6 t -99.32 144.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.775 -1.194 . . . . 55.32 107.775 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.9 t -97.62 125.57 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 105.731 -1.952 . . . . 73.409999999999997 105.731 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -97.67 117.8 32.78 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.931 -2.248 . . . . 63.100000000000001 104.931 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.12 130.32 11.2 Favored 'General case' 0 CA--C 1.482 -1.637 0 C-N-CA 119.281 -0.968 . . . . 65.5 108.474 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.06 143.51 30.54 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.354 -0.98 . . . . 42.43 108.354 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.698 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -116.08 158.92 22.43 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.438 -1.69 . . . . 75.140000000000001 106.438 178.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -126.72 131.51 51.35 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 102.47 -3.159 . . . . 52.009999999999998 102.47 169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -67.9 136.82 54.62 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 107.921 -1.14 . . . . 54.219999999999999 107.921 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.603 0 C-N-CA 119.9 -1.143 . . . . 72.5 110.725 -168.364 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.329 0 N-CA-C 109.73 -1.348 . . . . 75.510000000000005 109.73 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.09 146.96 23.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.472 -1.677 . . . . 73.129999999999995 106.472 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.622 HD12 HD11 ' A' ' 60' ' ' LEU . 11.4 mm -96.94 129.11 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 106.515 -1.661 . . . . 75.230000000000004 106.515 -173.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.59 ' CD2' HD23 ' A' ' 90' ' ' LEU . 6.2 p90 -131.87 148.36 52.54 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 106.655 -1.609 . . . . 74.25 106.655 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.22 148.64 29.67 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 106.454 -1.684 . . . . 71.239999999999995 106.454 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.708 HG22 HD21 ' A' ' 90' ' ' LEU . 26.8 m -140.21 150.79 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.392 -1.707 . . . . 62.140000000000001 106.392 173.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -120.48 138.92 53.56 Favored 'General case' 0 CA--C 1.465 -2.315 0 N-CA-C 104.533 -2.395 . . . . 72.329999999999998 104.533 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.08 144.83 28.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.423 -1.325 . . . . 73.340000000000003 107.423 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.34 123.65 29.28 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 105.883 -1.895 . . . . 73.310000000000002 105.883 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -71.33 -22.52 61.91 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.023 -0.732 . . . . 60.329999999999998 109.023 -173.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 t30 73.61 109.19 0.07 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.706 0.802 . . . . 73.239999999999995 109.767 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.33 53.02 12.54 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.364 1.065 . . . . 63.119999999999997 110.685 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 53.31 -8.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.811 1.782 . . . . 71.439999999999998 115.811 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.6 m -131.39 130.22 42.32 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.379 -1.341 . . . . 75.209999999999994 107.379 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.5 179.84 3.84 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 104.242 -2.503 . . . . 72.310000000000002 104.242 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.02 53.57 0.46 Allowed Glycine 0 CA--C 1.475 -2.456 0 N-CA-C 106.644 -2.582 . . . . 34.539999999999999 106.644 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.9 mt -87.85 176.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 104.573 -2.381 . . . . 63.039999999999999 104.573 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.506 ' H ' HG22 ' A' ' 21' ' ' ILE . 77.1 m -141.78 167.28 22.52 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 106.312 -1.736 . . . . 42.310000000000002 106.312 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.487 ' HB ' HG23 ' A' ' 36' ' ' ILE . 6.2 m -148.79 172.92 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.073 -1.454 . . . . 42.049999999999997 107.073 -167.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.8 t -154.37 160.8 41.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 103.902 -2.629 . . . . 72.049999999999997 103.902 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 31' ' ' VAL . . . 90.19 -164.95 31.22 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 108.02 -2.032 . . . . 53.399999999999999 108.02 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 133.61 -88.69 0.26 Allowed Glycine 0 CA--C 1.479 -2.203 0 N-CA-C 108.418 -1.873 . . . . 61.030000000000001 108.418 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.481 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -72.63 16.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.028 0 C-N-CA 122.551 0.341 . . . . 41.32 111.446 -171.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 26' ' ' GLY . 7.1 t30 85.39 5.99 0.48 Allowed 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.483 1.113 . . . . 71.430000000000007 108.784 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -45.41 -171.05 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 126.279 1.832 . . . . 63.109999999999999 112.987 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 p -40.45 -40.71 1.26 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 127.272 2.229 . . . . 73.150000000000006 114.002 -164.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.426 HG21 ' HA3' ' A' ' 25' ' ' GLY . 27.6 m -56.46 135.82 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.64 0.733 . . . . 64.409999999999997 110.286 -173.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -39.69 -66.96 0.25 Allowed 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.017 1.327 . . . . 64.209999999999994 113.475 -171.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -77.72 -13.34 59.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.322 -0.951 . . . . 54.340000000000003 109.866 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.95 -14.62 64.77 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.361 -1.496 . . . . 53.350000000000001 109.361 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.78 -179.87 53.17 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.172 -1.571 . . . . 61.210000000000001 109.172 -173.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 HG23 ' HB ' ' A' ' 23' ' ' VAL . 19.3 mm -86.32 117.87 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 103.929 -2.619 . . . . 72.299999999999997 103.929 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.83 154.5 19.53 Favored 'General case' 0 CA--C 1.463 -2.399 0 N-CA-C 105.275 -2.12 . . . . 64.450000000000003 105.275 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.44 102.45 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 N-CA-C 106.206 -1.775 . . . . 74.010000000000005 106.206 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -71.16 -41.63 70.15 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 113.966 -1.47 . . . . 72.5 109.735 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.97 143.8 17.18 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 105.418 -2.067 . . . . 74.120000000000005 105.418 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.8 133.53 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.655 -2.72 . . . . 74.129999999999995 103.655 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.35 148.78 78.0 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 106.163 -1.791 . . . . 71.120000000000005 106.163 175.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.87 169.24 23.05 Favored 'Trans proline' 0 CA--C 1.458 -3.301 0 N-CA-C 105.438 -2.562 . . . . 52.450000000000003 105.438 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 65.04 -1.36 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.877 0.736 . . . . 75.329999999999998 111.942 166.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.75 171.59 43.34 Favored Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 106.702 -2.559 . . . . 72.040000000000006 106.702 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.95 67.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.405 -0.961 . . . . 63.130000000000003 108.405 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB1' ' HB ' ' A' ' 53' ' ' ILE . . . -53.78 -50.82 65.25 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.283 -0.872 . . . . 63.450000000000003 110.717 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -63.24 -56.27 17.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 120.872 0.368 . . . . 43.439999999999998 110.112 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -34.88 71.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.207 0.603 . . . . 71.200000000000003 110.982 -172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.446 ' CG ' ' HE ' ' A' ' 52' ' ' ARG . 6.3 t70 -83.2 -34.52 25.9 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.698 -1.593 . . . . 54.240000000000002 106.698 -174.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.81 16.25 61.82 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 110.638 -0.985 . . . . 63.350000000000001 110.638 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.446 ' HE ' ' CG ' ' A' ' 50' ' ' ASP . 67.3 mtt180 -91.89 6.09 47.51 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 118.361 1.08 . . . . 74.430000000000007 108.201 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.434 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 2.9 mp -147.71 148.41 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.227 -2.509 . . . . 72.439999999999998 104.227 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -158.6 171.8 19.45 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 104.541 -2.392 . . . . 74.099999999999994 104.541 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -67.05 146.46 54.29 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.556 -0.905 . . . . 71.340000000000003 108.556 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.77 -32.95 6.98 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 109.263 -1.535 . . . . 74.209999999999994 109.263 169.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.43 158.52 34.82 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.662 -1.236 . . . . 53.109999999999999 107.662 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.459 HH22 ' CD ' ' A' ' 91' ' ' GLU . 24.6 ttp85 -123.88 143.79 50.15 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.741 -1.207 . . . . 61.039999999999999 107.741 -165.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.0 t -95.21 139.36 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.929 -1.878 . . . . 74.420000000000002 105.929 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.622 HD11 HD12 ' A' ' 7' ' ' ILE . 46.2 mt -102.01 -58.88 1.8 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.314 -1.365 . . . . 72.129999999999995 107.314 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.73 151.52 48.28 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.115 -1.809 . . . . 54.100000000000001 106.115 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.38 127.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.616 -2.365 . . . . 71.230000000000004 104.616 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.0 t30 59.04 31.28 21.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.91 0.862 . . . . 73.099999999999994 109.371 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.77 -8.14 73.96 Favored Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 109.156 -1.578 . . . . 43.43 109.156 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.77 118.52 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.572 0 N-CA-C 106.493 -1.669 . . . . 72.230000000000004 106.493 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 t -55.99 118.63 4.82 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.729 -1.211 . . . . 63.200000000000003 107.729 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.443 HD12 HG13 ' A' ' 36' ' ' ILE . 1.2 tm? -104.87 -13.47 15.81 Favored 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 106.552 -1.648 . . . . 70.340000000000003 106.552 -167.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.55 127.41 31.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.501 -0.749 . . . . 71.109999999999999 109.054 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.83 61.99 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.315 -1.914 . . . . 51.439999999999998 108.315 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.39 154.81 25.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.158 -1.793 . . . . 63.420000000000002 106.158 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.481 HG22 HG22 ' A' ' 27' ' ' VAL . 22.8 p -81.29 176.83 9.41 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.781 0.801 . . . . 75.430000000000007 110.393 -168.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -58.48 -50.79 72.46 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.815 1.246 . . . . 74.0 107.906 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -55.13 -54.48 42.68 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 122.063 -0.398 . . . . 75.120000000000005 110.759 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -53.93 -41.34 67.62 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.864 -0.421 . . . . 74.209999999999994 109.864 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.33 -54.27 27.94 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 122.798 0.439 . . . . 73.430000000000007 110.33 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.62 -38.5 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 109.302 -0.629 . . . . 63.299999999999997 109.302 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.6 -32.74 72.87 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 105.801 -1.926 . . . . 73.409999999999997 105.801 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -70.69 -46.46 63.1 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.175 -1.578 . . . . 65.129999999999995 108.05 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.36 -30.3 69.47 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 109.388 -0.597 . . . . 72.230000000000004 109.388 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -59.9 2.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.139 -1.43 . . . . 55.520000000000003 107.139 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -48.73 -20.59 0.49 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 126.163 1.785 . . . . 72.209999999999994 114.019 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -74.13 171.84 12.83 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.35 -0.844 . . . . 74.319999999999993 109.422 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.23 -148.69 5.4 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.1 -1.2 . . . . 74.239999999999995 110.1 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -70.82 -55.93 7.43 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.839 -0.8 . . . . 62.439999999999998 108.839 -170.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.06 142.58 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.727 0 N-CA-C 104.428 -2.434 . . . . 73.340000000000003 104.428 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.65 134.9 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 104.987 -2.227 . . . . 61.32 104.987 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -103.46 121.32 42.59 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.085 -2.561 . . . . 65.409999999999997 104.085 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 125.91 14.4 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 107.914 -1.143 . . . . 61.329999999999998 107.914 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.432 ' HB3' HD12 ' A' ' 60' ' ' LEU . 4.3 mp -81.9 144.39 31.0 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 107.999 -1.111 . . . . 63.049999999999997 107.999 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.708 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.28 162.18 18.31 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.105 -2.183 . . . . 55.210000000000001 105.105 174.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HG3' HD13 ' A' ' 7' ' ' ILE . 41.5 tt0 -129.01 144.58 51.23 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 102.254 -3.239 . . . . 75.0 102.254 163.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -57.88 140.78 51.2 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.721 0.772 . . . . 73.040000000000006 110.389 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.414 -2.83 0 N-CA-C 104.132 -3.587 . . . . 53.530000000000001 104.132 174.51 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.033 0 N-CA-C 108.819 -1.712 . . . . 43.520000000000003 108.819 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.66 139.9 38.45 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 106.691 -1.596 . . . . 74.540000000000006 106.691 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.408 HG12 HD11 ' A' ' 60' ' ' LEU . 54.0 mt -99.42 130.25 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 106.718 -1.586 . . . . 72.010000000000005 106.718 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.1 p90 -137.5 154.23 49.9 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 108.005 -1.109 . . . . 62.340000000000003 108.005 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.66 143.56 33.65 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.232 -1.766 . . . . 71.239999999999995 106.232 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.634 HG22 HD21 ' A' ' 90' ' ' LEU . 29.1 m -142.54 151.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.511 -1.663 . . . . 53.450000000000003 106.511 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.82 129.21 56.52 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 106.213 -1.773 . . . . 63.439999999999998 106.213 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.51 140.21 50.5 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 108.493 -0.928 . . . . 75.519999999999996 108.493 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.04 137.76 32.02 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 105.818 -1.919 . . . . 64.319999999999993 105.818 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.43 -25.76 59.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.613 -0.884 . . . . 72.349999999999994 108.613 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 67.87 111.28 0.04 OUTLIER 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.184 -0.673 . . . . 62.310000000000002 109.184 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.12 40.29 30.2 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.35 -0.982 . . . . 73.310000000000002 108.35 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 t30 43.22 12.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.223 2.209 . . . . 63.240000000000002 114.649 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -97.11 129.17 44.55 Favored 'General case' 0 CA--C 1.494 -1.195 0 O-C-N 120.517 -1.364 . . . . 61.520000000000003 107.328 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 tp -124.78 142.51 51.37 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 102.738 -3.06 . . . . 75.310000000000002 102.738 173.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.51 64.34 0.27 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 106.406 -2.678 . . . . 51.229999999999997 106.406 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.0 mm -87.89 177.35 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 104.929 -2.248 . . . . 74.129999999999995 104.929 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.516 ' H ' HG22 ' A' ' 21' ' ' ILE . 16.8 m -124.78 156.85 37.08 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 103.662 -2.718 . . . . 74.129999999999995 103.662 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.7 m -150.53 171.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 108.092 -1.077 . . . . 72.109999999999999 108.092 -166.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -161.99 164.75 28.17 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.498 -2.408 . . . . 71.239999999999995 104.498 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.62 -160.84 22.76 Favored Glycine 0 CA--C 1.486 -1.774 0 N-CA-C 107.052 -2.419 . . . . 73.120000000000005 107.052 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.72 -104.84 0.56 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 108.89 -1.684 . . . . 70.109999999999999 108.89 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.82 16.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 113.374 0.879 . . . . 74.319999999999993 113.374 -164.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 86.64 12.96 0.14 Allowed 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.804 1.242 . . . . 73.420000000000002 108.877 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 p -46.15 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 124.334 1.054 . . . . 74.430000000000007 110.859 155.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.7 m -29.46 -44.02 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.487 1.662 . . . . 71.439999999999998 115.487 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 37' ' ' TYR . 30.0 m -76.12 140.22 17.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.22 -0.925 . . . . 53.149999999999999 108.517 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -68.31 -47.58 67.21 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.148 -0.97 . . . . 74.040000000000006 111.138 -171.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.424 ' HE1' ' CD ' ' A' ' 68' ' ' GLU . 8.3 t-80 -73.23 0.66 11.2 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.189 -0.319 . . . . 73.450000000000003 110.248 -166.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.97 61.21 7.11 Favored Glycine 0 C--N 1.362 1.991 0 N-CA-C 109.495 -1.442 . . . . 72.040000000000006 109.495 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.4 28.19 Favored Glycine 0 CA--C 1.454 -3.759 0 N-CA-C 103.721 -3.752 . . . . 42.229999999999997 103.721 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 72' ' ' HIS . 0.7 OUTLIER -90.61 131.17 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.707 0 N-CA-C 104.25 -2.5 . . . . 75.200000000000003 104.25 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.466 ' CZ ' ' HB ' ' A' ' 31' ' ' VAL . 3.7 m-30 -108.55 151.67 25.79 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 102.899 -3.0 . . . . 75.209999999999994 102.899 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.52 102.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 107.103 -1.443 . . . . 71.019999999999996 107.103 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -71.6 -36.61 70.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.196 -1.366 . . . . 74.420000000000002 110.113 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.71 152.7 14.08 Favored 'General case' 0 CA--C 1.466 -2.278 0 N-CA-C 105.464 -2.05 . . . . 70.030000000000001 105.464 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.71 136.16 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 104.308 -2.479 . . . . 62.409999999999997 104.308 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.24 145.22 79.83 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 106.259 -1.756 . . . . 74.219999999999999 106.259 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.83 168.38 24.36 Favored 'Trans proline' 0 CA--C 1.462 -3.09 0 N-CA-C 105.786 -2.428 . . . . 73.109999999999999 105.786 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 63.41 1.54 1.0 Allowed 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 123.665 0.603 . . . . 71.340000000000003 111.732 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.6 -178.22 41.11 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 106.667 -2.573 . . . . 65.340000000000003 106.667 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.67 -52.99 31.43 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 108.151 -1.055 . . . . 63.439999999999998 108.151 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.07 65.86 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.066 -0.516 . . . . 65.439999999999998 110.879 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -62.39 -56.11 21.44 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.56 -0.533 . . . . 74.530000000000001 109.56 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.7 m -62.79 -30.49 71.5 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.683 0.278 . . . . 61.119999999999997 111.232 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -77.21 -35.8 55.3 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.773 -1.566 . . . . 62.32 106.773 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.38 12.59 72.69 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.109 -1.596 . . . . 74.049999999999997 109.109 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB2' HD12 ' A' ' 53' ' ' ILE . 23.8 mmt180 -90.19 -1.93 57.99 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.275 -1.38 . . . . 73.099999999999994 107.275 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 52' ' ' ARG . 2.1 mp -142.77 145.26 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 102.857 -3.016 . . . . 72.219999999999999 102.857 -176.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -156.79 173.03 17.58 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.699 -2.704 . . . . 72.200000000000003 103.699 170.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -66.35 145.62 55.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-O 121.391 0.615 . . . . 74.019999999999996 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -33.03 6.86 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.764 -1.734 . . . . 45.32 108.764 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -67.55 157.01 35.36 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.981 -0.748 . . . . 75.010000000000005 108.981 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -117.0 142.84 46.43 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.3 -1.37 . . . . 74.340000000000003 107.3 -166.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -93.01 126.71 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 105.761 -1.94 . . . . 74.219999999999999 105.761 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.408 HD11 HG12 ' A' ' 7' ' ' ILE . 19.9 mt -94.47 -58.64 2.14 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 107.417 -1.327 . . . . 60.240000000000002 107.417 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.36 147.62 47.45 Favored 'General case' 0 CA--C 1.471 -2.079 0 N-CA-C 106.379 -1.712 . . . . 72.010000000000005 106.379 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.43 119.12 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 104.897 -2.26 . . . . 71.329999999999998 104.897 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.3 t30 52.28 38.06 23.81 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.046 0.938 . . . . 64.420000000000002 110.618 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.7 -18.38 57.29 Favored Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 108.784 -1.726 . . . . 53.520000000000003 108.784 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.3 117.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.888 0 N-CA-C 106.78 -1.563 . . . . 73.109999999999999 106.78 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.0 t -56.02 122.73 12.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.243 -1.021 . . . . 65.120000000000005 108.243 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.6 tm? -93.42 -16.63 24.38 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.431 -2.063 . . . . 74.129999999999995 105.431 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CD ' ' HE1' ' A' ' 33' ' ' HIS . 53.3 mt-10 -59.85 123.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.816 -0.809 . . . . 62.329999999999998 108.816 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.56 -14.94 62.74 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 108.968 -1.653 . . . . 62.200000000000003 108.968 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.01 147.33 46.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.569 -1.271 . . . . 61.200000000000003 107.569 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 59.6 p -81.65 178.69 8.19 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.147 -1.427 . . . . 73.140000000000001 107.147 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.401 ' HA ' HD11 ' A' ' 36' ' ' ILE . 43.5 p-80 -62.26 -51.06 69.23 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.935 -0.765 . . . . 63.229999999999997 108.935 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.57 -56.07 24.62 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 121.707 -0.621 . . . . 73.219999999999999 110.12 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -60.9 -45.49 94.42 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 110.184 -0.302 . . . . 55.219999999999999 110.184 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -53.65 -51.29 63.62 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-O 120.918 0.389 . . . . 60.43 110.716 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.63 -36.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.827 -1.175 . . . . 75.329999999999998 107.827 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.6 -34.19 73.85 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.031 -1.84 . . . . 70.430000000000007 106.031 -176.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.9 m -73.14 -42.32 62.97 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 107.393 -1.336 . . . . 74.549999999999997 107.393 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.78 -39.58 94.66 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 110.109 -0.33 . . . . 64.450000000000003 110.109 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -75.99 -54.64 6.56 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.662 -0.815 . . . . 63.130000000000003 109.139 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -70.48 47.78 0.1 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.039 0.447 . . . . 72.109999999999999 111.591 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -101.08 -176.07 3.05 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.702 -1.962 . . . . 72.310000000000002 105.702 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.65 -157.26 18.57 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 107.113 -2.395 . . . . 13.199999999999999 107.113 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.34 -54.02 39.57 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.088 -0.708 . . . . 63.450000000000003 109.088 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.27 141.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 105.928 -1.879 . . . . 71.439999999999998 105.928 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.2 130.68 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.491 0 N-CA-C 105.718 -1.956 . . . . 75.310000000000002 105.718 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -107.17 124.61 49.97 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 105.413 -2.069 . . . . 72.409999999999997 105.413 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -156.36 136.55 12.89 Favored 'General case' 0 CA--C 1.473 -2.004 0 C-N-CA 119.01 -1.076 . . . . 75.5 108.458 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.33 141.0 33.23 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.394 -1.336 . . . . 72.510000000000005 107.394 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.634 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.8 159.02 18.7 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 104.595 -2.372 . . . . 75.200000000000003 104.595 174.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -123.4 134.4 53.98 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 101.292 -3.596 . . . . 51.420000000000002 101.292 164.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.76 130.29 44.28 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.163 -1.421 . . . . 73.140000000000001 107.163 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.463 -3.208 0 N-CA-C 107.303 -2.319 . . . . 21.109999999999999 107.303 -169.806 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.204 0 N-CA-C 109.567 -1.413 . . . . 74.540000000000006 109.567 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -99.77 153.8 18.83 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.869 -1.901 . . . . 74.430000000000007 105.869 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 60' ' ' LEU . 4.6 mm -99.63 137.51 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 106.59 -1.633 . . . . 63.219999999999999 106.59 -169.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.563 ' CD2' HD23 ' A' ' 90' ' ' LEU . 9.1 p90 -135.28 151.96 51.05 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.302 -1.37 . . . . 74.140000000000001 107.302 170.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.427 ' OE2' ' HE1' ' A' ' 87' ' ' HIS . 52.8 mt-10 -108.09 147.29 31.42 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.237 -1.764 . . . . 64.239999999999995 106.237 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.73 HG22 HD21 ' A' ' 90' ' ' LEU . 35.1 m -142.96 152.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 105.984 -1.858 . . . . 62.5 105.984 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -118.71 127.25 53.39 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.745 -1.946 . . . . 73.129999999999995 105.745 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 137.69 45.45 Favored 'General case' 0 CA--C 1.474 -1.961 0 N-CA-C 107.694 -1.224 . . . . 70.340000000000003 107.694 -169.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.29 142.3 28.63 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.693 -1.965 . . . . 64.319999999999993 105.693 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -69.88 -32.41 70.74 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.413 -0.958 . . . . 75.209999999999994 108.413 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 75.03 107.08 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.607 0.763 . . . . 64.129999999999995 109.299 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 50.84 45.38 27.43 Favored 'General case' 0 C--N 1.37 1.474 0 C-N-CA 124.576 1.151 . . . . 43.299999999999997 110.937 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 54.97 -9.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.549 1.94 . . . . 74.209999999999994 113.805 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -84.3 158.28 21.24 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 119.975 1.262 . . . . 71.109999999999999 108.341 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.96 -157.15 0.78 Allowed 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 102.952 -2.981 . . . . 53.439999999999998 102.952 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.36 40.79 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.657 0 N-CA-C 105.292 -3.123 . . . . 55.219999999999999 105.292 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mm -87.99 175.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 103.438 -2.801 . . . . 70.230000000000004 103.438 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.7 m -147.61 159.55 43.64 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.358 -2.09 . . . . 73.299999999999997 105.358 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.3 m -150.4 167.3 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 N-CA-C 107.766 -1.198 . . . . 73.129999999999995 107.766 -164.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -166.17 169.49 14.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.665 -2.346 . . . . 63.409999999999997 104.665 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -138.61 14.64 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.695 -2.162 . . . . 25.43 107.695 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.77 -88.17 0.68 Allowed Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 109.404 -1.478 . . . . 64.019999999999996 109.404 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 16.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 112.832 0.679 . . . . 71.219999999999999 112.832 -165.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 17.7 t-20 82.55 6.92 0.9 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.677 0.791 . . . . 74.129999999999995 109.301 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 t -46.28 -170.23 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.427 1.491 . . . . 54.420000000000002 111.478 160.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -35.08 -40.33 0.12 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.071 1.748 . . . . 72.540000000000006 114.982 -166.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 34.6 m -72.25 142.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.559 -0.904 . . . . 34.130000000000003 108.559 -174.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.19 -59.11 4.07 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 121.725 -0.609 . . . . 72.329999999999998 112.556 -167.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 33' ' ' HIS . 22.8 t-160 -75.84 15.16 0.55 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.588 -0.695 . . . . 70.349999999999994 110.874 -164.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 28' ' ' ASN . . . 46.35 57.19 6.6 Favored Glycine 0 C--N 1.358 1.788 0 N-CA-C 109.559 -1.416 . . . . 54.409999999999997 109.559 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.95 178.27 23.78 Favored Glycine 1 CA--C 1.442 -4.49 0 N-CA-C 103.252 -3.939 . . . . 61.229999999999997 103.252 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.493 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.6 mm -92.63 132.09 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 106.214 -1.772 . . . . 71.200000000000003 106.214 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.429 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 2.7 m-85 -109.82 148.52 31.34 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.584 -2.747 . . . . 72.120000000000005 103.584 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.12 103.2 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 N-CA-C 106.702 -1.592 . . . . 71.519999999999996 106.702 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -70.58 -38.64 74.09 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.547 -1.206 . . . . 63.229999999999997 109.745 -174.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.35 155.56 17.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 N-CA-C 105.368 -2.086 . . . . 43.32 105.368 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.5 143.2 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 102.763 -3.051 . . . . 54.420000000000002 102.763 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.16 142.6 72.26 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 105.903 -1.888 . . . . 74.140000000000001 105.903 171.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.14 173.89 13.73 Favored 'Trans proline' 0 CA--C 1.472 -2.585 0 N-CA-C 105.896 -2.386 . . . . 64.140000000000001 105.896 -176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 69.66 -2.73 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.024 0.828 . . . . 71.209999999999994 111.213 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.57 -176.25 38.6 Favored Glycine 0 CA--C 1.48 -2.139 0 N-CA-C 107.221 -2.352 . . . . 63.009999999999998 107.221 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -52.84 46.75 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.137 -1.061 . . . . 75.519999999999996 108.137 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.53 -49.65 64.42 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.224 -0.444 . . . . 74.019999999999996 110.589 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -64.54 -55.98 17.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.819 0.342 . . . . 52.450000000000003 110.124 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 m -64.04 -29.66 70.79 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 121.928 -0.482 . . . . 73.409999999999997 111.694 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -78.56 -34.15 47.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 105.773 -1.936 . . . . 74.349999999999994 105.773 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.49 63.97 Favored Glycine 0 CA--C 1.482 -2.02 0 N-CA-C 108.898 -1.681 . . . . 61.210000000000001 108.898 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.505 ' HB3' HG11 ' A' ' 10' ' ' VAL . 13.4 mmt180 -89.89 -2.62 58.23 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 107.805 -1.183 . . . . 75.5 107.805 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.8 mt -146.64 143.9 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 N-CA-C 103.26 -2.867 . . . . 74.430000000000007 103.26 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.496 ' CE1' ' OD1' ' A' ' 57' ' ' ASP . 25.6 p80 -153.23 165.39 35.83 Favored 'General case' 0 CA--C 1.463 -2.375 0 N-CA-C 104.497 -2.409 . . . . 74.519999999999996 104.497 173.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.716 ' H ' ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -67.93 145.08 54.9 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.612 -1.255 . . . . 72.430000000000007 107.612 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.74 -32.72 7.09 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.493 -1.443 . . . . 52.520000000000003 109.493 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 68.1 m-20 -66.4 158.0 30.47 Favored 'General case' 0 C--N 1.373 1.588 0 N-CA-C 108.292 -1.003 . . . . 73.5 108.292 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 52.5 mtm-85 -112.7 137.66 50.67 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.506 -1.294 . . . . 72.409999999999997 107.506 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.36 128.49 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 105.08 -2.193 . . . . 74.010000000000005 105.08 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.521 ' CD1' HG23 ' A' ' 7' ' ' ILE . 17.5 mt -99.28 -59.14 1.78 Allowed 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 107.467 -1.309 . . . . 73.420000000000002 107.467 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.06 146.53 51.77 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 106.433 -1.691 . . . . 64.540000000000006 106.433 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.78 125.42 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.213 -2.514 . . . . 74.120000000000005 104.213 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.64 29.84 17.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.114 0.959 . . . . 73.019999999999996 109.287 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.06 -12.06 68.85 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 109.26 -1.536 . . . . 72.510000000000005 109.26 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.04 118.54 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.557 -1.645 . . . . 74.109999999999999 106.557 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.5 m -56.7 118.38 4.82 Favored 'General case' 0 C--N 1.368 1.381 0 N-CA-C 108.435 -0.95 . . . . 55.439999999999998 108.435 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -104.52 -10.82 17.37 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.136 -1.802 . . . . 54.409999999999997 106.136 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.91 126.59 28.09 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.655 -0.868 . . . . 73.510000000000005 108.655 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -13.37 67.16 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 108.963 -1.655 . . . . 63.149999999999999 108.963 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.4 152.89 30.1 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.228 -1.767 . . . . 64.510000000000005 106.228 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -81.73 179.24 7.91 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.952 -0.758 . . . . 64.049999999999997 108.952 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -67.44 -46.15 73.93 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 108.202 -1.036 . . . . 74.349999999999994 108.202 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -52.19 -56.43 14.65 Favored 'General case' 0 C--N 1.362 1.136 0 O-C-N 121.733 -0.604 . . . . 53.219999999999999 110.07 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -53.96 -42.63 69.11 Favored 'General case' 0 C--N 1.369 1.452 0 N-CA-C 110.0 -0.37 . . . . 73.439999999999998 110.0 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -52.1 -53.9 36.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.096 0.558 . . . . 73.230000000000004 110.432 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.57 -40.57 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.657 -1.238 . . . . 73.430000000000007 107.657 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.05 -37.27 76.61 Favored 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 106.823 -1.547 . . . . 72.430000000000007 106.823 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.3 m -74.01 -48.06 32.79 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 120.355 -1.466 . . . . 73.439999999999998 107.627 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 124.024 0.929 . . . . 74.430000000000007 109.933 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -70.07 -55.47 9.41 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.998 -1.112 . . . . 72.530000000000001 107.998 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -70.84 55.26 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.875 0.845 . . . . 54.310000000000002 110.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.562 HG21 HG13 ' A' ' 86' ' ' VAL . 10.1 p -104.79 -175.53 2.82 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.226 -1.768 . . . . 74.109999999999999 106.226 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.12 -155.73 31.97 Favored Glycine 0 CA--C 1.485 -1.815 0 N-CA-C 107.189 -2.364 . . . . 50.0 107.189 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -63.24 -55.34 25.71 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.023 -1.103 . . . . 74.349999999999994 108.023 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.48 144.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.673 -1.973 . . . . 70.219999999999999 105.673 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.562 HG13 HG21 ' A' ' 82' ' ' THR . 46.8 t -103.01 131.84 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.715 0 N-CA-C 105.568 -2.012 . . . . 74.109999999999999 105.568 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.427 ' HE1' ' OE2' ' A' ' 9' ' ' GLU . 50.1 t-80 -112.5 124.18 51.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.089 -2.189 . . . . 63.340000000000003 105.089 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.29 136.4 14.74 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 107.781 -1.192 . . . . 73.510000000000005 107.781 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -81.29 140.14 35.0 Favored 'General case' 0 CA--C 1.469 -2.138 0 N-CA-C 107.712 -1.218 . . . . 70.230000000000004 107.712 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.73 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.92 156.91 20.51 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.412 -2.44 . . . . 45.530000000000001 104.412 172.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.3 tt0 -118.75 129.82 55.47 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 101.566 -3.494 . . . . 71.099999999999994 101.566 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -66.89 129.24 39.23 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.225 -1.768 . . . . 71.209999999999994 106.225 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.475 -2.438 0 N-CA-C 107.835 -2.106 . . . . 30.140000000000001 107.835 -168.119 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.33 0 N-CA-C 109.348 -1.501 . . . . 62.340000000000003 109.348 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.5 138.52 39.26 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.432 -1.322 . . . . 73.200000000000003 107.432 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 60' ' ' LEU . 10.1 mm -97.53 133.28 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.321 -1.363 . . . . 74.109999999999999 107.321 -172.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.586 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -142.89 153.21 42.9 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.139 -1.06 . . . . 61.409999999999997 108.139 175.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -104.94 146.83 28.49 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 105.942 -1.873 . . . . 70.230000000000004 105.942 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.648 HG22 HD21 ' A' ' 90' ' ' LEU . 22.5 m -140.61 150.0 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.78 -1.563 . . . . 74.219999999999999 106.78 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -108.67 127.86 54.35 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 105.142 -2.17 . . . . 64.5 105.142 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 53' ' ' ILE . 3.6 mp -129.6 140.08 51.28 Favored 'General case' 0 CA--C 1.448 -2.967 0 N-CA-C 107.528 -1.286 . . . . 73.150000000000006 107.528 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.57 140.07 31.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 104.964 -2.236 . . . . 64.430000000000007 104.964 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.67 -31.97 67.37 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.539 -1.282 . . . . 71.099999999999994 107.539 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 74.83 102.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.251 -1.389 . . . . 74.349999999999994 107.251 -175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.16 45.83 11.22 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.243 -0.89 . . . . 75.409999999999997 109.22 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.7 t30 45.34 3.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.816 2.046 . . . . 61.420000000000002 115.634 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -102.6 121.94 43.4 Favored 'General case' 0 CA--C 1.485 -1.548 0 O-C-N 120.358 -1.464 . . . . 61.340000000000003 107.049 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.9 tp -127.19 151.37 48.78 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 104.202 -2.518 . . . . 54.310000000000002 104.202 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.18 0.07 OUTLIER Glycine 0 CA--C 1.467 -2.934 0 N-CA-C 105.184 -3.166 . . . . 65.109999999999999 105.184 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.7 mm -89.22 178.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.415 -2.439 . . . . 64.209999999999994 104.415 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.534 ' H ' HG22 ' A' ' 21' ' ' ILE . 40.0 t -122.06 154.59 37.11 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 103.345 -2.835 . . . . 53.100000000000001 103.345 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.481 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.4 m -147.63 169.69 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 107.406 -1.331 . . . . 74.349999999999994 107.406 -164.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 t -162.67 165.88 25.16 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.884 -2.265 . . . . 55.439999999999998 104.884 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -152.67 31.24 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 107.067 -2.413 . . . . 42.340000000000003 107.067 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 118.48 -78.77 0.3 Allowed Glycine 0 CA--C 1.477 -2.332 0 N-CA-C 108.979 -1.649 . . . . 73.219999999999999 108.979 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -67.71 16.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 C-N-CA 124.557 1.143 . . . . 72.219999999999999 112.057 -168.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 26' ' ' GLY . 12.5 t-20 81.32 5.14 1.38 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.213 1.405 . . . . 65.420000000000002 108.072 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.1 p -49.02 -170.86 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 126.071 1.748 . . . . 70.450000000000003 113.186 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 m -31.43 -42.41 0.05 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.63 2.372 . . . . 64.120000000000005 115.089 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -62.75 134.91 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.816 0.817 . . . . 62.219999999999999 109.967 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -52.44 -50.25 62.95 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 114.855 -1.066 . . . . 73.120000000000005 112.404 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -90.31 16.95 7.78 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.208 -0.933 . . . . 74.120000000000005 110.079 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.09 62.63 2.0 Favored Glycine 0 C--N 1.368 2.327 0 N-CA-C 111.206 -0.758 . . . . 72.329999999999998 111.206 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.1 179.73 24.73 Favored Glycine 0 CA--C 1.455 -3.681 0 N-CA-C 104.162 -3.575 . . . . 70.129999999999995 104.162 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.564 HG13 ' HB2' ' A' ' 75' ' ' ALA . 8.6 mm -88.87 125.54 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 105.479 -2.045 . . . . 73.140000000000001 105.479 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -109.32 152.86 24.71 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 103.84 -2.652 . . . . 64.519999999999996 103.84 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.81 104.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.464 -1.68 . . . . 75.200000000000003 106.464 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.37 -31.93 69.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.729 -0.841 . . . . 64.430000000000007 108.729 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.49 146.22 16.6 Favored 'General case' 0 CA--C 1.459 -2.525 0 N-CA-C 105.645 -1.983 . . . . 63.25 105.645 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.89 122.46 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.349 -3.204 . . . . 73.040000000000006 102.349 172.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.406 ' H ' ' CD1' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.79 146.23 72.1 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 106.052 -1.833 . . . . 73.129999999999995 106.052 178.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.5 173.61 14.2 Favored 'Trans proline' 0 CA--C 1.47 -2.679 0 N-CA-C 107.109 -1.919 . . . . 72.409999999999997 107.109 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 63.65 53.98 1.94 Allowed 'General case' 0 N--CA 1.422 -1.829 0 O-C-N 124.664 1.228 . . . . 72.319999999999993 108.136 164.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.34 176.53 37.87 Favored Glycine 0 CA--C 1.466 -2.992 0 N-CA-C 106.659 -2.576 . . . . 75.25 106.659 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.43 -52.73 24.02 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.661 -0.866 . . . . 62.399999999999999 108.661 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -49.32 67.45 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.623 -0.262 . . . . 71.25 110.558 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -59.53 -57.5 12.67 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 122.104 -0.373 . . . . 73.120000000000005 110.129 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -63.58 -28.7 70.11 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.581 0.229 . . . . 42.039999999999999 110.948 -170.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.34 -40.37 58.38 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.146 -1.427 . . . . 64.439999999999998 107.146 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.56 9.61 78.39 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 109.794 -1.322 . . . . 62.439999999999998 109.794 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -100.22 7.07 44.73 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.594 -1.262 . . . . 72.109999999999999 107.594 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 12' ' ' LEU . 1.4 mp -134.5 140.75 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 102.987 -2.968 . . . . 43.549999999999997 102.987 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -140.83 158.71 43.56 Favored 'General case' 0 CA--C 1.465 -2.325 0 N-CA-C 104.666 -2.346 . . . . 74.409999999999997 104.666 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.21 140.48 57.43 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.487 -1.672 . . . . 72.239999999999995 106.487 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.5 -32.83 6.34 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 108.663 -1.775 . . . . 72.040000000000006 108.663 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -67.45 155.92 37.84 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.119 -1.808 . . . . 74.030000000000001 106.119 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.426 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 1.6 ppt_? -133.38 156.55 47.44 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.233 -0.987 . . . . 64.430000000000007 109.247 -169.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -93.02 138.73 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.474 -1.676 . . . . 60.509999999999998 106.474 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.527 ' CD1' HG23 ' A' ' 7' ' ' ILE . 7.0 mt -99.12 -59.29 1.75 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.216 -1.772 . . . . 64.329999999999998 106.216 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.56 152.28 50.3 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 106.474 -1.676 . . . . 64.120000000000005 106.474 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.91 121.14 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 104.522 -2.399 . . . . 62.340000000000003 104.522 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.96 36.48 22.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.937 0.895 . . . . 74.109999999999999 110.532 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.95 -19.95 52.24 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.694 -1.762 . . . . 75.349999999999994 108.694 169.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.4 116.09 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 107.565 -1.272 . . . . 62.420000000000002 107.565 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -55.52 117.91 4.0 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 107.664 -1.236 . . . . 71.150000000000006 107.664 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -102.12 -13.09 17.62 Favored 'General case' 0 C--O 1.202 -1.402 0 N-CA-C 106.608 -1.627 . . . . 54.329999999999998 106.608 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.84 128.72 37.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.523 -0.917 . . . . 64.519999999999996 108.523 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.41 -17.67 58.65 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 108.239 -1.945 . . . . 61.030000000000001 108.239 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 106.316 -1.735 . . . . 62.43 106.316 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -84.77 -179.37 7.09 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.384 0.611 . . . . 62.539999999999999 109.362 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -60.89 -52.44 65.05 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.073 -1.084 . . . . 70.439999999999998 108.073 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -60.27 -44.83 94.98 Favored 'General case' 0 C--N 1.372 1.564 0 O-C-N 121.859 -0.525 . . . . 63.009999999999998 110.37 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -55.44 -46.6 76.72 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 109.171 -0.677 . . . . 54.409999999999997 109.171 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -51.43 -53.83 32.9 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.893 -0.594 . . . . 55.43 110.722 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.16 -43.64 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.044 -1.095 . . . . 74.219999999999999 108.044 -171.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 t -68.04 -30.34 69.54 Favored 'General case' 0 C--O 1.193 -1.912 0 C-N-CA 116.924 -1.91 . . . . 75.140000000000001 107.253 -170.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -67.96 -43.42 79.06 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.876 -1.765 . . . . 74.219999999999999 106.892 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.68 -29.0 69.04 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 109.526 -0.546 . . . . 63.100000000000001 109.526 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.24 -60.39 2.29 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 107.77 -1.196 . . . . 74.349999999999994 107.77 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -58.85 -3.37 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.775 1.23 . . . . 74.340000000000003 113.607 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 p -73.97 -176.33 2.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.678 -0.86 . . . . 72.439999999999998 108.678 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.77 -149.17 24.42 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 109.432 -1.467 . . . . 64.420000000000002 109.432 -167.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -65.95 -55.18 18.15 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.177 -1.416 . . . . 75.409999999999997 107.177 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -100.68 144.36 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 N-CA-C 105.441 -2.059 . . . . 72.400000000000006 105.441 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -108.49 133.41 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 106.128 -1.804 . . . . 75.420000000000002 106.128 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -107.08 121.87 45.35 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 104.902 -2.259 . . . . 75.230000000000004 104.902 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.5 134.42 13.01 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.074 -1.084 . . . . 74.430000000000007 108.074 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -84.63 141.33 30.72 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 108.232 -1.025 . . . . 71.400000000000006 108.232 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.648 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -118.3 163.24 17.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.054 -2.202 . . . . 64.040000000000006 105.054 176.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.426 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 36.2 tt0 -124.17 137.28 54.56 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 102.25 -3.241 . . . . 62.119999999999997 102.25 166.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 8' ' ' PHE . 11.8 mmmm -61.16 149.88 36.01 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.822 -0.807 . . . . 75.010000000000005 108.822 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.416 -2.678 0 N-CA-C 105.654 -2.978 . . . . 72.329999999999998 105.654 175.708 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.958 0 N-CA-C 108.598 -1.801 . . . . 73.019999999999996 108.598 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -78.91 132.37 36.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.435 -1.321 . . . . 74.200000000000003 107.435 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.513 HG23 ' CD1' ' A' ' 60' ' ' LEU . 18.5 mm -100.38 135.58 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 106.196 -1.779 . . . . 73.200000000000003 106.196 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -145.88 161.61 39.62 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 107.669 -1.234 . . . . 74.319999999999993 107.669 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.49 151.76 29.57 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 105.548 -2.019 . . . . 72.340000000000003 105.548 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -145.04 153.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 106.715 -1.587 . . . . 74.010000000000005 106.715 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -111.96 131.22 55.53 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 105.116 -2.179 . . . . 75.030000000000001 105.116 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.424 HD22 HD12 ' A' ' 53' ' ' ILE . 4.6 mp -136.76 145.15 44.27 Favored 'General case' 0 CA--C 1.462 -2.409 0 N-CA-C 107.881 -1.155 . . . . 72.099999999999994 107.881 174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.15 144.83 26.67 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.139 -1.43 . . . . 52.119999999999997 107.139 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -75.22 -27.52 59.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.773 -1.195 . . . . 63.530000000000001 107.773 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 t30 71.02 96.89 0.07 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.831 0.852 . . . . 73.439999999999998 109.226 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 62.13 40.51 11.8 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.139 -1.06 . . . . 73.349999999999994 108.139 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 50.29 -8.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.067 2.547 . . . . 62.020000000000003 114.952 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.7 m -93.06 115.69 28.34 Favored 'General case' 0 CA--C 1.47 -2.105 0 N-CA-C 106.745 -1.576 . . . . 70.420000000000002 106.745 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -87.12 -150.75 0.16 Allowed 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.516 -2.401 . . . . 73.010000000000005 104.516 173.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.79 29.89 0.02 OUTLIER Glycine 0 CA--C 1.463 -3.203 0 N-CA-C 107.169 -2.372 . . . . 71.200000000000003 107.169 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.38 176.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 103.14 -2.911 . . . . 62.210000000000001 103.14 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -151.04 166.48 30.6 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 104.166 -2.531 . . . . 54.399999999999999 104.166 172.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.06 177.32 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 107.827 -1.175 . . . . 74.319999999999993 107.827 -166.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 170.78 20.74 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.525 -2.398 . . . . 73.519999999999996 104.525 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.53 -153.16 24.81 Favored Glycine 0 CA--C 1.484 -1.854 0 N-CA-C 109.091 -1.604 . . . . 70.219999999999999 109.091 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.45 -80.93 0.32 Allowed Glycine 0 CA--C 1.477 -2.299 0 N-CA-C 108.864 -1.695 . . . . 61.439999999999998 108.864 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -76.71 16.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 122.755 0.422 . . . . 63.109999999999999 111.643 -166.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.3 t30 85.64 6.43 0.43 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.241 -1.022 . . . . 75.230000000000004 108.241 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -45.89 -168.39 0.0 OUTLIER 'General case' 0 C--O 1.192 -1.933 0 C-N-CA 126.821 2.048 . . . . 75.200000000000003 112.051 162.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.6 m -33.06 -43.58 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.568 1.547 . . . . 74.109999999999999 114.441 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.1 m -71.3 130.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 107.524 -1.287 . . . . 65.340000000000003 107.524 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -55.93 11.51 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 121.138 -0.976 . . . . 74.430000000000007 108.854 -166.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -61.74 -20.72 63.84 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 111.81 0.3 . . . . 61.43 111.81 -164.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 55.64 2.63 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 107.817 -2.113 . . . . 64.400000000000006 107.817 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.01 -179.77 29.62 Favored Glycine 0 CA--C 1.456 -3.629 1 N-CA-C 101.923 -4.471 . . . . 54.119999999999997 101.923 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.13 136.66 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.593 0 N-CA-C 104.734 -2.321 . . . . 65.310000000000002 104.734 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -105.48 151.43 24.27 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 103.487 -2.783 . . . . 63.119999999999997 103.487 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.95 101.41 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.724 -1.954 . . . . 74.209999999999994 105.724 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.09 -37.02 66.89 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.116 -1.402 . . . . 72.400000000000006 110.978 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.43 140.54 24.03 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.283 -1.747 . . . . 74.230000000000004 106.283 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.57 132.97 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 103.368 -2.827 . . . . 74.530000000000001 103.368 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 154.03 84.95 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 106.647 -1.612 . . . . 75.409999999999997 106.647 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.18 172.34 16.24 Favored 'Trans proline' 0 CA--C 1.472 -2.6 0 N-CA-C 107.079 -1.931 . . . . 51.130000000000003 107.079 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 53.41 55.67 8.38 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 124.612 1.195 . . . . 73.209999999999994 109.541 164.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.34 176.37 35.31 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 104.011 -3.635 . . . . 73.409999999999997 104.011 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.35 55.77 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 117.291 0.546 . . . . 74.430000000000007 109.765 -168.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.39 -49.79 63.73 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 122.542 -0.099 . . . . 70.230000000000004 111.115 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -62.86 -55.8 22.98 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 122.094 -0.379 . . . . 64.430000000000007 110.483 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 m -65.78 -29.03 69.46 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 110.051 -0.351 . . . . 73.129999999999995 110.051 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.14 -38.13 52.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.318 -1.734 . . . . 65.019999999999996 106.318 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 15.22 76.39 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 109.889 -1.285 . . . . 74.319999999999993 109.889 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -101.56 7.65 42.19 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.043 -1.465 . . . . 74.349999999999994 107.043 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.424 HD12 HD22 ' A' ' 12' ' ' LEU . 64.0 mt -141.49 143.72 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 103.756 -2.683 . . . . 75.200000000000003 103.756 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -141.63 169.31 17.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.089 -2.56 . . . . 75.310000000000002 104.089 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -68.09 138.47 55.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.569 -2.011 . . . . 60.329999999999998 105.569 164.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.04 -28.07 12.92 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 108.991 -1.644 . . . . 73.099999999999994 108.991 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.442 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 1.1 m-20 -57.57 139.51 53.33 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 118.057 0.929 . . . . 72.120000000000005 108.708 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.7 130.24 56.12 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 104.839 -2.282 . . . . 73.25 104.839 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.75 130.61 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.281 -2.118 . . . . 73.439999999999998 105.281 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' CD1' HG23 ' A' ' 7' ' ' ILE . 19.8 mt -97.79 -58.31 2.02 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 106.366 -1.716 . . . . 73.349999999999994 106.366 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.7 151.47 50.21 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.51 -1.663 . . . . 71.430000000000007 106.51 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.08 117.93 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 105.485 -2.043 . . . . 61.299999999999997 105.485 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 t30 49.42 40.39 18.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.246 1.018 . . . . 53.329999999999998 111.033 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.68 7.05 Favored Glycine 0 CA--C 1.472 -2.621 0 N-CA-C 108.157 -1.977 . . . . 73.299999999999997 108.157 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.15 117.04 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 N-CA-C 108.643 -0.873 . . . . 72.420000000000002 108.643 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -56.27 126.17 25.05 Favored 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.377 -0.971 . . . . 75.340000000000003 108.377 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.469 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -103.66 -12.09 17.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.237 -1.764 . . . . 55.100000000000001 106.237 -169.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.8 124.31 19.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.677 -0.861 . . . . 74.030000000000001 108.677 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.81 -16.53 61.07 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.764 -1.735 . . . . 62.149999999999999 108.764 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.31 154.01 31.25 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 106.814 -1.55 . . . . 44.43 106.814 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.7 p -85.57 179.38 7.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.56 -0.904 . . . . 75.349999999999994 108.56 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -68.83 -42.92 76.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.559 -0.904 . . . . 74.109999999999999 108.559 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -56.35 16.18 Favored 'General case' 0 C--N 1.367 1.352 0 O-C-N 121.915 -0.491 . . . . 70.430000000000007 110.085 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -54.79 -45.11 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 122.19 -0.319 . . . . 42.520000000000003 110.248 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -52.03 -54.48 29.51 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 116.085 -0.507 . . . . 75.230000000000004 110.488 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.64 -38.17 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 108.758 -0.83 . . . . 54.340000000000003 108.758 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 8.2 t -56.29 -40.03 73.63 Favored 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 105.935 -1.876 . . . . 64.519999999999996 105.935 -173.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 m -74.42 -48.84 25.24 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.054 -1.43 . . . . 72.230000000000004 109.194 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.11 -31.43 72.62 Favored 'General case' 0 C--N 1.368 1.391 0 N-CA-C 110.259 -0.274 . . . . 73.420000000000002 110.259 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -79.51 -53.71 6.61 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 108.246 -1.02 . . . . 73.400000000000006 108.246 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -68.79 53.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.295 1.045 . . . . 63.310000000000002 110.973 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.47 HG21 HG13 ' A' ' 86' ' ' VAL . 10.4 p -110.77 -175.74 2.79 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.384 -1.71 . . . . 71.540000000000006 106.384 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.1 -156.11 32.5 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.497 -2.641 . . . . 34.200000000000003 106.497 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -62.24 -54.69 37.23 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.784 -1.191 . . . . 72.25 107.784 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.46 142.36 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 106.461 -1.681 . . . . 75.409999999999997 106.461 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 HG21 ' A' ' 82' ' ' THR . 48.9 t -103.71 132.17 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 N-CA-C 105.052 -2.203 . . . . 64.340000000000003 105.052 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -110.24 127.75 55.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.831 -2.285 . . . . 73.510000000000005 104.831 173.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 139.17 16.02 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.727 -1.212 . . . . 73.239999999999995 107.727 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.4 140.53 33.41 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 107.271 -1.381 . . . . 75.409999999999997 107.271 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.83 160.82 38.24 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.994 -1.457 . . . . 71.140000000000001 107.474 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -123.57 120.77 33.82 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.387 -2.079 . . . . 75.409999999999997 105.387 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.419 0.0 OUTLIER 34.79 -79.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 127.146 2.178 . . . . 75.329999999999998 116.195 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 57' ' ' ASP . . . . . . . . 0 CA--C 1.461 -3.285 0 N-CA-C 106.043 -2.823 . . . . 33.219999999999999 106.043 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.244 0 N-CA-C 108.946 -1.661 . . . . 74.420000000000002 108.946 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -75.9 137.24 40.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.557 -1.275 . . . . 72.409999999999997 107.557 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.472 HG23 ' CD1' ' A' ' 60' ' ' LEU . 11.8 mt -101.11 128.82 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 N-CA-C 107.653 -1.24 . . . . 72.450000000000003 107.653 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.3 p90 -139.76 156.23 46.88 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.212 -1.403 . . . . 54.549999999999997 107.212 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.1 145.93 31.86 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.483 -2.043 . . . . 62.210000000000001 105.483 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 90' ' ' LEU . 16.1 m -140.39 151.69 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.038 -1.467 . . . . 54.240000000000002 107.038 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.58 128.54 54.91 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 105.35 -2.093 . . . . 64.129999999999995 105.35 168.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mp -132.27 143.93 50.25 Favored 'General case' 0 CA--C 1.454 -2.731 0 N-CA-C 107.438 -1.319 . . . . 72.0 107.438 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.66 142.18 28.4 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 105.521 -2.029 . . . . 72.310000000000002 105.521 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -71.72 -30.55 65.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.071 -1.085 . . . . 65.200000000000003 108.071 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 72.43 104.38 0.07 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.76 -0.83 . . . . 63.409999999999997 108.76 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 62.27 46.47 6.05 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.817 0.847 . . . . 74.519999999999996 110.192 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 53.39 -9.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 127.12 2.168 . . . . 63.43 114.791 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 m -109.61 149.69 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.203 -1.036 . . . . 63.240000000000002 108.203 -167.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.43 167.4 30.15 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 105.629 -1.989 . . . . 54.450000000000003 105.629 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.05 95.54 0.1 Allowed Glycine 0 CA--C 1.46 -3.356 0 N-CA-C 104.225 -3.55 . . . . 74.430000000000007 104.225 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.66 153.07 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.091 -2.929 . . . . 74.150000000000006 103.091 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 6.5 m -91.77 159.41 15.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 103.657 -2.72 . . . . 71.010000000000005 103.657 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 m -151.0 167.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.99 -2.226 . . . . 73.5 104.99 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -167.92 170.6 10.47 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.668 -2.345 . . . . 65.019999999999996 104.668 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.57 -148.88 21.42 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 107.421 -2.272 . . . . 61.219999999999999 107.421 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 115.1 -78.69 0.27 Allowed Glycine 0 CA--C 1.481 -2.048 0 N-CA-C 108.953 -1.659 . . . . 72.140000000000001 108.953 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 27' ' ' VAL . 2.3 t -75.6 15.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 123.304 0.642 . . . . 53.210000000000001 109.819 -170.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 26' ' ' GLY . 63.0 m-80 83.81 7.05 0.65 Allowed 'General case' 0 CA--C 1.486 -1.494 0 C-N-CA 124.373 1.069 . . . . 74.109999999999999 108.182 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.8 p -47.52 -171.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.058 1.743 . . . . 74.239999999999995 113.114 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -34.99 -44.04 0.21 Allowed 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.545 1.938 . . . . 72.549999999999997 114.544 -164.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.9 m -58.39 126.44 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 122.281 1.038 . . . . 64.109999999999999 110.301 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -51.62 -52.64 46.06 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.463 -1.244 . . . . 63.5 113.833 -165.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.24 -18.88 61.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 119.088 -1.045 . . . . 63.509999999999998 109.509 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.22 54.83 2.9 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 108.271 -1.931 . . . . 72.120000000000005 108.271 172.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.43 -179.17 22.38 Favored Glycine 0 CA--C 1.461 -3.328 0 N-CA-C 104.051 -3.62 . . . . 75.329999999999998 104.051 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.463 ' HA ' HD13 ' A' ' 36' ' ' ILE . 10.0 mm -82.49 128.02 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.353 0 N-CA-C 104.409 -2.441 . . . . 53.240000000000002 104.409 171.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -106.37 150.91 25.54 Favored 'General case' 0 CA--C 1.459 -2.536 0 N-CA-C 104.432 -2.433 . . . . 64.340000000000003 104.432 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.95 103.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 N-CA-C 105.5 -2.037 . . . . 75.230000000000004 105.5 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 84.9 tttt -70.21 -33.99 72.35 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 114.393 -1.276 . . . . 72.019999999999996 109.3 -172.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.5 155.55 9.18 Favored 'General case' 0 CA--C 1.464 -2.348 0 N-CA-C 105.636 -1.987 . . . . 64.430000000000007 105.636 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.97 134.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 103.045 -2.946 . . . . 75.329999999999998 103.045 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.402 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 150.18 77.56 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 105.31 -2.108 . . . . 75.340000000000003 105.31 176.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.02 168.82 23.86 Favored 'Trans proline' 0 CA--C 1.465 -2.928 0 N-CA-C 105.528 -2.528 . . . . 74.400000000000006 105.528 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 62.93 -0.33 0.6 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.297 0.851 . . . . 73.150000000000006 113.297 167.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.5 173.81 49.89 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 106.712 -2.555 . . . . 73.430000000000007 106.712 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.79 73.95 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.961 -1.125 . . . . 51.240000000000002 107.961 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.95 -49.48 65.98 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 115.826 -0.624 . . . . 75.219999999999999 110.377 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -65.36 -56.15 14.19 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 122.145 -0.347 . . . . 71.340000000000003 110.072 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -63.73 -28.8 70.13 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 122.103 -0.373 . . . . 72.150000000000006 111.009 -170.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -83.93 -30.99 25.86 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 106.515 -1.661 . . . . 71.239999999999995 106.515 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.89 20.0 79.69 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.375 -1.09 . . . . 72.439999999999998 110.375 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB3' HG11 ' A' ' 10' ' ' VAL . 90.6 mtt-85 -97.16 6.54 48.3 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.691 -1.596 . . . . 71.040000000000006 106.691 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.2 mt -140.96 141.66 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.451 -3.166 . . . . 62.109999999999999 102.451 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -142.3 153.5 43.93 Favored 'General case' 0 CA--C 1.46 -2.482 0 N-CA-C 105.205 -2.146 . . . . 65.439999999999998 105.205 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.68 141.9 56.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.273 -1.38 . . . . 64.439999999999998 107.273 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.21 -32.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 108.898 -1.681 . . . . 72.349999999999994 108.898 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.62 154.32 29.43 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 107.83 -1.174 . . . . 62.439999999999998 107.83 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.14 135.35 53.9 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.474 -1.676 . . . . 75.420000000000002 106.474 -167.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.0 129.57 41.56 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 105.454 -2.054 . . . . 70.430000000000007 105.454 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' CD1' HG23 ' A' ' 7' ' ' ILE . 13.3 mt -95.53 -60.5 1.65 Allowed 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.527 -1.286 . . . . 62.299999999999997 107.527 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.88 48.96 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 106.099 -1.815 . . . . 74.239999999999995 106.099 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.5 t -115.31 114.85 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 105.23 -2.137 . . . . 71.349999999999994 105.23 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 t30 44.09 47.25 7.4 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.046 1.338 . . . . 64.120000000000005 111.34 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.45 -32.96 6.9 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 108.301 -1.92 . . . . 33.229999999999997 108.301 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.52 118.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.751 0 N-CA-C 109.384 -0.599 . . . . 62.420000000000002 109.384 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -54.22 109.47 0.49 Allowed 'General case' 0 C--N 1.369 1.425 0 N-CA-C 106.976 -1.49 . . . . 70.129999999999995 106.976 168.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -100.49 -13.28 18.74 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.357 -1.72 . . . . 74.129999999999995 106.357 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.27 134.32 56.35 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.458 -0.941 . . . . 65.439999999999998 108.458 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.77 -17.69 58.12 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.172 -1.971 . . . . 72.519999999999996 108.172 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 151.71 28.06 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.607 -1.998 . . . . 51.399999999999999 105.607 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.3 p -79.54 178.41 8.15 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.813 0.816 . . . . 60.329999999999998 108.935 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -68.03 -45.17 74.72 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 108.533 -0.914 . . . . 71.319999999999993 108.533 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -56.37 -51.5 68.07 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 121.577 -0.702 . . . . 74.230000000000004 110.585 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -53.61 -41.49 66.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.831 -0.433 . . . . 63.210000000000001 109.831 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.16 64.09 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.975 -0.557 . . . . 64.420000000000002 110.02 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.38 -47.41 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 107.793 -1.188 . . . . 73.049999999999997 107.793 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.9 m -56.72 -35.59 68.72 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 107.38 -1.341 . . . . 53.409999999999997 107.38 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -69.9 -47.11 63.79 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 120.484 -1.385 . . . . 75.010000000000005 108.012 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.46 -32.94 72.95 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 109.126 -0.694 . . . . 71.329999999999998 109.126 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.55 -60.71 2.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.892 -1.151 . . . . 71.219999999999999 107.892 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -69.67 48.63 0.09 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 123.569 0.748 . . . . 63.530000000000001 111.706 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.488 HG21 HG13 ' A' ' 86' ' ' VAL . 12.8 p -102.5 -175.71 2.9 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.377 -2.083 . . . . 73.409999999999997 105.377 170.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.89 -148.12 22.75 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 106.799 -2.52 . . . . 42.229999999999997 106.799 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.44 -55.24 12.54 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.102 -1.073 . . . . 73.409999999999997 108.102 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.1 140.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.41 -1.7 . . . . 73.439999999999998 106.41 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.488 HG13 HG21 ' A' ' 82' ' ' THR . 48.8 t -104.99 135.62 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.053 -1.832 . . . . 75.239999999999995 106.053 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -110.43 129.3 55.8 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 104.889 -2.263 . . . . 72.420000000000002 104.889 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.74 133.88 10.48 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.126 -1.435 . . . . 75.329999999999998 107.126 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -80.86 138.02 36.19 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 107.71 -1.219 . . . . 74.310000000000002 107.71 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.666 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.89 155.99 22.76 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.492 -2.41 . . . . 74.439999999999998 104.492 177.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.77 132.19 55.55 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 100.827 -3.768 . . . . 72.319999999999993 100.827 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.99 138.62 58.17 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.708 -0.849 . . . . 74.549999999999997 108.708 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.305 0 N-CA-C 106.858 -2.497 . . . . 74.049999999999997 106.858 -176.211 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.136 0 N-CA-C 109.344 -1.502 . . . . 64.140000000000001 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.28 141.84 31.54 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.358 -1.349 . . . . 63.329999999999998 107.358 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.5 mt -104.63 135.11 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.997 0 N-CA-C 109.069 -0.715 . . . . 75.430000000000007 109.069 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.542 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.8 p90 -130.84 149.27 52.55 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 106.56 -1.644 . . . . 72.129999999999995 106.56 169.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -103.64 146.13 29.02 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.88 -2.267 . . . . 64.409999999999997 104.88 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.633 HG22 HD21 ' A' ' 90' ' ' LEU . 28.7 m -140.75 152.37 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 106.596 -1.631 . . . . 73.209999999999994 106.596 173.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -106.99 131.69 53.77 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.737 -2.32 . . . . 71.129999999999995 104.737 168.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.98 142.37 31.62 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.207 -1.035 . . . . 63.25 108.207 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.22 150.52 21.94 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 105.099 -2.186 . . . . 72.099999999999994 105.099 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HG3' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -76.85 -35.1 57.74 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.744 -1.576 . . . . 52.409999999999997 106.744 175.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 77.54 109.91 0.07 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.466 -1.309 . . . . 70.439999999999998 107.466 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 t0 57.69 36.12 26.3 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 107.804 -1.184 . . . . 74.230000000000004 107.804 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.3 t30 52.05 2.03 0.02 OUTLIER 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.752 1.621 . . . . 75.340000000000003 112.985 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.0 m -116.54 114.04 23.6 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 120.369 -1.457 . . . . 74.329999999999998 109.027 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.511 ' HG ' ' HG3' ' A' ' 14' ' ' LYS . 49.8 mt -94.22 -153.94 0.39 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 102.468 -3.16 . . . . 52.109999999999999 102.468 162.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.07 42.19 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 107.752 -2.139 . . . . 71.150000000000006 107.752 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.418 ' H ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.3 176.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 105.428 -2.064 . . . . 74.319999999999993 105.428 175.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.62 158.33 21.87 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 104.681 -2.34 . . . . 65.150000000000006 104.681 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -145.9 172.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 N-CA-C 106.16 -1.792 . . . . 65.200000000000003 106.16 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -164.48 167.35 19.59 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 104.353 -2.462 . . . . 63.420000000000002 104.353 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 -160.12 29.11 Favored Glycine 0 CA--C 1.494 -1.272 0 N-CA-C 109.004 -1.638 . . . . 71.099999999999994 109.004 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.43 -91.38 0.31 Allowed Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 109.063 -1.615 . . . . 60.0 109.063 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -67.14 16.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.506 1.123 . . . . 63.109999999999999 113.975 -162.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 85.24 6.78 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.503 1.121 . . . . 74.530000000000001 108.716 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 p -37.97 -170.06 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 127.266 2.226 . . . . 61.210000000000001 113.895 161.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 m -57.77 -21.27 40.6 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.134 0.974 . . . . 73.420000000000002 112.333 -168.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.86 136.23 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 109.053 -0.721 . . . . 70.239999999999995 109.053 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -70.57 0.1 Allowed 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.437 1.095 . . . . 65.0 111.424 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -86.21 15.75 4.95 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.497 -0.752 . . . . 63.030000000000001 110.977 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 49.68 62.58 4.75 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 110.205 -1.158 . . . . 62.329999999999998 110.205 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.01 179.76 28.3 Favored Glycine 0 CA--C 1.454 -3.734 0 N-CA-C 103.843 -3.703 . . . . 61.409999999999997 103.843 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.87 132.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.882 0 N-CA-C 105.373 -2.084 . . . . 64.430000000000007 105.373 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -110.25 148.39 31.97 Favored 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.881 -2.637 . . . . 71.329999999999998 103.881 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -82.06 102.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.049 -1.834 . . . . 62.43 106.049 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -71.9 -33.8 68.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.459 -1.246 . . . . 63.329999999999998 110.365 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 146.97 20.49 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 106.247 -1.761 . . . . 74.209999999999994 106.247 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 48' ' ' GLU . 41.6 t -121.5 125.98 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 N-CA-C 104.853 -2.277 . . . . 65.530000000000001 104.853 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.676 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -98.59 171.21 6.02 Favored Pre-proline 0 C--O 1.213 -0.817 0 N-CA-C 105.687 -1.968 . . . . 74.129999999999995 105.687 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 60.0 Cg_endo -84.43 179.62 4.38 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.398 1.399 . . . . 72.25 110.128 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 76.25 -14.15 0.83 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.184 1.394 . . . . 72.019999999999996 113.042 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.43 -179.51 45.16 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.58 -1.408 . . . . 74.109999999999999 109.58 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.12 -53.67 12.06 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.033 -0.584 . . . . 41.039999999999999 109.558 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.53 -50.83 66.93 Favored 'General case' 0 C--N 1.369 1.43 0 CA-C-O 121.08 0.467 . . . . 54.049999999999997 110.227 -170.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 49' ' ' SER . 3.8 pm0 -61.66 -55.88 25.73 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 123.907 0.883 . . . . 70.430000000000007 110.713 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.509 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 22.0 m -62.36 -25.13 67.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.958 0.503 . . . . 65.209999999999994 110.859 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -84.35 -28.28 27.14 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.917 -1.512 . . . . 71.129999999999995 106.917 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.22 15.15 81.43 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.052 -1.219 . . . . 52.329999999999998 110.052 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -99.11 6.71 46.4 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.274 -1.38 . . . . 74.439999999999998 107.274 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 mp -132.15 137.52 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 102.099 -3.297 . . . . 73.239999999999995 102.099 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -133.68 151.37 51.63 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.75 -2.315 . . . . 71.010000000000005 104.75 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -67.9 138.14 55.78 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.736 -1.579 . . . . 73.040000000000006 106.736 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.57 -27.79 11.49 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 109.496 -1.442 . . . . 75.420000000000002 109.496 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.39 154.61 35.0 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 107.141 -1.429 . . . . 73.420000000000002 107.141 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.546 HH21 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -117.63 139.01 51.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.472 -1.677 . . . . 64.140000000000001 106.472 -166.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.5 131.0 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 105.805 -1.924 . . . . 61.439999999999998 105.805 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mt -92.32 -60.08 1.93 Allowed 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.42 -1.696 . . . . 71.219999999999999 106.42 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.78 150.64 52.09 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 107.08 -1.452 . . . . 64.0 107.08 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -120.73 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 103.683 -2.71 . . . . 75.409999999999997 103.683 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.2 t30 60.58 30.07 19.47 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 121.636 0.732 . . . . 64.299999999999997 109.098 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.58 75.16 Favored Glycine 0 CA--C 1.483 -1.942 0 N-CA-C 109.326 -1.51 . . . . 51.240000000000002 109.326 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.33 122.29 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 106.77 -1.567 . . . . 71.310000000000002 106.77 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.68 111.65 0.86 Allowed 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.557 -1.275 . . . . 25.449999999999999 107.557 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -97.92 -10.99 23.64 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 106.477 -1.675 . . . . 74.310000000000002 106.477 -167.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HB3' HH21 ' A' ' 58' ' ' ARG . 25.9 pt-20 -62.99 131.89 50.18 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.265 -0.897 . . . . 74.340000000000003 108.69 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.41 -19.72 38.31 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.336 -1.505 . . . . 73.219999999999999 109.336 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 67' ' ' LEU . . . -81.44 154.62 26.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 105.78 -1.933 . . . . 74.219999999999999 105.78 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.445 HG22 HG22 ' A' ' 27' ' ' VAL . 14.2 p -86.04 178.87 7.1 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.682 0.753 . . . . 75.120000000000005 109.683 -166.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -64.14 -45.21 89.51 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.553 -0.906 . . . . 73.219999999999999 108.553 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -50.29 -56.06 12.82 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 109.939 -0.393 . . . . 73.439999999999998 109.939 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -57.43 -45.26 84.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 116.261 -0.427 . . . . 63.049999999999997 109.963 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.19 -56.47 12.65 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 122.603 0.361 . . . . 75.129999999999995 110.921 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.77 -39.3 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 109.514 -0.55 . . . . 75.120000000000005 109.514 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.69 -29.26 69.22 Favored 'General case' 0 C--O 1.186 -2.283 0 C-N-CA 117.021 -1.871 . . . . 74.439999999999998 106.503 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -67.77 -43.23 80.3 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.506 -1.371 . . . . 33.43 107.736 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.0 mt -65.97 -37.0 84.84 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.136 -0.69 . . . . 74.010000000000005 109.136 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -77.58 -61.79 1.88 Allowed 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.026 -0.731 . . . . 72.299999999999997 109.026 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.46 62.57 1.0 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.01 0.91 . . . . 54.340000000000003 110.75 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.07 -176.67 4.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.3 -1.741 . . . . 73.310000000000002 106.3 172.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.92 -138.4 4.22 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.758 -2.137 . . . . 60.229999999999997 107.758 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.0 -56.06 5.12 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.864 -0.791 . . . . 72.219999999999999 108.864 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.0 150.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 107.504 -1.295 . . . . 71.25 107.504 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.9 t -124.77 152.67 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.02 -2.215 . . . . 65.430000000000007 105.02 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -102.55 116.61 32.95 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 104.218 -2.512 . . . . 73.120000000000005 104.218 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -135.34 116.53 14.43 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 107.508 -1.293 . . . . 64.129999999999995 107.508 -176.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.61 141.64 33.52 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 108.393 -0.965 . . . . 62.5 108.393 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.633 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -115.37 154.83 28.49 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.19 -2.152 . . . . 75.010000000000005 105.19 178.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.15 133.03 54.29 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 101.87 -3.382 . . . . 73.209999999999994 101.87 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.46 139.59 56.96 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.685 -0.857 . . . . 74.040000000000006 108.685 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.125 0 N-CA-C 108.093 -2.003 . . . . 54.210000000000001 108.093 -178.172 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.328 0 N-CA-C 109.424 -1.47 . . . . 61.020000000000003 109.424 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -73.73 134.65 43.53 Favored 'General case' 0 C--N 1.363 1.164 0 N-CA-C 106.855 -1.535 . . . . 73.0 106.855 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.494 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.4 mt -104.31 136.49 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.515 0 N-CA-C 108.146 -1.057 . . . . 71.120000000000005 108.146 -173.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.8 159.0 43.82 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.028 -1.471 . . . . 74.239999999999995 107.028 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.63 145.37 30.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 75.510000000000005 105.67 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 90' ' ' LEU . 15.9 m -140.12 151.02 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.381 -1.34 . . . . 65.439999999999998 107.381 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -112.11 125.89 54.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.941 -1.874 . . . . 44.119999999999997 105.941 167.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.13 143.59 46.64 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 106.793 -1.558 . . . . 72.400000000000006 106.793 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.44 152.39 21.5 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.83 -1.915 . . . . 51.229999999999997 105.83 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -69.45 -36.01 76.21 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.846 -1.168 . . . . 73.310000000000002 107.846 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.24 112.84 0.07 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.44 -0.948 . . . . 71.040000000000006 108.44 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.3 32.95 21.39 Favored 'General case' 0 C--N 1.369 1.456 0 N-CA-C 108.603 -0.888 . . . . 53.350000000000001 108.603 -174.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.3 t30 48.6 -1.39 0.0 OUTLIER 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.284 1.834 . . . . 51.409999999999997 114.1 -174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -89.83 172.92 8.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.276 -1.379 . . . . 61.299999999999997 107.276 -170.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.88 -156.31 0.56 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 103.753 -2.684 . . . . 73.25 103.753 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.66 39.37 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.684 0 N-CA-C 105.912 -2.875 . . . . 65.0 105.912 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.99 177.11 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 104.309 -2.478 . . . . 71.310000000000002 104.309 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -141.83 166.52 24.51 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 104.905 -2.257 . . . . 53.43 104.905 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.406 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.6 m -147.65 172.13 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 N-CA-C 105.871 -1.9 . . . . 53.310000000000002 105.871 -172.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -167.94 168.49 12.07 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 104.404 -2.443 . . . . 71.510000000000005 104.404 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.46 -141.42 20.46 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 108.733 -1.747 . . . . 51.130000000000003 108.733 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 100.07 -70.19 0.49 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 109.038 -1.625 . . . . 61.399999999999999 109.038 174.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 71' ' ' THR . 1.9 t -76.98 13.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 121.397 0.618 . . . . 74.140000000000001 109.475 -171.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 26' ' ' GLY . 2.3 m120 78.77 6.39 2.31 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.521 1.128 . . . . 65.230000000000004 109.333 176.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.6 t -53.0 -170.7 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 124.2 1.0 . . . . 74.230000000000004 111.378 167.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 m -30.81 -44.87 0.06 Allowed 'General case' 0 C--N 1.366 1.307 0 C-N-CA 127.448 2.299 . . . . 75.340000000000003 115.657 -162.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.07 132.68 21.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.513 0.673 . . . . 72.310000000000002 110.722 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -49.94 -57.66 7.04 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-N 115.138 -0.937 . . . . 73.540000000000006 112.677 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -72.81 -20.9 61.06 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.897 -0.721 . . . . 72.120000000000005 109.478 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.21 -14.81 62.12 Favored Glycine 0 C--N 1.359 1.835 0 N-CA-C 109.323 -1.511 . . . . 60.210000000000001 109.323 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.19 -178.96 48.24 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 109.09 -1.604 . . . . 61.409999999999997 109.09 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.418 HG13 HD12 ' A' ' 67' ' ' LEU . 13.7 mm -81.66 124.5 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 103.014 -2.958 . . . . 65.329999999999998 103.014 171.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -100.87 150.4 22.87 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 103.688 -2.708 . . . . 73.239999999999995 103.688 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.1 t -80.18 102.97 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.078 -2.193 . . . . 64.200000000000003 105.078 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -71.57 -32.87 68.56 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.752 -1.113 . . . . 72.400000000000006 109.933 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.82 147.9 22.0 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 106.273 -1.751 . . . . 71.209999999999994 106.273 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.13 133.05 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 N-CA-C 103.174 -2.898 . . . . 64.099999999999994 103.174 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.476 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.95 152.5 71.75 Favored Pre-proline 0 CA--C 1.511 -0.526 0 N-CA-C 106.502 -1.666 . . . . 60.350000000000001 106.502 176.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 58.8 Cg_endo -76.86 172.57 15.96 Favored 'Trans proline' 0 CA--C 1.463 -3.053 0 N-CA-C 105.909 -2.381 . . . . 71.420000000000002 105.909 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 66.21 -1.72 1.13 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 124.294 0.996 . . . . 54.329999999999998 111.994 163.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.65 -179.1 36.5 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 107.334 -2.306 . . . . 63.340000000000003 107.334 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.89 -52.94 45.83 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.268 -1.012 . . . . 62.0 108.268 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.37 65.24 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.379 -0.373 . . . . 75.219999999999999 110.838 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.0 -55.31 26.85 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 109.583 -0.525 . . . . 75.409999999999997 109.583 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 t -58.35 -32.51 68.6 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.045 0.538 . . . . 64.209999999999994 110.641 -171.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.91 -29.6 29.1 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.797 -1.186 . . . . 62.399999999999999 107.797 -172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.25 83.65 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 110.36 -1.096 . . . . 64.049999999999997 110.36 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -99.31 6.39 46.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 106.709 -1.589 . . . . 72.540000000000006 106.709 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.0 mt -142.44 138.59 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 103.098 -2.927 . . . . 72.409999999999997 103.098 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.02 166.34 26.35 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.482 -2.414 . . . . 74.0 104.482 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.72 145.77 54.43 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 107.119 -1.437 . . . . 64.200000000000003 107.119 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.59 -33.01 5.97 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 107.982 -2.047 . . . . 64.439999999999998 107.982 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.92 149.08 45.52 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 106.941 -1.503 . . . . 70.439999999999998 106.941 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.79 143.86 47.62 Favored 'General case' 0 CA--C 1.473 -2.009 0 N-CA-C 107.259 -1.386 . . . . 72.200000000000003 107.259 -165.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.26 130.07 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 105.826 -1.916 . . . . 62.210000000000001 105.826 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.494 ' CD1' HG23 ' A' ' 7' ' ' ILE . 78.6 mt -95.27 -59.28 1.92 Allowed 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.275 -1.38 . . . . 72.120000000000005 107.275 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.95 51.17 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 105.946 -1.872 . . . . 62.530000000000001 105.946 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.73 121.45 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.376 -2.083 . . . . 63.310000000000002 105.376 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.47 30.5 13.01 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.524 0.678 . . . . 70.040000000000006 109.724 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.81 -18.2 57.2 Favored Glycine 0 CA--C 1.48 -2.152 0 N-CA-C 109.158 -1.577 . . . . 73.010000000000005 109.158 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.64 115.75 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 108.266 -1.013 . . . . 73.219999999999999 108.266 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 m -56.74 120.0 7.11 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 107.899 -1.148 . . . . 75.329999999999998 107.899 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.418 HD12 HG13 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -111.92 -11.83 13.84 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.663 -1.606 . . . . 63.530000000000001 106.663 -162.079 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -56.38 128.34 35.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.969 -0.752 . . . . 75.430000000000007 108.969 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.88 -13.03 68.31 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 108.773 -1.731 . . . . 65.430000000000007 108.773 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.74 157.04 20.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.56 -1.645 . . . . 63.229999999999997 106.56 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.421 HG22 HG22 ' A' ' 27' ' ' VAL . 41.1 p -85.68 179.08 7.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.735 0.778 . . . . 75.420000000000002 109.402 -171.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -64.7 -45.22 87.51 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 115.392 -0.822 . . . . 73.530000000000001 108.97 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -54.5 -55.24 31.14 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 121.567 -0.708 . . . . 62.140000000000001 109.955 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -53.84 -43.76 69.74 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.696 -0.483 . . . . 70.239999999999995 109.696 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.35 27.25 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.811 0.444 . . . . 42.039999999999999 110.531 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 m -74.98 -35.47 35.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 O-C-N 121.976 -0.453 . . . . 73.420000000000002 109.835 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 12.6 t -69.11 -32.9 72.63 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 116.854 -1.938 . . . . 63.310000000000002 105.986 -169.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -73.09 -45.14 58.87 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 106.996 -1.483 . . . . 61.340000000000003 106.996 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.0 -45.15 95.98 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.831 1.253 . . . . 74.310000000000002 109.562 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -67.38 -56.2 10.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.517 -0.92 . . . . 73.439999999999998 108.517 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -71.47 52.16 0.19 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.75 0.42 . . . . 54.509999999999998 110.854 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 86' ' ' VAL . 6.2 p -101.69 -175.49 2.87 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.589 -2.004 . . . . 71.150000000000006 105.589 168.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.79 -152.72 17.45 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.222 -2.351 . . . . 61.109999999999999 107.222 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -63.33 -55.34 25.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.191 -1.04 . . . . 73.239999999999995 108.191 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.59 145.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 106.388 -1.708 . . . . 73.230000000000004 106.388 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 82' ' ' THR . 23.6 t -101.17 129.03 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 N-CA-C 105.242 -2.133 . . . . 74.430000000000007 105.242 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -111.98 121.63 45.54 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 104.063 -2.569 . . . . 61.43 104.063 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.68 133.61 12.28 Favored 'General case' 0 CA--C 1.46 -2.498 0 N-CA-C 106.518 -1.66 . . . . 71.5 106.518 -174.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -86.98 145.38 26.53 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 107.938 -1.134 . . . . 54.299999999999997 107.938 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.568 ' H ' HD22 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -131.8 169.05 16.77 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.533 -2.025 . . . . 65.400000000000006 105.533 174.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.42 153.06 48.3 Favored 'General case' 0 N--CA 1.402 -2.843 0 N-CA-C 101.822 -3.399 . . . . 74.530000000000001 101.822 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 6.5 mmpt? -65.32 135.03 54.83 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.743 -1.206 . . . . 74.230000000000004 107.743 175.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.466 -2.969 0 N-CA-C 107.131 -2.388 . . . . 74.209999999999994 107.131 -176.514 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.642 0 N-CA-C 108.68 -1.768 . . . . 61.310000000000002 108.68 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -83.19 138.75 33.51 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.601 -1.629 . . . . 75.310000000000002 106.601 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.546 HG23 ' CD1' ' A' ' 60' ' ' LEU . 23.4 mm -95.91 122.44 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 105.949 -1.871 . . . . 65.430000000000007 105.949 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.63 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.8 p90 -136.68 157.02 47.74 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.397 -0.964 . . . . 74.450000000000003 108.397 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.515 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 47.1 mt-10 -103.01 148.44 25.69 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 104.512 -2.403 . . . . 74.430000000000007 104.512 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.779 HG22 HD21 ' A' ' 90' ' ' LEU . 15.9 m -137.05 147.1 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.062 0 N-CA-C 106.078 -1.823 . . . . 51.420000000000002 106.078 170.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.63 118.18 35.95 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 104.671 -2.344 . . . . 74.25 104.671 168.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.416 HD13 HD12 ' A' ' 53' ' ' ILE . 59.3 mt -139.61 135.88 33.79 Favored 'General case' 0 CA--C 1.455 -2.7 0 N-CA-C 105.673 -1.973 . . . . 74.049999999999997 105.673 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . . . -85.45 157.26 20.52 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 106.753 -1.573 . . . . 71.430000000000007 106.753 -176.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.23 -40.72 98.24 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 106.747 -1.575 . . . . 74.239999999999995 106.747 167.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 78.36 108.32 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 107.828 -1.175 . . . . 72.340000000000003 107.828 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 18' ' ' SER . 68.4 m-20 56.81 39.09 29.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.79 0.836 . . . . 73.430000000000007 108.843 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.3 t30 55.03 -9.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.728 1.611 . . . . 53.420000000000002 113.634 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 16' ' ' ASP . 32.6 t -99.67 120.53 39.85 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.712 -1.959 . . . . 75.430000000000007 105.712 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.714 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -70.91 -56.18 6.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.904 -1.147 . . . . 54.100000000000001 107.904 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.72 85.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 109.91 -1.276 . . . . 63.229999999999997 109.91 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 22' ' ' CYS . 5.2 mm -86.7 176.57 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 105.262 -2.125 . . . . 61.009999999999998 105.262 -174.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 21' ' ' ILE . 60.0 m -138.64 164.38 29.66 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 103.754 -2.684 . . . . 72.420000000000002 103.754 174.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.65 171.93 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 105.772 -1.936 . . . . 72.140000000000001 105.772 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 t -164.15 170.64 16.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.399 -2.075 . . . . 72.340000000000003 105.399 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 -154.53 21.97 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 107.165 -2.374 . . . . 55.43 107.165 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.12 -99.0 0.65 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 109.435 -1.466 . . . . 60.399999999999999 109.435 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -68.36 16.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.211 1.189 . . . . 63.530000000000001 114.211 -161.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m120 85.24 6.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.267 1.027 . . . . 51.399999999999999 108.714 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -43.09 -168.34 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 126.737 2.015 . . . . 63.340000000000003 110.009 151.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 m -28.75 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.205 1.802 . . . . 64.310000000000002 114.942 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 131.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.207 -1.035 . . . . 74.540000000000006 108.207 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.13 -40.34 38.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.492 -0.929 . . . . 73.049999999999997 108.492 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -64.14 -18.01 64.03 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.916 -0.772 . . . . 73.219999999999999 108.916 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.69 2.31 64.07 Favored Glycine 0 C--O 1.208 -1.477 0 N-CA-C 110.722 -0.951 . . . . 71.200000000000003 110.722 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.93 177.68 52.15 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 106.614 -2.594 . . . . 62.100000000000001 106.614 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -90.78 136.55 23.78 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 N-CA-C 104.415 -2.439 . . . . 73.510000000000005 104.415 174.539 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -108.4 148.73 29.72 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 103.358 -2.83 . . . . 71.319999999999993 103.358 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.65 102.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 106.547 -1.649 . . . . 63.149999999999999 106.547 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -71.66 -36.3 70.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.665 -1.152 . . . . 75.209999999999994 110.45 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.97 148.94 22.77 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.061 -1.829 . . . . 74.120000000000005 106.061 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.49 138.01 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 103.936 -2.616 . . . . 75.439999999999998 103.936 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -79.17 155.52 77.06 Favored Pre-proline 0 CA--C 1.515 -0.386 0 N-CA-C 105.738 -1.949 . . . . 74.019999999999996 105.738 173.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 75.2 Cg_endo -74.39 171.7 17.57 Favored 'Trans proline' 0 CA--C 1.461 -3.168 0 N-CA-C 105.72 -2.454 . . . . 61.43 105.72 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 65.07 -0.2 1.11 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.012 0.82 . . . . 74.450000000000003 112.13 164.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.55 174.14 41.1 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 106.624 -2.59 . . . . 70.430000000000007 106.624 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.17 -52.87 36.17 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 107.854 -1.165 . . . . 42.219999999999999 107.854 -173.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.23 -50.66 64.3 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 116.068 -0.515 . . . . 71.450000000000003 111.008 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.04 -54.47 21.27 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 109.933 -0.395 . . . . 73.030000000000001 109.933 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.3 t -61.76 -28.58 69.54 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.792 0.437 . . . . 72.239999999999995 110.965 -170.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.29 -30.2 38.26 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.105 -1.813 . . . . 75.510000000000005 106.105 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.47 20.01 61.05 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 110.146 -1.182 . . . . 71.549999999999997 110.146 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -107.59 7.24 28.56 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.696 -1.224 . . . . 75.400000000000006 107.696 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.416 HD12 HD13 ' A' ' 12' ' ' LEU . 77.7 mt -144.55 145.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 102.359 -3.2 . . . . 71.450000000000003 102.359 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -151.26 176.19 11.46 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 104.77 -2.307 . . . . 74.530000000000001 104.77 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -67.23 143.29 56.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.671 -1.233 . . . . 72.099999999999994 107.671 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.44 -32.01 7.66 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.029 -1.628 . . . . 64.25 109.029 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.19 160.1 31.76 Favored 'General case' 0 C--N 1.372 1.563 0 N-CA-C 107.347 -1.353 . . . . 62.539999999999999 107.347 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -128.42 151.51 49.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.829 -0.804 . . . . 74.439999999999998 108.829 -168.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.92 135.78 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.525 -2.028 . . . . 64.140000000000001 105.525 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.546 ' CD1' HG23 ' A' ' 7' ' ' ILE . 53.0 mt -98.5 -58.76 1.89 Allowed 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 107.391 -1.337 . . . . 54.219999999999999 107.391 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.97 148.99 48.7 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 106.149 -1.797 . . . . 71.140000000000001 106.149 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.46 122.2 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.376 -2.453 . . . . 72.019999999999996 104.376 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.31 6.2 p30 44.59 39.9 3.64 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.36 1.064 . . . . 61.109999999999999 111.161 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.87 -22.34 41.1 Favored Glycine 0 CA--C 1.471 -2.665 0 N-CA-C 108.936 -1.665 . . . . 74.120000000000005 108.936 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -78.25 114.83 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 N-CA-C 107.369 -1.345 . . . . 74.120000000000005 107.369 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 m -56.01 120.36 7.33 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.877 -0.786 . . . . 64.230000000000004 108.877 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -99.37 -17.29 18.08 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 106.916 -1.513 . . . . 75.439999999999998 106.916 -164.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -62.05 125.08 22.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.397 0.618 . . . . 72.420000000000002 109.878 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 -15.28 62.0 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 108.019 -2.032 . . . . 53.43 108.019 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 149.29 34.78 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 106.146 -1.798 . . . . 43.329999999999998 106.146 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.0 p -80.51 179.05 7.93 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.708 -0.849 . . . . 71.120000000000005 108.708 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -63.46 -50.18 70.7 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.117 -1.068 . . . . 74.219999999999999 108.117 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -54.2 -55.74 25.04 Favored 'General case' 0 C--N 1.362 1.148 0 O-C-N 121.66 -0.65 . . . . 73.329999999999998 110.601 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -54.59 -46.46 73.77 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 109.395 -0.594 . . . . 63.299999999999997 109.395 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.99 -52.47 50.32 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.163 0.585 . . . . 75.129999999999995 110.568 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.64 -40.11 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 108.025 -1.102 . . . . 75.219999999999999 108.025 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 t -63.95 -30.99 72.02 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 106.551 -1.648 . . . . 71.5 106.551 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.6 m -71.79 -45.79 60.43 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.602 -1.259 . . . . 74.349999999999994 107.602 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.99 -40.46 89.23 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 108.945 -0.761 . . . . 71.340000000000003 108.945 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.6 -60.56 3.35 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 108.2 -1.037 . . . . 63.340000000000003 108.2 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -71.36 53.37 0.2 Allowed 'General case' 0 C--N 1.373 1.605 0 C-N-CA 123.543 0.737 . . . . 53.439999999999998 110.572 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.469 HG21 HG13 ' A' ' 86' ' ' VAL . 16.1 p -112.38 -176.23 2.87 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.544 -2.021 . . . . 63.119999999999997 105.544 168.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.75 -159.69 32.4 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.195 -2.362 . . . . 63.32 107.195 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -56.86 -53.52 56.98 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.646 -0.872 . . . . 71.530000000000001 108.646 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' ALA . 86.5 t -105.66 147.2 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 106.012 -1.847 . . . . 45.020000000000003 106.012 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 82' ' ' THR . 39.6 t -100.37 129.53 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 106.66 -1.607 . . . . 74.239999999999995 106.66 -171.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.515 ' HE1' ' OE1' ' A' ' 9' ' ' GLU . 58.3 t60 -103.89 117.27 33.94 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 105.089 -2.189 . . . . 64.310000000000002 105.089 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.76 134.42 14.57 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 107.603 -1.258 . . . . 71.010000000000005 107.603 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.45 141.41 33.92 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.447 -1.316 . . . . 55.32 107.447 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.779 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.11 163.51 16.15 Favored 'General case' 0 CA--C 1.473 -2.001 0 N-CA-C 105.605 -1.998 . . . . 71.209999999999994 105.605 175.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HB2' HD11 ' A' ' 60' ' ' LEU . 33.9 tt0 -130.76 139.2 50.23 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 101.45 -3.537 . . . . 71.519999999999996 101.45 165.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -66.19 142.46 57.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.176 -1.046 . . . . 73.329999999999998 108.176 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.678 0 N-CA-C 105.859 -2.896 . . . . 72.329999999999998 105.859 179.592 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.744 0 N-CA-C 110.004 -1.239 . . . . 72.450000000000003 110.004 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.18 130.71 40.28 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.212 -1.403 . . . . 74.310000000000002 107.212 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 HD11 ' A' ' 60' ' ' LEU . 12.0 mm -98.45 136.16 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.19 -1.781 . . . . 73.340000000000003 106.19 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.79 160.09 43.11 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.68 -0.859 . . . . 73.239999999999995 108.68 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.497 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 50.5 mt-10 -105.83 145.96 30.52 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 105.511 -2.033 . . . . 70.030000000000001 105.511 176.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.99 156.5 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 106.82 -1.548 . . . . 54.409999999999997 106.82 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -116.11 134.76 54.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.517 -2.031 . . . . 65.099999999999994 105.517 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.409 HD22 HD13 ' A' ' 53' ' ' ILE . 4.3 mp -135.61 145.82 47.28 Favored 'General case' 0 CA--C 1.454 -2.721 0 N-CA-C 107.755 -1.202 . . . . 74.019999999999996 107.755 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.06 142.33 28.0 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 105.206 -2.146 . . . . 54.32 105.206 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HG2' ' HB2' ' A' ' 19' ' ' LEU . 37.0 mtpt -77.68 -33.44 53.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 106.133 -1.803 . . . . 73.109999999999999 106.133 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 70.55 126.13 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.066 -1.424 . . . . 65.340000000000003 108.79 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.0 t70 59.71 34.82 22.16 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.075 -0.713 . . . . 74.019999999999996 109.075 173.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.1 t30 55.38 -9.18 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.009 1.724 . . . . 74.129999999999995 113.582 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.4 m -99.2 130.68 45.52 Favored 'General case' 0 N--CA 1.424 -1.732 0 O-C-N 120.815 -1.178 . . . . 70.120000000000005 108.535 -168.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 24.7 tp -134.04 139.3 45.92 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 102.679 -3.082 . . . . 71.510000000000005 102.679 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.85 62.48 0.24 Allowed Glycine 0 CA--C 1.464 -3.137 0 N-CA-C 106.215 -2.754 . . . . 63.520000000000003 106.215 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 22' ' ' CYS . 1.1 mm -88.54 178.14 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.198 -2.519 . . . . 74.319999999999993 104.198 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' H ' HG22 ' A' ' 21' ' ' ILE . 8.2 m -118.43 160.35 21.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.016 -2.216 . . . . 75.010000000000005 105.016 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 m -152.05 173.03 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 106.1 -1.815 . . . . 60.229999999999997 106.1 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.404 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 12.4 t -167.22 170.54 11.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.115 -1.809 . . . . 61.299999999999997 106.115 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.57 -145.39 17.71 Favored Glycine 0 CA--C 1.485 -1.796 0 N-CA-C 109.857 -1.297 . . . . 65.439999999999998 109.857 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.67 -79.26 0.25 Allowed Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.784 -1.727 . . . . 61.229999999999997 108.784 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -77.07 15.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.817 0 N-CA-C 112.304 0.483 . . . . 72.019999999999996 112.304 -164.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 85.58 6.36 0.44 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 124.234 1.014 . . . . 54.200000000000003 109.35 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.1 p -46.94 -168.9 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.901 1.68 . . . . 71.420000000000002 112.188 165.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 m -35.13 -35.53 0.04 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.045 1.738 . . . . 74.530000000000001 113.596 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 m -58.84 113.28 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.412 1.101 . . . . 74.230000000000004 110.159 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -47.87 -58.97 3.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.812 -1.086 . . . . 73.420000000000002 112.626 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -69.18 -20.65 64.0 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.822 -0.548 . . . . 64.340000000000003 110.071 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 52.34 4.02 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 107.591 -2.204 . . . . 71.239999999999995 107.591 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.4 179.81 25.88 Favored Glycine 0 CA--C 1.459 -3.459 0 N-CA-C 103.108 -3.997 . . . . 74.040000000000006 103.108 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.9 mm -88.71 127.78 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.792 0 N-CA-C 105.236 -2.135 . . . . 73.200000000000003 105.236 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -107.41 154.66 21.0 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 104.677 -2.342 . . . . 75.209999999999994 104.677 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 41' ' ' VAL . 60.6 t -87.25 101.71 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 N-CA-C 105.089 -2.189 . . . . 72.140000000000001 105.089 171.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HE2' ' HB ' ' A' ' 24' ' ' THR . 11.5 ttmm -71.62 -26.2 62.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.121 -0.945 . . . . 74.019999999999996 109.082 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 142.96 16.69 Favored 'General case' 0 CA--C 1.46 -2.495 0 N-CA-C 105.627 -1.99 . . . . 64.450000000000003 105.627 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 38' ' ' VAL . 84.8 t -110.21 125.98 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 102.729 -3.064 . . . . 62.119999999999997 102.729 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.566 ' O ' HD12 ' A' ' 42' ' ' ILE . 2.4 pp -76.63 145.95 75.96 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.978 -1.86 . . . . 73.540000000000006 105.978 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.81 174.53 12.43 Favored 'Trans proline' 0 CA--C 1.469 -2.742 0 N-CA-C 105.813 -2.418 . . . . 74.329999999999998 105.813 -174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 69.05 -11.85 0.43 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.238 0.961 . . . . 73.420000000000002 112.597 161.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.23 -177.69 40.34 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 108.275 -1.93 . . . . 65.409999999999997 108.275 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.59 60.53 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 108.167 -1.049 . . . . 61.130000000000003 108.167 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.48 65.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.174 -0.466 . . . . 52.140000000000001 110.675 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.62 -53.87 44.79 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 122.009 -0.432 . . . . 74.549999999999997 109.876 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 t -60.14 -33.53 72.29 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.288 -0.634 . . . . 72.549999999999997 109.288 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.97 -43.42 35.1 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.342 -1.355 . . . . 60.240000000000002 107.342 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.94 11.08 79.78 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.615 -0.994 . . . . 52.030000000000001 110.615 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -95.24 7.33 46.48 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.583 -1.265 . . . . 64.409999999999997 107.583 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.449 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 1.6 mp -134.32 139.4 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 102.537 -3.134 . . . . 64.409999999999997 102.537 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.449 ' CD2' ' O ' ' A' ' 53' ' ' ILE . 26.3 m170 -148.04 161.45 41.36 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 104.986 -2.227 . . . . 70.030000000000001 104.986 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -66.6 138.93 57.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.996 -1.112 . . . . 60.43 107.996 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.41 -32.51 7.48 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 108.069 -2.012 . . . . 70.340000000000003 108.069 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.97 154.23 41.65 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 107.011 -1.478 . . . . 73.150000000000006 107.011 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 91' ' ' GLU . 19.1 ptt-85 -131.38 155.16 47.76 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.369 -0.974 . . . . 61.5 108.369 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.28 139.44 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 105.908 -1.886 . . . . 74.310000000000002 105.908 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD11 HD12 ' A' ' 7' ' ' ILE . 93.6 mt -102.28 -57.97 1.96 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.832 -1.544 . . . . 63.530000000000001 106.832 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.24 148.34 49.56 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.549 -2.019 . . . . 54.340000000000003 105.549 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.6 119.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 105.233 -2.136 . . . . 73.439999999999998 105.233 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.8 t30 53.57 36.12 22.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.606 0.762 . . . . 73.140000000000001 109.841 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.87 -21.77 44.25 Favored Glycine 0 CA--C 1.474 -2.524 0 N-CA-C 108.777 -1.729 . . . . 70.299999999999997 108.777 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.8 115.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 108.082 -1.081 . . . . 64.120000000000005 108.082 -172.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -52.41 120.97 6.16 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.523 0.729 . . . . 60.43 109.122 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -109.94 -19.16 13.2 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 107.549 -1.278 . . . . 64.340000000000003 107.549 -167.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.9 127.37 31.11 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 120.787 -1.196 . . . . 73.430000000000007 108.38 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.86 62.06 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 108.553 -1.819 . . . . 65.219999999999999 108.553 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.76 151.24 30.48 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 105.311 -2.107 . . . . 62.409999999999997 105.311 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.401 ' HA ' HG22 ' A' ' 27' ' ' VAL . 58.6 p -81.68 179.39 7.85 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.712 -0.847 . . . . 72.329999999999998 108.712 -171.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.5 -45.32 69.21 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.197 -1.038 . . . . 73.340000000000003 108.197 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -52.49 -56.11 17.38 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 121.339 -0.851 . . . . 53.219999999999999 109.852 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -53.75 -41.63 67.32 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 109.746 -0.465 . . . . 74.230000000000004 109.746 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -53.0 -50.04 65.01 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 116.087 -0.506 . . . . 62.420000000000002 109.933 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.2 t -73.52 -42.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 108.067 -1.086 . . . . 72.310000000000002 108.067 -174.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.4 m -57.97 -35.12 70.72 Favored 'General case' 0 N--CA 1.523 3.224 0 N-CA-C 106.177 -1.786 . . . . 64.340000000000003 106.177 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.6 m -73.24 -47.89 39.47 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.904 -1.043 . . . . 74.230000000000004 108.554 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.75 -37.67 82.46 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.379 -0.6 . . . . 53.240000000000002 109.379 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -69.12 -60.53 2.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.614 -1.254 . . . . 72.109999999999999 107.614 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -69.17 57.39 0.1 Allowed 'General case' 0 C--N 1.367 1.337 0 C-N-CA 123.595 0.758 . . . . 72.209999999999994 110.981 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -109.24 -176.38 3.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.775 -1.565 . . . . 55.399999999999999 106.775 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.27 -144.99 16.07 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.313 -2.315 . . . . 73.049999999999997 107.313 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -72.19 -55.58 7.01 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.666 -0.864 . . . . 74.230000000000004 108.666 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.52 146.84 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 106.19 -1.781 . . . . 75.319999999999993 106.19 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -105.08 132.85 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 105.241 -2.133 . . . . 64.239999999999995 105.241 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . 0.497 ' HE1' ' OE1' ' A' ' 9' ' ' GLU . 61.1 t-80 -113.21 132.55 55.46 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.73 -2.322 . . . . 63.229999999999997 104.73 173.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -159.49 143.5 14.88 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 108.582 -0.895 . . . . 74.510000000000005 108.582 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.08 137.88 35.98 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 107.267 -1.383 . . . . 61.030000000000001 107.267 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.69 161.9 36.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.531 -1.285 . . . . 74.239999999999995 107.531 176.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 58' ' ' ARG . 79.6 tt0 -133.69 141.76 47.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 104.183 -2.525 . . . . 64.400000000000006 104.183 -173.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -66.82 144.35 56.35 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.928 -0.767 . . . . 74.120000000000005 108.928 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.474 -2.485 0 N-CA-C 105.665 -2.974 . . . . 71.209999999999994 105.665 178.92 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 109.231 -1.547 . . . . 71.510000000000005 109.231 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -77.07 134.29 38.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.839 -1.541 . . . . 75.439999999999998 106.839 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.407 HD13 HD11 ' A' ' 60' ' ' LEU . 2.5 mt -105.25 138.12 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 N-CA-C 107.405 -1.332 . . . . 71.239999999999995 107.405 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -156.41 172.37 18.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.368 -1.345 . . . . 73.450000000000003 107.368 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.01 155.01 27.75 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 106.051 -1.833 . . . . 73.409999999999997 106.051 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.84 156.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 105.711 -1.959 . . . . 54.509999999999998 105.711 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.84 130.35 55.0 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.176 -1.787 . . . . 63.130000000000003 106.176 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.72 140.06 47.91 Favored 'General case' 0 CA--C 1.46 -2.501 0 N-CA-C 106.875 -1.528 . . . . 55.310000000000002 106.875 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 140.99 31.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.648 -1.982 . . . . 62.119999999999997 105.648 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -68.61 -28.2 66.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.648 -1.241 . . . . 73.0 107.648 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 t30 86.51 93.54 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.324 -1.361 . . . . 72.340000000000003 107.324 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.28 47.77 6.7 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.772 -1.195 . . . . 52.450000000000003 107.772 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 45.94 -0.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 127.588 2.355 . . . . 62.439999999999998 115.407 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -104.83 115.27 30.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.887 1.221 . . . . 62.310000000000002 108.03 -172.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.718 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.6 pt? -89.48 -155.39 0.35 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.432 -1.692 . . . . 71.010000000000005 106.432 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.34 55.56 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.189 0 N-CA-C 106.275 -2.73 . . . . 71.299999999999997 106.275 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.3 mm -106.65 178.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.119 -2.919 . . . . 72.420000000000002 103.119 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.417 ' H ' HG22 ' A' ' 21' ' ' ILE . 56.0 m -133.01 163.79 28.43 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.176 -2.157 . . . . 75.200000000000003 105.176 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.35 175.86 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.827 -1.546 . . . . 64.310000000000002 106.827 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -164.21 167.0 20.54 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 104.816 -2.29 . . . . 73.230000000000004 104.816 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.49 23.28 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 108.479 -1.849 . . . . 64.239999999999995 108.479 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.68 -74.13 0.21 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 108.776 -1.729 . . . . 63.340000000000003 108.776 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.14 15.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.203 0.525 . . . . 73.219999999999999 109.659 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.8 t30 84.46 5.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.962 1.305 . . . . 73.310000000000002 108.006 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -53.74 -170.69 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.53 1.132 . . . . 73.209999999999994 112.293 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 m -29.46 -45.73 0.05 OUTLIER 'General case' 0 C--N 1.367 1.366 0 C-N-CA 126.843 2.057 . . . . 52.140000000000001 115.934 -159.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.52 125.56 19.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 CA-C-O 122.05 0.929 . . . . 75.219999999999999 109.954 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.3 ptp85 -52.65 -44.31 66.07 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.583 -1.19 . . . . 63.149999999999999 112.884 -169.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.411 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 23.8 t-160 -75.45 -21.25 58.27 Favored 'General case' 0 C--N 1.37 1.486 0 O-C-N 120.823 -1.173 . . . . 73.510000000000005 108.719 -175.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -14.79 62.97 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 109.878 -1.289 . . . . 62.409999999999997 109.878 171.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.95 179.92 44.13 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 108.551 -1.82 . . . . 71.310000000000002 108.551 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.1 mm -83.2 127.85 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 N-CA-C 104.336 -2.468 . . . . 74.439999999999998 104.336 171.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.53 152.27 23.9 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 104.567 -2.383 . . . . 74.030000000000001 104.567 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.27 100.29 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 104.785 -2.302 . . . . 74.340000000000003 104.785 170.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.64 -17.97 42.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.788 -1.096 . . . . 73.540000000000006 111.725 -176.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.86 19.53 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 106.997 -1.483 . . . . 72.510000000000005 106.997 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.89 132.02 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 103.581 -2.748 . . . . 75.230000000000004 103.581 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.93 145.6 81.44 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 106.252 -1.759 . . . . 73.209999999999994 106.252 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.01 167.02 27.95 Favored 'Trans proline' 0 CA--C 1.464 -2.996 0 N-CA-C 106.848 -2.02 . . . . 64.420000000000002 106.848 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 69.06 2.1 3.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 124.474 1.109 . . . . 73.519999999999996 110.884 165.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.68 -175.77 38.43 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 108.515 -1.834 . . . . 53.43 108.515 -174.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.58 55.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 108.123 -1.066 . . . . 65.0 108.123 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.72 -49.39 62.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.978 -0.556 . . . . 52.310000000000002 110.417 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.31 -52.64 31.25 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.875 -0.33 . . . . 64.349999999999994 110.407 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.8 t -65.73 -36.24 83.04 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.686 -0.634 . . . . 70.540000000000006 109.973 -169.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.57 -25.57 35.69 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 106.672 -1.603 . . . . 62.420000000000002 106.672 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.1 78.78 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.75 -0.94 . . . . 74.420000000000002 110.75 167.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -87.24 1.99 51.45 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.684 -1.228 . . . . 74.310000000000002 107.684 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.9 mt -143.6 140.89 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 103.832 -2.655 . . . . 74.340000000000003 103.832 -168.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -142.72 159.4 42.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.029 -2.582 . . . . 75.140000000000001 104.029 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.45 142.88 57.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.007 -1.109 . . . . 72.549999999999997 108.007 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.56 -31.87 8.14 Favored Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 107.467 -2.253 . . . . 73.209999999999994 107.467 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -58.86 147.86 32.24 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 109.039 -0.726 . . . . 62.310000000000002 109.039 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -114.88 139.93 49.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.623 -1.251 . . . . 72.209999999999994 107.623 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.89 129.03 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.451 -2.055 . . . . 64.439999999999998 105.451 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.407 HD11 HD13 ' A' ' 7' ' ' ILE . 89.2 mt -97.33 -58.81 1.92 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 106.905 -1.517 . . . . 54.030000000000001 106.905 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.23 148.76 48.22 Favored 'General case' 0 CA--C 1.476 -1.865 0 N-CA-C 106.414 -1.699 . . . . 71.040000000000006 106.414 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.2 121.59 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 105.29 -2.115 . . . . 64.340000000000003 105.29 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.9 t30 53.16 37.32 24.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 71.140000000000001 110.046 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.49 -26.88 22.05 Favored Glycine 0 CA--C 1.471 -2.672 0 N-CA-C 108.513 -1.835 . . . . 61.32 108.513 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 83.4 t -79.4 116.69 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 107.809 -1.182 . . . . 74.400000000000006 107.809 -171.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 114.65 1.76 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 108.593 -0.892 . . . . 72.239999999999995 108.593 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 75' ' ' ALA . 2.1 tm? -102.27 -18.82 15.29 Favored 'General case' 0 C--O 1.191 -1.992 0 N-CA-C 106.363 -1.717 . . . . 73.400000000000006 106.363 -167.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.16 129.14 39.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.193 -0.942 . . . . 64.450000000000003 108.473 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.56 -16.56 56.34 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 108.044 -2.022 . . . . 34.210000000000001 108.044 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.61 154.1 27.61 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.435 -1.691 . . . . 54.25 106.435 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.0 p -81.13 179.88 7.66 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.109 -0.7 . . . . 64.430000000000007 109.109 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -58.76 -53.33 59.56 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 107.936 -1.135 . . . . 71.450000000000003 107.936 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.57 -48.3 80.07 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 110.282 -0.266 . . . . 74.549999999999997 110.282 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -57.84 -41.08 81.6 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.767 -0.457 . . . . 75.129999999999995 109.767 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' HD11 ' A' ' 67' ' ' LEU . . . -50.67 -56.22 12.9 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 120.818 0.342 . . . . 65.510000000000005 110.714 177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.7 m -74.64 -33.39 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 109.145 -0.687 . . . . 34.329999999999998 109.145 -173.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.9 t -68.79 -31.55 70.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 105.991 -1.855 . . . . 74.409999999999997 105.991 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.2 m -71.37 -41.83 69.22 Favored 'General case' 0 C--O 1.207 -1.133 0 O-C-N 120.319 -1.488 . . . . 74.299999999999997 107.464 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.3 -29.55 69.94 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 109.232 -0.655 . . . . 75.409999999999997 109.232 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -73.78 -61.21 1.92 Allowed 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.807 -1.183 . . . . 74.5 107.807 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.83 54.45 0.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.422 0.629 . . . . 64.430000000000007 111.548 -174.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 p -112.77 -175.06 2.58 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 104.956 -2.238 . . . . 75.219999999999999 104.956 167.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.78 -161.55 25.97 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 107.71 -2.156 . . . . 63.399999999999999 107.71 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -52.69 -53.34 48.87 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.8 -0.815 . . . . 55.240000000000002 108.8 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.5 t -102.99 148.8 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 105.465 -2.05 . . . . 63.509999999999998 105.465 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.4 t -104.59 131.11 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 N-CA-C 105.42 -2.067 . . . . 43.109999999999999 105.42 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -112.92 128.91 56.6 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.048 -2.575 . . . . 61.310000000000002 104.048 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 142.97 17.75 Favored 'General case' 0 CA--C 1.467 -2.227 0 N-CA-C 108.087 -1.079 . . . . 74.239999999999995 108.087 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 135.67 35.93 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.839 -1.541 . . . . 72.0 106.839 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.65 160.43 33.36 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 106.353 -1.721 . . . . 71.120000000000005 106.353 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.6 135.03 48.77 Favored 'General case' 0 N--CA 1.397 -3.106 0 N-CA-C 102.102 -3.296 . . . . 72.200000000000003 102.102 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.654 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 6.8 mmpt? -62.48 136.86 58.1 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 107.813 -1.18 . . . . 74.010000000000005 107.813 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.461 -3.326 0 N-CA-C 106.78 -2.528 . . . . 74.230000000000004 106.78 -171.425 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.105 0 N-CA-C 109.25 -1.54 . . . . 74.120000000000005 109.25 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -81.77 140.34 34.3 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.613 -1.625 . . . . 60.130000000000003 106.613 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.47 HG23 ' CD1' ' A' ' 60' ' ' LEU . 10.8 mt -104.86 137.75 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.467 0 N-CA-C 108.392 -0.966 . . . . 72.349999999999994 108.392 -173.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.488 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.2 p90 -138.89 155.8 47.8 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 107.098 -1.445 . . . . 51.210000000000001 107.098 172.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -105.89 145.71 30.9 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.757 -1.942 . . . . 73.310000000000002 105.757 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.677 HG22 HD21 ' A' ' 90' ' ' LEU . 30.4 m -142.34 155.86 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 106.888 -1.523 . . . . 63.409999999999997 106.888 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.66 122.96 46.1 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 105.088 -2.19 . . . . 65.109999999999999 105.088 167.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 52' ' ' ARG . 12.7 mt -131.97 133.12 44.13 Favored 'General case' 0 CA--C 1.458 -2.58 0 N-CA-C 105.018 -2.216 . . . . 63.240000000000002 105.018 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.02 22.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 105.805 -1.924 . . . . 53.229999999999997 105.805 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -70.04 -36.16 74.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.999 -1.852 . . . . 74.230000000000004 105.999 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 81.48 113.21 0.06 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 125.231 1.412 . . . . 61.109999999999999 108.117 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.57 36.21 25.01 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.791 -1.188 . . . . 75.099999999999994 107.791 -173.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 43.38 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 127.485 2.314 . . . . 63.399999999999999 115.25 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.7 m -97.24 124.52 41.35 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 119.985 1.266 . . . . 72.239999999999995 107.904 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.625 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.9 pt? -97.03 -158.88 0.7 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 105.817 -1.92 . . . . 73.219999999999999 105.817 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.76 32.09 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 106.671 -2.571 . . . . 71.420000000000002 106.671 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.1 mm -88.16 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.863 -2.273 . . . . 61.240000000000002 104.863 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.42 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.2 m -140.56 167.23 22.66 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 103.849 -2.649 . . . . 51.530000000000001 103.849 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 36' ' ' ILE . 9.0 m -148.38 173.18 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 106.985 -1.487 . . . . 74.219999999999999 106.985 -168.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 39' ' ' LYS . 8.2 t -159.32 164.01 35.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 104.037 -2.579 . . . . 44.549999999999997 104.037 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -139.16 18.31 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.356 -1.898 . . . . 71.010000000000005 108.356 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.61 -79.31 0.29 Allowed Glycine 0 CA--C 1.466 -3.001 0 N-CA-C 108.54 -1.824 . . . . 33.439999999999998 108.54 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -76.11 16.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 122.731 0.413 . . . . 74.319999999999993 111.045 -171.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 85.59 5.68 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.832 1.253 . . . . 70.519999999999996 108.099 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -55.85 -171.0 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.476 -0.784 . . . . 74.230000000000004 111.851 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 m -29.1 -45.03 0.04 OUTLIER 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.439 2.295 . . . . 63.329999999999998 116.009 -162.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.72 136.82 16.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-O 121.663 0.744 . . . . 72.219999999999999 111.855 -172.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -35.16 -71.53 0.07 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 126.17 1.788 . . . . 73.409999999999997 113.207 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -76.97 -15.6 59.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.26 -0.9 . . . . 72.430000000000007 110.104 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.38 61.79 2.16 Favored Glycine 0 CA--C 1.491 -1.449 0 N-CA-C 108.093 -2.003 . . . . 72.420000000000002 108.093 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.95 -178.81 25.23 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 104.376 -3.49 . . . . 72.409999999999997 104.376 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 36' ' ' ILE . 7.0 mm -83.72 122.3 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.131 0 N-CA-C 104.427 -2.434 . . . . 71.420000000000002 104.427 172.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -107.17 153.13 23.13 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 103.809 -2.663 . . . . 63.450000000000003 103.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -83.55 102.32 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.154 -1.795 . . . . 62.229999999999997 106.154 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HB2' HG22 ' A' ' 24' ' ' THR . 13.5 tptm -72.91 -31.11 64.42 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.423 -0.808 . . . . 75.420000000000002 111.036 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.73 145.4 18.61 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 106.495 -1.668 . . . . 75.120000000000005 106.495 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -122.27 133.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.413 -2.81 . . . . 65.430000000000007 103.413 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.97 151.49 86.34 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 106.398 -1.705 . . . . 65.109999999999999 106.398 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.33 167.66 25.35 Favored 'Trans proline' 0 CA--C 1.457 -3.336 0 N-CA-C 105.735 -2.448 . . . . 74.310000000000002 105.735 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 68.38 1.98 3.13 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.769 0.668 . . . . 73.040000000000006 110.109 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.99 175.06 42.98 Favored Glycine 0 CA--C 1.472 -2.642 0 N-CA-C 107.571 -2.212 . . . . 72.319999999999993 107.571 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.13 -48.6 64.97 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 107.355 -1.35 . . . . 64.010000000000005 107.355 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.19 64.9 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 116.067 -0.515 . . . . 73.439999999999998 110.019 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.08 -56.22 14.25 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.975 -0.379 . . . . 74.239999999999995 109.975 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -65.44 -28.94 69.59 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.908 0.385 . . . . 70.340000000000003 110.515 -166.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -83.17 -31.28 27.22 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 106.764 -1.569 . . . . 64.310000000000002 106.764 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 16.91 65.88 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 111.025 -0.83 . . . . 54.100000000000001 111.025 170.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HB2' HD11 ' A' ' 12' ' ' LEU . 17.1 mmp_? -91.71 5.65 48.93 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.523 -1.288 . . . . 70.209999999999994 107.523 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.9 mt -144.83 144.88 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 104.161 -2.533 . . . . 72.430000000000007 104.161 -171.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 55' ' ' LYS . 50.9 p-80 -149.3 168.24 23.88 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 101.871 -3.381 . . . . 73.420000000000002 101.871 172.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 39.5 mtmt -66.44 144.16 56.67 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.074 -1.084 . . . . 75.219999999999999 108.074 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.19 -32.5 7.47 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.07 -1.062 . . . . 54.420000000000002 110.839 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' CG ' ' CE1' ' A' ' 54' ' ' HIS . 34.8 m-20 -66.65 154.55 40.3 Favored 'General case' 0 C--N 1.378 1.822 0 CA-C-N 119.871 1.836 . . . . 72.430000000000007 107.859 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 137.41 51.92 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.047 -1.464 . . . . 74.349999999999994 107.047 -164.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.5 127.27 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 106.452 -1.684 . . . . 70.439999999999998 106.452 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.47 ' CD1' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -95.12 -59.83 1.81 Allowed 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.017 -1.105 . . . . 72.040000000000006 108.017 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.38 148.66 47.94 Favored 'General case' 0 CA--C 1.467 -2.216 0 N-CA-C 106.254 -1.758 . . . . 64.439999999999998 106.254 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.6 t -119.92 119.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 105.864 -1.902 . . . . 74.340000000000003 105.864 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.9 t30 49.38 38.07 13.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.698 1.199 . . . . 71.430000000000007 110.318 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.22 -33.5 6.52 Favored Glycine 0 CA--C 1.469 -2.821 0 N-CA-C 108.212 -1.955 . . . . 63.140000000000001 108.212 171.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.0 114.98 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 107.753 -1.203 . . . . 61.43 107.753 -172.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.6 m -53.88 117.44 3.19 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 107.939 -1.134 . . . . 55.520000000000003 107.939 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -99.88 -10.48 21.68 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.291 -2.114 . . . . 61.140000000000001 105.291 -168.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.45 137.18 48.87 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.914 -1.143 . . . . 70.25 107.914 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.6 62.04 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.46 -1.456 . . . . 74.409999999999997 109.46 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.47 148.96 30.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.837 -1.172 . . . . 60.299999999999997 107.837 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.414 ' HA ' HG22 ' A' ' 27' ' ' VAL . 39.0 p -81.99 -179.48 7.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.844 -0.798 . . . . 73.530000000000001 108.844 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -60.64 -52.02 66.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.981 -1.118 . . . . 74.329999999999998 107.981 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -57.1 -55.5 33.9 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 121.638 -0.664 . . . . 72.209999999999994 110.783 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -53.62 -40.7 65.99 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 120.772 0.32 . . . . 73.329999999999998 110.529 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.13 -54.46 24.97 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.023 0.529 . . . . 72.540000000000006 110.787 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.98 -37.43 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.801 -0.444 . . . . 72.430000000000007 109.801 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.02 -31.67 72.85 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 116.943 -1.903 . . . . 55.409999999999997 106.266 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 82' ' ' THR . 26.5 m -71.85 -45.16 62.34 Favored 'General case' 0 C--O 1.206 -1.232 0 O-C-N 120.654 -1.279 . . . . 64.129999999999995 107.901 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.5 mt -62.48 -29.66 70.7 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 110.181 -0.303 . . . . 71.109999999999999 110.181 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -73.69 -59.0 2.92 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.194 -1.41 . . . . 74.530000000000001 107.194 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -70.51 46.77 0.09 Allowed 'General case' 0 C--N 1.362 1.139 0 C-N-CA 125.109 1.364 . . . . 63.439999999999998 111.441 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.572 HG21 HG13 ' A' ' 86' ' ' VAL . 2.7 p -105.22 -175.4 2.78 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.159 -1.793 . . . . 74.349999999999994 106.159 173.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.0 33.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 106.012 -2.835 . . . . 63.439999999999998 106.012 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.25 -54.54 44.6 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.22 -1.03 . . . . 72.319999999999993 108.22 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.0 t -101.79 145.18 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 105.995 -1.854 . . . . 61.240000000000002 105.995 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.572 HG13 HG21 ' A' ' 82' ' ' THR . 47.7 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 105.904 -1.887 . . . . 71.340000000000003 105.904 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -107.7 127.02 53.31 Favored 'General case' 0 CA--C 1.466 -2.271 0 N-CA-C 103.298 -2.853 . . . . 72.430000000000007 103.298 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.46 136.57 13.81 Favored 'General case' 0 CA--C 1.458 -2.583 0 N-CA-C 107.374 -1.343 . . . . 75.239999999999995 107.374 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.26 136.37 35.8 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.311 -1.366 . . . . 61.310000000000002 107.311 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.677 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -107.41 151.74 25.12 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 103.893 -2.632 . . . . 71.439999999999998 103.893 175.107 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.53 133.3 55.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 101.65 -3.463 . . . . 61.420000000000002 101.65 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.7 129.52 41.94 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.49 -0.929 . . . . 75.340000000000003 108.49 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.295 0 N-CA-C 105.177 -3.169 . . . . 71.400000000000006 105.177 179.407 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.522 0 N-CA-C 108.923 -1.671 . . . . 51.439999999999998 108.923 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -75.6 139.78 42.26 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.418 -1.327 . . . . 64.209999999999994 107.418 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' LEU . 9.4 mm -100.68 131.64 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.128 -1.434 . . . . 74.439999999999998 107.128 -171.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.582 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.8 p90 -143.34 155.8 44.53 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.255 -1.387 . . . . 74.219999999999999 107.255 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -108.77 147.07 32.59 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.729 -1.952 . . . . 74.230000000000004 105.729 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.67 HG22 HD21 ' A' ' 90' ' ' LEU . 18.8 m -141.22 152.51 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 N-CA-C 107.272 -1.381 . . . . 74.409999999999997 107.272 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.58 127.07 53.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.117 -2.179 . . . . 72.129999999999995 105.117 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 53' ' ' ILE . 3.0 mp -135.18 140.99 45.79 Favored 'General case' 0 CA--C 1.461 -2.445 0 N-CA-C 107.748 -1.204 . . . . 63.409999999999997 107.748 175.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.07 141.22 33.36 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.757 -1.571 . . . . 64.409999999999997 106.757 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -71.54 -25.88 62.4 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.333 -0.988 . . . . 72.329999999999998 108.333 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 72.64 108.05 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.25 -1.019 . . . . 73.510000000000005 108.25 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 51.94 53.1 13.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 109.549 -0.537 . . . . 71.409999999999997 109.549 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.1 t30 54.37 -9.09 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.043 1.737 . . . . 75.549999999999997 115.007 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.4 t -126.12 120.76 30.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 120.595 1.543 . . . . 72.120000000000005 108.317 -171.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.415 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.0 pt? -99.99 167.44 10.49 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.109 -2.182 . . . . 73.400000000000006 105.109 171.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.99 95.62 0.15 Allowed Glycine 0 CA--C 1.478 -2.232 0 N-CA-C 105.041 -3.223 . . . . 52.530000000000001 105.041 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.7 mm -118.95 177.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.273 -2.862 . . . . 73.150000000000006 103.273 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.473 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.1 t -127.79 154.74 45.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 102.987 -2.968 . . . . 72.519999999999996 102.987 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.0 m -149.46 169.55 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.818 -1.549 . . . . 54.340000000000003 106.818 -165.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.533 HG23 ' CE2' ' A' ' 37' ' ' TYR . 6.8 t -165.22 168.23 17.26 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.531 -2.396 . . . . 72.099999999999994 104.531 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.26 -167.03 22.33 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 105.573 -3.011 . . . . 64.430000000000007 105.573 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.91 -115.74 0.91 Allowed Glycine 0 CA--C 1.489 -1.55 0 C-N-CA 119.443 -1.361 . . . . 74.099999999999994 110.165 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -60.73 20.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.691 1.996 . . . . 71.310000000000002 116.32 -162.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 87.37 9.07 0.17 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.262 -1.014 . . . . 72.319999999999993 108.262 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.3 p -39.14 -166.96 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 126.283 1.833 . . . . 74.430000000000007 111.626 154.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -39.34 -29.11 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.9 0 O-C-N 120.458 -1.401 . . . . 74.510000000000005 114.616 -168.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG11 ' CE1' ' A' ' 37' ' ' TYR . 4.6 m -86.27 134.84 26.4 Favored 'Isoleucine or valine' 0 C--N 1.365 1.248 0 O-C-N 120.347 -1.471 . . . . 53.439999999999998 108.486 177.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -70.54 -24.17 62.76 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.857 -0.794 . . . . 72.510000000000005 108.857 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 60' ' ' LEU . 7.4 t-160 -83.69 -10.98 57.79 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.898 -0.721 . . . . 72.409999999999997 109.06 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.69 67.1 2.36 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 110.029 -1.229 . . . . 34.240000000000002 110.029 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.74 178.21 26.46 Favored Glycine 0 CA--C 1.472 -2.607 0 N-CA-C 105.348 -3.101 . . . . 74.120000000000005 105.348 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.76 141.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 N-CA-C 105.905 -1.887 . . . . 71.120000000000005 105.905 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -121.46 162.05 21.15 Favored 'General case' 0 CA--C 1.45 -2.898 0 N-CA-C 106.696 -1.594 . . . . 65.219999999999999 106.696 175.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.416 HG11 HG22 ' A' ' 41' ' ' VAL . 99.7 t -85.8 103.54 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 106.593 -1.632 . . . . 64.420000000000002 106.593 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -71.12 -30.48 66.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.535 -1.211 . . . . 75.120000000000005 108.949 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.7 151.16 10.69 Favored 'General case' 0 CA--C 1.467 -2.225 0 N-CA-C 105.869 -1.9 . . . . 73.420000000000002 105.869 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.416 HG22 HG11 ' A' ' 38' ' ' VAL . 7.0 t -118.33 134.15 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 103.657 -2.72 . . . . 63.32 103.657 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 148.68 84.01 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.826 -1.916 . . . . 75.040000000000006 105.826 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.26 168.12 25.34 Favored 'Trans proline' 0 CA--C 1.467 -2.84 0 N-CA-C 106.073 -2.318 . . . . 73.099999999999994 106.073 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 62.08 2.75 0.85 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.239 0.829 . . . . 73.319999999999993 113.239 164.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.19 -175.78 36.13 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 107.12 -2.392 . . . . 55.109999999999999 107.12 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.63 -53.01 38.76 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 108.579 -0.897 . . . . 74.409999999999997 108.579 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.49 -49.84 66.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 116.362 -0.381 . . . . 41.009999999999998 111.067 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.7 -53.1 59.6 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 109.616 -0.513 . . . . 73.530000000000001 109.616 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -55.71 -38.15 69.35 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.278 0.631 . . . . 71.140000000000001 109.962 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -77.48 -33.5 54.52 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.871 -1.159 . . . . 74.099999999999994 107.871 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.31 81.04 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.235 -1.146 . . . . 73.109999999999999 110.235 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -107.33 8.37 29.69 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.282 -1.006 . . . . 72.140000000000001 108.282 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 12' ' ' LEU . 1.4 mp -126.92 134.13 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 101.859 -3.386 . . . . 72.140000000000001 101.859 175.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -138.74 159.58 41.75 Favored 'General case' 0 CA--C 1.473 -2.0 0 N-CA-C 104.091 -2.559 . . . . 63.219999999999999 104.091 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -66.48 143.99 56.76 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.74 -1.207 . . . . 75.319999999999993 107.74 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -30.82 8.88 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 108.623 -1.791 . . . . 64.400000000000006 108.623 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -66.49 152.73 44.6 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 106.232 -1.766 . . . . 75.409999999999997 106.232 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.666 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 18.7 ptt-85 -132.23 157.67 43.75 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.954 -1.498 . . . . 75.140000000000001 106.954 -171.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.54 135.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.416 -1.698 . . . . 74.209999999999994 106.416 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.529 HD11 HD12 ' A' ' 7' ' ' ILE . 48.2 mt -96.92 -58.26 2.08 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.029 -1.471 . . . . 72.140000000000001 107.029 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.92 151.57 50.11 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.416 -1.698 . . . . 60.299999999999997 106.416 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.65 119.86 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 105.515 -2.031 . . . . 70.310000000000002 105.515 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.5 t30 54.71 32.85 18.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.133 0.973 . . . . 62.340000000000003 109.909 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.78 -28.99 13.42 Favored Glycine 0 CA--C 1.463 -3.183 0 N-CA-C 108.551 -1.82 . . . . 72.450000000000003 108.551 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.26 115.12 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 N-CA-C 107.533 -1.284 . . . . 34.32 107.533 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 t -55.65 130.56 43.62 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.689 -0.856 . . . . 75.450000000000003 108.689 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -98.98 -11.81 21.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.939 -1.874 . . . . 71.150000000000006 105.939 -170.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.77 126.13 20.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.863 -0.608 . . . . 63.5 109.634 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.17 -12.26 64.95 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 109.137 -1.585 . . . . 53.210000000000001 109.137 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.88 148.8 41.96 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 107.271 -1.381 . . . . 73.310000000000002 107.271 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 p -81.77 177.32 8.95 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 107.317 -1.364 . . . . 73.430000000000007 107.317 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -65.85 -43.93 86.98 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.541 -0.911 . . . . 45.009999999999998 108.541 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -54.59 -56.73 15.91 Favored 'General case' 0 C--N 1.362 1.125 0 O-C-N 121.881 -0.512 . . . . 53.43 110.176 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -56.46 -44.42 80.52 Favored 'General case' 0 C--N 1.365 1.246 0 N-CA-C 110.089 -0.337 . . . . 71.030000000000001 110.089 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -50.54 -52.76 35.85 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.792 0.437 . . . . 42.130000000000003 110.831 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.14 -42.12 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.775 -1.195 . . . . 71.129999999999995 107.775 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -53.23 -40.6 64.65 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 123.722 1.725 . . . . 40.420000000000002 106.442 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -65.5 -40.34 92.92 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 120.338 -1.476 . . . . 71.010000000000005 108.776 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.87 -29.57 70.28 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 109.813 -0.44 . . . . 74.420000000000002 109.813 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -73.26 -60.42 2.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.531 -0.544 . . . . 64.409999999999997 109.531 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -68.97 40.79 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 113.563 0.949 . . . . 73.219999999999999 113.563 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 p -106.72 -176.12 2.99 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 106.303 -1.74 . . . . 71.140000000000001 106.303 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.02 -153.87 28.97 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 108.415 -1.874 . . . . 73.430000000000007 108.415 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -61.14 -54.39 45.07 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.923 -0.769 . . . . 72.430000000000007 108.923 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.52 145.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 105.82 -1.919 . . . . 54.240000000000002 105.82 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.06 139.41 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.673 0 N-CA-C 105.592 -2.003 . . . . 72.230000000000004 105.592 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -114.08 135.8 53.62 Favored 'General case' 0 CA--C 1.463 -2.376 0 N-CA-C 104.608 -2.367 . . . . 72.420000000000002 104.608 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.54 135.69 9.92 Favored 'General case' 0 CA--C 1.461 -2.448 0 N-CA-C 106.975 -1.491 . . . . 74.519999999999996 106.975 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.19 139.08 35.76 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 107.318 -1.364 . . . . 75.439999999999998 107.318 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.67 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.76 155.5 21.5 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 104.62 -2.363 . . . . 74.140000000000001 104.62 176.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.425 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.9 tt0 -120.74 128.75 53.21 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 101.604 -3.48 . . . . 70.239999999999995 101.604 165.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -61.93 146.83 48.76 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.736 -0.838 . . . . 73.140000000000001 108.736 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.411 0 N-CA-C 105.577 -3.009 . . . . 44.310000000000002 105.577 178.813 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.237 0 N-CA-C 108.713 -1.755 . . . . 64.510000000000005 108.713 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.36 133.48 42.5 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 108.131 -1.063 . . . . 74.239999999999995 108.131 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.485 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.9 mt -99.27 128.08 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.522 -1.288 . . . . 71.349999999999994 107.522 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -138.25 159.58 41.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.793 -1.558 . . . . 72.209999999999994 106.793 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.86 152.12 22.3 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 105.172 -2.158 . . . . 74.430000000000007 105.172 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.712 HG22 HD21 ' A' ' 90' ' ' LEU . 11.5 m -131.79 142.75 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 N-CA-C 104.35 -2.463 . . . . 71.430000000000007 104.35 167.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -101.06 116.84 33.78 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 103.782 -2.673 . . . . 70.010000000000005 103.782 167.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.08 134.04 37.98 Favored 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.434 -1.691 . . . . 71.230000000000004 106.434 -172.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.44 148.59 25.49 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.831 -1.544 . . . . 51.5 106.831 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -75.1 -33.88 61.68 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.12 -1.807 . . . . 73.120000000000005 106.12 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.84 104.88 0.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.379 1.071 . . . . 71.129999999999995 108.164 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.66 37.59 19.06 Favored 'General case' 0 C--N 1.366 1.288 0 N-CA-C 107.85 -1.167 . . . . 75.420000000000002 107.85 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 47.75 2.41 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.36 1.864 . . . . 72.25 114.747 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -86.41 139.25 31.11 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 106.706 -1.591 . . . . 74.450000000000003 106.706 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.2 pt? -128.01 -144.66 0.29 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 104.675 -2.343 . . . . 72.319999999999993 104.675 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.21 74.66 0.63 Allowed Glycine 0 CA--C 1.467 -2.953 0 N-CA-C 105.056 -3.218 . . . . 54.100000000000001 105.056 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 22' ' ' CYS . 8.5 mm -103.57 177.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 101.584 -3.487 . . . . 74.409999999999997 101.584 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.473 ' H ' HG22 ' A' ' 21' ' ' ILE . 3.1 m -121.34 151.97 39.49 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 103.205 -2.887 . . . . 72.329999999999998 103.205 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -152.11 169.23 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 N-CA-C 106.828 -1.545 . . . . 71.299999999999997 106.828 -165.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -160.46 164.64 32.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 104.334 -2.469 . . . . 71.340000000000003 104.334 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.71 -162.74 26.74 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.083 -2.007 . . . . 73.049999999999997 108.083 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.3 -88.43 0.35 Allowed Glycine 0 C--N 1.356 1.686 0 N-CA-C 109.112 -1.595 . . . . 30.210000000000001 109.112 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 71' ' ' THR . 0.8 OUTLIER -71.88 18.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 123.134 0.574 . . . . 62.32 112.251 -167.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 85.98 7.05 0.36 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.313 -0.995 . . . . 65.439999999999998 108.313 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.7 p -45.51 -169.31 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.413 1.885 . . . . 53.450000000000003 112.466 167.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -49.92 -18.39 0.51 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.939 1.088 . . . . 72.510000000000005 113.939 -167.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 15.3 m -66.53 128.78 30.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.525 0 N-CA-C 107.868 -1.16 . . . . 70.329999999999998 107.868 172.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.36 -52.69 44.35 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.256 -0.902 . . . . 74.430000000000007 110.958 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.64 -20.37 59.92 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 119.543 -0.863 . . . . 73.349999999999994 110.174 -168.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.43 -6.86 55.83 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.804 -1.718 . . . . 74.340000000000003 108.804 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 179.26 53.38 Favored Glycine 0 CA--C 1.501 -0.833 0 N-CA-C 108.198 -1.961 . . . . 51.219999999999999 108.198 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 75' ' ' ALA . 8.8 mm -88.97 132.24 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.215 0 N-CA-C 104.535 -2.395 . . . . 65.340000000000003 104.535 174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 3.8 m-30 -107.16 150.23 26.82 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 105.129 -2.174 . . . . 73.519999999999996 105.129 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.6 t -82.85 103.43 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.194 -1.78 . . . . 73.310000000000002 106.194 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -73.04 -34.56 66.38 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.13 -1.396 . . . . 74.109999999999999 108.751 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.76 151.06 8.82 Favored 'General case' 0 CA--C 1.46 -2.486 0 N-CA-C 104.598 -2.371 . . . . 73.040000000000006 104.598 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.36 131.58 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 102.975 -2.972 . . . . 74.530000000000001 102.975 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.77 146.63 83.34 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 106.332 -1.729 . . . . 70.239999999999995 106.332 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.9 172.03 16.92 Favored 'Trans proline' 0 CA--C 1.468 -2.794 0 N-CA-C 105.965 -2.36 . . . . 65.219999999999999 105.965 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 49.55 51.99 15.37 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.312 1.053 . . . . 71.510000000000005 109.743 164.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.47 34.41 Favored Glycine 0 CA--C 1.472 -2.612 1 N-CA-C 102.899 -4.08 . . . . 61.25 102.899 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -53.58 26.78 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-N 117.781 0.791 . . . . 72.040000000000006 109.734 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.5 -50.48 65.31 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.987 -0.097 . . . . 73.109999999999999 111.122 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -63.37 -55.36 25.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.664 0.385 . . . . 73.420000000000002 110.058 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.1 m -65.33 -30.23 71.05 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.694 -0.629 . . . . 71.540000000000006 110.75 -172.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.42 -35.56 54.04 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 105.914 -1.884 . . . . 72.409999999999997 105.914 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.8 30.2 59.98 Favored Glycine 0 CA--C 1.476 -2.398 0 CA-C-N 115.318 -0.855 . . . . 54.210000000000001 111.738 167.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -98.48 -47.85 5.23 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.387 -1.709 . . . . 74.349999999999994 106.387 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.07 148.06 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.53 0.681 . . . . 74.219999999999999 109.735 169.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 55' ' ' LYS . 27.5 p-80 -154.94 167.12 31.38 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 104.227 -2.509 . . . . 63.020000000000003 104.227 172.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 52.7 mtmt -66.73 143.16 57.1 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.156 0.503 . . . . 74.349999999999994 109.86 -176.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.94 -33.19 6.63 Favored Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 108.606 -1.797 . . . . 72.230000000000004 108.606 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -69.35 156.41 38.85 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 105.701 -1.963 . . . . 73.439999999999998 105.701 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -132.98 157.91 44.01 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.021 -1.103 . . . . 73.230000000000004 108.021 -168.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.26 135.27 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 106.177 -1.786 . . . . 52.539999999999999 106.177 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.485 ' CD1' HG23 ' A' ' 7' ' ' ILE . 15.2 mt -99.57 -58.67 1.87 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.638 -1.616 . . . . 74.209999999999994 106.638 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.48 149.97 50.76 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 105.76 -1.941 . . . . 62.329999999999998 105.76 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.54 121.47 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 N-CA-C 105.069 -2.197 . . . . 75.230000000000004 105.069 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.56 32.88 21.69 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 123.46 0.704 . . . . 52.149999999999999 109.278 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.81 -5.59 84.65 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 109.562 -1.415 . . . . 61.020000000000003 109.562 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.1 t -94.92 130.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 107.023 -1.473 . . . . 74.420000000000002 107.023 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -47.62 147.33 1.85 Allowed 'General case' 0 C--N 1.367 1.332 0 C-N-CA 123.907 0.883 . . . . 65.510000000000005 110.501 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.74 -25.18 0.42 Allowed 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.717 -1.586 . . . . 41.310000000000002 106.717 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.9 pm0 -56.3 127.19 29.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.603 -0.888 . . . . 63.399999999999999 108.603 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.8 -11.47 66.52 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.43 -1.468 . . . . 74.219999999999999 109.43 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 157.36 25.64 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 105.66 -1.978 . . . . 64.540000000000006 105.66 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 27' ' ' VAL . 29.2 p -87.64 179.49 6.51 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.146 -0.687 . . . . 63.409999999999997 109.146 -168.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.39 -51.34 69.16 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.638 -1.245 . . . . 72.120000000000005 107.638 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.72 -55.81 22.89 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 109.896 -0.409 . . . . 74.209999999999994 109.896 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -56.46 -42.38 78.1 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 122.169 -0.332 . . . . 60.409999999999997 110.623 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -51.16 -55.76 16.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 122.853 0.461 . . . . 72.439999999999998 110.311 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.5 m -74.72 -36.27 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 109.044 -0.724 . . . . 52.219999999999999 109.044 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -62.66 -34.66 77.55 Favored 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 106.055 -1.832 . . . . 72.340000000000003 106.055 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 82' ' ' THR . 28.7 m -71.83 -45.48 61.31 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 120.071 -1.643 . . . . 74.129999999999995 107.715 -175.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.46 -29.82 70.2 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.722 -0.473 . . . . 70.040000000000006 109.722 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -60.08 2.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.58 -1.637 . . . . 54.409999999999997 106.58 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -67.86 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.485 1.114 . . . . 64.230000000000004 112.219 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.422 HG21 HG13 ' A' ' 86' ' ' VAL . 19.3 p -101.81 -175.21 2.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.166 -1.79 . . . . 52.310000000000002 106.166 171.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.6 -150.89 26.95 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 107.694 -2.163 . . . . 74.319999999999993 107.694 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.61 -55.69 16.26 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.681 -0.859 . . . . 74.25 108.681 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.5 t -104.25 149.34 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 104.992 -2.225 . . . . 55.109999999999999 104.992 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 82' ' ' THR . 42.9 t -111.61 140.56 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.288 -1.745 . . . . 62.409999999999997 106.288 -174.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -110.62 130.8 55.48 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 103.657 -2.72 . . . . 62.329999999999998 103.657 167.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.97 132.49 12.1 Favored 'General case' 0 CA--C 1.456 -2.649 0 N-CA-C 106.786 -1.561 . . . . 64.420000000000002 106.786 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.65 136.01 36.14 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 106.82 -1.548 . . . . 44.340000000000003 106.82 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.68 159.45 17.13 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 103.968 -2.604 . . . . 74.510000000000005 103.968 174.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -120.37 134.1 55.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.77 -3.419 . . . . 74.25 101.77 167.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -62.89 138.18 58.47 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 107.945 -1.131 . . . . 72.030000000000001 107.945 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.471 -2.701 0 N-CA-C 106.459 -2.656 . . . . 71.099999999999994 106.459 -175.835 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.587 0 N-CA-C 109.328 -1.509 . . . . 74.540000000000006 109.328 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -80.84 143.33 32.86 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.037 -1.468 . . . . 61.409999999999997 107.037 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 60' ' ' LEU . 12.9 mm -98.19 132.79 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 105.879 -1.897 . . . . 71.430000000000007 105.879 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CD2' HD23 ' A' ' 90' ' ' LEU . 1.5 p90 -144.18 156.48 44.33 Favored 'General case' 0 CA--C 1.478 -1.803 0 C-N-CA 119.056 -1.057 . . . . 73.329999999999998 109.027 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' HD11 ' A' ' 89' ' ' LEU . 46.0 mt-10 -103.3 141.65 35.54 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 105.387 -2.079 . . . . 74.209999999999994 105.387 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.621 HG22 HD21 ' A' ' 90' ' ' LEU . 34.9 m -141.01 145.93 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 105.127 -2.175 . . . . 71.340000000000003 105.127 172.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -110.05 126.44 53.99 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.336 -2.098 . . . . 62.329999999999998 105.336 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 52' ' ' ARG . 58.1 mt -134.83 139.48 45.1 Favored 'General case' 0 CA--C 1.451 -2.836 0 N-CA-C 106.948 -1.501 . . . . 74.439999999999998 106.948 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.54 152.68 23.74 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.352 -2.092 . . . . 71.25 105.352 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -77.22 -28.58 53.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.221 -1.399 . . . . 62.450000000000003 107.221 172.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 81.38 104.93 0.06 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.442 1.097 . . . . 73.439999999999998 108.105 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 57.56 41.68 25.4 Favored 'General case' 0 C--N 1.366 1.293 0 N-CA-C 107.271 -1.381 . . . . 62.420000000000002 107.271 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 43.26 2.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 127.516 2.326 . . . . 65.010000000000005 115.504 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.0 m -100.23 114.69 28.32 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 120.34 1.427 . . . . 63.119999999999997 107.269 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.622 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -89.63 -173.18 3.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 104.697 -2.334 . . . . 72.439999999999998 104.697 169.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 40.95 0.04 OUTLIER Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 104.43 -3.468 . . . . 45.240000000000002 104.43 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.6 mt -98.09 174.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.479 -2.786 . . . . 75.340000000000003 103.479 -176.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.438 ' H ' HG22 ' A' ' 21' ' ' ILE . 34.4 t -138.86 156.39 47.34 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 104.738 -2.319 . . . . 71.120000000000005 104.738 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.65 173.29 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.617 0 N-CA-C 104.716 -2.327 . . . . 70.439999999999998 104.716 -167.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.4 t -162.09 167.12 24.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.446 -1.686 . . . . 73.040000000000006 106.446 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.87 -154.08 30.36 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 108.578 -1.809 . . . . 75.219999999999999 108.578 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.55 -82.38 0.34 Allowed Glycine 0 CA--C 1.474 -2.497 0 N-CA-C 108.849 -1.7 . . . . 65.5 108.849 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.48 16.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.497 0 C-N-CA 123.438 0.695 . . . . 51.509999999999998 112.199 -165.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 85.71 5.54 0.46 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.954 1.301 . . . . 73.129999999999995 108.345 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.5 p -49.29 -170.82 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.237 1.415 . . . . 74.409999999999997 111.352 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 m -30.19 -41.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 126.268 1.827 . . . . 74.510000000000005 115.359 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 14.7 m -57.28 120.0 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 122.348 1.07 . . . . 54.439999999999998 110.774 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -49.27 -64.33 0.84 Allowed 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.786 -1.097 . . . . 71.319999999999993 111.824 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -73.99 -19.85 60.52 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 120.209 -0.597 . . . . 73.239999999999995 110.112 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.36 60.19 1.57 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 109.754 -1.338 . . . . 53.109999999999999 109.754 170.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.73 -178.76 29.39 Favored Glycine 0 CA--C 1.466 -3.015 0 N-CA-C 103.184 -3.966 . . . . 73.129999999999995 103.184 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.94 133.67 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 103.973 -2.603 . . . . 74.099999999999994 103.973 175.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.443 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 9.2 m-85 -106.47 150.58 25.94 Favored 'General case' 0 CA--C 1.463 -2.367 0 N-CA-C 104.755 -2.313 . . . . 74.219999999999999 104.755 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.15 102.28 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.179 -1.786 . . . . 60.310000000000002 106.179 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -71.89 -35.2 69.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.495 -1.23 . . . . 75.209999999999994 109.67 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.86 144.08 19.98 Favored 'General case' 0 CA--C 1.464 -2.355 0 N-CA-C 105.841 -1.911 . . . . 51.210000000000001 105.841 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.99 127.62 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 103.409 -2.812 . . . . 63.130000000000003 103.409 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.23 147.03 63.82 Favored Pre-proline 0 CA--C 1.51 -0.577 0 N-CA-C 106.365 -1.717 . . . . 75.299999999999997 106.365 176.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 45' ' ' GLY . 65.5 Cg_endo -76.29 172.67 15.82 Favored 'Trans proline' 0 CA--C 1.473 -2.526 0 N-CA-C 106.063 -2.322 . . . . 73.409999999999997 106.063 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 70.35 -11.75 0.57 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 124.116 0.885 . . . . 64.549999999999997 111.132 167.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -91.19 178.91 42.09 Favored Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 107.198 -2.361 . . . . 71.129999999999995 107.198 -174.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.51 69.87 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.211 -1.033 . . . . 74.120000000000005 108.211 -174.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.54 63.61 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 116.056 -0.52 . . . . 61.210000000000001 110.41 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.08 -53.95 17.63 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.69 -0.485 . . . . 62.329999999999998 109.69 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -61.27 -34.89 75.92 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.118 0.567 . . . . 70.129999999999995 110.531 -169.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -90.39 -23.22 21.13 Favored 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.077 -1.453 . . . . 73.219999999999999 107.077 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.0 24.57 59.52 Favored Glycine 0 C--N 1.358 1.755 0 N-CA-C 110.5 -1.04 . . . . 72.219999999999999 110.5 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.522 ' HB2' HD11 ' A' ' 12' ' ' LEU . 23.4 mmt180 -96.33 6.45 48.77 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.264 -1.013 . . . . 73.329999999999998 108.264 -174.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.4 mt -142.34 146.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.172 -2.529 . . . . 75.099999999999994 104.172 -173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -147.2 156.41 42.93 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 103.984 -2.599 . . . . 75.299999999999997 103.984 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -66.86 146.14 54.73 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.685 -1.228 . . . . 74.430000000000007 107.685 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.11 -30.71 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 108.221 -1.952 . . . . 72.129999999999995 108.221 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.25 153.93 39.61 Favored 'General case' 0 C--N 1.364 1.221 0 N-CA-C 107.896 -1.149 . . . . 74.430000000000007 107.896 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.8 ttp85 -112.56 138.43 49.34 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 105.967 -1.864 . . . . 75.310000000000002 105.967 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.67 126.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 105.089 -2.189 . . . . 64.340000000000003 105.089 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.521 ' CD1' HG23 ' A' ' 7' ' ' ILE . 16.3 mt -92.31 -58.71 2.29 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 107.841 -1.17 . . . . 55.140000000000001 107.841 -173.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.49 148.68 46.22 Favored 'General case' 0 CA--C 1.472 -2.03 0 N-CA-C 105.534 -2.024 . . . . 51.210000000000001 105.534 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -121.55 127.01 75.52 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.604 0 N-CA-C 104.665 -2.346 . . . . 52.210000000000001 104.665 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 t30 57.48 29.63 17.36 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.89 -0.781 . . . . 71.299999999999997 108.89 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.17 -20.04 52.38 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 108.887 -1.685 . . . . 64.310000000000002 108.887 173.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.27 123.29 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.917 0 N-CA-C 108.529 -0.915 . . . . 72.140000000000001 108.529 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.4 m -52.92 122.91 10.18 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 123.273 0.629 . . . . 72.120000000000005 109.924 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.79 -21.95 14.49 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.358 -1.349 . . . . 73.140000000000001 107.358 -171.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -65.65 129.04 38.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.39 -0.819 . . . . 64.019999999999996 109.467 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 -17.08 57.11 Favored Glycine 0 C--N 1.363 2.055 0 N-CA-C 108.614 -1.795 . . . . 70.030000000000001 108.614 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.796 ' HB1' ' CG ' ' A' ' 74' ' ' GLN . . . -79.67 154.78 28.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.495 -1.669 . . . . 72.439999999999998 106.495 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 p -82.74 176.43 9.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.528 0.68 . . . . 64.310000000000002 110.242 -165.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -62.79 -51.46 67.02 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.669 -1.234 . . . . 72.120000000000005 107.669 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -53.7 -56.16 19.82 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 122.406 0.283 . . . . 62.409999999999997 111.083 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.796 ' CG ' ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -60.57 -35.67 76.63 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 109.26 -0.644 . . . . 63.200000000000003 109.26 -171.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 74' ' ' GLN . . . -51.13 -48.83 61.68 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 123.144 0.577 . . . . 72.420000000000002 109.583 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.27 -40.35 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 108.296 -1.002 . . . . 74.549999999999997 108.296 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -54.9 -40.45 69.82 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.526 -1.657 . . . . 51.530000000000001 106.526 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.4 m -74.33 -36.73 63.67 Favored 'General case' 0 C--O 1.215 -0.762 0 O-C-N 120.564 -1.335 . . . . 51.450000000000003 109.207 -171.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 mt -71.2 -39.84 71.54 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.086 -0.709 . . . . 61.219999999999999 109.086 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -78.74 -60.59 2.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.816 -0.438 . . . . 74.430000000000007 109.816 -171.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -67.06 60.27 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.901 0.858 . . . . 74.049999999999997 110.928 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -127.41 -176.28 3.7 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.913 -1.514 . . . . 55.020000000000003 106.913 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.18 -149.44 20.58 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 107.159 -2.376 . . . . 65.25 107.159 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -67.08 -55.77 12.86 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.259 -0.645 . . . . 51.109999999999999 109.259 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.62 145.02 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 106.214 -1.773 . . . . 71.409999999999997 106.214 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.49 146.01 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 106.101 -1.814 . . . . 74.540000000000006 106.101 -171.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -106.79 128.91 54.65 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 105.919 -1.882 . . . . 70.340000000000003 105.919 173.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.07 125.49 19.0 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 105.831 -1.914 . . . . 63.130000000000003 105.831 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.416 HD11 ' HG2' ' A' ' 9' ' ' GLU . 3.1 mm? -80.08 138.36 36.95 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.834 -1.543 . . . . 74.019999999999996 106.834 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.621 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.05 154.24 24.5 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 104.974 -2.232 . . . . 73.120000000000005 104.974 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -120.75 134.0 55.31 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 101.2 -3.63 . . . . 70.140000000000001 101.2 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -61.76 128.06 34.43 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.997 -1.112 . . . . 71.329999999999998 107.997 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.471 -2.702 0 N-CA-C 106.752 -2.539 . . . . 52.210000000000001 106.752 -173.262 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.121 0 N-CA-C 109.584 -1.406 . . . . 62.210000000000001 109.584 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.38 136.85 36.45 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 118.822 1.311 . . . . 75.329999999999998 107.724 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.525 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.9 mt -102.78 132.89 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.915 0 N-CA-C 107.249 -1.389 . . . . 74.209999999999994 107.249 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.497 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.7 p90 -140.83 157.18 45.76 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.673 -1.232 . . . . 74.349999999999994 107.673 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.84 146.06 29.2 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.46 -2.052 . . . . 70.150000000000006 105.46 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.644 HG22 HD21 ' A' ' 90' ' ' LEU . 31.3 m -140.7 148.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 N-CA-C 106.378 -1.712 . . . . 72.019999999999996 106.378 174.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -107.19 122.32 46.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.632 -1.988 . . . . 62.350000000000001 105.632 171.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.62 131.61 53.9 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 106.775 -1.565 . . . . 72.019999999999996 106.775 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.78 139.07 33.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 104.332 -2.47 . . . . 55.140000000000001 104.332 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -67.37 -34.54 77.52 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.354 -1.35 . . . . 74.450000000000003 107.354 175.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.7 t30 68.08 113.33 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.785 -0.82 . . . . 41.130000000000003 108.785 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.71 31.82 16.45 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.7 -1.222 . . . . 62.130000000000003 107.7 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 46.8 3.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 126.33 1.852 . . . . 72.129999999999995 114.117 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m -103.41 143.25 32.94 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.667 -1.235 . . . . 72.299999999999997 107.667 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.8 -143.75 0.35 Allowed 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.351 -2.833 . . . . 73.430000000000007 103.351 172.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.95 47.66 0.04 OUTLIER Glycine 0 CA--C 1.467 -2.954 0 N-CA-C 106.334 -2.706 . . . . 24.420000000000002 106.334 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mm -91.22 177.09 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 103.374 -2.825 . . . . 72.329999999999998 103.374 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.0 m -133.27 157.68 44.82 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.689 -2.708 . . . . 74.109999999999999 103.689 172.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 36' ' ' ILE . 4.2 m -148.3 171.47 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 106.588 -1.634 . . . . 65.109999999999999 106.588 -168.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.6 t -165.25 168.12 17.31 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.25 -2.13 . . . . 65.340000000000003 105.25 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -145.19 17.68 Favored Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 107.746 -2.141 . . . . 54.130000000000003 107.746 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.9 -85.51 0.42 Allowed Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.417 -1.473 . . . . 71.150000000000006 109.417 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.02 17.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.247 0 O-C-N 121.88 -0.777 . . . . 72.099999999999994 113.056 -166.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.7 t30 86.24 6.38 0.37 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.251 -1.018 . . . . 64.140000000000001 108.251 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -45.71 -168.98 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 126.497 1.919 . . . . 75.329999999999998 111.696 159.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 m -33.7 -39.54 0.06 Allowed 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.663 1.585 . . . . 64.310000000000002 114.836 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 20.2 m -77.27 139.96 17.86 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 O-C-N 121.184 -0.948 . . . . 63.109999999999999 108.934 -175.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -69.42 -52.29 28.25 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 122.031 -0.418 . . . . 74.310000000000002 111.854 -169.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -78.25 5.05 11.15 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.64 -0.663 . . . . 75.329999999999998 110.49 -169.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.6 7.36 14.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 111.228 -0.749 . . . . 64.109999999999999 111.228 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.28 178.93 50.69 Favored Glycine 0 CA--C 1.473 -2.583 0 N-CA-C 106.09 -2.804 . . . . 74.109999999999999 106.09 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.445 HG13 ' HB ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -88.9 136.65 22.9 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.4 0 N-CA-C 104.688 -2.338 . . . . 70.239999999999995 104.688 173.835 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.405 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 3.1 m-85 -109.81 146.58 34.79 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 102.991 -2.966 . . . . 72.340000000000003 102.991 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.75 103.29 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 107.085 -1.45 . . . . 64.519999999999996 107.085 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -71.18 -35.15 71.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.271 -1.331 . . . . 71.200000000000003 109.758 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.77 153.9 12.96 Favored 'General case' 0 CA--C 1.465 -2.309 0 N-CA-C 105.935 -1.876 . . . . 72.120000000000005 105.935 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.37 139.58 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 103.317 -2.845 . . . . 64.140000000000001 103.317 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.402 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -75.88 151.8 84.47 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 106.279 -1.748 . . . . 73.120000000000005 106.279 174.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.7 174.3 13.04 Favored 'Trans proline' 0 CA--C 1.468 -2.807 0 N-CA-C 105.449 -2.558 . . . . 61.420000000000002 105.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 49.26 52.01 15.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.74 0.781 . . . . 54.329999999999998 110.02 166.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.73 171.27 30.53 Favored Glycine 0 CA--C 1.461 -3.324 0 N-CA-C 103.184 -3.966 . . . . 23.100000000000001 103.184 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.92 -53.11 43.53 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 118.182 0.991 . . . . 72.230000000000004 108.847 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.6 63.52 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 116.898 -0.137 . . . . 71.329999999999998 111.28 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -69.86 -54.19 14.62 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.971 -0.381 . . . . 73.439999999999998 109.971 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.7 m -61.45 -30.59 70.69 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.983 -0.448 . . . . 70.109999999999999 110.777 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -81.35 -35.5 30.79 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.298 -1.742 . . . . 65.329999999999998 106.298 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.48 63.01 Favored Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 109.827 -1.309 . . . . 65.420000000000002 109.827 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -93.28 1.28 57.07 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.292 -1.374 . . . . 64.239999999999995 107.292 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.8 mt -144.64 139.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.157 -2.905 . . . . 73.030000000000001 103.157 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -143.9 162.46 36.06 Favored 'General case' 0 CA--C 1.459 -2.548 0 N-CA-C 106.054 -1.832 . . . . 72.129999999999995 106.054 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -67.19 137.58 56.33 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.195 -1.409 . . . . 62.310000000000002 107.195 170.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.38 -33.03 6.67 Favored Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 108.151 -1.98 . . . . 74.310000000000002 108.151 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.41 155.0 38.68 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.48 -1.674 . . . . 72.310000000000002 106.48 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.34 148.33 51.26 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.336 -1.357 . . . . 72.430000000000007 107.336 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.92 129.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.831 -1.914 . . . . 73.109999999999999 105.831 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.525 ' CD1' HG23 ' A' ' 7' ' ' ILE . 32.5 mt -93.79 -58.66 2.19 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 106.937 -1.505 . . . . 70.120000000000005 106.937 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.25 150.63 51.03 Favored 'General case' 0 CA--C 1.475 -1.923 0 N-CA-C 106.455 -1.683 . . . . 72.120000000000005 106.455 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.66 122.38 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 104.929 -2.248 . . . . 35.229999999999997 104.929 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 56.11 33.43 21.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.976 0.893 . . . . 55.009999999999998 108.875 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.41 -21.62 41.73 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 108.143 -1.983 . . . . 42.350000000000001 108.143 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.91 118.73 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.132 0 N-CA-C 107.873 -1.158 . . . . 55.140000000000001 107.873 -172.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -49.21 116.97 1.9 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.814 -0.81 . . . . 74.430000000000007 108.814 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.472 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -98.85 -19.59 17.31 Favored 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 105.936 -1.876 . . . . 74.109999999999999 105.936 -173.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.99 124.62 21.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.664 -0.865 . . . . 71.239999999999995 108.664 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.63 60.84 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.465 -1.854 . . . . 42.32 108.465 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.55 147.17 39.9 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.195 -1.78 . . . . 73.329999999999998 106.195 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.1 p -77.04 178.57 6.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.143 -1.058 . . . . 51.439999999999998 108.143 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -68.47 -46.96 68.34 Favored 'General case' 0 C--O 1.204 -1.314 0 N-CA-C 108.665 -0.865 . . . . 62.509999999999998 108.665 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.17 -54.39 45.79 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.366 -0.834 . . . . 74.310000000000002 110.518 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -57.92 -40.77 81.23 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 110.141 -0.318 . . . . 74.540000000000006 110.141 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.95 -52.15 52.26 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 122.604 0.362 . . . . 75.010000000000005 110.438 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -73.7 -39.72 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.621 -1.252 . . . . 72.430000000000007 107.621 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.0 t -57.14 -35.58 69.67 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 106.423 -1.695 . . . . 64.439999999999998 106.423 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.4 m -71.69 -43.82 65.3 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 120.388 -1.445 . . . . 71.430000000000007 107.829 -174.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.04 -39.35 94.48 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 109.069 -0.715 . . . . 72.040000000000006 109.069 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -68.28 -59.76 2.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.868 -1.16 . . . . 74.019999999999996 107.868 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.17 53.31 0.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.877 0.846 . . . . 75.25 110.723 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.435 HG21 HG13 ' A' ' 86' ' ' VAL . 7.0 p -103.74 -175.97 2.95 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 105.161 -2.162 . . . . 53.409999999999997 105.161 169.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.21 -148.85 16.93 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 107.225 -2.35 . . . . 75.230000000000004 107.225 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -66.61 -54.99 17.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.55 -0.907 . . . . 74.409999999999997 108.55 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.6 t -99.29 144.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.67 -1.604 . . . . 74.349999999999994 106.67 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.435 HG13 HG21 ' A' ' 82' ' ' THR . 58.0 t -100.69 129.3 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 105.459 -2.052 . . . . 61.539999999999999 105.459 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -113.33 128.26 56.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.723 -2.325 . . . . 64.010000000000005 104.723 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.05 138.31 12.58 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.406 -1.331 . . . . 63.409999999999997 107.406 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -81.76 139.58 34.75 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.617 -1.253 . . . . 64.209999999999994 107.617 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.644 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.76 159.05 17.5 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 104.174 -2.528 . . . . 73.140000000000001 104.174 175.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.79 131.25 53.96 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 100.542 -3.873 . . . . 74.439999999999998 100.542 161.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -70.61 139.97 51.52 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 106.208 -1.775 . . . . 73.450000000000003 106.208 -174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.286 0 N-CA-C 107.737 -2.145 . . . . 52.340000000000003 107.737 -173.861 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.586 0 N-CA-C 108.385 -1.886 . . . . 62.399999999999999 108.385 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.99 131.34 42.03 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.237 -1.394 . . . . 65.5 107.237 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.488 HG23 ' CD1' ' A' ' 60' ' ' LEU . 4.6 mt -94.8 136.31 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 N-CA-C 107.0 -1.482 . . . . 53.219999999999999 107.0 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.1 p90 -141.21 154.85 46.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.144 -1.428 . . . . 73.239999999999995 107.144 174.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -104.66 148.81 26.14 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 105.574 -2.01 . . . . 73.140000000000001 105.574 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.621 HG22 HD21 ' A' ' 90' ' ' LEU . 17.1 m -138.17 150.97 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 106.481 -1.674 . . . . 54.130000000000003 106.481 173.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -106.58 124.99 50.43 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 104.619 -2.363 . . . . 64.439999999999998 104.619 164.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.7 mt -139.46 137.42 35.56 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.599 -1.63 . . . . 64.230000000000004 106.599 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.48 161.18 17.15 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 106.416 -1.698 . . . . 55.509999999999998 106.416 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -43.68 63.03 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 105.919 -1.882 . . . . 44.43 105.919 168.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 70.13 117.35 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.325 1.05 . . . . 62.229999999999997 108.983 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 59.2 37.54 23.82 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-O 121.816 0.817 . . . . 50.0 109.021 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 55.1 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.253 1.821 . . . . 70.5 114.392 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.3 m -93.73 136.54 33.91 Favored 'General case' 0 CA--C 1.483 -1.606 0 O-C-N 120.51 -1.369 . . . . 63.32 108.759 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.01 -165.01 1.22 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.725 -3.065 . . . . 72.140000000000001 102.725 172.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.468 ' H ' HD13 ' A' ' 19' ' ' LEU . . . 163.43 23.6 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.328 0 C-N-CA 117.315 -2.374 . . . . 63.25 110.339 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.505 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -87.79 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 104.411 -2.44 . . . . 64.030000000000001 104.411 179.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 m -138.31 160.3 39.84 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.114 -2.18 . . . . 74.329999999999998 105.114 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 169.47 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.629 -0.878 . . . . 74.409999999999997 108.629 -163.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.2 t -160.41 165.45 31.08 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 104.805 -2.294 . . . . 70.450000000000003 104.805 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.18 -149.72 24.18 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 108.938 -1.665 . . . . 64.030000000000001 108.938 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' HA2' HG12 ' A' ' 36' ' ' ILE . . . 113.61 -75.85 0.24 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 109.46 -1.456 . . . . 75.5 109.46 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.39 15.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 O-C-N 122.579 -0.365 . . . . 62.520000000000003 110.953 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.8 t30 83.8 5.15 0.76 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.619 1.168 . . . . 74.540000000000006 108.15 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.1 p -47.44 -170.11 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.542 1.937 . . . . 72.230000000000004 113.623 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 m -40.94 -37.58 0.82 Allowed 'General case' 0 C--N 1.373 1.597 0 C-N-CA 125.969 1.707 . . . . 70.010000000000005 113.853 -165.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 132.07 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.537 0.684 . . . . 70.099999999999994 110.171 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ptt85 -44.53 -63.63 0.86 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-N 114.79 -1.095 . . . . 74.310000000000002 113.397 -168.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -77.78 -19.92 54.22 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 118.708 0.686 . . . . 73.299999999999997 109.229 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.42 -12.54 43.47 Favored Glycine 0 C--N 1.361 1.949 0 N-CA-C 109.916 -1.274 . . . . 53.210000000000001 109.916 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.17 179.94 49.62 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 109.855 -1.298 . . . . 64.019999999999996 109.855 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.514 HG13 ' CD1' ' A' ' 67' ' ' LEU . 2.8 mm -86.53 127.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 102.05 -3.315 . . . . 64.510000000000005 102.05 170.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -104.9 155.59 18.79 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 105.426 -2.065 . . . . 74.129999999999995 105.426 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -83.5 102.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 105.675 -1.972 . . . . 70.409999999999997 105.675 174.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.83 -31.28 66.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.497 -1.228 . . . . 74.140000000000001 110.163 -172.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.48 149.95 17.45 Favored 'General case' 0 CA--C 1.463 -2.387 0 N-CA-C 105.849 -1.908 . . . . 45.130000000000003 105.849 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.0 t -127.4 134.96 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 104.512 -2.403 . . . . 73.209999999999994 104.512 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -81.97 151.43 67.1 Favored Pre-proline 0 N--CA 1.445 -0.695 0 N-CA-C 106.669 -1.604 . . . . 72.430000000000007 106.669 176.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.45 -179.14 5.01 Favored 'Trans proline' 0 CA--C 1.479 -2.274 0 N-CA-C 105.928 -2.374 . . . . 72.25 105.928 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 49.43 52.24 14.86 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.023 0.827 . . . . 72.510000000000005 110.641 162.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.59 32.85 Favored Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 103.41 -3.876 . . . . 75.140000000000001 103.41 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.36 53.54 Favored 'General case' 0 C--O 1.205 -1.263 0 CA-C-N 117.632 0.716 . . . . 72.129999999999995 109.173 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.91 -50.26 64.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.547 -0.297 . . . . 32.130000000000003 110.99 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -68.79 -50.15 52.66 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.958 -0.464 . . . . 71.510000000000005 110.016 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.7 t -63.81 -33.69 76.25 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.754 -0.461 . . . . 71.319999999999993 109.754 -171.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -79.17 -32.0 44.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.074 -1.824 . . . . 70.120000000000005 106.074 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.29 60.98 Favored Glycine 0 C--N 1.359 1.818 0 N-CA-C 110.327 -1.109 . . . . 75.209999999999994 110.327 170.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -101.87 8.26 41.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.94 -1.133 . . . . 63.130000000000003 107.94 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.0 mt -144.27 145.75 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.009 -2.219 . . . . 64.319999999999993 105.009 -171.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.504 ' CE1' ' OD1' ' A' ' 57' ' ' ASP . 54.0 p-80 -154.12 159.69 41.58 Favored 'General case' 0 N--CA 1.401 -2.911 0 N-CA-C 102.815 -3.031 . . . . 62.439999999999998 102.815 172.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 17.1 ptpt -66.5 147.0 53.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.57 -0.9 . . . . 72.310000000000002 108.57 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.54 -33.26 6.7 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 109.975 -1.25 . . . . 62.219999999999999 109.975 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.504 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 83.0 m-20 -69.75 155.95 39.76 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 105.32 -2.104 . . . . 62.340000000000003 105.32 172.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -132.66 157.89 43.69 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.633 -0.877 . . . . 73.140000000000001 108.633 -169.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.83 140.82 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 106.723 -1.584 . . . . 71.409999999999997 106.723 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.488 ' CD1' HG23 ' A' ' 7' ' ' ILE . 10.3 mt -101.11 -59.48 1.69 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.36 -1.718 . . . . 73.340000000000003 106.36 174.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.13 151.31 49.64 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 106.487 -1.672 . . . . 63.509999999999998 106.487 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.78 123.5 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.336 -2.098 . . . . 73.019999999999996 105.336 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.4 t30 50.99 35.35 12.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.874 1.27 . . . . 75.549999999999997 110.854 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.58 -22.04 38.75 Favored Glycine 0 CA--C 1.473 -2.566 0 N-CA-C 108.856 -1.698 . . . . 73.430000000000007 108.856 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.64 115.78 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 N-CA-C 108.095 -1.076 . . . . 72.420000000000002 108.095 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.0 m -54.12 112.92 1.06 Allowed 'General case' 0 C--N 1.371 1.537 0 N-CA-C 107.6 -1.259 . . . . 72.200000000000003 107.6 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 36' ' ' ILE . 1.1 tm? -104.44 -11.79 16.87 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 106.882 -1.525 . . . . 75.340000000000003 106.882 -162.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -60.16 129.2 40.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.62 -0.881 . . . . 65.219999999999999 108.62 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.91 -14.5 65.16 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.64 -1.784 . . . . 74.420000000000002 108.64 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.6 150.91 27.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.399 -1.704 . . . . 73.219999999999999 106.399 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -83.58 178.84 7.81 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.795 -0.446 . . . . 70.219999999999999 109.795 -167.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -56.21 -52.0 66.01 Favored 'General case' 0 C--N 1.382 2.007 0 N-CA-C 107.093 -1.447 . . . . 62.530000000000001 107.093 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -58.72 -48.51 80.91 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 116.538 -0.301 . . . . 45.140000000000001 110.764 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -56.64 -42.71 79.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.7 -0.4 . . . . 65.400000000000006 110.543 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -52.06 -51.4 57.81 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 120.727 -0.389 . . . . 73.040000000000006 110.657 177.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.26 -39.98 49.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 C-N-CA 119.932 -0.707 . . . . 75.030000000000001 109.831 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.67 -33.25 74.67 Favored 'General case' 0 N--CA 1.521 3.077 0 N-CA-C 106.131 -1.803 . . . . 74.450000000000003 106.131 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 m -71.31 -42.93 68.0 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 120.242 -1.536 . . . . 60.409999999999997 108.209 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.5 mt -69.49 -35.26 75.39 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.409 -0.589 . . . . 60.439999999999998 109.409 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -61.86 1.61 Allowed 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.556 -1.276 . . . . 61.539999999999999 107.556 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -73.07 58.46 0.49 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.409 0.623 . . . . 74.340000000000003 110.67 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 86' ' ' VAL . 3.2 p -102.68 -175.79 2.92 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.323 -1.362 . . . . 62.149999999999999 107.323 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.01 -154.28 30.35 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 106.224 -2.75 . . . . 64.239999999999995 106.224 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.61 -53.98 50.88 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.829 -0.434 . . . . 72.409999999999997 109.829 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.0 t -110.57 154.09 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 105.729 -1.952 . . . . 70.109999999999999 105.729 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 82' ' ' THR . 21.8 t -107.47 139.04 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.441 0 N-CA-C 105.912 -1.884 . . . . 62.229999999999997 105.912 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.87 123.99 49.42 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 104.418 -2.438 . . . . 65.340000000000003 104.418 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.8 133.31 11.97 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.052 -1.092 . . . . 53.140000000000001 108.052 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -84.86 144.34 28.47 Favored 'General case' 0 CA--C 1.474 -1.98 0 N-CA-C 108.832 -0.803 . . . . 74.219999999999999 108.832 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.621 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.79 162.71 17.65 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 104.711 -2.329 . . . . 63.140000000000001 104.711 175.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -124.39 137.38 54.47 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.233 -3.247 . . . . 71.319999999999993 102.233 165.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.8 145.75 54.2 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.006 -0.739 . . . . 64.299999999999997 109.006 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.904 0 N-CA-C 105.427 -3.069 . . . . 74.010000000000005 105.427 179.765 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.959 0 N-CA-C 109.569 -1.413 . . . . 64.310000000000002 109.569 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.86 145.52 26.55 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 106.604 -1.628 . . . . 71.530000000000001 106.604 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.436 HG23 ' CD1' ' A' ' 60' ' ' LEU . 12.2 mt -101.53 139.02 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.986 0 N-CA-C 108.083 -1.08 . . . . 75.349999999999994 108.083 -175.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.541 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.5 p90 -144.67 162.27 37.1 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.012 -1.477 . . . . 75.030000000000001 107.012 171.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.59 150.38 24.02 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.003 -1.851 . . . . 74.340000000000003 106.003 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.624 HG22 HD21 ' A' ' 90' ' ' LEU . 15.7 m -132.89 140.27 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.543 0 N-CA-C 105.178 -2.156 . . . . 72.140000000000001 105.178 168.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.38 116.4 31.88 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.65 -2.352 . . . . 65.230000000000004 104.65 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 12' ' ' LEU . 8.1 mt -138.46 138.24 37.94 Favored 'General case' 0 CA--C 1.454 -2.726 0 N-CA-C 107.615 -1.254 . . . . 73.400000000000006 107.615 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . . . -89.1 159.58 17.47 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 105.746 -1.946 . . . . 74.219999999999999 105.746 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.85 -50.69 71.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.879 -1.526 . . . . 74.209999999999994 106.879 171.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 t30 74.62 119.24 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.446 -1.252 . . . . 72.409999999999997 107.954 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 57.16 34.48 24.9 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.734 0.814 . . . . 75.5 109.445 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.1 t30 54.61 -5.11 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.746 1.618 . . . . 54.119999999999997 113.679 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 m -95.66 136.99 35.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.894 -0.78 . . . . 73.540000000000006 108.894 -171.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -149.95 0.45 Allowed 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 103.008 -2.96 . . . . 63.420000000000002 103.008 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.12 76.17 0.86 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 106.542 -2.623 . . . . 73.430000000000007 106.542 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.3 mm -102.02 176.74 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 102.531 -3.137 . . . . 74.310000000000002 102.531 176.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.403 ' H ' HG22 ' A' ' 21' ' ' ILE . 7.0 m -106.11 152.71 23.06 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 103.843 -2.651 . . . . 55.240000000000002 103.843 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.35 165.0 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.98 -1.119 . . . . 64.439999999999998 107.98 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.9 t -160.2 165.96 30.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.683 -2.339 . . . . 74.150000000000006 104.683 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.431 ' O ' ' CE1' ' A' ' 72' ' ' HIS . . . 82.7 -141.25 20.94 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 107.292 -2.323 . . . . 73.5 107.292 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.51 -84.11 0.38 Allowed Glycine 0 CA--C 1.471 -2.664 0 N-CA-C 108.437 -1.865 . . . . 53.310000000000002 108.437 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -69.06 8.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.041 0 N-CA-C 112.396 0.517 . . . . 65.310000000000002 112.396 -166.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 68.66 68.08 0.3 Allowed 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 106.71 -1.589 . . . . 72.140000000000001 106.71 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 p -107.04 -164.66 1.0 Allowed 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 101.956 -3.35 . . . . 63.32 101.956 -172.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -44.84 -18.43 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.152 0.981 . . . . 73.150000000000006 113.152 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.67 150.85 8.49 Favored 'Isoleucine or valine' 0 C--N 1.38 1.934 0 N-CA-C 106.06 -1.83 . . . . 74.340000000000003 106.06 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -78.77 -72.17 0.4 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 120.403 -1.436 . . . . 61.509999999999998 110.121 -169.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -69.9 -21.55 63.3 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 120.29 -0.564 . . . . 61.119999999999997 110.944 -160.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.27 59.99 1.7 Allowed Glycine 0 CA--C 1.484 -1.897 0 C-N-CA 119.554 -1.307 . . . . 74.150000000000006 110.168 164.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.18 179.41 20.73 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 104.643 -3.383 . . . . 70.319999999999993 104.643 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 36' ' ' ILE . 8.1 mm -82.17 127.91 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.428 0 N-CA-C 103.356 -2.831 . . . . 65.310000000000002 103.356 169.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -106.1 150.93 25.32 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 105.045 -2.206 . . . . 73.219999999999999 105.045 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -83.9 102.03 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.053 -1.832 . . . . 73.409999999999997 106.053 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.47 -25.97 63.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.054 -1.43 . . . . 53.030000000000001 109.861 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -173.62 161.38 3.95 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 104.642 -2.355 . . . . 71.120000000000005 104.642 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -116.88 132.57 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 103.134 -2.913 . . . . 54.020000000000003 103.134 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -82.35 151.0 65.1 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.964 -1.865 . . . . 63.539999999999999 105.964 175.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.95 177.47 8.76 Favored 'Trans proline' 0 CA--C 1.482 -2.084 0 N-CA-C 106.587 -2.12 . . . . 64.150000000000006 106.587 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 53.96 53.47 11.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.031 0.832 . . . . 73.040000000000006 109.157 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.55 166.89 33.43 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 105.447 -3.061 . . . . 55.450000000000003 105.447 -176.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.6 -50.74 70.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.508 -0.923 . . . . 51.25 108.508 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.97 66.04 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.857 -0.61 . . . . 72.439999999999998 110.688 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -65.85 -53.72 36.12 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.71 -0.478 . . . . 73.209999999999994 109.71 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -56.95 -29.12 62.87 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 122.226 -0.296 . . . . 75.109999999999999 111.271 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.55 -28.39 20.79 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.867 -1.16 . . . . 74.400000000000006 107.867 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.0 19.9 74.16 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.77 -0.932 . . . . 54.409999999999997 110.77 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HB3' HG11 ' A' ' 10' ' ' VAL . 85.0 mtt-85 -104.55 7.1 35.11 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 117.753 0.777 . . . . 64.420000000000002 108.94 -176.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.471 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 1.5 mp -127.56 136.57 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.183 -3.266 . . . . 71.5 102.183 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 53' ' ' ILE . 40.8 m170 -145.34 162.72 36.56 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 106.118 -1.808 . . . . 72.420000000000002 106.118 -177.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -66.6 136.78 56.11 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.274 -1.01 . . . . 75.340000000000003 108.274 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.31 -29.25 12.31 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 108.338 -1.905 . . . . 51.030000000000001 108.338 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.92 155.03 41.0 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 106.91 -1.515 . . . . 72.329999999999998 106.91 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -124.76 153.81 41.87 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.216 -1.031 . . . . 74.019999999999996 108.216 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -92.59 132.32 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 N-CA-C 105.739 -1.949 . . . . 74.450000000000003 105.739 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.436 ' CD1' HG23 ' A' ' 7' ' ' ILE . 11.5 mt -95.36 -59.41 1.89 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.942 -1.503 . . . . 74.230000000000004 106.942 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.69 51.37 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.788 -1.56 . . . . 34.539999999999999 106.788 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.52 131.07 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 104.722 -2.325 . . . . 62.109999999999999 104.722 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 56.23 29.94 15.74 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 122.009 0.909 . . . . 75.430000000000007 109.489 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.39 -9.07 76.89 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.573 -1.811 . . . . 50.100000000000001 108.573 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.9 t -87.9 115.6 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 N-CA-C 106.507 -1.664 . . . . 72.109999999999999 106.507 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.46 119.82 5.76 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 107.898 -1.149 . . . . 61.130000000000003 107.898 172.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -108.97 -15.17 14.42 Favored 'General case' 0 C--O 1.2 -1.541 0 N-CA-C 107.262 -1.385 . . . . 54.109999999999999 107.262 -163.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.43 122.33 13.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.505 -0.924 . . . . 73.400000000000006 108.505 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.78 -16.63 57.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 108.635 -1.786 . . . . 60.420000000000002 108.635 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.39 151.45 29.37 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.606 -1.627 . . . . 75.310000000000002 106.606 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.547 ' HA ' HG22 ' A' ' 27' ' ' VAL . 68.6 p -79.96 179.78 7.41 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.202 0.525 . . . . 65.120000000000005 109.745 -170.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' HIS . . . . . 0.431 ' CE1' ' O ' ' A' ' 25' ' ' GLY . 14.4 m-70 -59.66 -51.31 70.35 Favored 'General case' 0 C--N 1.371 1.511 0 N-CA-C 107.589 -1.263 . . . . 62.32 107.589 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -55.7 -55.08 36.39 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 109.988 -0.375 . . . . 65.140000000000001 109.988 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -53.86 -43.95 69.97 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.775 -0.454 . . . . 63.509999999999998 109.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -50.78 -54.49 23.11 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 122.663 0.385 . . . . 34.039999999999999 110.369 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 m -74.22 -37.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 C-N-CA 120.506 -0.478 . . . . 71.209999999999994 109.778 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 82.9 m -62.71 -32.23 73.29 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.305 -1.739 . . . . 73.010000000000005 106.305 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -73.62 -40.69 63.6 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.357 -1.464 . . . . 71.150000000000006 108.195 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.5 -28.4 69.81 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.242 -0.651 . . . . 74.219999999999999 109.242 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -58.04 3.34 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 107.775 -1.194 . . . . 75.420000000000002 107.775 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -68.58 43.32 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 124.781 1.232 . . . . 55.539999999999999 112.212 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.452 ' CG2' HG22 ' A' ' 86' ' ' VAL . 1.4 t -123.82 -174.61 3.02 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 102.942 -2.985 . . . . 72.099999999999994 102.942 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.34 -145.16 18.3 Favored Glycine 0 CA--C 1.49 -1.48 0 N-CA-C 107.7 -2.16 . . . . 53.340000000000003 107.7 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.78 -55.49 16.93 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.46 -0.941 . . . . 62.039999999999999 108.46 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' ALA . 94.9 t -107.16 142.5 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 106.04 -1.837 . . . . 55.030000000000001 106.04 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.452 HG22 ' CG2' ' A' ' 82' ' ' THR . 45.8 t -115.08 144.82 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 105.634 -1.987 . . . . 62.439999999999998 105.634 -172.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.38 122.1 45.27 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 104.698 -2.334 . . . . 71.329999999999998 104.698 168.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -136.49 118.29 15.12 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.182 -2.155 . . . . 73.230000000000004 105.182 177.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.5 mp -83.94 143.62 29.71 Favored 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 106.624 -1.621 . . . . 73.129999999999995 106.624 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.624 HD21 HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -112.34 156.23 22.8 Favored 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.96 -2.237 . . . . 43.32 104.96 -179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -123.54 135.44 54.01 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 101.08 -3.674 . . . . 71.219999999999999 101.08 162.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.29 137.11 58.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.618 -1.252 . . . . 73.129999999999995 107.618 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.464 -3.125 0 N-CA-C 110.233 -1.147 . . . . 64.519999999999996 110.233 -168.567 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.792 0 N-CA-C 108.211 -1.956 . . . . 20.52 108.211 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.24 143.91 66.44 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.885 2.39 . . . . 63.130000000000003 108.595 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.55 168.31 19.12 Favored Pre-proline 0 N--CA 1.451 -0.416 0 N-CA-C 106.148 -1.797 . . . . 65.329999999999998 106.148 -178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -61.46 116.2 3.26 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.884 2.389 . . . . 72.299999999999997 109.679 177.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.65 8.83 63.46 Favored Glycine 0 C--N 1.344 0.988 0 N-CA-C 108.487 -1.845 . . . . 54.109999999999999 108.487 177.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -89.86 143.44 26.79 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 106.273 -1.751 . . . . 62.340000000000003 106.273 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.53 HG23 ' CD1' ' A' ' 60' ' ' LEU . 19.1 mm -95.95 129.51 45.93 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 105.524 -2.028 . . . . 73.099999999999994 105.524 -176.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.621 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.2 p90 -137.07 152.41 50.03 Favored 'General case' 0 CA--C 1.489 -1.389 0 N-CA-C 107.81 -1.181 . . . . 73.349999999999994 107.81 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -106.53 146.34 30.74 Favored 'General case' 0 CA--C 1.474 -1.966 0 N-CA-C 106.044 -1.836 . . . . 72.540000000000006 106.044 -179.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.722 HG22 HD21 ' A' ' 90' ' ' LEU . 30.1 m -142.26 152.66 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.928 0 N-CA-C 105.958 -1.867 . . . . 50.32 105.958 174.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -113.85 132.04 56.04 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 106.381 -1.711 . . . . 73.319999999999993 106.381 172.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -131.03 139.13 49.9 Favored 'General case' 0 CA--C 1.457 -2.626 0 N-CA-C 106.833 -1.543 . . . . 43.229999999999997 106.833 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.49 131.36 38.97 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 105.927 -1.879 . . . . 73.010000000000005 105.927 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.1 ttpt -67.28 -23.91 65.72 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.637 -0.875 . . . . 71.010000000000005 108.637 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 70.71 104.86 0.06 Allowed 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 124.171 0.988 . . . . 55.43 110.394 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 56.85 43.47 24.87 Favored 'General case' 0 CA--C 1.484 -1.582 0 CA-C-N 115.448 -0.796 . . . . 72.109999999999999 109.203 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 42.64 9.68 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 126.708 2.003 . . . . 73.230000000000004 116.031 178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 56.1 m -126.88 129.78 48.89 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 106.437 -1.69 . . . . 52.009999999999998 106.437 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.3 167.34 12.4 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.836 -2.283 . . . . 55.140000000000001 104.836 168.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -158.56 68.62 0.27 Allowed Glycine 0 CA--C 1.47 -2.746 0 N-CA-C 104.507 -3.437 . . . . 72.219999999999999 104.507 -178.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.513 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.4 mt -101.15 176.94 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.943 0 N-CA-C 103.458 -2.793 . . . . 73.319999999999993 103.458 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.513 ' H ' HG22 ' A' ' 21' ' ' ILE . 70.9 m -138.28 165.07 27.65 Favored 'General case' 0 CA--C 1.477 -1.835 0 N-CA-C 106.402 -1.703 . . . . 73.129999999999995 106.402 -178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 m -152.33 177.15 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.513 0 N-CA-C 106.085 -1.82 . . . . 43.240000000000002 106.085 -168.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.471 ' HB ' ' HG3' ' A' ' 39' ' ' LYS . 10.0 t -160.95 166.21 28.71 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 104.0 -2.593 . . . . 62.149999999999999 104.0 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.97 -151.74 29.12 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 108.927 -1.669 . . . . 50.5 108.927 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.444 ' CA ' HD12 ' A' ' 36' ' ' ILE . . . 116.62 -70.64 0.28 Allowed Glycine 0 C--N 1.364 2.107 0 N-CA-C 109.692 -1.363 . . . . 44.340000000000003 109.692 173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.422 HG22 HG22 ' A' ' 71' ' ' THR . 1.4 t -72.32 16.84 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-O 121.097 0.475 . . . . 61.329999999999998 111.252 -172.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 26' ' ' GLY . 35.7 t30 78.41 5.14 2.61 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.597 1.159 . . . . 73.409999999999997 108.743 176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.3 t -49.77 -171.36 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 C-N-CA 125.337 1.455 . . . . 62.329999999999998 112.037 169.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 11.4 p -38.56 -38.22 0.37 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 126.63 1.972 . . . . 73.409999999999997 115.164 -164.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 28.7 m -59.71 140.77 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 CA-C-O 121.544 0.688 . . . . 74.099999999999994 110.215 -173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.407 ' HD3' ' H ' ' A' ' 97' ' ' THR . 96.1 mtt-85 -41.62 -70.28 0.11 Allowed 'General case' 0 C--N 1.356 0.868 0 C-N-CA 125.029 1.332 . . . . 74.109999999999999 112.824 -170.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -87.97 15.74 6.87 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 108.632 -0.877 . . . . 62.399999999999999 108.632 -171.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.43 -7.98 2.42 Favored Glycine 0 C--N 1.359 1.842 0 O-C-N 121.792 -0.567 . . . . 71.409999999999997 113.149 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.11 -178.64 49.44 Favored Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.656 -1.378 . . . . 64.310000000000002 109.656 -170.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.444 HD12 ' CA ' ' A' ' 26' ' ' GLY . 1.1 mp -76.96 128.3 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.637 0 N-CA-C 101.922 -3.362 . . . . 42.130000000000003 101.922 170.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -107.08 147.56 29.85 Favored 'General case' 0 CA--C 1.469 -2.163 0 N-CA-C 104.089 -2.56 . . . . 72.25 104.089 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 96.9 t -77.47 102.22 3.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.724 -1.584 . . . . 60.299999999999997 106.724 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.471 ' HG3' ' HB ' ' A' ' 24' ' ' THR . 0.7 OUTLIER -72.82 -37.59 67.43 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 113.831 -1.531 . . . . 64.299999999999997 110.441 -173.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.21 142.34 18.21 Favored 'General case' 0 CA--C 1.465 -2.312 0 N-CA-C 105.952 -1.87 . . . . 61.420000000000002 105.952 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 39.3 t -117.16 131.09 70.91 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.986 0 N-CA-C 102.96 -2.978 . . . . 75.120000000000005 102.96 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -73.27 144.58 84.56 Favored Pre-proline 0 N--CA 1.447 -0.611 0 N-CA-C 106.482 -1.673 . . . . 70.219999999999999 106.482 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -75.43 169.55 22.17 Favored 'Trans proline' 0 CA--C 1.462 -3.088 0 N-CA-C 105.07 -2.704 . . . . 62.520000000000003 105.07 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 66.51 -3.94 0.79 Allowed 'General case' 0 N--CA 1.442 -0.861 0 O-C-N 124.04 0.837 . . . . 73.129999999999995 111.317 167.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.48 -179.2 40.97 Favored Glycine 0 CA--C 1.479 -2.216 0 N-CA-C 108.122 -1.991 . . . . 71.420000000000002 108.122 -177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.92 -51.74 63.09 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 108.118 -1.068 . . . . 72.319999999999993 108.118 -176.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.02 -49.97 65.18 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 116.277 -0.42 . . . . 50.539999999999999 110.882 -176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.61 -55.87 15.29 Favored 'General case' 0 CA--C 1.53 0.174 0 O-C-N 122.174 -0.328 . . . . 71.519999999999996 110.285 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 68.5 m -65.02 -31.24 72.37 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 122.056 -0.402 . . . . 64.140000000000001 111.256 -171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -81.3 -32.59 33.08 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 106.494 -1.669 . . . . 72.510000000000005 106.494 -177.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.44 18.04 69.72 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 110.552 -1.019 . . . . 71.25 110.552 171.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.4 mmt-85 -86.48 2.46 47.8 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 107.854 -1.165 . . . . 60.119999999999997 107.854 178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 64.9 mt -147.42 147.46 17.43 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.278 0 N-CA-C 104.449 -2.426 . . . . 72.340000000000003 104.449 -168.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -153.97 167.11 30.87 Favored 'General case' 0 CA--C 1.471 -2.069 0 N-CA-C 104.186 -2.524 . . . . 74.319999999999993 104.186 172.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -66.3 145.41 55.77 Favored 'General case' 0 N--CA 1.442 -0.866 0 N-CA-C 108.121 -1.066 . . . . 55.399999999999999 108.121 177.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 103.7 -33.08 6.86 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 108.988 -1.645 . . . . 74.120000000000005 108.988 172.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -71.38 161.38 31.15 Favored 'General case' 0 CA--C 1.485 -1.524 0 N-CA-C 108.004 -1.11 . . . . 74.430000000000007 108.004 177.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -126.07 150.66 48.0 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 107.997 -1.112 . . . . 74.420000000000002 107.997 -172.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.3 t -96.01 139.24 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.38 0 N-CA-C 105.705 -1.961 . . . . 61.119999999999997 105.705 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.53 ' CD1' HG23 ' A' ' 7' ' ' ILE . 16.3 mt -102.18 -59.49 1.69 Allowed 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 106.992 -1.484 . . . . 74.439999999999998 106.992 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.55 150.4 50.74 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 106.199 -1.778 . . . . 61.539999999999999 106.199 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.8 t -120.44 120.33 62.42 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 105.015 -2.217 . . . . 75.109999999999999 105.015 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.4 t30 51.79 36.0 16.78 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.027 0.931 . . . . 75.439999999999998 109.979 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.34 -29.41 12.56 Favored Glycine 0 CA--C 1.474 -2.509 0 N-CA-C 108.134 -1.987 . . . . 44.140000000000001 108.134 170.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.8 t -73.69 115.32 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 108.383 -0.969 . . . . 72.230000000000004 108.383 -171.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.9 m -55.4 115.54 2.35 Favored 'General case' 0 C--N 1.37 1.486 0 N-CA-C 107.193 -1.41 . . . . 43.299999999999997 107.193 172.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -101.33 -15.29 17.29 Favored 'General case' 0 C--O 1.193 -1.907 0 N-CA-C 106.427 -1.694 . . . . 71.409999999999997 106.427 -165.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -63.09 128.77 37.37 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.498 -0.927 . . . . 75.219999999999999 108.498 178.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.07 -16.98 57.78 Favored Glycine 0 CA--C 1.498 -0.977 0 N-CA-C 107.815 -2.114 . . . . 54.109999999999999 107.815 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.88 152.2 28.24 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 105.554 -2.017 . . . . 75.430000000000007 105.554 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.422 HG22 HG22 ' A' ' 27' ' ' VAL . 31.1 p -79.16 176.32 9.78 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.094 -0.706 . . . . 73.409999999999997 109.094 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 21.4 p80 -70.34 -41.14 73.58 Favored 'General case' 0 C--O 1.21 -1.002 0 N-CA-C 108.726 -0.842 . . . . 75.430000000000007 108.726 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -58.67 -54.41 47.34 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.075 -1.015 . . . . 73.120000000000005 110.644 172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -55.85 -34.96 65.91 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.441 -0.787 . . . . 64.510000000000005 111.294 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.41 ' CB ' HG12 ' A' ' 36' ' ' ILE . . . -50.72 -52.33 41.33 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.579 0.228 . . . . 73.019999999999996 111.282 176.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 5.0 m -74.95 -35.03 34.36 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.808 0 N-CA-C 108.276 -1.009 . . . . 74.5 108.276 -175.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 18.3 t -56.41 -39.76 73.56 Favored 'General case' 0 N--CA 1.518 2.973 0 N-CA-C 105.775 -1.935 . . . . 72.030000000000001 105.775 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.2 m -69.3 -40.15 77.86 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 120.294 -1.503 . . . . 75.230000000000004 108.125 -173.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.6 mt -64.71 -30.11 71.11 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 109.788 -0.449 . . . . 73.319999999999993 109.788 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 -72.15 -57.67 4.06 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.529 -0.915 . . . . 74.349999999999994 108.529 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -69.14 48.11 0.07 Allowed 'General case' 0 N--CA 1.501 2.075 0 C-N-CA 122.918 0.487 . . . . 72.510000000000005 111.978 -177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.417 HG21 HG13 ' A' ' 86' ' ' VAL . 23.3 p -108.05 -175.58 2.82 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.21 -1.774 . . . . 72.340000000000003 106.21 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.06 -153.6 30.33 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 106.471 -2.652 . . . . 65.329999999999998 106.471 175.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -65.95 -54.86 20.87 Favored 'General case' 0 CA--C 1.507 -0.675 0 N-CA-C 108.75 -0.833 . . . . 73.129999999999995 108.75 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 77.9 t -95.07 142.74 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 N-CA-C 105.335 -2.098 . . . . 75.439999999999998 105.335 177.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.417 HG13 HG21 ' A' ' 82' ' ' THR . 48.1 t -102.56 128.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 N-CA-C 105.123 -2.177 . . . . 62.049999999999997 105.123 179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -107.29 125.62 51.39 Favored 'General case' 0 CA--C 1.484 -1.572 0 N-CA-C 103.527 -2.768 . . . . 72.310000000000002 103.527 175.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -157.22 136.36 11.85 Favored 'General case' 0 CA--C 1.472 -2.052 0 N-CA-C 108.169 -1.048 . . . . 72.310000000000002 108.169 -176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.4 ' HB3' HD12 ' A' ' 60' ' ' LEU . 5.7 mp -86.43 143.05 27.98 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 108.283 -1.006 . . . . 74.109999999999999 108.283 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.722 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -120.32 165.42 14.89 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 104.878 -2.267 . . . . 72.5 104.878 177.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -132.48 145.79 51.44 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 102.608 -3.108 . . . . 72.239999999999995 102.608 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -64.82 131.11 45.88 Favored 'General case' 0 CA--C 1.502 -0.89 0 N-CA-C 107.839 -1.171 . . . . 72.430000000000007 107.839 178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -109.09 10.45 33.99 Favored Glycine 0 CA--C 1.479 -2.196 0 N-CA-C 106.892 -2.483 . . . . 72.349999999999994 106.892 -174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -65.91 -40.02 91.11 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.621 -1.252 . . . . 71.049999999999997 107.621 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.401 ' HA ' ' HD2' ' A' ' 96' ' ' PRO . 1.8 m -45.09 112.47 1.55 Allowed Pre-proline 0 C--O 1.253 1.257 0 C-N-CA 124.286 1.035 . . . . 62.439999999999998 111.078 -178.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 95' ' ' SER . 44.4 Cg_endo -68.4 98.89 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.77 2.313 . . . . 63.32 107.325 173.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.407 ' H ' ' HD3' ' A' ' 32' ' ' ARG . 26.8 m . . . . . 0 N--CA 1.418 -2.066 0 N-CA-C 105.376 -2.083 . . . . 70.319999999999993 105.376 -173.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.579 ' C1 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.454 0 N-CA-C 108.288 -1.925 . . . . 70.430000000000007 108.288 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -67.78 149.94 78.68 Favored 'Trans proline' 0 CA--C 1.494 -1.485 0 C-N-CA 122.828 2.352 . . . . 65.349999999999994 108.068 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 57.6 mttp -86.43 161.47 48.48 Favored Pre-proline 0 N--CA 1.433 -1.311 0 N-CA-C 106.212 -1.773 . . . . 73.340000000000003 106.212 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -66.44 118.88 5.88 Favored 'Trans proline' 0 N--CA 1.444 -1.419 0 C-N-CA 122.599 2.199 . . . . 74.349999999999994 108.938 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.513 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 88.7 9.09 69.14 Favored Glycine 0 CA--C 1.497 -1.034 0 N-CA-C 108.511 -1.836 . . . . 71.239999999999995 108.511 177.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -75.66 135.07 40.44 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 106.817 -1.549 . . . . 62.329999999999998 106.817 177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.539 HD12 HD11 ' A' ' 60' ' ' LEU . 22.4 mm -98.8 130.07 48.21 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.98 0 N-CA-C 106.1 -1.815 . . . . 74.329999999999998 106.1 -177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.612 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -141.91 153.77 44.62 Favored 'General case' 0 CA--C 1.493 -1.241 0 N-CA-C 108.054 -1.091 . . . . 71.329999999999998 108.054 -177.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 12.5 mp0 -107.81 144.09 35.46 Favored 'General case' 0 CA--C 1.483 -1.628 0 N-CA-C 105.07 -2.196 . . . . 65.019999999999996 105.07 -178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.698 HG22 HD21 ' A' ' 90' ' ' LEU . 27.6 m -141.6 153.71 19.59 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 N-CA-C 107.068 -1.456 . . . . 64.239999999999995 107.068 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.462 ' HB2' HG11 ' A' ' 85' ' ' VAL . 7.4 pt-20 -112.08 130.71 55.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 105.892 -1.892 . . . . 64.239999999999995 105.892 170.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.17 134.1 39.79 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 106.865 -1.532 . . . . 75.219999999999999 106.865 -176.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 141.81 30.0 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 105.379 -2.082 . . . . 72.420000000000002 105.379 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.479 ' HG2' HD23 ' A' ' 19' ' ' LEU . 42.3 mtpt -75.41 -31.83 60.53 Favored 'General case' 0 CA--C 1.505 -0.763 0 N-CA-C 108.178 -1.045 . . . . 73.400000000000006 108.178 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 68.4 110.59 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 109.122 -0.696 . . . . 74.310000000000002 109.122 -177.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 30.8 t70 58.3 32.15 21.72 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 107.992 -1.114 . . . . 73.329999999999998 107.992 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 43.13 19.04 0.01 OUTLIER 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.722 1.609 . . . . 62.310000000000002 113.324 -175.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -90.56 119.36 30.75 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 106.215 -1.772 . . . . 65.530000000000001 106.215 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.742 HD13 ' H ' ' A' ' 20' ' ' GLY . 0.5 OUTLIER -111.6 -143.64 0.39 Allowed 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 102.911 -2.996 . . . . 63.130000000000003 102.911 179.068 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.742 ' H ' HD13 ' A' ' 19' ' ' LEU . . . 103.36 66.25 0.73 Allowed Glycine 0 CA--C 1.474 -2.482 0 N-CA-C 106.855 -2.498 . . . . 74.239999999999995 106.855 174.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.442 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.6 mm -89.43 177.47 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 N-CA-C 102.447 -3.168 . . . . 55.310000000000002 102.447 170.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.442 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.6 m -122.5 154.49 37.78 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.037 -2.579 . . . . 61.43 104.037 177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' HA ' ' H ' ' A' ' 39' ' ' LYS . 30.9 m -149.25 176.48 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 N-CA-C 107.424 -1.324 . . . . 61.299999999999997 107.424 -166.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 105.15 -2.167 . . . . 71.310000000000002 105.15 177.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.53 -158.75 25.54 Favored Glycine 0 CA--C 1.487 -1.677 0 N-CA-C 108.454 -1.858 . . . . 45.130000000000003 108.454 -178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.29 -95.06 0.3 Allowed Glycine 0 C--N 1.36 1.863 0 N-CA-C 109.08 -1.608 . . . . 63.439999999999998 109.08 172.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -68.31 17.15 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.433 1.093 . . . . 63.43 113.782 -165.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 85.79 6.04 0.43 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 124.437 1.095 . . . . 74.519999999999996 108.499 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 53.0 p -42.39 -169.44 0.0 OUTLIER 'General case' 0 CA--C 1.564 1.51 0 C-N-CA 127.044 2.138 . . . . 71.030000000000001 112.431 161.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 9.8 m -40.86 -33.1 0.27 Allowed 'General case' 0 C--N 1.356 0.869 0 C-N-CA 125.126 1.37 . . . . 44.009999999999998 113.485 -172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.4 m -62.08 129.48 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 122.465 1.126 . . . . 73.430000000000007 110.318 -178.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -51.17 -65.07 0.62 Allowed 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 114.041 -1.436 . . . . 74.010000000000005 111.48 -176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -84.48 16.66 3.01 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 121.573 -0.704 . . . . 72.310000000000002 110.646 -171.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 47.36 65.51 2.3 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 111.372 -0.691 . . . . 62.030000000000001 111.372 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.83 -179.15 31.57 Favored Glycine 0 CA--C 1.457 -3.574 0 N-CA-C 103.98 -3.648 . . . . 73.310000000000002 103.98 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.78 131.72 35.44 Favored 'Isoleucine or valine' 1 N--CA 1.379 -4.011 0 N-CA-C 104.988 -2.227 . . . . 60.119999999999997 104.988 178.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -108.26 151.81 25.46 Favored 'General case' 0 CA--C 1.46 -2.503 0 N-CA-C 103.621 -2.733 . . . . 74.510000000000005 103.621 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.9 t -82.29 102.49 8.29 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.848 0 N-CA-C 106.233 -1.766 . . . . 55.329999999999998 106.233 179.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' H ' ' HA ' ' A' ' 23' ' ' VAL . 46.9 tttp -71.82 -32.86 68.01 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-N 115.088 -0.96 . . . . 75.319999999999993 109.359 -177.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -161.06 149.64 16.18 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 105.401 -2.074 . . . . 61.509999999999998 105.401 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.9 t -118.29 130.3 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 102.805 -3.035 . . . . 74.439999999999998 102.805 174.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.427 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 143.36 65.7 Favored Pre-proline 0 N--CA 1.439 -0.977 0 N-CA-C 105.541 -2.022 . . . . 72.099999999999994 105.541 176.707 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 45' ' ' GLY . 97.8 Cg_endo -75.59 173.58 14.26 Favored 'Trans proline' 0 CA--C 1.464 -2.984 0 N-CA-C 106.428 -2.181 . . . . 62.039999999999999 106.428 -175.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 71.22 -12.1 0.63 Allowed 'General case' 0 N--CA 1.447 -0.599 0 O-C-N 124.364 1.04 . . . . 72.530000000000001 111.674 164.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -90.11 -179.71 44.15 Favored Glycine 0 CA--C 1.476 -2.388 0 N-CA-C 107.439 -2.264 . . . . 75.019999999999996 107.439 -176.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.06 -52.79 45.74 Favored 'General case' 0 CA--C 1.496 -1.101 0 N-CA-C 108.675 -0.861 . . . . 70.129999999999995 108.675 -174.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -49.27 66.8 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 116.217 -0.447 . . . . 55.109999999999999 110.281 -173.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -61.16 -55.66 29.81 Favored 'General case' 0 N--CA 1.455 -0.194 0 N-CA-C 109.59 -0.522 . . . . 65.510000000000005 109.59 178.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.9 m -64.85 -32.66 74.46 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.557 -0.292 . . . . 74.010000000000005 111.595 -170.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -81.61 -25.22 35.87 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 106.236 -1.764 . . . . 55.049999999999997 106.236 -176.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.04 19.4 77.42 Favored Glycine 0 CA--C 1.484 -1.853 0 N-CA-C 110.518 -1.033 . . . . 72.549999999999997 110.518 167.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB3' HG11 ' A' ' 10' ' ' VAL . 6.6 mmp_? -94.44 6.46 48.7 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 107.891 -1.151 . . . . 73.540000000000006 107.891 -178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 66.5 mt -144.02 138.91 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 103.804 -2.665 . . . . 74.010000000000005 103.804 -169.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -149.94 159.96 43.98 Favored 'General case' 0 CA--C 1.465 -2.304 0 N-CA-C 105.196 -2.15 . . . . 61.409999999999997 105.196 -178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -67.22 144.14 56.14 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.171 -1.048 . . . . 75.310000000000002 108.171 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.22 -32.66 7.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 108.081 -2.008 . . . . 73.010000000000005 108.081 174.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -63.65 155.16 30.67 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 108.128 -1.064 . . . . 33.32 108.128 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.5 ttp180 -116.27 141.54 48.02 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 106.783 -1.562 . . . . 54.409999999999997 106.783 -175.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.55 126.07 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 N-CA-C 105.138 -2.171 . . . . 73.140000000000001 105.138 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.539 HD11 HD12 ' A' ' 7' ' ' ILE . 75.2 mt -91.17 -59.12 2.24 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 107.668 -1.234 . . . . 72.040000000000006 107.668 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.89 149.81 49.12 Favored 'General case' 0 CA--C 1.472 -2.046 0 N-CA-C 106.51 -1.663 . . . . 63.409999999999997 106.51 -177.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.6 t -116.4 110.88 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 105.629 -1.989 . . . . 65.239999999999995 105.629 176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.6 t30 49.82 44.82 25.12 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 125.173 1.389 . . . . 63.130000000000003 110.622 178.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 103.22 -31.85 8.25 Favored Glycine 0 CA--C 1.464 -3.149 0 N-CA-C 108.186 -1.966 . . . . 65.340000000000003 108.186 169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 81.9 t -81.56 116.79 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 107.56 -1.274 . . . . 65.219999999999999 107.56 -172.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 t -55.32 126.64 25.83 Favored 'General case' 0 C--N 1.363 1.172 0 N-CA-C 108.281 -1.007 . . . . 61.130000000000003 108.281 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -97.23 -13.43 22.04 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 106.099 -1.815 . . . . 74.420000000000002 106.099 -171.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -61.1 127.62 32.44 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.787 -0.819 . . . . 63.25 108.787 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.4 -13.54 66.21 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.817 -1.713 . . . . 74.400000000000006 108.817 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.65 148.06 39.01 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 107.067 -1.457 . . . . 64.209999999999994 107.067 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.469 HG22 HG22 ' A' ' 27' ' ' VAL . 50.5 p -82.82 -179.93 7.58 Favored 'General case' 0 N--CA 1.43 -1.441 0 N-CA-C 107.824 -1.176 . . . . 44.210000000000001 107.824 -174.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.417 ' CE1' HG23 ' A' ' 23' ' ' VAL . 7.6 t60 -60.97 -51.39 69.47 Favored 'General case' 0 CA--C 1.507 -0.678 0 N-CA-C 108.213 -1.032 . . . . 64.329999999999998 108.213 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -52.95 -56.29 17.07 Favored 'General case' 0 C--N 1.37 1.478 0 N-CA-C 110.096 -0.335 . . . . 75.340000000000003 110.096 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -56.02 -47.63 77.45 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 109.509 -0.552 . . . . 74.329999999999998 109.509 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.42 -56.93 10.57 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.051 0.54 . . . . 70.420000000000002 111.242 -176.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 22.2 m -74.24 -35.83 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 N-CA-C 109.066 -0.716 . . . . 72.430000000000007 109.066 -172.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.36 -32.54 74.24 Favored 'General case' 0 N--CA 1.503 2.191 0 N-CA-C 106.338 -1.727 . . . . 74.400000000000006 106.338 -173.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 26.5 m -74.22 -38.82 63.43 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 120.413 -1.429 . . . . 71.340000000000003 108.087 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 75.2 mt -64.52 -48.67 74.26 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 108.61 -0.885 . . . . 62.409999999999997 108.61 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -55.88 13.58 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 108.582 -0.896 . . . . 30.120000000000001 108.582 -174.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.24 60.95 0.2 Allowed 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.97 0.891 . . . . 53.020000000000003 111.194 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 p -112.53 -176.11 2.84 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 106.54 -1.652 . . . . 70.430000000000007 106.54 171.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.59 -141.02 7.57 Favored Glycine 0 N--CA 1.437 -1.263 0 N-CA-C 106.647 -2.581 . . . . 65.120000000000005 106.647 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -68.44 -55.13 12.89 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.785 -0.82 . . . . 74.340000000000003 108.785 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.462 HG11 ' HB2' ' A' ' 11' ' ' GLU . 73.6 t -99.32 144.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.263 0 N-CA-C 107.775 -1.194 . . . . 55.32 107.775 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 37.9 t -97.62 125.57 50.73 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.186 0 N-CA-C 105.731 -1.952 . . . . 73.409999999999997 105.731 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -97.67 117.8 32.78 Favored 'General case' 0 CA--C 1.484 -1.594 0 N-CA-C 104.931 -2.248 . . . . 63.100000000000001 104.931 171.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.12 130.32 11.2 Favored 'General case' 0 CA--C 1.482 -1.637 0 C-N-CA 119.281 -0.968 . . . . 65.5 108.474 -179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.5 mp -83.06 143.51 30.54 Favored 'General case' 0 CA--C 1.482 -1.661 0 N-CA-C 108.354 -0.98 . . . . 42.43 108.354 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.698 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -116.08 158.92 22.43 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 106.438 -1.69 . . . . 75.140000000000001 106.438 178.43 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -126.72 131.51 51.35 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 102.47 -3.159 . . . . 52.009999999999998 102.47 169.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.513 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 30.1 mmmt -67.9 136.82 54.62 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 107.921 -1.14 . . . . 54.219999999999999 107.921 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -131.81 11.58 5.4 Favored Glycine 0 CA--C 1.488 -1.603 0 C-N-CA 119.9 -1.143 . . . . 72.5 110.725 -168.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.42 ' OE1' ' HE3' ' A' ' 92' ' ' LYS . 24.7 mp0 -64.28 -37.06 86.13 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 107.578 -1.267 . . . . 74.140000000000001 107.578 175.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.0 m -116.04 97.03 48.62 Favored Pre-proline 0 N--CA 1.444 -0.769 0 N-CA-C 104.722 -2.325 . . . . 73.150000000000006 104.722 170.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.38 106.37 1.58 Allowed 'Trans proline' 0 CA--C 1.5 -1.176 0 C-N-CA 122.068 1.845 . . . . 61.119999999999997 107.595 -176.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.421 -1.893 0 N-CA-C 104.181 -2.526 . . . . 71.420000000000002 104.181 -176.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.535 ' C1 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.639 0 N-CA-C 108.757 -1.737 . . . . 74.409999999999997 108.757 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -65.58 164.93 24.51 Favored 'Trans proline' 0 C--O 1.25 1.105 0 C-N-CA 123.235 2.623 . . . . 73.329999999999998 109.223 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp -88.55 165.41 28.12 Favored Pre-proline 0 N--CA 1.434 -1.236 0 N-CA-C 107.824 -1.176 . . . . 65.209999999999994 107.824 -175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -65.05 117.59 4.68 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.761 2.307 . . . . 62.399999999999999 108.181 179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.413 ' H ' ' HB2' ' A' ' 92' ' ' LYS . . . 91.82 5.71 66.16 Favored Glycine 0 CA--C 1.493 -1.329 0 N-CA-C 109.73 -1.348 . . . . 75.510000000000005 109.73 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -90.09 146.96 23.93 Favored 'General case' 0 CA--C 1.496 -1.109 0 N-CA-C 106.472 -1.677 . . . . 73.129999999999995 106.472 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.622 HD12 HD11 ' A' ' 60' ' ' LEU . 11.4 mm -96.94 129.11 47.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 106.515 -1.661 . . . . 75.230000000000004 106.515 -173.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.59 ' CD2' HD23 ' A' ' 90' ' ' LEU . 6.2 p90 -131.87 148.36 52.54 Favored 'General case' 0 CA--C 1.486 -1.513 0 N-CA-C 106.655 -1.609 . . . . 74.25 106.655 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -108.22 148.64 29.67 Favored 'General case' 0 CA--C 1.475 -1.909 0 N-CA-C 106.454 -1.684 . . . . 71.239999999999995 106.454 -177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.708 HG22 HD21 ' A' ' 90' ' ' LEU . 26.8 m -140.21 150.79 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 106.392 -1.707 . . . . 62.140000000000001 106.392 173.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -120.48 138.92 53.56 Favored 'General case' 0 CA--C 1.465 -2.315 0 N-CA-C 104.533 -2.395 . . . . 72.329999999999998 104.533 171.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.08 144.83 28.13 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.423 -1.325 . . . . 73.340000000000003 107.423 -173.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.34 123.65 29.28 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 105.883 -1.895 . . . . 73.310000000000002 105.883 -178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -71.33 -22.52 61.91 Favored 'General case' 0 CA--C 1.507 -0.695 0 N-CA-C 109.023 -0.732 . . . . 60.329999999999998 109.023 -173.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.3 t30 73.61 109.19 0.07 Allowed 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 123.706 0.802 . . . . 73.239999999999995 109.767 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 48.33 53.02 12.54 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 124.364 1.065 . . . . 63.119999999999997 110.685 176.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 53.31 -8.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 115.811 1.782 . . . . 71.439999999999998 115.811 172.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 53.6 m -131.39 130.22 42.32 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 107.379 -1.341 . . . . 75.209999999999994 107.379 -175.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.5 pp -114.5 179.84 3.84 Favored 'General case' 0 CA--C 1.487 -1.449 0 N-CA-C 104.242 -2.503 . . . . 72.310000000000002 104.242 169.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -153.02 53.57 0.46 Allowed Glycine 0 CA--C 1.475 -2.456 0 N-CA-C 106.644 -2.582 . . . . 34.539999999999999 106.644 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.506 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.9 mt -87.85 176.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 104.573 -2.381 . . . . 63.039999999999999 104.573 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.506 ' H ' HG22 ' A' ' 21' ' ' ILE . 77.1 m -141.78 167.28 22.52 Favored 'General case' 0 CA--C 1.479 -1.754 0 N-CA-C 106.312 -1.736 . . . . 42.310000000000002 106.312 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.487 ' HB ' HG23 ' A' ' 36' ' ' ILE . 6.2 m -148.79 172.92 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 N-CA-C 107.073 -1.454 . . . . 42.049999999999997 107.073 -167.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.8 t -154.37 160.8 41.88 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 103.902 -2.629 . . . . 72.049999999999997 103.902 177.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 31' ' ' VAL . . . 90.19 -164.95 31.22 Favored Glycine 0 CA--C 1.481 -2.077 0 N-CA-C 108.02 -2.032 . . . . 53.399999999999999 108.02 -178.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.402 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 133.61 -88.69 0.26 Allowed Glycine 0 CA--C 1.479 -2.203 0 N-CA-C 108.418 -1.873 . . . . 61.030000000000001 108.418 175.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.481 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -72.63 16.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.028 0 C-N-CA 122.551 0.341 . . . . 41.32 111.446 -171.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 26' ' ' GLY . 7.1 t30 85.39 5.99 0.48 Allowed 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 124.483 1.113 . . . . 71.430000000000007 108.784 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.5 t -45.41 -171.05 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.957 0 C-N-CA 126.279 1.832 . . . . 63.109999999999999 112.987 169.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 p -40.45 -40.71 1.26 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 127.272 2.229 . . . . 73.150000000000006 114.002 -164.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.426 HG21 ' HA3' ' A' ' 25' ' ' GLY . 27.6 m -56.46 135.82 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.64 0.733 . . . . 64.409999999999997 110.286 -173.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -39.69 -66.96 0.25 Allowed 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.017 1.327 . . . . 64.209999999999994 113.475 -171.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -77.72 -13.34 59.93 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 119.322 -0.951 . . . . 54.340000000000003 109.866 -174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.95 -14.62 64.77 Favored Glycine 0 C--N 1.352 1.419 0 N-CA-C 109.361 -1.496 . . . . 53.350000000000001 109.361 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.78 -179.87 53.17 Favored Glycine 0 CA--C 1.484 -1.846 0 N-CA-C 109.172 -1.571 . . . . 61.210000000000001 109.172 -173.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 HG23 ' HB ' ' A' ' 23' ' ' VAL . 19.3 mm -86.32 117.87 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.973 0 N-CA-C 103.929 -2.619 . . . . 72.299999999999997 103.929 178.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -103.83 154.5 19.53 Favored 'General case' 0 CA--C 1.463 -2.399 0 N-CA-C 105.275 -2.12 . . . . 64.450000000000003 105.275 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.3 t -79.44 102.45 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.051 0 N-CA-C 106.206 -1.775 . . . . 74.010000000000005 106.206 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -71.16 -41.63 70.15 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 113.966 -1.47 . . . . 72.5 109.735 -175.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.97 143.8 17.18 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 105.418 -2.067 . . . . 74.120000000000005 105.418 -173.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.5 t -120.8 133.53 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.655 -2.72 . . . . 74.129999999999995 103.655 174.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.453 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.35 148.78 78.0 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 106.163 -1.791 . . . . 71.120000000000005 106.163 175.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -74.87 169.24 23.05 Favored 'Trans proline' 0 CA--C 1.458 -3.301 0 N-CA-C 105.438 -2.562 . . . . 52.450000000000003 105.438 -175.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 65.04 -1.36 0.88 Allowed 'General case' 0 N--CA 1.448 -0.528 0 O-C-N 123.877 0.736 . . . . 75.329999999999998 111.942 166.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.75 171.59 43.34 Favored Glycine 0 CA--C 1.477 -2.289 0 N-CA-C 106.702 -2.559 . . . . 72.040000000000006 106.702 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.95 67.82 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 108.405 -0.961 . . . . 63.130000000000003 108.405 -175.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.434 ' HB1' ' HB ' ' A' ' 53' ' ' ILE . . . -53.78 -50.82 65.25 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 115.283 -0.872 . . . . 63.450000000000003 110.717 -177.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -63.24 -56.27 17.95 Favored 'General case' 0 C--N 1.346 0.42 0 CA-C-O 120.872 0.368 . . . . 43.439999999999998 110.112 -179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 50.7 m -58.75 -34.88 71.89 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 123.207 0.603 . . . . 71.200000000000003 110.982 -172.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.446 ' CG ' ' HE ' ' A' ' 52' ' ' ARG . 6.3 t70 -83.2 -34.52 25.9 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 106.698 -1.593 . . . . 54.240000000000002 106.698 -174.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.81 16.25 61.82 Favored Glycine 0 C--N 1.351 1.412 0 N-CA-C 110.638 -0.985 . . . . 63.350000000000001 110.638 173.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.446 ' HE ' ' CG ' ' A' ' 50' ' ' ASP . 67.3 mtt180 -91.89 6.09 47.51 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 118.361 1.08 . . . . 74.430000000000007 108.201 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.434 ' HB ' ' HB1' ' A' ' 47' ' ' ALA . 2.9 mp -147.71 148.41 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 104.227 -2.509 . . . . 72.439999999999998 104.227 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.8 p80 -158.6 171.8 19.45 Favored 'General case' 0 CA--C 1.47 -2.124 0 N-CA-C 104.541 -2.392 . . . . 74.099999999999994 104.541 174.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -67.05 146.46 54.29 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 108.556 -0.905 . . . . 71.340000000000003 108.556 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.77 -32.95 6.98 Favored Glycine 0 CA--C 1.486 -1.731 0 N-CA-C 109.263 -1.535 . . . . 74.209999999999994 109.263 169.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.43 158.52 34.82 Favored 'General case' 0 CA--C 1.498 -1.038 0 N-CA-C 107.662 -1.236 . . . . 53.109999999999999 107.662 176.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.459 HH22 ' CD ' ' A' ' 91' ' ' GLU . 24.6 ttp85 -123.88 143.79 50.15 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 107.741 -1.207 . . . . 61.039999999999999 107.741 -165.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.0 t -95.21 139.36 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.512 0 N-CA-C 105.929 -1.878 . . . . 74.420000000000002 105.929 -178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.622 HD11 HD12 ' A' ' 7' ' ' ILE . 46.2 mt -102.01 -58.88 1.8 Allowed 'General case' 0 CA--C 1.49 -1.335 0 N-CA-C 107.314 -1.365 . . . . 72.129999999999995 107.314 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.73 151.52 48.28 Favored 'General case' 0 CA--C 1.475 -1.94 0 N-CA-C 106.115 -1.809 . . . . 54.100000000000001 106.115 -172.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.1 t -122.38 127.17 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 104.616 -2.365 . . . . 71.230000000000004 104.616 173.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.0 t30 59.04 31.28 21.2 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.91 0.862 . . . . 73.099999999999994 109.371 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.77 -8.14 73.96 Favored Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 109.156 -1.578 . . . . 43.43 109.156 172.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.0 t -86.77 118.52 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.388 -3.572 0 N-CA-C 106.493 -1.669 . . . . 72.230000000000004 106.493 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 15.8 t -55.99 118.63 4.82 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 107.729 -1.211 . . . . 63.200000000000003 107.729 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.443 HD12 HG13 ' A' ' 36' ' ' ILE . 1.2 tm? -104.87 -13.47 15.81 Favored 'General case' 0 C--O 1.196 -1.711 0 N-CA-C 106.552 -1.648 . . . . 70.340000000000003 106.552 -167.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -61.55 127.41 31.31 Favored 'General case' 0 N--CA 1.448 -0.553 0 O-C-N 121.501 -0.749 . . . . 71.109999999999999 109.054 -179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.83 -15.83 61.99 Favored Glycine 0 C--N 1.343 0.935 0 N-CA-C 108.315 -1.914 . . . . 51.439999999999998 108.315 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.39 154.81 25.02 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.158 -1.793 . . . . 63.420000000000002 106.158 178.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.481 HG22 HG22 ' A' ' 27' ' ' VAL . 22.8 p -81.29 176.83 9.41 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 121.781 0.801 . . . . 75.430000000000007 110.393 -168.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -58.48 -50.79 72.46 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 124.815 1.246 . . . . 74.0 107.906 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 tppp? -55.13 -54.48 42.68 Favored 'General case' 0 C--N 1.354 0.774 0 O-C-N 122.063 -0.398 . . . . 75.120000000000005 110.759 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -53.93 -41.34 67.62 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.864 -0.421 . . . . 74.209999999999994 109.864 -177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.33 -54.27 27.94 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 122.798 0.439 . . . . 73.430000000000007 110.33 178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.7 m -74.62 -38.5 45.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 N-CA-C 109.302 -0.629 . . . . 63.299999999999997 109.302 -175.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 3.2 t -61.6 -32.74 72.87 Favored 'General case' 0 N--CA 1.512 2.664 0 N-CA-C 105.801 -1.926 . . . . 73.409999999999997 105.801 -175.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.0 m -70.69 -46.46 63.1 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 120.175 -1.578 . . . . 65.129999999999995 108.05 -177.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.36 -30.3 69.47 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 109.388 -0.597 . . . . 72.230000000000004 109.388 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.33 -59.9 2.54 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.139 -1.43 . . . . 55.520000000000003 107.139 178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -48.73 -20.59 0.49 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 126.163 1.785 . . . . 72.209999999999994 114.019 -177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.4 p -74.13 171.84 12.83 Favored 'General case' 0 C--N 1.313 -0.99 0 O-C-N 121.35 -0.844 . . . . 74.319999999999993 109.422 -175.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.23 -148.69 5.4 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.1 -1.2 . . . . 74.239999999999995 110.1 -174.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -70.82 -55.93 7.43 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 108.839 -0.8 . . . . 62.439999999999998 108.839 -170.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.06 142.58 13.33 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.727 0 N-CA-C 104.428 -2.434 . . . . 73.340000000000003 104.428 173.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.65 134.9 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 104.987 -2.227 . . . . 61.32 104.987 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -103.46 121.32 42.59 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.085 -2.561 . . . . 65.409999999999997 104.085 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -145.04 125.91 14.4 Favored 'General case' 0 N--CA 1.417 -2.078 0 N-CA-C 107.914 -1.143 . . . . 61.329999999999998 107.914 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.432 ' HB3' HD12 ' A' ' 60' ' ' LEU . 4.3 mp -81.9 144.39 31.0 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 107.999 -1.111 . . . . 63.049999999999997 107.999 -178.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.708 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.28 162.18 18.31 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 105.105 -2.183 . . . . 55.210000000000001 105.105 174.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.465 ' HG3' HD13 ' A' ' 7' ' ' ILE . 41.5 tt0 -129.01 144.58 51.23 Favored 'General case' 0 N--CA 1.421 -1.893 0 N-CA-C 102.254 -3.239 . . . . 75.0 102.254 163.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.413 ' HB2' ' H ' ' A' ' 5' ' ' GLY . 26.2 mmmt -57.88 140.78 51.2 Favored 'General case' 0 CA--C 1.493 -1.227 0 CA-C-O 121.721 0.772 . . . . 73.040000000000006 110.389 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -111.75 -162.47 16.91 Favored Glycine 0 N--CA 1.414 -2.83 0 N-CA-C 104.132 -3.587 . . . . 53.530000000000001 104.132 174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 63.5 46.23 4.38 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.104 -1.443 . . . . 50.229999999999997 107.104 -175.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 44.1 m -113.54 128.2 25.97 Favored Pre-proline 0 N--CA 1.432 -1.356 0 N-CA-C 103.439 -2.8 . . . . 65.219999999999999 103.439 177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -67.33 98.66 0.47 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.299 1.999 . . . . 74.230000000000004 107.972 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 82.0 m . . . . . 0 N--CA 1.425 -1.686 0 N-CA-C 105.131 -2.174 . . . . 64.239999999999995 105.131 -176.652 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.572 ' C1 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.854 0 N-CA-C 108.617 -1.793 . . . . 71.219999999999999 108.617 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.22 156.87 52.94 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 123.608 2.872 . . . . 62.149999999999999 110.109 -169.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.1 mttm -96.25 167.44 12.37 Favored Pre-proline 0 N--CA 1.433 -1.287 0 N-CA-C 106.573 -1.64 . . . . 73.150000000000006 106.573 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.69 118.39 5.27 Favored 'Trans proline' 0 C--O 1.246 0.876 0 C-N-CA 122.792 2.328 . . . . 54.509999999999998 109.996 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.51 -0.52 68.15 Favored Glycine 0 C--N 1.345 1.05 0 N-CA-C 108.819 -1.712 . . . . 43.520000000000003 108.819 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -78.66 139.9 38.45 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 106.691 -1.596 . . . . 74.540000000000006 106.691 -178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.408 HG12 HD11 ' A' ' 60' ' ' LEU . 54.0 mt -99.42 130.25 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 106.718 -1.586 . . . . 72.010000000000005 106.718 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.513 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.1 p90 -137.5 154.23 49.9 Favored 'General case' 0 CA--C 1.481 -1.697 0 N-CA-C 108.005 -1.109 . . . . 62.340000000000003 108.005 177.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -105.66 143.56 33.65 Favored 'General case' 0 CA--C 1.482 -1.643 0 N-CA-C 106.232 -1.766 . . . . 71.239999999999995 106.232 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.634 HG22 HD21 ' A' ' 90' ' ' LEU . 29.1 m -142.54 151.66 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 N-CA-C 106.511 -1.663 . . . . 53.450000000000003 106.511 177.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -112.82 129.21 56.52 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 106.213 -1.773 . . . . 63.439999999999998 106.213 172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.2 mp -130.51 140.21 50.5 Favored 'General case' 0 CA--C 1.459 -2.52 0 N-CA-C 108.493 -0.928 . . . . 75.519999999999996 108.493 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.04 137.76 32.02 Favored 'General case' 0 CA--C 1.477 -1.828 0 N-CA-C 105.818 -1.919 . . . . 64.319999999999993 105.818 175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.43 -25.76 59.63 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 108.613 -0.884 . . . . 72.349999999999994 108.613 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 67.87 111.28 0.04 OUTLIER 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.184 -0.673 . . . . 62.310000000000002 109.184 -178.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.12 40.29 30.2 Favored 'General case' 0 C--N 1.36 1.045 0 N-CA-C 108.35 -0.982 . . . . 73.310000000000002 108.35 -176.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 36.9 t30 43.22 12.01 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 127.223 2.209 . . . . 63.240000000000002 114.649 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.5 t -97.11 129.17 44.55 Favored 'General case' 0 CA--C 1.494 -1.195 0 O-C-N 120.517 -1.364 . . . . 61.520000000000003 107.328 -176.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 33.8 tp -124.78 142.51 51.37 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 102.738 -3.06 . . . . 75.310000000000002 102.738 173.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -161.51 64.34 0.27 Allowed Glycine 0 CA--C 1.48 -2.1 0 N-CA-C 106.406 -2.678 . . . . 51.229999999999997 106.406 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.0 mm -87.89 177.35 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 104.929 -2.248 . . . . 74.129999999999995 104.929 179.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.516 ' H ' HG22 ' A' ' 21' ' ' ILE . 16.8 m -124.78 156.85 37.08 Favored 'General case' 0 CA--C 1.488 -1.44 0 N-CA-C 103.662 -2.718 . . . . 74.129999999999995 103.662 177.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.7 m -150.53 171.03 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.5 -0.972 0 N-CA-C 108.092 -1.077 . . . . 72.109999999999999 108.092 -166.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.1 t -161.99 164.75 28.17 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.498 -2.408 . . . . 71.239999999999995 104.498 177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.62 -160.84 22.76 Favored Glycine 0 CA--C 1.486 -1.774 0 N-CA-C 107.052 -2.419 . . . . 73.120000000000005 107.052 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 132.72 -104.84 0.56 Allowed Glycine 0 CA--C 1.49 -1.519 0 N-CA-C 108.89 -1.684 . . . . 70.109999999999999 108.89 175.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -69.82 16.75 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 113.374 0.879 . . . . 74.319999999999993 113.374 -164.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 86.64 12.96 0.14 Allowed 'General case' 0 CA--C 1.487 -1.449 0 C-N-CA 124.804 1.242 . . . . 73.420000000000002 108.877 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 44.1 p -46.15 -170.56 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 124.334 1.054 . . . . 74.430000000000007 110.859 155.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.7 m -29.46 -44.02 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 115.487 1.662 . . . . 71.439999999999998 115.487 -170.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.466 ' HB ' ' CZ ' ' A' ' 37' ' ' TYR . 30.0 m -76.12 140.22 17.63 Favored 'Isoleucine or valine' 0 C--N 1.351 0.643 0 O-C-N 121.22 -0.925 . . . . 53.149999999999999 108.517 -173.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 59.3 ttt180 -68.31 -47.58 67.21 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 121.148 -0.97 . . . . 74.040000000000006 111.138 -171.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.424 ' HE1' ' CD ' ' A' ' 68' ' ' GLU . 8.3 t-80 -73.23 0.66 11.2 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 122.189 -0.319 . . . . 73.450000000000003 110.248 -166.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 52.97 61.21 7.11 Favored Glycine 0 C--N 1.362 1.991 0 N-CA-C 109.495 -1.442 . . . . 72.040000000000006 109.495 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.53 179.4 28.19 Favored Glycine 0 CA--C 1.454 -3.759 0 N-CA-C 103.721 -3.752 . . . . 42.229999999999997 103.721 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.401 HD11 ' HA ' ' A' ' 72' ' ' HIS . 0.7 OUTLIER -90.61 131.17 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.385 -3.707 0 N-CA-C 104.25 -2.5 . . . . 75.200000000000003 104.25 178.065 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.466 ' CZ ' ' HB ' ' A' ' 31' ' ' VAL . 3.7 m-30 -108.55 151.67 25.79 Favored 'General case' 0 CA--C 1.486 -1.489 0 N-CA-C 102.899 -3.0 . . . . 75.209999999999994 102.899 177.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.4 t -82.52 102.78 8.88 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.587 0 N-CA-C 107.103 -1.443 . . . . 71.019999999999996 107.103 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -71.6 -36.61 70.88 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 114.196 -1.366 . . . . 74.420000000000002 110.113 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.71 152.7 14.08 Favored 'General case' 0 CA--C 1.466 -2.278 0 N-CA-C 105.464 -2.05 . . . . 70.030000000000001 105.464 -176.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 13.2 t -126.71 136.16 61.6 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.719 0 N-CA-C 104.308 -2.479 . . . . 62.409999999999997 104.308 178.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.24 145.22 79.83 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 106.259 -1.756 . . . . 74.219999999999999 106.259 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -75.83 168.38 24.36 Favored 'Trans proline' 0 CA--C 1.462 -3.09 0 N-CA-C 105.786 -2.428 . . . . 73.109999999999999 105.786 -176.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 63.41 1.54 1.0 Allowed 'General case' 0 N--CA 1.442 -0.872 0 O-C-N 123.665 0.603 . . . . 71.340000000000003 111.732 166.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.6 -178.22 41.11 Favored Glycine 0 CA--C 1.479 -2.16 0 N-CA-C 106.667 -2.573 . . . . 65.340000000000003 106.667 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.67 -52.99 31.43 Favored 'General case' 0 C--O 1.207 -1.171 0 N-CA-C 108.151 -1.055 . . . . 63.439999999999998 108.151 -175.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.37 -50.07 65.86 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 116.066 -0.516 . . . . 65.439999999999998 110.879 -175.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -62.39 -56.11 21.44 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 109.56 -0.533 . . . . 74.530000000000001 109.56 178.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.7 m -62.79 -30.49 71.5 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 120.683 0.278 . . . . 61.119999999999997 111.232 -170.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -77.21 -35.8 55.3 Favored 'General case' 0 CA--C 1.506 -0.728 0 N-CA-C 106.773 -1.566 . . . . 62.32 106.773 -175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.38 12.59 72.69 Favored Glycine 0 C--N 1.35 1.36 0 N-CA-C 109.109 -1.596 . . . . 74.049999999999997 109.109 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.414 ' HB2' HD12 ' A' ' 53' ' ' ILE . 23.8 mmt180 -90.19 -1.93 57.99 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 107.275 -1.38 . . . . 73.099999999999994 107.275 -179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.414 HD12 ' HB2' ' A' ' 52' ' ' ARG . 2.1 mp -142.77 145.26 23.35 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.368 0 N-CA-C 102.857 -3.016 . . . . 72.219999999999999 102.857 -176.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -156.79 173.03 17.58 Favored 'General case' 0 CA--C 1.472 -2.053 0 N-CA-C 103.699 -2.704 . . . . 72.200000000000003 103.699 170.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -66.35 145.62 55.51 Favored 'General case' 0 CA--C 1.496 -1.119 0 CA-C-O 121.391 0.615 . . . . 74.019999999999996 109.392 -177.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -33.03 6.86 Favored Glycine 0 CA--C 1.481 -2.08 0 N-CA-C 108.764 -1.734 . . . . 45.32 108.764 169.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -67.55 157.01 35.36 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 108.981 -0.748 . . . . 75.010000000000005 108.981 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 76.0 mtt180 -117.0 142.84 46.43 Favored 'General case' 0 CA--C 1.487 -1.451 0 N-CA-C 107.3 -1.37 . . . . 74.340000000000003 107.3 -166.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 41.8 t -93.01 126.71 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 105.761 -1.94 . . . . 74.219999999999999 105.761 173.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.408 HD11 HG12 ' A' ' 7' ' ' ILE . 19.9 mt -94.47 -58.64 2.14 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 107.417 -1.327 . . . . 60.240000000000002 107.417 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.36 147.62 47.45 Favored 'General case' 0 CA--C 1.471 -2.079 0 N-CA-C 106.379 -1.712 . . . . 72.010000000000005 106.379 -177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.5 t -115.43 119.12 60.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.598 0 N-CA-C 104.897 -2.26 . . . . 71.329999999999998 104.897 177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.3 t30 52.28 38.06 23.81 Favored 'General case' 0 C--O 1.22 -0.454 0 C-N-CA 124.046 0.938 . . . . 64.420000000000002 110.618 179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.7 -18.38 57.29 Favored Glycine 0 CA--C 1.478 -2.24 0 N-CA-C 108.784 -1.726 . . . . 53.520000000000003 108.784 172.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 60.0 t -84.3 117.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.888 0 N-CA-C 106.78 -1.563 . . . . 73.109999999999999 106.78 -174.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.0 t -56.02 122.73 12.3 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.243 -1.021 . . . . 65.120000000000005 108.243 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.6 tm? -93.42 -16.63 24.38 Favored 'General case' 0 C--O 1.198 -1.64 0 N-CA-C 105.431 -2.063 . . . . 74.129999999999995 105.431 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.424 ' CD ' ' HE1' ' A' ' 33' ' ' HIS . 53.3 mt-10 -59.85 123.36 16.78 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 108.816 -0.809 . . . . 62.329999999999998 108.816 -178.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.56 -14.94 62.74 Favored Glycine 0 C--N 1.349 1.293 0 N-CA-C 108.968 -1.653 . . . . 62.200000000000003 108.968 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.01 147.33 46.97 Favored 'General case' 0 CA--C 1.498 -1.02 0 N-CA-C 107.569 -1.271 . . . . 61.200000000000003 107.569 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 59.6 p -81.65 178.69 8.19 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.147 -1.427 . . . . 73.140000000000001 107.147 -177.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.401 ' HA ' HD11 ' A' ' 36' ' ' ILE . 43.5 p-80 -62.26 -51.06 69.23 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 108.935 -0.765 . . . . 63.229999999999997 108.935 177.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.57 -56.07 24.62 Favored 'General case' 0 C--N 1.372 1.565 0 O-C-N 121.707 -0.621 . . . . 73.219999999999999 110.12 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.2 mm-40 -60.9 -45.49 94.42 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 110.184 -0.302 . . . . 55.219999999999999 110.184 -175.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.573 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -53.65 -51.29 63.62 Favored 'General case' 0 CA--C 1.5 -0.979 0 CA-C-O 120.918 0.389 . . . . 60.43 110.716 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 58.7 t -73.63 -36.55 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 107.827 -1.175 . . . . 75.329999999999998 107.827 -174.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -60.6 -34.19 73.85 Favored 'General case' 0 N--CA 1.506 2.361 0 N-CA-C 106.031 -1.84 . . . . 70.430000000000007 106.031 -176.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.9 m -73.14 -42.32 62.97 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 107.393 -1.336 . . . . 74.549999999999997 107.393 -175.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.5 mt -62.78 -39.58 94.66 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 110.109 -0.33 . . . . 64.450000000000003 110.109 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -75.99 -54.64 6.56 Favored 'General case' 0 CA--C 1.509 -0.617 0 C-N-CA 119.662 -0.815 . . . . 63.130000000000003 109.139 -175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -70.48 47.78 0.1 Allowed 'General case' 0 N--CA 1.504 2.229 0 CA-C-O 121.039 0.447 . . . . 72.109999999999999 111.591 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 7.1 p -101.08 -176.07 3.05 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.702 -1.962 . . . . 72.310000000000002 105.702 172.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -81.65 -157.26 18.57 Favored Glycine 0 N--CA 1.433 -1.559 0 N-CA-C 107.113 -2.395 . . . . 13.199999999999999 107.113 177.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.34 -54.02 39.57 Favored 'General case' 0 C--O 1.244 0.8 0 N-CA-C 109.088 -0.708 . . . . 63.450000000000003 109.088 -177.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.7 t -94.27 141.92 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 105.928 -1.879 . . . . 71.439999999999998 105.928 176.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.3 t -102.2 130.68 51.65 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.491 0 N-CA-C 105.718 -1.956 . . . . 75.310000000000002 105.718 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.0 t60 -107.17 124.61 49.97 Favored 'General case' 0 CA--C 1.483 -1.626 0 N-CA-C 105.413 -2.069 . . . . 72.409999999999997 105.413 175.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -156.36 136.55 12.89 Favored 'General case' 0 CA--C 1.473 -2.004 0 C-N-CA 119.01 -1.076 . . . . 75.5 108.458 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.7 mp -82.33 141.0 33.23 Favored 'General case' 0 CA--C 1.478 -1.824 0 N-CA-C 107.394 -1.336 . . . . 72.510000000000005 107.394 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.634 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.8 159.02 18.7 Favored 'General case' 0 CA--C 1.48 -1.717 0 N-CA-C 104.595 -2.372 . . . . 75.200000000000003 104.595 174.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -123.4 134.4 53.98 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 101.292 -3.596 . . . . 51.420000000000002 101.292 164.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -62.76 130.29 44.28 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 107.163 -1.421 . . . . 73.140000000000001 107.163 178.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -115.02 12.05 20.13 Favored Glycine 0 CA--C 1.463 -3.208 0 N-CA-C 107.303 -2.319 . . . . 21.109999999999999 107.303 -169.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -68.98 116.86 9.93 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.099 -1.815 . . . . 60.240000000000002 106.099 170.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.6 t -97.84 133.09 23.72 Favored Pre-proline 0 N--CA 1.422 -1.83 0 N-CA-C 106.465 -1.68 . . . . 51.329999999999998 106.465 -168.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -74.07 -179.04 4.29 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 N-CA-C 106.018 -2.339 . . . . 64.230000000000004 106.018 161.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.3 m . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 104.502 -2.407 . . . . 74.120000000000005 104.502 176.289 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.451 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.665 0 N-CA-C 108.959 -1.656 . . . . 62.130000000000003 108.959 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.55 151.34 75.4 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 122.985 2.457 . . . . 72.510000000000005 109.057 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -83.33 165.24 41.68 Favored Pre-proline 0 N--CA 1.435 -1.184 0 N-CA-C 105.975 -1.861 . . . . 74.430000000000007 105.975 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -63.28 128.87 23.76 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 122.716 2.277 . . . . 62.119999999999997 108.611 173.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.84 10.62 78.61 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 109.567 -1.413 . . . . 74.540000000000006 109.567 179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -99.77 153.8 18.83 Favored 'General case' 0 CA--C 1.489 -1.392 0 N-CA-C 105.869 -1.901 . . . . 74.430000000000007 105.869 174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 60' ' ' LEU . 4.6 mm -99.63 137.51 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.462 0 N-CA-C 106.59 -1.633 . . . . 63.219999999999999 106.59 -169.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.563 ' CD2' HD23 ' A' ' 90' ' ' LEU . 9.1 p90 -135.28 151.96 51.05 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 107.302 -1.37 . . . . 74.140000000000001 107.302 170.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' OE2' ' HE1' ' A' ' 87' ' ' HIS . 52.8 mt-10 -108.09 147.29 31.42 Favored 'General case' 0 CA--C 1.474 -1.952 0 N-CA-C 106.237 -1.764 . . . . 64.239999999999995 106.237 -178.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.73 HG22 HD21 ' A' ' 90' ' ' LEU . 35.1 m -142.96 152.6 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.867 0 N-CA-C 105.984 -1.858 . . . . 62.5 105.984 173.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -118.71 127.25 53.39 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 105.745 -1.946 . . . . 73.129999999999995 105.745 171.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.68 137.69 45.45 Favored 'General case' 0 CA--C 1.474 -1.961 0 N-CA-C 107.694 -1.224 . . . . 70.340000000000003 107.694 -169.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.29 142.3 28.63 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.693 -1.965 . . . . 64.319999999999993 105.693 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 6.7 mtmp? -69.88 -32.41 70.74 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.413 -0.958 . . . . 75.209999999999994 108.413 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 75.03 107.08 0.07 Allowed 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.607 0.763 . . . . 64.129999999999995 109.299 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 50.84 45.38 27.43 Favored 'General case' 0 C--N 1.37 1.474 0 C-N-CA 124.576 1.151 . . . . 43.299999999999997 110.937 -178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.7 m-80 54.97 -9.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 126.549 1.94 . . . . 74.209999999999994 113.805 176.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -84.3 158.28 21.24 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 119.975 1.262 . . . . 71.109999999999999 108.341 -173.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.96 -157.15 0.78 Allowed 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 102.952 -2.981 . . . . 53.439999999999998 102.952 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.36 40.79 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.657 0 N-CA-C 105.292 -3.123 . . . . 55.219999999999999 105.292 -178.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.3 mm -87.99 175.91 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.336 0 N-CA-C 103.438 -2.801 . . . . 70.230000000000004 103.438 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 48.7 m -147.61 159.55 43.64 Favored 'General case' 0 CA--C 1.462 -2.412 0 N-CA-C 105.358 -2.09 . . . . 73.299999999999997 105.358 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.413 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.3 m -150.4 167.3 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.095 0 N-CA-C 107.766 -1.198 . . . . 73.129999999999995 107.766 -164.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -166.17 169.49 14.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.665 -2.346 . . . . 63.409999999999997 104.665 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.92 -138.61 14.64 Favored Glycine 0 CA--C 1.49 -1.525 0 N-CA-C 107.695 -2.162 . . . . 25.43 107.695 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.77 -88.17 0.68 Allowed Glycine 0 CA--C 1.485 -1.804 0 N-CA-C 109.404 -1.478 . . . . 64.019999999999996 109.404 173.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.32 16.85 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 112.832 0.679 . . . . 71.219999999999999 112.832 -165.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.454 ' HA ' ' HA2' ' A' ' 34' ' ' GLY . 17.7 t-20 82.55 6.92 0.9 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.677 0.791 . . . . 74.129999999999995 109.301 175.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.0 t -46.28 -170.23 0.0 OUTLIER 'General case' 0 CA--C 1.577 2.012 0 C-N-CA 125.427 1.491 . . . . 54.420000000000002 111.478 160.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -35.08 -40.33 0.12 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 126.071 1.748 . . . . 72.540000000000006 114.982 -166.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.429 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 34.6 m -72.25 142.89 14.67 Favored 'Isoleucine or valine' 0 C--N 1.347 0.491 0 N-CA-C 108.559 -0.904 . . . . 34.130000000000003 108.559 -174.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -66.19 -59.11 4.07 Favored 'General case' 0 CA--C 1.509 -0.6 0 O-C-N 121.725 -0.609 . . . . 72.329999999999998 112.556 -167.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 33' ' ' HIS . 22.8 t-160 -75.84 15.16 0.55 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.588 -0.695 . . . . 70.349999999999994 110.874 -164.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 28' ' ' ASN . . . 46.35 57.19 6.6 Favored Glycine 0 C--N 1.358 1.788 0 N-CA-C 109.559 -1.416 . . . . 54.409999999999997 109.559 177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -145.95 178.27 23.78 Favored Glycine 1 CA--C 1.442 -4.49 0 N-CA-C 103.252 -3.939 . . . . 61.229999999999997 103.252 -175.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.493 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.6 mm -92.63 132.09 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 106.214 -1.772 . . . . 71.200000000000003 106.214 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.429 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 2.7 m-85 -109.82 148.52 31.34 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 103.584 -2.747 . . . . 72.120000000000005 103.584 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.5 t -80.12 103.2 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.7 0 N-CA-C 106.702 -1.592 . . . . 71.519999999999996 106.702 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -70.58 -38.64 74.09 Favored 'General case' 0 CA--C 1.503 -0.856 0 CA-C-N 114.547 -1.206 . . . . 63.229999999999997 109.745 -174.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -163.35 155.56 17.93 Favored 'General case' 0 CA--C 1.462 -2.413 0 N-CA-C 105.368 -2.086 . . . . 43.32 105.368 -175.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.5 t -137.5 143.2 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 N-CA-C 102.763 -3.051 . . . . 54.420000000000002 102.763 174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.16 142.6 72.26 Favored Pre-proline 0 N--CA 1.448 -0.53 0 N-CA-C 105.903 -1.888 . . . . 74.140000000000001 105.903 171.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -75.14 173.89 13.73 Favored 'Trans proline' 0 CA--C 1.472 -2.585 0 N-CA-C 105.896 -2.386 . . . . 64.140000000000001 105.896 -176.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 69.66 -2.73 1.86 Allowed 'General case' 0 N--CA 1.447 -0.622 0 O-C-N 124.024 0.828 . . . . 71.209999999999994 111.213 166.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.57 -176.25 38.6 Favored Glycine 0 CA--C 1.48 -2.139 0 N-CA-C 107.221 -2.352 . . . . 63.009999999999998 107.221 -175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.88 -52.84 46.75 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 108.137 -1.061 . . . . 75.519999999999996 108.137 -173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.53 -49.65 64.42 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.224 -0.444 . . . . 74.019999999999996 110.589 -177.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -64.54 -55.98 17.03 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 120.819 0.342 . . . . 52.450000000000003 110.124 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.0 m -64.04 -29.66 70.79 Favored 'General case' 0 C--O 1.242 0.696 0 O-C-N 121.928 -0.482 . . . . 73.409999999999997 111.694 -171.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -78.56 -34.15 47.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 105.773 -1.936 . . . . 74.349999999999994 105.773 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.54 17.49 63.97 Favored Glycine 0 CA--C 1.482 -2.02 0 N-CA-C 108.898 -1.681 . . . . 61.210000000000001 108.898 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.505 ' HB3' HG11 ' A' ' 10' ' ' VAL . 13.4 mmt180 -89.89 -2.62 58.23 Favored 'General case' 0 CA--C 1.481 -1.707 0 N-CA-C 107.805 -1.183 . . . . 75.5 107.805 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.8 mt -146.64 143.9 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.758 0 N-CA-C 103.26 -2.867 . . . . 74.430000000000007 103.26 -170.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.496 ' CE1' ' OD1' ' A' ' 57' ' ' ASP . 25.6 p80 -153.23 165.39 35.83 Favored 'General case' 0 CA--C 1.463 -2.375 0 N-CA-C 104.497 -2.409 . . . . 74.519999999999996 104.497 173.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.716 ' H ' ' HE3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -67.93 145.08 54.9 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.612 -1.255 . . . . 72.430000000000007 107.612 -177.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.74 -32.72 7.09 Favored Glycine 0 CA--C 1.501 -0.792 0 N-CA-C 109.493 -1.443 . . . . 52.520000000000003 109.493 175.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.496 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 68.1 m-20 -66.4 158.0 30.47 Favored 'General case' 0 C--N 1.373 1.588 0 N-CA-C 108.292 -1.003 . . . . 73.5 108.292 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.438 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 52.5 mtm-85 -112.7 137.66 50.67 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 107.506 -1.294 . . . . 72.409999999999997 107.506 -170.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -93.36 128.49 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 105.08 -2.193 . . . . 74.010000000000005 105.08 175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' CD1' HG23 ' A' ' 7' ' ' ILE . 17.5 mt -99.28 -59.14 1.78 Allowed 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 107.467 -1.309 . . . . 73.420000000000002 107.467 -176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.06 146.53 51.77 Favored 'General case' 0 CA--C 1.471 -2.081 0 N-CA-C 106.433 -1.691 . . . . 64.540000000000006 106.433 -176.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.6 t -119.78 125.42 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.422 0 N-CA-C 104.213 -2.514 . . . . 74.120000000000005 104.213 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 57.5 t30 57.64 29.84 17.89 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.114 0.959 . . . . 73.019999999999996 109.287 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 90.06 -12.06 68.85 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 109.26 -1.536 . . . . 72.510000000000005 109.26 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 89.3 t -85.04 118.54 32.23 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 106.557 -1.645 . . . . 74.109999999999999 106.557 -176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 64.5 m -56.7 118.38 4.82 Favored 'General case' 0 C--N 1.368 1.381 0 N-CA-C 108.435 -0.95 . . . . 55.439999999999998 108.435 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -104.52 -10.82 17.37 Favored 'General case' 0 C--O 1.202 -1.419 0 N-CA-C 106.136 -1.802 . . . . 54.409999999999997 106.136 -169.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -57.91 126.59 28.09 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 108.655 -0.868 . . . . 73.510000000000005 108.655 176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -13.37 67.16 Favored Glycine 0 C--N 1.35 1.353 0 N-CA-C 108.963 -1.655 . . . . 63.149999999999999 108.963 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.4 152.89 30.1 Favored 'General case' 0 CA--C 1.49 -1.349 0 N-CA-C 106.228 -1.767 . . . . 64.510000000000005 106.228 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 62.1 p -81.73 179.24 7.91 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 108.952 -0.758 . . . . 64.049999999999997 108.952 -169.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -67.44 -46.15 73.93 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 108.202 -1.036 . . . . 74.349999999999994 108.202 178.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -52.19 -56.43 14.65 Favored 'General case' 0 C--N 1.362 1.136 0 O-C-N 121.733 -0.604 . . . . 53.219999999999999 110.07 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -53.96 -42.63 69.11 Favored 'General case' 0 C--N 1.369 1.452 0 N-CA-C 110.0 -0.37 . . . . 73.439999999999998 110.0 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.493 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -52.1 -53.9 36.95 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 123.096 0.558 . . . . 73.230000000000004 110.432 -178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 t -73.57 -40.57 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 107.657 -1.238 . . . . 73.430000000000007 107.657 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 76.8 m -59.05 -37.27 76.61 Favored 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 106.823 -1.547 . . . . 72.430000000000007 106.823 -174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 22.3 m -74.01 -48.06 32.79 Favored 'General case' 0 C--O 1.208 -1.09 0 O-C-N 120.355 -1.466 . . . . 73.439999999999998 107.627 -174.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.61 -38.36 90.83 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 124.024 0.929 . . . . 74.430000000000007 109.933 -176.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -70.07 -55.47 9.41 Favored 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 107.998 -1.112 . . . . 72.530000000000001 107.998 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -70.84 55.26 0.17 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.875 0.845 . . . . 54.310000000000002 110.595 178.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.562 HG21 HG13 ' A' ' 86' ' ' VAL . 10.1 p -104.79 -175.53 2.82 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 106.226 -1.768 . . . . 74.109999999999999 106.226 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.12 -155.73 31.97 Favored Glycine 0 CA--C 1.485 -1.815 0 N-CA-C 107.189 -2.364 . . . . 50.0 107.189 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 66.8 tt0 -63.24 -55.34 25.71 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.023 -1.103 . . . . 74.349999999999994 108.023 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.3 t -97.48 144.64 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.562 0 N-CA-C 105.673 -1.973 . . . . 70.219999999999999 105.673 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.562 HG13 HG21 ' A' ' 82' ' ' THR . 46.8 t -103.01 131.84 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.715 0 N-CA-C 105.568 -2.012 . . . . 74.109999999999999 105.568 -178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.427 ' HE1' ' OE2' ' A' ' 9' ' ' GLU . 50.1 t-80 -112.5 124.18 51.94 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 105.089 -2.189 . . . . 63.340000000000003 105.089 173.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.29 136.4 14.74 Favored 'General case' 0 CA--C 1.466 -2.263 0 N-CA-C 107.781 -1.192 . . . . 73.510000000000005 107.781 -175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -81.29 140.14 35.0 Favored 'General case' 0 CA--C 1.469 -2.138 0 N-CA-C 107.712 -1.218 . . . . 70.230000000000004 107.712 179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.73 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -110.92 156.91 20.51 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 104.412 -2.44 . . . . 45.530000000000001 104.412 172.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.438 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.3 tt0 -118.75 129.82 55.47 Favored 'General case' 0 CA--C 1.456 -2.644 0 N-CA-C 101.566 -3.494 . . . . 71.099999999999994 101.566 166.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 58.2 tttt -66.89 129.24 39.23 Favored 'General case' 0 N--CA 1.384 -3.772 0 N-CA-C 106.225 -1.768 . . . . 71.209999999999994 106.225 -178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.08 -159.0 34.64 Favored Glycine 0 CA--C 1.475 -2.438 0 N-CA-C 107.835 -2.106 . . . . 30.140000000000001 107.835 -168.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.7 mm100 -75.61 -47.87 24.69 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 107.735 -1.209 . . . . 73.209999999999994 107.735 -177.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.2 m -65.94 127.67 93.3 Favored Pre-proline 0 C--N 1.361 1.103 0 N-CA-C 106.941 -1.503 . . . . 73.200000000000003 106.941 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -69.97 151.62 67.95 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.364 2.043 . . . . 70.400000000000006 109.458 -167.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.413 -2.309 0 N-CA-C 104.467 -2.42 . . . . 75.219999999999999 104.467 175.989 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.551 ' C1 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.421 0 N-CA-C 107.935 -2.066 . . . . 72.299999999999997 107.935 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.76 169.42 20.22 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.164 2.576 . . . . 73.430000000000007 109.532 -178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -105.11 166.55 11.23 Favored Pre-proline 0 N--CA 1.427 -1.612 0 N-CA-C 104.884 -2.265 . . . . 73.299999999999997 104.884 173.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -61.78 138.7 76.09 Favored 'Trans proline' 0 CA--C 1.499 -1.227 0 C-N-CA 122.324 2.016 . . . . 65.200000000000003 108.214 -178.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.88 -7.5 65.05 Favored Glycine 0 N--CA 1.436 -1.33 0 N-CA-C 109.348 -1.501 . . . . 62.340000000000003 109.348 175.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -77.5 138.52 39.26 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 107.432 -1.322 . . . . 73.200000000000003 107.432 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.527 HG23 ' CD1' ' A' ' 60' ' ' LEU . 10.1 mm -97.53 133.28 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 107.321 -1.363 . . . . 74.109999999999999 107.321 -172.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.586 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.0 OUTLIER -142.89 153.21 42.9 Favored 'General case' 0 CA--C 1.492 -1.282 0 N-CA-C 108.139 -1.06 . . . . 61.409999999999997 108.139 175.154 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -104.94 146.83 28.49 Favored 'General case' 0 CA--C 1.471 -2.07 0 N-CA-C 105.942 -1.873 . . . . 70.230000000000004 105.942 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.648 HG22 HD21 ' A' ' 90' ' ' LEU . 22.5 m -140.61 150.0 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.78 -1.563 . . . . 74.219999999999999 106.78 176.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -108.67 127.86 54.35 Favored 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 105.142 -2.17 . . . . 64.5 105.142 168.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.412 HD22 HD13 ' A' ' 53' ' ' ILE . 3.6 mp -129.6 140.08 51.28 Favored 'General case' 0 CA--C 1.448 -2.967 0 N-CA-C 107.528 -1.286 . . . . 73.150000000000006 107.528 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.57 140.07 31.67 Favored 'General case' 0 N--CA 1.418 -2.049 0 N-CA-C 104.964 -2.236 . . . . 64.430000000000007 104.964 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -71.67 -31.97 67.37 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 107.539 -1.282 . . . . 71.099999999999994 107.539 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 74.83 102.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 107.251 -1.389 . . . . 74.349999999999994 107.251 -175.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 34.4 t70 60.16 45.83 11.22 Favored 'General case' 0 C--N 1.348 0.532 0 CA-C-N 115.243 -0.89 . . . . 75.409999999999997 109.22 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.7 t30 45.34 3.08 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.816 2.046 . . . . 61.420000000000002 115.634 175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.0 t -102.6 121.94 43.4 Favored 'General case' 0 CA--C 1.485 -1.548 0 O-C-N 120.358 -1.464 . . . . 61.340000000000003 107.049 -174.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 11.9 tp -127.19 151.37 48.78 Favored 'General case' 0 CA--C 1.464 -2.343 0 N-CA-C 104.202 -2.518 . . . . 54.310000000000002 104.202 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -175.64 81.18 0.07 OUTLIER Glycine 0 CA--C 1.467 -2.934 0 N-CA-C 105.184 -3.166 . . . . 65.109999999999999 105.184 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.534 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.7 mm -89.22 178.99 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 N-CA-C 104.415 -2.439 . . . . 64.209999999999994 104.415 175.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.534 ' H ' HG22 ' A' ' 21' ' ' ILE . 40.0 t -122.06 154.59 37.11 Favored 'General case' 0 CA--C 1.497 -1.084 0 N-CA-C 103.345 -2.835 . . . . 53.100000000000001 103.345 175.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.481 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.4 m -147.63 169.69 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.677 0 N-CA-C 107.406 -1.331 . . . . 74.349999999999994 107.406 -164.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 t -162.67 165.88 25.16 Favored 'General case' 0 N--CA 1.431 -1.375 0 N-CA-C 104.884 -2.265 . . . . 55.439999999999998 104.884 177.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.28 -152.67 31.24 Favored Glycine 0 C--N 1.346 1.128 0 N-CA-C 107.067 -2.413 . . . . 42.340000000000003 107.067 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 118.48 -78.77 0.3 Allowed Glycine 0 CA--C 1.477 -2.332 0 N-CA-C 108.979 -1.649 . . . . 73.219999999999999 108.979 174.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.9 OUTLIER -67.71 16.21 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 C-N-CA 124.557 1.143 . . . . 72.219999999999999 112.057 -168.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.441 ' H ' ' C ' ' A' ' 26' ' ' GLY . 12.5 t-20 81.32 5.14 1.38 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 125.213 1.405 . . . . 65.420000000000002 108.072 178.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 37.1 p -49.02 -170.86 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 126.071 1.748 . . . . 70.450000000000003 113.186 169.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 m -31.43 -42.41 0.05 OUTLIER 'General case' 0 C--N 1.362 1.147 0 C-N-CA 127.63 2.372 . . . . 64.120000000000005 115.089 -169.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 31.6 m -62.75 134.91 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 121.816 0.817 . . . . 62.219999999999999 109.967 -172.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -52.44 -50.25 62.95 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 114.855 -1.066 . . . . 73.120000000000005 112.404 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 46.5 m170 -90.31 16.95 7.78 Favored 'General case' 0 CA--C 1.504 -0.794 0 O-C-N 121.208 -0.933 . . . . 74.120000000000005 110.079 -175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 42.09 62.63 2.0 Favored Glycine 0 C--N 1.368 2.327 0 N-CA-C 111.206 -0.758 . . . . 72.329999999999998 111.206 173.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.1 179.73 24.73 Favored Glycine 0 CA--C 1.455 -3.681 0 N-CA-C 104.162 -3.575 . . . . 70.129999999999995 104.162 -172.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.564 HG13 ' HB2' ' A' ' 75' ' ' ALA . 8.6 mm -88.87 125.54 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.5 0 N-CA-C 105.479 -2.045 . . . . 73.140000000000001 105.479 176.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -109.32 152.86 24.71 Favored 'General case' 0 CA--C 1.473 -1.99 0 N-CA-C 103.84 -2.652 . . . . 64.519999999999996 103.84 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.1 t -81.81 104.15 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 106.464 -1.68 . . . . 75.200000000000003 106.464 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 27.1 ttmt -70.37 -31.93 69.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.729 -0.841 . . . . 64.430000000000007 108.729 -176.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -159.49 146.22 16.6 Favored 'General case' 0 CA--C 1.459 -2.525 0 N-CA-C 105.645 -1.983 . . . . 63.25 105.645 -178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.5 t -105.89 122.46 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.349 -3.204 . . . . 73.040000000000006 102.349 172.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.406 ' H ' ' CD1' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -77.79 146.23 72.1 Favored Pre-proline 0 N--CA 1.439 -0.982 0 N-CA-C 106.052 -1.833 . . . . 73.129999999999995 106.052 178.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -76.5 173.61 14.2 Favored 'Trans proline' 0 CA--C 1.47 -2.679 0 N-CA-C 107.109 -1.919 . . . . 72.409999999999997 107.109 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 63.65 53.98 1.94 Allowed 'General case' 0 N--CA 1.422 -1.829 0 O-C-N 124.664 1.228 . . . . 72.319999999999993 108.136 164.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.34 176.53 37.87 Favored Glycine 0 CA--C 1.466 -2.992 0 N-CA-C 106.659 -2.576 . . . . 75.25 106.659 -172.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -69.43 -52.73 24.02 Favored 'General case' 0 C--O 1.206 -1.205 0 N-CA-C 108.661 -0.866 . . . . 62.399999999999999 108.661 -174.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -49.32 67.45 Favored 'General case' 0 C--O 1.243 0.727 0 CA-C-N 116.623 -0.262 . . . . 71.25 110.558 -174.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -59.53 -57.5 12.67 Favored 'General case' 0 C--N 1.351 0.655 0 O-C-N 122.104 -0.373 . . . . 73.120000000000005 110.129 177.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -63.58 -28.7 70.11 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 120.581 0.229 . . . . 42.039999999999999 110.948 -170.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -75.34 -40.37 58.38 Favored 'General case' 0 CA--C 1.51 -0.561 0 N-CA-C 107.146 -1.427 . . . . 64.439999999999998 107.146 -175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.56 9.61 78.39 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 109.794 -1.322 . . . . 62.439999999999998 109.794 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.7 mtt85 -100.22 7.07 44.73 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 107.594 -1.262 . . . . 72.109999999999999 107.594 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.412 HD13 HD22 ' A' ' 12' ' ' LEU . 1.4 mp -134.5 140.75 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 102.987 -2.968 . . . . 43.549999999999997 102.987 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.4 m170 -140.83 158.71 43.56 Favored 'General case' 0 CA--C 1.465 -2.325 0 N-CA-C 104.666 -2.346 . . . . 74.409999999999997 104.666 179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -67.21 140.48 57.43 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 106.487 -1.672 . . . . 72.239999999999995 106.487 174.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.5 -32.83 6.34 Favored Glycine 0 CA--C 1.49 -1.497 0 N-CA-C 108.663 -1.775 . . . . 72.040000000000006 108.663 175.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -67.45 155.92 37.84 Favored 'General case' 0 CA--C 1.49 -1.36 0 N-CA-C 106.119 -1.808 . . . . 74.030000000000001 106.119 177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.426 ' HE ' ' CD ' ' A' ' 91' ' ' GLU . 1.6 ppt_? -133.38 156.55 47.44 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.233 -0.987 . . . . 64.430000000000007 109.247 -169.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -93.02 138.73 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.474 -1.676 . . . . 60.509999999999998 106.474 -175.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.527 ' CD1' HG23 ' A' ' 7' ' ' ILE . 7.0 mt -99.12 -59.29 1.75 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 106.216 -1.772 . . . . 64.329999999999998 106.216 176.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.56 152.28 50.3 Favored 'General case' 0 CA--C 1.478 -1.795 0 N-CA-C 106.474 -1.676 . . . . 64.120000000000005 106.474 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -118.91 121.14 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 N-CA-C 104.522 -2.399 . . . . 62.340000000000003 104.522 173.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.96 36.48 22.02 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 123.937 0.895 . . . . 74.109999999999999 110.532 177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.95 -19.95 52.24 Favored Glycine 0 CA--C 1.478 -2.248 0 N-CA-C 108.694 -1.762 . . . . 75.349999999999994 108.694 169.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 62.3 t -85.4 116.09 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 N-CA-C 107.565 -1.272 . . . . 62.420000000000002 107.565 -174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 49.0 m -55.52 117.91 4.0 Favored 'General case' 0 C--N 1.366 1.318 0 N-CA-C 107.664 -1.236 . . . . 71.150000000000006 107.664 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -102.12 -13.09 17.62 Favored 'General case' 0 C--O 1.202 -1.402 0 N-CA-C 106.608 -1.627 . . . . 54.329999999999998 106.608 -164.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -60.84 128.72 37.9 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 108.523 -0.917 . . . . 64.519999999999996 108.523 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.41 -17.67 58.65 Favored Glycine 0 C--N 1.345 1.046 0 N-CA-C 108.239 -1.945 . . . . 61.030000000000001 108.239 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.97 152.17 29.64 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 106.316 -1.735 . . . . 62.43 106.316 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.1 p -84.77 -179.37 7.09 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.384 0.611 . . . . 62.539999999999999 109.362 -169.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -60.89 -52.44 65.05 Favored 'General case' 0 C--O 1.205 -1.254 0 N-CA-C 108.073 -1.084 . . . . 70.439999999999998 108.073 -178.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.7 pttp -60.27 -44.83 94.98 Favored 'General case' 0 C--N 1.372 1.564 0 O-C-N 121.859 -0.525 . . . . 63.009999999999998 110.37 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 16.9 mm100 -55.44 -46.6 76.72 Favored 'General case' 0 C--N 1.365 1.241 0 N-CA-C 109.171 -0.677 . . . . 54.409999999999997 109.171 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.564 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -51.43 -53.83 32.9 Favored 'General case' 0 CA--C 1.493 -1.228 0 CA-C-N 115.893 -0.594 . . . . 55.43 110.722 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.3 t -73.16 -43.64 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.378 0 N-CA-C 108.044 -1.095 . . . . 74.219999999999999 108.044 -171.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 19.2 t -68.04 -30.34 69.54 Favored 'General case' 0 C--O 1.193 -1.912 0 C-N-CA 116.924 -1.91 . . . . 75.140000000000001 107.253 -170.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.8 m -67.96 -43.42 79.06 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 119.876 -1.765 . . . . 74.219999999999999 106.892 -178.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.6 mt -60.68 -29.0 69.04 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 109.526 -0.546 . . . . 63.100000000000001 109.526 176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -74.24 -60.39 2.29 Favored 'General case' 0 C--O 1.21 -0.977 0 N-CA-C 107.77 -1.196 . . . . 74.349999999999994 107.77 177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -58.85 -3.37 0.32 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 124.775 1.23 . . . . 74.340000000000003 113.607 -172.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 p -73.97 -176.33 2.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.678 -0.86 . . . . 72.439999999999998 108.678 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.77 -149.17 24.42 Favored Glycine 0 CA--C 1.494 -1.266 0 N-CA-C 109.432 -1.467 . . . . 64.420000000000002 109.432 -167.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -65.95 -55.18 18.15 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.177 -1.416 . . . . 75.409999999999997 107.177 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 68.8 t -100.68 144.36 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.925 0 N-CA-C 105.441 -2.059 . . . . 72.400000000000006 105.441 175.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -108.49 133.41 53.57 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.329 0 N-CA-C 106.128 -1.804 . . . . 75.420000000000002 106.128 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -107.08 121.87 45.35 Favored 'General case' 0 CA--C 1.491 -1.308 0 N-CA-C 104.902 -2.259 . . . . 75.230000000000004 104.902 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.5 134.42 13.01 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 108.074 -1.084 . . . . 74.430000000000007 108.074 -175.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.0 mp -84.63 141.33 30.72 Favored 'General case' 0 CA--C 1.488 -1.442 0 N-CA-C 108.232 -1.025 . . . . 71.400000000000006 108.232 178.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.648 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -118.3 163.24 17.0 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 105.054 -2.202 . . . . 64.040000000000006 105.054 176.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.426 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 36.2 tt0 -124.17 137.28 54.56 Favored 'General case' 0 N--CA 1.412 -2.341 0 N-CA-C 102.25 -3.241 . . . . 62.119999999999997 102.25 166.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.453 ' HD2' ' CE1' ' A' ' 8' ' ' PHE . 11.8 mmmm -61.16 149.88 36.01 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 108.822 -0.807 . . . . 75.010000000000005 108.822 178.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.82 -144.96 8.97 Favored Glycine 0 N--CA 1.416 -2.678 0 N-CA-C 105.654 -2.978 . . . . 72.329999999999998 105.654 175.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 84.13 57.98 0.01 OUTLIER 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 105.437 -2.06 . . . . 75.439999999999998 105.437 -174.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 23.1 t -68.8 124.15 89.54 Favored Pre-proline 0 N--CA 1.439 -0.984 0 N-CA-C 107.525 -1.287 . . . . 44.420000000000002 107.525 -174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.13 -163.56 0.16 Allowed 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.346 2.697 . . . . 74.340000000000003 108.555 178.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.426 -1.633 0 N-CA-C 103.424 -2.806 . . . . 74.530000000000001 103.424 174.088 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.408 ' O2 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.476 -2.345 0 N-CA-C 108.49 -1.844 . . . . 55.109999999999999 108.49 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.73 158.6 55.32 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 122.639 2.226 . . . . 73.209999999999994 108.313 175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.1 pttm -91.07 165.55 21.36 Favored Pre-proline 0 N--CA 1.437 -1.1 0 N-CA-C 105.91 -1.885 . . . . 75.209999999999994 105.91 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.19 113.43 1.66 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.712 2.274 . . . . 63.0 110.27 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.94 11.82 57.27 Favored Glycine 0 C--N 1.349 1.291 0 N-CA-C 108.598 -1.801 . . . . 73.019999999999996 108.598 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -78.91 132.37 36.73 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 107.435 -1.321 . . . . 74.200000000000003 107.435 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.513 HG23 ' CD1' ' A' ' 60' ' ' LEU . 18.5 mm -100.38 135.58 35.63 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.769 0 N-CA-C 106.196 -1.779 . . . . 73.200000000000003 106.196 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -145.88 161.61 39.62 Favored 'General case' 0 CA--C 1.48 -1.731 0 N-CA-C 107.669 -1.234 . . . . 74.319999999999993 107.669 175.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -112.49 151.76 29.57 Favored 'General case' 0 CA--C 1.47 -2.11 0 N-CA-C 105.548 -2.019 . . . . 72.340000000000003 105.548 -178.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 16.8 m -145.04 153.23 14.35 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.142 0 N-CA-C 106.715 -1.587 . . . . 74.010000000000005 106.715 176.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -111.96 131.22 55.53 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 105.116 -2.179 . . . . 75.030000000000001 105.116 172.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.424 HD22 HD12 ' A' ' 53' ' ' ILE . 4.6 mp -136.76 145.15 44.27 Favored 'General case' 0 CA--C 1.462 -2.409 0 N-CA-C 107.881 -1.155 . . . . 72.099999999999994 107.881 174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.15 144.83 26.67 Favored 'General case' 0 CA--C 1.494 -1.187 0 N-CA-C 107.139 -1.43 . . . . 52.119999999999997 107.139 178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -75.22 -27.52 59.57 Favored 'General case' 0 CA--C 1.509 -0.615 0 N-CA-C 107.773 -1.195 . . . . 63.530000000000001 107.773 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 6.5 t30 71.02 96.89 0.07 Allowed 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.831 0.852 . . . . 73.439999999999998 109.226 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 57.9 m-20 62.13 40.51 11.8 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 108.139 -1.06 . . . . 73.349999999999994 108.139 -179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 50.29 -8.99 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.067 2.547 . . . . 62.020000000000003 114.952 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.7 m -93.06 115.69 28.34 Favored 'General case' 0 CA--C 1.47 -2.105 0 N-CA-C 106.745 -1.576 . . . . 70.420000000000002 106.745 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -87.12 -150.75 0.16 Allowed 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.516 -2.401 . . . . 73.010000000000005 104.516 173.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 166.79 29.89 0.02 OUTLIER Glycine 0 CA--C 1.463 -3.203 0 N-CA-C 107.169 -2.372 . . . . 71.200000000000003 107.169 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.38 176.0 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.219 0 N-CA-C 103.14 -2.911 . . . . 62.210000000000001 103.14 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 57.4 m -151.04 166.48 30.6 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 104.166 -2.531 . . . . 54.399999999999999 104.166 172.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.06 177.32 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 N-CA-C 107.827 -1.175 . . . . 74.319999999999993 107.827 -166.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 t -159.81 170.78 20.74 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.525 -2.398 . . . . 73.519999999999996 104.525 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.53 -153.16 24.81 Favored Glycine 0 CA--C 1.484 -1.854 0 N-CA-C 109.091 -1.604 . . . . 70.219999999999999 109.091 175.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 119.45 -80.93 0.32 Allowed Glycine 0 CA--C 1.477 -2.299 0 N-CA-C 108.864 -1.695 . . . . 61.439999999999998 108.864 173.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.42 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.0 OUTLIER -76.71 16.54 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 C-N-CA 122.755 0.422 . . . . 63.109999999999999 111.643 -166.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 28.3 t30 85.64 6.43 0.43 Allowed 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.241 -1.022 . . . . 75.230000000000004 108.241 178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 73.0 p -45.89 -168.39 0.0 OUTLIER 'General case' 0 C--O 1.192 -1.933 0 C-N-CA 126.821 2.048 . . . . 75.200000000000003 112.051 162.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.6 m -33.06 -43.58 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.568 1.547 . . . . 74.109999999999999 114.441 -172.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 22.1 m -71.3 130.08 35.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.739 0 N-CA-C 107.524 -1.287 . . . . 65.340000000000003 107.524 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -55.93 11.51 Favored 'General case' 0 CA--C 1.487 -1.46 0 O-C-N 121.138 -0.976 . . . . 74.430000000000007 108.854 -166.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -61.74 -20.72 63.84 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 111.81 0.3 . . . . 61.43 111.81 -164.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 55.64 2.63 Favored Glycine 0 CA--C 1.482 -2.005 0 N-CA-C 107.817 -2.113 . . . . 64.400000000000006 107.817 171.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.01 -179.77 29.62 Favored Glycine 0 CA--C 1.456 -3.629 1 N-CA-C 101.923 -4.471 . . . . 54.119999999999997 101.923 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -88.13 136.66 22.72 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.593 0 N-CA-C 104.734 -2.321 . . . . 65.310000000000002 104.734 177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.3 m-30 -105.48 151.43 24.27 Favored 'General case' 0 CA--C 1.473 -1.989 0 N-CA-C 103.487 -2.783 . . . . 63.119999999999997 103.487 174.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.1 t -81.95 101.41 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.786 0 N-CA-C 105.724 -1.954 . . . . 74.209999999999994 105.724 176.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -73.09 -37.02 66.89 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.116 -1.402 . . . . 72.400000000000006 110.978 -174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -148.43 140.54 24.03 Favored 'General case' 0 CA--C 1.472 -2.039 0 N-CA-C 106.283 -1.747 . . . . 74.230000000000004 106.283 -176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.8 t -128.57 132.97 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.714 0 N-CA-C 103.368 -2.827 . . . . 74.530000000000001 103.368 173.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.89 154.03 84.95 Favored Pre-proline 0 C--O 1.237 0.445 0 N-CA-C 106.647 -1.612 . . . . 75.409999999999997 106.647 175.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.18 172.34 16.24 Favored 'Trans proline' 0 CA--C 1.472 -2.6 0 N-CA-C 107.079 -1.931 . . . . 51.130000000000003 107.079 176.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 53.41 55.67 8.38 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 124.612 1.195 . . . . 73.209999999999994 109.541 164.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.34 176.37 35.31 Favored Glycine 0 CA--C 1.476 -2.394 0 N-CA-C 104.011 -3.635 . . . . 73.409999999999997 104.011 -176.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.35 55.77 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 117.291 0.546 . . . . 74.430000000000007 109.765 -168.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.39 -49.79 63.73 Favored 'General case' 0 C--N 1.359 0.985 0 O-C-N 122.542 -0.099 . . . . 70.230000000000004 111.115 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -62.86 -55.8 22.98 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 122.094 -0.379 . . . . 64.430000000000007 110.483 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.1 m -65.78 -29.03 69.46 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 110.051 -0.351 . . . . 73.129999999999995 110.051 -168.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -77.14 -38.13 52.58 Favored 'General case' 0 CA--C 1.511 -0.548 0 N-CA-C 106.318 -1.734 . . . . 65.019999999999996 106.318 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.61 15.22 76.39 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 109.889 -1.285 . . . . 74.319999999999993 109.889 171.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 73.6 mtt85 -101.56 7.65 42.19 Favored 'General case' 0 CA--C 1.49 -1.353 0 N-CA-C 107.043 -1.465 . . . . 74.349999999999994 107.043 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.424 HD12 HD22 ' A' ' 12' ' ' LEU . 64.0 mt -141.49 143.72 27.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 N-CA-C 103.756 -2.683 . . . . 75.200000000000003 103.756 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -141.63 169.31 17.84 Favored 'General case' 0 N--CA 1.419 -1.988 0 N-CA-C 104.089 -2.56 . . . . 75.310000000000002 104.089 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -68.09 138.47 55.79 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 105.569 -2.011 . . . . 60.329999999999998 105.569 164.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 108.04 -28.07 12.92 Favored Glycine 0 CA--C 1.494 -1.22 0 N-CA-C 108.991 -1.644 . . . . 73.099999999999994 108.991 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.442 ' HA ' ' HA2' ' A' ' 93' ' ' GLY . 1.1 m-20 -57.57 139.51 53.33 Favored 'General case' 0 CA--C 1.472 -2.043 0 CA-C-N 118.057 0.929 . . . . 72.120000000000005 108.708 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.7 130.24 56.12 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 104.839 -2.282 . . . . 73.25 104.839 -174.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 84.6 t -89.75 130.61 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.478 0 N-CA-C 105.281 -2.118 . . . . 73.439999999999998 105.281 -177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' CD1' HG23 ' A' ' 7' ' ' ILE . 19.8 mt -97.79 -58.31 2.02 Favored 'General case' 0 CA--C 1.477 -1.854 0 N-CA-C 106.366 -1.716 . . . . 73.349999999999994 106.366 -176.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.7 151.47 50.21 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 106.51 -1.663 . . . . 71.430000000000007 106.51 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.8 t -117.08 117.93 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.347 0 N-CA-C 105.485 -2.043 . . . . 61.299999999999997 105.485 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 59.7 t30 49.42 40.39 18.68 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.246 1.018 . . . . 53.329999999999998 111.033 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 106.7 -32.68 7.05 Favored Glycine 0 CA--C 1.472 -2.621 0 N-CA-C 108.157 -1.977 . . . . 73.299999999999997 108.157 170.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.15 117.04 27.42 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.822 0 N-CA-C 108.643 -0.873 . . . . 72.420000000000002 108.643 -169.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.8 t -56.27 126.17 25.05 Favored 'General case' 0 C--N 1.363 1.173 0 N-CA-C 108.377 -0.971 . . . . 75.340000000000003 108.377 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.469 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.7 OUTLIER -103.66 -12.09 17.25 Favored 'General case' 0 N--CA 1.432 -1.367 0 N-CA-C 106.237 -1.764 . . . . 55.100000000000001 106.237 -169.512 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.8 124.31 19.76 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.677 -0.861 . . . . 74.030000000000001 108.677 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 94.81 -16.53 61.07 Favored Glycine 0 C--N 1.357 1.718 0 N-CA-C 108.764 -1.735 . . . . 62.149999999999999 108.764 179.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.31 154.01 31.25 Favored 'General case' 0 CA--C 1.49 -1.351 0 N-CA-C 106.814 -1.55 . . . . 44.43 106.814 -178.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.7 p -85.57 179.38 7.13 Favored 'General case' 0 N--CA 1.431 -1.414 0 N-CA-C 108.56 -0.904 . . . . 75.349999999999994 108.56 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 32.4 p80 -68.83 -42.92 76.55 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 108.559 -0.904 . . . . 74.109999999999999 108.559 178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.72 -56.35 16.18 Favored 'General case' 0 C--N 1.367 1.352 0 O-C-N 121.915 -0.491 . . . . 70.430000000000007 110.085 174.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -54.79 -45.11 74.28 Favored 'General case' 0 C--N 1.363 1.167 0 O-C-N 122.19 -0.319 . . . . 42.520000000000003 110.248 178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.469 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -52.03 -54.48 29.51 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-N 116.085 -0.507 . . . . 75.230000000000004 110.488 -178.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.64 -38.17 51.13 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.178 0 N-CA-C 108.758 -0.83 . . . . 54.340000000000003 108.758 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.44 ' SG ' ' H15' ' A' ' 101' ' ' 33B . 8.2 t -56.29 -40.03 73.63 Favored 'General case' 0 N--CA 1.515 2.803 0 N-CA-C 105.935 -1.876 . . . . 64.519999999999996 105.935 -173.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 7.7 m -74.42 -48.84 25.24 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-N 114.054 -1.43 . . . . 72.230000000000004 109.194 -174.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.3 mt -64.11 -31.43 72.62 Favored 'General case' 0 C--N 1.368 1.391 0 N-CA-C 110.259 -0.274 . . . . 73.420000000000002 110.259 -175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 78.8 mtp85 -79.51 -53.71 6.61 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 108.246 -1.02 . . . . 73.400000000000006 108.246 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -68.79 53.21 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 122.295 1.045 . . . . 63.310000000000002 110.973 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.47 HG21 HG13 ' A' ' 86' ' ' VAL . 10.4 p -110.77 -175.74 2.79 Favored 'General case' 0 N--CA 1.417 -2.121 0 N-CA-C 106.384 -1.71 . . . . 71.540000000000006 106.384 176.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.1 -156.11 32.5 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 106.497 -2.641 . . . . 34.200000000000003 106.497 177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -62.24 -54.69 37.23 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 107.784 -1.191 . . . . 72.25 107.784 -178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 56.9 t -94.46 142.36 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.821 0 N-CA-C 106.461 -1.681 . . . . 75.409999999999997 106.461 177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.47 HG13 HG21 ' A' ' 82' ' ' THR . 48.9 t -103.71 132.17 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.534 0 N-CA-C 105.052 -2.203 . . . . 64.340000000000003 105.052 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.3 t60 -110.24 127.75 55.14 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 104.831 -2.285 . . . . 73.510000000000005 104.831 173.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.54 139.17 16.02 Favored 'General case' 0 CA--C 1.478 -1.814 0 N-CA-C 107.727 -1.212 . . . . 73.239999999999995 107.727 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.4 140.53 33.41 Favored 'General case' 0 CA--C 1.466 -2.257 0 N-CA-C 107.271 -1.381 . . . . 75.409999999999997 107.271 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.83 160.82 38.24 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.994 -1.457 . . . . 71.140000000000001 107.474 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -123.57 120.77 33.82 Favored 'General case' 0 N--CA 1.419 -2.016 0 N-CA-C 105.387 -2.079 . . . . 75.409999999999997 105.387 -169.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . 0.419 0.0 OUTLIER 34.79 -79.96 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 127.146 2.178 . . . . 75.329999999999998 116.195 178.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.442 ' HA2' ' HA ' ' A' ' 57' ' ' ASP . . . 100.74 -60.68 0.64 Allowed Glycine 0 CA--C 1.461 -3.285 0 N-CA-C 106.043 -2.823 . . . . 33.219999999999999 106.043 -173.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -64.8 109.58 2.11 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 107.152 -1.425 . . . . 63.009999999999998 107.152 174.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 69.6 m -102.66 129.41 25.94 Favored Pre-proline 0 N--CA 1.43 -1.454 0 N-CA-C 106.614 -1.625 . . . . 55.409999999999997 106.614 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -73.5 177.83 7.46 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.365 2.044 . . . . 71.129999999999995 106.957 170.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 CA--C 1.564 1.485 0 N-CA-C 107.834 -1.172 . . . . 75.049999999999997 107.834 -178.492 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.44 ' H15' ' SG ' ' A' ' 77' ' ' CYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.742 0 N-CA-C 108.192 -1.963 . . . . 63.399999999999999 108.192 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -65.87 128.79 20.55 Favored 'Trans proline' 0 CA--C 1.497 -1.337 0 C-N-CA 122.782 2.321 . . . . 71.219999999999999 108.582 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -96.09 162.1 24.96 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 106.243 -1.762 . . . . 65.540000000000006 106.243 -175.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -64.33 127.42 19.06 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.679 2.253 . . . . 53.32 109.381 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.73 1.35 65.85 Favored Glycine 0 CA--C 1.494 -1.244 0 N-CA-C 108.946 -1.661 . . . . 74.420000000000002 108.946 176.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -75.9 137.24 40.27 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.557 -1.275 . . . . 72.409999999999997 107.557 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.472 HG23 ' CD1' ' A' ' 60' ' ' LEU . 11.8 mt -101.11 128.82 52.96 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 N-CA-C 107.653 -1.24 . . . . 72.450000000000003 107.653 -178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.3 p90 -139.76 156.23 46.88 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 107.212 -1.403 . . . . 54.549999999999997 107.212 177.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -107.1 145.93 31.86 Favored 'General case' 0 CA--C 1.478 -1.822 0 N-CA-C 105.483 -2.043 . . . . 62.210000000000001 105.483 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.666 HG22 HD21 ' A' ' 90' ' ' LEU . 16.1 m -140.39 151.69 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.709 0 N-CA-C 107.038 -1.467 . . . . 54.240000000000002 107.038 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -108.58 128.54 54.91 Favored 'General case' 0 N--CA 1.424 -1.768 0 N-CA-C 105.35 -2.093 . . . . 64.129999999999995 105.35 168.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.0 mp -132.27 143.93 50.25 Favored 'General case' 0 CA--C 1.454 -2.731 0 N-CA-C 107.438 -1.319 . . . . 72.0 107.438 175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.66 142.18 28.4 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 105.521 -2.029 . . . . 72.310000000000002 105.521 175.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 24.2 mtpt -71.72 -30.55 65.75 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.071 -1.085 . . . . 65.200000000000003 108.071 175.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 45.4 t-20 72.43 104.38 0.07 Allowed 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.76 -0.83 . . . . 63.409999999999997 108.76 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.4 t70 62.27 46.47 6.05 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 123.817 0.847 . . . . 74.519999999999996 110.192 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 53.39 -9.91 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 127.12 2.168 . . . . 63.43 114.791 173.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 14.7 m -109.61 149.69 29.31 Favored 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.203 -1.036 . . . . 63.240000000000002 108.203 -167.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -154.43 167.4 30.15 Favored 'General case' 0 CA--C 1.469 -2.143 0 N-CA-C 105.629 -1.989 . . . . 54.450000000000003 105.629 175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.05 95.54 0.1 Allowed Glycine 0 CA--C 1.46 -3.356 0 N-CA-C 104.225 -3.55 . . . . 74.430000000000007 104.225 172.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.66 153.07 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.279 0 N-CA-C 103.091 -2.929 . . . . 74.150000000000006 103.091 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 39' ' ' LYS . 6.5 m -91.77 159.41 15.84 Favored 'General case' 0 N--CA 1.483 1.197 0 N-CA-C 103.657 -2.72 . . . . 71.010000000000005 103.657 -177.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.7 m -151.0 167.12 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.43 -1.442 0 N-CA-C 104.99 -2.226 . . . . 73.5 104.99 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.4 t -167.92 170.6 10.47 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 104.668 -2.345 . . . . 65.019999999999996 104.668 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.57 -148.88 21.42 Favored Glycine 0 CA--C 1.492 -1.347 0 N-CA-C 107.421 -2.272 . . . . 61.219999999999999 107.421 -175.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 115.1 -78.69 0.27 Allowed Glycine 0 CA--C 1.481 -2.048 0 N-CA-C 108.953 -1.659 . . . . 72.140000000000001 108.953 173.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 27' ' ' VAL . 2.3 t -75.6 15.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.716 0 C-N-CA 123.304 0.642 . . . . 53.210000000000001 109.819 -170.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 26' ' ' GLY . 63.0 m-80 83.81 7.05 0.65 Allowed 'General case' 0 CA--C 1.486 -1.494 0 C-N-CA 124.373 1.069 . . . . 74.109999999999999 108.182 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 11.8 p -47.52 -171.14 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 126.058 1.743 . . . . 74.239999999999995 113.114 170.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.1 m -34.99 -44.04 0.21 Allowed 'General case' 0 C--N 1.365 1.25 0 C-N-CA 126.545 1.938 . . . . 72.549999999999997 114.544 -164.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.9 m -58.39 126.44 16.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 CA-C-O 122.281 1.038 . . . . 64.109999999999999 110.301 -176.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -51.62 -52.64 46.06 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 114.463 -1.244 . . . . 63.5 113.833 -165.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -73.24 -18.88 61.18 Favored 'General case' 0 C--N 1.348 0.515 0 C-N-CA 119.088 -1.045 . . . . 63.509999999999998 109.509 -172.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.22 54.83 2.9 Favored Glycine 0 CA--C 1.491 -1.464 0 N-CA-C 108.271 -1.931 . . . . 72.120000000000005 108.271 172.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.43 -179.17 22.38 Favored Glycine 0 CA--C 1.461 -3.328 0 N-CA-C 104.051 -3.62 . . . . 75.329999999999998 104.051 -176.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.463 ' HA ' HD13 ' A' ' 36' ' ' ILE . 10.0 mm -82.49 128.02 39.11 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.353 0 N-CA-C 104.409 -2.441 . . . . 53.240000000000002 104.409 171.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -106.37 150.91 25.54 Favored 'General case' 0 CA--C 1.459 -2.536 0 N-CA-C 104.432 -2.433 . . . . 64.340000000000003 104.432 178.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -78.95 103.23 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.188 0 N-CA-C 105.5 -2.037 . . . . 75.230000000000004 105.5 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 84.9 tttt -70.21 -33.99 72.35 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-N 114.393 -1.276 . . . . 72.019999999999996 109.3 -172.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -167.5 155.55 9.18 Favored 'General case' 0 CA--C 1.464 -2.348 0 N-CA-C 105.636 -1.987 . . . . 64.430000000000007 105.636 179.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 40.3 t -127.97 134.49 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.101 0 N-CA-C 103.045 -2.946 . . . . 75.329999999999998 103.045 176.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.402 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -78.04 150.18 77.56 Favored Pre-proline 0 N--CA 1.448 -0.534 0 N-CA-C 105.31 -2.108 . . . . 75.340000000000003 105.31 176.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.02 168.82 23.86 Favored 'Trans proline' 0 CA--C 1.465 -2.928 0 N-CA-C 105.528 -2.528 . . . . 74.400000000000006 105.528 -175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 76.5 mm-40 62.93 -0.33 0.6 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.297 0.851 . . . . 73.150000000000006 113.297 167.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -84.5 173.81 49.89 Favored Glycine 0 CA--C 1.485 -1.831 0 N-CA-C 106.712 -2.555 . . . . 73.430000000000007 106.712 175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.46 -48.79 73.95 Favored 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 107.961 -1.125 . . . . 51.240000000000002 107.961 -174.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.95 -49.48 65.98 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 115.826 -0.624 . . . . 75.219999999999999 110.377 -179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -65.36 -56.15 14.19 Favored 'General case' 0 C--N 1.347 0.46 0 O-C-N 122.145 -0.347 . . . . 71.340000000000003 110.072 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 49.8 m -63.73 -28.8 70.13 Favored 'General case' 0 C--N 1.345 0.411 0 O-C-N 122.103 -0.373 . . . . 72.150000000000006 111.009 -170.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -83.93 -30.99 25.86 Favored 'General case' 0 C--O 1.214 -0.782 0 N-CA-C 106.515 -1.661 . . . . 71.239999999999995 106.515 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 72.89 20.0 79.69 Favored Glycine 0 CA--C 1.493 -1.341 0 N-CA-C 110.375 -1.09 . . . . 72.439999999999998 110.375 172.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB3' HG11 ' A' ' 10' ' ' VAL . 90.6 mtt-85 -97.16 6.54 48.3 Favored 'General case' 0 CA--C 1.495 -1.169 0 N-CA-C 106.691 -1.596 . . . . 71.040000000000006 106.691 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.2 mt -140.96 141.66 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.281 0 N-CA-C 102.451 -3.166 . . . . 62.109999999999999 102.451 -176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -142.3 153.5 43.93 Favored 'General case' 0 CA--C 1.46 -2.482 0 N-CA-C 105.205 -2.146 . . . . 65.439999999999998 105.205 -172.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -67.68 141.9 56.52 Favored 'General case' 0 CA--C 1.5 -0.976 0 N-CA-C 107.273 -1.38 . . . . 64.439999999999998 107.273 174.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 95.21 -32.24 6.36 Favored Glycine 0 CA--C 1.493 -1.326 0 N-CA-C 108.898 -1.681 . . . . 72.349999999999994 108.898 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -62.62 154.32 29.43 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 107.83 -1.174 . . . . 62.439999999999998 107.83 178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.14 135.35 53.9 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.474 -1.676 . . . . 75.420000000000002 106.474 -167.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.3 t -91.0 129.57 41.56 Favored 'Isoleucine or valine' 0 C--O 1.252 1.208 0 N-CA-C 105.454 -2.054 . . . . 70.430000000000007 105.454 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' CD1' HG23 ' A' ' 7' ' ' ILE . 13.3 mt -95.53 -60.5 1.65 Allowed 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 107.527 -1.286 . . . . 62.299999999999997 107.527 -176.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.44 150.88 48.96 Favored 'General case' 0 CA--C 1.467 -2.226 0 N-CA-C 106.099 -1.815 . . . . 74.239999999999995 106.099 -174.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 73.5 t -115.31 114.85 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.325 0 N-CA-C 105.23 -2.137 . . . . 71.349999999999994 105.23 176.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 50.7 t30 44.09 47.25 7.4 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 125.046 1.338 . . . . 64.120000000000005 111.34 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 105.45 -32.96 6.9 Favored Glycine 0 CA--C 1.472 -2.635 0 N-CA-C 108.301 -1.92 . . . . 33.229999999999997 108.301 168.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.3 t -72.52 118.03 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.404 -2.751 0 N-CA-C 109.384 -0.599 . . . . 62.420000000000002 109.384 -170.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.3 m -54.22 109.47 0.49 Allowed 'General case' 0 C--N 1.369 1.425 0 N-CA-C 106.976 -1.49 . . . . 70.129999999999995 106.976 168.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -100.49 -13.28 18.74 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 106.357 -1.72 . . . . 74.129999999999995 106.357 -167.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -62.27 134.32 56.35 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.458 -0.941 . . . . 65.439999999999998 108.458 178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.77 -17.69 58.12 Favored Glycine 0 N--CA 1.443 -0.869 0 N-CA-C 108.172 -1.971 . . . . 72.519999999999996 108.172 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.19 151.71 28.06 Favored 'General case' 0 CA--C 1.489 -1.374 0 N-CA-C 105.607 -1.998 . . . . 51.399999999999999 105.607 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 24.3 p -79.54 178.41 8.15 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.813 0.816 . . . . 60.329999999999998 108.935 -172.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 13.7 p80 -68.03 -45.17 74.72 Favored 'General case' 0 C--O 1.2 -1.543 0 N-CA-C 108.533 -0.914 . . . . 71.319999999999993 108.533 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.0 mtmt -56.37 -51.5 68.07 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 121.577 -0.702 . . . . 74.230000000000004 110.585 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -53.61 -41.49 66.7 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 109.831 -0.433 . . . . 63.210000000000001 109.831 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.16 64.09 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.975 -0.557 . . . . 64.420000000000002 110.02 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 6.7 t -73.38 -47.41 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 107.793 -1.188 . . . . 73.049999999999997 107.793 -175.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 98.9 m -56.72 -35.59 68.72 Favored 'General case' 0 N--CA 1.515 2.815 0 N-CA-C 107.38 -1.341 . . . . 53.409999999999997 107.38 -172.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.7 m -69.9 -47.11 63.79 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 120.484 -1.385 . . . . 75.010000000000005 108.012 -174.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 65.2 mt -61.46 -32.94 72.95 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 109.126 -0.694 . . . . 71.329999999999998 109.126 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -68.55 -60.71 2.22 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 107.892 -1.151 . . . . 71.219999999999999 107.892 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -69.67 48.63 0.09 Allowed 'General case' 0 N--CA 1.498 1.956 0 C-N-CA 123.569 0.748 . . . . 63.530000000000001 111.706 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.488 HG21 HG13 ' A' ' 86' ' ' VAL . 12.8 p -102.5 -175.71 2.9 Favored 'General case' 0 N--CA 1.412 -2.342 0 N-CA-C 105.377 -2.083 . . . . 73.409999999999997 105.377 170.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.89 -148.12 22.75 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 106.799 -2.52 . . . . 42.229999999999997 106.799 178.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.44 -55.24 12.54 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.102 -1.073 . . . . 73.409999999999997 108.102 178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 82.6 t -98.1 140.89 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 N-CA-C 106.41 -1.7 . . . . 73.439999999999998 106.41 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.488 HG13 HG21 ' A' ' 82' ' ' THR . 48.8 t -104.99 135.62 42.2 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.423 0 N-CA-C 106.053 -1.832 . . . . 75.239999999999995 106.053 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -110.43 129.3 55.8 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 104.889 -2.263 . . . . 72.420000000000002 104.889 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -156.74 133.88 10.48 Favored 'General case' 0 CA--C 1.473 -2.007 0 N-CA-C 107.126 -1.435 . . . . 75.329999999999998 107.126 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 5.8 mp -80.86 138.02 36.19 Favored 'General case' 0 CA--C 1.475 -1.935 0 N-CA-C 107.71 -1.219 . . . . 74.310000000000002 107.71 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.666 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.89 155.99 22.76 Favored 'General case' 0 CA--C 1.486 -1.492 0 N-CA-C 104.492 -2.41 . . . . 74.439999999999998 104.492 177.011 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -119.77 132.19 55.55 Favored 'General case' 0 N--CA 1.416 -2.153 0 N-CA-C 100.827 -3.768 . . . . 72.319999999999993 100.827 168.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -60.99 138.62 58.17 Favored 'General case' 0 CA--C 1.49 -1.347 0 N-CA-C 108.708 -0.849 . . . . 74.549999999999997 108.708 176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -87.09 -177.27 48.99 Favored Glycine 0 CA--C 1.477 -2.305 0 N-CA-C 106.858 -2.497 . . . . 74.049999999999997 106.858 -176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 66.73 33.37 6.31 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 106.261 -1.755 . . . . 74.099999999999994 106.261 -173.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.5 p -91.42 124.23 61.69 Favored Pre-proline 0 N--CA 1.419 -2.011 0 N-CA-C 104.225 -2.509 . . . . 54.039999999999999 104.225 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.24 96.41 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.259 1.973 . . . . 71.219999999999999 109.274 -170.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 29.3 m . . . . . 0 N--CA 1.42 -1.928 0 N-CA-C 104.387 -2.449 . . . . 63.0 104.387 170.439 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.495 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.488 -1.635 0 N-CA-C 107.801 -2.12 . . . . 63.219999999999999 107.801 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -68.74 175.4 7.28 Favored 'Trans proline' 0 CA--C 1.504 -0.989 0 C-N-CA 123.137 2.558 . . . . 53.450000000000003 110.436 -174.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.07 168.66 7.56 Favored Pre-proline 0 N--CA 1.423 -1.807 0 N-CA-C 103.907 -2.627 . . . . 63.119999999999997 103.907 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.457 ' HA ' ' HB2' ' A' ' 92' ' ' LYS . 46.1 Cg_exo -61.3 145.33 98.51 Favored 'Trans proline' 0 CA--C 1.506 -0.878 0 C-N-CA 122.811 2.34 . . . . 74.299999999999997 108.819 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 101.97 -12.79 57.61 Favored Glycine 0 CA--C 1.496 -1.136 0 N-CA-C 109.344 -1.502 . . . . 64.140000000000001 109.344 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -83.28 141.84 31.54 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 107.358 -1.349 . . . . 63.329999999999998 107.358 -177.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.5 mt -104.63 135.11 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.997 0 N-CA-C 109.069 -0.715 . . . . 75.430000000000007 109.069 -173.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.542 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.8 p90 -130.84 149.27 52.55 Favored 'General case' 0 CA--C 1.494 -1.205 0 N-CA-C 106.56 -1.644 . . . . 72.129999999999995 106.56 169.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 28.6 mp0 -103.64 146.13 29.02 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 104.88 -2.267 . . . . 64.409999999999997 104.88 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.633 HG22 HD21 ' A' ' 90' ' ' LEU . 28.7 m -140.75 152.37 20.7 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.998 0 N-CA-C 106.596 -1.631 . . . . 73.209999999999994 106.596 173.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -106.99 131.69 53.77 Favored 'General case' 0 N--CA 1.411 -2.413 0 N-CA-C 104.737 -2.32 . . . . 71.129999999999995 104.737 168.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.98 142.37 31.62 Favored 'General case' 0 N--CA 1.419 -2.023 0 N-CA-C 108.207 -1.035 . . . . 63.25 108.207 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -90.22 150.52 21.94 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 105.099 -2.186 . . . . 72.099999999999994 105.099 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.511 ' HG3' ' HG ' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -76.85 -35.1 57.74 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.744 -1.576 . . . . 52.409999999999997 106.744 175.458 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 77.54 109.91 0.07 Allowed 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 107.466 -1.309 . . . . 70.439999999999998 107.466 -176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 42.8 t0 57.69 36.12 26.3 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 107.804 -1.184 . . . . 74.230000000000004 107.804 -174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 61.3 t30 52.05 2.03 0.02 OUTLIER 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.752 1.621 . . . . 75.340000000000003 112.985 -175.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.0 m -116.54 114.04 23.6 Favored 'General case' 0 N--CA 1.424 -1.743 0 O-C-N 120.369 -1.457 . . . . 74.329999999999998 109.027 -169.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.511 ' HG ' ' HG3' ' A' ' 14' ' ' LYS . 49.8 mt -94.22 -153.94 0.39 Allowed 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 102.468 -3.16 . . . . 52.109999999999999 102.468 162.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.07 42.19 0.02 OUTLIER Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 107.752 -2.139 . . . . 71.150000000000006 107.752 175.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.418 ' H ' HD13 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -87.3 176.79 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.754 0 N-CA-C 105.428 -2.064 . . . . 74.319999999999993 105.428 175.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 41.9 t -114.62 158.33 21.87 Favored 'General case' 0 CA--C 1.483 -1.623 0 N-CA-C 104.681 -2.34 . . . . 65.150000000000006 104.681 -172.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.8 m -145.9 172.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.042 0 N-CA-C 106.16 -1.792 . . . . 65.200000000000003 106.16 -170.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.8 t -164.48 167.35 19.59 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 104.353 -2.462 . . . . 63.420000000000002 104.353 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.32 -160.12 29.11 Favored Glycine 0 CA--C 1.494 -1.272 0 N-CA-C 109.004 -1.638 . . . . 71.099999999999994 109.004 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 129.43 -91.38 0.31 Allowed Glycine 0 CA--C 1.488 -1.612 0 N-CA-C 109.063 -1.615 . . . . 60.0 109.063 175.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 71' ' ' THR . 0.2 OUTLIER -67.14 16.13 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 124.506 1.123 . . . . 63.109999999999999 113.975 -162.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 85.24 6.78 0.46 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.503 1.121 . . . . 74.530000000000001 108.716 -179.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.8 p -37.97 -170.06 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 127.266 2.226 . . . . 61.210000000000001 113.895 161.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.3 m -57.77 -21.27 40.6 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.134 0.974 . . . . 73.420000000000002 112.333 -168.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -66.86 136.23 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 109.053 -0.721 . . . . 70.239999999999995 109.053 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.23 -70.57 0.1 Allowed 'General case' 0 C--N 1.358 0.973 0 C-N-CA 124.437 1.095 . . . . 65.0 111.424 -171.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -86.21 15.75 4.95 Favored 'General case' 0 CA--C 1.509 -0.631 0 O-C-N 121.497 -0.752 . . . . 63.030000000000001 110.977 -169.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 49.68 62.58 4.75 Favored Glycine 0 C--N 1.355 1.638 0 N-CA-C 110.205 -1.158 . . . . 62.329999999999998 110.205 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -152.01 179.76 28.3 Favored Glycine 0 CA--C 1.454 -3.734 0 N-CA-C 103.843 -3.703 . . . . 61.409999999999997 103.843 -174.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.87 132.36 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.882 0 N-CA-C 105.373 -2.084 . . . . 64.430000000000007 105.373 178.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -110.25 148.39 31.97 Favored 'General case' 0 CA--C 1.471 -2.082 0 N-CA-C 103.881 -2.637 . . . . 71.329999999999998 103.881 174.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.7 t -82.06 102.62 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.049 -1.834 . . . . 62.43 106.049 179.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -71.9 -33.8 68.6 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 114.459 -1.246 . . . . 63.329999999999998 110.365 -171.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.24 146.97 20.49 Favored 'General case' 0 CA--C 1.465 -2.319 0 N-CA-C 106.247 -1.761 . . . . 74.209999999999994 106.247 -177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.42 ' CG1' ' HB3' ' A' ' 48' ' ' GLU . 41.6 t -121.5 125.98 74.25 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.935 0 N-CA-C 104.853 -2.277 . . . . 65.530000000000001 104.853 178.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.676 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.2 OUTLIER -98.59 171.21 6.02 Favored Pre-proline 0 C--O 1.213 -0.817 0 N-CA-C 105.687 -1.968 . . . . 74.129999999999995 105.687 179.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 60.0 Cg_endo -84.43 179.62 4.38 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 121.398 1.399 . . . . 72.25 110.128 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? 76.25 -14.15 0.83 Allowed 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.184 1.394 . . . . 72.019999999999996 113.042 160.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.43 -179.51 45.16 Favored Glycine 0 C--N 1.295 -1.725 0 N-CA-C 109.58 -1.408 . . . . 74.109999999999999 109.58 -177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -72.12 -53.67 12.06 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 115.033 -0.584 . . . . 41.039999999999999 109.558 -178.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.53 -50.83 66.93 Favored 'General case' 0 C--N 1.369 1.43 0 CA-C-O 121.08 0.467 . . . . 54.049999999999997 110.227 -170.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 49' ' ' SER . 3.8 pm0 -61.66 -55.88 25.73 Favored 'General case' 0 N--CA 1.428 -1.527 0 C-N-CA 123.907 0.883 . . . . 70.430000000000007 110.713 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.509 ' H ' ' HG2' ' A' ' 48' ' ' GLU . 22.0 m -62.36 -25.13 67.74 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 122.958 0.503 . . . . 65.209999999999994 110.859 -175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -84.35 -28.28 27.14 Favored 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 106.917 -1.512 . . . . 71.129999999999995 106.917 -177.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.22 15.15 81.43 Favored Glycine 0 C--N 1.353 1.491 0 N-CA-C 110.052 -1.219 . . . . 52.329999999999998 110.052 173.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -99.11 6.71 46.4 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.274 -1.38 . . . . 74.439999999999998 107.274 -176.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.3 mp -132.15 137.52 54.44 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.341 0 N-CA-C 102.099 -3.297 . . . . 73.239999999999995 102.099 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -133.68 151.37 51.63 Favored 'General case' 0 CA--C 1.467 -2.23 0 N-CA-C 104.75 -2.315 . . . . 71.010000000000005 104.75 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.4 ttpp -67.9 138.14 55.78 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 106.736 -1.579 . . . . 73.040000000000006 106.736 175.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.57 -27.79 11.49 Favored Glycine 0 CA--C 1.499 -0.924 0 N-CA-C 109.496 -1.442 . . . . 75.420000000000002 109.496 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -64.39 154.61 35.0 Favored 'General case' 0 C--N 1.371 1.53 0 N-CA-C 107.141 -1.429 . . . . 73.420000000000002 107.141 174.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.546 HH21 ' HB3' ' A' ' 68' ' ' GLU . 0.5 OUTLIER -117.63 139.01 51.58 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 106.472 -1.677 . . . . 64.140000000000001 106.472 -166.207 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.3 t -93.5 131.0 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.229 0 N-CA-C 105.805 -1.924 . . . . 61.439999999999998 105.805 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.5 mt -92.32 -60.08 1.93 Allowed 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 106.42 -1.696 . . . . 71.219999999999999 106.42 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -131.78 150.64 52.09 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 107.08 -1.452 . . . . 64.0 107.08 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.6 t -120.73 129.13 75.98 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.698 0 N-CA-C 103.683 -2.71 . . . . 75.409999999999997 103.683 169.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 55.2 t30 60.58 30.07 19.47 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-O 121.636 0.732 . . . . 64.299999999999997 109.098 176.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.52 -9.58 75.16 Favored Glycine 0 CA--C 1.483 -1.942 0 N-CA-C 109.326 -1.51 . . . . 51.240000000000002 109.326 172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 99.1 t -88.33 122.29 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.232 0 N-CA-C 106.77 -1.567 . . . . 71.310000000000002 106.77 -175.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.68 111.65 0.86 Allowed 'General case' 0 C--N 1.372 1.583 0 N-CA-C 107.557 -1.275 . . . . 25.449999999999999 107.557 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.458 HD13 ' HB3' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -97.92 -10.99 23.64 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 106.477 -1.675 . . . . 74.310000000000002 106.477 -167.456 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.546 ' HB3' HH21 ' A' ' 58' ' ' ARG . 25.9 pt-20 -62.99 131.89 50.18 Favored 'General case' 0 N--CA 1.436 -1.161 0 O-C-N 121.265 -0.897 . . . . 74.340000000000003 108.69 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.41 -19.72 38.31 Favored Glycine 0 C--N 1.345 1.06 0 N-CA-C 109.336 -1.505 . . . . 73.219999999999999 109.336 -177.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.458 ' HB3' HD13 ' A' ' 67' ' ' LEU . . . -81.44 154.62 26.28 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 105.78 -1.933 . . . . 74.219999999999999 105.78 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.445 HG22 HG22 ' A' ' 27' ' ' VAL . 14.2 p -86.04 178.87 7.1 Favored 'General case' 0 N--CA 1.427 -1.592 0 CA-C-O 121.682 0.753 . . . . 75.120000000000005 109.683 -166.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.5 p-80 -64.14 -45.21 89.51 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.553 -0.906 . . . . 73.219999999999999 108.553 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -50.29 -56.06 12.82 Favored 'General case' 0 C--N 1.374 1.643 0 N-CA-C 109.939 -0.393 . . . . 73.439999999999998 109.939 175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -57.43 -45.26 84.86 Favored 'General case' 0 C--N 1.356 0.883 0 CA-C-N 116.261 -0.427 . . . . 63.049999999999997 109.963 -177.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.19 -56.47 12.65 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 122.603 0.361 . . . . 75.129999999999995 110.921 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 24.2 m -73.77 -39.3 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.225 0 N-CA-C 109.514 -0.55 . . . . 75.120000000000005 109.514 -170.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.69 -29.26 69.22 Favored 'General case' 0 C--O 1.186 -2.283 0 C-N-CA 117.021 -1.871 . . . . 74.439999999999998 106.503 -172.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.8 m -67.77 -43.23 80.3 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 120.506 -1.371 . . . . 33.43 107.736 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 36.0 mt -65.97 -37.0 84.84 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 109.136 -0.69 . . . . 74.010000000000005 109.136 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -77.58 -61.79 1.88 Allowed 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 109.026 -0.731 . . . . 72.299999999999997 109.026 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -74.46 62.57 1.0 Allowed 'General case' 0 N--CA 1.484 1.258 0 CA-C-O 122.01 0.91 . . . . 54.340000000000003 110.75 -175.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -135.07 -176.67 4.33 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 106.3 -1.741 . . . . 73.310000000000002 106.3 172.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.92 -138.4 4.22 Favored Glycine 0 N--CA 1.431 -1.699 0 N-CA-C 107.758 -2.137 . . . . 60.229999999999997 107.758 -176.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -75.0 -56.06 5.12 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.864 -0.791 . . . . 72.219999999999999 108.864 -174.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.0 150.69 16.86 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 107.504 -1.295 . . . . 71.25 107.504 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.9 t -124.77 152.67 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.347 0 N-CA-C 105.02 -2.215 . . . . 65.430000000000007 105.02 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -102.55 116.61 32.95 Favored 'General case' 0 CA--C 1.487 -1.481 0 N-CA-C 104.218 -2.512 . . . . 73.120000000000005 104.218 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.416 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -135.34 116.53 14.43 Favored 'General case' 0 CA--C 1.482 -1.642 0 N-CA-C 107.508 -1.293 . . . . 64.129999999999995 107.508 -176.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.3 mp -81.61 141.64 33.52 Favored 'General case' 0 CA--C 1.477 -1.849 0 N-CA-C 108.393 -0.965 . . . . 62.5 108.393 -176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.633 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -115.37 154.83 28.49 Favored 'General case' 0 CA--C 1.482 -1.663 0 N-CA-C 105.19 -2.152 . . . . 75.010000000000005 105.19 178.193 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -123.15 133.03 54.29 Favored 'General case' 0 N--CA 1.415 -2.191 0 N-CA-C 101.87 -3.382 . . . . 73.209999999999994 101.87 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 4' ' ' PRO . 0.7 OUTLIER -59.46 139.59 56.96 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 108.685 -0.857 . . . . 74.040000000000006 108.685 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -138.89 -10.97 0.85 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 108.093 -2.003 . . . . 54.210000000000001 108.093 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -154.12 -103.96 0.04 OUTLIER 'General case' 0 C--N 1.363 1.167 0 N-CA-C 106.73 -1.582 . . . . 75.310000000000002 106.73 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.7 t -71.18 141.06 85.83 Favored Pre-proline 0 C--N 1.355 0.811 0 N-CA-C 106.973 -1.492 . . . . 71.209999999999994 106.973 -169.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.77 178.54 3.28 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 123.163 2.575 . . . . 71.010000000000005 109.47 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.7 t . . . . . 0 N--CA 1.423 -1.776 0 N-CA-C 102.812 -3.033 . . . . 55.420000000000002 102.812 174.466 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.477 -2.33 0 N-CA-C 108.088 -2.005 . . . . 55.140000000000001 108.088 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.9 148.35 89.8 Favored 'Trans proline' 0 CA--C 1.497 -1.349 0 C-N-CA 122.965 2.443 . . . . 63.140000000000001 108.664 -171.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -94.8 167.35 13.26 Favored Pre-proline 0 N--CA 1.432 -1.374 0 N-CA-C 105.383 -2.08 . . . . 42.530000000000001 105.383 -174.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -63.32 128.56 22.94 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 C-N-CA 122.288 1.992 . . . . 74.219999999999999 108.311 175.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.23 -2.72 65.87 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 109.424 -1.47 . . . . 61.020000000000003 109.424 176.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -73.73 134.65 43.53 Favored 'General case' 0 C--N 1.363 1.164 0 N-CA-C 106.855 -1.535 . . . . 73.0 106.855 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.494 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.4 mt -104.31 136.49 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.515 0 N-CA-C 108.146 -1.057 . . . . 71.120000000000005 108.146 -173.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -145.8 159.0 43.82 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 107.028 -1.471 . . . . 74.239999999999995 107.028 174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -103.63 145.37 30.16 Favored 'General case' 0 CA--C 1.478 -1.801 0 N-CA-C 105.67 -1.974 . . . . 75.510000000000005 105.67 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 90' ' ' LEU . 15.9 m -140.12 151.02 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.913 0 N-CA-C 107.381 -1.34 . . . . 65.439999999999998 107.381 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -112.11 125.89 54.6 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 105.941 -1.874 . . . . 44.119999999999997 105.941 167.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 mp -135.13 143.59 46.64 Favored 'General case' 0 CA--C 1.459 -2.552 0 N-CA-C 106.793 -1.558 . . . . 72.400000000000006 106.793 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.44 152.39 21.5 Favored 'General case' 0 CA--C 1.476 -1.868 0 N-CA-C 105.83 -1.915 . . . . 51.229999999999997 105.83 178.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.1 mtmp? -69.45 -36.01 76.21 Favored 'General case' 0 C--O 1.223 -0.314 0 N-CA-C 107.846 -1.168 . . . . 73.310000000000002 107.846 173.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 74.24 112.84 0.07 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.44 -0.948 . . . . 71.040000000000006 108.44 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 t0 56.3 32.95 21.39 Favored 'General case' 0 C--N 1.369 1.456 0 N-CA-C 108.603 -0.888 . . . . 53.350000000000001 108.603 -174.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.3 t30 48.6 -1.39 0.0 OUTLIER 'General case' 0 C--N 1.36 1.051 0 C-N-CA 126.284 1.834 . . . . 51.409999999999997 114.1 -174.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 7.5 t -89.83 172.92 8.55 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 107.276 -1.379 . . . . 61.299999999999997 107.276 -170.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -157.88 -156.31 0.56 Allowed 'General case' 0 N--CA 1.411 -2.424 0 N-CA-C 103.753 -2.684 . . . . 73.25 103.753 -179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 152.66 39.37 0.03 OUTLIER Glycine 0 CA--C 1.471 -2.684 0 N-CA-C 105.912 -2.875 . . . . 65.0 105.912 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -87.99 177.11 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 104.309 -2.478 . . . . 71.310000000000002 104.309 -176.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 92.8 m -141.83 166.52 24.51 Favored 'General case' 0 CA--C 1.468 -2.195 0 N-CA-C 104.905 -2.257 . . . . 53.43 104.905 174.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.406 ' HB ' HG23 ' A' ' 36' ' ' ILE . 2.6 m -147.65 172.13 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.298 0 N-CA-C 105.871 -1.9 . . . . 53.310000000000002 105.871 -172.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.9 t -167.94 168.49 12.07 Favored 'General case' 0 N--CA 1.419 -1.979 0 N-CA-C 104.404 -2.443 . . . . 71.510000000000005 104.404 175.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.46 -141.42 20.46 Favored Glycine 0 CA--C 1.494 -1.238 0 N-CA-C 108.733 -1.747 . . . . 51.130000000000003 108.733 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' A' ' 28' ' ' ASN . . . 100.07 -70.19 0.49 Allowed Glycine 0 CA--C 1.472 -2.655 0 N-CA-C 109.038 -1.625 . . . . 61.399999999999999 109.038 174.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.421 HG22 HG22 ' A' ' 71' ' ' THR . 1.9 t -76.98 13.13 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.772 0 CA-C-O 121.397 0.618 . . . . 74.140000000000001 109.475 -171.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 26' ' ' GLY . 2.3 m120 78.77 6.39 2.31 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.521 1.128 . . . . 65.230000000000004 109.333 176.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.6 t -53.0 -170.7 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 124.2 1.0 . . . . 74.230000000000004 111.378 167.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.3 m -30.81 -44.87 0.06 Allowed 'General case' 0 C--N 1.366 1.307 0 C-N-CA 127.448 2.299 . . . . 75.340000000000003 115.657 -162.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 35.4 m -57.07 132.68 21.51 Favored 'Isoleucine or valine' 0 C--N 1.355 0.818 0 CA-C-O 121.513 0.673 . . . . 72.310000000000002 110.722 -173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 64.6 ttp85 -49.94 -57.66 7.04 Favored 'General case' 0 C--N 1.361 1.075 0 CA-C-N 115.138 -0.937 . . . . 73.540000000000006 112.677 -168.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -72.81 -20.9 61.06 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.897 -0.721 . . . . 72.120000000000005 109.478 -171.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 98.21 -14.81 62.12 Favored Glycine 0 C--N 1.359 1.835 0 N-CA-C 109.323 -1.511 . . . . 60.210000000000001 109.323 172.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.19 -178.96 48.24 Favored Glycine 0 CA--C 1.491 -1.434 0 N-CA-C 109.09 -1.604 . . . . 61.409999999999997 109.09 -175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.418 HG13 HD12 ' A' ' 67' ' ' LEU . 13.7 mm -81.66 124.5 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 103.014 -2.958 . . . . 65.329999999999998 103.014 171.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -100.87 150.4 22.87 Favored 'General case' 0 CA--C 1.459 -2.537 0 N-CA-C 103.688 -2.708 . . . . 73.239999999999995 103.688 178.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 86.1 t -80.18 102.97 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 105.078 -2.193 . . . . 64.200000000000003 105.078 170.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -71.57 -32.87 68.56 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.752 -1.113 . . . . 72.400000000000006 109.933 -172.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.82 147.9 22.0 Favored 'General case' 0 CA--C 1.464 -2.346 0 N-CA-C 106.273 -1.751 . . . . 71.209999999999994 106.273 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 36.5 t -129.13 133.05 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.996 0 N-CA-C 103.174 -2.898 . . . . 64.099999999999994 103.174 174.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.476 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.95 152.5 71.75 Favored Pre-proline 0 CA--C 1.511 -0.526 0 N-CA-C 106.502 -1.666 . . . . 60.350000000000001 106.502 176.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 58.8 Cg_endo -76.86 172.57 15.96 Favored 'Trans proline' 0 CA--C 1.463 -3.053 0 N-CA-C 105.909 -2.381 . . . . 71.420000000000002 105.909 -176.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 66.21 -1.72 1.13 Allowed 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 124.294 0.996 . . . . 54.329999999999998 111.994 163.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -95.65 -179.1 36.5 Favored Glycine 0 CA--C 1.481 -2.054 0 N-CA-C 107.334 -2.306 . . . . 63.340000000000003 107.334 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.89 -52.94 45.83 Favored 'General case' 0 C--O 1.211 -0.934 0 N-CA-C 108.268 -1.012 . . . . 62.0 108.268 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.38 -50.37 65.24 Favored 'General case' 0 C--N 1.357 0.91 0 CA-C-N 116.379 -0.373 . . . . 75.219999999999999 110.838 -175.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -63.0 -55.31 26.85 Favored 'General case' 0 C--N 1.348 0.543 0 N-CA-C 109.583 -0.525 . . . . 75.409999999999997 109.583 178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.7 t -58.35 -32.51 68.6 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 123.045 0.538 . . . . 64.209999999999994 110.641 -171.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.91 -29.6 29.1 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.797 -1.186 . . . . 62.399999999999999 107.797 -172.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.75 13.25 83.65 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 110.36 -1.096 . . . . 64.049999999999997 110.36 171.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 42.0 mtt180 -99.31 6.39 46.2 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 106.709 -1.589 . . . . 72.540000000000006 106.709 -179.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.0 mt -142.44 138.59 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.223 0 N-CA-C 103.098 -2.927 . . . . 72.409999999999997 103.098 -176.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -146.02 166.34 26.35 Favored 'General case' 0 CA--C 1.47 -2.125 0 N-CA-C 104.482 -2.414 . . . . 74.0 104.482 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -67.72 145.77 54.43 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 107.119 -1.437 . . . . 64.200000000000003 107.119 174.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.59 -33.01 5.97 Favored Glycine 0 CA--C 1.482 -1.976 0 N-CA-C 107.982 -2.047 . . . . 64.439999999999998 107.982 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -62.92 149.08 45.52 Favored 'General case' 0 C--N 1.372 1.585 0 N-CA-C 106.941 -1.503 . . . . 70.439999999999998 106.941 177.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.7 mtt180 -119.79 143.86 47.62 Favored 'General case' 0 CA--C 1.473 -2.009 0 N-CA-C 107.259 -1.386 . . . . 72.200000000000003 107.259 -165.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.2 t -89.26 130.07 39.21 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.611 0 N-CA-C 105.826 -1.916 . . . . 62.210000000000001 105.826 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.494 ' CD1' HG23 ' A' ' 7' ' ' ILE . 78.6 mt -95.27 -59.28 1.92 Allowed 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 107.275 -1.38 . . . . 72.120000000000005 107.275 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.95 51.17 Favored 'General case' 0 CA--C 1.471 -2.061 0 N-CA-C 105.946 -1.872 . . . . 62.530000000000001 105.946 -178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.73 121.45 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.376 -2.083 . . . . 63.310000000000002 105.376 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 54.47 30.5 13.01 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-O 121.524 0.678 . . . . 70.040000000000006 109.724 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.81 -18.2 57.2 Favored Glycine 0 CA--C 1.48 -2.152 0 N-CA-C 109.158 -1.577 . . . . 73.010000000000005 109.158 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 90.2 t -76.64 115.75 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.657 0 N-CA-C 108.266 -1.013 . . . . 73.219999999999999 108.266 -173.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.5 m -56.74 120.0 7.11 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 107.899 -1.148 . . . . 75.329999999999998 107.899 174.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.418 HD12 HG13 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -111.92 -11.83 13.84 Favored 'General case' 0 C--O 1.201 -1.469 0 N-CA-C 106.663 -1.606 . . . . 63.530000000000001 106.663 -162.079 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -56.38 128.34 35.43 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.969 -0.752 . . . . 75.430000000000007 108.969 175.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.88 -13.03 68.31 Favored Glycine 0 C--N 1.349 1.262 0 N-CA-C 108.773 -1.731 . . . . 65.430000000000007 108.773 177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -85.74 157.04 20.38 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 106.56 -1.645 . . . . 63.229999999999997 106.56 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.421 HG22 HG22 ' A' ' 27' ' ' VAL . 41.1 p -85.68 179.08 7.15 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 121.735 0.778 . . . . 75.420000000000002 109.402 -171.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 50.9 p-80 -64.7 -45.22 87.51 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 115.392 -0.822 . . . . 73.530000000000001 108.97 177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -54.5 -55.24 31.14 Favored 'General case' 0 C--N 1.375 1.694 0 O-C-N 121.567 -0.708 . . . . 62.140000000000001 109.955 175.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -53.84 -43.76 69.74 Favored 'General case' 0 C--N 1.354 0.791 0 N-CA-C 109.696 -0.483 . . . . 70.239999999999995 109.696 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.35 -54.35 27.25 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 122.811 0.444 . . . . 42.039999999999999 110.531 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 m -74.98 -35.47 35.55 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.226 0 O-C-N 121.976 -0.453 . . . . 73.420000000000002 109.835 -174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . 0.45 ' SG ' ' H15' ' A' ' 101' ' ' 33B . 12.6 t -69.11 -32.9 72.63 Favored 'General case' 0 N--CA 1.508 2.471 0 C-N-CA 116.854 -1.938 . . . . 63.310000000000002 105.986 -169.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 18.7 m -73.09 -45.14 58.87 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 106.996 -1.483 . . . . 61.340000000000003 106.996 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -61.0 -45.15 95.98 Favored 'General case' 0 N--CA 1.433 -1.318 0 C-N-CA 124.831 1.253 . . . . 74.310000000000002 109.562 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.7 ttp85 -67.38 -56.2 10.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.517 -0.92 . . . . 73.439999999999998 108.517 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -71.47 52.16 0.19 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 122.75 0.42 . . . . 54.509999999999998 110.854 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 86' ' ' VAL . 6.2 p -101.69 -175.49 2.87 Favored 'General case' 0 N--CA 1.419 -2.003 0 N-CA-C 105.589 -2.004 . . . . 71.150000000000006 105.589 168.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -84.79 -152.72 17.45 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 107.222 -2.351 . . . . 61.109999999999999 107.222 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -63.33 -55.34 25.43 Favored 'General case' 0 C--O 1.248 1.021 0 N-CA-C 108.191 -1.04 . . . . 73.239999999999995 108.191 -178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 60.6 t -98.59 145.01 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.657 0 N-CA-C 106.388 -1.708 . . . . 73.230000000000004 106.388 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 82' ' ' THR . 23.6 t -101.17 129.03 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.233 0 N-CA-C 105.242 -2.133 . . . . 74.430000000000007 105.242 -178.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -111.98 121.63 45.54 Favored 'General case' 0 CA--C 1.486 -1.506 0 N-CA-C 104.063 -2.569 . . . . 61.43 104.063 170.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.68 133.61 12.28 Favored 'General case' 0 CA--C 1.46 -2.498 0 N-CA-C 106.518 -1.66 . . . . 71.5 106.518 -174.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.8 mp -86.98 145.38 26.53 Favored 'General case' 0 CA--C 1.471 -2.089 0 N-CA-C 107.938 -1.134 . . . . 54.299999999999997 107.938 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.568 ' H ' HD22 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -131.8 169.05 16.77 Favored 'General case' 0 N--CA 1.415 -2.21 0 N-CA-C 105.533 -2.025 . . . . 65.400000000000006 105.533 174.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -129.42 153.06 48.3 Favored 'General case' 0 N--CA 1.402 -2.843 0 N-CA-C 101.822 -3.399 . . . . 74.530000000000001 101.822 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.595 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 6.5 mmpt? -65.32 135.03 54.83 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 107.743 -1.206 . . . . 74.230000000000004 107.743 175.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -133.58 -8.04 2.3 Favored Glycine 0 CA--C 1.466 -2.969 0 N-CA-C 107.131 -2.388 . . . . 74.209999999999994 107.131 -176.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.5 mt-30 22.18 -88.09 0.0 OUTLIER 'General case' 0 C--N 1.373 1.62 0 C-N-CA 127.183 2.193 . . . . 60.140000000000001 114.465 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.7 m -75.03 133.79 75.24 Favored Pre-proline 0 N--CA 1.44 -0.944 0 N-CA-C 107.744 -1.206 . . . . 71.129999999999995 107.744 -173.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.54 3.74 2.49 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 123.363 2.709 . . . . 72.430000000000007 111.507 -167.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.391 -3.376 0 N-CA-C 102.488 -3.153 . . . . 63.039999999999999 102.488 176.111 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.479 ' O2 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.55 0 N-CA-C 108.672 -1.771 . . . . 62.140000000000001 108.672 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.51 143.63 69.87 Favored 'Trans proline' 0 CA--C 1.495 -1.444 0 C-N-CA 122.905 2.403 . . . . 63.310000000000002 108.361 170.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mttp -84.89 166.56 31.2 Favored Pre-proline 0 N--CA 1.427 -1.593 0 N-CA-C 106.916 -1.513 . . . . 73.400000000000006 106.916 -175.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.9 106.51 0.53 Allowed 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.662 2.242 . . . . 72.239999999999995 109.503 175.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.81 7.34 56.63 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 108.68 -1.768 . . . . 61.310000000000002 108.68 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -83.19 138.75 33.51 Favored 'General case' 0 CA--C 1.496 -1.112 0 N-CA-C 106.601 -1.629 . . . . 75.310000000000002 106.601 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.546 HG23 ' CD1' ' A' ' 60' ' ' LEU . 23.4 mm -95.91 122.44 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.829 0 N-CA-C 105.949 -1.871 . . . . 65.430000000000007 105.949 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.63 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.8 p90 -136.68 157.02 47.74 Favored 'General case' 0 CA--C 1.49 -1.354 0 N-CA-C 108.397 -0.964 . . . . 74.450000000000003 108.397 -176.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.515 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 47.1 mt-10 -103.01 148.44 25.69 Favored 'General case' 0 CA--C 1.468 -2.189 0 N-CA-C 104.512 -2.403 . . . . 74.430000000000007 104.512 177.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.779 HG22 HD21 ' A' ' 90' ' ' LEU . 15.9 m -137.05 147.1 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.471 -2.062 0 N-CA-C 106.078 -1.823 . . . . 51.420000000000002 106.078 170.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -104.63 118.18 35.95 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 104.671 -2.344 . . . . 74.25 104.671 168.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.416 HD13 HD12 ' A' ' 53' ' ' ILE . 59.3 mt -139.61 135.88 33.79 Favored 'General case' 0 CA--C 1.455 -2.7 0 N-CA-C 105.673 -1.973 . . . . 74.049999999999997 105.673 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . . . -85.45 157.26 20.52 Favored 'General case' 0 CA--C 1.48 -1.72 0 N-CA-C 106.753 -1.573 . . . . 71.430000000000007 106.753 -176.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -63.23 -40.72 98.24 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 106.747 -1.575 . . . . 74.239999999999995 106.747 167.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 78.36 108.32 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 107.828 -1.175 . . . . 72.340000000000003 107.828 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' C ' ' H ' ' A' ' 18' ' ' SER . 68.4 m-20 56.81 39.09 29.79 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.79 0.836 . . . . 73.430000000000007 108.843 -173.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 38.3 t30 55.03 -9.94 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.728 1.611 . . . . 53.420000000000002 113.634 179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 16' ' ' ASP . 32.6 t -99.67 120.53 39.85 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.712 -1.959 . . . . 75.430000000000007 105.712 -174.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.714 ' H ' HD23 ' A' ' 19' ' ' LEU . 0.3 OUTLIER -70.91 -56.18 6.81 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.904 -1.147 . . . . 54.100000000000001 107.904 -178.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 82.73 -2.72 85.48 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 109.91 -1.276 . . . . 63.229999999999997 109.91 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.507 HG22 ' H ' ' A' ' 22' ' ' CYS . 5.2 mm -86.7 176.57 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.706 0 N-CA-C 105.262 -2.125 . . . . 61.009999999999998 105.262 -174.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.507 ' H ' HG22 ' A' ' 21' ' ' ILE . 60.0 m -138.64 164.38 29.66 Favored 'General case' 0 CA--C 1.475 -1.931 0 N-CA-C 103.754 -2.684 . . . . 72.420000000000002 103.754 174.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -147.65 171.93 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.963 0 N-CA-C 105.772 -1.936 . . . . 72.140000000000001 105.772 -173.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.5 t -164.15 170.64 16.13 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 105.399 -2.075 . . . . 72.340000000000003 105.399 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.0 -154.53 21.97 Favored Glycine 0 CA--C 1.493 -1.328 0 N-CA-C 107.165 -2.374 . . . . 55.43 107.165 -179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 122.12 -99.0 0.65 Allowed Glycine 0 CA--C 1.488 -1.651 0 N-CA-C 109.435 -1.466 . . . . 60.399999999999999 109.435 173.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.441 HG23 ' H ' ' A' ' 27' ' ' VAL . 0.1 OUTLIER -68.36 16.07 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 114.211 1.189 . . . . 63.530000000000001 114.211 -161.687 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.8 m120 85.24 6.77 0.46 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.267 1.027 . . . . 51.399999999999999 108.714 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.4 t -43.09 -168.34 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.75 0 C-N-CA 126.737 2.015 . . . . 63.340000000000003 110.009 151.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 m -28.75 -40.97 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 126.205 1.802 . . . . 64.310000000000002 114.942 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 26.9 m -83.34 131.66 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.207 -1.035 . . . . 74.540000000000006 108.207 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.0 mpt_? -78.13 -40.34 38.44 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 108.492 -0.929 . . . . 73.049999999999997 108.492 -174.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -64.14 -18.01 64.03 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.916 -0.772 . . . . 73.219999999999999 108.916 -174.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.69 2.31 64.07 Favored Glycine 0 C--O 1.208 -1.477 0 N-CA-C 110.722 -0.951 . . . . 71.200000000000003 110.722 176.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -83.93 177.68 52.15 Favored Glycine 0 CA--C 1.483 -1.962 0 N-CA-C 106.614 -2.594 . . . . 62.100000000000001 106.614 177.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.479 HD12 ' HA ' ' A' ' 36' ' ' ILE . 1.0 OUTLIER -90.78 136.55 23.78 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.554 0 N-CA-C 104.415 -2.439 . . . . 73.510000000000005 104.415 174.539 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 4.1 m-30 -108.4 148.73 29.72 Favored 'General case' 0 CA--C 1.478 -1.826 0 N-CA-C 103.358 -2.83 . . . . 71.319999999999993 103.358 -177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.3 t -83.65 102.62 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.804 0 N-CA-C 106.547 -1.649 . . . . 63.149999999999999 106.547 -178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -71.66 -36.3 70.62 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-N 114.665 -1.152 . . . . 75.209999999999994 110.45 -176.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.97 148.94 22.77 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.061 -1.829 . . . . 74.120000000000005 106.061 -173.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.2 t -133.49 138.01 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.028 0 N-CA-C 103.936 -2.616 . . . . 75.439999999999998 103.936 175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.436 ' HB ' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -79.17 155.52 77.06 Favored Pre-proline 0 CA--C 1.515 -0.386 0 N-CA-C 105.738 -1.949 . . . . 74.019999999999996 105.738 173.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 42' ' ' ILE . 75.2 Cg_endo -74.39 171.7 17.57 Favored 'Trans proline' 0 CA--C 1.461 -3.168 0 N-CA-C 105.72 -2.454 . . . . 61.43 105.72 178.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 65.07 -0.2 1.11 Allowed 'General case' 0 N--CA 1.449 -0.505 0 O-C-N 124.012 0.82 . . . . 74.450000000000003 112.13 164.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.55 174.14 41.1 Favored Glycine 0 CA--C 1.476 -2.362 0 N-CA-C 106.624 -2.59 . . . . 70.430000000000007 106.624 178.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.17 -52.87 36.17 Favored 'General case' 0 C--O 1.209 -1.067 0 N-CA-C 107.854 -1.165 . . . . 42.219999999999999 107.854 -173.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.23 -50.66 64.3 Favored 'General case' 0 C--N 1.352 0.703 0 CA-C-N 116.068 -0.515 . . . . 71.450000000000003 111.008 -176.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -67.04 -54.47 21.27 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 109.933 -0.395 . . . . 73.030000000000001 109.933 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.3 t -61.76 -28.58 69.54 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 122.792 0.437 . . . . 72.239999999999995 110.965 -170.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -80.29 -30.2 38.26 Favored 'General case' 0 C--N 1.347 0.468 0 N-CA-C 106.105 -1.813 . . . . 75.510000000000005 106.105 -178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.47 20.01 61.05 Favored Glycine 0 CA--C 1.485 -1.81 0 N-CA-C 110.146 -1.182 . . . . 71.549999999999997 110.146 171.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -107.59 7.24 28.56 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 107.696 -1.224 . . . . 75.400000000000006 107.696 -175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.416 HD12 HD13 ' A' ' 12' ' ' LEU . 77.7 mt -144.55 145.87 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.505 0 N-CA-C 102.359 -3.2 . . . . 71.450000000000003 102.359 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -151.26 176.19 11.46 Favored 'General case' 0 N--CA 1.392 -3.346 0 N-CA-C 104.77 -2.307 . . . . 74.530000000000001 104.77 173.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -67.23 143.29 56.59 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.671 -1.233 . . . . 72.099999999999994 107.671 179.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.44 -32.01 7.66 Favored Glycine 0 CA--C 1.494 -1.278 0 N-CA-C 109.029 -1.628 . . . . 64.25 109.029 174.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 71.8 m-20 -69.19 160.1 31.76 Favored 'General case' 0 C--N 1.372 1.563 0 N-CA-C 107.347 -1.353 . . . . 62.539999999999999 107.347 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.7 ptp180 -128.42 151.51 49.29 Favored 'General case' 0 CA--C 1.487 -1.48 0 N-CA-C 108.829 -0.804 . . . . 74.439999999999998 108.829 -168.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.92 135.78 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 105.525 -2.028 . . . . 64.140000000000001 105.525 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.546 ' CD1' HG23 ' A' ' 7' ' ' ILE . 53.0 mt -98.5 -58.76 1.89 Allowed 'General case' 0 CA--C 1.476 -1.893 0 N-CA-C 107.391 -1.337 . . . . 54.219999999999999 107.391 -178.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.97 148.99 48.7 Favored 'General case' 0 CA--C 1.479 -1.774 0 N-CA-C 106.149 -1.797 . . . . 71.140000000000001 106.149 -177.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -118.46 122.2 68.95 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.447 0 N-CA-C 104.376 -2.453 . . . . 72.019999999999996 104.376 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . 0.31 6.2 p30 44.59 39.9 3.64 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.36 1.064 . . . . 61.109999999999999 111.161 -173.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.87 -22.34 41.1 Favored Glycine 0 CA--C 1.471 -2.665 0 N-CA-C 108.936 -1.665 . . . . 74.120000000000005 108.936 169.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -78.25 114.83 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.981 0 N-CA-C 107.369 -1.345 . . . . 74.120000000000005 107.369 -175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 10.8 m -56.01 120.36 7.33 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 108.877 -0.786 . . . . 64.230000000000004 108.877 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.512 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -99.37 -17.29 18.08 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 106.916 -1.513 . . . . 75.439999999999998 106.916 -164.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -62.05 125.08 22.6 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-O 121.397 0.618 . . . . 72.420000000000002 109.878 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.82 -15.28 62.0 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 108.019 -2.032 . . . . 53.43 108.019 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.62 149.29 34.78 Favored 'General case' 0 CA--C 1.49 -1.356 0 N-CA-C 106.146 -1.798 . . . . 43.329999999999998 106.146 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 31.0 p -80.51 179.05 7.93 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 108.708 -0.849 . . . . 71.120000000000005 108.708 -171.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 40.0 p-80 -63.46 -50.18 70.7 Favored 'General case' 0 C--O 1.205 -1.242 0 N-CA-C 108.117 -1.068 . . . . 74.219999999999999 108.117 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -54.2 -55.74 25.04 Favored 'General case' 0 C--N 1.362 1.148 0 O-C-N 121.66 -0.65 . . . . 73.329999999999998 110.601 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.5 mm-40 -54.59 -46.46 73.77 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 109.395 -0.594 . . . . 63.299999999999997 109.395 -179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.99 -52.47 50.32 Favored 'General case' 0 CA--C 1.5 -0.955 0 C-N-CA 123.163 0.585 . . . . 75.129999999999995 110.568 -179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.64 -40.11 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.077 0 N-CA-C 108.025 -1.102 . . . . 75.219999999999999 108.025 -173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 6.6 t -63.95 -30.99 72.02 Favored 'General case' 0 N--CA 1.507 2.384 0 N-CA-C 106.551 -1.648 . . . . 71.5 106.551 -173.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.6 m -71.79 -45.79 60.43 Favored 'General case' 0 C--N 1.361 1.093 0 N-CA-C 107.602 -1.259 . . . . 74.349999999999994 107.602 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 76.7 mt -59.99 -40.46 89.23 Favored 'General case' 0 C--N 1.367 1.355 0 N-CA-C 108.945 -0.761 . . . . 71.340000000000003 108.945 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -62.6 -60.56 3.35 Favored 'General case' 0 C--O 1.243 0.744 0 N-CA-C 108.2 -1.037 . . . . 63.340000000000003 108.2 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -71.36 53.37 0.2 Allowed 'General case' 0 C--N 1.373 1.605 0 C-N-CA 123.543 0.737 . . . . 53.439999999999998 110.572 -176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.469 HG21 HG13 ' A' ' 86' ' ' VAL . 16.1 p -112.38 -176.23 2.87 Favored 'General case' 0 N--CA 1.425 -1.696 0 N-CA-C 105.544 -2.021 . . . . 63.119999999999997 105.544 168.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.75 -159.69 32.4 Favored Glycine 0 N--CA 1.436 -1.348 0 N-CA-C 107.195 -2.362 . . . . 63.32 107.195 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -56.86 -53.52 56.98 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.646 -0.872 . . . . 71.530000000000001 108.646 -176.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 13' ' ' ALA . 86.5 t -105.66 147.2 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.703 0 N-CA-C 106.012 -1.847 . . . . 45.020000000000003 106.012 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 82' ' ' THR . 39.6 t -100.37 129.53 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 106.66 -1.607 . . . . 74.239999999999995 106.66 -171.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.515 ' HE1' ' OE1' ' A' ' 9' ' ' GLU . 58.3 t60 -103.89 117.27 33.94 Favored 'General case' 0 CA--C 1.488 -1.422 0 N-CA-C 105.089 -2.189 . . . . 64.310000000000002 105.089 174.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -152.76 134.42 14.57 Favored 'General case' 0 CA--C 1.474 -1.953 0 N-CA-C 107.603 -1.258 . . . . 71.010000000000005 107.603 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.45 141.41 33.92 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 107.447 -1.316 . . . . 55.32 107.447 177.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.779 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.11 163.51 16.15 Favored 'General case' 0 CA--C 1.473 -2.001 0 N-CA-C 105.605 -1.998 . . . . 71.209999999999994 105.605 175.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.411 ' HB2' HD11 ' A' ' 60' ' ' LEU . 33.9 tt0 -130.76 139.2 50.23 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 101.45 -3.537 . . . . 71.519999999999996 101.45 165.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 13.3 mmmm -66.19 142.46 57.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.176 -1.046 . . . . 73.329999999999998 108.176 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.8 14.6 52.96 Favored Glycine 0 CA--C 1.487 -1.678 0 N-CA-C 105.859 -2.896 . . . . 72.329999999999998 105.859 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -60.75 -51.46 69.23 Favored 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 125.38 1.472 . . . . 55.509999999999998 108.476 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 3.9 p -67.89 122.93 85.73 Favored Pre-proline 0 CA--C 1.546 0.793 0 N-CA-C 106.196 -1.779 . . . . 74.310000000000002 106.196 170.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.45 157.97 59.05 Favored 'Trans proline' 0 CA--C 1.492 -1.594 0 C-N-CA 122.422 2.081 . . . . 74.219999999999999 108.701 -169.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 C--O 1.255 1.359 0 N-CA-C 105.528 -2.027 . . . . 75.319999999999993 105.528 -177.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.463 0 N-CA-C 108.882 -1.687 . . . . 74.530000000000001 108.882 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.32 169.55 12.22 Favored 'Trans proline' 0 CA--C 1.507 -0.872 0 C-N-CA 123.348 2.698 . . . . 42.020000000000003 109.13 -175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -109.46 163.43 17.07 Favored Pre-proline 0 N--CA 1.434 -1.268 0 N-CA-C 105.398 -2.075 . . . . 63.399999999999999 105.398 -176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -63.03 133.46 41.32 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 122.387 2.058 . . . . 61.100000000000001 108.343 176.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.61 -7.06 57.63 Favored Glycine 0 CA--C 1.486 -1.744 0 N-CA-C 110.004 -1.239 . . . . 72.450000000000003 110.004 171.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.18 130.71 40.28 Favored 'General case' 0 CA--C 1.5 -0.95 0 N-CA-C 107.212 -1.403 . . . . 74.310000000000002 107.212 176.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.494 HD12 HD11 ' A' ' 60' ' ' LEU . 12.0 mm -98.45 136.16 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 106.19 -1.781 . . . . 73.340000000000003 106.19 -175.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -147.79 160.09 43.11 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 108.68 -0.859 . . . . 73.239999999999995 108.68 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.497 ' OE1' ' HE1' ' A' ' 87' ' ' HIS . 50.5 mt-10 -105.83 145.96 30.52 Favored 'General case' 0 CA--C 1.475 -1.906 0 N-CA-C 105.511 -2.033 . . . . 70.030000000000001 105.511 176.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.4 m -144.99 156.5 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.932 0 N-CA-C 106.82 -1.548 . . . . 54.409999999999997 106.82 173.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -116.11 134.76 54.59 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 105.517 -2.031 . . . . 65.099999999999994 105.517 170.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.409 HD22 HD13 ' A' ' 53' ' ' ILE . 4.3 mp -135.61 145.82 47.28 Favored 'General case' 0 CA--C 1.454 -2.721 0 N-CA-C 107.755 -1.202 . . . . 74.019999999999996 107.755 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.06 142.33 28.0 Favored 'General case' 0 N--CA 1.416 -2.169 0 N-CA-C 105.206 -2.146 . . . . 54.32 105.206 175.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.481 ' HG2' ' HB2' ' A' ' 19' ' ' LEU . 37.0 mtpt -77.68 -33.44 53.3 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 106.133 -1.803 . . . . 73.109999999999999 106.133 174.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 70.55 126.13 0.03 OUTLIER 'General case' 0 CA--C 1.497 -1.07 0 CA-C-N 114.066 -1.424 . . . . 65.340000000000003 108.79 -177.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.0 t70 59.71 34.82 22.16 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 109.075 -0.713 . . . . 74.019999999999996 109.075 173.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 53.1 t30 55.38 -9.18 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 126.009 1.724 . . . . 74.129999999999995 113.582 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 42.4 m -99.2 130.68 45.52 Favored 'General case' 0 N--CA 1.424 -1.732 0 O-C-N 120.815 -1.178 . . . . 70.120000000000005 108.535 -168.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.481 ' HB2' ' HG2' ' A' ' 14' ' ' LYS . 24.7 tp -134.04 139.3 45.92 Favored 'General case' 0 CA--C 1.464 -2.35 0 N-CA-C 102.679 -3.082 . . . . 71.510000000000005 102.679 175.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -164.85 62.48 0.24 Allowed Glycine 0 CA--C 1.464 -3.137 0 N-CA-C 106.215 -2.754 . . . . 63.520000000000003 106.215 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 22' ' ' CYS . 1.1 mm -88.54 178.14 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.198 -2.519 . . . . 74.319999999999993 104.198 175.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' H ' HG22 ' A' ' 21' ' ' ILE . 8.2 m -118.43 160.35 21.85 Favored 'General case' 0 CA--C 1.493 -1.236 0 N-CA-C 105.016 -2.216 . . . . 75.010000000000005 105.016 -177.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.1 m -152.05 173.03 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.495 -1.146 0 N-CA-C 106.1 -1.815 . . . . 60.229999999999997 106.1 -169.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.404 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 12.4 t -167.22 170.54 11.61 Favored 'General case' 0 N--CA 1.425 -1.681 0 N-CA-C 106.115 -1.809 . . . . 61.299999999999997 106.115 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.57 -145.39 17.71 Favored Glycine 0 CA--C 1.485 -1.796 0 N-CA-C 109.857 -1.297 . . . . 65.439999999999998 109.857 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.67 -79.26 0.25 Allowed Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.784 -1.727 . . . . 61.229999999999997 108.784 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -77.07 15.94 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.817 0 N-CA-C 112.304 0.483 . . . . 72.019999999999996 112.304 -164.528 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 85.58 6.36 0.44 Allowed 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 124.234 1.014 . . . . 54.200000000000003 109.35 178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 75.1 p -46.94 -168.9 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 125.901 1.68 . . . . 71.420000000000002 112.188 165.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 m -35.13 -35.53 0.04 OUTLIER 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.045 1.738 . . . . 74.530000000000001 113.596 -174.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.4 m -58.84 113.28 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 CA-C-O 122.412 1.101 . . . . 74.230000000000004 110.159 178.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 38.5 mtp85 -47.87 -58.97 3.7 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 114.812 -1.086 . . . . 73.420000000000002 112.626 -175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.9 t-80 -69.18 -20.65 64.0 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.822 -0.548 . . . . 64.340000000000003 110.071 -172.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 52.34 4.02 Favored Glycine 0 C--N 1.352 1.456 0 N-CA-C 107.591 -2.204 . . . . 71.239999999999995 107.591 176.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.4 179.81 25.88 Favored Glycine 0 CA--C 1.459 -3.459 0 N-CA-C 103.108 -3.997 . . . . 74.040000000000006 103.108 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.488 HG13 ' HB2' ' A' ' 75' ' ' ALA . 14.9 mm -88.71 127.78 41.32 Favored 'Isoleucine or valine' 0 CA--C 1.452 -2.792 0 N-CA-C 105.236 -2.135 . . . . 73.200000000000003 105.236 178.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -107.41 154.66 21.0 Favored 'General case' 0 CA--C 1.464 -2.337 0 N-CA-C 104.677 -2.342 . . . . 75.209999999999994 104.677 -178.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.422 HG11 HG22 ' A' ' 41' ' ' VAL . 60.6 t -87.25 101.71 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.241 0 N-CA-C 105.089 -2.189 . . . . 72.140000000000001 105.089 171.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.404 ' HE2' ' HB ' ' A' ' 24' ' ' THR . 11.5 ttmm -71.62 -26.2 62.48 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 115.121 -0.945 . . . . 74.019999999999996 109.082 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.9 142.96 16.69 Favored 'General case' 0 CA--C 1.46 -2.495 0 N-CA-C 105.627 -1.99 . . . . 64.450000000000003 105.627 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG22 HG11 ' A' ' 38' ' ' VAL . 84.8 t -110.21 125.98 67.45 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 102.729 -3.064 . . . . 62.119999999999997 102.729 175.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.566 ' O ' HD12 ' A' ' 42' ' ' ILE . 2.4 pp -76.63 145.95 75.96 Favored Pre-proline 0 N--CA 1.431 -1.411 0 N-CA-C 105.978 -1.86 . . . . 73.540000000000006 105.978 177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.81 174.53 12.43 Favored 'Trans proline' 0 CA--C 1.469 -2.742 0 N-CA-C 105.813 -2.418 . . . . 74.329999999999998 105.813 -174.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 69.05 -11.85 0.43 Allowed 'General case' 0 N--CA 1.444 -0.762 0 O-C-N 124.238 0.961 . . . . 73.420000000000002 112.597 161.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -93.23 -177.69 40.34 Favored Glycine 0 CA--C 1.481 -2.07 0 N-CA-C 108.275 -1.93 . . . . 65.409999999999997 108.275 -175.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.52 -52.59 60.53 Favored 'General case' 0 C--O 1.197 -1.691 0 N-CA-C 108.167 -1.049 . . . . 61.130000000000003 108.167 -175.191 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.86 -49.48 65.73 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.174 -0.466 . . . . 52.140000000000001 110.675 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.8 tp10 -63.62 -53.87 44.79 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 122.009 -0.432 . . . . 74.549999999999997 109.876 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 t -60.14 -33.53 72.29 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 109.288 -0.634 . . . . 72.549999999999997 109.288 -172.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.97 -43.42 35.1 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.342 -1.355 . . . . 60.240000000000002 107.342 -174.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.94 11.08 79.78 Favored Glycine 0 C--N 1.351 1.381 0 N-CA-C 110.615 -0.994 . . . . 52.030000000000001 110.615 175.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -95.24 7.33 46.48 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 107.583 -1.265 . . . . 64.409999999999997 107.583 177.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.449 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 1.6 mp -134.32 139.4 48.11 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 102.537 -3.134 . . . . 64.409999999999997 102.537 174.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.449 ' CD2' ' O ' ' A' ' 53' ' ' ILE . 26.3 m170 -148.04 161.45 41.36 Favored 'General case' 0 CA--C 1.466 -2.253 0 N-CA-C 104.986 -2.227 . . . . 70.030000000000001 104.986 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -66.6 138.93 57.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 107.996 -1.112 . . . . 60.43 107.996 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.41 -32.51 7.48 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 108.069 -2.012 . . . . 70.340000000000003 108.069 175.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -66.97 154.23 41.65 Favored 'General case' 0 C--N 1.368 1.386 0 N-CA-C 107.011 -1.478 . . . . 73.150000000000006 107.011 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.437 HH21 ' CD ' ' A' ' 91' ' ' GLU . 19.1 ptt-85 -131.38 155.16 47.76 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.369 -0.974 . . . . 61.5 108.369 -170.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -96.28 139.44 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 105.908 -1.886 . . . . 74.310000000000002 105.908 -177.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD11 HD12 ' A' ' 7' ' ' ILE . 93.6 mt -102.28 -57.97 1.96 Allowed 'General case' 0 CA--C 1.485 -1.534 0 N-CA-C 106.832 -1.544 . . . . 63.530000000000001 106.832 179.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.24 148.34 49.56 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 105.549 -2.019 . . . . 54.340000000000003 105.549 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.2 t -116.6 119.17 61.15 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 N-CA-C 105.233 -2.136 . . . . 73.439999999999998 105.233 177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 61.8 t30 53.57 36.12 22.62 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.606 0.762 . . . . 73.140000000000001 109.841 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.87 -21.77 44.25 Favored Glycine 0 CA--C 1.474 -2.524 0 N-CA-C 108.777 -1.729 . . . . 70.299999999999997 108.777 172.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.6 t -81.8 115.78 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.932 0 N-CA-C 108.082 -1.081 . . . . 64.120000000000005 108.082 -172.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.6 m -52.41 120.97 6.16 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 123.523 0.729 . . . . 60.43 109.122 175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 67' ' ' LEU . 0.8 OUTLIER -109.94 -19.16 13.2 Favored 'General case' 0 C--O 1.197 -1.701 0 N-CA-C 107.549 -1.278 . . . . 64.340000000000003 107.549 -167.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -63.9 127.37 31.11 Favored 'General case' 0 C--O 1.231 0.117 0 O-C-N 120.787 -1.196 . . . . 73.430000000000007 108.38 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 96.47 -15.86 62.06 Favored Glycine 0 C--N 1.347 1.185 0 N-CA-C 108.553 -1.819 . . . . 65.219999999999999 108.553 -177.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.76 151.24 30.48 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 105.311 -2.107 . . . . 62.409999999999997 105.311 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.401 ' HA ' HG22 ' A' ' 27' ' ' VAL . 58.6 p -81.68 179.39 7.85 Favored 'General case' 0 N--CA 1.422 -1.843 0 N-CA-C 108.712 -0.847 . . . . 72.329999999999998 108.712 -171.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.9 p80 -69.5 -45.32 69.21 Favored 'General case' 0 C--O 1.2 -1.552 0 N-CA-C 108.197 -1.038 . . . . 73.340000000000003 108.197 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -52.49 -56.11 17.38 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 121.339 -0.851 . . . . 53.219999999999999 109.852 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -53.75 -41.63 67.32 Favored 'General case' 0 C--N 1.377 1.768 0 N-CA-C 109.746 -0.465 . . . . 74.230000000000004 109.746 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.488 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -53.0 -50.04 65.01 Favored 'General case' 0 CA--C 1.49 -1.351 0 CA-C-N 116.087 -0.506 . . . . 62.420000000000002 109.933 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 19.2 t -73.52 -42.68 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 108.067 -1.086 . . . . 72.310000000000002 108.067 -174.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 23.4 m -57.97 -35.12 70.72 Favored 'General case' 0 N--CA 1.523 3.224 0 N-CA-C 106.177 -1.786 . . . . 64.340000000000003 106.177 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 11.6 m -73.24 -47.89 39.47 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 114.904 -1.043 . . . . 74.230000000000004 108.554 -173.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.75 -37.67 82.46 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.379 -0.6 . . . . 53.240000000000002 109.379 -177.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -69.12 -60.53 2.29 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 107.614 -1.254 . . . . 72.109999999999999 107.614 -175.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -69.17 57.39 0.1 Allowed 'General case' 0 C--N 1.367 1.337 0 C-N-CA 123.595 0.758 . . . . 72.209999999999994 110.981 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.5 p -109.24 -176.38 3.01 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 106.775 -1.565 . . . . 55.399999999999999 106.775 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -93.27 -144.99 16.07 Favored Glycine 0 CA--C 1.489 -1.549 0 N-CA-C 107.313 -2.315 . . . . 73.049999999999997 107.313 -179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -72.19 -55.58 7.01 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 108.666 -0.864 . . . . 74.230000000000004 108.666 -175.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.52 146.84 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 106.19 -1.781 . . . . 75.319999999999993 106.19 176.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 51.1 t -105.08 132.85 50.88 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.66 0 N-CA-C 105.241 -2.133 . . . . 64.239999999999995 105.241 177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.497 ' HE1' ' OE1' ' A' ' 9' ' ' GLU . 61.1 t-80 -113.21 132.55 55.46 Favored 'General case' 0 CA--C 1.482 -1.65 0 N-CA-C 104.73 -2.322 . . . . 63.229999999999997 104.73 173.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -159.49 143.5 14.88 Favored 'General case' 0 CA--C 1.473 -1.996 0 N-CA-C 108.582 -0.895 . . . . 74.510000000000005 108.582 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.08 137.88 35.98 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 107.267 -1.383 . . . . 61.030000000000001 107.267 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.69 161.9 36.0 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 107.531 -1.285 . . . . 74.239999999999995 107.531 176.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.437 ' CD ' HH21 ' A' ' 58' ' ' ARG . 79.6 tt0 -133.69 141.76 47.71 Favored 'General case' 0 N--CA 1.422 -1.86 0 N-CA-C 104.183 -2.525 . . . . 64.400000000000006 104.183 -173.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -66.82 144.35 56.35 Favored 'General case' 0 CA--C 1.486 -1.517 0 N-CA-C 108.928 -0.767 . . . . 74.120000000000005 108.928 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -106.17 -161.22 22.6 Favored Glycine 0 CA--C 1.474 -2.485 0 N-CA-C 105.665 -2.974 . . . . 71.209999999999994 105.665 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -112.63 158.31 20.16 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 104.105 -2.554 . . . . 73.040000000000006 104.105 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 25.9 m -64.2 130.61 94.67 Favored Pre-proline 0 N--CA 1.436 -1.168 0 N-CA-C 108.904 -0.776 . . . . 70.230000000000004 108.904 -175.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -71.44 -172.84 0.83 Allowed 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 123.344 2.696 . . . . 74.340000000000003 108.159 174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.426 -1.647 0 N-CA-C 106.392 -1.707 . . . . 71.019999999999996 106.392 -178.827 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.58 ' H15' ' C20' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.897 0 N-CA-C 107.831 -2.108 . . . . 75.030000000000001 107.831 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -72.1 164.32 36.01 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 N-CA-C 106.795 -2.04 . . . . 62.539999999999999 106.795 174.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -107.51 157.76 34.93 Favored Pre-proline 0 N--CA 1.445 -0.69 0 N-CA-C 106.386 -1.709 . . . . 72.129999999999995 106.386 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.89 130.24 28.65 Favored 'Trans proline' 0 CA--C 1.507 -0.875 0 C-N-CA 122.603 2.202 . . . . 43.43 108.94 -178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.57 -8.08 59.92 Favored Glycine 0 CA--C 1.497 -1.071 0 N-CA-C 109.231 -1.547 . . . . 71.510000000000005 109.231 177.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -77.07 134.29 38.81 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.839 -1.541 . . . . 75.439999999999998 106.839 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.407 HD13 HD11 ' A' ' 60' ' ' LEU . 2.5 mt -105.25 138.12 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.14 0 N-CA-C 107.405 -1.332 . . . . 71.239999999999995 107.405 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -156.41 172.37 18.64 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 107.368 -1.345 . . . . 73.450000000000003 107.368 179.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.01 155.01 27.75 Favored 'General case' 0 CA--C 1.476 -1.87 0 N-CA-C 106.051 -1.833 . . . . 73.409999999999997 106.051 177.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 15.4 m -147.84 156.46 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.816 0 N-CA-C 105.711 -1.959 . . . . 54.509999999999998 105.711 176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -107.84 130.35 55.0 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 106.176 -1.787 . . . . 63.130000000000003 106.176 173.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.72 140.06 47.91 Favored 'General case' 0 CA--C 1.46 -2.501 0 N-CA-C 106.875 -1.528 . . . . 55.310000000000002 106.875 175.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -83.71 140.99 31.78 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 105.648 -1.982 . . . . 62.119999999999997 105.648 174.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -68.61 -28.2 66.71 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 107.648 -1.241 . . . . 73.0 107.648 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.2 t30 86.51 93.54 0.03 OUTLIER 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 107.324 -1.361 . . . . 72.340000000000003 107.324 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.9 t70 61.28 47.77 6.7 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 107.772 -1.195 . . . . 52.450000000000003 107.772 -177.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 63.3 m-80 45.94 -0.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 127.588 2.355 . . . . 62.439999999999998 115.407 -177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.9 m -104.83 115.27 30.02 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-N 119.887 1.221 . . . . 62.310000000000002 108.03 -172.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.718 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.6 pt? -89.48 -155.39 0.35 Allowed 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.432 -1.692 . . . . 71.010000000000005 106.432 178.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 147.34 55.56 0.02 OUTLIER Glycine 0 CA--C 1.479 -2.189 0 N-CA-C 106.275 -2.73 . . . . 71.299999999999997 106.275 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.417 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.3 mm -106.65 178.01 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 103.119 -2.919 . . . . 72.420000000000002 103.119 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.417 ' H ' HG22 ' A' ' 21' ' ' ILE . 56.0 m -133.01 163.79 28.43 Favored 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 105.176 -2.157 . . . . 75.200000000000003 105.176 176.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.35 175.86 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 N-CA-C 106.827 -1.546 . . . . 64.310000000000002 106.827 -171.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -164.21 167.0 20.54 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 104.816 -2.29 . . . . 73.230000000000004 104.816 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.17 -145.49 23.28 Favored Glycine 0 CA--C 1.489 -1.551 0 N-CA-C 108.479 -1.849 . . . . 64.239999999999995 108.479 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.68 -74.13 0.21 Allowed Glycine 0 CA--C 1.481 -2.052 0 N-CA-C 108.776 -1.729 . . . . 63.340000000000003 108.776 174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 1.5 t -80.14 15.61 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.473 0 CA-C-O 121.203 0.525 . . . . 73.219999999999999 109.659 -172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 41.8 t30 84.46 5.17 0.65 Allowed 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 124.962 1.305 . . . . 73.310000000000002 108.006 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 24.4 p -53.74 -170.69 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.53 1.132 . . . . 73.209999999999994 112.293 168.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 m -29.46 -45.73 0.05 OUTLIER 'General case' 0 C--N 1.367 1.366 0 C-N-CA 126.843 2.057 . . . . 52.140000000000001 115.934 -159.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.4 m -62.52 125.56 19.16 Favored 'Isoleucine or valine' 0 C--N 1.352 0.706 0 CA-C-O 122.05 0.929 . . . . 75.219999999999999 109.954 -175.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.437 ' HD2' HE22 ' A' ' 94' ' ' GLN . 11.3 ptp85 -52.65 -44.31 66.07 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 114.583 -1.19 . . . . 63.149999999999999 112.884 -169.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.411 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 23.8 t-160 -75.45 -21.25 58.27 Favored 'General case' 0 C--N 1.37 1.486 0 O-C-N 120.823 -1.173 . . . . 73.510000000000005 108.719 -175.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.48 -14.79 62.97 Favored Glycine 0 C--N 1.345 1.078 0 N-CA-C 109.878 -1.289 . . . . 62.409999999999997 109.878 171.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -74.95 179.92 44.13 Favored Glycine 0 CA--C 1.5 -0.895 0 N-CA-C 108.551 -1.82 . . . . 71.310000000000002 108.551 -177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.443 HD13 ' HA ' ' A' ' 36' ' ' ILE . 6.1 mm -83.2 127.85 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.882 0 N-CA-C 104.336 -2.468 . . . . 74.439999999999998 104.336 171.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -106.53 152.27 23.9 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 104.567 -2.383 . . . . 74.030000000000001 104.567 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -90.27 100.29 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.605 0 N-CA-C 104.785 -2.302 . . . . 74.340000000000003 104.785 170.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.64 -17.97 42.75 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.788 -1.096 . . . . 73.540000000000006 111.725 -176.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -156.1 143.86 19.53 Favored 'General case' 0 CA--C 1.472 -2.045 0 N-CA-C 106.997 -1.483 . . . . 72.510000000000005 106.997 177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -126.89 132.02 70.43 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.783 0 N-CA-C 103.581 -2.748 . . . . 75.230000000000004 103.581 175.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.93 145.6 81.44 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 106.252 -1.759 . . . . 73.209999999999994 106.252 177.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -75.01 167.02 27.95 Favored 'Trans proline' 0 CA--C 1.464 -2.996 0 N-CA-C 106.848 -2.02 . . . . 64.420000000000002 106.848 -174.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 69.06 2.1 3.46 Favored 'General case' 0 N--CA 1.431 -1.409 0 O-C-N 124.474 1.109 . . . . 73.519999999999996 110.884 165.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.68 -175.77 38.43 Favored Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 108.515 -1.834 . . . . 53.43 108.515 -174.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -64.9 -52.58 55.7 Favored 'General case' 0 C--O 1.205 -1.279 0 N-CA-C 108.123 -1.066 . . . . 65.0 108.123 -177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -51.72 -49.39 62.6 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 115.978 -0.556 . . . . 52.310000000000002 110.417 -177.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -68.31 -52.64 31.25 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.875 -0.33 . . . . 64.349999999999994 110.407 178.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 21.8 t -65.73 -36.24 83.04 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.686 -0.634 . . . . 70.540000000000006 109.973 -169.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -81.57 -25.57 35.69 Favored 'General case' 0 C--O 1.212 -0.87 0 N-CA-C 106.672 -1.603 . . . . 62.420000000000002 106.672 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.52 20.1 78.78 Favored Glycine 0 C--N 1.352 1.436 0 N-CA-C 110.75 -0.94 . . . . 74.420000000000002 110.75 167.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.6 mmt180 -87.24 1.99 51.45 Favored 'General case' 0 CA--C 1.496 -1.119 0 N-CA-C 107.684 -1.228 . . . . 74.310000000000002 107.684 179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.9 mt -143.6 140.89 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.078 0 N-CA-C 103.832 -2.655 . . . . 74.340000000000003 103.832 -168.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -142.72 159.4 42.31 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.029 -2.582 . . . . 75.140000000000001 104.029 177.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.3 mtpt -66.45 142.88 57.41 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.007 -1.109 . . . . 72.549999999999997 108.007 179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.56 -31.87 8.14 Favored Glycine 0 CA--C 1.486 -1.762 0 N-CA-C 107.467 -2.253 . . . . 73.209999999999994 107.467 177.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -58.86 147.86 32.24 Favored 'General case' 0 CA--C 1.477 -1.839 0 N-CA-C 109.039 -0.726 . . . . 62.310000000000002 109.039 -176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 31.0 mtm-85 -114.88 139.93 49.38 Favored 'General case' 0 CA--C 1.481 -1.685 0 N-CA-C 107.623 -1.251 . . . . 72.209999999999994 107.623 -172.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -93.89 129.03 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 105.451 -2.055 . . . . 64.439999999999998 105.451 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.407 HD11 HD13 ' A' ' 7' ' ' ILE . 89.2 mt -97.33 -58.81 1.92 Allowed 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 106.905 -1.517 . . . . 54.030000000000001 106.905 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.23 148.76 48.22 Favored 'General case' 0 CA--C 1.476 -1.865 0 N-CA-C 106.414 -1.699 . . . . 71.040000000000006 106.414 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.2 121.59 67.01 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.307 0 N-CA-C 105.29 -2.115 . . . . 64.340000000000003 105.29 177.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 19.9 t30 53.16 37.32 24.72 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.086 0.954 . . . . 71.140000000000001 110.046 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 98.49 -26.88 22.05 Favored Glycine 0 CA--C 1.471 -2.672 0 N-CA-C 108.513 -1.835 . . . . 61.32 108.513 171.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 83.4 t -79.4 116.69 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.081 0 N-CA-C 107.809 -1.182 . . . . 74.400000000000006 107.809 -171.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 19.8 m -54.55 114.65 1.76 Allowed 'General case' 0 C--N 1.358 0.976 0 N-CA-C 108.593 -0.892 . . . . 72.239999999999995 108.593 176.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD11 ' HA ' ' A' ' 75' ' ' ALA . 2.1 tm? -102.27 -18.82 15.29 Favored 'General case' 0 C--O 1.191 -1.992 0 N-CA-C 106.363 -1.717 . . . . 73.400000000000006 106.363 -167.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -63.16 129.14 39.02 Favored 'General case' 0 N--CA 1.443 -0.814 0 O-C-N 121.193 -0.942 . . . . 64.450000000000003 108.473 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 101.56 -16.56 56.34 Favored Glycine 0 C--N 1.343 0.929 0 N-CA-C 108.044 -2.022 . . . . 34.210000000000001 108.044 -175.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.61 154.1 27.61 Favored 'General case' 0 CA--C 1.49 -1.358 0 N-CA-C 106.435 -1.691 . . . . 54.25 106.435 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 37.0 p -81.13 179.88 7.66 Favored 'General case' 0 N--CA 1.428 -1.535 0 N-CA-C 109.109 -0.7 . . . . 64.430000000000007 109.109 -171.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 9.8 m80 -58.76 -53.33 59.56 Favored 'General case' 0 C--N 1.363 1.181 0 N-CA-C 107.936 -1.135 . . . . 71.450000000000003 107.936 176.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.57 -48.3 80.07 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 110.282 -0.266 . . . . 74.549999999999997 110.282 -175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 58.5 mm-40 -57.84 -41.08 81.6 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 109.767 -0.457 . . . . 75.129999999999995 109.767 178.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' HD11 ' A' ' 67' ' ' LEU . . . -50.67 -56.22 12.9 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-O 120.818 0.342 . . . . 65.510000000000005 110.714 177.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 18.7 m -74.64 -33.39 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 N-CA-C 109.145 -0.687 . . . . 34.329999999999998 109.145 -173.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.9 t -68.79 -31.55 70.65 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 105.991 -1.855 . . . . 74.409999999999997 105.991 -173.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.2 m -71.37 -41.83 69.22 Favored 'General case' 0 C--O 1.207 -1.133 0 O-C-N 120.319 -1.488 . . . . 74.299999999999997 107.464 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 82.1 mt -61.3 -29.55 69.94 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 109.232 -0.655 . . . . 75.409999999999997 109.232 176.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -73.78 -61.21 1.92 Allowed 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 107.807 -1.183 . . . . 74.5 107.807 178.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -75.83 54.45 0.81 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.422 0.629 . . . . 64.430000000000007 111.548 -174.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 p -112.77 -175.06 2.58 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 104.956 -2.238 . . . . 75.219999999999999 104.956 167.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -80.78 -161.55 25.97 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 107.71 -2.156 . . . . 63.399999999999999 107.71 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -52.69 -53.34 48.87 Favored 'General case' 0 C--O 1.245 0.837 0 N-CA-C 108.8 -0.815 . . . . 55.240000000000002 108.8 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 76.5 t -102.99 148.8 7.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 N-CA-C 105.465 -2.05 . . . . 63.509999999999998 105.465 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.4 t -104.59 131.11 54.35 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.413 0 N-CA-C 105.42 -2.067 . . . . 43.109999999999999 105.42 -177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -112.92 128.91 56.6 Favored 'General case' 0 N--CA 1.432 -1.351 0 N-CA-C 104.048 -2.575 . . . . 61.310000000000002 104.048 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -157.09 142.97 17.75 Favored 'General case' 0 CA--C 1.467 -2.227 0 N-CA-C 108.087 -1.079 . . . . 74.239999999999995 108.087 -175.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.92 135.67 35.93 Favored 'General case' 0 CA--C 1.481 -1.698 0 N-CA-C 106.839 -1.541 . . . . 72.0 106.839 172.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.65 160.43 33.36 Favored 'General case' 0 N--CA 1.408 -2.552 0 N-CA-C 106.353 -1.721 . . . . 71.120000000000005 106.353 173.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -128.6 135.03 48.77 Favored 'General case' 0 N--CA 1.397 -3.106 0 N-CA-C 102.102 -3.296 . . . . 72.200000000000003 102.102 -174.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.654 ' HA ' ' HE2' ' A' ' 92' ' ' LYS . 6.8 mmpt? -62.48 136.86 58.1 Favored 'General case' 0 CA--C 1.475 -1.911 0 N-CA-C 107.813 -1.18 . . . . 74.010000000000005 107.813 -179.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -86.88 -173.3 48.82 Favored Glycine 0 CA--C 1.461 -3.326 0 N-CA-C 106.78 -2.528 . . . . 74.230000000000004 106.78 -171.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.437 HE22 ' HD2' ' A' ' 32' ' ' ARG . 36.0 mt-30 -82.91 136.8 34.46 Favored 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 105.035 -2.209 . . . . 62.43 105.035 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 4.2 m -46.61 121.39 6.52 Favored Pre-proline 0 C--N 1.348 0.528 0 O-C-N 123.855 0.722 . . . . 72.239999999999995 110.734 -170.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -67.24 159.72 50.92 Favored 'Trans proline' 0 CA--C 1.498 -1.291 0 C-N-CA 122.985 2.456 . . . . 73.120000000000005 108.646 -169.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.42 -1.953 0 N-CA-C 104.077 -2.564 . . . . 63.450000000000003 104.077 178.878 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.409 ' O2 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.478 -2.239 0 N-CA-C 108.087 -2.005 . . . . 41.350000000000001 108.087 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -65.25 149.47 88.54 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.649 2.233 . . . . 73.430000000000007 108.449 -176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -102.78 165.33 13.9 Favored Pre-proline 0 N--CA 1.437 -1.104 0 N-CA-C 106.556 -1.646 . . . . 75.129999999999995 106.556 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -64.17 127.67 19.83 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.54 2.16 . . . . 74.530000000000001 108.207 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.46 1.92 65.99 Favored Glycine 0 N--CA 1.439 -1.105 0 N-CA-C 109.25 -1.54 . . . . 74.120000000000005 109.25 177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -81.77 140.34 34.3 Favored 'General case' 0 C--N 1.363 1.159 0 N-CA-C 106.613 -1.625 . . . . 60.130000000000003 106.613 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.47 HG23 ' CD1' ' A' ' 60' ' ' LEU . 10.8 mt -104.86 137.75 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.467 0 N-CA-C 108.392 -0.966 . . . . 72.349999999999994 108.392 -173.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.488 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.2 p90 -138.89 155.8 47.8 Favored 'General case' 0 CA--C 1.485 -1.547 0 N-CA-C 107.098 -1.445 . . . . 51.210000000000001 107.098 172.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 81.8 mt-10 -105.89 145.71 30.9 Favored 'General case' 0 CA--C 1.48 -1.741 0 N-CA-C 105.757 -1.942 . . . . 73.310000000000002 105.757 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.677 HG22 HD21 ' A' ' 90' ' ' LEU . 30.4 m -142.34 155.86 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.705 0 N-CA-C 106.888 -1.523 . . . . 63.409999999999997 106.888 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -103.66 122.96 46.1 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 105.088 -2.19 . . . . 65.109999999999999 105.088 167.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.404 HD11 ' HB2' ' A' ' 52' ' ' ARG . 12.7 mt -131.97 133.12 44.13 Favored 'General case' 0 CA--C 1.458 -2.58 0 N-CA-C 105.018 -2.216 . . . . 63.240000000000002 105.018 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.06 153.02 22.99 Favored 'General case' 0 N--CA 1.424 -1.745 0 N-CA-C 105.805 -1.924 . . . . 53.229999999999997 105.805 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.5 mtmm -70.04 -36.16 74.82 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 105.999 -1.852 . . . . 74.230000000000004 105.999 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.4 t30 81.48 113.21 0.06 Allowed 'General case' 0 CA--C 1.493 -1.228 0 C-N-CA 125.231 1.412 . . . . 61.109999999999999 108.117 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.6 t70 58.57 36.21 25.01 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.791 -1.188 . . . . 75.099999999999994 107.791 -173.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 82.0 m-20 43.38 2.65 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.105 0 C-N-CA 127.485 2.314 . . . . 63.399999999999999 115.25 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.7 m -97.24 124.52 41.35 Favored 'General case' 0 CA--C 1.488 -1.406 0 CA-C-N 119.985 1.266 . . . . 72.239999999999995 107.904 -175.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.625 HD23 ' H ' ' A' ' 19' ' ' LEU . 1.9 pt? -97.03 -158.88 0.7 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 105.817 -1.92 . . . . 73.219999999999999 105.817 173.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 160.76 32.09 0.02 OUTLIER Glycine 0 CA--C 1.474 -2.491 0 N-CA-C 106.671 -2.571 . . . . 71.420000000000002 106.671 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.42 HG22 ' H ' ' A' ' 22' ' ' CYS . 2.1 mm -88.16 174.08 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 N-CA-C 104.863 -2.273 . . . . 61.240000000000002 104.863 -175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.42 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.2 m -140.56 167.23 22.66 Favored 'General case' 0 CA--C 1.479 -1.775 0 N-CA-C 103.849 -2.649 . . . . 51.530000000000001 103.849 177.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 36' ' ' ILE . 9.0 m -148.38 173.18 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 N-CA-C 106.985 -1.487 . . . . 74.219999999999999 106.985 -168.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.429 HG22 ' HB2' ' A' ' 39' ' ' LYS . 8.2 t -159.32 164.01 35.17 Favored 'General case' 0 N--CA 1.42 -1.963 0 N-CA-C 104.037 -2.579 . . . . 44.549999999999997 104.037 175.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.86 -139.16 18.31 Favored Glycine 0 CA--C 1.494 -1.241 0 N-CA-C 108.356 -1.898 . . . . 71.010000000000005 108.356 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.61 -79.31 0.29 Allowed Glycine 0 CA--C 1.466 -3.001 0 N-CA-C 108.54 -1.824 . . . . 33.439999999999998 108.54 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -76.11 16.77 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.364 0 C-N-CA 122.731 0.413 . . . . 74.319999999999993 111.045 -171.163 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 85.59 5.68 0.47 Allowed 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 124.832 1.253 . . . . 70.519999999999996 108.099 176.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.9 p -55.85 -171.0 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 115.476 -0.784 . . . . 74.230000000000004 111.851 170.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.2 m -29.1 -45.03 0.04 OUTLIER 'General case' 0 C--N 1.368 1.386 0 C-N-CA 127.439 2.295 . . . . 63.329999999999998 116.009 -162.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.2 m -54.72 136.82 16.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.669 0 CA-C-O 121.663 0.744 . . . . 72.219999999999999 111.855 -172.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -35.16 -71.53 0.07 Allowed 'General case' 0 C--N 1.356 0.877 0 C-N-CA 126.17 1.788 . . . . 73.409999999999997 113.207 -177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 21.1 t-160 -76.97 -15.6 59.6 Favored 'General case' 0 CA--C 1.508 -0.671 0 O-C-N 121.26 -0.9 . . . . 72.430000000000007 110.104 -169.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.38 61.79 2.16 Favored Glycine 0 CA--C 1.491 -1.449 0 N-CA-C 108.093 -2.003 . . . . 72.420000000000002 108.093 178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.95 -178.81 25.23 Favored Glycine 0 CA--C 1.471 -2.711 0 N-CA-C 104.376 -3.49 . . . . 72.409999999999997 104.376 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.457 HD13 ' HA ' ' A' ' 36' ' ' ILE . 7.0 mm -83.72 122.3 37.51 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.131 0 N-CA-C 104.427 -2.434 . . . . 71.420000000000002 104.427 172.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -107.17 153.13 23.13 Favored 'General case' 0 CA--C 1.47 -2.12 0 N-CA-C 103.809 -2.663 . . . . 63.450000000000003 103.809 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 70.6 t -83.55 102.32 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 106.154 -1.795 . . . . 62.229999999999997 106.154 174.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.429 ' HB2' HG22 ' A' ' 24' ' ' THR . 13.5 tptm -72.91 -31.11 64.42 Favored 'General case' 0 CA--C 1.499 -1.0 0 CA-C-N 115.423 -0.808 . . . . 75.420000000000002 111.036 -176.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -157.73 145.4 18.61 Favored 'General case' 0 CA--C 1.46 -2.483 0 N-CA-C 106.495 -1.668 . . . . 75.120000000000005 106.495 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -122.27 133.79 67.46 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.103 0 N-CA-C 103.413 -2.81 . . . . 65.430000000000007 103.413 175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.97 151.49 86.34 Favored Pre-proline 0 C--O 1.238 0.499 0 N-CA-C 106.398 -1.705 . . . . 65.109999999999999 106.398 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -76.33 167.66 25.35 Favored 'Trans proline' 0 CA--C 1.457 -3.336 0 N-CA-C 105.735 -2.448 . . . . 74.310000000000002 105.735 -176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 68.38 1.98 3.13 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.769 0.668 . . . . 73.040000000000006 110.109 167.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.99 175.06 42.98 Favored Glycine 0 CA--C 1.472 -2.642 0 N-CA-C 107.571 -2.212 . . . . 72.319999999999993 107.571 -176.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -68.13 -48.6 64.97 Favored 'General case' 0 C--O 1.205 -1.267 0 N-CA-C 107.355 -1.35 . . . . 64.010000000000005 107.355 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.19 64.9 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 116.067 -0.515 . . . . 73.439999999999998 110.019 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -65.08 -56.22 14.25 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.975 -0.379 . . . . 74.239999999999995 109.975 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.9 m -65.44 -28.94 69.59 Favored 'General case' 0 C--N 1.349 0.544 0 CA-C-O 120.908 0.385 . . . . 70.340000000000003 110.515 -166.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -83.17 -31.28 27.22 Favored 'General case' 0 C--O 1.214 -0.769 0 N-CA-C 106.764 -1.569 . . . . 64.310000000000002 106.764 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 16.91 65.88 Favored Glycine 0 C--N 1.351 1.41 0 N-CA-C 111.025 -0.83 . . . . 54.100000000000001 111.025 170.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HB2' HD11 ' A' ' 12' ' ' LEU . 17.1 mmp_? -91.71 5.65 48.93 Favored 'General case' 0 CA--C 1.494 -1.189 0 N-CA-C 107.523 -1.288 . . . . 70.209999999999994 107.523 -179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 58.9 mt -144.83 144.88 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.129 0 N-CA-C 104.161 -2.533 . . . . 72.430000000000007 104.161 -171.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 55' ' ' LYS . 50.9 p-80 -149.3 168.24 23.88 Favored 'General case' 0 N--CA 1.403 -2.81 0 N-CA-C 101.871 -3.381 . . . . 73.420000000000002 101.871 172.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.546 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 39.5 mtmt -66.44 144.16 56.67 Favored 'General case' 0 C--O 1.212 -0.914 0 N-CA-C 108.074 -1.084 . . . . 75.219999999999999 108.074 -179.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.19 -32.5 7.47 Favored Glycine 0 CA--C 1.498 -1.002 0 C-N-CA 120.07 -1.062 . . . . 54.420000000000002 110.839 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' CG ' ' CE1' ' A' ' 54' ' ' HIS . 34.8 m-20 -66.65 154.55 40.3 Favored 'General case' 0 C--N 1.378 1.822 0 CA-C-N 119.871 1.836 . . . . 72.430000000000007 107.859 178.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.62 137.41 51.92 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 107.047 -1.464 . . . . 74.349999999999994 107.047 -164.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.9 t -93.5 127.27 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.935 0 N-CA-C 106.452 -1.684 . . . . 70.439999999999998 106.452 179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.47 ' CD1' HG23 ' A' ' 7' ' ' ILE . 15.1 mt -95.12 -59.83 1.81 Allowed 'General case' 0 CA--C 1.481 -1.708 0 N-CA-C 108.017 -1.105 . . . . 72.040000000000006 108.017 -177.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.38 148.66 47.94 Favored 'General case' 0 CA--C 1.467 -2.216 0 N-CA-C 106.254 -1.758 . . . . 64.439999999999998 106.254 -176.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.6 t -119.92 119.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 N-CA-C 105.864 -1.902 . . . . 74.340000000000003 105.864 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.9 t30 49.38 38.07 13.19 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.698 1.199 . . . . 71.430000000000007 110.318 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 104.22 -33.5 6.52 Favored Glycine 0 CA--C 1.469 -2.821 0 N-CA-C 108.212 -1.955 . . . . 63.140000000000001 108.212 171.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -75.0 114.98 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.944 0 N-CA-C 107.753 -1.203 . . . . 61.43 107.753 -172.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.6 m -53.88 117.44 3.19 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 107.939 -1.134 . . . . 55.520000000000003 107.939 173.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -99.88 -10.48 21.68 Favored 'General case' 0 CA--C 1.483 -1.624 0 N-CA-C 105.291 -2.114 . . . . 61.140000000000001 105.291 -168.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -55.45 137.18 48.87 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.914 -1.143 . . . . 70.25 107.914 173.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.6 62.04 Favored Glycine 0 C--N 1.341 0.835 0 N-CA-C 109.46 -1.456 . . . . 74.409999999999997 109.46 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.47 148.96 30.25 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 107.837 -1.172 . . . . 60.299999999999997 107.837 -177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.414 ' HA ' HG22 ' A' ' 27' ' ' VAL . 39.0 p -81.99 -179.48 7.41 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.844 -0.798 . . . . 73.530000000000001 108.844 -176.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -60.64 -52.02 66.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 107.981 -1.118 . . . . 74.329999999999998 107.981 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.3 mttm -57.1 -55.5 33.9 Favored 'General case' 0 C--N 1.368 1.401 0 O-C-N 121.638 -0.664 . . . . 72.209999999999994 110.783 179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 94.2 mm-40 -53.62 -40.7 65.99 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 120.772 0.32 . . . . 73.329999999999998 110.529 -176.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -51.13 -54.46 24.97 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 123.023 0.529 . . . . 72.540000000000006 110.787 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.6 m -74.98 -37.43 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 109.801 -0.444 . . . . 72.430000000000007 109.801 -173.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 1.5 m -63.02 -31.67 72.85 Favored 'General case' 0 N--CA 1.521 3.105 0 C-N-CA 116.943 -1.903 . . . . 55.409999999999997 106.266 -176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 82' ' ' THR . 26.5 m -71.85 -45.16 62.34 Favored 'General case' 0 C--O 1.206 -1.232 0 O-C-N 120.654 -1.279 . . . . 64.129999999999995 107.901 -175.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 70.5 mt -62.48 -29.66 70.7 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 110.181 -0.303 . . . . 71.109999999999999 110.181 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 61.1 ttp85 -73.69 -59.0 2.92 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 107.194 -1.41 . . . . 74.530000000000001 107.194 176.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -70.51 46.77 0.09 Allowed 'General case' 0 C--N 1.362 1.139 0 C-N-CA 125.109 1.364 . . . . 63.439999999999998 111.441 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.572 HG21 HG13 ' A' ' 86' ' ' VAL . 2.7 p -105.22 -175.4 2.78 Favored 'General case' 0 N--CA 1.427 -1.598 0 N-CA-C 106.159 -1.793 . . . . 74.349999999999994 106.159 173.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -85.9 -160.0 33.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 106.012 -2.835 . . . . 63.439999999999998 106.012 176.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -60.25 -54.54 44.6 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.22 -1.03 . . . . 72.319999999999993 108.22 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 84.0 t -101.79 145.18 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 105.995 -1.854 . . . . 61.240000000000002 105.995 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.572 HG13 HG21 ' A' ' 82' ' ' THR . 47.7 t -104.04 130.12 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.044 0 N-CA-C 105.904 -1.887 . . . . 71.340000000000003 105.904 -175.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -107.7 127.02 53.31 Favored 'General case' 0 CA--C 1.466 -2.271 0 N-CA-C 103.298 -2.853 . . . . 72.430000000000007 103.298 172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.46 136.57 13.81 Favored 'General case' 0 CA--C 1.458 -2.583 0 N-CA-C 107.374 -1.343 . . . . 75.239999999999995 107.374 -177.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 4.9 mp -81.26 136.37 35.8 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 107.311 -1.366 . . . . 61.310000000000002 107.311 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.677 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -107.41 151.74 25.12 Favored 'General case' 0 CA--C 1.477 -1.85 0 N-CA-C 103.893 -2.632 . . . . 71.439999999999998 103.893 175.107 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -121.53 133.3 55.02 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 101.65 -3.463 . . . . 61.420000000000002 101.65 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.7 129.52 41.94 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.49 -0.929 . . . . 75.340000000000003 108.49 179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -113.15 0.41 25.38 Favored Glycine 0 CA--C 1.477 -2.295 0 N-CA-C 105.177 -3.169 . . . . 71.400000000000006 105.177 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.433 ' CD ' ' H ' ' A' ' 95' ' ' SER . 0.0 OUTLIER 67.19 -172.08 0.19 Allowed 'General case' 0 C--N 1.38 1.929 0 N-CA-C 107.446 -1.316 . . . . 74.310000000000002 107.446 178.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.433 ' H ' ' CD ' ' A' ' 94' ' ' GLN . 53.4 m -102.44 97.51 8.98 Favored Pre-proline 0 N--CA 1.44 -0.951 0 N-CA-C 104.751 -2.314 . . . . 75.299999999999997 104.751 167.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.83 124.13 11.52 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 122.813 2.342 . . . . 61.119999999999997 109.081 -172.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.408 -2.567 0 N-CA-C 103.604 -2.739 . . . . 75.140000000000001 103.604 175.824 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.525 ' C20' ' H15' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.481 -2.041 0 N-CA-C 108.368 -1.893 . . . . 74.409999999999997 108.368 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -67.05 155.96 68.5 Favored 'Trans proline' 0 CA--C 1.5 -1.182 0 C-N-CA 122.636 2.224 . . . . 71.5 108.654 -178.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -97.79 166.82 12.81 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 104.737 -2.32 . . . . 74.219999999999999 104.737 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -60.26 129.91 31.9 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.749 2.299 . . . . 63.420000000000002 109.123 175.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.37 -8.86 72.14 Favored Glycine 0 N--CA 1.433 -1.522 0 N-CA-C 108.923 -1.671 . . . . 51.439999999999998 108.923 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -75.6 139.78 42.26 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 107.418 -1.327 . . . . 64.209999999999994 107.418 -177.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.529 HD12 HD11 ' A' ' 60' ' ' LEU . 9.4 mm -100.68 131.64 47.89 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.775 0 N-CA-C 107.128 -1.434 . . . . 74.439999999999998 107.128 -171.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.582 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.8 p90 -143.34 155.8 44.53 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 107.255 -1.387 . . . . 74.219999999999999 107.255 175.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -108.77 147.07 32.59 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.729 -1.952 . . . . 74.230000000000004 105.729 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.67 HG22 HD21 ' A' ' 90' ' ' LEU . 18.8 m -141.22 152.51 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.484 0 N-CA-C 107.272 -1.381 . . . . 74.409999999999997 107.272 177.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -106.58 127.07 53.03 Favored 'General case' 0 N--CA 1.427 -1.591 0 N-CA-C 105.117 -2.179 . . . . 72.129999999999995 105.117 169.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.401 HD22 HD13 ' A' ' 53' ' ' ILE . 3.0 mp -135.18 140.99 45.79 Favored 'General case' 0 CA--C 1.461 -2.445 0 N-CA-C 107.748 -1.204 . . . . 63.409999999999997 107.748 175.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.07 141.22 33.36 Favored 'General case' 0 CA--C 1.488 -1.433 0 N-CA-C 106.757 -1.571 . . . . 64.409999999999997 106.757 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -71.54 -25.88 62.4 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.333 -0.988 . . . . 72.329999999999998 108.333 173.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 72.64 108.05 0.07 Allowed 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.25 -1.019 . . . . 73.510000000000005 108.25 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 51.94 53.1 13.15 Favored 'General case' 0 CA--C 1.487 -1.45 0 N-CA-C 109.549 -0.537 . . . . 71.409999999999997 109.549 -178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 31.1 t30 54.37 -9.09 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 126.043 1.737 . . . . 75.549999999999997 115.007 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.4 t -126.12 120.76 30.98 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 120.595 1.543 . . . . 72.120000000000005 108.317 -171.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.415 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.0 pt? -99.99 167.44 10.49 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 105.109 -2.182 . . . . 73.400000000000006 105.109 171.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -157.99 95.62 0.15 Allowed Glycine 0 CA--C 1.478 -2.232 0 N-CA-C 105.041 -3.223 . . . . 52.530000000000001 105.041 176.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.7 mm -118.95 177.83 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 103.273 -2.862 . . . . 73.150000000000006 103.273 -177.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' H ' HG22 ' A' ' 21' ' ' ILE . 4.1 t -127.79 154.74 45.06 Favored 'General case' 0 CA--C 1.498 -1.048 0 N-CA-C 102.987 -2.968 . . . . 72.519999999999996 102.987 175.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 4.0 m -149.46 169.55 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.818 -1.549 . . . . 54.340000000000003 106.818 -165.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.533 HG23 ' CE2' ' A' ' 37' ' ' TYR . 6.8 t -165.22 168.23 17.26 Favored 'General case' 0 N--CA 1.429 -1.506 0 N-CA-C 104.531 -2.396 . . . . 72.099999999999994 104.531 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 98.26 -167.03 22.33 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 105.573 -3.011 . . . . 64.430000000000007 105.573 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.91 -115.74 0.91 Allowed Glycine 0 CA--C 1.489 -1.55 0 C-N-CA 119.443 -1.361 . . . . 74.099999999999994 110.165 171.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . 0.261 0.2 OUTLIER -60.73 20.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.691 1.996 . . . . 71.310000000000002 116.32 -162.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 87.37 9.07 0.17 Allowed 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 108.262 -1.014 . . . . 72.319999999999993 108.262 -177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 66.3 p -39.14 -166.96 0.0 OUTLIER 'General case' 0 CA--C 1.573 1.84 0 C-N-CA 126.283 1.833 . . . . 74.430000000000007 111.626 154.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.7 t -39.34 -29.11 0.04 OUTLIER 'General case' 0 CA--C 1.574 1.9 0 O-C-N 120.458 -1.401 . . . . 74.510000000000005 114.616 -168.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG11 ' CE1' ' A' ' 37' ' ' TYR . 4.6 m -86.27 134.84 26.4 Favored 'Isoleucine or valine' 0 C--N 1.365 1.248 0 O-C-N 120.347 -1.471 . . . . 53.439999999999998 108.486 177.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -70.54 -24.17 62.76 Favored 'General case' 0 CA--C 1.495 -1.15 0 N-CA-C 108.857 -0.794 . . . . 72.510000000000005 108.857 -179.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 60' ' ' LEU . 7.4 t-160 -83.69 -10.98 57.79 Favored 'General case' 0 C--O 1.209 -1.043 0 C-N-CA 119.898 -0.721 . . . . 72.409999999999997 109.06 -173.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 54.69 67.1 2.36 Favored Glycine 0 C--N 1.36 1.872 0 N-CA-C 110.029 -1.229 . . . . 34.240000000000002 110.029 179.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.74 178.21 26.46 Favored Glycine 0 CA--C 1.472 -2.607 0 N-CA-C 105.348 -3.101 . . . . 74.120000000000005 105.348 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.76 141.87 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.284 0 N-CA-C 105.905 -1.887 . . . . 71.120000000000005 105.905 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.666 ' HA ' ' HA ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -121.46 162.05 21.15 Favored 'General case' 0 CA--C 1.45 -2.898 0 N-CA-C 106.696 -1.594 . . . . 65.219999999999999 106.696 175.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.416 HG11 HG22 ' A' ' 41' ' ' VAL . 99.7 t -85.8 103.54 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.166 0 N-CA-C 106.593 -1.632 . . . . 64.420000000000002 106.593 -176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 40.0 tttm -71.12 -30.48 66.56 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 114.535 -1.211 . . . . 75.120000000000005 108.949 -178.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.7 151.16 10.69 Favored 'General case' 0 CA--C 1.467 -2.225 0 N-CA-C 105.869 -1.9 . . . . 73.420000000000002 105.869 -176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.416 HG22 HG11 ' A' ' 38' ' ' VAL . 7.0 t -118.33 134.15 62.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.022 0 N-CA-C 103.657 -2.72 . . . . 63.32 103.657 178.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.25 148.68 84.01 Favored Pre-proline 0 N--CA 1.447 -0.604 0 N-CA-C 105.826 -1.916 . . . . 75.040000000000006 105.826 174.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -75.26 168.12 25.34 Favored 'Trans proline' 0 CA--C 1.467 -2.84 0 N-CA-C 106.073 -2.318 . . . . 73.099999999999994 106.073 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 62.08 2.75 0.85 Allowed 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 113.239 0.829 . . . . 73.319999999999993 113.239 164.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.19 -175.78 36.13 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 107.12 -2.392 . . . . 55.109999999999999 107.12 176.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -66.63 -53.01 38.76 Favored 'General case' 0 C--O 1.209 -1.03 0 N-CA-C 108.579 -0.897 . . . . 74.409999999999997 108.579 -173.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.49 -49.84 66.65 Favored 'General case' 0 C--N 1.352 0.714 0 CA-C-N 116.362 -0.381 . . . . 41.009999999999998 111.067 -176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.5 tp10 -62.7 -53.1 59.6 Favored 'General case' 0 C--N 1.348 0.513 0 N-CA-C 109.616 -0.513 . . . . 73.530000000000001 109.616 178.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 23.2 t -55.71 -38.15 69.35 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.278 0.631 . . . . 71.140000000000001 109.962 -175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -77.48 -33.5 54.52 Favored 'General case' 0 CA--C 1.507 -0.71 0 N-CA-C 107.871 -1.159 . . . . 74.099999999999994 107.871 -174.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.31 81.04 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 110.235 -1.146 . . . . 73.109999999999999 110.235 172.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -107.33 8.37 29.69 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 108.282 -1.006 . . . . 72.140000000000001 108.282 -177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.401 HD13 HD22 ' A' ' 12' ' ' LEU . 1.4 mp -126.92 134.13 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 101.859 -3.386 . . . . 72.140000000000001 101.859 175.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.6 m170 -138.74 159.58 41.75 Favored 'General case' 0 CA--C 1.473 -2.0 0 N-CA-C 104.091 -2.559 . . . . 63.219999999999999 104.091 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -66.48 143.99 56.76 Favored 'General case' 0 CA--C 1.496 -1.134 0 N-CA-C 107.74 -1.207 . . . . 75.319999999999993 107.74 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.45 -30.82 8.88 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 108.623 -1.791 . . . . 64.400000000000006 108.623 173.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -66.49 152.73 44.6 Favored 'General case' 0 C--N 1.365 1.282 0 N-CA-C 106.232 -1.766 . . . . 75.409999999999997 106.232 178.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.666 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 18.7 ptt-85 -132.23 157.67 43.75 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 106.954 -1.498 . . . . 75.140000000000001 106.954 -171.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.2 t -95.54 135.17 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.026 0 N-CA-C 106.416 -1.698 . . . . 74.209999999999994 106.416 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.529 HD11 HD12 ' A' ' 7' ' ' ILE . 48.2 mt -96.92 -58.26 2.08 Favored 'General case' 0 CA--C 1.488 -1.438 0 N-CA-C 107.029 -1.471 . . . . 72.140000000000001 107.029 178.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.92 151.57 50.11 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 106.416 -1.698 . . . . 60.299999999999997 106.416 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.7 t -118.65 119.86 62.41 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.131 0 N-CA-C 105.515 -2.031 . . . . 70.310000000000002 105.515 175.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 62.5 t30 54.71 32.85 18.18 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.133 0.973 . . . . 62.340000000000003 109.909 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.78 -28.99 13.42 Favored Glycine 0 CA--C 1.463 -3.183 0 N-CA-C 108.551 -1.82 . . . . 72.450000000000003 108.551 173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 65.0 t -77.26 115.12 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.128 0 N-CA-C 107.533 -1.284 . . . . 34.32 107.533 -173.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 7.7 t -55.65 130.56 43.62 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 108.689 -0.856 . . . . 75.450000000000003 108.689 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 75' ' ' ALA . 0.5 OUTLIER -98.98 -11.81 21.21 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 105.939 -1.874 . . . . 71.150000000000006 105.939 -170.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -53.77 126.13 20.95 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.863 -0.608 . . . . 63.5 109.634 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 88.17 -12.26 64.95 Favored Glycine 0 CA--C 1.49 -1.495 0 N-CA-C 109.137 -1.585 . . . . 53.210000000000001 109.137 174.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.88 148.8 41.96 Favored 'General case' 0 CA--C 1.488 -1.419 0 N-CA-C 107.271 -1.381 . . . . 73.310000000000002 107.271 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 67.6 p -81.77 177.32 8.95 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 107.317 -1.364 . . . . 73.430000000000007 107.317 -176.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 34.4 p80 -65.85 -43.93 86.98 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 108.541 -0.911 . . . . 45.009999999999998 108.541 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -54.59 -56.73 15.91 Favored 'General case' 0 C--N 1.362 1.125 0 O-C-N 121.881 -0.512 . . . . 53.43 110.176 175.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -56.46 -44.42 80.52 Favored 'General case' 0 C--N 1.365 1.246 0 N-CA-C 110.089 -0.337 . . . . 71.030000000000001 110.089 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.55 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -50.54 -52.76 35.85 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 122.792 0.437 . . . . 42.130000000000003 110.831 -178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 25.2 t -74.14 -42.12 51.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 107.775 -1.195 . . . . 71.129999999999995 107.775 -175.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 49.2 t -53.23 -40.6 64.65 Favored 'General case' 0 N--CA 1.513 2.695 0 CA-C-O 123.722 1.725 . . . . 40.420000000000002 106.442 -175.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.2 m -65.5 -40.34 92.92 Favored 'General case' 0 C--N 1.368 1.403 0 O-C-N 120.338 -1.476 . . . . 71.010000000000005 108.776 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.9 mt -61.87 -29.57 70.28 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 109.813 -0.44 . . . . 74.420000000000002 109.813 178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 37.7 mmt180 -73.26 -60.42 2.25 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.531 -0.544 . . . . 64.409999999999997 109.531 -178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 13.4 p30 -68.97 40.79 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.581 0 N-CA-C 113.563 0.949 . . . . 73.219999999999999 113.563 -174.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.2 p -106.72 -176.12 2.99 Favored 'General case' 0 N--CA 1.428 -1.575 0 N-CA-C 106.303 -1.74 . . . . 71.140000000000001 106.303 174.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.02 -153.87 28.97 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 108.415 -1.874 . . . . 73.430000000000007 108.415 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.2 tt0 -61.14 -54.39 45.07 Favored 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.923 -0.769 . . . . 72.430000000000007 108.923 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.3 t -102.52 145.83 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.297 0 N-CA-C 105.82 -1.919 . . . . 54.240000000000002 105.82 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.6 t -111.06 139.41 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.673 0 N-CA-C 105.592 -2.003 . . . . 72.230000000000004 105.592 -177.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -114.08 135.8 53.62 Favored 'General case' 0 CA--C 1.463 -2.376 0 N-CA-C 104.608 -2.367 . . . . 72.420000000000002 104.608 172.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -158.54 135.69 9.92 Favored 'General case' 0 CA--C 1.461 -2.448 0 N-CA-C 106.975 -1.491 . . . . 74.519999999999996 106.975 -179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.5 mp -81.19 139.08 35.76 Favored 'General case' 0 CA--C 1.477 -1.859 0 N-CA-C 107.318 -1.364 . . . . 75.439999999999998 107.318 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.67 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.76 155.5 21.5 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 104.62 -2.363 . . . . 74.140000000000001 104.62 176.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.425 ' CD ' ' HE ' ' A' ' 58' ' ' ARG . 83.9 tt0 -120.74 128.75 53.21 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 101.604 -3.48 . . . . 70.239999999999995 101.604 165.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -61.93 146.83 48.76 Favored 'General case' 0 CA--C 1.489 -1.401 0 N-CA-C 108.736 -0.838 . . . . 73.140000000000001 108.736 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.96 -166.03 18.81 Favored Glycine 0 N--CA 1.42 -2.411 0 N-CA-C 105.577 -3.009 . . . . 44.310000000000002 105.577 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.5 tt0 168.42 -78.82 0.0 OUTLIER 'General case' 0 CA--C 1.448 -2.972 0 N-CA-C 101.343 -3.577 . . . . 52.520000000000003 101.343 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.5 m -88.4 152.47 49.88 Favored Pre-proline 0 N--CA 1.397 -3.114 0 N-CA-C 104.543 -2.391 . . . . 74.329999999999998 104.543 174.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.86 -174.08 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.872 2.381 . . . . 70.230000000000004 109.122 170.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.559 1.324 0 CA-C-O 118.209 -0.901 . . . . 61.210000000000001 109.18 176.526 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.538 0 N-CA-C 109.122 -1.591 . . . . 74.310000000000002 109.122 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -68.15 158.32 57.97 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 122.964 2.443 . . . . 73.140000000000001 108.251 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 16.6 pttm -117.99 161.24 35.5 Favored Pre-proline 0 N--CA 1.445 -0.683 0 N-CA-C 106.356 -1.72 . . . . 55.32 106.356 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.91 132.59 40.33 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 123.011 2.474 . . . . 55.32 109.367 -176.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.21 -15.83 35.91 Favored Glycine 0 CA--C 1.494 -1.237 0 N-CA-C 108.713 -1.755 . . . . 64.510000000000005 108.713 176.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -74.36 133.48 42.5 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 108.131 -1.063 . . . . 74.239999999999995 108.131 -176.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.485 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.9 mt -99.27 128.08 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.992 0 N-CA-C 107.522 -1.288 . . . . 71.349999999999994 107.522 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.559 ' CE2' HD23 ' A' ' 90' ' ' LEU . 0.9 OUTLIER -138.25 159.58 41.67 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 106.793 -1.558 . . . . 72.209999999999994 106.793 178.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -103.86 152.12 22.3 Favored 'General case' 0 CA--C 1.467 -2.237 0 N-CA-C 105.172 -2.158 . . . . 74.430000000000007 105.172 172.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.712 HG22 HD21 ' A' ' 90' ' ' LEU . 11.5 m -131.79 142.75 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.777 0 N-CA-C 104.35 -2.463 . . . . 71.430000000000007 104.35 167.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -101.06 116.84 33.78 Favored 'General case' 0 N--CA 1.415 -2.193 0 N-CA-C 103.782 -2.673 . . . . 70.010000000000005 103.782 167.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.08 134.04 37.98 Favored 'General case' 0 CA--C 1.464 -2.329 0 N-CA-C 106.434 -1.691 . . . . 71.230000000000004 106.434 -172.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.44 148.59 25.49 Favored 'General case' 0 N--CA 1.416 -2.172 0 N-CA-C 106.831 -1.544 . . . . 51.5 106.831 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.2 mtpt -75.1 -33.88 61.68 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 106.12 -1.807 . . . . 73.120000000000005 106.12 171.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 73.84 104.88 0.07 Allowed 'General case' 0 CA--C 1.509 -0.626 0 C-N-CA 124.379 1.071 . . . . 71.129999999999995 108.164 177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 60.66 37.59 19.06 Favored 'General case' 0 C--N 1.366 1.288 0 N-CA-C 107.85 -1.167 . . . . 75.420000000000002 107.85 -173.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 47.75 2.41 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 126.36 1.864 . . . . 72.25 114.747 -179.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 32.4 t -86.41 139.25 31.11 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 106.706 -1.591 . . . . 74.450000000000003 106.706 -174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.407 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.2 pt? -128.01 -144.66 0.29 Allowed 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 104.675 -2.343 . . . . 72.319999999999993 104.675 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 114.21 74.66 0.63 Allowed Glycine 0 CA--C 1.467 -2.953 0 N-CA-C 105.056 -3.218 . . . . 54.100000000000001 105.056 -178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 22' ' ' CYS . 8.5 mm -103.57 177.01 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 101.584 -3.487 . . . . 74.409999999999997 101.584 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.473 ' H ' HG22 ' A' ' 21' ' ' ILE . 3.1 m -121.34 151.97 39.49 Favored 'General case' 0 CA--C 1.495 -1.137 0 N-CA-C 103.205 -2.887 . . . . 72.329999999999998 103.205 177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.4 m -152.11 169.23 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.488 -1.417 0 N-CA-C 106.828 -1.545 . . . . 71.299999999999997 106.828 -165.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.2 t -160.46 164.64 32.06 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 104.334 -2.469 . . . . 71.340000000000003 104.334 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.71 -162.74 26.74 Favored Glycine 0 CA--C 1.485 -1.801 0 N-CA-C 108.083 -2.007 . . . . 73.049999999999997 108.083 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.3 -88.43 0.35 Allowed Glycine 0 C--N 1.356 1.686 0 N-CA-C 109.112 -1.595 . . . . 30.210000000000001 109.112 176.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 71' ' ' THR . 0.8 OUTLIER -71.88 18.11 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 123.134 0.574 . . . . 62.32 112.251 -167.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 85.98 7.05 0.36 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.313 -0.995 . . . . 65.439999999999998 108.313 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 41.7 p -45.51 -169.31 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.557 0 C-N-CA 126.413 1.885 . . . . 53.450000000000003 112.466 167.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.1 m -49.92 -18.39 0.51 Allowed 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 113.939 1.088 . . . . 72.510000000000005 113.939 -167.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.437 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 15.3 m -66.53 128.78 30.21 Favored 'Isoleucine or valine' 0 C--N 1.348 0.525 0 N-CA-C 107.868 -1.16 . . . . 70.329999999999998 107.868 172.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -66.36 -52.69 44.35 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 121.256 -0.902 . . . . 74.430000000000007 110.958 -169.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 -74.64 -20.37 59.92 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 119.543 -0.863 . . . . 73.349999999999994 110.174 -168.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.43 -6.86 55.83 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.804 -1.718 . . . . 74.340000000000003 108.804 171.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -81.93 179.26 53.38 Favored Glycine 0 CA--C 1.501 -0.833 0 N-CA-C 108.198 -1.961 . . . . 51.219999999999999 108.198 178.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.498 HG13 ' HB2' ' A' ' 75' ' ' ALA . 8.8 mm -88.97 132.24 34.27 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.215 0 N-CA-C 104.535 -2.395 . . . . 65.340000000000003 104.535 174.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.437 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 3.8 m-30 -107.16 150.23 26.82 Favored 'General case' 0 CA--C 1.483 -1.613 0 N-CA-C 105.129 -2.174 . . . . 73.519999999999996 105.129 -174.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 63.6 t -82.85 103.43 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 106.194 -1.78 . . . . 73.310000000000002 106.194 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -73.04 -34.56 66.38 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 114.13 -1.396 . . . . 74.109999999999999 108.751 -175.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -165.76 151.06 8.82 Favored 'General case' 0 CA--C 1.46 -2.486 0 N-CA-C 104.598 -2.371 . . . . 73.040000000000006 104.598 -177.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.4 t -114.36 131.58 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.202 0 N-CA-C 102.975 -2.972 . . . . 74.530000000000001 102.975 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.77 146.63 83.34 Favored Pre-proline 0 N--CA 1.443 -0.819 0 N-CA-C 106.332 -1.729 . . . . 70.239999999999995 106.332 177.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -76.9 172.03 16.92 Favored 'Trans proline' 0 CA--C 1.468 -2.794 0 N-CA-C 105.965 -2.36 . . . . 65.219999999999999 105.965 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 49.55 51.99 15.37 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 122.312 1.053 . . . . 71.510000000000005 109.743 164.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.9 175.47 34.41 Favored Glycine 0 CA--C 1.472 -2.612 1 N-CA-C 102.899 -4.08 . . . . 61.25 102.899 -174.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.63 -53.58 26.78 Favored 'General case' 0 C--O 1.203 -1.364 0 CA-C-N 117.781 0.791 . . . . 72.040000000000006 109.734 -167.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.5 -50.48 65.31 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-N 116.987 -0.097 . . . . 73.109999999999999 111.122 -173.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 tp10 -63.37 -55.36 25.1 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.664 0.385 . . . . 73.420000000000002 110.058 178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.1 m -65.33 -30.23 71.05 Favored 'General case' 0 C--N 1.346 0.454 0 O-C-N 121.694 -0.629 . . . . 71.540000000000006 110.75 -172.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -77.42 -35.56 54.04 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 105.914 -1.884 . . . . 72.409999999999997 105.914 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.8 30.2 59.98 Favored Glycine 0 CA--C 1.476 -2.398 0 CA-C-N 115.318 -0.855 . . . . 54.210000000000001 111.738 167.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 -98.48 -47.85 5.23 Favored 'General case' 0 CA--C 1.479 -1.78 0 N-CA-C 106.387 -1.709 . . . . 74.349999999999994 106.387 175.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.07 148.06 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 CA-C-O 121.53 0.681 . . . . 74.219999999999999 109.735 169.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.521 ' CD2' ' O ' ' A' ' 55' ' ' LYS . 27.5 p-80 -154.94 167.12 31.38 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 104.227 -2.509 . . . . 63.020000000000003 104.227 172.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 52.7 mtmt -66.73 143.16 57.1 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.156 0.503 . . . . 74.349999999999994 109.86 -176.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.94 -33.19 6.63 Favored Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 108.606 -1.797 . . . . 72.230000000000004 108.606 172.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -69.35 156.41 38.85 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 105.701 -1.963 . . . . 73.439999999999998 105.701 174.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -132.98 157.91 44.01 Favored 'General case' 0 N--CA 1.42 -1.961 0 N-CA-C 108.021 -1.103 . . . . 73.230000000000004 108.021 -168.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.8 t -95.26 135.27 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.632 0 N-CA-C 106.177 -1.786 . . . . 52.539999999999999 106.177 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.485 ' CD1' HG23 ' A' ' 7' ' ' ILE . 15.2 mt -99.57 -58.67 1.87 Allowed 'General case' 0 CA--C 1.488 -1.432 0 N-CA-C 106.638 -1.616 . . . . 74.209999999999994 106.638 178.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.48 149.97 50.76 Favored 'General case' 0 CA--C 1.477 -1.858 0 N-CA-C 105.76 -1.941 . . . . 62.329999999999998 105.76 -176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -115.54 121.47 67.32 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.668 0 N-CA-C 105.069 -2.197 . . . . 75.230000000000004 105.069 176.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 56.56 32.88 21.69 Favored 'General case' 0 C--O 1.217 -0.611 0 C-N-CA 123.46 0.704 . . . . 52.149999999999999 109.278 178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.81 -5.59 84.65 Favored Glycine 0 CA--C 1.483 -1.929 0 N-CA-C 109.562 -1.415 . . . . 61.020000000000003 109.562 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.1 t -94.92 130.17 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.187 0 N-CA-C 107.023 -1.473 . . . . 74.420000000000002 107.023 -173.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.6 m -47.62 147.33 1.85 Allowed 'General case' 0 C--N 1.367 1.332 0 C-N-CA 123.907 0.883 . . . . 65.510000000000005 110.501 176.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.74 -25.18 0.42 Allowed 'General case' 0 CA--C 1.474 -1.957 0 N-CA-C 106.717 -1.586 . . . . 41.310000000000002 106.717 -168.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.9 pm0 -56.3 127.19 29.7 Favored 'General case' 0 N--CA 1.431 -1.415 0 N-CA-C 108.603 -0.888 . . . . 63.399999999999999 108.603 174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.8 -11.47 66.52 Favored Glycine 0 C--N 1.346 1.121 0 N-CA-C 109.43 -1.468 . . . . 74.219999999999999 109.43 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.9 157.36 25.64 Favored 'General case' 0 CA--C 1.48 -1.715 0 N-CA-C 105.66 -1.978 . . . . 64.540000000000006 105.66 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 27' ' ' VAL . 29.2 p -87.64 179.49 6.51 Favored 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 109.146 -0.687 . . . . 63.409999999999997 109.146 -168.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -61.39 -51.34 69.16 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 107.638 -1.245 . . . . 72.120000000000005 107.638 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -53.72 -55.81 22.89 Favored 'General case' 0 C--N 1.372 1.551 0 N-CA-C 109.896 -0.409 . . . . 74.209999999999994 109.896 176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.0 mm100 -56.46 -42.38 78.1 Favored 'General case' 0 C--N 1.347 0.464 0 O-C-N 122.169 -0.332 . . . . 60.409999999999997 110.623 -178.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -51.16 -55.76 16.2 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 122.853 0.461 . . . . 72.439999999999998 110.311 178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 23.5 m -74.72 -36.27 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.207 0 N-CA-C 109.044 -0.724 . . . . 52.219999999999999 109.044 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 52.4 t -62.66 -34.66 77.55 Favored 'General case' 0 N--CA 1.509 2.494 0 N-CA-C 106.055 -1.832 . . . . 72.340000000000003 106.055 -174.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 82' ' ' THR . 28.7 m -71.83 -45.48 61.31 Favored 'General case' 0 C--O 1.201 -1.49 0 O-C-N 120.071 -1.643 . . . . 74.129999999999995 107.715 -175.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 50.4 mt -61.46 -29.82 70.2 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.722 -0.473 . . . . 70.040000000000006 109.722 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.86 -60.08 2.44 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.58 -1.637 . . . . 54.409999999999997 106.58 177.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -67.86 39.18 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.485 1.114 . . . . 64.230000000000004 112.219 -177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.422 HG21 HG13 ' A' ' 86' ' ' VAL . 19.3 p -101.81 -175.21 2.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 106.166 -1.79 . . . . 52.310000000000002 106.166 171.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.6 -150.89 26.95 Favored Glycine 0 N--CA 1.437 -1.28 0 N-CA-C 107.694 -2.163 . . . . 74.319999999999993 107.694 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -65.61 -55.69 16.26 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.681 -0.859 . . . . 74.25 108.681 -176.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 70.5 t -104.25 149.34 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.32 0 N-CA-C 104.992 -2.225 . . . . 55.109999999999999 104.992 177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 82' ' ' THR . 42.9 t -111.61 140.56 30.48 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 106.288 -1.745 . . . . 62.409999999999997 106.288 -174.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -110.62 130.8 55.48 Favored 'General case' 0 CA--C 1.463 -2.389 0 N-CA-C 103.657 -2.72 . . . . 62.329999999999998 103.657 167.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -153.97 132.49 12.1 Favored 'General case' 0 CA--C 1.456 -2.649 0 N-CA-C 106.786 -1.561 . . . . 64.420000000000002 106.786 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.4 mp -80.65 136.01 36.14 Favored 'General case' 0 CA--C 1.466 -2.259 0 N-CA-C 106.82 -1.548 . . . . 44.340000000000003 106.82 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.712 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.68 159.45 17.13 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 103.968 -2.604 . . . . 74.510000000000005 103.968 174.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -120.37 134.1 55.32 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 101.77 -3.419 . . . . 74.25 101.77 167.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -62.89 138.18 58.47 Favored 'General case' 0 CA--C 1.5 -0.975 0 N-CA-C 107.945 -1.131 . . . . 72.030000000000001 107.945 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -120.32 -156.61 9.95 Favored Glycine 0 CA--C 1.471 -2.701 0 N-CA-C 106.459 -2.656 . . . . 71.099999999999994 106.459 -175.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -144.11 166.65 24.4 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 105.535 -2.024 . . . . 53.340000000000003 105.535 -177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 51.0 m -98.17 124.37 47.52 Favored Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 105.375 -2.083 . . . . 71.099999999999994 105.375 175.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -69.95 112.71 3.18 Favored 'Trans proline' 0 CA--C 1.502 -1.081 0 C-N-CA 122.338 2.025 . . . . 72.019999999999996 108.431 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.8 t . . . . . 0 CA--C 1.576 1.965 0 O-C-N 124.969 1.418 . . . . 71.219999999999999 111.54 -179.862 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.444 0 N-CA-C 108.922 -1.671 . . . . 72.409999999999997 108.922 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.23 156.56 64.35 Favored 'Trans proline' 0 C--O 1.242 0.724 0 C-N-CA 122.79 2.327 . . . . 62.549999999999997 108.133 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -85.54 165.5 35.26 Favored Pre-proline 0 N--CA 1.447 -0.605 0 N-CA-C 107.027 -1.472 . . . . 53.439999999999998 107.027 -175.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.66 121.45 9.74 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.425 2.084 . . . . 74.430000000000007 110.147 -178.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.73 11.99 69.89 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 109.328 -1.509 . . . . 74.540000000000006 109.328 173.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -80.84 143.33 32.86 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.037 -1.468 . . . . 61.409999999999997 107.037 -177.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.521 HG23 ' CD1' ' A' ' 60' ' ' LEU . 12.9 mm -98.19 132.79 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.354 0 N-CA-C 105.879 -1.897 . . . . 71.430000000000007 105.879 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CD2' HD23 ' A' ' 90' ' ' LEU . 1.5 p90 -144.18 156.48 44.33 Favored 'General case' 0 CA--C 1.478 -1.803 0 C-N-CA 119.056 -1.057 . . . . 73.329999999999998 109.027 176.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' HG2' HD11 ' A' ' 89' ' ' LEU . 46.0 mt-10 -103.3 141.65 35.54 Favored 'General case' 0 CA--C 1.471 -2.058 0 N-CA-C 105.387 -2.079 . . . . 74.209999999999994 105.387 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.621 HG22 HD21 ' A' ' 90' ' ' LEU . 34.9 m -141.01 145.93 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 105.127 -2.175 . . . . 71.340000000000003 105.127 172.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -110.05 126.44 53.99 Favored 'General case' 0 N--CA 1.42 -1.936 0 N-CA-C 105.336 -2.098 . . . . 62.329999999999998 105.336 176.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' A' ' 52' ' ' ARG . 58.1 mt -134.83 139.48 45.1 Favored 'General case' 0 CA--C 1.451 -2.836 0 N-CA-C 106.948 -1.501 . . . . 74.439999999999998 106.948 -175.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -84.54 152.68 23.74 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 105.352 -2.092 . . . . 71.25 105.352 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -77.22 -28.58 53.81 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.221 -1.399 . . . . 62.450000000000003 107.221 172.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 81.38 104.93 0.06 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 124.442 1.097 . . . . 73.439999999999998 108.105 176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 57.56 41.68 25.4 Favored 'General case' 0 C--N 1.366 1.293 0 N-CA-C 107.271 -1.381 . . . . 62.420000000000002 107.271 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 43.26 2.26 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 127.516 2.326 . . . . 65.010000000000005 115.504 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 67.0 m -100.23 114.69 28.32 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 120.34 1.427 . . . . 63.119999999999997 107.269 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.622 ' H ' HD23 ' A' ' 19' ' ' LEU . 1.8 pt? -89.63 -173.18 3.85 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 104.697 -2.334 . . . . 72.439999999999998 104.697 169.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 173.89 40.95 0.04 OUTLIER Glycine 0 CA--C 1.47 -2.725 0 N-CA-C 104.43 -3.468 . . . . 45.240000000000002 104.43 -178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.438 HG22 ' H ' ' A' ' 22' ' ' CYS . 3.6 mt -98.09 174.06 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 103.479 -2.786 . . . . 75.340000000000003 103.479 -176.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.438 ' H ' HG22 ' A' ' 21' ' ' ILE . 34.4 t -138.86 156.39 47.34 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 104.738 -2.319 . . . . 71.120000000000005 104.738 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.1 m -145.65 173.29 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.617 0 N-CA-C 104.716 -2.327 . . . . 70.439999999999998 104.716 -167.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.4 t -162.09 167.12 24.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 106.446 -1.686 . . . . 73.040000000000006 106.446 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.87 -154.08 30.36 Favored Glycine 0 CA--C 1.485 -1.833 0 N-CA-C 108.578 -1.809 . . . . 75.219999999999999 108.578 179.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 128.55 -82.38 0.34 Allowed Glycine 0 CA--C 1.474 -2.497 0 N-CA-C 108.849 -1.7 . . . . 65.5 108.849 173.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -74.48 16.42 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.497 0 C-N-CA 123.438 0.695 . . . . 51.509999999999998 112.199 -165.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 85.71 5.54 0.46 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.954 1.301 . . . . 73.129999999999995 108.345 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 34.5 p -49.29 -170.82 0.0 OUTLIER 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 125.237 1.415 . . . . 74.409999999999997 111.352 162.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.6 m -30.19 -41.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 126.268 1.827 . . . . 74.510000000000005 115.359 -169.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 14.7 m -57.28 120.0 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 122.348 1.07 . . . . 54.439999999999998 110.774 -178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -49.27 -64.33 0.84 Allowed 'General case' 0 C--N 1.351 0.635 0 CA-C-N 114.786 -1.097 . . . . 71.319999999999993 111.824 -175.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -73.99 -19.85 60.52 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 120.209 -0.597 . . . . 73.239999999999995 110.112 -168.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.36 60.19 1.57 Allowed Glycine 0 C--N 1.358 1.751 0 N-CA-C 109.754 -1.338 . . . . 53.109999999999999 109.754 170.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.73 -178.76 29.39 Favored Glycine 0 CA--C 1.466 -3.015 0 N-CA-C 103.184 -3.966 . . . . 73.129999999999995 103.184 177.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.94 133.67 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.19 0 N-CA-C 103.973 -2.603 . . . . 74.099999999999994 103.973 175.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.443 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 9.2 m-85 -106.47 150.58 25.94 Favored 'General case' 0 CA--C 1.463 -2.367 0 N-CA-C 104.755 -2.313 . . . . 74.219999999999999 104.755 178.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.9 t -80.15 102.28 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.777 0 N-CA-C 106.179 -1.786 . . . . 60.310000000000002 106.179 175.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -71.89 -35.2 69.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 114.495 -1.23 . . . . 75.209999999999994 109.67 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -155.86 144.08 19.98 Favored 'General case' 0 CA--C 1.464 -2.355 0 N-CA-C 105.841 -1.911 . . . . 51.210000000000001 105.841 -176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.99 127.62 74.58 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 103.409 -2.812 . . . . 63.130000000000003 103.409 175.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.426 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -80.23 147.03 63.82 Favored Pre-proline 0 CA--C 1.51 -0.577 0 N-CA-C 106.365 -1.717 . . . . 75.299999999999997 106.365 176.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 45' ' ' GLY . 65.5 Cg_endo -76.29 172.67 15.82 Favored 'Trans proline' 0 CA--C 1.473 -2.526 0 N-CA-C 106.063 -2.322 . . . . 73.409999999999997 106.063 -178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 70.35 -11.75 0.57 Allowed 'General case' 0 N--CA 1.442 -0.845 0 O-C-N 124.116 0.885 . . . . 64.549999999999997 111.132 167.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.419 ' H ' ' C ' ' A' ' 43' ' ' PRO . . . -91.19 178.91 42.09 Favored Glycine 0 CA--C 1.473 -2.533 0 N-CA-C 107.198 -2.361 . . . . 71.129999999999995 107.198 -174.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.47 -47.51 69.87 Favored 'General case' 0 CA--C 1.497 -1.062 0 N-CA-C 108.211 -1.033 . . . . 74.120000000000005 108.211 -174.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.54 63.61 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 116.056 -0.52 . . . . 61.210000000000001 110.41 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.08 -53.95 17.63 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 109.69 -0.485 . . . . 62.329999999999998 109.69 178.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.5 t -61.27 -34.89 75.92 Favored 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.118 0.567 . . . . 70.129999999999995 110.531 -169.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -90.39 -23.22 21.13 Favored 'General case' 0 C--N 1.348 0.531 0 N-CA-C 107.077 -1.453 . . . . 73.219999999999999 107.077 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.0 24.57 59.52 Favored Glycine 0 C--N 1.358 1.755 0 N-CA-C 110.5 -1.04 . . . . 72.219999999999999 110.5 169.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.522 ' HB2' HD11 ' A' ' 12' ' ' LEU . 23.4 mmt180 -96.33 6.45 48.77 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 108.264 -1.013 . . . . 73.329999999999998 108.264 -174.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.4 mt -142.34 146.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 104.172 -2.529 . . . . 75.099999999999994 104.172 -173.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -147.2 156.41 42.93 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 103.984 -2.599 . . . . 75.299999999999997 103.984 177.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.4 mtmm -66.86 146.14 54.73 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 107.685 -1.228 . . . . 74.430000000000007 107.685 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.11 -30.71 8.98 Favored Glycine 0 CA--C 1.484 -1.897 0 N-CA-C 108.221 -1.952 . . . . 72.129999999999995 108.221 174.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -65.25 153.93 39.61 Favored 'General case' 0 C--N 1.364 1.221 0 N-CA-C 107.896 -1.149 . . . . 74.430000000000007 107.896 179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 29.8 ttp85 -112.56 138.43 49.34 Favored 'General case' 0 CA--C 1.487 -1.456 0 N-CA-C 105.967 -1.864 . . . . 75.310000000000002 105.967 -169.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.1 t -91.67 126.72 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.259 0 N-CA-C 105.089 -2.189 . . . . 64.340000000000003 105.089 177.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.521 ' CD1' HG23 ' A' ' 7' ' ' ILE . 16.3 mt -92.31 -58.71 2.29 Favored 'General case' 0 CA--C 1.473 -2.016 0 N-CA-C 107.841 -1.17 . . . . 55.140000000000001 107.841 -173.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.49 148.68 46.22 Favored 'General case' 0 CA--C 1.472 -2.03 0 N-CA-C 105.534 -2.024 . . . . 51.210000000000001 105.534 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 91.5 t -121.55 127.01 75.52 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.604 0 N-CA-C 104.665 -2.346 . . . . 52.210000000000001 104.665 177.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 35.0 t30 57.48 29.63 17.36 Favored 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 108.89 -0.781 . . . . 71.299999999999997 108.89 178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.17 -20.04 52.38 Favored Glycine 0 CA--C 1.485 -1.818 0 N-CA-C 108.887 -1.685 . . . . 64.310000000000002 108.887 173.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.27 123.29 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.917 0 N-CA-C 108.529 -0.915 . . . . 72.140000000000001 108.529 -169.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.4 m -52.92 122.91 10.18 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 123.273 0.629 . . . . 72.120000000000005 109.924 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.79 -21.95 14.49 Favored 'General case' 0 C--O 1.204 -1.302 0 N-CA-C 107.358 -1.349 . . . . 73.140000000000001 107.358 -171.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -65.65 129.04 38.37 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.39 -0.819 . . . . 64.019999999999996 109.467 -174.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.18 -17.08 57.11 Favored Glycine 0 C--N 1.363 2.055 0 N-CA-C 108.614 -1.795 . . . . 70.030000000000001 108.614 -176.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.796 ' HB1' ' CG ' ' A' ' 74' ' ' GLN . . . -79.67 154.78 28.4 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 106.495 -1.669 . . . . 72.439999999999998 106.495 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 49.0 p -82.74 176.43 9.34 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 121.528 0.68 . . . . 64.310000000000002 110.242 -165.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -62.79 -51.46 67.02 Favored 'General case' 0 C--O 1.203 -1.383 0 N-CA-C 107.669 -1.234 . . . . 72.120000000000005 107.669 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -53.7 -56.16 19.82 Favored 'General case' 0 C--N 1.359 1.007 0 C-N-CA 122.406 0.283 . . . . 62.409999999999997 111.083 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.796 ' CG ' ' HB1' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -60.57 -35.67 76.63 Favored 'General case' 0 C--N 1.373 1.594 0 N-CA-C 109.26 -0.644 . . . . 63.200000000000003 109.26 -171.024 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' N ' ' HG3' ' A' ' 74' ' ' GLN . . . -51.13 -48.83 61.68 Favored 'General case' 0 C--N 1.375 1.682 0 C-N-CA 123.144 0.577 . . . . 72.420000000000002 109.583 176.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 2.0 t -73.27 -40.35 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 N-CA-C 108.296 -1.002 . . . . 74.549999999999997 108.296 -174.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 85.3 m -54.9 -40.45 69.82 Favored 'General case' 0 N--CA 1.524 3.266 0 N-CA-C 106.526 -1.657 . . . . 51.530000000000001 106.526 -177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.4 m -74.33 -36.73 63.67 Favored 'General case' 0 C--O 1.215 -0.762 0 O-C-N 120.564 -1.335 . . . . 51.450000000000003 109.207 -171.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 59.3 mt -71.2 -39.84 71.54 Favored 'General case' 0 C--N 1.349 0.568 0 N-CA-C 109.086 -0.709 . . . . 61.219999999999999 109.086 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 58.9 ttt85 -78.74 -60.59 2.32 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.816 -0.438 . . . . 74.430000000000007 109.816 -171.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 27.6 t30 -67.06 60.27 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 CA-C-O 121.901 0.858 . . . . 74.049999999999997 110.928 -174.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.5 p -127.41 -176.28 3.7 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 106.913 -1.514 . . . . 55.020000000000003 106.913 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.18 -149.44 20.58 Favored Glycine 0 N--CA 1.431 -1.687 0 N-CA-C 107.159 -2.376 . . . . 65.25 107.159 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -67.08 -55.77 12.86 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.259 -0.645 . . . . 51.109999999999999 109.259 -174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.7 t -108.62 145.02 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 N-CA-C 106.214 -1.773 . . . . 71.409999999999997 106.214 -177.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.4 t -119.49 146.01 24.82 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 N-CA-C 106.101 -1.814 . . . . 74.540000000000006 106.101 -171.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 72.3 m80 -106.79 128.91 54.65 Favored 'General case' 0 CA--C 1.485 -1.533 0 N-CA-C 105.919 -1.882 . . . . 70.340000000000003 105.919 173.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.07 125.49 19.0 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 105.831 -1.914 . . . . 63.130000000000003 105.831 174.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.416 HD11 ' HG2' ' A' ' 9' ' ' GLU . 3.1 mm? -80.08 138.36 36.95 Favored 'General case' 0 CA--C 1.479 -1.76 0 N-CA-C 106.834 -1.543 . . . . 74.019999999999996 106.834 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.621 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -111.05 154.24 24.5 Favored 'General case' 0 CA--C 1.474 -1.962 0 N-CA-C 104.974 -2.232 . . . . 73.120000000000005 104.974 179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -120.75 134.0 55.31 Favored 'General case' 0 N--CA 1.412 -2.337 0 N-CA-C 101.2 -3.63 . . . . 70.140000000000001 101.2 165.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -61.76 128.06 34.43 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 107.997 -1.112 . . . . 71.329999999999998 107.997 176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -95.25 13.0 67.56 Favored Glycine 0 CA--C 1.471 -2.702 0 N-CA-C 106.752 -2.539 . . . . 52.210000000000001 106.752 -173.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 66.0 tt0 -55.05 -46.21 75.34 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 106.53 -1.655 . . . . 64.150000000000006 106.53 171.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 24.6 m -86.44 127.61 60.26 Favored Pre-proline 0 N--CA 1.427 -1.581 0 N-CA-C 105.746 -1.946 . . . . 65.099999999999994 105.746 170.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.9 -14.46 29.5 Favored 'Trans proline' 0 CA--C 1.485 -1.93 0 C-N-CA 122.611 2.207 . . . . 72.120000000000005 109.27 -178.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.404 -2.737 0 N-CA-C 102.573 -3.121 . . . . 71.230000000000004 102.573 -179.453 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.489 -1.544 0 N-CA-C 109.104 -1.598 . . . . 43.43 109.104 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.95 139.05 55.01 Favored 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 122.592 2.195 . . . . 75.329999999999998 108.804 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -96.43 169.53 8.78 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 103.543 -2.762 . . . . 60.509999999999998 103.543 -179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -58.31 115.61 2.66 Favored 'Trans proline' 0 CA--C 1.512 -0.592 0 C-N-CA 122.46 2.107 . . . . 74.129999999999995 109.032 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.05 -11.69 37.49 Favored Glycine 0 N--CA 1.439 -1.121 0 N-CA-C 109.584 -1.406 . . . . 62.210000000000001 109.584 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.38 136.85 36.45 Favored 'General case' 0 CA--C 1.472 -2.054 0 CA-C-N 118.822 1.311 . . . . 75.329999999999998 107.724 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.525 HG23 ' CD1' ' A' ' 60' ' ' LEU . 3.9 mt -102.78 132.89 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.381 -3.915 0 N-CA-C 107.249 -1.389 . . . . 74.209999999999994 107.249 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.497 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.7 p90 -140.83 157.18 45.76 Favored 'General case' 0 CA--C 1.495 -1.162 0 N-CA-C 107.673 -1.232 . . . . 74.349999999999994 107.673 178.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -103.84 146.06 29.2 Favored 'General case' 0 CA--C 1.471 -2.091 0 N-CA-C 105.46 -2.052 . . . . 70.150000000000006 105.46 178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.644 HG22 HD21 ' A' ' 90' ' ' LEU . 31.3 m -140.7 148.7 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 N-CA-C 106.378 -1.712 . . . . 72.019999999999996 106.378 174.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -107.19 122.32 46.27 Favored 'General case' 0 N--CA 1.43 -1.471 0 N-CA-C 105.632 -1.988 . . . . 62.350000000000001 105.632 171.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.62 131.61 53.9 Favored 'General case' 0 CA--C 1.454 -2.739 0 N-CA-C 106.775 -1.565 . . . . 72.019999999999996 106.775 -178.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.78 139.07 33.76 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 104.332 -2.47 . . . . 55.140000000000001 104.332 172.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -67.37 -34.54 77.52 Favored 'General case' 0 CA--C 1.507 -0.708 0 N-CA-C 107.354 -1.35 . . . . 74.450000000000003 107.354 175.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.7 t30 68.08 113.33 0.04 OUTLIER 'General case' 0 C--N 1.351 0.66 0 N-CA-C 108.785 -0.82 . . . . 41.130000000000003 108.785 -178.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.8 t70 62.71 31.82 16.45 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.7 -1.222 . . . . 62.130000000000003 107.7 -175.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 46.8 3.09 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 126.33 1.852 . . . . 72.129999999999995 114.117 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.5 m -103.41 143.25 32.94 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.667 -1.235 . . . . 72.299999999999997 107.667 -171.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.8 -143.75 0.35 Allowed 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 103.351 -2.833 . . . . 73.430000000000007 103.351 172.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 143.95 47.66 0.04 OUTLIER Glycine 0 CA--C 1.467 -2.954 0 N-CA-C 106.334 -2.706 . . . . 24.420000000000002 106.334 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mm -91.22 177.09 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 103.374 -2.825 . . . . 72.329999999999998 103.374 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.0 m -133.27 157.68 44.82 Favored 'General case' 0 CA--C 1.473 -1.987 0 N-CA-C 103.689 -2.708 . . . . 74.109999999999999 103.689 172.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 36' ' ' ILE . 4.2 m -148.3 171.47 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.853 0 N-CA-C 106.588 -1.634 . . . . 65.109999999999999 106.588 -168.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.6 t -165.25 168.12 17.31 Favored 'General case' 0 N--CA 1.422 -1.874 0 N-CA-C 105.25 -2.13 . . . . 65.340000000000003 105.25 -177.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.94 -145.19 17.68 Favored Glycine 0 CA--C 1.487 -1.716 0 N-CA-C 107.746 -2.141 . . . . 54.130000000000003 107.746 -179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.9 -85.51 0.42 Allowed Glycine 0 CA--C 1.482 -1.999 0 N-CA-C 109.417 -1.473 . . . . 71.150000000000006 109.417 172.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -74.02 17.98 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.342 0.247 0 O-C-N 121.88 -0.777 . . . . 72.099999999999994 113.056 -166.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 32.7 t30 86.24 6.38 0.37 Allowed 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.251 -1.018 . . . . 64.140000000000001 108.251 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 38.7 p -45.71 -168.98 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 126.497 1.919 . . . . 75.329999999999998 111.696 159.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 m -33.7 -39.54 0.06 Allowed 'General case' 0 C--N 1.363 1.157 0 C-N-CA 125.663 1.585 . . . . 64.310000000000002 114.836 -172.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.405 ' HB ' ' CE1' ' A' ' 37' ' ' TYR . 20.2 m -77.27 139.96 17.86 Favored 'Isoleucine or valine' 0 C--N 1.349 0.55 0 O-C-N 121.184 -0.948 . . . . 63.109999999999999 108.934 -175.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.4 mtt180 -69.42 -52.29 28.25 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 122.031 -0.418 . . . . 74.310000000000002 111.854 -169.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -78.25 5.05 11.15 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 121.64 -0.663 . . . . 75.329999999999998 110.49 -169.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 62.6 7.36 14.76 Favored Glycine 0 C--O 1.21 -1.347 0 N-CA-C 111.228 -0.749 . . . . 64.109999999999999 111.228 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -85.28 178.93 50.69 Favored Glycine 0 CA--C 1.473 -2.583 0 N-CA-C 106.09 -2.804 . . . . 74.109999999999999 106.09 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.445 HG13 ' HB ' ' A' ' 23' ' ' VAL . 1.0 OUTLIER -88.9 136.65 22.9 Favored 'Isoleucine or valine' 1 N--CA 1.371 -4.4 0 N-CA-C 104.688 -2.338 . . . . 70.239999999999995 104.688 173.835 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.405 ' CE1' ' HB ' ' A' ' 31' ' ' VAL . 3.1 m-85 -109.81 146.58 34.79 Favored 'General case' 0 CA--C 1.472 -2.037 0 N-CA-C 102.991 -2.966 . . . . 72.340000000000003 102.991 -178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.2 t -81.75 103.29 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.727 0 N-CA-C 107.085 -1.45 . . . . 64.519999999999996 107.085 -176.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 79.3 tttt -71.18 -35.15 71.5 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 114.271 -1.331 . . . . 71.200000000000003 109.758 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -164.77 153.9 12.96 Favored 'General case' 0 CA--C 1.465 -2.309 0 N-CA-C 105.935 -1.876 . . . . 72.120000000000005 105.935 -177.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.37 139.58 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.88 0 N-CA-C 103.317 -2.845 . . . . 64.140000000000001 103.317 174.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.402 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -75.88 151.8 84.47 Favored Pre-proline 0 N--CA 1.452 -0.372 0 N-CA-C 106.279 -1.748 . . . . 73.120000000000005 106.279 174.433 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -75.7 174.3 13.04 Favored 'Trans proline' 0 CA--C 1.468 -2.807 0 N-CA-C 105.449 -2.558 . . . . 61.420000000000002 105.449 176.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 95.1 mm-40 49.26 52.01 15.23 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 121.74 0.781 . . . . 54.329999999999998 110.02 166.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -150.73 171.27 30.53 Favored Glycine 0 CA--C 1.461 -3.324 0 N-CA-C 103.184 -3.966 . . . . 23.100000000000001 103.184 -176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.92 -53.11 43.53 Favored 'General case' 0 C--O 1.209 -1.039 0 CA-C-N 118.182 0.991 . . . . 72.230000000000004 108.847 -170.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.87 -50.6 63.52 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 116.898 -0.137 . . . . 71.329999999999998 111.28 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 20.1 tp10 -69.86 -54.19 14.62 Favored 'General case' 0 C--N 1.341 0.238 0 N-CA-C 109.971 -0.381 . . . . 73.439999999999998 109.971 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.7 m -61.45 -30.59 70.69 Favored 'General case' 0 C--N 1.345 0.383 0 O-C-N 121.983 -0.448 . . . . 70.109999999999999 110.777 -172.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -81.35 -35.5 30.79 Favored 'General case' 0 CA--C 1.513 -0.445 0 N-CA-C 106.298 -1.742 . . . . 65.329999999999998 106.298 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.18 22.48 63.01 Favored Glycine 0 CA--C 1.488 -1.645 0 N-CA-C 109.827 -1.309 . . . . 65.420000000000002 109.827 174.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 24.9 mmt180 -93.28 1.28 57.07 Favored 'General case' 0 CA--C 1.501 -0.93 0 N-CA-C 107.292 -1.374 . . . . 64.239999999999995 107.292 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.8 mt -144.64 139.71 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.978 0 N-CA-C 103.157 -2.905 . . . . 73.030000000000001 103.157 -173.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -143.9 162.46 36.06 Favored 'General case' 0 CA--C 1.459 -2.548 0 N-CA-C 106.054 -1.832 . . . . 72.129999999999995 106.054 -178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -67.19 137.58 56.33 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 107.195 -1.409 . . . . 62.310000000000002 107.195 170.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.38 -33.03 6.67 Favored Glycine 0 CA--C 1.486 -1.768 0 N-CA-C 108.151 -1.98 . . . . 74.310000000000002 108.151 174.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -66.41 155.0 38.68 Favored 'General case' 0 CA--C 1.491 -1.311 0 N-CA-C 106.48 -1.674 . . . . 72.310000000000002 106.48 174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.34 148.33 51.26 Favored 'General case' 0 N--CA 1.415 -2.219 0 N-CA-C 107.336 -1.357 . . . . 72.430000000000007 107.336 -173.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 45.1 t -94.92 129.61 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 N-CA-C 105.831 -1.914 . . . . 73.109999999999999 105.831 -176.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.525 ' CD1' HG23 ' A' ' 7' ' ' ILE . 32.5 mt -93.79 -58.66 2.19 Favored 'General case' 0 CA--C 1.48 -1.749 0 N-CA-C 106.937 -1.505 . . . . 70.120000000000005 106.937 -178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.25 150.63 51.03 Favored 'General case' 0 CA--C 1.475 -1.923 0 N-CA-C 106.455 -1.683 . . . . 72.120000000000005 106.455 -178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 85.5 t -121.66 122.38 66.86 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 104.929 -2.248 . . . . 35.229999999999997 104.929 176.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 56.11 33.43 21.95 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.976 0.893 . . . . 55.009999999999998 108.875 177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.41 -21.62 41.73 Favored Glycine 0 CA--C 1.482 -2.031 0 N-CA-C 108.143 -1.983 . . . . 42.350000000000001 108.143 172.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.5 t -79.91 118.73 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.132 0 N-CA-C 107.873 -1.158 . . . . 55.140000000000001 107.873 -172.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 m -49.21 116.97 1.9 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.814 -0.81 . . . . 74.430000000000007 108.814 173.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.472 HD21 ' HA ' ' A' ' 75' ' ' ALA . 1.0 OUTLIER -98.85 -19.59 17.31 Favored 'General case' 0 C--O 1.196 -1.712 0 N-CA-C 105.936 -1.876 . . . . 74.109999999999999 105.936 -173.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.99 124.62 21.01 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 108.664 -0.865 . . . . 71.239999999999995 108.664 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.63 -16.63 60.84 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.465 -1.854 . . . . 42.32 108.465 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.55 147.17 39.9 Favored 'General case' 0 CA--C 1.489 -1.396 0 N-CA-C 106.195 -1.78 . . . . 73.329999999999998 106.195 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 46.1 p -77.04 178.57 6.88 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 108.143 -1.058 . . . . 51.439999999999998 108.143 -172.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 27.6 p80 -68.47 -46.96 68.34 Favored 'General case' 0 C--O 1.204 -1.314 0 N-CA-C 108.665 -0.865 . . . . 62.509999999999998 108.665 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -56.17 -54.39 45.79 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.366 -0.834 . . . . 74.310000000000002 110.518 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 27.5 mm100 -57.92 -40.77 81.23 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 110.141 -0.318 . . . . 74.540000000000006 110.141 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -51.95 -52.15 52.26 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 122.604 0.362 . . . . 75.010000000000005 110.438 178.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.2 t -73.7 -39.72 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 107.621 -1.252 . . . . 72.430000000000007 107.621 -174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 44.0 t -57.14 -35.58 69.67 Favored 'General case' 0 N--CA 1.511 2.618 0 N-CA-C 106.423 -1.695 . . . . 64.439999999999998 106.423 -176.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 34.4 m -71.69 -43.82 65.3 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 120.388 -1.445 . . . . 71.430000000000007 107.829 -174.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 72.9 mt -63.04 -39.35 94.48 Favored 'General case' 0 C--N 1.361 1.103 0 N-CA-C 109.069 -0.715 . . . . 72.040000000000006 109.069 179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 3.0 tmm_? -68.28 -59.76 2.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 107.868 -1.16 . . . . 74.019999999999996 107.868 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -72.17 53.31 0.27 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.877 0.846 . . . . 75.25 110.723 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.435 HG21 HG13 ' A' ' 86' ' ' VAL . 7.0 p -103.74 -175.97 2.95 Favored 'General case' 0 N--CA 1.41 -2.468 0 N-CA-C 105.161 -2.162 . . . . 53.409999999999997 105.161 169.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -88.21 -148.85 16.93 Favored Glycine 0 N--CA 1.421 -2.361 0 N-CA-C 107.225 -2.35 . . . . 75.230000000000004 107.225 177.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -66.61 -54.99 17.47 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.55 -0.907 . . . . 74.409999999999997 108.55 -179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 75.6 t -99.29 144.6 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 106.67 -1.604 . . . . 74.349999999999994 106.67 178.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.435 HG13 HG21 ' A' ' 82' ' ' THR . 58.0 t -100.69 129.3 51.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.69 0 N-CA-C 105.459 -2.052 . . . . 61.539999999999999 105.459 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -113.33 128.26 56.4 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 104.723 -2.325 . . . . 64.010000000000005 104.723 172.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -158.05 138.31 12.58 Favored 'General case' 0 CA--C 1.469 -2.136 0 N-CA-C 107.406 -1.331 . . . . 63.409999999999997 107.406 -177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 8.0 mp -81.76 139.58 34.75 Favored 'General case' 0 CA--C 1.478 -1.806 0 N-CA-C 107.617 -1.253 . . . . 64.209999999999994 107.617 176.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.644 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -109.76 159.05 17.5 Favored 'General case' 0 CA--C 1.473 -2.002 0 N-CA-C 104.174 -2.528 . . . . 73.140000000000001 104.174 175.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -121.79 131.25 53.96 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 100.542 -3.873 . . . . 74.439999999999998 100.542 161.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.472 ' HD2' ' H ' ' A' ' 95' ' ' SER . 1.5 tppp? -70.61 139.97 51.52 Favored 'General case' 0 N--CA 1.394 -3.247 0 N-CA-C 106.208 -1.775 . . . . 73.450000000000003 106.208 -174.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -158.42 2.15 0.11 Allowed Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 107.737 -2.145 . . . . 52.340000000000003 107.737 -173.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -74.15 -54.57 7.49 Favored 'General case' 0 CA--C 1.488 -1.423 0 N-CA-C 106.509 -1.663 . . . . 74.310000000000002 106.509 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.472 ' H ' ' HD2' ' A' ' 92' ' ' LYS . 6.4 m -60.98 126.2 85.27 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 106.597 -1.631 . . . . 72.239999999999995 106.597 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.91 121.77 8.83 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 122.888 2.392 . . . . 73.140000000000001 109.407 -165.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 50.6 m . . . . . 0 CA--C 1.561 1.401 0 N-CA-C 107.343 -1.354 . . . . 62.439999999999998 107.343 176.55 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.44 ' O2 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.349 0 N-CA-C 107.026 -2.43 . . . . 34.439999999999998 107.026 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.38 163.53 38.77 Favored 'Trans proline' 0 CA--C 1.496 -1.406 0 C-N-CA 122.437 2.091 . . . . 53.439999999999998 108.695 -170.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -116.28 162.29 27.06 Favored Pre-proline 0 N--CA 1.432 -1.365 0 N-CA-C 104.965 -2.235 . . . . 74.0 104.965 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.4 131.87 43.13 Favored 'Trans proline' 0 CA--C 1.495 -1.47 0 C-N-CA 122.83 2.354 . . . . 72.329999999999998 108.928 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.62 -22.07 20.18 Favored Glycine 0 CA--C 1.489 -1.586 0 N-CA-C 108.385 -1.886 . . . . 62.399999999999999 108.385 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -72.99 131.34 42.03 Favored 'General case' 0 CA--C 1.496 -1.115 0 N-CA-C 107.237 -1.394 . . . . 65.5 107.237 -177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.488 HG23 ' CD1' ' A' ' 60' ' ' LEU . 4.6 mt -94.8 136.31 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.394 0 N-CA-C 107.0 -1.482 . . . . 53.219999999999999 107.0 -177.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.536 ' CE2' HD23 ' A' ' 90' ' ' LEU . 1.1 p90 -141.21 154.85 46.03 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 107.144 -1.428 . . . . 73.239999999999995 107.144 174.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -104.66 148.81 26.14 Favored 'General case' 0 CA--C 1.481 -1.704 0 N-CA-C 105.574 -2.01 . . . . 73.140000000000001 105.574 177.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.621 HG22 HD21 ' A' ' 90' ' ' LEU . 17.1 m -138.17 150.97 24.7 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.639 0 N-CA-C 106.481 -1.674 . . . . 54.130000000000003 106.481 173.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -106.58 124.99 50.43 Favored 'General case' 0 N--CA 1.42 -1.95 0 N-CA-C 104.619 -2.363 . . . . 64.439999999999998 104.619 164.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 50.7 mt -139.46 137.42 35.56 Favored 'General case' 0 CA--C 1.472 -2.026 0 N-CA-C 106.599 -1.63 . . . . 64.230000000000004 106.599 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -88.48 161.18 17.15 Favored 'General case' 0 CA--C 1.485 -1.546 0 N-CA-C 106.416 -1.698 . . . . 55.509999999999998 106.416 -175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -43.68 63.03 Favored 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 105.919 -1.882 . . . . 44.43 105.919 168.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 70.13 117.35 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.339 0 C-N-CA 124.325 1.05 . . . . 62.229999999999997 108.983 -173.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.6 t70 59.2 37.54 23.82 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-O 121.816 0.817 . . . . 50.0 109.021 -178.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 57.5 t30 55.1 -9.12 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 126.253 1.821 . . . . 70.5 114.392 177.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.3 m -93.73 136.54 33.91 Favored 'General case' 0 CA--C 1.483 -1.606 0 O-C-N 120.51 -1.369 . . . . 63.32 108.759 -175.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.505 HD13 ' H ' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -96.01 -165.01 1.22 Allowed 'General case' 0 N--CA 1.426 -1.63 0 N-CA-C 102.725 -3.065 . . . . 72.140000000000001 102.725 172.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.468 ' H ' HD13 ' A' ' 19' ' ' LEU . . . 163.43 23.6 0.02 OUTLIER Glycine 0 CA--C 1.477 -2.328 0 C-N-CA 117.315 -2.374 . . . . 63.25 110.339 176.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.505 ' H ' HD13 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -87.79 175.88 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 104.411 -2.44 . . . . 64.030000000000001 104.411 179.21 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.3 m -138.31 160.3 39.84 Favored 'General case' 0 CA--C 1.477 -1.844 0 N-CA-C 105.114 -2.18 . . . . 74.329999999999998 105.114 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.56 169.47 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 108.629 -0.878 . . . . 74.409999999999997 108.629 -163.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.2 t -160.41 165.45 31.08 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 104.805 -2.294 . . . . 70.450000000000003 104.805 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.18 -149.72 24.18 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 108.938 -1.665 . . . . 64.030000000000001 108.938 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' HA2' HG12 ' A' ' 36' ' ' ILE . . . 113.61 -75.85 0.24 Allowed Glycine 0 CA--C 1.474 -2.507 0 N-CA-C 109.46 -1.456 . . . . 75.5 109.46 174.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -74.39 15.65 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.214 -0.796 0 O-C-N 122.579 -0.365 . . . . 62.520000000000003 110.953 -169.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.8 t30 83.8 5.15 0.76 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.619 1.168 . . . . 74.540000000000006 108.15 177.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 43.1 p -47.44 -170.11 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.542 1.937 . . . . 72.230000000000004 113.623 170.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.4 m -40.94 -37.58 0.82 Allowed 'General case' 0 C--N 1.373 1.597 0 C-N-CA 125.969 1.707 . . . . 70.010000000000005 113.853 -165.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 27.7 m -57.21 132.07 21.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.537 0.684 . . . . 70.099999999999994 110.171 -175.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.9 ptt85 -44.53 -63.63 0.86 Allowed 'General case' 0 C--N 1.354 0.778 0 CA-C-N 114.79 -1.095 . . . . 74.310000000000002 113.397 -168.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -77.78 -19.92 54.22 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 118.708 0.686 . . . . 73.299999999999997 109.229 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 106.42 -12.54 43.47 Favored Glycine 0 C--N 1.361 1.949 0 N-CA-C 109.916 -1.274 . . . . 53.210000000000001 109.916 174.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.17 179.94 49.62 Favored Glycine 0 C--O 1.218 -0.88 0 N-CA-C 109.855 -1.298 . . . . 64.019999999999996 109.855 -174.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.514 HG13 ' CD1' ' A' ' 67' ' ' LEU . 2.8 mm -86.53 127.17 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.161 0 N-CA-C 102.05 -3.315 . . . . 64.510000000000005 102.05 170.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.2 m-85 -104.9 155.59 18.79 Favored 'General case' 0 CA--C 1.467 -2.233 0 N-CA-C 105.426 -2.065 . . . . 74.129999999999995 105.426 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.1 t -83.5 102.56 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.958 0 N-CA-C 105.675 -1.972 . . . . 70.409999999999997 105.675 174.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -71.83 -31.28 66.37 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-N 114.497 -1.228 . . . . 74.140000000000001 110.163 -172.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.48 149.95 17.45 Favored 'General case' 0 CA--C 1.463 -2.387 0 N-CA-C 105.849 -1.908 . . . . 45.130000000000003 105.849 -178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.0 t -127.4 134.96 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 N-CA-C 104.512 -2.403 . . . . 73.209999999999994 104.512 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.45 ' H ' HD13 ' A' ' 42' ' ' ILE . 0.1 OUTLIER -81.97 151.43 67.1 Favored Pre-proline 0 N--CA 1.445 -0.695 0 N-CA-C 106.669 -1.604 . . . . 72.430000000000007 106.669 176.353 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.45 -179.14 5.01 Favored 'Trans proline' 0 CA--C 1.479 -2.274 0 N-CA-C 105.928 -2.374 . . . . 72.25 105.928 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 49.43 52.24 14.86 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.023 0.827 . . . . 72.510000000000005 110.641 162.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.46 178.59 32.85 Favored Glycine 0 CA--C 1.47 -2.727 0 N-CA-C 103.41 -3.876 . . . . 75.140000000000001 103.41 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -63.41 -53.36 53.54 Favored 'General case' 0 C--O 1.205 -1.263 0 CA-C-N 117.632 0.716 . . . . 72.129999999999995 109.173 -172.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.91 -50.26 64.28 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 116.547 -0.297 . . . . 32.130000000000003 110.99 -176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 tp10 -68.79 -50.15 52.66 Favored 'General case' 0 C--N 1.343 0.322 0 O-C-N 121.958 -0.464 . . . . 71.510000000000005 110.016 -179.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.7 t -63.81 -33.69 76.25 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 109.754 -0.461 . . . . 71.319999999999993 109.754 -171.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -79.17 -32.0 44.11 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 106.074 -1.824 . . . . 70.120000000000005 106.074 -178.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.26 22.29 60.98 Favored Glycine 0 C--N 1.359 1.818 0 N-CA-C 110.327 -1.109 . . . . 75.209999999999994 110.327 170.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 72.2 mtt180 -101.87 8.26 41.31 Favored 'General case' 0 CA--C 1.497 -1.073 0 N-CA-C 107.94 -1.133 . . . . 63.130000000000003 107.94 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 55.0 mt -144.27 145.75 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.661 0 N-CA-C 105.009 -2.219 . . . . 64.319999999999993 105.009 -171.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.504 ' CE1' ' OD1' ' A' ' 57' ' ' ASP . 54.0 p-80 -154.12 159.69 41.58 Favored 'General case' 0 N--CA 1.401 -2.911 0 N-CA-C 102.815 -3.031 . . . . 62.439999999999998 102.815 172.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.462 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 17.1 ptpt -66.5 147.0 53.91 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 108.57 -0.9 . . . . 72.310000000000002 108.57 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.54 -33.26 6.7 Favored Glycine 0 CA--C 1.489 -1.582 0 N-CA-C 109.975 -1.25 . . . . 62.219999999999999 109.975 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.504 ' OD1' ' CE1' ' A' ' 54' ' ' HIS . 83.0 m-20 -69.75 155.95 39.76 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 105.32 -2.104 . . . . 62.340000000000003 105.32 172.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 ppt_? -132.66 157.89 43.69 Favored 'General case' 0 N--CA 1.421 -1.876 0 N-CA-C 108.633 -0.877 . . . . 73.140000000000001 108.633 -169.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.8 t -92.83 140.82 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.801 0 N-CA-C 106.723 -1.584 . . . . 71.409999999999997 106.723 -174.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.488 ' CD1' HG23 ' A' ' 7' ' ' ILE . 10.3 mt -101.11 -59.48 1.69 Allowed 'General case' 0 CA--C 1.499 -0.985 0 N-CA-C 106.36 -1.718 . . . . 73.340000000000003 106.36 174.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -136.13 151.31 49.64 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 106.487 -1.672 . . . . 63.509999999999998 106.487 -176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -120.78 123.5 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.336 -2.098 . . . . 73.019999999999996 105.336 174.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.4 t30 50.99 35.35 12.49 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.874 1.27 . . . . 75.549999999999997 110.854 178.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 102.58 -22.04 38.75 Favored Glycine 0 CA--C 1.473 -2.566 0 N-CA-C 108.856 -1.698 . . . . 73.430000000000007 108.856 170.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.6 t -81.64 115.78 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.979 0 N-CA-C 108.095 -1.076 . . . . 72.420000000000002 108.095 -172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.0 m -54.12 112.92 1.06 Allowed 'General case' 0 C--N 1.371 1.537 0 N-CA-C 107.6 -1.259 . . . . 72.200000000000003 107.6 172.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.514 ' CD1' HG13 ' A' ' 36' ' ' ILE . 1.1 tm? -104.44 -11.79 16.87 Favored 'General case' 0 C--O 1.198 -1.626 0 N-CA-C 106.882 -1.525 . . . . 75.340000000000003 106.882 -162.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -60.16 129.2 40.54 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.62 -0.881 . . . . 65.219999999999999 108.62 175.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 93.91 -14.5 65.16 Favored Glycine 0 CA--C 1.494 -1.224 0 N-CA-C 108.64 -1.784 . . . . 74.420000000000002 108.64 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.6 150.91 27.91 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 106.399 -1.704 . . . . 73.219999999999999 106.399 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.1 p -83.58 178.84 7.81 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 109.795 -0.446 . . . . 70.219999999999999 109.795 -167.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -56.21 -52.0 66.01 Favored 'General case' 0 C--N 1.382 2.007 0 N-CA-C 107.093 -1.447 . . . . 62.530000000000001 107.093 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.0 mmtp -58.72 -48.51 80.91 Favored 'General case' 0 C--N 1.362 1.138 0 CA-C-N 116.538 -0.301 . . . . 45.140000000000001 110.764 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 50.8 mt-30 -56.64 -42.71 79.38 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.7 -0.4 . . . . 65.400000000000006 110.543 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.475 ' HB2' HD12 ' A' ' 36' ' ' ILE . . . -52.06 -51.4 57.81 Favored 'General case' 0 C--N 1.37 1.458 0 C-N-CA 120.727 -0.389 . . . . 73.040000000000006 110.657 177.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.26 -39.98 49.84 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.47 0 C-N-CA 119.932 -0.707 . . . . 75.030000000000001 109.831 -173.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 45.1 t -62.67 -33.25 74.67 Favored 'General case' 0 N--CA 1.521 3.077 0 N-CA-C 106.131 -1.803 . . . . 74.450000000000003 106.131 -173.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 m -71.31 -42.93 68.0 Favored 'General case' 0 C--N 1.357 0.904 0 O-C-N 120.242 -1.536 . . . . 60.409999999999997 108.209 -175.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 52.5 mt -69.49 -35.26 75.39 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 109.409 -0.589 . . . . 60.439999999999998 109.409 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.43 -61.86 1.61 Allowed 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 107.556 -1.276 . . . . 61.539999999999999 107.556 -174.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 45.7 t30 -73.07 58.46 0.49 Allowed 'General case' 0 N--CA 1.481 1.103 0 CA-C-O 121.409 0.623 . . . . 74.340000000000003 110.67 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.483 HG21 HG13 ' A' ' 86' ' ' VAL . 3.2 p -102.68 -175.79 2.92 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 107.323 -1.362 . . . . 62.149999999999999 107.323 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.01 -154.28 30.35 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 106.224 -2.75 . . . . 64.239999999999995 106.224 173.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -60.61 -53.98 50.88 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.829 -0.434 . . . . 72.409999999999997 109.829 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 71.0 t -110.57 154.09 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 N-CA-C 105.729 -1.952 . . . . 70.109999999999999 105.729 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.483 HG13 HG21 ' A' ' 82' ' ' THR . 21.8 t -107.47 139.04 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.441 0 N-CA-C 105.912 -1.884 . . . . 62.229999999999997 105.912 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -107.87 123.99 49.42 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 104.418 -2.438 . . . . 65.340000000000003 104.418 168.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.8 133.31 11.97 Favored 'General case' 0 N--CA 1.42 -1.968 0 N-CA-C 108.052 -1.092 . . . . 53.140000000000001 108.052 -176.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 7.2 mp -84.86 144.34 28.47 Favored 'General case' 0 CA--C 1.474 -1.98 0 N-CA-C 108.832 -0.803 . . . . 74.219999999999999 108.832 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.621 HD21 HG22 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -117.79 162.71 17.65 Favored 'General case' 0 CA--C 1.487 -1.46 0 N-CA-C 104.711 -2.329 . . . . 63.140000000000001 104.711 175.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -124.39 137.38 54.47 Favored 'General case' 0 N--CA 1.42 -1.928 0 N-CA-C 102.233 -3.247 . . . . 71.319999999999993 102.233 165.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 30.0 mmmt -62.8 145.75 54.2 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 109.006 -0.739 . . . . 64.299999999999997 109.006 179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -127.94 -150.7 7.4 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 105.427 -3.069 . . . . 74.010000000000005 105.427 179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 77.94 147.15 0.09 Allowed 'General case' 0 C--N 1.361 1.079 0 C-N-CA 124.343 1.057 . . . . 74.239999999999995 108.149 -173.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.3 m -68.15 127.56 93.28 Favored Pre-proline 0 N--CA 1.446 -0.639 0 N-CA-C 108.173 -1.047 . . . . 64.430000000000007 108.173 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -68.23 151.91 76.37 Favored 'Trans proline' 0 CA--C 1.5 -1.224 0 C-N-CA 122.743 2.295 . . . . 73.230000000000004 110.94 -172.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.3 m . . . . . 0 N--CA 1.421 -1.902 0 N-CA-C 105.247 -2.131 . . . . 70.200000000000003 105.247 172.906 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.412 ' O19' ' H15' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.906 0 N-CA-C 108.03 -2.028 . . . . 73.430000000000007 108.03 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.49 151.67 84.64 Favored 'Trans proline' 0 CA--C 1.502 -1.104 0 C-N-CA 122.663 2.242 . . . . 72.530000000000001 108.207 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -82.58 166.5 35.87 Favored Pre-proline 0 N--CA 1.435 -1.202 0 N-CA-C 106.192 -1.781 . . . . 64.409999999999997 106.192 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -63.98 123.23 11.58 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 122.444 2.096 . . . . 73.25 107.688 172.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 86.62 8.59 76.71 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 109.569 -1.413 . . . . 64.310000000000002 109.569 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.86 145.52 26.55 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 106.604 -1.628 . . . . 71.530000000000001 106.604 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.436 HG23 ' CD1' ' A' ' 60' ' ' LEU . 12.2 mt -101.53 139.02 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.986 0 N-CA-C 108.083 -1.08 . . . . 75.349999999999994 108.083 -175.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.541 ' CE2' HD23 ' A' ' 90' ' ' LEU . 2.5 p90 -144.67 162.27 37.1 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 107.012 -1.477 . . . . 75.030000000000001 107.012 171.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -103.59 150.38 24.02 Favored 'General case' 0 CA--C 1.469 -2.173 0 N-CA-C 106.003 -1.851 . . . . 74.340000000000003 106.003 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.624 HG22 HD21 ' A' ' 90' ' ' LEU . 15.7 m -132.89 140.27 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.543 0 N-CA-C 105.178 -2.156 . . . . 72.140000000000001 105.178 168.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -105.38 116.4 31.88 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 104.65 -2.352 . . . . 65.230000000000004 104.65 172.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.408 HD23 ' HA ' ' A' ' 12' ' ' LEU . 8.1 mt -138.46 138.24 37.94 Favored 'General case' 0 CA--C 1.454 -2.726 0 N-CA-C 107.615 -1.254 . . . . 73.400000000000006 107.615 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . . . -89.1 159.58 17.47 Favored 'General case' 0 N--CA 1.418 -2.067 0 N-CA-C 105.746 -1.946 . . . . 74.219999999999999 105.746 -177.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -61.85 -50.69 71.24 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 106.879 -1.526 . . . . 74.209999999999994 106.879 171.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 2.3 t30 74.62 119.24 0.05 OUTLIER 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.446 -1.252 . . . . 72.409999999999997 107.954 -173.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 57.16 34.48 24.9 Favored 'General case' 0 CA--C 1.497 -1.093 0 C-N-CA 123.734 0.814 . . . . 75.5 109.445 -173.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 47.1 t30 54.61 -5.11 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.746 1.618 . . . . 54.119999999999997 113.679 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.5 m -95.66 136.99 35.35 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 108.894 -0.78 . . . . 73.540000000000006 108.894 -171.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.23 -149.95 0.45 Allowed 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 103.008 -2.96 . . . . 63.420000000000002 103.008 170.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 110.12 76.17 0.86 Allowed Glycine 0 CA--C 1.482 -2.016 0 N-CA-C 106.542 -2.623 . . . . 73.430000000000007 106.542 177.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.403 HG22 ' H ' ' A' ' 22' ' ' CYS . 4.3 mm -102.02 176.74 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.775 0 N-CA-C 102.531 -3.137 . . . . 74.310000000000002 102.531 176.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.403 ' H ' HG22 ' A' ' 21' ' ' ILE . 7.0 m -106.11 152.71 23.06 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 103.843 -2.651 . . . . 55.240000000000002 103.843 178.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 2.7 m -151.35 165.0 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.98 -1.119 . . . . 64.439999999999998 107.98 -169.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.9 t -160.2 165.96 30.56 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 104.683 -2.339 . . . . 74.150000000000006 104.683 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.431 ' O ' ' CE1' ' A' ' 72' ' ' HIS . . . 82.7 -141.25 20.94 Favored Glycine 0 CA--C 1.493 -1.299 0 N-CA-C 107.292 -2.323 . . . . 73.5 107.292 179.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 106.51 -84.11 0.38 Allowed Glycine 0 CA--C 1.471 -2.664 0 N-CA-C 108.437 -1.865 . . . . 53.310000000000002 108.437 175.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.547 HG22 ' HA ' ' A' ' 71' ' ' THR . 0.2 OUTLIER -69.06 8.15 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.041 0 N-CA-C 112.396 0.517 . . . . 65.310000000000002 112.396 -166.79 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 68.66 68.08 0.3 Allowed 'General case' 0 CA--C 1.475 -1.908 0 N-CA-C 106.71 -1.589 . . . . 72.140000000000001 106.71 -178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.0 p -107.04 -164.66 1.0 Allowed 'General case' 0 N--CA 1.404 -2.758 0 N-CA-C 101.956 -3.35 . . . . 63.32 101.956 -172.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -44.84 -18.43 0.02 OUTLIER 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.152 0.981 . . . . 73.150000000000006 113.152 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 29.5 m -62.67 150.85 8.49 Favored 'Isoleucine or valine' 0 C--N 1.38 1.934 0 N-CA-C 106.06 -1.83 . . . . 74.340000000000003 106.06 172.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -78.77 -72.17 0.4 Allowed 'General case' 0 N--CA 1.435 -1.217 0 O-C-N 120.403 -1.436 . . . . 61.509999999999998 110.121 -169.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -69.9 -21.55 63.3 Favored 'General case' 0 C--N 1.355 0.845 0 C-N-CA 120.29 -0.564 . . . . 61.119999999999997 110.944 -160.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.27 59.99 1.7 Allowed Glycine 0 CA--C 1.484 -1.897 0 C-N-CA 119.554 -1.307 . . . . 74.150000000000006 110.168 164.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -143.18 179.41 20.73 Favored Glycine 0 CA--C 1.466 -2.994 0 N-CA-C 104.643 -3.383 . . . . 70.319999999999993 104.643 174.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.421 HD13 ' HA ' ' A' ' 36' ' ' ILE . 8.1 mm -82.17 127.91 39.2 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.428 0 N-CA-C 103.356 -2.831 . . . . 65.310000000000002 103.356 169.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -106.1 150.93 25.32 Favored 'General case' 0 CA--C 1.465 -2.291 0 N-CA-C 105.045 -2.206 . . . . 73.219999999999999 105.045 -178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.6 t -83.9 102.03 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.135 0 N-CA-C 106.053 -1.832 . . . . 73.409999999999997 106.053 174.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.47 -25.97 63.41 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 114.054 -1.43 . . . . 53.030000000000001 109.861 -176.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -173.62 161.38 3.95 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 104.642 -2.355 . . . . 71.120000000000005 104.642 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 15.2 t -116.88 132.57 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 103.134 -2.913 . . . . 54.020000000000003 103.134 177.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.412 HD13 ' H ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -82.35 151.0 65.1 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 105.964 -1.865 . . . . 63.539999999999999 105.964 175.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -77.95 177.47 8.76 Favored 'Trans proline' 0 CA--C 1.482 -2.084 0 N-CA-C 106.587 -2.12 . . . . 64.150000000000006 106.587 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 53.96 53.47 11.16 Favored 'General case' 0 N--CA 1.446 -0.643 0 O-C-N 124.031 0.832 . . . . 73.040000000000006 109.157 166.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -156.55 166.89 33.43 Favored Glycine 0 CA--C 1.473 -2.553 0 N-CA-C 105.447 -3.061 . . . . 55.450000000000003 105.447 -176.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.6 -50.74 70.07 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 108.508 -0.923 . . . . 51.25 108.508 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -53.35 -49.97 66.04 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 115.857 -0.61 . . . . 72.439999999999998 110.688 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -65.85 -53.72 36.12 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 109.71 -0.478 . . . . 73.209999999999994 109.71 178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.8 m -56.95 -29.12 62.87 Favored 'General case' 0 C--O 1.24 0.573 0 O-C-N 122.226 -0.296 . . . . 75.109999999999999 111.271 -172.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -88.55 -28.39 20.79 Favored 'General case' 0 C--O 1.215 -0.737 0 N-CA-C 107.867 -1.16 . . . . 74.400000000000006 107.867 -178.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 78.0 19.9 74.16 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.77 -0.932 . . . . 54.409999999999997 110.77 172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HB3' HG11 ' A' ' 10' ' ' VAL . 85.0 mtt-85 -104.55 7.1 35.11 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 117.753 0.777 . . . . 64.420000000000002 108.94 -176.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.471 ' O ' ' CD2' ' A' ' 54' ' ' HIS . 1.5 mp -127.56 136.57 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.183 -3.266 . . . . 71.5 102.183 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 53' ' ' ILE . 40.8 m170 -145.34 162.72 36.56 Favored 'General case' 0 CA--C 1.485 -1.544 0 N-CA-C 106.118 -1.808 . . . . 72.420000000000002 106.118 -177.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 43.9 mtmt -66.6 136.78 56.11 Favored 'General case' 0 CA--C 1.494 -1.198 0 N-CA-C 108.274 -1.01 . . . . 75.340000000000003 108.274 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.31 -29.25 12.31 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 108.338 -1.905 . . . . 51.030000000000001 108.338 170.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.92 155.03 41.0 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 106.91 -1.515 . . . . 72.329999999999998 106.91 -178.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 16.1 ptt180 -124.76 153.81 41.87 Favored 'General case' 0 N--CA 1.425 -1.714 0 N-CA-C 108.216 -1.031 . . . . 74.019999999999996 108.216 -174.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 t -92.59 132.32 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.788 0 N-CA-C 105.739 -1.949 . . . . 74.450000000000003 105.739 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.436 ' CD1' HG23 ' A' ' 7' ' ' ILE . 11.5 mt -95.36 -59.41 1.89 Allowed 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 106.942 -1.503 . . . . 74.230000000000004 106.942 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.88 150.69 51.37 Favored 'General case' 0 CA--C 1.478 -1.797 0 N-CA-C 106.788 -1.56 . . . . 34.539999999999999 106.788 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 95.6 t -124.52 131.07 73.25 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.283 0 N-CA-C 104.722 -2.325 . . . . 62.109999999999999 104.722 173.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 56.23 29.94 15.74 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-O 122.009 0.909 . . . . 75.430000000000007 109.489 175.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.39 -9.07 76.89 Favored Glycine 0 CA--C 1.489 -1.547 0 N-CA-C 108.573 -1.811 . . . . 50.100000000000001 108.573 173.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.9 t -87.9 115.6 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.142 0 N-CA-C 106.507 -1.664 . . . . 72.109999999999999 106.507 -178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.6 m -54.46 119.82 5.76 Favored 'General case' 0 C--N 1.347 0.474 0 N-CA-C 107.898 -1.149 . . . . 61.130000000000003 107.898 172.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -108.97 -15.17 14.42 Favored 'General case' 0 C--O 1.2 -1.541 0 N-CA-C 107.262 -1.385 . . . . 54.109999999999999 107.262 -163.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -58.43 122.33 13.06 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 108.505 -0.924 . . . . 73.400000000000006 108.505 178.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.78 -16.63 57.37 Favored Glycine 0 C--N 1.352 1.439 0 N-CA-C 108.635 -1.786 . . . . 60.420000000000002 108.635 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.39 151.45 29.37 Favored 'General case' 0 N--CA 1.436 -1.152 0 N-CA-C 106.606 -1.627 . . . . 75.310000000000002 106.606 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.547 ' HA ' HG22 ' A' ' 27' ' ' VAL . 68.6 p -79.96 179.78 7.41 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-O 121.202 0.525 . . . . 65.120000000000005 109.745 -170.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . 0.431 ' CE1' ' O ' ' A' ' 25' ' ' GLY . 14.4 m-70 -59.66 -51.31 70.35 Favored 'General case' 0 C--N 1.371 1.511 0 N-CA-C 107.589 -1.263 . . . . 62.32 107.589 176.23 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.6 ttmp? -55.7 -55.08 36.39 Favored 'General case' 0 C--N 1.369 1.416 0 N-CA-C 109.988 -0.375 . . . . 65.140000000000001 109.988 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -53.86 -43.95 69.97 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 109.775 -0.454 . . . . 63.509999999999998 109.775 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HB2' HG13 ' A' ' 36' ' ' ILE . . . -50.78 -54.49 23.11 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 122.663 0.385 . . . . 34.039999999999999 110.369 178.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.5 m -74.22 -37.64 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 C-N-CA 120.506 -0.478 . . . . 71.209999999999994 109.778 -174.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CYS . . . . . . . . . . . . . 82.9 m -62.71 -32.23 73.29 Favored 'General case' 0 N--CA 1.511 2.62 0 N-CA-C 106.305 -1.739 . . . . 73.010000000000005 106.305 -175.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.0 m -73.62 -40.69 63.6 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.357 -1.464 . . . . 71.150000000000006 108.195 -176.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 57.5 mt -62.5 -28.4 69.81 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 109.242 -0.651 . . . . 74.219999999999999 109.242 175.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.06 -58.04 3.34 Favored 'General case' 0 C--O 1.214 -0.787 0 N-CA-C 107.775 -1.194 . . . . 75.420000000000002 107.775 176.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 61.5 m-20 -68.58 43.32 0.04 OUTLIER 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 124.781 1.232 . . . . 55.539999999999999 112.212 -173.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.452 ' CG2' HG22 ' A' ' 86' ' ' VAL . 1.4 t -123.82 -174.61 3.02 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 102.942 -2.985 . . . . 72.099999999999994 102.942 172.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -98.34 -145.16 18.3 Favored Glycine 0 CA--C 1.49 -1.48 0 N-CA-C 107.7 -2.16 . . . . 53.340000000000003 107.7 -170.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -65.78 -55.49 16.93 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.46 -0.941 . . . . 62.039999999999999 108.46 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' ALA . 94.9 t -107.16 142.5 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 N-CA-C 106.04 -1.837 . . . . 55.030000000000001 106.04 -178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.452 HG22 ' CG2' ' A' ' 82' ' ' THR . 45.8 t -115.08 144.82 21.78 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.284 0 N-CA-C 105.634 -1.987 . . . . 62.439999999999998 105.634 -172.087 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -105.38 122.1 45.27 Favored 'General case' 0 CA--C 1.471 -2.074 0 N-CA-C 104.698 -2.334 . . . . 71.329999999999998 104.698 168.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.409 HD22 ' O ' ' A' ' 88' ' ' LEU . 0.0 OUTLIER -136.49 118.29 15.12 Favored 'General case' 0 N--CA 1.406 -2.665 0 N-CA-C 105.182 -2.155 . . . . 73.230000000000004 105.182 177.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 6.5 mp -83.94 143.62 29.71 Favored 'General case' 0 CA--C 1.462 -2.442 0 N-CA-C 106.624 -1.621 . . . . 73.129999999999995 106.624 -175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.624 HD21 HG22 ' A' ' 10' ' ' VAL . 0.1 OUTLIER -112.34 156.23 22.8 Favored 'General case' 0 CA--C 1.467 -2.249 0 N-CA-C 104.96 -2.237 . . . . 43.32 104.96 -179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -123.54 135.44 54.01 Favored 'General case' 0 N--CA 1.413 -2.31 0 N-CA-C 101.08 -3.674 . . . . 71.219999999999999 101.08 162.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -62.29 137.11 58.2 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 107.618 -1.252 . . . . 73.129999999999995 107.618 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -64.23 172.32 17.23 Favored Glycine 0 CA--C 1.464 -3.125 0 N-CA-C 110.233 -1.147 . . . . 64.519999999999996 110.233 -168.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -79.57 137.03 37.02 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 105.265 -2.124 . . . . 73.25 105.265 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.3 m -55.39 122.23 42.66 Favored Pre-proline 0 N--CA 1.442 -0.835 0 N-CA-C 107.686 -1.227 . . . . 72.349999999999994 107.686 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.22 161.96 40.6 Favored 'Trans proline' 0 CA--C 1.491 -1.657 0 C-N-CA 122.599 2.199 . . . . 75.310000000000002 109.237 -165.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.406 -2.673 0 N-CA-C 103.589 -2.745 . . . . 72.510000000000005 103.589 172.982 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' 33B . . . . . 0.436 ' O2 ' ' H5 ' ' A' ' 101' ' ' 33B . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_